GLP-1 Market
LLY $1169.60 ▼ -1.6% NVO $38.18 ▼ -0.2% PFE $27.82 ▼ -0.6% VKTX $27.73 ▼ -2.8% KLRA $10.00 ▼ -5.0% GPCR $25.67 ▼ -3.8% RHHBY $53.29 ▼ -1.4%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Blood samples

Company
Rigshospitalet, Denmark
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1269 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1269 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 9, 2026

Find a Clinical Trial Near Me

See recruiting studies for Blood samples and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00001352

    Fungal Infection Susceptibility

    National Institute of Allergy and Infectious Diseases (NIAID) 800 participants 1 site
    Other conditions: Cryptococcal Infection, Cryptococcal Pneumonia, Pulmonary Cryptococcosis, Cryptococcal Meningitis, Cryptococcosis
    View official trial listing →
  • Recruiting NCT NCT00001846

    Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use

    National Institutes of Health Clinical Center (CC) 5000 participants 1 site
    Other conditions: Blood Donors, Research Subjects, Apheresis
    View official trial listing →
  • Recruiting NCT NCT00018044

    Study of Mycobacterial Infections

    National Institute of Allergy and Infectious Diseases (NIAID) 1000 participants 1 site
    Other conditions: Mycobacterium Infections
    View official trial listing →
  • Recruiting NCT NCT00026884

    Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

    National Cancer Institute (NCI) 5950 participants 1 site
    Other conditions: Malignant Neoplasms, Hereditary Neoplastic Syndromes, Kidney Cancer, Renal Cancer, Bladder Cancer
    View official trial listing →
  • Recruiting NCT NCT00104325

    Cytapheresis of Volunteer Donors

    National Institute on Aging (NIA) 10000 participants 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT00230165

    The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.

    Rockefeller University 60 participants Est. completion 2030-06 1 site
    Other conditions: Glanzmann Thrombasthenia
    View official trial listing →
  • Recruiting NCT NCT00412594

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

    Not yet reported M.D. Anderson Cancer Center 150 participants Est. completion 2027-06-30 1 site
    Other conditions: Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia
    View official trial listing →
  • Recruiting NCT NCT00442195

    Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers

    National Heart, Lung, and Blood Institute (NHLBI) 1000 participants 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT00477100

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

    M.D. Anderson Cancer Center 1200 participants Est. completion 2030-04-30 10 sites
    Other conditions: Inflammatory Breast Carcinoma, Invasive Breast Carcinoma, Second Primary Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT00682032

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

    Not yet reported University of Louisville 300 participants Est. completion 2029-03 1 site
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT00692939

    Autologous Stem Cell Transplantation for Crohn's Disease

    Not yet reported, Not yet reported Paul Szabolcs 20 participants Est. completion 2027-12 2 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Recruiting NCT NCT00823563

    Evaluation of Patients With Non-obstructive Coronary Arteries

    Stanford University 2000 participants Est. completion 2047-06 1 site
    Other conditions: Chest Pain, Ischemia
    View official trial listing →
  • Recruiting NCT NCT01042379

    I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    Not yet reported QuantumLeap Healthcare Collaborative 5000 participants Est. completion 2031-12 42 sites
    Obstructive sleep apnea Other conditions: Breast Neoplasms, Breast Cancer, Breast Tumors, TNBC - Triple-Negative Breast Cancer, HER2-positive Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Hormone Receptor Negative Tumor, Early-stage Breast Cancer, Locally Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT01132859

    VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

    National Institute of Allergy and Infectious Diseases (NIAID) 500 participants 1 site
    Obstructive sleep apnea Other conditions: Immune System Processes, Blood Specimen Collection
    View official trial listing →
  • Recruiting NCT NCT01132885

    Defining the Brain Phenotype of Children With Williams Syndrome

    National Institute of Mental Health (NIMH) 415 participants 1 site
    Other conditions: Williams Syndrome, Duplication
    View official trial listing →
  • Recruiting NCT NCT01189786

    Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection

    Not yet reported Baylor College of Medicine 241 participants Est. completion 2027-11 2 sites
    Other conditions: Stem Cell Transplant, Allogeneic
    View official trial listing →
  • Recruiting NCT NCT01356290

    Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

    Not yet reported Medical University of Vienna 232 participants Est. completion 2030-04 22 sites
    Other conditions: Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor Recurrent
    View official trial listing →
  • Recruiting NCT NCT01397669

    Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection

    Not yet reported SEARCH Research Foundation 232 participants Est. completion 2031-02 1 site
    Other conditions: HIV-infection
    View official trial listing →
  • Recruiting NCT NCT01524211

    Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms

    Not yet reported Baptist Health South Florida 235 participants Est. completion 2032-01 1 site
    Other conditions: Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm
    View official trial listing →
  • Recruiting NCT NCT01624805

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 140 participants Est. completion 2029-06-30 1 site
    Other conditions: Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT01706692

    Swiss Dermatology Network of Targeted Therapies (SDNTT)

    Swiss Dermatology Network for Targeted Therapies 1121 participants Est. completion 2032-03-15 6 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Recruiting NCT NCT01731444

    Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

    Not yet reported University of Manitoba 24 participants Est. completion 2028-12-31 1 site
    Other conditions: Blood Loss, Surgical
    View official trial listing →
  • Recruiting NCT NCT01776398

    Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

    Weill Medical College of Cornell University 2000 participants Est. completion 2028-12 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD), Smoking, Smoking Cessation, Idiopathic Pulmonary Fibrosis (IPF), Rheumatoid Arthritis-Associated Interstitial Lung Disease, Scleroderma-Associated Interstitial Lung Disease (SSC-ILD)
    View official trial listing →
  • Recruiting NCT NCT01904188

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

    Michigan State University 2500 participants Est. completion 2032-07 2 sites
    Other conditions: Sepsis, Systemic Inflammatory Response Syndrome, Infection Mixed, Infection, Bacterial, Infection, Fungal, Infection, Coronavirus, Antibiotic Resistance Genes, Human Genome Analysis
    View official trial listing →
  • Recruiting NCT NCT01962415

    Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

    Not yet reported Paul Szabolcs 100 participants Est. completion 2027-11 1 site
    Other conditions: Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias, Inflammatory Conditions, Systemic Juvenile Idiopathic Arthritis (sJIA), Juvenile Rheumatoid Arthritis (JRA)
    View official trial listing →
  • Recruiting NCT NCT02090530

    Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

    Ohio State University Comprehensive Cancer Center 1000 participants Est. completion 2027-12-31 1 site
    Other conditions: Cancer
    View official trial listing →
  • Recruiting NCT NCT02155621

    Personalized Oncogenomics (POG) Program of British Columbia

    Not yet reported British Columbia Cancer Agency 5000 participants Est. completion 2026-03 1 site Stand-alone
    Other conditions: Metastatic Cancers, Advanced Cancers, Cancers That Cannot be Treated With Curative Intent
    View official trial listing →
  • Recruiting NCT NCT02172651

    Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

    Not yet reported Dana-Farber Cancer Institute 80 participants Est. completion 2027-06-30 1 site
    Other conditions: Stage, Colon Cancer, Stage I-III Colon Cancer, Stage IV Colon Cancer With Resectable Liver Metastases
    View official trial listing →
  • Recruiting NCT NCT02323581

    Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

    Not yet reported Darren Schneider, M.D. 520 participants Est. completion 2033-12 2 sites
    Other conditions: Aortic Aneurysm, Thoracoabdominal, Aortic Aneurysm, Thoracic, Aortic Dissection, Thoracoabdominal
    View official trial listing →
  • Recruiting NCT NCT02370199

    Peripheral Blood Flow Responses to Electromagnetic Energy

    Not yet reported University of Alabama at Birmingham 40 participants Est. completion 2027-12-31 1 site
    Other conditions: Exposure to Man-made Visible Light
    View official trial listing →
  • Recruiting NCT NCT02402244

    Project: Every Child for Younger Patients With Cancer

    Children's Oncology Group 75000 participants Est. completion 2030-12-31 279 sites
    Other conditions: Adrenal Gland Pheochromocytoma, Carcinoma In Situ, Central Nervous System Neoplasm, Childhood Immature Teratoma, Childhood Kidney Neoplasm, Childhood Langerhans Cell Histiocytosis, Childhood Mature Teratoma, Congenital Mesoblastic Nephroma, Desmoid Fibromatosis, Ganglioneuroma, Lymphoproliferative Disorder, Malignant Neoplasm, Malignant Solid Neoplasm, Melanocytic Neoplasm, Myeloproliferative Neoplasm, Neoplasm of Uncertain Malignant Potential, Neuroendocrine Neoplasm, Stromal Neoplasm
    View official trial listing →
  • Recruiting NCT NCT02438904

    Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

    Not yet reported M.D. Anderson Cancer Center 200 participants Est. completion 2027-05-01 1 site
    Other conditions: Blood And Marrow Transplantation
    View official trial listing →
  • Recruiting NCT NCT02442011

    Hematology Biobank: In Vitro Study of Blood Disorders

    Albert Einstein College of Medicine 2000 participants Est. completion 2030-01 1 site
    Other conditions: Hematological Disorders
    View official trial listing →
  • Recruiting NCT NCT02456974

    Antibiotic Dosing in Pediatric Intensive Care

    University Hospital, Ghent 640 participants Est. completion 2027-09-01 1 site
    Other conditions: Pharmacokinetics, Amoxicillin-clavulanate, Piperacillin-tazobactam, Vancomycin, Teicoplanin, Meropenem, Ciprofloxacin, Amikacin
    View official trial listing →
  • Recruiting NCT NCT02497534

    Biomarkers in Friedreich's Ataxia

    University of Florida 203 participants Est. completion 2030-06-03 1 site
    Other conditions: Friedreich's Ataxia
    View official trial listing →
  • Recruiting NCT NCT02530658

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

    St. Jude Children's Research Hospital 2500 participants Est. completion 2053-12-31 1 site
    Other conditions: Solid, Liquid, Central Nervous System Tumors
    View official trial listing →
  • Recruiting NCT NCT02534649

    Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

    Not yet reported Institut Bergonié 10000 participants Est. completion 2029-12 7 sites
    Other conditions: Solid Tumor, Hematological Malignancy
    View official trial listing →
  • Recruiting NCT NCT02570815

    Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer

    Not yet reported St. Joseph's Healthcare Hamilton 250 participants Est. completion 2026-12 1 site
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT02579967

    Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

    Not yet reported National Cancer Institute (NCI) 354 participants Est. completion 2036-12-31 2 sites
    Other conditions: Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases, Autoimmune Lymphoproliferative, Lymphoproliferative Disorders
    View official trial listing →
  • Recruiting NCT NCT02582021

    WISE CVD - Continuation (WISE HFpEF)

    Cedars-Sinai Medical Center 220 participants Est. completion 2030-02 1 site
    Cardiovascular disease Other conditions: Microvascular Coronary Dysfunction
    View official trial listing →
  • Recruiting NCT NCT02604563

    Aging, Geriatric Syndromes and Clonal Hematopoiesis

    Washington University School of Medicine 2000 participants Est. completion 2030-04-30 1 site
    Cardiovascular disease Other conditions: Geriatrics, Aged, Geriatric Syndromes
    View official trial listing →
  • Recruiting NCT NCT02608996

    Nesiritide in Hypertension

    Not yet reported, Not yet reported Oslo University Hospital 15 participants Est. completion 2030-12 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT02610179

    Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial

    Not yet reported Baylor College of Medicine 617 participants Est. completion 2027-03 1 site
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT02693535

    TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

    Not yet reported American Society of Clinical Oncology 4200 participants Est. completion 2028-12-31 181 sites
    Other conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT02851784

    Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

    Not yet reported, Not yet reported Chinese PLA General Hospital 80 participants Est. completion 2028-12-31 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT02972385

    Pharmacogenomics of Warfarin in Hispanics and Latinos

    University of Arizona 400 participants Est. completion 2026-09 1 site
    Other conditions: Thrombosis, Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT02996656

    Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery

    Not yet reported Université de Montréal 88 participants Est. completion 2026-12 1 site
    Other conditions: Propionibacterium Infection
    View official trial listing →
  • Recruiting NCT NCT03011814

    Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

    Not yet reported, Not yet reported City of Hope Medical Center 78 participants Est. completion 2030-04-14 4 sites
    Other conditions: Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides, Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Mycosis Fungoides, Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, Sezary Syndrome, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT03016806

    Umbilical Cord Blood Transplantation From Unrelated Donors

    University of Rochester 30 participants Est. completion 2027-06 1 site
    Other conditions: Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder, Metabolism Disorder, Aplastic Anemia, Myelodysplastic Syndromes, Chronic Leukemia, Lymphoma, Multiple Myeloma, Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT03022682

    Inflammation, Diabetes, Ethnicity and Obesity Cohort

    University of California, San Francisco 350 participants Est. completion 2029-12 1 site
    Other conditions: Obesity, Diabetes Mellitus, Pre Diabetes
    View official trial listing →
  • Recruiting NCT NCT03044509

    Diagnosis of Tuberculosis in Swiss Children

    University Children's Hospital Basel 190 participants Est. completion 2028-12 8 sites
    Other conditions: Tuberculosis, Mycobacterium Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT03099850

    Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

    M.D. Anderson Cancer Center 2345 participants Est. completion 2030-06-30 1 site
    Other conditions: Pancreatitis
    View official trial listing →
  • Recruiting NCT NCT03128034

    211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 75 participants Est. completion 2029-03-31 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Excess Blasts, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory Acute Myeloid Leukemia, Refractory Mixed Phenotype Acute Leukemia, Mixed Phenotype Acute Leukemia
    View official trial listing →
  • Recruiting NCT NCT03132129

    Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus

    University of Leicester 593 participants Est. completion 2029-10-31 1 site
    Type 2 diabetes Other conditions: Diabetic Cardiomyopathies
    View official trial listing →
  • Recruiting NCT NCT03150693

    Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

    Not yet reported Alliance for Clinical Trials in Oncology 303 participants Est. completion 2027-08 460 sites
    Other conditions: B Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT03153683

    Brain, Blood And Clot or Tissue Registry And Collaboration

    Justin Fraser 1000 participants Est. completion 2029-12-28 1 site
    Cardiovascular disease Other conditions: Cerebrovascular Disorders
    View official trial listing →
  • Recruiting NCT NCT03161652

    Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

    Not yet reported Carmen Clapp 120 participants Est. completion 2027-06 2 sites
    Other conditions: Diabetic Macular Edema, Diabetic Retinopathy
    View official trial listing →
  • Recruiting NCT NCT03174938

    The Swedish BioFINDER 2 Study

    Not yet reported Skane University Hospital 2950 participants Est. completion 2036-12 2 sites
    Other conditions: Dementia, Alzheimer Disease, Parkinson Disease, Lewy Body Disease, Parkinson-Dementia Syndrome, Frontotemporal Degeneration, Semantic Dementia, Progressive Nonfluent Aphasia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy, Mild Cognitive Impairment, ALS (Amyotrophic Lateral Sclerosis)
    View official trial listing →
  • Recruiting NCT NCT03199651

    Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 3584 participants Est. completion 2028-12-31 1 site
    Other conditions: Cigarette Smoker, Current Smoker, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT03203239

    Red Light Treatment in Peripheral Artery Disease

    Not yet reported University of Alabama at Birmingham 40 participants Est. completion 2028-12-31 1 site
    Alcohol use disorder Other conditions: Peripheral Artery Disease, Vasodilation
    View official trial listing →
  • Recruiting NCT NCT03224949

    Comparison of ALD, NASH, and Healthy Control Patients

    The Cleveland Clinic 500 participants Est. completion 2028-09-30 1 site
    Other conditions: ALD - Alcoholic Liver Disease
    View official trial listing →
  • Recruiting NCT NCT03231241

    Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics

    Stanford University 700 participants Est. completion 2026-09-01 1 site
    Other conditions: Chronic Daily Headache, Chronic Migraine
    View official trial listing →
  • Recruiting NCT NCT03250091

    Surveillance of Patients With Precancerous Lesions of the Stomach

    University of Latvia 2000 participants Est. completion 2027-12 1 site
    Other conditions: Gastric Cancer, Gastric Intestinal Metaplasia, Gastric Atrophy, Gastric Dysplasia
    View official trial listing →
  • Recruiting NCT NCT03259867

    Combination of TATE and PD-1 Inhibitor in Liver Cancer

    Not yet reported Teclison Ltd. 54 participants Est. completion 2027-06-30 3 sites
    Other conditions: Hepatocellular Carcinoma, Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT03287193

    Identification of the Molecular and/or Pathophysiological Bases of Rare Diseases of Genetic Origin (or Rare Forms of Frequent Diseases Suspected of Being of Genetic Origin).

    Centre Hospitalier Universitaire Dijon 850 participants Est. completion 2027-12 1 site
    Other conditions: Rare Diseases of Genetic Origin, Rare Forms of Common Diseases Suspected of Being Genetic in Origin
    View official trial listing →
  • Recruiting NCT NCT03302195

    Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery

    Not yet reported Laval University 410 participants Est. completion 2027-12-31 1 site
    Other conditions: Cardiopulmonary Bypass, Obesity
    View official trial listing →
  • Recruiting NCT NCT03321201

    Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

    Not yet reported University of Split, School of Medicine 164 participants Est. completion 2026-12-31 1 site
    Other conditions: Pterygium of Conjunctiva and Cornea
    View official trial listing →
  • Recruiting NCT NCT03357536

    Genetic Susceptibility to Listeriosis

    Not yet reported Institut Pasteur 100 participants Est. completion 2027-11-30 1 site
    Other conditions: Listeriosis
    View official trial listing →
  • Recruiting NCT NCT03369821

    EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

    University of Exeter 300 participants Est. completion 2028-11-30 4 sites
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT03384238

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

    Not yet reported, Not yet reported George Poultsides 27 participants Est. completion 2027-09 1 site
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT03401294

    Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.

    Not yet reported University of Saskatchewan 32 participants Est. completion 2026-12-31 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT03408964

    Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients

    Oncology Institute of Southern Switzerland 600 participants Est. completion 2028-12-31 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT03449264

    Development of Clinical and Biological Database

    Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 4000 participants Est. completion 2037-11 1 site Stand-alone
    Other conditions: Digestive Cancer, Gynecologic Cancer, Breast Cancer, Sarcoma
    View official trial listing →
  • Recruiting NCT NCT03457493

    The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

    Not yet reported, Not yet reported University of Alabama at Birmingham 205 participants Est. completion 2028-06 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT03500731

    Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

    Not yet reported, Not yet reported Paul Szabolcs 8 participants Est. completion 2028-12 2 sites
    Other conditions: Idiopathic Pulmonary Fibrosis, Emphysema or COPD
    View official trial listing →
  • Recruiting NCT NCT03518099

    Searching Biomarkers of Acute Intestinal Ischemic Injuries

    Not yet reported Assistance Publique - Hôpitaux de Paris 556 participants Est. completion 2028-07-30 1 site
    Other conditions: Acute Mesenteric Ischemia
    View official trial listing →
  • Recruiting NCT NCT03536793

    Tumour Regulatory Molecules in Early Pancreatic Cancer Detection

    Hull University Teaching Hospitals NHS Trust 180 participants Est. completion 2029-02-28 1 site
    Other conditions: Cancer of Pancreas, Pancreas Cyst
    View official trial listing →
  • Recruiting NCT NCT03541889

    REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

    Not yet reported University of Oklahoma 50 participants Est. completion 2027-11 4 sites
    Other conditions: Primary Graft Failure
    View official trial listing →
  • Recruiting NCT NCT03547856

    A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"

    Yan Li 10000 participants Est. completion 2026-12-30 1 site
    Cardiovascular disease Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT03586518

    Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients

    University of Leicester 9 participants Est. completion 2025-12-31 1 site
    Other conditions: End Stage Kidney Disease, Fibrosis Myocardial
    View official trial listing →
  • Recruiting NCT NCT03589729

    Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

    Not yet reported M.D. Anderson Cancer Center 100 participants Est. completion 2027-12-31 1 site
    Other conditions: Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome, Myeloid Sarcoma, Myeloproliferative Neoplasm, Philadelphia Chromosome Positive
    View official trial listing →
  • Recruiting NCT NCT03611816

    Biological Bank for Atrial Fibrillation and Stroke

    Hospices Civils de Lyon 1000 participants Est. completion 2033-04-23 5 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Recruiting NCT NCT03612310

    Developing Protocols for Modelling of Genetic Diseases Using Induced Pluripotent Stem Cells

    Sapna Vyas 3000 participants Est. completion 2028-07-01 1 site
    Other conditions: Genetic Disease
    View official trial listing →
  • Recruiting NCT NCT03617939

    A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

    University of Colorado, Denver 20000 participants Est. completion 2037-09 6 sites
    Other conditions: Cancer Risk
    View official trial listing →
  • Recruiting NCT NCT03653338

    T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

    Not yet reported, Not yet reported Paul Szabolcs 5 participants Est. completion 2028-08-01 1 site
    Other conditions: Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia
    View official trial listing →
  • Recruiting NCT NCT03671889

    ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

    Not yet reported InSightec 50 participants Est. completion 2030-01 10 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT03694626

    Objectively Diagnose and Monitor Treatment of Light Sensitivity

    Not yet reported Randy Kardon 120 participants Est. completion 2028-01-01 1 site
    Other conditions: Photophobia, Traumatic Brain Injury, Migraine
    View official trial listing →
  • Recruiting NCT NCT03704766

    Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

    Not yet reported Hospital for Special Surgery, New York 442 participants Est. completion 2027-01 3 sites
    Other conditions: Joint Infection, Infection of Hip Joint (Disorder), Infection of Shoulder Joint, Septic Arthritis
    View official trial listing →
  • Recruiting NCT NCT03715933

    Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    Not yet reported Inhibrx Biosciences, Inc 411 participants Est. completion 2029-06 37 sites
    Other conditions: Ewing Sarcoma, Colorectal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT03720522

    The Bern Heart and Brain Interaction Study - Interaction Between Brain and Heart in Acute Ischemic Stroke

    Insel Gruppe AG, University Hospital Bern 220 participants Est. completion 2026-12-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT03750227

    Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

    Not yet reported Mayo Clinic 140 participants Est. completion 2030-11-08 4 sites
    Other conditions: Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Brain
    View official trial listing →
  • Recruiting NCT NCT03838926

    Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

    Not yet reported Vanda Pharmaceuticals 42 participants Est. completion 2027-12 11 sites
    Other conditions: Relapsed or Refractory Hematologic Malignancies
    View official trial listing →
  • Recruiting NCT NCT03893929

    The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population

    Chinese University of Hong Kong 5000 participants Est. completion 2025-12-31 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT03909477

    Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking

    Western University, Canada 200 participants Est. completion 2030-12-01 1 site
    Other conditions: Cannabis Use, Cannabis Smoking, Marijuana Smoking, Marijuana Usage
    View official trial listing →
  • Recruiting NCT NCT03916302

    Pulmonary Embolism WArsaw REgistry

    Medical University of Warsaw 1500 participants Est. completion 2028-12-31 1 site
    Other conditions: Acute Pulmonary Embolism
    View official trial listing →
  • Recruiting NCT NCT03938701

    Fluorescence Imaging of IBD and RA Using Adalimumab-800CW

    Not yet reported University Medical Center Groningen 36 participants Est. completion 2026-08-01 1 site
    Other conditions: IBD, Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT03959904

    The Impact of Abdominal Wall Closure Technique on Incidence of Incisional Hernia in Kidney Transplantation

    Not yet reported Manchester University NHS Foundation Trust 50 participants Est. completion 2026-06-30 1 site
    Other conditions: Surgery--Complications
    View official trial listing →
  • Recruiting NCT NCT03976245

    Advanced Therapeutics in Rheumatoid Arthritis (RA)

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 144 participants Est. completion 2025-03 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT03976999

    Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

    Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 300 participants Est. completion 2032-07 1 site Stand-alone
    Other conditions: Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms
    View official trial listing →
  • Recruiting NCT NCT03991897

    Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?

    Not yet reported Universitaire Ziekenhuizen KU Leuven 81 participants Est. completion 2028-08-01 1 site
    Other conditions: Lymphedema, Ketogenic Dieting, Ketone Ester Supplement
    View official trial listing →
  • Recruiting NCT NCT03997253

    Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management

    Not yet reported University Hospital, Limoges 430 participants Est. completion 2027-06 4 sites
    Other conditions: Organ Transplantation
    View official trial listing →
  • Recruiting NCT NCT04002947

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 132 participants Est. completion 2031-03-31 1 site
    Other conditions: Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, NHL
    View official trial listing →
  • Recruiting NCT NCT04018118

    Natural History of Hypereosinophilia and Hypereosinophilic Syndromes

    University Hospital, Lille 600 participants Est. completion 2031-05 1 site
    Other conditions: Eosinophilia, Hypereosinophilic Syndrome
    View official trial listing →
  • Recruiting NCT NCT04023019

    Treatment of Hemophilia A Patients With FVIII Inhibitors

    Emory University 120 participants Est. completion 2029-06 2 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Recruiting NCT NCT04026776

    Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm

    Not yet reported Wake Forest University Health Sciences 120 participants Est. completion 2026-12 1 site
    Other conditions: Salt; Excess, Blood Pressure Disorders
    View official trial listing →
  • Recruiting NCT NCT04052048

    Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

    Immunis.AI 2000 participants Est. completion 2029-09-30 1 site
    Other conditions: Prostate Cancer Aggressiveness
    View official trial listing →
  • Recruiting NCT NCT04053439

    Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

    Sunnybrook Health Sciences Centre 188 participants Est. completion 2026-09 1 site
    Other conditions: Lymphoma, Chemotherapeutic Toxicity
    View official trial listing →
  • Recruiting NCT NCT04074720

    Prospective Breast Cancer Biospecimen Collection

    Thomas Jefferson University 200 participants Est. completion 2028-07-01 1 site
    Other conditions: Breast Cancer, Invasive Breast Cancer, Carcinoma in Situ of the Breast
    View official trial listing →
  • Recruiting NCT NCT04079361

    Early PrEgnancy Complications Testing

    Not yet reported University Hospital, Ghent 250 participants Est. completion 2024-12-31 1 site
    Other conditions: Pregnancy Complications
    View official trial listing →
  • Recruiting NCT NCT04083183

    Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2028-01-09 1 site
    Other conditions: Non-Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04088370

    Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis

    The Cleveland Clinic 30 participants Est. completion 2028-12-31 1 site
    Other conditions: Alcoholic Hepatitis
    View official trial listing →
  • Recruiting NCT NCT04088422

    Cell Free DNA in Mature B-cell Lymphoma

    Ruijin Hospital 320 participants Est. completion 2026-12 1 site
    Other conditions: Mature B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04106830

    Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

    Beijing Tiantan Hospital 1000 participants Est. completion 2028-12-31 1 site
    Other conditions: NMO Spectrum Disorder, MRI, Multiple Sclerosis, MOGAD
    View official trial listing →
  • Recruiting NCT NCT04113759

    Blood Flow Restriction Following Hip Arthroscopy

    Not yet reported Rush University Medical Center 56 participants Est. completion 2028-01 1 site
    Other conditions: Labral Tear, Glenoid, Femoral Acetabular Impingement
    View official trial listing →
  • Recruiting NCT NCT04124029

    Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

    VA Office of Research and Development 800 participants Est. completion 2026-12-31 1 site
    Other conditions: Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury, Mild Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT04137549

    Registry Study on "Control Nocturnal Hypertension to Reach the Target "

    Shanghai Institute of Hypertension 4500 participants Est. completion 2026-12-31 1 site
    Other conditions: Nocturnal Hypertension
    View official trial listing →
  • Recruiting NCT NCT04143724

    Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

    Not yet reported Celgene 99 participants Est. completion 2035-08-31 26 sites
    Other conditions: Beta-Thalassemia
    View official trial listing →
  • Recruiting NCT NCT04144023

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

    Not yet reported Mayo Clinic 43 participants Est. completion 2027-12-31 2 sites Stand-alone
    Other conditions: Breast Ductal Carcinoma In Situ
    View official trial listing →
  • Recruiting NCT NCT04150640

    Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

    Not yet reported University of Wisconsin, Madison 52 participants Est. completion 2028-05 1 site
    Other conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT04154332

    Exosome Cargo From Preeclampsia Patients

    University of Alabama at Birmingham 64 participants Est. completion 2031-12-15 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Recruiting NCT NCT04163614

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

    Not yet reported VA Office of Research and Development 69 participants Est. completion 2026-10-01 1 site
    Other conditions: End Stage Renal Disease, Hypertension, Extracellular Volume Overload, Intradialytic Hypotension
    View official trial listing →
  • Recruiting NCT NCT04165590

    Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

    Not yet reported, Not yet reported CAS Lamvac Biotech Co., Ltd. 60 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: Advanced Malignant Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT04165798

    KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

    Merck Sharp & Dohme LLC 1065 participants Est. completion 2032-02-13 47 sites
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Recruiting NCT NCT04168502

    Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML

    Not yet reported Gruppo Italiano Malattie EMatologiche dell'Adulto 414 participants Est. completion 2027-04 48 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT04170244

    Skin Microbial Ecology in Atopic Dermatitis

    University of Rochester 240 participants Est. completion 2027-04-01 1 site
    Other conditions: Atopic Dermatitis, Psoriasis, Healthy
    View official trial listing →
  • Recruiting NCT NCT04196413

    GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

    Not yet reported Stanford University 97 participants Est. completion 2043-07-31 1 site
    Other conditions: Glioma of Spinal Cord, Glioma of Brainstem
    View official trial listing →
  • Recruiting NCT NCT04197648

    Effects of Exercise on Thoracic Aneurysms

    Not yet reported Laval University 30 participants Est. completion 2027-04 2 sites
    Other conditions: Thoracic Aortic Aneurysm
    View official trial listing →
  • Recruiting NCT NCT04201600

    Glucose Variability and Cognition in Prediabetes

    University of Maryland, Baltimore 30 participants Est. completion 2026-12-31 1 site
    Prediabetes Other conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus), Cognitive Decline, Functional Status, Aging, Depression
    View official trial listing →
  • Recruiting NCT NCT04226612

    Association of Inpatient Blood Pressure Levels With In-hospital Adverse Events(APPLE Study)

    Guangdong Provincial People's Hospital 100000 participants Est. completion 2030-12-31 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT04261192

    Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies

    Centre Francois Baclesse 120 participants Est. completion 2032-02 2 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Recruiting NCT NCT04269902

    Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

    Not yet reported National Cancer Institute (NCI) 247 participants Est. completion 2028-10-01 632 sites Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04288635

    Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study

    University Hospital, Angers 55 participants Est. completion 2027-08-09 1 site
    Other conditions: Septic Shock, Multiple Organ Failure
    View official trial listing →
  • Recruiting NCT NCT04300998

    Study of CAR-T Therapy in Older Patients

    Memorial Sloan Kettering Cancer Center 154 participants Est. completion 2027-03-04 1 site
    Other conditions: Lymphoma, Refractory B-Cell Lymphoma, Lymphoma, B-Cell, DLBCL NOS, High-grade B-cell Lymphoma, Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT04304625

    TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA

    Not yet reported University Hospital, Bordeaux 1380 participants Est. completion 2027-09 1 site
    Other conditions: Postpartum Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT04304820

    Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 80 participants Est. completion 2033-12-18 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT04319627

    Statins for Venous Event Reduction in Patients With Venous Thromboembolism

    Not yet reported Ottawa Hospital Research Institute 2700 participants Est. completion 2028-04 31 sites
    Other conditions: Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome
    View official trial listing →
  • Recruiting NCT NCT04326218

    Immunopathological Analysis in a French National Cohort of Membranous Nephropathy

    Not yet reported Centre Hospitalier Universitaire de Nice 400 participants Est. completion 2031-12-03 1 site
    Other conditions: Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04334031

    Deployment o the Multidisciplinary Prospective Cohort Imminent

    Not yet reported University Hospital, Lille 2200 participants Est. completion 2031-07-21 1 site Stand-alone
    Other conditions: Chronic Inflammatory Disease, Angioedema, Severe Asthma, Lupus, Atopic Dermatitis, Psoriatic Arthritis, Multiple Sclerosis, Systemic Sclerosis, Behçet Disease
    View official trial listing →
  • Recruiting NCT NCT04372108

    A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

    Janssen Scientific Affairs, LLC 1536 participants Est. completion 2030-08-30 1 site
    Other conditions: Crohn Disease, Colitis, Ulcerative
    View official trial listing →
  • Recruiting NCT NCT04373564

    Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

    Not yet reported Guerbet 2076 participants Est. completion 2028-12-31 51 sites Stand-alone
    Other conditions: Motor Function, Cognitive Function, Contrast Media
    View official trial listing →
  • Recruiting NCT NCT04390035

    BFRT in Adolescents After ACL Reconstruction

    Not yet reported Children's Healthcare of Atlanta 120 participants Est. completion 2023-04 1 site
    Other conditions: Anterior Cruciate Ligament Rupture
    View official trial listing →
  • Recruiting NCT NCT04390308

    Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation?

    ART Fertility Clinics LLC 70 participants Est. completion 2025-12-31 1 site
    Other conditions: Infertility, Female, Premature Ovarian Failure, IVF
    View official trial listing →
  • Recruiting NCT NCT04435834

    Individual Cerebral Hemodynamic Oxygenation Relationships

    Not yet reported Matthew Borzage 30 participants Est. completion 2026-09-10 1 site
    Other conditions: Anesthesia, Anesthesia; Reaction
    View official trial listing →
  • Recruiting NCT NCT04439370

    Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women

    University of Minnesota 160 participants Est. completion 2026-12-30 1 site
    Other conditions: Hypertension, Menopause, Premature, Menopause, Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT04439708

    Biomarkers and Choroidal Neovascularization

    Institut National de la Santé Et de la Recherche Médicale, France 250 participants Est. completion 2027-07-06 2 sites
    Other conditions: Choroidal Neovascularization, Mineralocorticoid Excess
    View official trial listing →
  • Recruiting NCT NCT04442451

    Mechanisms of Fatigability With Diabetes

    Not yet reported University of Michigan 80 participants Est. completion 2027-08-31 1 site
    PrediabetesType 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT04442516

    Cisplatin Induced Kidney Toxicity

    The Hospital for Sick Children 600 participants Est. completion 2028-12-31 1 site
    Other conditions: Acute Kidney Injury, Cancer
    View official trial listing →
  • Recruiting NCT NCT04452162

    Physiologic MR Imaging of Salivary Gland Tumors

    Not yet reported Abramson Cancer Center at Penn Medicine 30 participants Est. completion 2026-06 1 site
    Other conditions: Salivary Gland Tumor
    View official trial listing →
  • Recruiting NCT NCT04459065

    Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery

    Not yet reported, Not yet reported University of Saskatchewan 36 participants Est. completion 2026-10 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT04466852

    Brazilian Heart Insufficiency With Telemedicine

    Not yet reported University Hospital Bispebjerg and Frederiksberg 720 participants Est. completion 2025-12-31 2 sites
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04472767

    Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

    Not yet reported University of California, Irvine 35 participants Est. completion 2027-09-01 1 site
    Other conditions: Hepatocellular Carcinoma, HCC
    View official trial listing →
  • Recruiting NCT NCT04475640

    Cancer Genetic Testing in Ethnic Populations

    Not yet reported Mayo Clinic 1800 participants Est. completion 2028-10-15 2 sites
    Other conditions: Breast Carcinoma, Carcinoma of Unknown Primary, Central Nervous System Carcinoma, Digestive System Carcinoma, Genitourinary System Carcinoma, Head and Neck Carcinoma, Malignant Brain Neoplasm, Malignant Female Reproductive System Neoplasm, Malignant Musculoskeletal Neoplasm, Malignant Solid Neoplasm, Skin Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04476901

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

    Not yet reported Joshua M Hare 136 participants Est. completion 2027-04 4 sites
    Other conditions: Non-ischemic Dilated Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT04478409

    Characterization of a Functional Test for Mediterranean Family Fever Screening - 2

    Hospices Civils de Lyon 160 participants Est. completion 2029-07 8 sites
    Other conditions: Familial Mediterranean Fever, MEFV Gene Mutation
    View official trial listing →
  • Recruiting NCT NCT04504604

    TCF-001 TRACK (Target Rare Cancer Knowledge) Study

    Not yet reported TargetCancer Foundation 400 participants Est. completion 2028-12 1 site
    Other conditions: Rare Cancers, Cholangiocarcinoma, Cancer of Unknown Primary Site
    View official trial listing →
  • Recruiting NCT NCT04514965

    Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)

    University of Aarhus 100 participants Est. completion 2026-09 2 sites
    Other conditions: Primary Biliary Cirrhosis
    View official trial listing →
  • Recruiting NCT NCT04517656

    Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 40 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Malignant Hemopathy
    View official trial listing →
  • Recruiting NCT NCT04520672

    Circulating Tumor Cells (CTC) in Cancer

    University Hospital, Basel, Switzerland 3000 participants Est. completion 2030-08 2 sites
    Other conditions: Cancer
    View official trial listing →
  • Recruiting NCT NCT04545502

    PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

    Vascutek Ltd. 2000 participants Est. completion 2037-01 30 sites
    Other conditions: Aneurysm, Dissection, Aortic Root Aneurysm, Aortic Root Dissection, Carotid Artery Injuries, Aortic Arch, Bypass Extremity Graft, Occlusive Vascular Disease, Aortic Diseases
    View official trial listing →
  • Recruiting NCT NCT04558450

    Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)

    Not yet reported Assistance Publique - Hôpitaux de Paris 360 participants Est. completion 2033-03 3 sites
    Other conditions: Covid19, Arterial Stiffness, Endothelial Dysfunction, Diastolic Dysfunction
    View official trial listing →
  • Recruiting NCT NCT04573231

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

    Not yet reported University of Wisconsin, Madison 13 participants Est. completion 2026-08 1 site
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04575363

    RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer

    Not yet reported CHU de Reims 90 participants Est. completion 2027-10-18 1 site
    Other conditions: Pancreatic Ductal Adenocarcinoma (PDAC)
    View official trial listing →
  • Recruiting NCT NCT04608630

    Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

    Not yet reported Australian and New Zealand Intensive Care Research Centre 450 participants Est. completion 2027-02-28 22 sites
    Other conditions: Critical Illness, Osteoporosis
    View official trial listing →
  • Recruiting NCT NCT04616313

    Novel Pulmonary Imaging of Lung Structure and Function in E-cigarette Smokers

    Western University, Canada 150 participants Est. completion 2027-12 1 site
    Other conditions: E Cigarette Use
    View official trial listing →
  • Recruiting NCT NCT04638725

    Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer

    Centre Paul Strauss 9000 participants Est. completion 2033-12-15 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04639622

    GENetic Fronto Temporal Dementia Initiative in Lille

    Not yet reported University Hospital, Lille 20 participants Est. completion 2027-04-23 1 site
    Other conditions: Frontotemporal Dementia
    View official trial listing →
  • Recruiting NCT NCT04641416

    Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps

    Thomas Schlöglhofer, PhD, MSc 60 participants Est. completion 2026-12-30 1 site
    Heart failure Other conditions: Cardiomyopathies, Mechanical Circulatory Support
    View official trial listing →
  • Recruiting NCT NCT04643106

    Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function

    Not yet reported Seoul National University Hospital 90 participants Est. completion 2026-12-31 2 sites
    Other conditions: Benign Ovarian Cyst
    View official trial listing →
  • Recruiting NCT NCT04656184

    A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment

    Not yet reported Assistance Publique - Hôpitaux de Paris 84 participants Est. completion 2027-03 1 site
    Other conditions: Kawasaki Disease
    View official trial listing →
  • Recruiting NCT NCT04662658

    Hyperpolarized Xenon-129 MR Imaging of the Lung

    Not yet reported, Not yet reported University of Virginia 24 participants Est. completion 2025-12 1 site
    Other conditions: E-Cig Use
    View official trial listing →
  • Recruiting NCT NCT04663750

    Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

    Not yet reported King's College Hospital NHS Trust 210 participants Est. completion 2028-12 42 sites
    Other conditions: Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT04680442

    Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

    Not yet reported Population Health Research Institute 130 participants Est. completion 2026-06-30 8 sites
    Heart failure Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04684368

    A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

    Not yet reported Children's Oncology Group 160 participants Est. completion 2029-12-21 170 sites Stand-alone
    Other conditions: Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma, Malignant Teratoma, Mixed Germ Cell Tumor, Pineal Region Germ Cell Tumor, Pineal Region Immature Teratoma, Pineal Region Yolk Sac Tumor, Suprasellar Germ Cell Tumor
    View official trial listing →
  • Recruiting NCT NCT04700358

    Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis

    University Hospital of Cologne 75 participants Est. completion 2027-12-31 1 site
    Other conditions: Pulmonary Cystic Fibrosis, Neutralizing Antibodies
    View official trial listing →
  • Recruiting NCT NCT04703244

    Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

    Mayo Clinic 999 participants Est. completion 2042-01-15 1 site
    Other conditions: Breast Cancer, Residual
    View official trial listing →
  • Recruiting NCT NCT04720339

    Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.

    Not yet reported University Hospital, Strasbourg, France 250 participants Est. completion 2027-10-27 8 sites
    Other conditions: NSCLC, IMMUNOTHERAPY, QUANTIFICATION OF CELL-FREE DNA
    View official trial listing →
  • Recruiting NCT NCT04722835

    Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

    University of California, San Francisco 40 participants Est. completion 2030-12-31 3 sites
    Other conditions: Copd, Smoking, Tobacco Use
    View official trial listing →
  • Recruiting NCT NCT04724941

    Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study

    University Hospital Schleswig-Holstein 2000 participants Est. completion 2027-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT04731246

    Video-oculography and Parkinson's Disease

    Not yet reported Association de Recherche Bibliographique pour les Neurosciences 30 participants Est. completion 2032-01 1 site
    Other conditions: Parkinson Disease, Idiopathic
    View official trial listing →
  • Recruiting NCT NCT04739072

    Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

    M.D. Anderson Cancer Center 1000 participants Est. completion 2028-12-31 10 sites
    Other conditions: Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8, Stage IIB Colorectal Cancer AJCC v8, Stage IIC Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v6, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT04742608

    Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

    Jonsson Comprehensive Cancer Center 250 participants Est. completion 2027-02-01 1 site
    Other conditions: Thyroid Gland Carcinoma, Thyroid Gland Nodule
    View official trial listing →
  • Recruiting NCT NCT04743479

    Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

    Changhai Hospital 5000 participants Est. completion 2030-12-30 1 site
    Other conditions: Pancreatic Cancer, Diabetes, Familial Pancreatic Cancer, Pancreatic Cystic Neoplasm, Chronic Pancreatitis, Hereditary Pancreatitis
    View official trial listing →
  • Recruiting NCT NCT04765865

    Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program

    Washington University School of Medicine 1350 participants Est. completion 2027-05-01 3 sites
    Other conditions: Dietary Sources of Sodium, Population Sodium Intake
    View official trial listing →
  • Recruiting NCT NCT04766866

    sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 9132 participants Est. completion 2026-12-31 21 sites
    Other conditions: Preeclampsia, Intrauterine Growth Restriction, Maternal Hypertension, Neonatal Outcome, Perinatal Death
    View official trial listing →
  • Recruiting NCT NCT04783597

    Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies

    McGill University Health Centre/Research Institute of the McGill University Health Centre 2400 participants Est. completion 2027-01 1 site
    Other conditions: High Risk Pregnancy, Arterial Stiffness, Pre-Eclampsia
    View official trial listing →
  • Recruiting NCT NCT04791540

    Sarcopenia and Nutritional Status in a Rehabilitation Setting

    Fondazione Don Carlo Gnocchi ETS 30 participants Est. completion 2025-12-31 1 site
    Other conditions: Sarcopenia
    View official trial listing →
  • Recruiting NCT NCT04792554

    Singapore Perioperative Ageing Study (Sing-PAS)

    National University Hospital, Singapore 600 participants Est. completion 2026-12 2 sites
    Other conditions: Postoperative Delirium, Aging, Myocardial Injury
    View official trial listing →
  • Recruiting NCT NCT04802759

    A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 316 participants Est. completion 2029-05-30 32 sites
    Other conditions: Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04816227

    Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

    Institut National de la Santé Et de la Recherche Médicale, France 180 participants Est. completion 2027-09 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Recruiting NCT NCT04831957

    Hypothyroidism After the TAVI Procedure in Elderly Patients

    Not yet reported Universitair Ziekenhuis Brussel 20 participants Est. completion 2050-12-31 1 site
    Other conditions: Hypothyroidism, TAVI
    View official trial listing →
  • Recruiting NCT NCT04840602

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

    Not yet reported National Cancer Institute (NCI) 92 participants Est. completion 2028-03-31 145 sites
    Other conditions: Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Recruiting NCT NCT04843371

    PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

    Tulane University 500 participants Est. completion 2026-12 3 sites
    Other conditions: Valvular Heart Disease, Pericardial Disease, Cardiomyopathies
    View official trial listing →
  • Recruiting NCT NCT04848064

    Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

    Not yet reported John Reneau 12 participants Est. completion 2027-01-30 1 site
    Other conditions: Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell Leukemia/Lymphoma, Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04859218

    Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?

    Not yet reported McMaster University 30 participants Est. completion 2025-12 1 site
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT04869098

    Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy)

    Not yet reported University of Adelaide 30 participants Est. completion 2026-07-31 1 site
    Type 2 diabetes Other conditions: Shift-work Disorder
    View official trial listing →
  • Recruiting NCT NCT04870944

    CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

    Not yet reported, Not yet reported Children's Oncology Group 63 participants Est. completion 2026-12-31 35 sites Stand-alone
    Other conditions: Diffuse Midline Glioma, H3 K27-Altered, Metastatic Malignant Neoplasm in the Central Nervous System, Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Diffuse Midline Glioma, H3 K27-Altered, Recurrent Lymphoma, Recurrent Malignant Solid Neoplasm, Recurrent Primary Malignant Central Nervous System Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Primary Malignant Central Nervous System Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04883502

    Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs

    Direction Centrale du Service de Santé des Armées 80 participants Est. completion 2028-04 2 sites
    Other conditions: Bone Loss
    View official trial listing →
  • Recruiting NCT NCT04896281

    Phenylalanine-free Diet for Patients With Secondary Hyperphenylalaninemia in ICU

    Not yet reported Chang Gung Memorial Hospital 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Non-Phenylketonuric Hyperphenylalaninemia
    View official trial listing →
  • Recruiting NCT NCT04900623

    Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

    Not yet reported Jonathan Schoenfeld, MD, MPH 145 participants Est. completion 2032-06-01 2 sites
    Other conditions: HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage, HPV-Related Squamous Cell Carcinoma, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage, HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Pathologic Stage
    View official trial listing →
  • Recruiting NCT NCT04900818

    Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

    Not yet reported I-Mab Biopharma US Limited 330 participants Est. completion 2027-12 21 sites
    Other conditions: Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC)
    View official trial listing →
  • Recruiting NCT NCT04910841

    Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine

    Not yet reported Centre Hospitalier Universitaire de Nice 55 participants Est. completion 2026-09 1 site
    Other conditions: Hyperglycemia, Hypotension, Shock, Septic
    View official trial listing →
  • Recruiting NCT NCT04912518

    Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

    Not yet reported Harbin Medical University 250 participants Est. completion 2025-12 9 sites
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention, Cardioprotection
    View official trial listing →
  • Recruiting NCT NCT04912765

    Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC

    Not yet reported National Cancer Centre, Singapore 60 participants Est. completion 2027-06 1 site
    Other conditions: Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer, Colorectal Carcinoma, Liver Metastases
    View official trial listing →
  • Recruiting NCT NCT04923958

    Rapid Research in Diagnostics Development for TB Network

    Not yet reported University of California, San Francisco 26436 participants Est. completion 2031-05-31 16 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT04927429

    Technical Development of Cardiovascular Magnetic Resonance Imaging

    National Heart, Lung, and Blood Institute (NHLBI) 3400 participants Est. completion 2031-12-31 2 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT04931160

    B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome

    Not yet reported University Hospital, Brest 1000 participants Est. completion 2035-02-10 1 site
    Other conditions: Sjogren's Syndrome
    View official trial listing →
  • Recruiting NCT NCT04934228

    Mitigating the Pro-inflammatory Phenotype of Obesity

    Not yet reported University of Kansas Medical Center 60 participants Est. completion 2027-08-01 1 site
    Other conditions: Blood Pressure, Diabetes, Obesity, Insulin Resistance, Diuretics Drug Reactions, Sympathetic Nerve Activity
    View official trial listing →
  • Recruiting NCT NCT04943848

    rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

    Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 36 participants Est. completion 2027-09 3 sites
    Other conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
    View official trial listing →
  • Recruiting NCT NCT04944030

    Clinico-biological Data Collection Study of Metastatic Lung Cancer

    Not yet reported Institut Cancerologie de l'Ouest 200 participants Est. completion 2031-10 2 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT04946721

    2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD

    University of Maryland, Baltimore 150 participants Est. completion 2027-12-31 1 site
    Other conditions: Dry Eye Disease, oGVHD
    View official trial listing →
  • Recruiting NCT NCT04956133

    IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment

    Not yet reported University of Calgary 250 participants Est. completion 2028-06-01 2 sites
    Other conditions: Pediatric Cancer, Pediatric Hematology
    View official trial listing →
  • Recruiting NCT NCT04959474

    Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

    Not yet reported Thomas Jefferson University 80 participants Est. completion 2028-11-01 1 site
    Other conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage 2 Breast Cancer AJCC v8, Anatomic Stage 3 Breast Cancer AJCC v8, Breast Ductal Carcinoma in Situ, Invasive Breast Carcinoma, Triple Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT04966351

    Countermeasures to Circadian Misalignment

    Not yet reported Colorado State University 32 participants Est. completion 2026-06-30 1 site
    Other conditions: Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease, Insulin Sensitivity
    View official trial listing →
  • Recruiting NCT NCT04970888

    Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure

    Not yet reported Montreal Heart Institute 216 participants Est. completion 2026-12-01 1 site
    Heart failure Other conditions: Aging
    View official trial listing →
  • Recruiting NCT NCT04985435

    Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)

    Not yet reported R.Bos 100 participants Est. completion 2025-09-30 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT04991025

    Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

    Not yet reported Memorial Sloan Kettering Cancer Center 60 participants Est. completion 2026-10 7 sites
    Other conditions: Lung Cancer, Lung Cancer Stage II, Lung Cancer Stage III
    View official trial listing →
  • Recruiting NCT NCT05005403

    Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    Not yet reported AbbVie 694 participants Est. completion 2027-07 48 sites
    Other conditions: Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Micro Satellite Stable Colorectal Cancer, Gastric/Esophageal Cancer, High-Grade Serous Ovarian Cancer, Pancreatic Cancer, Triple Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05009758

    Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps

    Not yet reported Medical University of Vienna 30 participants Est. completion 2026-12 1 site
    Other conditions: Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis), Nasal Polyps
    View official trial listing →
  • Recruiting NCT NCT05014165

    Backtracking Leukemia-Typical Somatic Mutations in Cord Blood

    Children's Oncology Group 300 participants Est. completion 2026-09-30 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT05019625

    Biomarker Development for Muscular Dystrophies

    Massachusetts General Hospital 465 participants Est. completion 2028-06 5 sites
    Other conditions: Myotonic Dystrophy, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy
    View official trial listing →
  • Recruiting NCT NCT05030545

    Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study

    Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2027-02-28 1 site
    Other conditions: Primary Aldosteronism, Hypertension
    View official trial listing →
  • Recruiting NCT NCT05030571

    The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients

    Not yet reported Chulalongkorn University 40 participants Est. completion 2027-04-01 1 site
    Other conditions: Acute-On-Chronic Liver Failure, Acute on Chronic Hepatic Failure
    View official trial listing →
  • Recruiting NCT NCT05041907

    Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

    Not yet reported University of Oxford 3800 participants Est. completion 2027-01 7 sites
    Other conditions: COVID-19
    View official trial listing →
  • Recruiting NCT NCT05047133

    Effect of Early Administration of TXA in Adult Hip Fractures

    Not yet reported, Not yet reported Ascension Health 170 participants Est. completion 2022-07-01 1 site
    Other conditions: Postoperative Blood Loss
    View official trial listing →
  • Recruiting NCT NCT05056220

    Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

    Not yet reported Aleksander Krag 240 participants Est. completion 2026-09 12 sites
    Other conditions: Decompensated Cirrhosis and Ascites
    View official trial listing →
  • Recruiting NCT NCT05059158

    Amyloid-β Clearance Mechanisms in Alzheimer's Disease

    Ludwig-Maximilians - University of Munich 60 participants Est. completion 2025-10 1 site
    Other conditions: Alzheimer's Disease (AD)
    View official trial listing →
  • Recruiting NCT NCT05067283

    A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

    Not yet reported Merck Sharp & Dohme LLC 830 participants Est. completion 2030-02-25 75 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05082961

    Circulating Immunes Cells, Cytokines and Brain Radiotherapy

    Not yet reported Centre Francois Baclesse 40 participants Est. completion 2028-10 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Recruiting NCT NCT05089149

    Chronic Heart Failure - COngestion eValuation

    Not yet reported Pr. Nicolas GIRERD 200 participants Est. completion 2029-06-14 2 sites
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT05091424

    A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

    Not yet reported Hoffmann-La Roche 332 participants Est. completion 2032-02-10 31 sites
    Other conditions: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05097898

    Chronic Heart Failure With Preserved Ejection Fraction - COngestion eValuation

    Not yet reported Central Hospital, Nancy, France 200 participants Est. completion 2029-06-10 1 site
    Heart failure Other conditions: Preserved Ejection Fraction
    View official trial listing →
  • Recruiting NCT NCT05099341

    DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls

    Not yet reported Centre Hospitalier Universitaire Dijon 90 participants Est. completion 2027-10 1 site
    Other conditions: Depression
    View official trial listing →
  • Recruiting NCT NCT05100121

    To Live Better After Prostate Cancer Treatment:

    Not yet reported Karolinska Institutet 40 participants Est. completion 2025-12-25 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT05110742

    Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2030-12-31 1 site
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Recruiting NCT NCT05112588

    Gestational Diabetes - PrEvention of PostPartum Diabetes Study

    Not yet reported Vastra Gotaland Region 600 participants Est. completion 2030-12-31 1 site
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Recruiting NCT NCT05112601

    Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

    Not yet reported National Cancer Institute (NCI) 81 participants Est. completion 2032-07-30 138 sites Stand-alone
    Other conditions: Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Endometrial Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05136196

    BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    Not yet reported National Cancer Institute (NCI) 150 participants Est. completion 2027-01-01 229 sites Stand-alone
    Other conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma, Locally Recurrent Laryngeal Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oropharyngeal Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Melanoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Recurrent Melanoma, Stage III Hypopharyngeal Carcinoma AJCC v8, Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Unresectable Melanoma
    View official trial listing →
  • Recruiting NCT NCT05136976

    Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 90 participants Est. completion 2028-12 15 sites
    Other conditions: Anti-MAG Neuropathy
    View official trial listing →
  • Recruiting NCT NCT05139849

    VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial

    Not yet reported Tiohundra AB 1276 participants Est. completion 2027-04-30 2 sites
    Other conditions: Cardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical Trial
    View official trial listing →
  • Recruiting NCT NCT05146726

    Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective Interventions

    Charite University, Berlin, Germany 2700 participants Est. completion 2027-02 1 site
    Other conditions: Anemia
    View official trial listing →
  • Recruiting NCT NCT05161702

    Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).

    SCF Pharma 200 participants Est. completion 2027-01-01 1 site
    Other conditions: Resolution of Inflammation, Reduction of Cell Proliferation
    View official trial listing →
  • Recruiting NCT NCT05180253

    Esophageal and Gastric Registry and Biorepository

    University of Louisville 40 participants Est. completion 2026-06 1 site
    Other conditions: Gastro Esophageal Reflux
    View official trial listing →
  • Recruiting NCT NCT05187182

    CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

    Not yet reported Washington University School of Medicine 42 participants Est. completion 2029-04-30 1 site
    Other conditions: Gastric Cancer, Esophageal Cancer, Stomach Cancer, Esophagus Cancer, Gastroesophageal Junction Cancer
    View official trial listing →
  • Recruiting NCT NCT05194787

    TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease

    University of Tasmania 3000 participants Est. completion 2030-12 1 site
    Other conditions: Alzheimer Disease, Dementia, Age-related Cognitive Decline
    View official trial listing →
  • Recruiting NCT NCT05198661

    Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection

    Not yet reported Hospices Civils de Lyon 3500 participants Est. completion 2032-08-02 62 sites
    Other conditions: Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
    View official trial listing →
  • Recruiting NCT NCT05199194

    Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke

    Not yet reported Hospital Moinhos de Vento 398 participants Est. completion 2027-07 13 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT05199259

    Multi-analyte Blood Test Clinical Trial

    Helio Genomics 1200 participants Est. completion 2028-12 7 sites
    Other conditions: Liver Cirrhosis, Liver Cancer, HCC, Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05209776

    Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy

    Not yet reported University Hospital, Toulouse 80 participants Est. completion 2027-02 1 site
    Other conditions: Arrhythmogenic Right Ventricular Dysplasia
    View official trial listing →
  • Recruiting NCT NCT05212272

    MRI in High-Grade Glioma Patients Undergoing Chemoradiation

    Not yet reported Wake Forest University Health Sciences 16 participants Est. completion 2027-12 1 site
    Other conditions: High Grade Glioma
    View official trial listing →
  • Recruiting NCT NCT05223608

    Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy

    Not yet reported Centre Oscar Lambret 651 participants Est. completion 2028-03 1 site
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Recruiting NCT NCT05237687

    The Role of Sirolimus in Preventing Functional Decline in Older Adults

    Not yet reported Irina Timofte 10 participants Est. completion 2028-01 1 site
    Other conditions: Aging
    View official trial listing →
  • Recruiting NCT NCT05242965

    A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

    Not yet reported University of Washington 40 participants Est. completion 2032-11-21 2 sites
    Other conditions: Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05251324

    The Cardiovascular Impact of Hot Flushes

    University of Minnesota 60 participants Est. completion 2027-05-26 1 site
    Other conditions: Hot Flashes, Menopause
    View official trial listing →
  • Recruiting NCT NCT05251415

    Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

    University Hospital, Toulouse 3000 participants Est. completion 2032-04-04 1 site
    Other conditions: Lupus Erythematosus, Scleroderma, Myositis, Vasculitis, Inflammatory Bowel Diseases
    View official trial listing →
  • Recruiting NCT NCT05259553

    Biomarkers in Multiple Myeloma

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 70 participants Est. completion 2027-10-30 2 sites Stand-alone
    Other conditions: Hematological Patients, Newly Diagnosed Multiple Myeloma, Chemotherapy
    View official trial listing →
  • Recruiting NCT NCT05263804

    CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke - HIBISCUS-STROKE II

    Not yet reported Hospices Civils de Lyon 500 participants Est. completion 2029-06 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT05265429

    Biology of Young Lung Cancer Study: The YOUNG LUNG Study

    Dana-Farber Cancer Institute 500 participants Est. completion 2027-08-01 4 sites
    Other conditions: Non Small Cell Lung Cancer, Small Cell Lung Carcinoma, NUT Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05267041

    Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)

    Not yet reported Hospices Civils de Lyon 4000 participants Est. completion 2042-05-05 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT05269381

    Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

    Not yet reported, Not yet reported Mayo Clinic 138 participants Est. completion 2028-03-31 1 site
    Obstructive sleep apnea Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8, Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8, Locally Advanced Cervical Carcinoma, Locally Advanced Endometrial Carcinoma, Locally Advanced Gastric Adenocarcinoma, Locally Advanced Gastroesophageal Junction Adenocarcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced Hepatocellular Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Malignant Solid Neoplasm, Locally Advanced Melanoma, Locally Advanced Merkel Cell Carcinoma, Locally Advanced Renal Cell Carcinoma, Locally Advanced Skin Squamous Cell Carcinoma, Locally Advanced Triple-Negative Breast Carcinoma, Locally Advanced Unresectable Breast Carcinoma, Locally Advanced Unresectable Cervical Carcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma, Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma, Locally Advanced Unresectable Renal Cell Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Cervical Carcinoma, Metastatic Endometrial Carcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hepatocellular Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Metastatic Merkel Cell Carcinoma, Metastatic Renal Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma, Metastatic Triple-Negative Breast Carcinoma, Metastatic Urothelial Carcinoma, Skin Squamous Cell Carcinoma, Stage III Cervical Cancer AJCC v8, Stage III Hepatocellular Carcinoma AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IIIA Cervical Cancer AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIA Uterine Corpus Cancer AJCC v8, Stage IIIB Cervical Cancer AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIB Uterine Corpus Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IIIC Uterine Corpus Cancer AJCC v8, Stage IIIC1 Uterine Corpus Cancer AJCC v8, Stage IIIC2 Uterine Corpus Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Stage IVA Cervical Cancer AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Cervical Cancer AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Stage IVB Lung Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8, Triple-Negative Breast Carcinoma, Unresectable Cervical Carcinoma, Unresectable Endometrial Carcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma, Unresectable Head and Neck Squamous Cell Carcinoma, Unresectable Hepatocellular Carcinoma, Unresectable Lung Non-Small Cell Carcinoma, Unresectable Malignant Solid Neoplasm, Unresectable Melanoma, Unresectable Merkel Cell Carcinoma, Unresectable Renal Cell Carcinoma, Unresectable Skin Squamous Cell Carcinoma, Unresectable Triple-Negative Breast Carcinoma, Unresectable Urothelial Carcinoma, Breast Adenocarcinoma, Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Invasive Breast Lobular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05272384

    Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 32 participants Est. completion 2027-06-28 9 sites Stand-alone
    Other conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05283044

    Implementing Precision Medicine in cOmmunity HospiTALs

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 10000 participants Est. completion 2030-04-15 21 sites
    Other conditions: Metastatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05287464

    International Multicentric Study ARON-1

    Hospital of Macerata 1220 participants Est. completion 2027-09-30 1 site
    Other conditions: Metastatic Renal Cell Carcinoma (mRCC)
    View official trial listing →
  • Recruiting NCT NCT05288842

    Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

    University Hospital, Lille 102 participants Est. completion 2026-10 1 site
    Other conditions: Alzheimer Disease, Frontotemporal Dementia
    View official trial listing →
  • Recruiting NCT NCT05292742

    Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer

    Not yet reported Fujian Medical University Union Hospital 206 participants Est. completion 2027-12-31 1 site
    Other conditions: Breast Cancer, Adjuvant Therapy
    View official trial listing →
  • Recruiting NCT NCT05297708

    Office, Home, and Ambulatory Blood Pressure

    Children's Hospital Medical Center, Cincinnati 52 participants Est. completion 2028-01-01 1 site
    Other conditions: Elevated Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT05300997

    Translational Immunodiagnostics in Stroke (TrImS)

    The University of Hong Kong 650 participants Est. completion 2027-08-31 1 site
    Cardiovascular disease Other conditions: Transient Ischemic Attacks, Large-Artery Atherosclerosis (Embolus/Thrombosis), Small Vessel Disease, Atrial Fibrillation
    View official trial listing →
  • Recruiting NCT NCT05305066

    Stand UP to Rheumatoid Arthritis (SUPRA)

    Not yet reported Marie Hudson, MD 75 participants Est. completion 2030-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT05306912

    Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules

    Not yet reported University Hospital, Toulouse 60 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Lung Cancer, Lung; Node
    View official trial listing →
  • Recruiting NCT NCT05313243

    Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

    Not yet reported Yale University 32 participants Est. completion 2028-07-30 2 sites
    Other conditions: T-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05318196

    Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

    University Hospital, Toulouse 5000 participants Est. completion 2032-09-01 1 site
    Chronic kidney disease Other conditions: Acute Kidney Injury, Solid-organ Transplantation, Cancer, Metabolic Disease, Immune Diseases
    View official trial listing →
  • Recruiting NCT NCT05320796

    The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

    Not yet reported Prof Urs Zingg 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Obesity, Gastric Reflux, Ulcer, Gastric
    View official trial listing →
  • Recruiting NCT NCT05322343

    Biobank and Brain Health in Bordeaux.

    University Hospital, Bordeaux 2050 participants Est. completion 2030-03-22 1 site
    Other conditions: Brain, Aging, Cognitive Aging, Immunosenescence, Mental Processes, Mental Disorders, Neurocognitive Disorders, Cognition, Brain Diseases, Dementia, Alzheimer Disease, Mental Health, Behavioral Symptoms, Depression, Anxiety
    View official trial listing →
  • Recruiting NCT NCT05324553

    Patient Derived Preclinical Models

    Mayo Clinic 50 participants Est. completion 2028-03-31 1 site
    Other conditions: Cancer
    View official trial listing →
  • Recruiting NCT NCT05325008

    A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

    Not yet reported The University of Queensland 280 participants Est. completion 2029-06-30 13 sites
    Other conditions: BK Viremia, Kidney Transplant Infection, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT05327608

    Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery

    Not yet reported Thomas Jefferson University 55 participants Est. completion 2027-05-01 5 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05333458

    Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

    Not yet reported National Cancer Institute (NCI) 27 participants Est. completion 2027-05-01 13 sites Stand-alone
    Other conditions: Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Refractory Alveolar Soft Part Sarcoma, Unresectable Alveolar Soft Part Sarcoma
    View official trial listing →
  • Recruiting NCT NCT05334069

    Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Alliance for Clinical Trials in Oncology 2000 participants Est. completion 2027-02-28 745 sites
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ann Arbor Stage I Lymphoma, Ann Arbor Stage II Lymphoma, Ann Arbor Stage III Lymphoma, Ann Arbor Stage IV Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Gastroesophageal Junction Adenocarcinoma, Head and Neck Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Invasive Breast Carcinoma, Kidney Carcinoma, Malignant Hepatobiliary Neoplasm, Malignant Solid Neoplasm, Melanoma, Muscle-Invasive Bladder Carcinoma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma, RISS Stage III Plasma Cell Myeloma, Sarcoma, Stage I Bladder Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage I Colorectal Cancer AJCC v6 and v7, Stage I Esophageal Cancer AJCC V7, Stage I Gastric Cancer AJCC V7, Stage I Lung Cancer AJCC v7, Stage I Ovarian Cancer AJCC v6 and v7, Stage I Pancreatic Cancer AJCC v6 and v7, Stage I Prostate Cancer AJCC v7, Stage I Uterine Corpus Cancer AJCC v7, Stage II Bladder Cancer AJCC v6 and v7, Stage II Breast Cancer AJCC v6 and v7, Stage II Colorectal Cancer AJCC v7, Stage II Esophageal Cancer AJCC v7, Stage II Gastric Cancer AJCC v7, Stage II Lung Cancer AJCC v7, Stage II Ovarian Cancer AJCC v6 and v7, Stage II Pancreatic Cancer AJCC v6 and v7, Stage II Prostate Cancer AJCC v7, Stage II Uterine Corpus Cancer AJCC v7, Stage III Bladder Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage III Colorectal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage III Gastric Cancer AJCC v7, Stage III Lung Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Pancreatic Cancer AJCC v6 and v7, Stage III Prostate Cancer AJCC v7, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Bladder Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Colorectal Cancer AJCC v7, Stage IV Esophageal Cancer AJCC v7, Stage IV Gastric Cancer AJCC v7, Stage IV Lung Cancer AJCC v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7, Stage IV Prostate Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7, Thyroid Gland Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05334979

    Oxalate and Citrate

    Not yet reported University of Chicago 50 participants Est. completion 2026-12-01 1 site
    Other conditions: Kidney Stone, Normal Controls
    View official trial listing →
  • Recruiting NCT NCT05335928

    Abatacept in Immune Checkpoint Inhibitor Myocarditis

    Not yet reported Massachusetts General Hospital 390 participants Est. completion 2029-10-09 31 sites
    Other conditions: Myocarditis Acute, Cancer
    View official trial listing →
  • Recruiting NCT NCT05336851

    Emergency PWAS in Respiratory Infectious Disease

    The University of Hong Kong 2000 participants Est. completion 2028-05-01 1 site
    Other conditions: Viral Infections, Bacterial Infections, Fungal Infections, Mixed Infection, Mycobacterium Infection, Infection of Uncertain Aetiology, Pneumonia, Sepsis
    View official trial listing →
  • Recruiting NCT NCT05340023

    Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension

    Centre Hospitalier Universitaire de Saint Etienne 120 participants Est. completion 2027-05 1 site
    Other conditions: Chronic Thromboembolic Pulmonary Hypertension
    View official trial listing →
  • Recruiting NCT NCT05342233

    Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection

    Xiangya Hospital of Central South University 200 participants Est. completion 2028-04-01 1 site
    Other conditions: Spontaneous Isolated Superior Mesenteric Artery Dissection
    View official trial listing →
  • Recruiting NCT NCT05343286

    Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity

    Not yet reported Centre Hospitalier Universitaire de Nice 900 participants Est. completion 2028-04-15 1 site
    Other conditions: Elderly
    View official trial listing →
  • Recruiting NCT NCT05348486

    FMISO-based Adaptive Radiotherapy for Head and Neck Cancer

    Not yet reported University Hospital Olomouc 120 participants Est. completion 2030-06-30 3 sites
    Other conditions: Head and Neck Cancer, Hypoxia, FMISO, Dose Escalation
    View official trial listing →
  • Recruiting NCT NCT05348863

    SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes

    Not yet reported Karolinska Institutet 360 participants Est. completion 2027-12-31 1 site
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT05353322

    Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health

    Not yet reported Columbia University 324 participants Est. completion 2028-03-31 1 site
    Other conditions: Sedentary Behavior, Cardiometabolic Risk Factors, Blood Pressure, Glucose
    View official trial listing →
  • Recruiting NCT NCT05357794

    Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

    Not yet reported M.D. Anderson Cancer Center 30 participants Est. completion 2027-01-30 1 site
    Other conditions: Mycosis Fungoides
    View official trial listing →
  • Recruiting NCT NCT05367297

    South Asians and Coronary Plaque Registry

    University of Texas Southwestern Medical Center 300 participants Est. completion 2027-04-30 1 site
    Cardiovascular disease Other conditions: Heart Diseases
    View official trial listing →
  • Recruiting NCT NCT05376878

    An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2027-04-27 1 site
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain
    View official trial listing →
  • Recruiting NCT NCT05378204

    Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

    Not yet reported Institut Claudius Regaud 120 participants Est. completion 2027-06 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05380414

    Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

    Not yet reported Centre Leon Berard 750 participants Est. completion 2027-09-01 1 site Stand-alone
    Other conditions: Metastatic Pancreatic Cancer, Advanced Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05382338

    A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

    Not yet reported Children's Oncology Group 225 participants Est. completion 2029-12-31 111 sites
    Other conditions: Childhood Medulloblastoma
    View official trial listing →
  • Recruiting NCT NCT05382559

    A Study of ASP3082 in Adults With Advanced Solid Tumors

    Not yet reported Astellas Pharma Inc 681 participants Est. completion 2028-12-31 68 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT05386719

    Cardiometabolic Screening Program

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 450 participants Est. completion 2027-08-01 1 site
    Other conditions: Breast Cancer, Early-stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05387031

    Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

    Second Affiliated Hospital, Zhejiang University, School of Medicine 239 participants Est. completion 2028-08-01 8 sites
    Other conditions: Crohn Disease, Stricture; Bowel, Intestinal Stricture
    View official trial listing →
  • Recruiting NCT NCT05389930

    Cannabis' Impact on Alcohol Consumption

    Not yet reported Brown University 350 participants Est. completion 2027-12-31 1 site
    Alcohol use disorder Other conditions: Cannabis Use, Cannabis
    View official trial listing →
  • Recruiting NCT NCT05399537

    Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

    Not yet reported Vantive Health LLC 40 participants Est. completion 2026-12 14 sites
    Other conditions: Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT), Acute Kidney Injury (AKI)
    View official trial listing →
  • Recruiting NCT NCT05405595

    ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

    Not yet reported, Not yet reported Adagene Inc 186 participants Est. completion 2027-04-30 21 sites
    Other conditions: Advanced/Metastatic Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05417867

    Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

    Mayo Clinic 70 participants Est. completion 2027-03-31 5 sites
    Other conditions: Chemotherapy-Related Nausea and/or Vomiting, Early Stage Breast Carcinoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05418010

    Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)

    Not yet reported Queen Mary University of London 40 participants Est. completion 2027-10-31 2 sites
    Other conditions: Multiple Sclerosis, Clinically Isolated Syndrome of Demyelination
    View official trial listing →
  • Recruiting NCT NCT05423262

    A Study of TRK-950 in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Toray Industries, Inc 49 participants Est. completion 2027-12 10 sites
    Other conditions: Solid Tumor, Melanoma
    View official trial listing →
  • Recruiting NCT NCT05423587

    Genicular Artery Embolisation for Knee Osteoarthritis II

    Not yet reported Varian, a Siemens Healthineers Company 110 participants Est. completion 2028-06-30 1 site
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT05423691

    Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

    Not yet reported Cellenkos, Inc. 24 participants Est. completion 2026-12-30 4 sites
    Other conditions: Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT05428631

    Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients with Cardio Renal Syndrome with Severe Renal Impairment

    Not yet reported Centre Hospitalier Universitaire de Nīmes 10 participants Est. completion 2027-08-26 2 sites
    Heart failure Other conditions: Renal Insufficiency
    View official trial listing →
  • Recruiting NCT NCT05432635

    Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 15 participants Est. completion 2028-12-30 1 site
    Other conditions: B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma, Transformed Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05432804

    Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

    Not yet reported, Not yet reported National Cancer Institute (NCI) 97 participants Est. completion 2027-06-30 36 sites
    Other conditions: Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
    View official trial listing →
  • Recruiting NCT NCT05435495

    Mechanisms of Resistance to PSMA Radioligand Therapy

    University of California, San Francisco 125 participants Est. completion 2026-12-31 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT05442463

    Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

    University of Calgary 200 participants Est. completion 2025-11-30 1 site
    Other conditions: Hormone Therapy
    View official trial listing →
  • Recruiting NCT NCT05446155

    BioMEL- Diagnostic and Prognostic Factors in Melanoma.

    Region Skane 2000 participants Est. completion 2028-12 4 sites
    Other conditions: Melanoma, Melanoma in Situ, Dysplastic Nevi, Mole (Dermatology), Image, Mutation
    View official trial listing →
  • Recruiting NCT NCT05449119

    Loss of Autonomy in the Elderly: Relationships Between Gut Microbiota Diversity, Nutrition and Cognitive and Sensory-motor Disturbances in "Small Eaters" and "Non Small Eaters"

    Centre Hospitalier Universitaire Dijon 140 participants Est. completion 2028-06 1 site
    Other conditions: Elderly Small Eater
    View official trial listing →
  • Recruiting NCT NCT05473910

    A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported TScan Therapeutics, Inc. 310 participants Est. completion 2028-06 21 sites
    Other conditions: AML, MDS
    View official trial listing →
  • Recruiting NCT NCT05482321

    Pancreas Ultrasound Imaging in type1 Diabetes

    University of Colorado, Denver 50 participants Est. completion 2026-09 1 site
    Other conditions: Type1diabetes, Insulitis, Pancreas Inflamed
    View official trial listing →
  • Recruiting NCT NCT05482789

    Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

    Not yet reported Maisa N. Feghali, MD 13 participants Est. completion 2026-12-31 1 site Added to GLP-1
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Recruiting NCT NCT05484115

    Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

    Not yet reported Rijnstate Hospital 300 participants Est. completion 2033-04 36 sites
    Other conditions: Aortic Aneurysm, Abdominal
    View official trial listing →
  • Recruiting NCT NCT05487534

    Do "sugar Swings" Impact the Brain Function and the Eating Behaviors of People with Type 1 Diabetes

    Laval University 150 participants Est. completion 2026-09 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT05505669

    Circulating Biomarkers in the Development of Type 1 Diabetes

    City of Hope Medical Center 165 participants Est. completion 2029-06-21 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Recruiting NCT NCT05512351

    Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma

    Not yet reported Henan Provincial People's Hospital 80 participants Est. completion 2026-12 1 site
    Other conditions: Oligodendroglioma
    View official trial listing →
  • Recruiting NCT NCT05514015

    Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

    Not yet reported First Affiliated Hospital, Sun Yat-Sen University 78 participants Est. completion 2026-12-31 1 site
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT05518617

    Molecular and Functional Imaging in Monogenic PD.

    University of Exeter 45 participants Est. completion 2026-06-30 1 site
    Other conditions: Parkinson Disease, Nervous System Disorder, Neurodegenerative Diseases, Neurodegenerative Disease, Hereditary, Parkinson's
    View official trial listing →
  • Recruiting NCT NCT05521698

    A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

    Not yet reported University of Wisconsin, Madison 80 participants Est. completion 2028-12-01 6 sites
    Other conditions: Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05528952

    Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

    Not yet reported Centre Hospitalier Universitaire de Besancon 105 participants Est. completion 2030-02-27 14 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05536505

    Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

    Not yet reported Guangdong Association of Clinical Trials 180 participants Est. completion 2030-10-01 16 sites
    Other conditions: MRD
    View official trial listing →
  • Recruiting NCT NCT05537298

    Muscle Recovery After Critical Illness

    Esther Dupont-Versteegden 209 participants Est. completion 2027-08-01 3 sites
    Other conditions: ICU Acquired Weakness, Post Intensive Care Unit Syndrome, Muscle Weakness, Critical Illness
    View official trial listing →
  • Recruiting NCT NCT05546099

    Patient-driven Management of BP in CKD

    Not yet reported VA Office of Research and Development 160 participants Est. completion 2026-11-20 1 site
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT05556395

    Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

    Johns Hopkins University 150 participants Est. completion 2027-04-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT05564273

    Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

    Not yet reported Viome 150 participants Est. completion 2026-12 1 site
    Other conditions: Metabolic Health
    View official trial listing →
  • Recruiting NCT NCT05570825

    SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer

    Not yet reported University of Washington 30 participants Est. completion 2028-07-01 1 site Stand-alone
    Other conditions: Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05572801

    NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer

    Not yet reported Aarhus University Hospital 400 participants Est. completion 2031-06-01 13 sites Stand-alone
    Other conditions: Anal Cancer
    View official trial listing →
  • Recruiting NCT NCT05577143

    Blood Screening for Adult Colorectal Cancer

    University Hospital, Lille 303 participants Est. completion 2027-03 1 site
    Other conditions: Cancer Colorectal
    View official trial listing →
  • Recruiting NCT NCT05579366

    Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    Not yet reported, Not yet reported Genmab 884 participants Est. completion 2027-10 66 sites
    Other conditions: High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Breast Adenocarcinoma, Triple Negative Breast Cancer, Hormone Receptor-positive/Her2 Negative Breast Cancer, Platinum-resistant Ovarian Cancer (PROC), Platinum Sensitive Ovarian Cancer (PSOC), Primary Refractory Ovarian Cancer, Uterine Cancer
    View official trial listing →
  • Recruiting NCT NCT05582993

    A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

    Not yet reported Takeda 24 participants Est. completion 2030-04-11 23 sites
    Other conditions: Von Willebrand Disease (VWD)
    View official trial listing →
  • Recruiting NCT NCT05584488

    Allergy and Immunology Natural History Study

    Columbia University 10000 participants Est. completion 2027-01 1 site
    Other conditions: Immune Deficiency, Immune Dysregulation Disorder, Allergic Inflammation
    View official trial listing →
  • Recruiting NCT NCT05594706

    Anhydroglucitol in Children With Type 1 Diabetes

    University Hospital, Geneva 60 participants Est. completion 2026-12-31 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT05595447

    Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

    Not yet reported, Not yet reported Hospital Regional de Alta Especialidad del Bajio 20 participants Est. completion 2025-10-18 1 site
    Other conditions: Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult
    View official trial listing →
  • Recruiting NCT NCT05598203

    Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes

    Not yet reported Hospital de Clinicas de Porto Alegre 252 participants Est. completion 2025-10-30 2 sites
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT05625594

    Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

    Not yet reported City of Hope Medical Center 20 participants Est. completion 2028-05-22 1 site Stand-alone
    Other conditions: Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05629845

    Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients

    Not yet reported Chinese University of Hong Kong 84 participants Est. completion 2026-12-31 1 site
    Other conditions: Hepatocellular Carcinoma, Variceal Bleeding
    View official trial listing →
  • Recruiting NCT NCT05630963

    Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

    Mclean Hospital 228 participants Est. completion 2027-02-28 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Recruiting NCT NCT05632406

    Breathing & Blood Pressure

    Florida State University 80 participants Est. completion 2027-06-30 1 site
    Other conditions: Healthy, Overweight and Obesity
    View official trial listing →
  • Recruiting NCT NCT05632497

    Alteration of Symbiosis Intestinal Microbiota on Patients With Anorexia Nervosa

    Assistance Publique - Hôpitaux de Paris 120 participants Est. completion 2026-10 1 site
    Obstructive sleep apnea Other conditions: Dysbiosis, Anxious Depression
    View official trial listing →
  • Recruiting NCT NCT05640609

    Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer

    Not yet reported, Not yet reported West China Hospital 57 participants Est. completion 2026-11-01 1 site
    Other conditions: Stomach Neoplasm
    View official trial listing →
  • Recruiting NCT NCT05646485

    Bladder Cancer Screening Trial

    Not yet reported University of Texas Southwestern Medical Center 1000 participants Est. completion 2028-04 1 site
    Other conditions: Bladder Cancer, Urothelial Carcinoma, Hematuria, Smoking Cessation
    View official trial listing →
  • Recruiting NCT NCT05648136

    Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage

    Not yet reported Centre Hospitalier Universitaire, Amiens 150 participants Est. completion 2026-08 1 site
    Other conditions: Repeated Embryo Implantation Failure, Recurrent Miscarriage, Immune System
    View official trial listing →
  • Recruiting NCT NCT05650905

    Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

    Medical University of Vienna 90 participants Est. completion 2025-12-31 1 site
    Other conditions: COVID-19, Post-COVID-19 Syndrome
    View official trial listing →
  • Recruiting NCT NCT05653388

    Metastatic Leiomyosarcoma Biomarker Protocol

    University of Michigan Rogel Cancer Center 200 participants Est. completion 2026-12 11 sites
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT05654675

    Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

    Academisch Ziekenhuis Maastricht 30 participants Est. completion 2025-06-01 1 site
    Other conditions: Lung Cancer, Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05662371

    Influence of Nociception Level Monitor (NOL) Guided Analgesic Delivery on Robot-assisted Colorectal Surgery

    Not yet reported University of Southern Denmark 60 participants Est. completion 2027-03-31 1 site
    Other conditions: Opioid Use, Unspecified, Pain, Postoperative
    View official trial listing →
  • Recruiting NCT NCT05663710

    Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 100 participants Est. completion 2027-10-30 1 site
    Other conditions: Advanced Cancer, Clear Cell Renal Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05664126

    Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

    Not yet reported St. Jude Children's Research Hospital 42 participants Est. completion 2029-12-31 1 site
    Other conditions: Cytomegalovirus, Adenovirus
    View official trial listing →
  • Recruiting NCT NCT05672615

    Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

    Johns Hopkins University 42 participants Est. completion 2028-03 1 site
    Other conditions: Non-Muscle Invasive Bladder Cancer
    View official trial listing →
  • Recruiting NCT NCT05672927

    Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

    Not yet reported The University of Texas Medical Branch, Galveston 618 participants Est. completion 2028-08 1 site
    Other conditions: Immunization, HPV Infection, Human Papillomavirus
    View official trial listing →
  • Recruiting NCT NCT05674695

    Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy

    Fundación Academia Española de Dermatología 2500 participants Est. completion 2029-01-01 9 sites
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Recruiting NCT NCT05677802

    Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2027-06-30 2 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Negative Breast Carcinoma, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05681988

    Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage (EMINENT-ICH)

    Not yet reported University Hospital, Basel, Switzerland 200 participants Est. completion 2029-12 10 sites
    Other conditions: Intracerebral Haemorrhage
    View official trial listing →
  • Recruiting NCT NCT05690048

    Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

    Not yet reported Michael Dill 48 participants Est. completion 2028-03 7 sites
    Other conditions: Immunotherapy, HCC - Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05693701

    Multicomponent Intervention Study- Blood Donors With High Cholesterol

    Not yet reported University of Texas Southwestern Medical Center 100 participants Est. completion 2027-04-30 1 site
    Other conditions: Lipid Metabolism Disorder
    View official trial listing →
  • Recruiting NCT NCT05698147

    Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

    Not yet reported, Not yet reported Tong Chen, MD 30 participants Est. completion 2026-12-31 5 sites
    Other conditions: Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05702944

    The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

    Not yet reported Seoul National University Hospital 24 participants Est. completion 2027-12-31 1 site
    Other conditions: Pheochromocytoma, Paraganglioma, Adrenalectomy; Status, Adrenergics Causing Adverse Effects in Therapeutic Use
    View official trial listing →
  • Recruiting NCT NCT05706779

    Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer

    Not yet reported Federation Francophone de Cancerologie Digestive 30 participants Est. completion 2029-05-31 1 site
    Other conditions: Colorectal Cancer, BRAF V600E Mutation Positive
    View official trial listing →
  • Recruiting NCT NCT05714241

    BIOmarkers and PLAtelet Function Assessment in Myocardial Ischemia and Non Obstructive Coronary Arteries Study

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 200 participants Est. completion 2027-03-01 2 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT05733949

    Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors

    Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-10-11 1 site Stand-alone
    Other conditions: Metastatic Malignant Solid Neoplasm
    View official trial listing →
  • Recruiting NCT NCT05736029

    Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics

    OncoHost Ltd. 350 participants Est. completion 2028-06-30 1 site
    Other conditions: Non Small Cell Lung Cancer, Healthy
    View official trial listing →
  • Recruiting NCT NCT05739331

    Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence

    Norwegian University of Science and Technology 50 participants Est. completion 2027-12-01 2 sites
    Other conditions: Artificial Intelligence, Endobronchial Ultrasound, Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT05741164

    Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

    Not yet reported Emory University 37 participants Est. completion 2029-06-30 2 sites
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Refractory Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05745857

    Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

    Not yet reported University Medical Center Groningen 25 participants Est. completion 2026-12 1 site
    Other conditions: Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, Esophageal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05747625

    (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

    Not yet reported Eben Rosenthal 60 participants Est. completion 2030-03-01 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Recruiting NCT NCT05751447

    Sarcoidosis and Immune Cells in Lung, Lymph Nodes and Blood

    Not yet reported Region Stockholm 560 participants Est. completion 2034-05-01 1 site
    Other conditions: Sarcoidosis
    View official trial listing →
  • Recruiting NCT NCT05752682

    Global Approach to Faint and Falls

    Istituto Auxologico Italiano 340 participants Est. completion 2026-12-31 1 site
    Other conditions: Syncope, Fall
    View official trial listing →
  • Recruiting NCT NCT05753306

    Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

    Not yet reported Mayo Clinic 40 participants Est. completion 2030-03-25 1 site
    Other conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum
    View official trial listing →
  • Recruiting NCT NCT05754632

    The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial

    Not yet reported Connecticut Children's Medical Center 40 participants Est. completion 2029-05-01 1 site
    Other conditions: Anterior Cruciate Ligament Injuries, Knee Injuries, Quadriceps Muscle Atrophy
    View official trial listing →
  • Recruiting NCT NCT05755087

    Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma

    Not yet reported Lapo Alinari 18 participants Est. completion 2028-03-05 1 site
    Other conditions: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05756257

    Blood Pressure Variability and Ischemic Stroke Outcome

    Yale University 150 participants Est. completion 2027-07-15 3 sites
    Cardiovascular disease Other conditions: Blood Pressure Variability
    View official trial listing →
  • Recruiting NCT NCT05772611

    Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes

    Hospices Civils de Lyon 180 participants Est. completion 2029-02-15 1 site
    Other conditions: Autoimmune Encephalitis, Paraneoplastic Neurological Syndrome
    View official trial listing →
  • Recruiting NCT NCT05773040

    A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2028-12-31 1 site
    Other conditions: Lymphomas, B-cell Lymphomas
    View official trial listing →
  • Recruiting NCT NCT05773274

    Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

    Not yet reported National Cancer Institute (NCI) 100 participants Est. completion 2029-04-30 40 sites Stand-alone
    Other conditions: Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Digestive System Neuroendocrine Tumor G2, Unresectable Digestive System Neuroendocrine Tumor G1, Unresectable Digestive System Neuroendocrine Tumor G2
    View official trial listing →
  • Recruiting NCT NCT05775198

    Effect of Intrauterine Administration of Autologous PBMC Modulated With IFNt on IVF Outcome

    Not yet reported Nadezhda Women's Health Hospital 300 participants Est. completion 2026-04-28 1 site
    Other conditions: Infertility, Female, IVF
    View official trial listing →
  • Recruiting NCT NCT05775445

    Extremes of Coronary Artery Disease and Normality:CAD Extremes

    National Heart Centre Singapore 1500 participants Est. completion 2027-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT05786924

    Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    Not yet reported, Not yet reported Institut de Recherches Internationales Servier 554 participants Est. completion 2028-06 49 sites
    Other conditions: Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, BRAF Gene Mutation, BRAF V600E, BRAF V600 Mutation, BRAF Mutation-Related Tumors, BRAF, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Cancer, Recurrent Lung Cancer, Recurrent Lung Non-Small Cell Carcinoma, NSCLC, Solid Tumor, Solid Carcinoma, KRAS G12D, KRAS G12V, KRAS Mutation-Related Tumors, NRAS Gene Mutation, Thyroid Cancer, Thyroid Carcinoma, Colorectal Cancer, Colorectal Carcinoma, Recurrent Histiocytic and Dendritic Cell Neoplasm, Brain Metastases, Recurrent NSCLC, KRAS G13C, Acquired Resistance to KRAS G12C Inhibitor, KRAS G12A, KRAS G12F, KRAS G12R, KRAS G13D
    View official trial listing →
  • Recruiting NCT NCT05787470

    State of Hormones Impact Nociceptive Expression

    University of Alabama at Birmingham 120 participants Est. completion 2027-07-31 1 site
    Other conditions: Pain, Gender Identity
    View official trial listing →
  • Recruiting NCT NCT05794971

    Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases

    Not yet reported Sun Yat-sen University 126 participants Est. completion 2028-03-31 1 site
    Other conditions: Colorectal Cancer Liver Metastases, Regorafenib
    View official trial listing →
  • Recruiting NCT NCT05800366

    A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

    Not yet reported Jennifer Crombie, MD 41 participants Est. completion 2029-09-15 3 sites
    Other conditions: Lymphoma, Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Recruiting NCT NCT05803382

    Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

    Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2027-06-30 22 sites Stand-alone
    Other conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Neoplasm, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma, Unresectable Malignant Solid Neoplasm
    View official trial listing →
  • Recruiting NCT NCT05805202

    Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy

    Not yet reported Mario Negri Institute for Pharmacological Research 112 participants Est. completion 2026-12-31 1 site
    Other conditions: Atypical Hemolytic Uremic Syndrome
    View official trial listing →
  • Recruiting NCT NCT05805371

    PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer

    Not yet reported City of Hope Medical Center 21 participants Est. completion 2028-11-11 1 site
    Other conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05805605

    Allo HSCT Using RIC and PTCy for Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 56 participants Est. completion 2028-10-22 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia, Undifferentiated Leukemia, Prolymphocytic Leukemia, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Myelodysplastic Syndrome With Excess Blasts-1, Burkitt Lymphoma, Relapsed T-Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma, Follicular Lymphoma, Myeloproliferative Neoplasm, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT05806515

    Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

    Not yet reported SWOG Cancer Research Network 44 participants Est. completion 2031-06 133 sites Stand-alone
    Other conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05806931

    Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

    Not yet reported Rutgers, The State University of New Jersey 50 participants Est. completion 2027-05-01 9 sites
    Other conditions: Colon Cancer, Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05808686

    Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals

    Not yet reported Medical College of Wisconsin 60 participants Est. completion 2029-12 1 site
    Other conditions: Aging, Fragility, Endothelial Dysfunction
    View official trial listing →
  • Recruiting NCT NCT05808920

    The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck

    Royal Marsden NHS Foundation Trust 400 participants Est. completion 2029-04-30 9 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Recruiting NCT NCT05812807

    Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

    Not yet reported Alliance for Clinical Trials in Oncology 1295 participants Est. completion 2033-05-31 846 sites
    Other conditions: Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05823532

    Anti-Inflammatory Challenge in Schizophrenia

    Not yet reported Emory University 60 participants Est. completion 2028-03 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT05824442

    Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis

    Not yet reported Centre Hospitalier Universitaire de Besancon 43 participants Est. completion 2026-10 1 site
    Other conditions: Echinococcosis, Diagnosis
    View official trial listing →
  • Recruiting NCT NCT05831631

    Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

    Pietro Mortini, MD, Prof. 200 participants Est. completion 2029-08-01 1 site
    Other conditions: Brain Tumor, Primary, Brain Tumor - Metastatic
    View official trial listing →
  • Recruiting NCT NCT05837091

    Low Sodium Oxybate in Patients With Idiopathic Hypersomnia

    Not yet reported Mayo Clinic 30 participants Est. completion 2027-06 4 sites
    Other conditions: Idiopathic Hypersomnia
    View official trial listing →
  • Recruiting NCT NCT05838508

    Effect of Physical Activity Pattern on Cardiometabolic Health

    Not yet reported Brigham and Women's Hospital 26 participants Est. completion 2027-08-30 1 site
    Other conditions: Life Style
    View official trial listing →
  • Recruiting NCT NCT05844046

    Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

    Not yet reported Enrico De Toni 83 participants Est. completion 2026-12-31 3 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05847569

    Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

    Not yet reported Mayo Clinic 62 participants Est. completion 2034-06-29 1 site Stand-alone
    Other conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT05848765

    Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

    Not yet reported University of Birmingham 284 participants Est. completion 2031-11-30 25 sites
    Other conditions: Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05852925

    Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers

    Not yet reported American Research Labs 2500 participants Est. completion 2026-07 1 site
    Other conditions: Blood Self-Collection for Clinical Diagnostic Assessments
    View official trial listing →
  • Recruiting NCT NCT05854498

    Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

    Not yet reported University of Wisconsin, Madison 50 participants Est. completion 2028-12 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05855317

    Association Between the Level of EV-TF and the Occurence of Pulmonary Embolism in Patients With ARDS

    Assistance Publique Hopitaux De Marseille 170 participants Est. completion 2027-10-30 1 site
    Other conditions: Acute Respiratory Distress Syndrome
    View official trial listing →
  • Recruiting NCT NCT05858645

    Correction of Psoriatic T Cell Signatures by Deucravacitinib

    Not yet reported University of California, San Francisco 25 participants Est. completion 2028-06 1 site
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Recruiting NCT NCT05864521

    Beetroot Juice and Sleep

    Not yet reported Mayo Clinic 60 participants Est. completion 2028-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT05867420

    A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

    Not yet reported, Not yet reported AskGene Pharma, Inc. 594 participants Est. completion 2028-06-30 4 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05876923

    The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

    Not yet reported Mayo Clinic 70 participants Est. completion 2028-04 2 sites Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent Non-hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05884333

    Cord Blood Transplant in Adults With Blood Cancers

    Not yet reported Memorial Sloan Kettering Cancer Center 54 participants Est. completion 2028-05-22 1 site
    Other conditions: Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05884736

    Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant

    Western University, Canada 30 participants Est. completion 2027-12 2 sites
    Other conditions: Organ Transplant
    View official trial listing →
  • Recruiting NCT NCT05885048

    Impact of Gonadotoxic Therapies on Fertility

    Michael von Wolff 7000 participants Est. completion 2038-12-31 1 site
    Other conditions: Cancer, Fertility Issues, Fertility Preservation, Toxicity Due to Chemotherapy, Toxicity Due to Radiotherapy, Effects of Immunotherapy
    View official trial listing →
  • Recruiting NCT NCT05893407

    Brain PERfusion Evaluation by Contrast-Enhanced UltraSound

    Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2025-07 1 site
    Cardiovascular disease Other conditions: Cerebral Hemorrhage, Subarachnoid Hemorrhage, Cerebrovascular Circulation, Perfusion
    View official trial listing →
  • Recruiting NCT NCT05899010

    MIcronized PROgesterone in Frozen Embryo Transfer Cycles

    Not yet reported Fundación Santiago Dexeus Font 1020 participants Est. completion 2028-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Recruiting NCT NCT05899387

    Seroma of the Mammary Gland

    Not yet reported University Hospital Augsburg 2000 participants Est. completion 2027-07-01 1 site
    Other conditions: Seroma, Breast Cancer, Mastectomy, Breast Implant; Complications
    View official trial listing →
  • Recruiting NCT NCT05901259

    The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes

    Otto Bock Healthcare Products GmbH 200 participants Est. completion 2027-12-31 1 site
    Cardiovascular disease Other conditions: Cerebral Palsy, Multiple Sclerosis, Neurologic Disorder, Fibromyalgia
    View official trial listing →
  • Recruiting NCT NCT05901285

    Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

    Not yet reported Vaxiion Therapeutics 48 participants Est. completion 2027-11 8 sites
    Other conditions: Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab
    View official trial listing →
  • Recruiting NCT NCT05908760

    CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study

    Not yet reported University of Calgary 28 participants Est. completion 2030-12-31 1 site
    Other conditions: Neurogenic Orthostatic Hypotension, Autonomic Failure
    View official trial listing →
  • Recruiting NCT NCT05909293

    Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2028-05-30 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT05910827

    A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

    Not yet reported, Not yet reported Hummingbird Bioscience 398 participants Est. completion 2027-12 20 sites
    Other conditions: Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Nasopharyngeal Cancinoma (NPC), Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05915013

    Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

    Not yet reported Yale University 50 participants Est. completion 2032-12 1 site
    Other conditions: Depressive Disorder, Major, Post Traumatic Stress Disorder
    View official trial listing →
  • Recruiting NCT NCT05922176

    Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis

    Yonsei University 30 participants Est. completion 2026-03-31 1 site
    Other conditions: Rhinitis, Allergic
    View official trial listing →
  • Recruiting NCT NCT05924971

    Aspirin for Postpartum Patients With Preeclampsia

    Not yet reported MemorialCare Health System 86 participants Est. completion 2026-12 1 site
    Other conditions: Preeclampsia Postpartum
    View official trial listing →
  • Recruiting NCT NCT05930483

    Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

    Not yet reported Fred Hutchinson Cancer Center 640 participants Est. completion 2028-03-01 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05934188

    Exploring the Gut-Brain Axis in Ageing and Neurodegeneration

    IRCCS San Camillo, Venezia, Italy 200 participants Est. completion 2027-04-30 3 sites
    Other conditions: Healthy, Prodromal Alzheimer's Disease, Parkinson Disease, Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT05934331

    A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

    Not yet reported LaNova Medicines Zhejiang Co., Ltd. 276 participants Est. completion 2028-07-01 1 site
    Other conditions: Malignant Neoplasms of Digestive Organs
    View official trial listing →
  • Recruiting NCT NCT05939739

    Study of the Value of Trio Exome Sequencing in the Etiological Assessment of Specific Non-syndromic Language and Learning Disorders

    Not yet reported Centre Hospitalier Universitaire Dijon 101 participants Est. completion 2027-01 1 site
    Other conditions: Specific Language and Learning Disorders (SLLD)
    View official trial listing →
  • Recruiting NCT NCT05940311

    Versatile Ampification Single-Molecule Detection in Liquid Biopsy

    Regina Elena Cancer Institute 20 participants Est. completion 2026-03-31 1 site
    Other conditions: Liquid Biopsy, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV
    View official trial listing →
  • Recruiting NCT NCT05941520

    Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

    Not yet reported National Cancer Institute (NCI) 80 participants Est. completion 2028-09-01 4 sites Stand-alone
    Other conditions: Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
    View official trial listing →
  • Recruiting NCT NCT05945849

    CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

    Not yet reported University of Pennsylvania 16 participants Est. completion 2044-02-23 1 site
    Other conditions: Leukemia, Myeloid, Acute
    View official trial listing →
  • Recruiting NCT NCT05946213

    Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    Not yet reported NRG Oncology 1209 participants Est. completion 2041-03-31 413 sites
    Other conditions: Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05947851

    A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

    Not yet reported Merck Sharp & Dohme LLC 735 participants Est. completion 2035-07-01 79 sites
    Other conditions: Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma, Lymphoma, Small Lymphocytic, CLL, SLL
    View official trial listing →
  • Recruiting NCT NCT05950464

    Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

    Not yet reported National Cancer Institute (NCI) 65 participants Est. completion 2027-06-30 14 sites Stand-alone
    Other conditions: Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05967416

    Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported SIRPant Immunotherapeutics, Inc. 24 participants Est. completion 2025-12 3 sites
    Other conditions: Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05970666

    Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma

    Not yet reported The First Affiliated Hospital of Xiamen University 71 participants Est. completion 2026-11-15 1 site
    Other conditions: Adebrelimab, Hepatocellular Carcinoma, Transformation, Bevacizumab, TACE
    View official trial listing →
  • Recruiting NCT NCT05973084

    COVID-19 Transmission and Morbidity in Malawi

    Boston University 1500 participants Est. completion 2028-03 2 sites
    Other conditions: SARS CoV 2 Infection, SARS CoV 2 Vaccination
    View official trial listing →
  • Recruiting NCT NCT05977712

    Circadian Rhythm and Other Factors in Memory Clinic Patients

    Assistance Publique - Hôpitaux de Paris 1200 participants Est. completion 2042-03 2 sites
    Other conditions: Dementia
    View official trial listing →
  • Recruiting NCT NCT05979545

    EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

    Not yet reported National University of Singapore 1900 participants Est. completion 2026-12-31 4 sites
    Other conditions: Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection, Carbapenem-Resistant Enterobacteriaceae Infection, Hospital-acquired Pneumonia
    View official trial listing →
  • Recruiting NCT NCT05981573

    Assessment of Methadone Dose Taken

    Cari Health Inc. 30 participants Est. completion 2026-04 1 site
    Other conditions: Methadone Toxicity, Methadone Overdose, Pain, Chronic, Drug Metabolism, Poor, CYP2D6-Related, Metabolism Medication Toxicity
    View official trial listing →
  • Recruiting NCT NCT05998772

    Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease

    University Hospital Schleswig-Holstein 50 participants Est. completion 2025-12 1 site
    Other conditions: Parkinson Disease, Nutritional and Metabolic Diseases, Sugar Intake
    View official trial listing →
  • Recruiting NCT NCT06004349

    Autoimmune and Autoinflammatory Genetics Study

    NYU Langone Health 1500 participants Est. completion 2032-04-05 2 sites
    Other conditions: VEXAS Syndome, Autoinflammatory Disease, Autoimmune Disease, Rheumatic Disease
    View official trial listing →
  • Recruiting NCT NCT06005324

    Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

    Not yet reported University of Chicago 36 participants Est. completion 2026-12 1 site
    Other conditions: HPV-Negative Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06005987

    Mobile App Logging for Diabetes in Pregnancy

    Not yet reported Carolyn Zahler-Miller 40 participants Est. completion 2027-01-01 1 site
    Type 2 diabetes Other conditions: Gestational Diabetes Mellitus in Pregnancy
    View official trial listing →
  • Recruiting NCT NCT06006117

    Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma

    Not yet reported The Lymphoma Academic Research Organisation 260 participants Est. completion 2032-09 48 sites
    Other conditions: Marginal Zone Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06007248

    Disease Characteristics of IR-CAD: a Case-control Study

    Peking Union Medical College Hospital 30 participants Est. completion 2026-09 1 site
    Cardiovascular disease Other conditions: Coronary Artery Stenosis, Coronary Artery Restenosis, Inflammation, Inflammatory Disease, Inflammation Vascular
    View official trial listing →
  • Recruiting NCT NCT06007794

    Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)

    Not yet reported Hospices Civils de Lyon 55 participants Est. completion 2029-05-10 1 site
    Other conditions: Cancer, Post-cancer, Hematology
    View official trial listing →
  • Recruiting NCT NCT06008730

    Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

    Not yet reported Emory University 10 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Resectable Lung Non-Small Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06008938

    An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

    CSL Behring 500 participants Est. completion 2043-08-01 12 sites
    Other conditions: Hemophilia B
    View official trial listing →
  • Recruiting NCT NCT06011694

    The Jinling Cohort

    Nanjing Shihejiyin Technology, Inc. 15000 participants Est. completion 2027-05-15 2 sites
    Other conditions: Cancer, Multi Cancer Early Screening, Liquid Biopsy
    View official trial listing →
  • Recruiting NCT NCT06011889

    Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

    Not yet reported, Not yet reported National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland 60 participants Est. completion 2028-10-18 1 site
    Other conditions: SAPHO Syndrome
    View official trial listing →
  • Recruiting NCT NCT06012019

    Periodontitis and Inflammation: Study on Biological Samples

    Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2028-05-15 1 site
    Other conditions: Periodontitis
    View official trial listing →
  • Recruiting NCT NCT06013319

    Effect of Esmolol on Oxygenation Index in Patients With Acute Respiratory Distress Syndrome

    Not yet reported Zhiming Jiang 178 participants Est. completion 2026-10-30 1 site
    Other conditions: Acute Respiratory Distress Syndrome
    View official trial listing →
  • Recruiting NCT NCT06016387

    Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

    Not yet reported Sunnybrook Health Sciences Centre 30 participants Est. completion 2028-10-05 2 sites
    Other conditions: HER2-positive Breast Cancer, LMD
    View official trial listing →
  • Recruiting NCT NCT06016569

    Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

    Not yet reported The Institute of Molecular and Translational Medicine, Czech Republic 3200 participants Est. completion 2030-12 3 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06018831

    Urine and Ultrasound Screening for Kidney Disease in Children

    Not yet reported Children's Hospital of Fudan University 13000 participants Est. completion 2028-02 2 sites
    Other conditions: Kidney Diseases, Diagnostic Techniques, Ultrasound, Urinalysis, Child, Only
    View official trial listing →
  • Recruiting NCT NCT06021626

    A Study of CRD3874-SI in People With Solid Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 81 participants Est. completion 2029-08 7 sites
    Other conditions: Sarcoma, Merkel Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06022861

    A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Not yet reported Shandong Boan Biotechnology Co., Ltd 510 participants Est. completion 2026-12 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06023862

    A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

    Not yet reported Yonsei University 198 participants Est. completion 2029-12-31 27 sites
    Other conditions: Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Vulvar Cancer, Vagina Neoplasm, Clear Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06025630

    Targeting Endoplasmic Reticulum Stress in Human Hypertension

    Not yet reported, Not yet reported University of North Texas Health Science Center 70 participants Est. completion 2028-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06029270

    Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

    Not yet reported National Cancer Institute (NCI) 156 participants Est. completion 2029-04-30 88 sites
    Other conditions: Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06031714

    Fetal Cell Receptors Repertoire

    Not yet reported Assistance Publique - Hôpitaux de Paris 160 participants Est. completion 2027-02-01 1 site
    Other conditions: Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer, Post-partum Women, Mixed Ulcer
    View official trial listing →
  • Recruiting NCT NCT06037187

    Coagulopathy of Immunodermatologic Diseases

    University of Nebraska 39 participants Est. completion 2026-12 1 site
    Other conditions: Autoimmune Bullous Dermatosis
    View official trial listing →
  • Recruiting NCT NCT06037941

    Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

    Not yet reported Memorial Sloan Kettering Cancer Center 20 participants Est. completion 2027-09 7 sites
    Other conditions: Malignant Pleural Mesothelioma
    View official trial listing →
  • Recruiting NCT NCT06038578

    A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

    Not yet reported Toray Industries, Inc 146 participants Est. completion 2026-06-30 27 sites
    Other conditions: Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06042387

    Genome Analysis Across Populations in Inflammatory Bowel Disease

    Mount Sinai Hospital, Canada 150 participants Est. completion 2027-09 1 site
    Other conditions: Ulcerative Colitis, Healthy, Crohn Disease, Inflammatory Bowel Diseases
    View official trial listing →
  • Recruiting NCT NCT06042803

    UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk

    Universitaire Ziekenhuizen KU Leuven 30 participants Est. completion 2027-02 1 site
    Other conditions: Breast Feeding, Human Milk
    View official trial listing →
  • Recruiting NCT NCT06043323

    A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

    Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2028-09-01 1 site
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06046131

    Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

    Not yet reported Centre Hospitalier Universitaire de la Guadeloupe 3000 participants Est. completion 2039-02-28 2 sites
    Other conditions: Prostatic Neoplasm, Adenocarcinoma, Neoplasm Recurrence, Neoplasm Metastasis
    View official trial listing →
  • Recruiting NCT NCT06052163

    Bumetanide in Patients With Alzheimer's Disease

    Not yet reported Stanford University 40 participants Est. completion 2026-12-15 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT06053333

    Social Determinants of Health in Hepatobiliary Cancer Patients

    Mayo Clinic 400 participants Est. completion 2028-07-17 1 site
    Other conditions: Malignant Hepatobiliary Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06056635

    A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures

    Not yet reported Boston Children's Hospital 50 participants Est. completion 2027-05-01 1 site
    Other conditions: Fetal Conditions, Maternal; Procedure, Pregnancy Related, Twin to Twin Transfusion Syndrome, In Utero Procedure Affecting Fetus or Newborn, Chorion; Abnormal, Twin Reversal Arterial Perfusion Syndrome, Twin Monochorionic Monoamniotic Placenta, Chorioangioma, Vasa Previa
    View official trial listing →
  • Recruiting NCT NCT06061705

    Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies

    Not yet reported Fondation Hôpital Saint-Joseph 100 participants Est. completion 2026-06-30 3 sites Stand-alone
    Other conditions: Squamous Cell Carcinoma of the Oropharynx
    View official trial listing →
  • Recruiting NCT NCT06062394

    Penn Medicine Healthy Heart

    Not yet reported University of Pennsylvania 1980 participants Est. completion 2026-12 1 site
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Recruiting NCT NCT06062745

    Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

    Not yet reported Brigham and Women's Hospital 30 participants Est. completion 2028-09-01 2 sites
    Other conditions: Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06065852

    National Registry of Rare Kidney Diseases

    UK Kidney Association 35000 participants Est. completion 2039-12-31 1 site
    Alcohol use disorder Other conditions: Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, Alport Syndrome, Atypical Hemolytic Uremic Syndrome, Autoimmune Distal Renal Tubular Acidosis, Autosomal Recessive Proximal Renal Tubular Acidosis, Autosomal Recessive Distal Renal Tubular Acidosis, Autosomal Dominant Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney Disease, Bartter Syndrome, BK Nephropathy, C3 Glomerulopathy With Monoclonal Gammopathy, C3 Glomerulopathy, Calciphylaxis, Crystalglobulinaemia, Crystal-storing Histiocytosis, Cystinosis, Cystinuria, Dense Deposit Disease, Dent Disease, Denys-Drash Syndrome, Dominant Hypophosphataemia With Nephrolithiasis and/or Osteoporosis, Drug Induced Fanconi Syndrome, Drug-Induced Hypomagnesemia, Drug-Induced Nephrogenic Diabetes Insipidus, Epilepsy, Ataxia, Sensorineural Deafness and Tubulopathy, Fabry Disease, Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis, Familial Primary Hypomagnesemia With Hypocalcuria, Familial Primary Hypomagnesaemia With Normocalciuria, Familial Renal Glucosuria, Fanconi Renotubular Syndrome 1, Fanconi Renotubular Syndrome 2, Fanconi Renotubular Syndrome 3, Fibrillary Glomerulonephritis, Fibromuscular Dysplasia, Focal Segmental Glomerulosclerosis, Generalised Pseudohypoaldosteronism Type 1, Gitelman Syndrome, Heavy-Metal-Induced Fanconi Syndrome, Hepatocyte Nuclear Factor 1-Beta-Associated Monogenic Diabetes, Hereditary Renal Hypouricemia, Hereditary Hypophosphatemic Rickets With Hypercalciuria, Hyperuricaemic Nephropathy, IgA Nephropathy, Immunotactoid Glomerulonephritis With Organised Microtubular Mononoclonal Immunoglobulin Deposits, Inherited Renal Cancer Syndromes, Intracapillary Monoclonal IgM Without Cryoglobulin, Intraglomerular/Capillary Lymphoma/Leukaemia, Liddle Syndrome, Light Chain Cast Nephropathy, Light Chain Proximal Tubulopathy Without Crystals, Light Chain Proximal Tubulopathy With Crystals, Lowe Syndrome, Membranous Nephropathy, Membranoproliferative Glomerulonephritis, Medullary Cystic Kidney Disease, Minimal Change Nephropathy, Mitochondrial Disease Of The Kidney, Monoclonal Immunoglobulin Deposition Disease, Nail Patella Syndrome, Nephrogenic Diabetes Insipidus, Nephrogenic Syndrome of Inappropriate Antidiuresis, Nephronophthisis, Primary Hypomagnesemia With Secondary Hypocalcemia, Primary Hyperoxaluria, Proliferative Glomerulonephritis With Monoclonal IgG Deposits, Proximal Tubulopathy Without Crystals, Pseudohypoaldosteronism Type 1, 2A-2E, Pure Red Cell Aplasia, Retroperitoneal Fibrosis, Sickle Cell Nephropathy, Shiga Toxin Associated Haemolytic Uraemic Syndrome, Steroid Resistant Nephrotic Syndrome, Steroid-Sensitive Nephrotic Syndrome, Thin Basement Membrane Nephropathy, Thrombotic Microangiopathy With Monoclonal Gammopathy, Type 1 Cryoglobulinaemic Glomerulonephritis, Tuberous Sclerosis, Unclassified Monoclonal Gammopathy Of Renal Significance, Vasculitis
    View official trial listing →
  • Recruiting NCT NCT06069570

    Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

    Not yet reported Kiromic BioPharma Inc. 48 participants Est. completion 2026-10 5 sites
    Other conditions: Carcinoma, Non-Small-Cell Lung Cancer, Bone Metastases From Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06071377

    Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

    National Alliance for Sickle Cell Centers 1000 participants Est. completion 2027-02 10 sites
    Other conditions: Sickle Cell Trait
    View official trial listing →
  • Recruiting NCT NCT06072963

    COMMETS- Combination MCI Metabolic Syndrome

    Not yet reported Rutgers, The State University of New Jersey 80 participants Est. completion 2028-12-01 1 site
    Metabolic syndrome Other conditions: Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT06073171

    Genomic Study of Cutis Tricolor

    Not yet reported University Hospital, Montpellier 10 participants Est. completion 2026-12 1 site
    Other conditions: Pigmentary; Dermatosis
    View official trial listing →
  • Recruiting NCT NCT06081218

    Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users

    Not yet reported University Hospital, Lille 60 participants Est. completion 2029-12-31 1 site
    Other conditions: Cannabis User
    View official trial listing →
  • Recruiting NCT NCT06082765

    Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood

    Zhongnan Hospital 10000 participants Est. completion 2028-03-31 1 site
    Other conditions: Cervical Cancer
    View official trial listing →
  • Recruiting NCT NCT06083415

    Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context

    Not yet reported Lille Catholic University 62 participants Est. completion 2027-05-15 2 sites
    Other conditions: Puberty, Precocious, Breast, Environmental Exposure
    View official trial listing →
  • Recruiting NCT NCT06083636

    Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 500 participants Est. completion 2026-06 1 site
    Other conditions: Hypothyroidism
    View official trial listing →
  • Recruiting NCT NCT06083883

    Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

    Not yet reported M.D. Anderson Cancer Center 44 participants Est. completion 2028-11-30 1 site
    Obstructive sleep apnea Other conditions: Synovial Sarcoma
    View official trial listing →
  • Recruiting NCT NCT06085404

    Patients Derived Organoids in Ovarian Cancer

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48 participants Est. completion 2025-11-25 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT06091254

    A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

    Not yet reported Regeneron Pharmaceuticals 822 participants Est. completion 2029-11-03 190 sites
    Other conditions: Follicular Lymphoma (FL)
    View official trial listing →
  • Recruiting NCT NCT06095050

    Embolization Treatment of Chronic Refractory Shoulder Tendinopathy

    Not yet reported Brigham and Women's Hospital 41 participants Est. completion 2028-04-21 1 site
    Other conditions: Shoulder Pain, Tendinopathy, Rotator Cuff Tendinitis, Rotator Cuff Tendinosis, Embolization, Arterial Occlusion
    View official trial listing →
  • Recruiting NCT NCT06095960

    Telehealth Multi-Component Optional Model (MOM) Study

    Not yet reported University of Arkansas 1500 participants Est. completion 2027-12-31 6 sites
    Other conditions: Maternal Health
    View official trial listing →
  • Recruiting NCT NCT06096688

    Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

    Weill Medical College of Cornell University 1120 participants Est. completion 2027-06-30 1 site
    Other conditions: Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes
    View official trial listing →
  • Recruiting NCT NCT06102070

    Genetic Susceptibility to Severe Infections

    Institut National de la Santé Et de la Recherche Médicale, France 2000 participants Est. completion 2038-10-18 1 site
    Other conditions: Infectious Disease
    View official trial listing →
  • Recruiting NCT NCT06105749

    Biennial CEM in Women With a Personal History of Breast Cancer

    Not yet reported Wendie Berg 1600 participants Est. completion 2031-04 6 sites
    Other conditions: Breast Cancer, Breast Neoplasms, Breast Cancer Female, Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06109337

    Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder

    First Affiliated Hospital of Zhejiang University 100 participants Est. completion 2027-12 1 site
    Other conditions: ADHD, Immune System, Clinical Syndrome
    View official trial listing →
  • Recruiting NCT NCT06111833

    Optimized Diagnosis and Precision Medicine of MODY

    Taichung Veterans General Hospital 1500 participants Est. completion 2028-05-21 1 site
    Type 2 diabetes Other conditions: Maturity-Onset Diabetes of the Young (MODY), Diabetes Complications
    View official trial listing →
  • Recruiting NCT NCT06119685

    IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

    Not yet reported, Not yet reported Indapta Therapeutics, INC. 128 participants Est. completion 2029-12-31 12 sites
    Other conditions: NHL, Multiple Myeloma, Blood Cancer, Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT06120361

    The Swedish BioFINDER - Primary Care Study

    Skane University Hospital 1200 participants Est. completion 2028-12-31 1 site
    Other conditions: Mild Dementia, Mild Cognitive Impairment, SCD, Alzheimer Disease, Lewy Body Disease, Frontotemporal Degeneration, Vascular Dementia
    View official trial listing →
  • Recruiting NCT NCT06122077

    Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

    Freenome Holdings Inc. 20000 participants Est. completion 2027-06-15 36 sites
    Other conditions: Lung Cancer Diagnosis
    View official trial listing →
  • Recruiting NCT NCT06122246

    PRESSURE CHECK: Find Your Path to Better Health

    Not yet reported Yale University 1440 participants Est. completion 2027-08-31 4 sites
    Other conditions: Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06122896

    Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

    Not yet reported Dana-Farber Cancer Institute 5000 participants Est. completion 2041-10-31 2 sites
    Other conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06124833

    Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

    Chang Kyun Lee 900 participants Est. completion 2028-08-01 1 site
    Other conditions: Inflammatory Bowel Disease (IBD)
    View official trial listing →
  • Recruiting NCT NCT06126419

    Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 70 participants Est. completion 2026-12 1 site
    Other conditions: Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration
    View official trial listing →
  • Recruiting NCT NCT06131775

    Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer

    Not yet reported Hospices Civils de Lyon 300 participants Est. completion 2028-05-01 4 sites
    Other conditions: All Types of Solid Cancer
    View official trial listing →
  • Recruiting NCT NCT06132685

    Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

    Not yet reported Emory University 200 participants Est. completion 2028-07-30 1 site
    Other conditions: Low Grade Glioma, Malignant Brain Glioma, Malignant Brain Neoplasm, Meningioma
    View official trial listing →
  • Recruiting NCT NCT06136546

    Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

    Not yet reported Massachusetts General Hospital 100 participants Est. completion 2029-01-31 1 site
    Other conditions: Depressive Disorder, Major, Inflammation
    View official trial listing →
  • Recruiting NCT NCT06139627

    Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

    Not yet reported City of Hope Medical Center 180 participants Est. completion 2031-07-19 3 sites
    Other conditions: Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06142747

    Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons

    University Hospital Bispebjerg and Frederiksberg 135 participants Est. completion 2028-01 1 site
    Other conditions: Tendinopathy
    View official trial listing →
  • Recruiting NCT NCT06143488

    Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS

    Not yet reported First Affiliated Hospital of Wannan Medical College 264 participants Est. completion 2028-03-31 1 site
    Cardiovascular disease Other conditions: Mild Neurocognitive Disorder, Thrombectomy
    View official trial listing →
  • Recruiting NCT NCT06145633

    Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Fred Hutchinson Cancer Center 15 participants Est. completion 2027-12-30 1 site
    Other conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06150560

    A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

    Not yet reported Mayo Clinic 120 participants Est. completion 2028-06-01 1 site
    Other conditions: Coarctation of Aorta, High Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06150898

    Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

    Not yet reported Jules Bordet Institute 112 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06153056

    Identification of Factors Predictive of the Efficacy of Endoscopic Endoscopic Sleeve Gastroplasty

    Assistance Publique - Hôpitaux de Paris 205 participants Est. completion 2031-02-02 1 site
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT06156046

    Tolerance in Beekeepers

    University Hospital Plymouth NHS Trust 120 participants Est. completion 2027-10-01 1 site
    Other conditions: Bee Sting
    View official trial listing →
  • Recruiting NCT NCT06158828

    Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

    Not yet reported, Not yet reported Washington University School of Medicine 68 participants Est. completion 2030-05-31 1 site
    Other conditions: AML, Childhood, Aml, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06160921

    Prognostic Model of Hypertension

    Xinjiang Medical University 50000 participants Est. completion 2030-01-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06167967

    Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer

    Not yet reported Sir Run Run Shaw Hospital 990 participants Est. completion 2029-12-31 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06189755

    MicroRNAs as Biomarkers for Obstructive Sleep Apnea

    University of Pennsylvania 500 participants Est. completion 2028-04-30 3 sites
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT06189924

    Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients

    The Institute of Molecular and Translational Medicine, Czech Republic 200 participants Est. completion 2029-12-31 2 sites
    Other conditions: Acute Respiratory Failure, Critical Illness
    View official trial listing →
  • Recruiting NCT NCT06191302

    Post-acute COVID-19 Sequelae in Denmark

    Hvidovre University Hospital 800 participants Est. completion 2026-03-01 1 site
    Other conditions: Non-communicable Disease, COVID-19
    View official trial listing →
  • Recruiting NCT NCT06203106

    NYSCF Scientific Discovery Biobank

    New York Stem Cell Foundation Research Institute 10000 participants Est. completion 2045-11-10 1 site
    Type 2 diabetes Other conditions: ALS, Amyotrophic Lateral Sclerosis, Alzheimer Disease, Alzheimer Disease, Early Onset, Alzheimer Disease, Late Onset, Batten Disease, Corticobasal Degeneration, Dementia, Frontotemporal Dementia, Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson Disease, Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, INAD, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1, Macular Degeneration, Ovarian Cancer, Cervical Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer, PTSD, Post Traumatic Stress Disorder
    View official trial listing →
  • Recruiting NCT NCT06215404

    Fluid Management Strategies on Blood Loss in Liver Transplantation

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2025-12-31 1 site
    Other conditions: Liver Transplant
    View official trial listing →
  • Recruiting NCT NCT06216496

    Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer

    Not yet reported University Hospital, Grenoble 23 participants Est. completion 2026-12 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT06219135

    Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis

    Hospices Civils de Lyon 1372 participants Est. completion 2026-11-21 23 sites
    Other conditions: Sepsis
    View official trial listing →
  • Recruiting NCT NCT06220721

    Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

    Not yet reported Medical College of Wisconsin 618 participants Est. completion 2029-06-30 2 sites
    Other conditions: Hypertension, Pregnancy-Induced
    View official trial listing →
  • Recruiting NCT NCT06224309

    Preliminary Assessment of [18F]BL40 in PET/CT Scans

    British Columbia Cancer Agency 30 participants Est. completion 2027-09-15 1 site
    Other conditions: Diffuse Large B-cell Lymphoma, Multiple Myeloma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Recruiting NCT NCT06225505

    Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

    Not yet reported Institut Curie 450 participants Est. completion 2031-08-03 13 sites Stand-alone
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06233838

    Multi-center Clinical Study on Hemoperfusion of KHA80

    Not yet reported First Affiliated Hospital of Fujian Medical University 394 participants Est. completion 2027-05-31 1 site
    Other conditions: Uremia, Uremic Osteodystrophy, Dialysis Related Complication
    View official trial listing →
  • Recruiting NCT NCT06236633

    Safety & Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of Lower and Middle Rectum

    Not yet reported Centre Hospitalier Universitaire de Nīmes 30 participants Est. completion 2027-08-01 3 sites
    Other conditions: Cancer, Rectal
    View official trial listing →
  • Recruiting NCT NCT06241456

    FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

    Not yet reported Fate Therapeutics 351 participants Est. completion 2044-05-01 14 sites
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06247449

    MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

    Not yet reported Sunnybrook Health Sciences Centre 100 participants Est. completion 2028-06-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06249308

    Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )

    Fudan University 168 participants Est. completion 2026-12-31 3 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT06252870

    Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

    Not yet reported Nantes University Hospital 82 participants Est. completion 2028-07-18 3 sites
    Other conditions: Graft Versus Host Disease, Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT06253611

    First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 120 participants Est. completion 2029-04 37 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06253754

    Pathophysiological Mechanisms and Implication of Treatment in Postural Puncture Headache

    Umeå University 160 participants Est. completion 2027-12-28 1 site
    Other conditions: Post-Dural Puncture Headache
    View official trial listing →
  • Recruiting NCT NCT06254313

    The Role of Cxcr4Hi neutrOPhils in InflueNza

    University Hospital, Bordeaux 90 participants Est. completion 2026-12 2 sites
    Other conditions: Influenza, Acute Respiratory Distress Syndrome
    View official trial listing →
  • Recruiting NCT NCT06254794

    Effect of BFR Rehab After Achilles Tendon Rupture

    Not yet reported The Methodist Hospital Research Institute 19 participants Est. completion 2028-12 1 site
    Other conditions: Achilles Tendon Rupture
    View official trial listing →
  • Recruiting NCT NCT06259162

    LAG3 Expression in Triple Negative Breast Cancer

    Not yet reported Samsung Medical Center 128 participants Est. completion 2027-12-31 1 site
    Other conditions: Triple Negative Breast Cancer, Immune Checkpoint Inhibitor
    View official trial listing →
  • Recruiting NCT NCT06260410

    Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics

    Erasmus Medical Center 150 participants Est. completion 2027-02-01 1 site
    Other conditions: Prostate Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT06263075

    Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 30 participants Est. completion 2026-06 1 site
    Other conditions: Craniosynostoses, Hypovolemia, Hemorrhage, Hemodynamic Instability
    View official trial listing →
  • Recruiting NCT NCT06264570

    Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.

    Not yet reported S.LAB (SOLOWAYS) 111 participants Est. completion 2026-10-30 1 site
    Other conditions: Hyperhomocysteinemia
    View official trial listing →
  • Recruiting NCT NCT06265506

    Virtual Incentive Treatment for Alcohol

    Not yet reported Washington State University 200 participants Est. completion 2028-04-04 1 site
    Alcohol use disorder Other conditions: Alcohol Abuse
    View official trial listing →
  • Recruiting NCT NCT06267729

    Study of AZD0754 in Participants With Metastatic Prostate Cancer

    Not yet reported, Not yet reported AstraZeneca 60 participants Est. completion 2026-11-24 15 sites
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06268405

    Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings

    Not yet reported University Health Network, Toronto 100 participants Est. completion 2027-07-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06270771

    OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study

    Sunnybrook Health Sciences Centre 60 participants Est. completion 2027-02-01 1 site
    Other conditions: MDS, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, RARS-T
    View official trial listing →
  • Recruiting NCT NCT06273293

    Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)

    Not yet reported Fundación EPIC 150 participants Est. completion 2027-01-20 4 sites
    Other conditions: Coronary Disease
    View official trial listing →
  • Recruiting NCT NCT06277063

    nVNS for the Prevention and Treatment of Primary Headache

    Not yet reported Nanfang Hospital, Southern Medical University 15 participants Est. completion 2026-12-30 1 site
    Other conditions: Primary Headache, Migraine in Adolescence, Migraine in Children, Cluster Headache, Tension Headache
    View official trial listing →
  • Recruiting NCT NCT06279572

    Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

    Mayo Clinic 80 participants Est. completion 2027-12-31 3 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06280560

    Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation

    Fundación IVI 60 participants Est. completion 2026-12-30 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Recruiting NCT NCT06287749

    French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

    University Hospital, Montpellier 37 participants Est. completion 2028-10-31 1 site
    Other conditions: Pancreatic Cancer Resectable, Pancreatic Ductal Adenocarcinoma, Minimal Residual Disease, Liquid Biopsy, ctDNA
    View official trial listing →
  • Recruiting NCT NCT06287814

    French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

    University Hospital, Montpellier 70 participants Est. completion 2033-10-31 1 site
    Other conditions: Colorectal Cancer, Stage III Colon Cancer, Minimal Residual Disease, Liquid Biopsy
    View official trial listing →
  • Recruiting NCT NCT06288191

    Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

    Not yet reported Melanoma Institute Australia 20 participants Est. completion 2036-07 1 site
    Other conditions: Cutaneous Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06295159

    Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 90 participants Est. completion 2028-11 1 site
    Other conditions: Melanoma Stage III, Melanoma Stage IV, Advanced Melanoma, Melanoma
    View official trial listing →
  • Recruiting NCT NCT06295497

    Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device

    Not yet reported Chinese University of Hong Kong 3000 participants Est. completion 2028-12-01 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06295965

    Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

    University of Washington 2000 participants Est. completion 2031-12-31 1 site
    Other conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Recurrent Malignant Solid Neoplasm, Clonal Cytopenia of Undetermined Significance, Clonal Hematopoiesis, Idiopathic Cytopenia of Undetermined Significance, Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder, Ovarian Carcinoma, Myeloid Neoplasm Post Cytotoxic Therapy
    View official trial listing →
  • Recruiting NCT NCT06302985

    Atomized Inhalation ICG for Treatment of Congenital Lung Malformations

    Not yet reported Jiexiong Feng 50 participants Est. completion 2050-12-31 1 site
    Other conditions: Pulmonary Sequestration, Congenital Pulmonary Airway Malformation, Indocyanine Green, Thoracoscopic Surgery, Children
    View official trial listing →
  • Recruiting NCT NCT06305728

    Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

    Memorial Sloan Kettering Cancer Center 25 participants Est. completion 2030-03-04 8 sites
    Other conditions: Pancreatic Cyst
    View official trial listing →
  • Recruiting NCT NCT06307249

    Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

    Not yet reported Lebanese University 50 participants Est. completion 2027-12 2 sites
    Other conditions: Cancer, Solid Tumor, Colorectal Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Targeted Therapy, Chemotherapy, Immunotherapy, Precision Therapy
    View official trial listing →
  • Recruiting NCT NCT06311214

    Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

    Not yet reported National Cancer Institute (NCI) 500 participants Est. completion 2028-03-31 27 sites Stand-alone
    Other conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06315595

    Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI

    Mayo Clinic 1000 participants Est. completion 2030-09-30 2 sites
    Other conditions: Prostate Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06316427

    Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

    Not yet reported, Not yet reported Beijing GoBroad Hospital 80 participants Est. completion 2028-03-30 4 sites
    Other conditions: T-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia, T-cell Malignancies
    View official trial listing →
  • Recruiting NCT NCT06318949

    Albumin Modifications as Early Biomarkers of Chronic Liver Diseases

    Not yet reported University Hospital, Limoges 756 participants Est. completion 2029-12-01 7 sites
    Other conditions: Chronic Liver Disease
    View official trial listing →
  • Recruiting NCT NCT06319456

    A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.

    Not yet reported Ascentage Pharma Group Inc. 344 participants Est. completion 2028-08 10 sites
    Other conditions: CLL/SLL
    View official trial listing →
  • Recruiting NCT NCT06320158

    Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly

    IRCCS San Raffaele 1108 participants Est. completion 2025-12-31 1 site
    Other conditions: Sarcopenic Obesity
    View official trial listing →
  • Recruiting NCT NCT06322290

    Epidemiological Study on Invasive Bacterial Diseases

    Meyer Children's Hospital IRCCS 5000 participants Est. completion 2032-03-30 38 sites
    Other conditions: Invasive Bacterial Diseases (IBD)
    View official trial listing →
  • Recruiting NCT NCT06323382

    Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma

    Sun Yat-sen University 240 participants Est. completion 2025-12-30 1 site
    Other conditions: Advanced Hepatocellular Carcinoma, Anti-PD1/PDL1 Antibody, Bevacizumab
    View official trial listing →
  • Recruiting NCT NCT06323460

    Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 45 participants Est. completion 2026-12-31 1 site
    Other conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06325800

    GlycOxiTOD: Multimodal Vascular and Target-Organ Damage Registry

    Complejo Hospitalario Universitario de Santiago 1000 participants Est. completion 2035-12-31 1 site
    Other conditions: Hypertension, Target Organ Damage, Heart Disease Risk Factors, Vascular Stiffness, Atherosclerosis
    View official trial listing →
  • Recruiting NCT NCT06326021

    Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia

    Not yet reported Beijing GoBroad Hospital 27 participants Est. completion 2026-12-30 4 sites
    Other conditions: Refractory/Relapsed Acute Myeloid Leukaemia
    View official trial listing →
  • Recruiting NCT NCT06330337

    Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma

    Not yet reported The Third Affiliated hospital of Zhejiang Chinese Medical University 58 participants Est. completion 2027-12-31 1 site
    Other conditions: Glioma
    View official trial listing →
  • Recruiting NCT NCT06330805

    Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 70 participants Est. completion 2027-12-31 1 site
    Other conditions: Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06330870

    Brain Metastasis Development Mechanism in BCBM Patients

    Not yet reported Samsung Medical Center 30 participants Est. completion 2027-12-31 1 site
    Other conditions: Breast Cancer, Brain Metastasis
    View official trial listing →
  • Recruiting NCT NCT06334172

    The Role of Oxytocin in Regulating Blood Glucose

    Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2026-12-31 1 site
    Other conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus)
    View official trial listing →
  • Recruiting NCT NCT06335381

    MOMs Chat and Care Study

    Not yet reported Northwell Health 674 participants Est. completion 2028-06-30 1 site
    Other conditions: Severe Maternal Morbidity
    View official trial listing →
  • Recruiting NCT NCT06335433

    Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension

    Not yet reported Swansea University 45 participants Est. completion 2028-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06335537

    Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers

    Not yet reported University of California, Irvine 100 participants Est. completion 2026-07 1 site
    Other conditions: Uric Acid Stones
    View official trial listing →
  • Recruiting NCT NCT06336031

    Impact of Blood Phobia on Fainting Susceptibility

    Not yet reported Simon Fraser University 20 participants Est. completion 2026-12 1 site
    Other conditions: Syncope, Vasovagal, Blood, Injection, Injury Type Phobia
    View official trial listing →
  • Recruiting NCT NCT06336395

    Ma-Spore ALL 2020 Study

    Not yet reported National University Hospital, Singapore 500 participants Est. completion 2030-03 3 sites
    Other conditions: B Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT06345027

    Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

    Not yet reported Baylor College of Medicine 78 participants Est. completion 2044-06-01 2 sites
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, B-cell, Leukemia, T-Cell
    View official trial listing →
  • Recruiting NCT NCT06346197

    Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas

    Not yet reported Centre Leon Berard 132 participants Est. completion 2028-05-15 7 sites
    Other conditions: Gastric Cancer, MSI-H, Metastatic Cancer, Advanced Cancer
    View official trial listing →
  • Recruiting NCT NCT06350851

    Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination

    Not yet reported Bioaster 400 participants Est. completion 2025-12 1 site
    Other conditions: Onchocerciasis, Loiasis, Mansonelliasis, Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT06356272

    Oropharynx (OPX) Biomarker Trial

    Mayo Clinic 560 participants Est. completion 2029-11-30 1 site
    Other conditions: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Head and Neck Carcinoma, Head and Neck Neoplasm, Salivary Gland Neoplasms, Thyroid Gland Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06357676

    Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

    Not yet reported, Not yet reported OHSU Knight Cancer Institute 27 participants Est. completion 2029-11-01 1 site
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06357728

    Continuous Glucose Monitoring Glycemic cHAracterization During Pregnancy

    Not yet reported KK Women's and Children's Hospital 60 participants Est. completion 2026-12-01 1 site
    Other conditions: Gestational Diabetes, Glucose Metabolism Disorders, Metabolic Disease
    View official trial listing →
  • Recruiting NCT NCT06357845

    Linking Somatic Mutation Rate With Baseline Exposure in East Palestine

    Not yet reported Case Comprehensive Cancer Center 500 participants Est. completion 2026-09-30 1 site
    Other conditions: Somatic Mutation
    View official trial listing →
  • Recruiting NCT NCT06359106

    Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia

    Not yet reported China Medical University, China 1176 participants Est. completion 2026-06-30 16 sites
    Other conditions: Oxygenation Index
    View official trial listing →
  • Recruiting NCT NCT06362369

    A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

    Not yet reported, Not yet reported 7 Hills Pharma, LLC 126 participants Est. completion 2028-12-31 5 sites
    Other conditions: Advanced Cancer, Advanced Solid Tumor, Melanoma, Metastasis, Pleural Mesothelioma, Renal Cell Carcinoma, MSI-High, Mismatch Repair Deficiency, Colorectal Cancer, Hepatocellular Carcinoma, Hepatocellular Cancer, Renal Cell Cancer, Kidney Cancer, Skin Cancer, Non Small Cell Lung Cancer, NSCLC, Anaplastic Lymphoma Kinase Genomic Tumor Aberrations, ALK Genomic Tumor Aberrations
    View official trial listing →
  • Recruiting NCT NCT06365619

    Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

    Not yet reported University of Utah 25 participants Est. completion 2030-08 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Recruiting NCT NCT06368206

    Recording of Physiological Data Via an Optical Sensor At the Fingertip Alongside with Double Auscultatory and Pulse Oximetry to Evaluate the Effectiveness of an Optical Blood Pressure Monitoring (OBPM)

    Not yet reported Aktiia SA 85 participants Est. completion 2025-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06368648

    CoMind Early Feasibility Study

    CoMind Technologies Limited 581 participants Est. completion 2026-11 17 sites
    Cardiovascular disease Other conditions: Intracranial Pressure, Intracranial Pressure Changes, Traumatic Brain Injury, Intracerebral Hemorrhage, Encephalitis, Encephalopathy, Hydrocephalus, Autoregulation
    View official trial listing →
  • Recruiting NCT NCT06368817

    A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

    Not yet reported Children's Oncology Group 240 participants Est. completion 2033-11-04 115 sites
    Other conditions: Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma, Pineal Region Germinoma, Suprasellar Germinoma, Thalamic Germinoma
    View official trial listing →
  • Recruiting NCT NCT06369766

    REtinal Markers In Neuroinflammatory Diseases ("REMIND")

    University Hospital, Basel, Switzerland 500 participants Est. completion 2029-02 1 site
    Other conditions: Multiple Sclerosis, Neuroinflammatory Diseases
    View official trial listing →
  • Recruiting NCT NCT06372249

    A Clinical Trial of Soluble Fiber for Asthma

    Not yet reported Phoenix Children's Hospital 105 participants Est. completion 2027-05-31 1 site
    Other conditions: Asthma in Children
    View official trial listing →
  • Recruiting NCT NCT06373211

    Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy

    Not yet reported Assistance Publique - Hôpitaux de Paris 21 participants Est. completion 2028-06 1 site
    Other conditions: Paraneoplastic Sensory Neuronopathy
    View official trial listing →
  • Recruiting NCT NCT06382844

    Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

    Instituto de Investigación Biomédica de Salamanca 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Cutaneous T-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06389305

    CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction

    Not yet reported Beijing GoBroad Hospital 213 participants Est. completion 2026-05-30 1 site
    Other conditions: B-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06393764

    Cancer-related Venous Thromboembolic Disease - Cohort Study

    University Hospital, Brest 150 participants Est. completion 2035-10 1 site
    Other conditions: Thrombosis Embolism, Thromboses, Venous, Cancer
    View official trial listing →
  • Recruiting NCT NCT06401421

    EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

    Exact Sciences Corporation 1800 participants Est. completion 2030-04 58 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06408220

    Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer

    Not yet reported City of Hope Medical Center 240 participants Est. completion 2029-10-09 1 site
    Other conditions: Gastric Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06409962

    A New Technological Intervention to Address Childhood Obesity:

    Not yet reported Universidad de Córdoba 215 participants Est. completion 2026-12-31 1 site
    Other conditions: Body Weight, Dyslipidemias, Musculoskeletal Diseases
    View official trial listing →
  • Recruiting NCT NCT06411600

    Combination Therapy for BRAF-V600E Metastatic CRCm

    Not yet reported Vall d'Hebron Institute of Oncology 94 participants Est. completion 2029-05-01 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06414148

    MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

    Not yet reported Peter MacCallum Cancer Centre, Australia 40 participants Est. completion 2028-05 6 sites
    Other conditions: Relapsed/Refractory Large B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06415032

    Quilting Sutures After Mastectomy

    Not yet reported Universitaire Ziekenhuizen KU Leuven 296 participants Est. completion 2027-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06423131

    Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT

    Not yet reported Sijia Gu 110 participants Est. completion 2028-03-31 1 site
    Other conditions: Graft-Versus-Host Disease, Hematopoietic Stem Cell Transplantation, Child, Only, Haploidentical Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT06423326

    Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

    Not yet reported Georgetown University 36 participants Est. completion 2027-12-31 2 sites
    Other conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06426836

    Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

    Not yet reported University Hospital, Ghent 300 participants Est. completion 2029-07-01 3 sites
    Other conditions: Pharmacokinetics, Amoxicillin-clavulanate, Piperacillin-tazobactam, Meropenem, Cefazolin, Teicoplanin, Vancomycin, Ciprofloxacin, Amikacin
    View official trial listing →
  • Recruiting NCT NCT06429332

    International Care Bundle Evaluation in Cerebral Hemorrhage Research

    Not yet reported Region Skane 3500 participants Est. completion 2027-07 54 sites
    Cardiovascular disease Other conditions: Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Cerebrovascular Disease
    View official trial listing →
  • Recruiting NCT NCT06429787

    Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

    Octapharma 3574 participants Est. completion 2032-06-30 1 site
    Other conditions: Vitamin K-Dependent Coagulation Defect, Significant Bleeding Risk
    View official trial listing →
  • Recruiting NCT NCT06431945

    Early Detection of HCV in Injection Drug Users

    Institute of Health Information and Statistics of the Czech Republic 3000 participants Est. completion 2025-12-31 18 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Recruiting NCT NCT06433869

    The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites

    Not yet reported Sun Yat-sen University 60 participants Est. completion 2026-12-31 3 sites
    Other conditions: Malignant Ascites
    View official trial listing →
  • Recruiting NCT NCT06441123

    Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein

    University Hospital, Montpellier 24 participants Est. completion 2027-02-10 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Recruiting NCT NCT06441955

    Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

    Not yet reported Well- Konnect Healthcare Services and Research Firm 100 participants Est. completion 2030-09-30 1 site
    Other conditions: COVID-19, Long Haul
    View official trial listing →
  • Recruiting NCT NCT06442592

    Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

    Not yet reported Nantes University Hospital 1206 participants Est. completion 2027-08-08 5 sites
    Other conditions: Congenital Heart Defects, Neurodevelopmental Disorder
    View official trial listing →
  • Recruiting NCT NCT06449339

    Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease

    Not yet reported Chinese University of Hong Kong 474 participants Est. completion 2031-07-30 1 site
    Other conditions: Portal Hypertension, Hepatic Decompensation, Advanced Chronic Liver Disease
    View official trial listing →
  • Recruiting NCT NCT06450171

    Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study

    Not yet reported Dana-Farber Cancer Institute 1000 participants Est. completion 2028-01-31 1 site
    Other conditions: Cancer Predisposition Syndrome, Predisposition, Genetic
    View official trial listing →
  • Recruiting NCT NCT06452862

    Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease

    Shengjing Hospital 150 participants Est. completion 2028-06-06 1 site
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT06455371

    Patient-centered Dosage of Levothyroxine

    Not yet reported University Hospital of North Norway 240 participants Est. completion 2027-12 3 sites Stand-alone
    Other conditions: Hypothyroidism, Thyroid Cancer, Thyroid
    View official trial listing →
  • Recruiting NCT NCT06457386

    Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

    Not yet reported Assistance Publique - Hôpitaux de Paris 700 participants Est. completion 2028-12 1 site
    Other conditions: Staphylococcus Aureus, Bacteremia, Infective Endocarditis
    View official trial listing →
  • Recruiting NCT NCT06458062

    Pocket Colposcopy Using CARE Algorithm

    Not yet reported Duke University 1079 participants Est. completion 2027-04-30 1 site
    Other conditions: Cervical Cancer, HPV Infection
    View official trial listing →
  • Recruiting NCT NCT06469307

    Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

    Not yet reported Dana-Farber Cancer Institute 40 participants Est. completion 2028-01-30 1 site
    Other conditions: Blood Cancer, Leukemia
    View official trial listing →
  • Recruiting NCT NCT06470243

    Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

    Not yet reported SWOG Cancer Research Network 528 participants Est. completion 2034-04 174 sites
    Other conditions: Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06470971

    Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

    Not yet reported Yuanquan Yang 40 participants Est. completion 2030-12-31 1 site
    Other conditions: Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06471374

    Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder

    Not yet reported University of Colorado, Boulder 66 participants Est. completion 2028-07 2 sites
    Other conditions: Delayed Sleep Phase Syndrome, Delayed Sleep Phase
    View official trial listing →
  • Recruiting NCT NCT06474182

    Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 36 participants Est. completion 2028-03 1 site
    Other conditions: Multiple Myeloma, Total Knee Replacement
    View official trial listing →
  • Recruiting NCT NCT06476171

    Validation of Hematological Indices

    Not yet reported Petrovsky National Research Centre of Surgery 200 participants Est. completion 2025-12-30 1 site
    Other conditions: Multiple Organ Dysfunction, Sepsis, Pneumonia, Wound Infection
    View official trial listing →
  • Recruiting NCT NCT06478160

    Closed-blood Sampling Devices in the Adult Critically Ill Patient

    Not yet reported University of Barcelona 216 participants Est. completion 2026-06-07 3 sites
    Other conditions: Acceptability of Health Care
    View official trial listing →
  • Recruiting NCT NCT06478186

    Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes

    Not yet reported University of Kansas Medical Center 120 participants Est. completion 2027-01-16 1 site
    OsteoarthritisType 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06479239

    Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

    Not yet reported, Not yet reported University of Virginia 23 participants Est. completion 2031-06 1 site
    Other conditions: Pancreas Cancer, Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT06481813

    Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients

    Not yet reported Nantes University Hospital 730 participants Est. completion 2034-12-01 4 sites
    Other conditions: Lung Cancer, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Metastatic Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06481852

    A Pilot Study of Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in Pulmonary Arterial Hypertension (GUT RESTORE-PAH)

    Not yet reported University of Minnesota 24 participants Est. completion 2027-04-30 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Recruiting NCT NCT06481878

    Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins

    University Hospital, Grenoble 115 participants Est. completion 2027-10-06 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT06483048

    MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

    Not yet reported Mayo Clinic 12 participants Est. completion 2028-09-30 1 site
    Obstructive sleep apnea Other conditions: Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Female Reproductive System Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Refractory Fallopian Tube Carcinoma, Refractory Female Reproductive System Carcinoma, Refractory Ovarian Carcinoma, Refractory Primary Peritoneal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06486597

    Whole Body Metabolism in Children With Cerebral Palsy With Low Skeletal Muscle Mass

    Not yet reported Copenhagen University Hospital, Rigshospitalet 20 participants Est. completion 2028-07-31 1 site Stand-alone
    Other conditions: Cerebral Palsy (CP)
    View official trial listing →
  • Recruiting NCT NCT06487052

    Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients

    Not yet reported Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 100 participants Est. completion 2027-12 1 site
    Other conditions: Pulmonary Embolism Acute
    View official trial listing →
  • Recruiting NCT NCT06487637

    CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona

    Not yet reported Northern Arizona University 60 participants Est. completion 2026-11-01 2 sites
    Other conditions: High Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06490536

    The Sagittarius Trial

    Not yet reported IFOM ETS - The AIRC Institute of Molecular Oncology 700 participants Est. completion 2028-09-01 26 sites
    Other conditions: Colon Cancer Stage II, Colon Cancer Stage III
    View official trial listing →
  • Recruiting NCT NCT06490627

    Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

    Not yet reported National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 54 participants Est. completion 2026-04-22 1 site
    Other conditions: Fetal Hemoglobin, Thalassemia Major, Genetic Disease
    View official trial listing →
  • Recruiting NCT NCT06495125

    Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

    Not yet reported Emory University 50 participants Est. completion 2029-09-17 3 sites
    Other conditions: Advanced Lung Adenocarcinoma, Refractory Lung Adenocarcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06495983

    Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism

    Haukeland University Hospital 80 participants Est. completion 2028-12 1 site
    Other conditions: Mineralocorticoid Excess, Primary Aldosteronism, Hypercortisolism
    View official trial listing →
  • Recruiting NCT NCT06496308

    Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment

    Not yet reported Ruijin Hospital 78 participants Est. completion 2027-07-10 1 site
    Other conditions: Mantle Cell Lymphoma (MCL)
    View official trial listing →
  • Recruiting NCT NCT06496971

    A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

    Not yet reported NaviFUS Corporation 32 participants Est. completion 2027-03-31 2 sites
    Other conditions: Glioblastoma Multiforme, Glioblastoma, Glioblastoma Multiforme, Adult, Glioma, Brain Tumor, Brain Tumor, Recurrent, Neoplasms, Neoplasms, Nerve Tissue
    View official trial listing →
  • Recruiting NCT NCT06500468

    PillSense for Suspected Upper Gastrointestinal Bleeding

    Not yet reported Tan Tock Seng Hospital 84 participants Est. completion 2026-01 1 site
    Other conditions: Bleeding Ugi
    View official trial listing →
  • Recruiting NCT NCT06502457

    Pain Management With Virtual Reality Hypnosis

    Not yet reported Centre Hospitalier Universitaire, Amiens 142 participants Est. completion 2025-08 1 site
    Other conditions: Hypnosis, Labor Pain, Virtual Reality, Labor Induction, Latent Period
    View official trial listing →
  • Recruiting NCT NCT06502548

    Endometriosis Transcriptomic Cell Atlas

    Not yet reported University Hospital, Toulouse 92 participants Est. completion 2027-09 1 site
    Other conditions: Endometriosis, Infertility
    View official trial listing →
  • Recruiting NCT NCT06503302

    The Effect of Doppler Ultrasound on Calcified Tendinitis

    Not yet reported Taipei Medical University Shuang Ho Hospital 100 participants Est. completion 2026-06 1 site
    Other conditions: Calcific Tendinitis of Shoulder
    View official trial listing →
  • Recruiting NCT NCT06510998

    Isometric Resistance Exercise for Hypertension

    Not yet reported Chinese University of Hong Kong 390 participants Est. completion 2027-09-28 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06514651

    MAQ-001 in Patients With Advanced Solid Tumors

    Not yet reported MabQuest SA 30 participants Est. completion 2028-06-30 4 sites
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06519682

    A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)

    Not yet reported Daniel Morgenstern 20 participants Est. completion 2029-08 1 site
    Other conditions: High Grade Glioma, Replication Repair Deficient
    View official trial listing →
  • Recruiting NCT NCT06520163

    Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

    Not yet reported The Affiliated People's Hospital of Ningbo University 99 participants Est. completion 2026-08 17 sites
    Other conditions: Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
    View official trial listing →
  • Recruiting NCT NCT06522555

    The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma

    Not yet reported Ruijin Hospital 100 participants Est. completion 2029-08-10 1 site
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06523296

    Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.

    Not yet reported Centre Hospitalier Universitaire de Nice 30 participants Est. completion 2028-09-18 1 site
    Other conditions: Alzheimer Disease, Myasthenia
    View official trial listing →
  • Recruiting NCT NCT06523868

    Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study

    Not yet reported Dana-Farber Cancer Institute 1500 participants Est. completion 2028-09-30 1 site
    Other conditions: Cancer Diagnosis
    View official trial listing →
  • Recruiting NCT NCT06530992

    The Effect of Tucking on Semen Quality of Adult Trans Women

    Medical University Innsbruck 40 participants Est. completion 2029-12 1 site
    Other conditions: Transgender, Gender Incongruence, Fertility Issues
    View official trial listing →
  • Recruiting NCT NCT06535087

    The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life

    Wenjing Zhou 600 participants Est. completion 2027-05-31 1 site
    Other conditions: Pediatric Asthma, Rhinitis, Allergic, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT06535113

    Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia

    Ciceri Fabio 80 participants Est. completion 2026-08-31 2 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06536127

    Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

    Not yet reported Institut Sainte Catherine 100 participants Est. completion 2028-07-30 1 site Stand-alone
    Other conditions: Rectal Cancer, Non Metastatic Cancer
    View official trial listing →
  • Recruiting NCT NCT06536439

    Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

    Not yet reported University Hospital, Ghent 235 participants Est. completion 2027-01-01 5 sites
    Other conditions: Kidney Cancer, Kidney Neoplasms, Kidney Diseases, Renal Cancer, Renal Cell Carcinoma, Renal Disease
    View official trial listing →
  • Recruiting NCT NCT06536452

    Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

    Mayo Clinic 50 participants Est. completion 2028-11-18 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis
    View official trial listing →
  • Recruiting NCT NCT06537258

    Heart Rate Variability and Inflammatory Bowel Disease

    Not yet reported Emory University 128 participants Est. completion 2028-10 3 sites
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Recruiting NCT NCT06537726

    Breath Analysis for the Detection of Invasive Fungal Infections

    University of Zurich 130 participants Est. completion 2027-10-31 1 site
    Other conditions: Leukemia, Leukemia, Myeloid, Leukemia, Lymphoblastic, Neutropenia, Chemotherapy-induced Neutropenia, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis
    View official trial listing →
  • Recruiting NCT NCT06539832

    Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

    Zhujiang Hospital 300 participants Est. completion 2026-12-30 1 site
    Other conditions: Multiple Myeloma, MGUS, Gut Microbiota, Infections, M-Protein
    View official trial listing →
  • Recruiting NCT NCT06540326

    Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2027-10-31 1 site
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT06544083

    Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

    Second Affiliated Hospital, Zhejiang University, School of Medicine 600 participants Est. completion 2026-12-31 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06545227

    Early Versus Late Monitoring Among Pregnant Women With a History of Gestational Diabetes

    Imperial College London 200 participants Est. completion 2026-12-31 1 site
    Other conditions: Pregnancy Complications, Gestational Diabetes
    View official trial listing →
  • Recruiting NCT NCT06548477

    Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages

    Not yet reported Hamad Medical Corporation 84 participants Est. completion 2027-07-31 1 site
    Other conditions: Aneurysmal Subarachnoid Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT06550102

    Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies

    University Children's Hospital, Zurich 1000 participants Est. completion 2031-12-31 1 site
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Recruiting NCT NCT06550115

    Impact of Circulating and Tissue-specific Lipids on Vascular Function and Insulin Sensitivity in Chronic Night Shift Workers

    Not yet reported Colorado State University 50 participants Est. completion 2029-06 1 site
    Other conditions: Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease, Insulin Sensitivity, Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06551337

    Vitamin D Replacement in Bronchiectasis

    Not yet reported Queen Mary Hospital, Hong Kong 104 participants Est. completion 2027-06-30 1 site
    Other conditions: Bronchiectasis
    View official trial listing →
  • Recruiting NCT NCT06552169

    REgulatory T Cell Therapy to Achieve Immunosuppression REduction

    Not yet reported Singulera Therapeutics Inc. 34 participants Est. completion 2031-12 7 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06552936

    Combination Therapy Effect of Laser on Wound Healing and Bone Regeneration of Dental Sockets

    Not yet reported Sharif Medical Research Center 44 participants Est. completion 2025-12 2 sites
    Other conditions: Tooth Extraction
    View official trial listing →
  • Recruiting NCT NCT06554561

    A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma

    Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 43 participants Est. completion 2029-08-31 1 site
    Other conditions: PCNSL
    View official trial listing →
  • Recruiting NCT NCT06554600

    A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 36 participants Est. completion 2028-08-31 1 site
    Other conditions: Refractory or Relapsed Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06556446

    Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

    Insel Gruppe AG, University Hospital Bern 2800 participants Est. completion 2026-12-31 33 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06557564

    Diagnosis of Graft Pathology by TruGraf

    University Health Network, Toronto 471 participants Est. completion 2027-12-30 1 site
    Other conditions: Acute Graft Rejection
    View official trial listing →
  • Recruiting NCT NCT06558253

    The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT

    Not yet reported Anhui Provincial Hospital 12 participants Est. completion 2026-09-30 1 site
    Other conditions: Hematopoietic Recovery
    View official trial listing →
  • Recruiting NCT NCT06558877

    Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients

    Not yet reported Xijing Hospital 1200 participants Est. completion 2027-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06566755

    Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer

    Not yet reported Caigang Liu 30 participants Est. completion 2027-02-01 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06566950

    BFR Training on Muscle Morphology

    Not yet reported Udayana University 75 participants Est. completion 2025-11-20 1 site
    Other conditions: Blood Flow Restriction Training, Eccentric Training, Muscle Morphology, Patellofemoral Pain Syndrome, Anterior Cruciate Ligament Injuries
    View official trial listing →
  • Recruiting NCT NCT06572930

    Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

    ART Fertility Clinics LLC 150 participants Est. completion 2026-12-01 1 site
    Other conditions: Ovarian Stimulation
    View official trial listing →
  • Recruiting NCT NCT06580106

    Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML

    Wake Forest University Health Sciences 50 participants Est. completion 2030-01 2 sites
    Other conditions: Leukemia, Myeloid, Acute
    View official trial listing →
  • Recruiting NCT NCT06581640

    Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma

    Not yet reported The First Affiliated Hospital of Xiamen University 5 participants Est. completion 2028-12-31 1 site
    Other conditions: Multiple Myeloma, Relapsed/Refractory
    View official trial listing →
  • Recruiting NCT NCT06591286

    Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control

    Not yet reported Shanghai 6th People's Hospital 150 participants Est. completion 2027-09-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06593756

    Hemodynamic Monitoring and Fluid Responsiveness in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) - "HemodynamECMOnitoring-VA Study"

    Not yet reported Medical University of Vienna 30 participants Est. completion 2027-01 1 site
    Other conditions: ECMO Treatment, ARDS, Pneumonia, Intensive Care, Hemodynamic Monitoring, Fluid Responsiveness
    View official trial listing →
  • Recruiting NCT NCT06594250

    Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia

    Centre Hospitalier Universitaire de Saint Etienne 405 participants Est. completion 2025-11 1 site
    Other conditions: Bacteria Infection Mechanism
    View official trial listing →
  • Recruiting NCT NCT06595602

    Intelligent Lung Support in the Intensive Care Unit

    Technische Universität Dresden 530 participants Est. completion 2027-12 5 sites
    Other conditions: Mechanical Ventilation, Intensive Care Medicine
    View official trial listing →
  • Recruiting NCT NCT06597240

    Home Monitoring During Chemoradiation

    University Medical Center Groningen 30 participants Est. completion 2026-10 1 site
    Other conditions: Locally Advanced Oesophageal Cancer
    View official trial listing →
  • Recruiting NCT NCT06598202

    Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

    Not yet reported, Not yet reported Xuanwu Hospital, Beijing 38 participants Est. completion 2026-05-30 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Recruiting NCT NCT06598436

    Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem

    Not yet reported University of California, San Francisco 600 participants Est. completion 2028-09 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Recruiting NCT NCT06600737

    Greater Manchester CARDIOvascular Pathology in Immune-Mediated Inflammatory Diseases

    University of Manchester 325 participants Est. completion 2032-09-01 1 site
    Cardiovascular disease Other conditions: Rheumatologic Disease
    View official trial listing →
  • Recruiting NCT NCT06600802

    Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

    Not yet reported Centre Jean Perrin 120 participants Est. completion 2034-06-30 5 sites Stand-alone
    Other conditions: Castration-resistant Metastatic Prostate Cancer, Treated by 177Lutetium-PSMA-617 (Lu-PSMA)
    View official trial listing →
  • Recruiting NCT NCT06607549

    Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)

    Not yet reported University of Utah 12 participants Est. completion 2030-11 3 sites
    Other conditions: Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06609668

    Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

    Centre Hospitalier Universitaire Dijon 78 participants Est. completion 2027-10 1 site
    Other conditions: Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)
    View official trial listing →
  • Recruiting NCT NCT06609928

    FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported Fred Hutchinson Cancer Center 12 participants Est. completion 2042-10-01 1 site Stand-alone
    Other conditions: Recurrent Childhood Acute Myeloid Leukemia, Refractory Childhood Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06610838

    Effects of E-cigarette Use on Health

    University of Wisconsin, Madison 600 participants Est. completion 2029-06-30 1 site
    Other conditions: Electronic Cigarette Use
    View official trial listing →
  • Recruiting NCT NCT06612099

    Comparison of the Effects of Aerobic Exercise Training and Mat Pilates Exercise on Blood Pressure, Functional Capacity and Quality of Life in Hypertensive Individuals

    Not yet reported Bezmialem Vakif University 27 participants Est. completion 2025-05-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06613581

    Patient-led Follow-up from Home After Surgery for Colorectal Carcinoma

    Not yet reported Erasmus Medical Center 200 participants Est. completion 2031-09 5 sites
    Other conditions: Colorectal Carcinoma (CRC)
    View official trial listing →
  • Recruiting NCT NCT06618989

    Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.

    Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2027-09-07 2 sites
    Other conditions: Children Under 3 Months of Age With Fever
    View official trial listing →
  • Recruiting NCT NCT06620016

    Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses.

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 60 participants Est. completion 2027-10-31 1 site
    Other conditions: Testicular Cancer
    View official trial listing →
  • Recruiting NCT NCT06622941

    Study to ONO-4538 in Patients With Rhabdoid Tumor

    Not yet reported Ono Pharmaceutical Co., Ltd. 23 participants Est. completion 2030-03-31 14 sites
    Other conditions: Rhabdoid Tumor
    View official trial listing →
  • Recruiting NCT NCT06624475

    Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

    Not yet reported University of California, San Diego 30 participants Est. completion 2028-05 3 sites
    Other conditions: Basal Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06624644

    A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

    Not yet reported, Not yet reported Linnaeus Therapeutics, Inc. 135 participants Est. completion 2031-02 9 sites
    Other conditions: Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma, Unresectable Melanoma
    View official trial listing →
  • Recruiting NCT NCT06624865

    Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors

    Hospices Civils de Lyon 75 participants Est. completion 2029-10 1 site
    Other conditions: Small-intestine Neuroendocrine Tumors
    View official trial listing →
  • Recruiting NCT NCT06626893

    Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

    Not yet reported Azienda Ospedaliero-Universitaria di Parma 100 participants Est. completion 2025-03-01 8 sites
    Other conditions: Myeloid Leukemia, Acute, Leukemia, Acute Lymphoblastic
    View official trial listing →
  • Recruiting NCT NCT06629077

    Brain Blood Vessel Responses to Changes in Blood Flow

    Not yet reported University of Wisconsin, Madison 36 participants Est. completion 2027-05 1 site
    Other conditions: Magnetic Resonance Imaging, Cerebrovascular Circulation
    View official trial listing →
  • Recruiting NCT NCT06637904

    TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

    Not yet reported Inflammatix 300 participants Est. completion 2025-03-31 2 sites Stand-alone
    Other conditions: Sepsis, Infections, Tachycardia, Fever
    View official trial listing →
  • Recruiting NCT NCT06639737

    Preoperative Blood Volume Optimization Using Transthoracic Echocardiography

    Not yet reported University Hospital, Caen 220 participants Est. completion 2027-12-30 1 site
    Other conditions: Anesthesia, Anesthesia Complication, Anesthesia Induction, Arterial Hypotension
    View official trial listing →
  • Recruiting NCT NCT06640283

    Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

    Not yet reported Instituto do Cancer do Estado de São Paulo 150 participants Est. completion 2027-01 1 site
    Other conditions: HPV-Related Carcinoma, Uterine Cervical Cancer, Anal Canal Cancer, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Cervical Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06645106

    Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department

    Not yet reported The University of Texas Health Science Center, Houston 1500 participants Est. completion 2028-02-01 1 site
    Other conditions: Syphilis
    View official trial listing →
  • Recruiting NCT NCT06646471

    PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies

    Not yet reported GFPC Investigation 500 participants Est. completion 2028-08-31 41 sites
    Other conditions: Non Small Cell Lung Cancer, Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06649474

    Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

    Not yet reported University Hospital, Clermont-Ferrand 100 participants Est. completion 2028-06-30 1 site
    Other conditions: Pancreatic Cancer, Resectable Pancreatic Adenocarcinoma, Adenocarcinoma, Resectable Esophageal Cancer, Resectable Gastric or Gastroesophageal Junction Adenocarcinoma, Oesophagogastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06650527

    Effect of Cognitive Empathy Training on Dementia Caregivers

    Not yet reported Emory University 118 participants Est. completion 2028-11-01 3 sites
    Other conditions: Caregivers of People Living With Dementia, Dementia
    View official trial listing →
  • Recruiting NCT NCT06650553

    Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study

    Not yet reported Shanxi Bethune Hospital 110 participants Est. completion 2027-07 1 site
    Other conditions: Aplastic Anemias
    View official trial listing →
  • Recruiting NCT NCT06651970

    Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

    Not yet reported AstraZeneca 60 participants Est. completion 2032-09-30 23 sites
    Other conditions: Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
    View official trial listing →
  • Recruiting NCT NCT06653946

    the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients

    Not yet reported Kafrelsheikh University 716 participants Est. completion 2024-11-01 1 site
    Cardiovascular disease Other conditions: Alteplase Adverse Reaction
    View official trial listing →
  • Recruiting NCT NCT06654037

    Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 39 participants Est. completion 2027-04-01 8 sites
    Obstructive sleep apnea Other conditions: Stage IV Colorectal Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06658067

    Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

    Not yet reported Yale University 17 participants Est. completion 2026-06 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Recruiting NCT NCT06660277

    DIALysis With EXpanded Solute Removal

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 4800 participants Est. completion 2030-08 1 site
    Chronic kidney disease Other conditions: End-Stage Kidney Disease (ESKD), Pragmatic Randomized Controlled Trial, Kidney Disease, Renal Insufficiency, Chronic, Kidney Failure, Chronic, Hemodialysis
    View official trial listing →
  • Recruiting NCT NCT06663111

    Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

    Haukeland University Hospital 60 participants Est. completion 2027-12-31 1 site
    Other conditions: Relapsing Remitting Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT06667063

    Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

    Zhongnan Hospital 130 participants Est. completion 2025-06-30 2 sites
    Other conditions: COVID-19, Influenza
    View official trial listing →
  • Recruiting NCT NCT06672146

    Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

    Not yet reported National Cancer Institute (NCI) 93 participants Est. completion 2027-03-31 136 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06673095

    Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial

    Not yet reported OHSU Knight Cancer Institute 1000 participants Est. completion 2027-12-31 5 sites
    Other conditions: Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06674772

    Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification

    Hospital Universitari Vall d'Hebron Research Institute 440 participants Est. completion 2025-05 1 site
    Other conditions: Headache (Migraine), Migraine, Migraine Headache, Migraine with Aura, Migraine Without Aura, Episodic Migraine, Chronic Migraine Headache, Chronic Migraine, Headache, Episodic Migraine Headache
    View official trial listing →
  • Recruiting NCT NCT06675136

    Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases

    Not yet reported City of Hope Medical Center 30 participants Est. completion 2029-01-14 1 site
    Other conditions: Clinical Stage IVB Gastric Cancer AJCC v8, Metastatic Gastric Adenocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum
    View official trial listing →
  • Recruiting NCT NCT06676553

    INtraprocedural Feedback-Optimized Renal Denervation Based on Measurements Obtained Through Renal Artery Stimulation: a Randomized Controlled Trial (INFORM)

    Not yet reported National Taiwan University Hospital 32 participants Est. completion 2028-06-30 1 site
    Other conditions: Hypertension, Uncontrolled, Hypertension, Resistant, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06679283

    Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF)

    Not yet reported University of Bern 40 participants Est. completion 2027-12-31 1 site
    Other conditions: Peri-Implantitis, Bone Resorption, Platelet-Rich Fibrin
    View official trial listing →
  • Recruiting NCT NCT06682195

    Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

    Not yet reported First Affiliated Hospital of Zhejiang University 35 participants Est. completion 2029-10-01 13 sites Stand-alone
    Other conditions: TNBC, Triple Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06683170

    Validity and Feasibility of the Pregnancy Monitoring Belt - a Clinical Pilot Study

    Anna Axelin 35 participants Est. completion 2026-09 1 site
    Other conditions: Validation
    View official trial listing →
  • Recruiting NCT NCT06683885

    A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma

    Not yet reported, Not yet reported Mingzhi Zhang 80 participants Est. completion 2026-05-01 1 site
    Other conditions: Newly Diagnosed Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06687564

    Role of ACTG2 Variants in Smooth Muscle Determination and Function in Pediatric Intestinal Pseudo-obstruction.

    Not yet reported University Hospital, Grenoble 4 participants Est. completion 2032-02-03 3 sites
    Other conditions: PIPO
    View official trial listing →
  • Recruiting NCT NCT06692335

    HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

    Not yet reported Chinese University of Hong Kong 112 participants Est. completion 2027-12-31 1 site
    Other conditions: Uterine Fibroids (UF)
    View official trial listing →
  • Recruiting NCT NCT06692933

    Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel

    Not yet reported Washington State University 24 participants Est. completion 2027-12-31 1 site
    Other conditions: Interaction
    View official trial listing →
  • Recruiting NCT NCT06693453

    Effects of Electronic Acupuncture Combined With Dry Cupping Therapy in Treating Back Pain Due to Lumbar Spondylosis

    Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 76 participants Est. completion 2024-11-30 1 site
    Other conditions: Back Pain
    View official trial listing →
  • Recruiting NCT NCT06693817

    Advanced Wireless Sensors for Neonatal Care in the Delivery Room

    Not yet reported Guilherme Sant'Anna, MD 600 participants Est. completion 2027-12-30 5 sites
    Substance use disorder Other conditions: Apnea of Newborn, Newborn Morbidity, Newborn Asphyxia, Birth Outcome, Adverse, Birth Asphyxia, Pregnancy Related, Newborn; Vitality, ECG Electrode Site Reaction, Infant ALL, Infant Death, Infant, Newborn, Diseases, Infant Apnea, Infant Conditions, Parents, Delivery Problem for Fetus, Delivery Complication
    View official trial listing →
  • Recruiting NCT NCT06693830

    ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

    Not yet reported Hua-Jay J Cherng, MD 40 participants Est. completion 2029-12 1 site
    Other conditions: Lymphoma, Lymphoma, B-Cell, Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06693960

    Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

    Not yet reported Washington State University 16 participants Est. completion 2027-01-31 1 site
    Other conditions: Interaction
    View official trial listing →
  • Recruiting NCT NCT06694415

    Determining Paediatric Usual Values for Hormones Dosages by LC-MS/MS

    Assistance Publique - Hôpitaux de Paris 1500 participants Est. completion 2026-12 1 site
    Other conditions: Control Condition
    View official trial listing →
  • Recruiting NCT NCT06696768

    Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2026-12-31 13 sites
    Other conditions: Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06699056

    AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

    Peerbridge Health, Inc 2000 participants Est. completion 2027-11-15 8 sites
    Heart failureCardiovascular disease Other conditions: Ventricular Ejection Fraction, LVF, LV Dysfunction, Atrial Enlargement, Conduction Defect, Valvular Heart Disease, Ischemic Heart Disease, Cardiotoxicity, Dilated Cardiomyopathy, Syncope, Remodeling, Cardiac
    View official trial listing →
  • Recruiting NCT NCT06699810

    Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

    Not yet reported Emory University 12 participants Est. completion 2027-01 2 sites
    Other conditions: Ketosis Prone Diabetes
    View official trial listing →
  • Recruiting NCT NCT06699901

    Antibiotic Concentrations After MassivE Transfusion Study

    Brooke Army Medical Center 417 participants Est. completion 2027-09-30 2 sites
    Other conditions: Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents
    View official trial listing →
  • Recruiting NCT NCT06700798

    Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL: A Randomized, Open Phase II Trial

    Not yet reported Fei Li 90 participants Est. completion 2027-12-04 1 site
    Other conditions: Marginal Zone Lymphoma(MZL)
    View official trial listing →
  • Recruiting NCT NCT06701214

    The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

    Vanderbilt-Ingram Cancer Center 800 participants Est. completion 2031-11-30 1 site
    Other conditions: Clonal Hematopoiesis
    View official trial listing →
  • Recruiting NCT NCT06701890

    Observational Study of Travellers Pathologies

    Not yet reported Institut Pasteur 11000 participants Est. completion 2036-12 1 site
    Other conditions: Travel-Related Illness
    View official trial listing →
  • Recruiting NCT NCT06707129

    Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal

    Beijing Municipal Administration of Hospitals 50 participants Est. completion 2027-08-31 1 site
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Recruiting NCT NCT06710418

    Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

    Not yet reported University of Washington 50 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Myeloid Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06711432

    Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients(PRECISION)

    Not yet reported Zhejiang Cancer Hospital 214 participants Est. completion 2026-06-01 1 site
    Cardiovascular disease Other conditions: Tumor
    View official trial listing →
  • Recruiting NCT NCT06711952

    German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

    Not yet reported Ludwig-Maximilians - University of Munich 300 participants Est. completion 2025-08-31 1 site
    Other conditions: Alzheimer Disease, Subjective Cognitive Decline
    View official trial listing →
  • Recruiting NCT NCT06716450

    Multiplo Tp/HIV Self-Test

    Not yet reported Unity Health Toronto 900 participants Est. completion 2026-12-10 3 sites
    Other conditions: HIV Infection, Syphilis Infection
    View official trial listing →
  • Recruiting NCT NCT06717295

    The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

    Javier Toledo 6000 participants Est. completion 2028-08-01 4 sites
    Other conditions: Brest Cancer, Lung Cancer (NSCLC), Pancreatic Cancer, Adult, Prostate Cancers, Ovarian Cancer, Colorectal Cancer, Glioblastoma (GBM), Liver Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06718933

    Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

    Not yet reported, Not yet reported Fudan University 74 participants Est. completion 2027-02-28 1 site
    Other conditions: Breast Cancer Metastatic, Breast Cancer Brain Metastases
    View official trial listing →
  • Recruiting NCT NCT06722222

    Gao's Triple Eversion Carotid Endarterectomy

    Second Affiliated Hospital, Zhejiang University, School of Medicine 11 participants Est. completion 2031-09-20 1 site
    Other conditions: Carotid Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT06725732

    Assessment of Nebulized Tranexamic Acid in Functional Endoscopic Sinus Surgery Using Modena Bleeding Score

    Not yet reported Assiut University 90 participants Est. completion 2026-01-01 1 site
    Other conditions: Blood Loss, Surgical
    View official trial listing →
  • Recruiting NCT NCT06731257

    Virtual Ward-Assisted Very earLy dIschArge of Low-rIsk STEMI patieNTs: the VALIANT-STEMI Trial

    Not yet reported The Leeds Teaching Hospitals NHS Trust 600 participants Est. completion 2026-03 1 site
    Other conditions: Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT06732232

    A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

    Not yet reported Shanghai Cell Therapy Group Co.,Ltd 12 participants Est. completion 2027-12-12 1 site
    Other conditions: Relapsed, Refractory, Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT06733038

    FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

    Not yet reported Gruppo Oncologico del Nord-Ovest 238 participants Est. completion 2029-04-01 24 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06733350

    Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

    Not yet reported Roswell Park Cancer Institute 600 participants Est. completion 2029-01-15 1 site
    Other conditions: Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06735001

    Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention

    Not yet reported University Hospital, Bordeaux 400 participants Est. completion 2029-10 1 site
    Other conditions: Atrial Fibrillation (AF)
    View official trial listing →
  • Recruiting NCT NCT06736158

    Early Genomic Testing for Inherited Bleeding Disorders

    Not yet reported Queen's University 212 participants Est. completion 2027-04-30 3 sites
    Other conditions: Bleeding Disorder
    View official trial listing →
  • Recruiting NCT NCT06741722

    Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML

    Not yet reported Beijing 302 Hospital 20 participants Est. completion 2027-12-31 1 site
    Other conditions: AML, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06742723

    A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

    Not yet reported AstraZeneca 5000 participants Est. completion 2029-12-18 771 sites
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT06743126

    SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

    Not yet reported Immatics US, Inc. 360 participants Est. completion 2031-10 71 sites
    Other conditions: Melanoma, Cutaneous Malignant
    View official trial listing →
  • Recruiting NCT NCT06744296

    Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

    Massachusetts Eye and Ear Infirmary 75 participants Est. completion 2029-01-06 1 site
    Other conditions: Squamous Cell Carcinoma of Head and Neck
    View official trial listing →
  • Recruiting NCT NCT06749223

    AQT90 FLEX D-dimer Clinical Sensitivity and Specificity

    Radiometer Medical ApS 600 participants Est. completion 2025-06-30 1 site
    Other conditions: VTE (Venous Thromboembolism)
    View official trial listing →
  • Recruiting NCT NCT06750094

    A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    Not yet reported Janssen Research & Development, LLC 700 participants Est. completion 2029-04-13 251 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06750575

    Study to Examine the Effect of the Diuretic Furosemide on the Plasma Levels of Toxins and the Removal of Toxins from the Blood in Patients with Chronic Kidney Disease

    UMC Utrecht 34 participants Est. completion 2025-07-01 1 site
    Chronic kidney disease Other conditions: Renal Failure Chronic
    View official trial listing →
  • Recruiting NCT NCT06750939

    The Impact of Propofol and Ketamine on Cardiovascular Collapse During Induction for Intubation

    Kocaeli City Hospital 128 participants Est. completion 2025-11-01 1 site
    Other conditions: Cardiovascular Collapse, Intubation Complication, Anaesthetic Complication Cardiac
    View official trial listing →
  • Recruiting NCT NCT06752928

    A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes

    Not yet reported Emory University 100 participants Est. completion 2026-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT06755372

    The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Population

    Ain Shams University 100 participants Est. completion 2025-08-01 1 site
    Other conditions: Periodontitis, End-stage Renal Disease
    View official trial listing →
  • Recruiting NCT NCT06763029

    Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer

    Not yet reported Fudan University 36 participants Est. completion 2026-12-31 1 site
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT06764069

    Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor

    Not yet reported Glucotrack 10 participants Est. completion 2025-02-28 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT06764875

    A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

    Not yet reported AstraZeneca 840 participants Est. completion 2030-12-09 302 sites
    Other conditions: HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06774300

    Evaluating Telehealth Delivery of Brief Alcohol Screening and Intervention for College Students

    Not yet reported University of Southern California 600 participants Est. completion 2030-07-31 1 site
    Other conditions: Alcohol Consumption
    View official trial listing →
  • Recruiting NCT NCT06777394

    Effects of High Intensity Interval Training in Down Syndrome

    Not yet reported Riphah International University 30 participants Est. completion 2025-01-15 1 site
    Other conditions: Down Syndrome
    View official trial listing →
  • Recruiting NCT NCT06777979

    CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia

    Not yet reported St. Jude Children's Research Hospital 30 participants Est. completion 2031-01 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT06781008

    SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden

    Region Jönköping County 600 participants Est. completion 2035-12 12 sites
    Other conditions: Tick-Borne Diseases
    View official trial listing →
  • Recruiting NCT NCT06782685

    Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

    Not yet reported, Not yet reported Dai, Guanghai 138 participants Est. completion 2027-03 2 sites
    Other conditions: Advanced Pancreatic Cancer (Part 1)
    View official trial listing →
  • Recruiting NCT NCT06784726

    Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

    Not yet reported University of Washington 27 participants Est. completion 2033-04-11 1 site
    Other conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma, Recurrent High Grade B-Cell Lymphoma, Recurrent Primary Mediastinal Large B-Cell Lymphoma, Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Refractory Grade 3b Follicular Lymphoma, Refractory High Grade B-Cell Lymphoma, Refractory Primary Mediastinal Large B-Cell Lymphoma, Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06788444

    Efficacy of Esketamine for Patients With Irritable Bowel Syndrome

    Not yet reported Beijing Tiantan Hospital 552 participants Est. completion 2027-12-31 1 site
    Other conditions: Irritable Bowel Syndrome
    View official trial listing →
  • Recruiting NCT NCT06790797

    Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients

    Zhao Jun 50 participants Est. completion 2027-07-30 1 site
    Other conditions: Lung Cancer, Esophageal Cancer
    View official trial listing →
  • Recruiting NCT NCT06793098

    Functional Proteins in Polycystic Ovary Syndrome

    Jagiellonian University 100 participants Est. completion 2027-12-31 1 site
    Other conditions: Reproductive Age, PCOS (Polycystic Ovary Syndrome)
    View official trial listing →
  • Recruiting NCT NCT06795113

    Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

    Ruijin Hospital 4000 participants Est. completion 2029-12-31 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06796322

    Clinical Evaluation of Non-invasive Blood Glucose Meter

    Not yet reported Shanghai Jiao Tong University School of Medicine 210 participants Est. completion 2025-03-31 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT06796751

    PREcision Diagnostics in Rare genetIC Diseases and Tumors - Long Read Sequencing

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 30 participants Est. completion 2026-09-30 1 site
    Other conditions: Whole Exome Sequencing, Rare Diseases
    View official trial listing →
  • Recruiting NCT NCT06800898

    Orexin Gene in Anorexia Nervosa

    Istituto Auxologico Italiano 60 participants Est. completion 2026-06-30 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT06801977

    The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study

    Sun Yat-sen University 10000 participants Est. completion 2030-12-31 2 sites
    Other conditions: Primary Pulmonary Lymphoepithelioma-like Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06802172

    Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

    Not yet reported Fred Hutchinson Cancer Center 100 participants Est. completion 2029-08-31 1 site
    Other conditions: Rectal Cancer Stage II, Rectal Cancer Stage III, Breast Cancer Stage I, Rectal Cancer Stage IV, Breast Cancer Stage II, Breast Cancer Stage III, Solid Tumor Cancer
    View official trial listing →
  • Recruiting NCT NCT06802874

    Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 300 participants Est. completion 2026-12-31 1 site
    Other conditions: Blood Loss
    View official trial listing →
  • Recruiting NCT NCT06803771

    Surveillance of Pancreatic Health After Diabetes Diagnosis

    Not yet reported University Hospital Southampton NHS Foundation Trust 15000 participants Est. completion 2029-02 31 sites Stand-alone
    Other conditions: Diabetes Mellitus, Pancreatic Cancer, Adult
    View official trial listing →
  • Recruiting NCT NCT06807502

    Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device

    Not yet reported ScreenCell 93 participants Est. completion 2026-11-30 1 site
    Other conditions: Breast Cancer, Metastatic, Breast Cancer Invasive, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06807606

    Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 35 participants Est. completion 2029-11-30 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Recruiting NCT NCT06809517

    Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis

    Not yet reported, Not yet reported Guangzhou Medical University 34 participants Est. completion 2026-05-01 1 site
    Other conditions: Leptomeningeal Metastasis, Intrathecal Drug Delivery
    View official trial listing →
  • Recruiting NCT NCT06812858

    PD-1 Inhibitors Maintenance for cHL Post-autoHCT

    Not yet reported St. Petersburg State Pavlov Medical University 83 participants Est. completion 2030-09 4 sites
    Other conditions: Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06814054

    Carotid Artery Corrected Flow Time and Inferior Vena Cava Collapsibility Index for Prediction of Hypotension After Induction of General Anesthesia in Geriatric Patients Undergoing Elective Surgery

    Tanta University 189 participants Est. completion 2026-05 1 site
    Other conditions: Geriatrics, Hypotension on Induction, General Anesthetic Drug Adverse Reaction, Elective Surgery
    View official trial listing →
  • Recruiting NCT NCT06814405

    Safety and Feasibility of a Multidisciplinary Programme of Integrated Hospital-home Management With Early Discharge of Patients With Haematological Malignancies Undergoing High-dose Chemotherapy in Hospital

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 100 participants Est. completion 2025-12-31 1 site
    Other conditions: Haematological Malignancy
    View official trial listing →
  • Recruiting NCT NCT06815367

    Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery

    Not yet reported University of Southern California 33 participants Est. completion 2026-05-01 1 site
    Other conditions: Delayed Onset Muscle Soreness
    View official trial listing →
  • Recruiting NCT NCT06816121

    Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers

    Everest Detection, Inc. 350 participants Est. completion 2029-06-30 1 site
    Other conditions: Lung Cancers
    View official trial listing →
  • Recruiting NCT NCT06816134

    Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

    Not yet reported The First Affiliated Hospital of Soochow University 48 participants Est. completion 2030-01-30 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell, Conditioning Therapy
    View official trial listing →
  • Recruiting NCT NCT06816147

    HealthyW8_60+ Pilot

    Not yet reported Luxembourg Institute of Health 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Obesity Prevention
    View official trial listing →
  • Recruiting NCT NCT06818149

    Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

    Shanghai Chest Hospital 50 participants Est. completion 2028-12-30 1 site
    Other conditions: Lung Cancer, Myocarditis Due to Drug
    View official trial listing →
  • Recruiting NCT NCT06818331

    Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial

    Not yet reported The Third Affiliated hospital of Zhejiang Chinese Medical University 20 participants Est. completion 2028-02-24 1 site
    Other conditions: Glioma
    View official trial listing →
  • Recruiting NCT NCT06819007

    Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

    Not yet reported Daiichi Sankyo 582 participants Est. completion 2032-01-31 208 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT06819475

    Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

    Not yet reported St. Jude Children's Research Hospital 60 participants Est. completion 2028-01 1 site
    Other conditions: Childhood Cancer, Muscle Weakness
    View official trial listing →
  • Recruiting NCT NCT06820463

    A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    Not yet reported AbbVie 390 participants Est. completion 2028-04 75 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06821386

    N-Care Project: Enhancing Asian-Pacific Collaboration

    National Taiwan University Hospital 70 participants Est. completion 2032-12-31 1 site
    Other conditions: Whole Genome Sequencing, Genetic Disease, Critical Care, Intensive Care, Nanopore Sequencing
    View official trial listing →
  • Recruiting NCT NCT06823479

    Towards Cure Via Only Ultra-short ICB in CSCC

    Not yet reported The Netherlands Cancer Institute 41 participants Est. completion 2029-02 5 sites
    Other conditions: Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Cutaneous Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06826118

    Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma

    Not yet reported The First Affiliated Hospital of Xiamen University 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Lymphoma, Follicular Lymphoma, Refractory Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06830031

    Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

    Not yet reported Shanghai Exuma Biotechnology Ltd. 18 participants Est. completion 2029-09-18 1 site
    Other conditions: Diffuse Large B-cell-lymphoma, DLBCL, Nos Genetic Subtypes, Follicular Lymphoma Grade 3B, PMBL, HGBL With MYC and BCL2 and/or BCL6 Rearrangements, HGBL, Nos
    View official trial listing →
  • Recruiting NCT NCT06830551

    The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 10 participants Est. completion 2025-12-31 1 site
    Other conditions: Dry Eye
    View official trial listing →
  • Recruiting NCT NCT06831019

    The ROAR Study: Reactive Oxygen Species and Reproduction

    University of California, San Francisco 1100 participants Est. completion 2027-03-01 1 site
    Other conditions: Ovarian Aging, IVF Outcome, Oxidative Stress
    View official trial listing →
  • Recruiting NCT NCT06833957

    Preparing for Maternal GBS Vaccine Trials in Africa

    Barcelona Institute for Global Health 18100 participants Est. completion 2027-02-28 10 sites
    Other conditions: Group B Streptococcus, Invasive Bacterial Diseases (IBD), Maternal Immunization
    View official trial listing →
  • Recruiting NCT NCT06834373

    Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

    Not yet reported Mayo Clinic 41 participants Est. completion 2028-09-09 7 sites
    Other conditions: Large B-Cell Lymphoma With IRF4 Rearrangement, Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma, Recurrent ALK-Positive Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Recurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation, Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent Intravascular Large B-Cell Lymphoma, Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Recurrent Primary Mediastinal Large B-Cell Lymphoma, Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory Aggressive B-Cell Non-Hodgkin Lymphoma, Refractory ALK-Positive Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation, Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Refractory Grade 3b Follicular Lymphoma, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified, Refractory Intravascular Large B-Cell Lymphoma, Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Refractory Primary Mediastinal Large B-Cell Lymphoma, Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Refractory Transformed Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06835426

    High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

    Not yet reported Algemeen Ziekenhuis Maria Middelares 150 participants Est. completion 2027-06-30 1 site
    Other conditions: Breast Carcinoma, Prostate Cancer Surgery, Thyroid Cancer, Parathyroid Adenomas, Skin Cancer, Genitourinary Cancer, Head and Neck Cancer, Hepatobiliary Cancers, Metabolic Abnormality, Neuro Endocrine Tumours, Brain Tumours, Gastro Intestinal Cancer, Thoracoscopic Surgery
    View official trial listing →
  • Recruiting NCT NCT06835569

    A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    Not yet reported Alterome Therapeutics, Inc. 448 participants Est. completion 2029-08 12 sites
    Other conditions: Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC (Non-small Cell Lung Cancer), CRC (Colorectal Cancer), Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06837181

    Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

    Jaeb Center for Health Research 200 participants Est. completion 2028-11-30 18 sites
    Other conditions: Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes, Diabetes, Retinopathy, Neuropathy, Nephropathy, Blood Pressure, Cardiovascular Risk, Microvascular
    View official trial listing →
  • Recruiting NCT NCT06839300

    The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study

    AO Foundation, AO Spine 260 participants Est. completion 2029-12-01 8 sites
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Recruiting NCT NCT06839456

    Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

    Not yet reported, Not yet reported Children's Hospital of Philadelphia 100 participants Est. completion 2032-03 1 site
    Other conditions: Leukemia, High Risk Acute Lymphoblastic Leukemia, High Risk Acute Myeloid Leukemia, Relapse Leukemia, MDS (Myelodysplastic Syndrome), Relapsed Non-Hodgkin Lymphoma, Acquired Aplastic Anemia, Inherited BMF Syndrome, Immunodeficiency, Primary Immune Regulatory Disorder, Hemoglobinopathies, Bone Marrow Failure, Inborn Errors of Metabolism, HLH
    View official trial listing →
  • Recruiting NCT NCT06840119

    Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers

    Not yet reported, Not yet reported Immunocore Ltd 600 participants Est. completion 2027-11-30 13 sites
    Other conditions: Cancer, HLA-A*02:01-positive
    View official trial listing →
  • Recruiting NCT NCT06840327

    Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome

    University Hospital, Toulouse 120 participants Est. completion 2027-10 1 site
    Other conditions: Cardiac Surgery, Extracorporeal Circulation
    View official trial listing →
  • Recruiting NCT NCT06843330

    Accuracy of Lactate Meter in GSDIa

    Connecticut Children's Medical Center 10 participants Est. completion 2027-12-10 1 site
    Other conditions: Glycogen Storage Disease Type Ia
    View official trial listing →
  • Recruiting NCT NCT06843707

    Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

    The First Affiliated Hospital of Guangzhou Medical University 2500 participants Est. completion 2027-12-31 1 site
    Other conditions: Lung Cancer, Lung, Lung Cancer (NSCLC), Metabolomics
    View official trial listing →
  • Recruiting NCT NCT06846671

    A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

    Not yet reported BeOne Medicines 250 participants Est. completion 2030-02-14 132 sites
    Other conditions: CLL, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT06855407

    Hypertension and Cerebrovascular Hemodynamics in General Anaesthesia

    Not yet reported Umeå University 30 participants Est. completion 2027-06-01 1 site
    Other conditions: Anesthesia, Cerebral Blood Flow, Regional Cerebral Oxygen Saturation, Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06857292

    Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy

    Not yet reported Sun Yat-sen University 97 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Chemotherapy-Induced Neutropenia
    View official trial listing →
  • Recruiting NCT NCT06859008

    Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 37 participants Est. completion 2029-01-31 1 site
    Obstructive sleep apnea Other conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3a Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Nodal Marginal Zone Lymphoma, Recurrent Splenic Marginal Zone Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Grade 1 Follicular Lymphoma, Refractory Grade 2 Follicular Lymphoma, Refractory Grade 3a Follicular Lymphoma, Refractory Mantle Cell Lymphoma, Refractory Nodal Marginal Zone Lymphoma, Refractory Splenic Marginal Zone Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06859814

    Value of Infection Control Programs on Infection Associated with Urinary Tract Catheterization in Sohag University Hospital

    Not yet reported Sohag University 200 participants Est. completion 2025-08-01 1 site
    Other conditions: UTI
    View official trial listing →
  • Recruiting NCT NCT06860516

    HLA Demographics Study in Adults With Type 1 Diabetes

    GentiBio, Inc 200 participants Est. completion 2027-03 5 sites
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Recruiting NCT NCT06860815

    Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

    Not yet reported City of Hope Medical Center 11 participants Est. completion 2027-01-30 1 site
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver
    View official trial listing →
  • Recruiting NCT NCT06861244

    Embryonal Tumor With Multilayered Rosettes

    Not yet reported University of California, San Francisco 70 participants Est. completion 2032-03-31 8 sites Stand-alone
    Other conditions: Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos
    View official trial listing →
  • Recruiting NCT NCT06863259

    Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

    Not yet reported Children's Hospital Medical Center, Cincinnati 28 participants Est. completion 2029-01-01 1 site
    Other conditions: B-cell Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT06864975

    Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

    Not yet reported Runhui WU 110 participants Est. completion 2028-06-21 1 site
    Other conditions: Hemophilia a with Inhibitor
    View official trial listing →
  • Recruiting NCT NCT06869031

    Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: A Doctor-Patient Interaction Approach

    Not yet reported Yuju Wu 320 participants Est. completion 2026-12-31 1 site
    Other conditions: Hypertension Self-management, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06873113

    BFRT for Subacromial Pain

    Not yet reported University of Florida 36 participants Est. completion 2028-12-31 1 site
    Other conditions: Shoulder Pain
    View official trial listing →
  • Recruiting NCT NCT06875609

    ctDNA in Cutaneous Squamous Cell Carcinoma

    Massachusetts Eye and Ear Infirmary 60 participants Est. completion 2029-04-30 1 site
    Other conditions: Cutaneous Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06876714

    ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    Not yet reported Alliance for Clinical Trials in Oncology 1524 participants Est. completion 2037-03-13 690 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2+ Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06878729

    Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI

    Not yet reported National Institute of Cardiology, Warsaw, Poland 74 participants Est. completion 2028-09-30 3 sites
    Cardiovascular disease Other conditions: Coronary Occlusion, Percutaneous Coronary Intervention
    View official trial listing →
  • Recruiting NCT NCT06880107

    Genetic Variants of Annexin A2 and Cryptogenic Stroke

    Not yet reported Centre Hospitalier Universitaire, Amiens 240 participants Est. completion 2027-04 1 site
    Cardiovascular disease Other conditions: Annexin A2, Genetic Variants of Host, Fibrinolysis
    View official trial listing →
  • Recruiting NCT NCT06881498

    A Substudy of the Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 32 participants Est. completion 2026-05 1 site
    Other conditions: Bone Tumor, Acute Normovolemic Hemodilution, Goal-Directed Fluid Therapy
    View official trial listing →
  • Recruiting NCT NCT06881628

    Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients

    Not yet reported Tanta University 194 participants Est. completion 2025-12-30 1 site
    Other conditions: Upper Gastrointestinal Bleeding (UGIB), Variceal Bleeding, Cirrhosis
    View official trial listing →
  • Recruiting NCT NCT06886802

    Multicentric Case Series of Uniportal Endoscopic Posterior Cervical Decompression for Cervical Spinal Stenosis

    TecSalud Investigación Clínica 50 participants Est. completion 2027-02 1 site
    Other conditions: Spinal Stenosis Cervical
    View official trial listing →
  • Recruiting NCT NCT06888817

    Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

    Not yet reported The Netherlands Cancer Institute 408 participants Est. completion 2030-07 6 sites
    Other conditions: Radiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases, Radiation Toxicity, Radiation Effect, Radiation Injury, Radiation Injuries
    View official trial listing →
  • Recruiting NCT NCT06888908

    Changes in Perioperative Blood Volume and Fluid Distribution in Patients Undergoing Primary Total Hip Replacement.

    Copenhagen University Hospital, Hvidovre 25 participants Est. completion 2026-09 1 site
    Other conditions: Hip Arthroplasty Replacement
    View official trial listing →
  • Recruiting NCT NCT06890780

    Observation on the Correlation Between Serum/Fecal Isoflavones, Abundance of TMA-producing Bacteria and Serum TMAO in Hyperlipidemia and Healthy Subjects

    Zhujiang Hospital 200 participants Est. completion 2025-12-31 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Recruiting NCT NCT06891742

    Phase I Study of OriC902 in Treatment of Advanced HCC

    Not yet reported Peking University 44 participants Est. completion 2028-03-31 2 sites
    Other conditions: HCC
    View official trial listing →
  • Recruiting NCT NCT06893861

    Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer

    National Cancer Institute, Naples 3100 participants Est. completion 2025-07 1 site
    Other conditions: Endometrial Carcinoma (EC)
    View official trial listing →
  • Recruiting NCT NCT06894654

    DERMATOMICS: Identifying Regulators of Skin Homeostasis

    Relation Therapeutics 500 participants Est. completion 2030-11-01 2 sites
    Other conditions: Systemic Sclerosis (SSc)
    View official trial listing →
  • Recruiting NCT NCT06894745

    PET [89Zr]DFO-starPEG in Solid Tumors

    Not yet reported Robert Flavell, MD, PhD 13 participants Est. completion 2027-12-31 1 site
    Other conditions: Solid Tumor, Solid Carcinoma, Soft Tissue Lesion
    View official trial listing →
  • Recruiting NCT NCT06896799

    Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM)

    Not yet reported Queen's University, Belfast 35 participants Est. completion 2027-02-01 1 site
    Other conditions: Gestational Diabetes Mellitus (GDM)
    View official trial listing →
  • Recruiting NCT NCT06896825

    Increasing Physical Activity Through Social Support and Stress Resilience

    Not yet reported Arizona State University 86 participants Est. completion 2027-04 1 site
    Other conditions: Healthy, Subjective Cognitive Decline (SCD), Sedentary Behavior, Social Isolation in Older Adults
    View official trial listing →
  • Recruiting NCT NCT06899399

    Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis

    Not yet reported Beijing Tiantan Hospital 982 participants Est. completion 2028-07 1 site
    Other conditions: Asymptomatic Carotid Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT06899750

    E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

    Not yet reported Rush University Medical Center 200 participants Est. completion 2026-10-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06899854

    Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.

    Fondazione IRCCS Policlinico San Matteo di Pavia 53 participants Est. completion 2026-03-01 1 site
    Other conditions: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06900595

    Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

    Not yet reported National Cancer Institute (NCI) 48 participants Est. completion 2029-06-02 80 sites
    Other conditions: Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Recurrent Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8, Stage IV Adrenal Cortical Carcinoma AJCC v8, Unresectable Adrenal Cortical Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06904131

    A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors

    Not yet reported Obstetrics & Gynecology Hospital of Fudan University 20 participants Est. completion 2027-12-31 1 site
    Other conditions: Gynecological Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06904313

    Ultralow Dose PET Imaging for PSMA Expression

    Not yet reported Akiva Mintz 200 participants Est. completion 2030-06-30 1 site
    Other conditions: Healthy Volunteer, Prostate CA
    View official trial listing →
  • Recruiting NCT NCT06905015

    Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection

    Not yet reported Warangkana Lapisatepun 74 participants Est. completion 2028-06-30 1 site
    Other conditions: Liver Tumor; Surgery, Primary Liver Tumor, Metastatic Liver, Primary Liver Cancer, Liver Resection, Benign Liver Tumor
    View official trial listing →
  • Recruiting NCT NCT06905509

    Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

    Not yet reported University of California, Davis 25 participants Est. completion 2030-08-01 1 site
    Other conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Recurrent High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent Nodal Marginal Zone Lymphoma, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Refractory High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements, Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified, Refractory Nodal Marginal Zone Lymphoma, Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06906341

    Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

    Not yet reported Corcept Therapeutics 270 participants Est. completion 2026-12 49 sites
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms, Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT06906549

    Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis

    Not yet reported University Hospital, Strasbourg, France 260 participants Est. completion 2026-07 1 site
    Other conditions: Rheumatoid Arthritis (RA), Rituximab (RTx)
    View official trial listing →
  • Recruiting NCT NCT06907524

    Preventative Screening and Health Coaching in a Food Insecure Population

    Not yet reported Rush University Medical Center 200 participants Est. completion 2027-07-01 1 site
    Cardiovascular disease Other conditions: Cardiometabolic Diseases, Cardiovascular Risk Factor, Cardiovascular Risk Score, Hypertension, Hyperlipidemia, Diabetes, Lifestyle Modification, Health Coaching
    View official trial listing →
  • Recruiting NCT NCT06908993

    Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

    Not yet reported Intergroupe Francophone de Cancerologie Thoracique 133 participants Est. completion 2028-07-15 29 sites
    Other conditions: Advanced Non Small Cell Lung Cancer, MET Exon 14 Mutation
    View official trial listing →
  • Recruiting NCT NCT06909110

    Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

    Not yet reported, Not yet reported Jessie L. Alexander 25 participants Est. completion 2032-01-01 3 sites
    Other conditions: Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections
    View official trial listing →
  • Recruiting NCT NCT06909695

    Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women

    United States Army Research Institute of Environmental Medicine 33 participants Est. completion 2027-09 1 site
    Other conditions: Contraception, Iron Deficiencies
    View official trial listing →
  • Recruiting NCT NCT06911502

    A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

    Not yet reported Celgene 400 participants Est. completion 2030-07-31 160 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06915038

    ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx

    Not yet reported Indiana University 120 participants Est. completion 2028-12 2 sites
    Other conditions: Squamous Cell Carcinoma of Oropharynx, HPV Positive Cancer, Throat Cancer, Tonsil Cancer
    View official trial listing →
  • Recruiting NCT NCT06925295

    Using Xe MRI to Guide Radiation Therapy for Lung Cancer

    Not yet reported Sean Fain 15 participants Est. completion 2027-01 1 site
    Other conditions: Imaging Techniques
    View official trial listing →
  • Recruiting NCT NCT06927180

    SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

    Not yet reported Henan Cancer Hospital 180 participants Est. completion 2030-12-01 1 site
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06929013

    Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.

    Not yet reported Hospices Civils de Lyon 58 participants Est. completion 2026-06-20 1 site
    Other conditions: Peritoneal Carcinomatosis, Peritoneal Metastases From Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06929208

    Heart Rate Variability and Music Listening

    Not yet reported KK Women's and Children's Hospital 120 participants Est. completion 2027-12 3 sites
    Other conditions: Heart Rate Variability, Anxiety, Depression
    View official trial listing →
  • Recruiting NCT NCT06930391

    Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium

    Not yet reported Samuel Lunenfeld Research Institute, Mount Sinai Hospital 40 participants Est. completion 2026-06 1 site
    Other conditions: Postpartum Hemorrhage (Primary)
    View official trial listing →
  • Recruiting NCT NCT06933056

    Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

    Not yet reported University of Michigan 20 participants Est. completion 2026-09 1 site
    Other conditions: Platelet Function and Reactivity Tests
    View official trial listing →
  • Recruiting NCT NCT06938347

    Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt

    Not yet reported Agitated Solutions, Inc. 300 participants Est. completion 2026-09 8 sites
    Other conditions: Right-To-Left Shunt
    View official trial listing →
  • Recruiting NCT NCT06938789

    How Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study

    Not yet reported University of Aarhus 198 participants Est. completion 2027-06-01 2 sites
    Other conditions: Bleeding, Hip Fracture, Delirium - Postoperative
    View official trial listing →
  • Recruiting NCT NCT06940414

    Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community

    Xiujuan Zang 1890 participants Est. completion 2025-09-30 1 site
    Chronic kidney disease Other conditions: Hyperkalemia
    View official trial listing →
  • Recruiting NCT NCT06940531

    Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis

    Alexander Horsley 300 participants Est. completion 2029-12-31 18 sites
    Other conditions: Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation
    View official trial listing →
  • Recruiting NCT NCT06942039

    Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

    Not yet reported C17 Council 15 participants Est. completion 2032-12-31 12 sites
    Other conditions: CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor, Medulloblastoma, Childhood, Medulloblastoma, Group 3, Medulloblastoma, Group 4, Pineoblastoma, Neuroblastoma, Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Abundant Neuropil and True Rosettes, Ependymoblastoma, Medulloepithelioma, CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Nos
    View official trial listing →
  • Recruiting NCT NCT06943820

    AK129 Combination Therapy for Advanced Solid Tumors

    Not yet reported, Not yet reported Akeso 230 participants Est. completion 2028-05 1 site
    Other conditions: Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma, Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06944067

    Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

    National Human Genome Research Institute (NHGRI) 50 participants Est. completion 2030-04-10 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT06946537

    Nutritional Status and Patient Characteristics Upon Length of Stay, Clinical Outcome, and Survival in Older Hospitalized Patients

    Bispebjerg Hospital 1500 participants Est. completion 2028-11 1 site
    Other conditions: Geriatric, Malnutrition, Length of Stay
    View official trial listing →
  • Recruiting NCT NCT06948838

    Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

    Not yet reported Boston Medical Center 16895 participants Est. completion 2029-09 7 sites
    Other conditions: Hypertension, Hypertension Complicated
    View official trial listing →
  • Recruiting NCT NCT06949995

    Effects of Blood Flow Restriction on Post-Exercise Recovery in Amateur Runners

    Not yet reported Paulista University 34 participants Est. completion 2026-12 1 site
    Other conditions: Recovery Methods, Recovery Time
    View official trial listing →
  • Recruiting NCT NCT06953141

    Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery

    Holy Family Hospital, Nazareth, Israel 250 participants Est. completion 2026-12-15 1 site
    Other conditions: Post-Operative Hematoma at Operative Site (Diagnosis), Post-Operative Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT06954584

    Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer

    Not yet reported Tongji Hospital 424 participants Est. completion 2032-03-01 2 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT06957093

    Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial

    Not yet reported The First Hospital of Jilin University 400 participants Est. completion 2026-12 1 site
    Type 2 diabetes Other conditions: Artificial Intelligence (AI)
    View official trial listing →
  • Recruiting NCT NCT06957158

    The Effect of Serum Calcium Levels on Postoperative Pain: A Prospective Observational Study

    The Second Affiliated Hospital of Chongqing Medical University 350 participants Est. completion 2025-12 1 site
    Other conditions: Postoperative Pain
    View official trial listing →
  • Recruiting NCT NCT06957587

    A Deep Learning Model for Blood Volume Estimation From Multi-modal Ultrasound

    Shanghai 6th People's Hospital 800 participants Est. completion 2027-08-31 2 sites
    Other conditions: Blood Volume Analysis, Ultrasound, Machine Learning
    View official trial listing →
  • Recruiting NCT NCT06959771

    Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1 participants Est. completion 2027-10-28 1 site
    Other conditions: CD40L-HyperIgM Syndrome
    View official trial listing →
  • Recruiting NCT NCT06962995

    Multi-Cancer Detection Observational Cohort Study

    Mayo Clinic 500 participants Est. completion 2029-06-30 3 sites
    Other conditions: Cancer
    View official trial listing →
  • Recruiting NCT NCT06965257

    Non-invasive Blood Pressure Monitoring in Carotid Surgery

    Assistance Publique - Hôpitaux de Paris 40 participants Est. completion 2026-05 1 site
    Other conditions: Carotid Endarterectomy Surgery
    View official trial listing →
  • Recruiting NCT NCT06967532

    Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients

    Medical University of Vienna 90 participants Est. completion 2026-09 1 site
    Other conditions: NSCLC (Non-small Cell Lung Cancer)
    View official trial listing →
  • Recruiting NCT NCT06967831

    Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

    Charite University, Berlin, Germany 80 participants Est. completion 2030-02-28 2 sites
    Other conditions: Leigh Syndrome (Maternally Inherited, MILS), Leigh Syndrome (AR, AD, XR)
    View official trial listing →
  • Recruiting NCT NCT06968780

    Buccal Fat Pad vs. Palatal Rotation Scarf Grafts for Soft Tissue Management Around Zygomatic Implants

    Not yet reported Cairo University 8 participants Est. completion 2026-12-01 1 site
    Other conditions: Zygomatic Implants, Atrophic Maxilla, Soft Tissue Defect, Soft Tissue Healing
    View official trial listing →
  • Recruiting NCT NCT06969326

    Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

    Not yet reported Women and Infants Hospital of Rhode Island 48 participants Est. completion 2026-12-01 1 site
    Other conditions: Postoperative Bleeding, Gender Dysphoria, Hysterectomy
    View official trial listing →
  • Recruiting NCT NCT06969547

    Mechanical Dyssynchrony and Microvascular Dysfunction by SPECT

    Tomsk National Research Medical Center of the Russian Academy of Sciences 75 participants Est. completion 2026-05-15 1 site
    Other conditions: Myocardial Blood Flow Reserve, Mechanical Dyssynchrony, Coronary Arterial Disease (CAD)
    View official trial listing →
  • Recruiting NCT NCT06971991

    qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver

    Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2026-12 1 site
    Other conditions: Transarterial Embolism, Transarterial Chemoembolization, Radioembolization
    View official trial listing →
  • Recruiting NCT NCT06974006

    Life Monitoring for Rural Older Adults

    European University Miguel de Cervantes 82 participants Est. completion 2027-01-15 2 sites
    Other conditions: Aged 60 Years or Older
    View official trial listing →
  • Recruiting NCT NCT06974461

    Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia

    Not yet reported The Hong Kong Polytechnic University 64 participants Est. completion 2027-12-28 2 sites
    Cardiovascular disease Other conditions: Sarcopenia
    View official trial listing →
  • Recruiting NCT NCT06977477

    Managing Congestion in Heart Failure: A Mechanistic Study in Patients With HFpEF

    Not yet reported Otto-von-Guericke University Magdeburg 20 participants Est. completion 2026-01-31 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06980038

    Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

    Not yet reported National Cancer Institute (NCI) 44 participants Est. completion 2027-11-24 12 sites
    Other conditions: Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Nasal Cavity Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Nasal Cavity Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Laryngeal Cancer AJCC v8, Stage IVA Lip and Oral Cavity Cancer AJCC v8, Stage IVA Nasopharyngeal Carcinoma AJCC v8, Stage IVB Laryngeal Cancer AJCC v8, Stage IVB Lip and Oral Cavity Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06982261

    Voice Technology-Based Self-Management Intervention

    Not yet reported Emory University 20 participants Est. completion 2026-10 1 site
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT06983743

    A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    Not yet reported Erasca, Inc. 600 participants Est. completion 2028-12-01 9 sites
    Other conditions: Metastatic Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06983899

    Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

    Not yet reported Fred Hutchinson Cancer Center 100 participants Est. completion 2028-05-31 1 site
    Other conditions: Lung Non-Small Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06993415

    Optimize Risk Prediction After Myocardial Infarction: The ORACLE Study

    Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 750 participants Est. completion 2028-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06993727

    Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor Therapy

    Not yet reported Laura ICONARU 500 participants Est. completion 2027-12 3 sites
    Other conditions: Autoimmunity
    View official trial listing →
  • Recruiting NCT NCT06994962

    Multi-Component Breath Alcohol Intervention Phase 3

    Not yet reported Northeastern University 90 participants Est. completion 2027-01-31 1 site
    Alcohol use disorder Other conditions: Alcohol Use, Drinking Behavior
    View official trial listing →
  • Recruiting NCT NCT06995690

    Ketamine for Preventing Post-Spinal Hypotension in Orthopedic Surgery

    Not yet reported Ain Shams University 30 participants Est. completion 2025-11-01 1 site
    Other conditions: Post-spinal Hypotension, Orthopedic Surgery, Spinal Aneshtesia
    View official trial listing →
  • Recruiting NCT NCT06996249

    Prospective Data Collection Initiative on Thoracic Malignancies

    Dutch Society of Physicians for Pulmonology and Tuberculosis 12000 participants Est. completion 2030-01-01 23 sites
    Other conditions: Lung Cancer, Thoracic Cancer, Lung Cancer, Nonsmall Cell, Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Lung Cancer, Thymus Cancer, Mesothelioma
    View official trial listing →
  • Recruiting NCT NCT06996652

    An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    Not yet reported Yale University 108 participants Est. completion 2030-01-01 19 sites
    Other conditions: REM Sleep Behavior Disorder
    View official trial listing →
  • Recruiting NCT NCT06999096

    Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia

    Not yet reported University Hospital, Strasbourg, France 150 participants Est. completion 2030-08 4 sites Stand-alone
    Other conditions: Dystonia, Movement Disorders, Combined Dystonia, Complex Dystonia
    View official trial listing →
  • Recruiting NCT NCT06999785

    Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage

    Not yet reported University Hospital, Angers 60 participants Est. completion 2027-11-15 1 site
    Other conditions: Hyperbaric Oxygen, Genotoxicity, Malignancy
    View official trial listing →
  • Recruiting NCT NCT07000786

    EUmetriosis: Insights Into the Pathogenesis of Endometriosis

    Not yet reported Université Catholique de Louvain 60 participants Est. completion 2029-12-31 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT07002346

    INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

    Not yet reported Tongji Hospital 226 participants Est. completion 2029-06-01 1 site
    Other conditions: Ovarian Clear Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07003100

    A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

    City of Hope Medical Center 100 participants Est. completion 2026-10-19 10 sites
    Other conditions: Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome, Refractory Mycosis Fungoides, Refractory Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07003295

    Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

    Not yet reported National Cancer Institute (NCI) 20 participants Est. completion 2027-08-31 11 sites
    Other conditions: Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07005349

    THUMB: Multi-centre Cluster Trial for Caesarean Section Haemorrhage

    Not yet reported Bruce Biccard 2400 participants Est. completion 2026-06-30 1 site
    Other conditions: Postpartum Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT07006987

    HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women

    Not yet reported Chinese University of Hong Kong 100 participants Est. completion 2037-06-01 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT07008092

    Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children

    KBC Split 100 participants Est. completion 2026-05-01 1 site
    Other conditions: Acute Appendicitis, Acute Appendicitis With Rupture, Abdominal Pain (AP)
    View official trial listing →
  • Recruiting NCT NCT07008261

    Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.

    Goethe University 60 participants Est. completion 2027-12-31 1 site
    Other conditions: Transfusions, Cystectomy, Blood Loss Requiring Transfusion, Anaemia, Anaemia Postoperative, Pain, Postoperative
    View official trial listing →
  • Recruiting NCT NCT07008703

    Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

    Not yet reported, Not yet reported Shenyang Sunshine Pharmaceutical Co., LTD. 132 participants Est. completion 2025-12 1 site
    Other conditions: Cancer Pain
    View official trial listing →
  • Recruiting NCT NCT07010302

    Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

    Not yet reported Massachusetts General Hospital 540 participants Est. completion 2030-05 3 sites
    Other conditions: NMOSD
    View official trial listing →
  • Recruiting NCT NCT07011147

    Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

    Not yet reported University of Colorado, Denver 240 participants Est. completion 2029-04-01 2 sites
    Type 2 diabetes Other conditions: Type 1 Diabetes (T1D), Diabetes, Autoimmune, Diabetes Mellitus, Diabetes Mellitus, Type I, Diabetes, Type II, Diabetes, Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus Type II, Diabetes Type 2 on Insulin
    View official trial listing →
  • Recruiting NCT NCT07011810

    Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

    Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2030-02-10 3 sites
    Other conditions: Chronic Graft Versus Host Disease
    View official trial listing →
  • Recruiting NCT NCT07013682

    PRF as Adjunct to Subgingival Instrumentation in Step 2 Periodontal Therapy

    Not yet reported University of Bern 20 participants Est. completion 2027-12-24 1 site
    Other conditions: Periodontitis, Periodontal Inflammation, Periodontal Attachment Loss
    View official trial listing →
  • Recruiting NCT NCT07015437

    A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

    Not yet reported Cerus Corporation 120 participants Est. completion 2027-02-13 2 sites
    Other conditions: Healthy Subjects
    View official trial listing →
  • Recruiting NCT NCT07017816

    A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

    Not yet reported Children's National Research Institute 18 participants Est. completion 2028-05-01 1 site
    Other conditions: CNS Malignancies, Medulloblastoma Recurrent, ATRT Recurrent, Pineoblastoma, Embryonal Neoplasm, Ependymoma Recurrent, High Grade Gliomas
    View official trial listing →
  • Recruiting NCT NCT07020533

    A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

    Not yet reported City of Hope Medical Center 46 participants Est. completion 2029-05-30 3 sites
    Other conditions: Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphatic System Neoplasm, Hodgkin Lymphoma, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07024433

    Tubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung Cancer

    Not yet reported Fujian Medical University Union Hospital 224 participants Est. completion 2027-12-03 1 site
    Other conditions: Lung Cancer Patients
    View official trial listing →
  • Recruiting NCT NCT07024784

    A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

    Not yet reported AbbVie 377 participants Est. completion 2028-02 16 sites
    Other conditions: Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer (PSOC)
    View official trial listing →
  • Recruiting NCT NCT07025369

    Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

    Not yet reported Mayo Clinic 30 participants Est. completion 2029-03-31 1 site Stand-alone
    Other conditions: Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07029503

    Swedish Cardiac And Renal Failure Study-1

    Not yet reported Karolinska Institutet 40 participants Est. completion 2027-10 1 site
    Heart failureChronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT07030166

    A Machine Learning Prediction Model for Postoperative Acute Kidney Injury in Non-Cardiac Surgery Patients

    Lanyue Zhu 10000 participants Est. completion 2026-12-31 1 site
    Other conditions: Kidney Injury, Acute
    View official trial listing →
  • Recruiting NCT NCT07033663

    Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development

    Fundació Sant Joan de Déu 90 participants Est. completion 2028-05-01 3 sites
    Other conditions: Pregnancy Related, Immune-mediated Diseases
    View official trial listing →
  • Recruiting NCT NCT07034352

    Health Impact 360: Advancing Physical, Social, and Mental Health Toward Cardiovascular Disease Prevention in Community Settings

    Not yet reported University of Michigan 328 participants Est. completion 2026-12 7 sites
    Other conditions: Health Promotion, Cardiovascular Health
    View official trial listing →
  • Recruiting NCT NCT07035587

    Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

    Yonsei University 1200 participants Est. completion 2029-07-28 1 site
    Other conditions: Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Neoplasm Micrometastasis, Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07035691

    New bioMarkers tO straTIfy cOlorectal caNcer Referrals

    Queen Mary University of London 582 participants Est. completion 2027-08-31 1 site
    Other conditions: Colorectal Carcinoma, Polyp, Colorectal Adenoma
    View official trial listing →
  • Recruiting NCT NCT07035795

    Cardiovascular Physiological Signal Recording Project

    Chinese University of Hong Kong 198 participants Est. completion 2030-03 1 site
    Other conditions: Cardiovascular Physiological Signal
    View official trial listing →
  • Recruiting NCT NCT07036588

    PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage

    Not yet reported Third Military Medical University 968 participants Est. completion 2030-12-31 1 site
    Other conditions: Anastomotic Leak
    View official trial listing →
  • Recruiting NCT NCT07036796

    Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy

    Not yet reported Ain Shams University 60 participants Est. completion 2027-07-04 1 site
    Other conditions: Diabetic Peripheral Neuropathy, Diabetic Neuropathy, Diabetic Peripheral Neuropathy in Type 2 Diabetic Patients
    View official trial listing →
  • Recruiting NCT NCT07039305

    Physical Capacity Building for Chronic Stroke

    Not yet reported Medical University of South Carolina 76 participants Est. completion 2029-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07040306

    A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China

    First Hospital of China Medical University 1000 participants Est. completion 2030-12-01 1 site
    Other conditions: Graves´ Disease
    View official trial listing →
  • Recruiting NCT NCT07041086

    Prehospital ECPR in Moravia Silesia Region

    University Hospital Ostrava 100 participants Est. completion 2028-12-31 2 sites
    Other conditions: Cardiac Arrest, Out-Of-Hospital
    View official trial listing →
  • Recruiting NCT NCT07042802

    A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer

    Not yet reported, Not yet reported Nanjing Leads Biolabs Co.,Ltd 180 participants Est. completion 2028-12-25 13 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT07044310

    5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

    Not yet reported Mayo Clinic 38 participants Est. completion 2027-07-25 1 site
    Other conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07045948

    Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD

    Not yet reported Universitair Ziekenhuis Brussel 100 participants Est. completion 2028-06 1 site
    Other conditions: COPD
    View official trial listing →
  • Recruiting NCT NCT07046910

    Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

    Not yet reported University of Virginia 60 participants Est. completion 2029-03-31 1 site
    Other conditions: Lung Transplant Rejection
    View official trial listing →
  • Recruiting NCT NCT07046936

    Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

    Wake Forest University Health Sciences 30 participants Est. completion 2027-04 2 sites
    Other conditions: Gynecologycal Cancer
    View official trial listing →
  • Recruiting NCT NCT07047014

    Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke

    Not yet reported Beijing Tiantan Hospital 596 participants Est. completion 2027-06-30 7 sites
    Cardiovascular disease Other conditions: Medium Vessel Occlusions
    View official trial listing →
  • Recruiting NCT NCT07048509

    Difference in Acute Responses of Vascular Function to Moderate-intensity and High-intensity Interval Training in Healthy and Prehypertensive Individuals

    Not yet reported University of Ljubljana 45 participants Est. completion 2026-06 1 site
    Other conditions: Prehypertension (Elevated Blood Pressure) or Hypertension, Healthy
    View official trial listing →
  • Recruiting NCT NCT07050043

    Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC

    Not yet reported Dr Arvindran A/L Alaga 123 participants Est. completion 2030-12-31 1 site
    Other conditions: NSCLC (Non-small Cell Lung Carcinoma), First Line Therapy, Locally Advanced/Metastatic NSCLC
    View official trial listing →
  • Recruiting NCT NCT07052123

    Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device

    Not yet reported Centre Hospitalier de Saint-Denis 2 participants Est. completion 2028-03-24 1 site
    Other conditions: Hemodynamics, Blood Pressure Monitoring, Intensive Care Units, Critical Illness, Monitoring, Physiologic
    View official trial listing →
  • Recruiting NCT NCT07057466

    Prospective Evaluation of AI-ECG for SHD Detection

    Imperial College London 590 participants Est. completion 2027-08-02 5 sites
    Heart failure Other conditions: Valvular Heart Disease Stenosis and Regurgitation (Diagnosis), Pulmonary Hypertension (Diagnosis)
    View official trial listing →
  • Recruiting NCT NCT07058948

    Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2027-07-01 3 sites
    Other conditions: Solid Cancers, Radiotherapy, Immune Checkpoint Inhibitor, Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT07061574

    A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

    Not yet reported, Not yet reported City of Hope Medical Center 120 participants Est. completion 2031-04-15 10 sites
    Other conditions: Type 1 Diabetes, New Onset
    View official trial listing →
  • Recruiting NCT NCT07066527

    Efficacy and Safety Analysis of Polylauric Alcohol More Stable Foam Versus Ordinary Foam in the Treatment of Head and Neck Venous Malformations

    Not yet reported Qilu Hospital of Shandong University 110 participants Est. completion 2026-06-30 1 site
    Other conditions: Venous Malformation
    View official trial listing →
  • Recruiting NCT NCT07066657

    A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

    Not yet reported ArriVent BioPharma, Inc. 572 participants Est. completion 2030-12 21 sites
    Other conditions: Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT07070583

    Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

    Not yet reported Rijnstate Hospital 20 participants Est. completion 2027-12-31 1 site
    Other conditions: Aorto Iliac Occlusive Disease, Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT07071051

    Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study

    Mayo Clinic 15 participants Est. completion 2026-12-31 1 site
    Other conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Lymphoblastic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07073456

    Viscoelastic Coagulation for Early Sepsis Detection

    Hellenic Institute for the Study of Sepsis 150 participants Est. completion 2025-11-25 1 site
    Other conditions: Infection, Sepsis
    View official trial listing →
  • Recruiting NCT NCT07074457

    Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients

    Not yet reported The First Affiliated Hospital of Soochow University 47 participants Est. completion 2028-11-01 1 site
    Other conditions: CD30+ Peripheral T-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07075601

    Non-interventional Study Exploring the Composition of the Valvular Microbiota of Patients Undergoing Cardiac Surgery

    Not yet reported University Hospital, Toulouse 200 participants Est. completion 2029-08-31 1 site
    Other conditions: Valvulopathy, Cardiac Surgery, Microbiota
    View official trial listing →
  • Recruiting NCT NCT07079930

    Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers

    Not yet reported Hadassah Medical Organization 10 participants Est. completion 2027-02 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07080229

    Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery

    Not yet reported Suez Canal University 126 participants Est. completion 2026-05 1 site
    Other conditions: Cataract, Hypertension
    View official trial listing →
  • Recruiting NCT NCT07084129

    Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

    Not yet reported Children's Hospital of Philadelphia 20 participants Est. completion 2027-05-31 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Recruiting NCT NCT07084727

    Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia

    Not yet reported University Hospital, Antwerp 60 participants Est. completion 2025-12-15 1 site
    Other conditions: Endothelial Function (FMD), Preeclampsia, Retinal Vessels
    View official trial listing →
  • Recruiting NCT NCT07085611

    Neutralizing Power of Serum Antibodies - 2

    Not yet reported Centre Hospitalier Régional d'Orléans 30 participants Est. completion 2035-07-11 1 site
    Obstructive sleep apnea Other conditions: COVID-19, SARS-CoV-2 Viraemia, Monkey Pox, Vaccination, Serum
    View official trial listing →
  • Recruiting NCT NCT07091799

    Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS

    Not yet reported University Hospital, Bordeaux 50 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders
    View official trial listing →
  • Recruiting NCT NCT07094750

    Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

    Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2029-06-08 1 site
    Other conditions: Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Neoplasm
    View official trial listing →
  • Recruiting NCT NCT07095023

    Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 112 participants Est. completion 2029-06-30 9 sites
    Other conditions: Breast Cancers
    View official trial listing →
  • Recruiting NCT NCT07095569

    Shoulder Denervation for Post Mastectomy Irradiation Shoulder Pain

    Not yet reported National Cancer Institute, Egypt 60 participants Est. completion 2026-08-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07100704

    Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab

    Not yet reported National Cancer Center Hospital East 14 participants Est. completion 2028-10-14 2 sites
    Other conditions: Recurrent/ Metastatic Olfactory Neuroblastoma
    View official trial listing →
  • Recruiting NCT NCT07101445

    Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

    Not yet reported Emory University 94 participants Est. completion 2027-12-31 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT07104019

    Biofiller and Gingival Phenotype Thickening

    Not yet reported Inonu University 34 participants Est. completion 2026-05-01 1 site
    Other conditions: Gingival Recession, Gingival Diseases, Gingival Inflammation
    View official trial listing →
  • Recruiting NCT NCT07109856

    The Peripheral(-Muscle) Oxygenation and Perfusion Score as a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates

    Medical University of Graz 93 participants Est. completion 2028-05-01 1 site
    Other conditions: Prematurity, Infections, NIRS, Near Infrared Spectroscopy, Preterm Neonates, Term Infant, Infection, Neonatal Sepsis, Early-Onset
    View official trial listing →
  • Recruiting NCT NCT07111221

    Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss

    Not yet reported Medical University of Warsaw 104 participants Est. completion 2029-12 1 site
    Other conditions: Liver Cirrhosis, Clinically Significant Portal Hypertension
    View official trial listing →
  • Recruiting NCT NCT07111598

    Immunological Effects of Iron Supplementation in HHT Disease

    Not yet reported Hospices Civils de Lyon 155 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Hereditary Haemorrhagic Telangiectasia
    View official trial listing →
  • Recruiting NCT NCT07118137

    Memory Deterioration in Alzheimer Disease

    Norwegian University of Science and Technology 30 participants Est. completion 2027-12-31 1 site
    Other conditions: Alzheimer Disease, Neurodegenerative Diseases, Magnetic Resonance Imaging, Memory Impairment
    View official trial listing →
  • Recruiting NCT NCT07119788

    Investigating the Effects of a Haskap Berry Supplement on Cognitive Health

    Not yet reported University of Reading 90 participants Est. completion 2026-04 1 site
    Other conditions: Cognition
    View official trial listing →
  • Recruiting NCT NCT07121595

    Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

    Not yet reported University of Michigan Rogel Cancer Center 50 participants Est. completion 2030-07-01 1 site
    Other conditions: Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage IVA Lip and Oral Cavity Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07129148

    Mobile Health and Wearable Devices for Diabetes Complication Management

    Not yet reported Second Xiangya Hospital of Central South University 6000 participants Est. completion 2027-10-01 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus Complications
    View official trial listing →
  • Recruiting NCT NCT07131007

    Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

    Hebei Medical University Fourth Hospital 2000 participants Est. completion 2029-01-01 1 site
    Other conditions: Malignant Neoplasm, Organ Damage
    View official trial listing →
  • Recruiting NCT NCT07131631

    Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

    Minneapolis Heart Institute Foundation 125 participants Est. completion 2027-07 6 sites
    Heart failure Other conditions: Functional Mitral Regurgitation
    View official trial listing →
  • Recruiting NCT NCT07132736

    Impact of Underwater Exercise Versus Regular Aerobic Exercise on Quality of Life and Power of Muscle

    Not yet reported October 6 University 100 participants Est. completion 2026-01-20 1 site
    Other conditions: Muscle Weakness | Patient, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT07133997

    Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

    Not yet reported City of Hope Medical Center 26 participants Est. completion 2028-06-01 1 site
    Other conditions: Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT07135531

    Continuous Glucose Monitoring (CGM) in an Underserved Population

    Not yet reported Tulane University 50 participants Est. completion 2027-07 1 site
    Other conditions: Diabetes, Diabetes Mellitus, Diabetes Type 2
    View official trial listing →
  • Recruiting NCT NCT07135583

    Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury

    Not yet reported Thomas Jefferson University 20 participants Est. completion 2027-08-15 1 site
    Other conditions: Spinal Cord Injury, Chronic, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic, Incomplete Spinal Cord Injury
    View official trial listing →
  • Recruiting NCT NCT07139873

    A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)

    Not yet reported Dizal Pharmaceuticals 250 participants Est. completion 2029-12 2 sites
    Other conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07148921

    Perception of Pain During Gender Affirming Hormone Therapy

    Medical University of Vienna 40 participants Est. completion 2026-03 1 site
    Other conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex Hormones
    View official trial listing →
  • Recruiting NCT NCT07150715

    Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma

    Not yet reported Jonsson Comprehensive Cancer Center 107 participants Est. completion 2031-10-31 1 site
    Other conditions: Oligometastatic Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07152678

    Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2028-09 1 site
    Other conditions: Esophageal Cancer, Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07158021

    Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

    Not yet reported University of Michigan Rogel Cancer Center 75 participants Est. completion 2028-01-01 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07167693

    Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

    Not yet reported, Not yet reported David K Carroll 60 participants Est. completion 2027-12-31 1 site
    Other conditions: Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes, Hyperglycaemia (Diabetic)
    View official trial listing →
  • Recruiting NCT NCT07168161

    BDB-001 Phase III Trial in ANCA-Associated Vasculitis

    Not yet reported Staidson (Beijing) Biopharmaceuticals Co., Ltd 300 participants Est. completion 2028-02-29 65 sites
    Other conditions: ANCA Associated Vasculitis (AAV)
    View official trial listing →
  • Recruiting NCT NCT07178509

    A Study of SCAD Using Stress Contrast Echocardiography

    Mayo Clinic 50 participants Est. completion 2027-09 1 site
    Other conditions: Spontaneous Coronary Artery Dissection
    View official trial listing →
  • Recruiting NCT NCT07178769

    Study To Evaluate The Efficacy And Safety Of A Nutritional Supplement Based On Bergamot, Artichoke And Other Ingredients For Reducing Cholesterol Levels In Patients With Hypercholesterolemia (Metachol+)

    Not yet reported Laboratoires Arkopharma 207 participants Est. completion 2026-07-30 7 sites
    Other conditions: Cholesterolemia
    View official trial listing →
  • Recruiting NCT NCT07182214

    An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

    Pharus Taiwan, Inc. 1340 participants Est. completion 2026-12-31 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT07183761

    A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy

    Not yet reported Min Long 140 participants Est. completion 2028-08-30 1 site
    Other conditions: Diabetic Peripheral Neuropathy (DPN)
    View official trial listing →
  • Recruiting NCT NCT07186179

    Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)

    Northwell Health 10 participants Est. completion 2027-04-01 1 site
    Other conditions: Diamond Blackfan Anemia
    View official trial listing →
  • Recruiting NCT NCT07188506

    Youth Suicide Risk Factors, Reduction of Suicide Risk Factor in Youth People

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 180 participants Est. completion 2028-10-31 1 site
    Other conditions: Mood Disorders, Suicide, Attempted, Suicidal Ideation, Suicide Prevention
    View official trial listing →
  • Recruiting NCT NCT07191717

    Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

    Not yet reported Jonsson Comprehensive Cancer Center 42 participants Est. completion 2031-04-30 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma, Localized Estrogen Receptor-Positive Breast Carcinoma, Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07193862

    Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

    Not yet reported Northwell Health 10 participants Est. completion 2028-04-15 2 sites
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT07195682

    A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

    Not yet reported Bristol-Myers Squibb 281 participants Est. completion 2031-04-03 11 sites
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07195734

    Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

    Not yet reported National Cancer Institute (NCI) 180 participants Est. completion 2033-02-01 110 sites
    Other conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma, Locally Recurrent Laryngeal Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oropharyngeal Squamous Cell Carcinoma, Stage II Laryngeal Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8, Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Laryngeal Cancer AJCC v8, Stage IVA Lip and Oral Cavity Cancer AJCC v8, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Laryngeal Cancer AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07199803

    OBS-QoR-10 in Patients With and Without Postpartum Hemorrhage

    Samuel Lunenfeld Research Institute, Mount Sinai Hospital 152 participants Est. completion 2026-07 1 site
    Other conditions: Postpartum Hemorrhage (Primary)
    View official trial listing →
  • Recruiting NCT NCT07199998

    Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota

    Centre National de la Recherche Scientifique, France 300 participants Est. completion 2027-03 1 site
    Other conditions: Sexual Transmitted Disease, Vaginosis, Bacterial, Mycosis, Urogenital Disease, HPV, Dysbiosis, Toxic Shock Syndrome, Menstrual Cup
    View official trial listing →
  • Recruiting NCT NCT07200778

    Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping

    Not yet reported Minia University 66 participants Est. completion 2026-03-11 1 site
    Other conditions: Laparoscopic Myomectomy
    View official trial listing →
  • Recruiting NCT NCT07200830

    Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    Not yet reported Alliance for Clinical Trials in Oncology 1524 participants Est. completion 2034-09-09 138 sites
    Other conditions: Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07201363

    Biomarkers of Inflammation and Fibrosis in Conduction Disorders After TAVI

    Clinical Hospital Center Rijeka 102 participants Est. completion 2026-08 1 site
    Other conditions: TAVI(Transcatheter Aortic Valve Implantation), Conduction Disorder, Aortic Stenosis, Permanent Pacemaker Implantation
    View official trial listing →
  • Recruiting NCT NCT07203833

    Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock

    Not yet reported Centre Hospitalier Universitaire, Amiens 144 participants Est. completion 2027-05 1 site
    Other conditions: Vasorin, Septic Shock, Shock, Biomarker, Infection
    View official trial listing →
  • Recruiting NCT NCT07206238

    Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

    Rigshospitalet, Denmark 122 participants Est. completion 2029-03-30 1 site
    Other conditions: Giant Cell Arteritis (GCA), Ischemic Optic Neuropathy, NAION - Non-Arteritic Ischemic Optic Neuropathy
    View official trial listing →
  • Recruiting NCT NCT07208019

    Electroacupuncture Treatment for Post-stroke Cognitive Impairment

    Not yet reported Ruijie Ma 340 participants Est. completion 2027-03-30 5 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07208097

    Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage

    Not yet reported Tongji Hospital 768 participants Est. completion 2028-06-30 2 sites
    Other conditions: Intracerebral Haemorrhage, Minimally Invasive Treatment
    View official trial listing →
  • Recruiting NCT NCT07208500

    Effect of Delayed Remote Ischemic Preconditioning on Postoperative Pulmonary Complications in Elderly Patients Having Non-Cardiac Thoracic Surgery

    Not yet reported Shanghai Geriatric Medical Center 390 participants Est. completion 2027-10 1 site
    Other conditions: Pulmonary Complications in Surgical Patients
    View official trial listing →
  • Recruiting NCT NCT07208669

    Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes

    Not yet reported Elizabeth Pfoh 4 participants Est. completion 2027-07-31 2 sites
    Other conditions: Blood Pressure Control
    View official trial listing →
  • Recruiting NCT NCT07212933

    The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial

    Not yet reported Chinese PLA General Hospital 90 participants Est. completion 2028-06-30 1 site
    Other conditions: Gastric (Stomach) Cancer, Biological Therapy, Immunotherapy
    View official trial listing →
  • Recruiting NCT NCT07217769

    Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers

    Not yet reported University of Pittsburgh 130 participants Est. completion 2030-08-31 1 site
    Other conditions: Shift Work
    View official trial listing →
  • Recruiting NCT NCT07217873

    IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study

    Not yet reported, Not yet reported Columbia University 120 participants Est. completion 2027-10-31 1 site
    Other conditions: Scoliosis Correction, Iron Deficiency, Transfusion Blood, Surgery Complications, Spinal Fusion, Scoliosis Idiopathic Adolescent, Scoliosis Neuromuscular
    View official trial listing →
  • Recruiting NCT NCT07218978

    Ripe for Revival: Outcomes Evaluation of a Mobile Produce Market With Vouchers

    Not yet reported North Carolina State University 150 participants Est. completion 2028-03-31 1 site
    Other conditions: Diet Interventions, Food Security, Nutrition Security, Fruit and Vegetable Intake
    View official trial listing →
  • Recruiting NCT NCT07223424

    Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

    Not yet reported Diwakar Davar 880 participants Est. completion 2030-11-30 1 site
    Other conditions: Renal Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma, Colo-rectal Cancer (dMMR/MSI-H CRC), Hepatocellular Carcinoma, Ulcerative Colitis, Esophageal Cancer, Squamous Cell Carcinoma, Gastric/GEJ, Cervical Cancer, Gastro-Esophageal Adenocarcinoma, Esophageal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07224750

    A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

    City of Hope Medical Center 1000 participants Est. completion 2028-06-18 1 site
    Other conditions: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer (GC), Colorectal Cancer Screening
    View official trial listing →
  • Recruiting NCT NCT07225270

    Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

    Not yet reported Genmab 544 participants Est. completion 2030-05 22 sites
    Other conditions: Ovarian Cancer, Platinum-sensitive Ovarian Cancer, PSOC
    View official trial listing →
  • Recruiting NCT NCT07225842

    The Bridging Antiplatelet Therapy With Cangrelor 2 Study

    Not yet reported University of Florida 50 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Coronary Arterial Disease (CAD)
    View official trial listing →
  • Recruiting NCT NCT07226544

    Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

    Not yet reported City of Hope Medical Center 31 participants Est. completion 2027-09-08 1 site
    Other conditions: Localized Clear Cell Renal Cell Carcinoma, Resectable Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07226843

    A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    Not yet reported Eli Lilly and Company 460 participants Est. completion 2030-02 46 sites
    Other conditions: Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07232277

    Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury

    Zhuan Zhang 114 participants Est. completion 2026-09-30 1 site
    Other conditions: Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury
    View official trial listing →
  • Recruiting NCT NCT07232342

    Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes

    Benha University 100 participants Est. completion 2026-10-30 1 site
    Other conditions: Peritonitis Infectious
    View official trial listing →
  • Recruiting NCT NCT07235111

    Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases

    Ospedale Policlinico San Martino 1200 participants Est. completion 2039-09-17 1 site
    Other conditions: Alzheimer Disease, FTD, Young-onset Dementia, MCI, Parkinson Disease, ALS (Amyotrophic Lateral Sclerosis)
    View official trial listing →
  • Recruiting NCT NCT07235865

    Non-Invasive Diagnosis and Monitoring of Cardiac Masses by Liquid Biopsy

    Niguarda Hospital 26 participants Est. completion 2026-12-25 1 site
    Other conditions: Cardiac Masses
    View official trial listing →
  • Recruiting NCT NCT07236190

    Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

    Not yet reported Massachusetts General Hospital 40 participants Est. completion 2027-06 1 site
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
    View official trial listing →
  • Recruiting NCT NCT07237984

    Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway

    Nordsjaellands Hospital 2000 participants Est. completion 2031-12-31 2 sites
    Other conditions: Colorectal Cancer, Colorectal Adenoma, Inflammatory Bowel Disease (IBD)
    View official trial listing →
  • Recruiting NCT NCT07238712

    Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

    Not yet reported St. Petersburg State Pavlov Medical University 60 participants Est. completion 2026-12-10 1 site
    Other conditions: Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia, Myelodysplastic Syndromes (MDS), Myeloprolipherative Neoplsm, Atypical Chronic Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07239245

    Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30 participants Est. completion 2030-11-10 4 sites
    Other conditions: Resectable Hepatocellular Carcinoma With High Risk of Recurrence
    View official trial listing →
  • Recruiting NCT NCT07239375

    Intraosseous Infusion in Hematologic Critical Patients

    Shanxi Bethune Hospital 52 participants Est. completion 2027-10-23 1 site
    Other conditions: Intraosseous Infusions
    View official trial listing →
  • Recruiting NCT NCT07240883

    ENDO1000 - A UK-wide Endometriosis Research Project

    University of Edinburgh 1000 participants Est. completion 2030-12-31 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT07243964

    Multi-Omics-Based Prediction of Allograft Dysfunction After Lung Transplantation

    Chang Chen 244 participants Est. completion 2030-03-01 1 site
    Other conditions: Lung Diseases
    View official trial listing →
  • Recruiting NCT NCT07244705

    A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

    Not yet reported, Not yet reported Anbogen Therapeutics, Inc. 66 participants Est. completion 2028-07 15 sites
    Other conditions: Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC), Immunotherapy
    View official trial listing →
  • Recruiting NCT NCT07246863

    Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

    Not yet reported CatalYm GmbH 131 participants Est. completion 2031-10-01 34 sites
    Other conditions: Metastatic Non-Squamous Non-Small Cell Lung Cancer, Adult Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT07248371

    Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

    Chang Gung Memorial Hospital 6266 participants Est. completion 2035-09-30 1 site
    Metabolic syndromeCardiovascular diseaseChronic kidney diseaseMASLD Other conditions: Obesity & Overweight, Healthy
    View official trial listing →
  • Recruiting NCT NCT07250217

    Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

    Not yet reported Groupe Hospitalier de la Region de Mulhouse et Sud Alsace 30 participants Est. completion 2027-12-01 2 sites
    Other conditions: Acute Myeloblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT07251179

    Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies

    University Hospital, Strasbourg, France 200 participants Est. completion 2031-12-31 1 site
    Other conditions: Systemic Lupus Erythematosus, Systemic Scleroderma, ANCA-associated Vasculitis, Antiphospholipid Syndrome, Primary Immunodeficiencies
    View official trial listing →
  • Recruiting NCT NCT07252778

    Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes

    Not yet reported, Not yet reported Krzysztof Durkalec-Michalski 30 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Sports Nutrition, Biochemical Markers, Exercise Performance, Aerobic Capacity, Supplementation
    View official trial listing →
  • Recruiting NCT NCT07254078

    Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension

    Irina E. Chazova 500 participants Est. completion 2035-05-01 1 site
    Other conditions: Chronic Thromboembolic Pulmonary Hypertension
    View official trial listing →
  • Recruiting NCT NCT07255157

    Peripheral Helper T-cells in Common Variable ImmunoDeficiency

    Not yet reported University Hospital, Bordeaux 60 participants Est. completion 2028-01 1 site
    Other conditions: Common Variable Immunodeficiency
    View official trial listing →
  • Recruiting NCT NCT07259226

    Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

    Not yet reported UNICANCER 400 participants Est. completion 2030-11-01 1 site
    Other conditions: Advanced Breast Cancer, Advanced Gastric Cancer, Advanced Urothelial Cancer, Advanced Non Small Cell Lung Cancer (NSCLC)
    View official trial listing →
  • Recruiting NCT NCT07259733

    Rapid Management of Resistant Hypertension in the Public Health System (Fast Control)

    Not yet reported Instituto Dante Pazzanese de Cardiologia 142 participants Est. completion 2026-12-31 1 site
    Other conditions: Apparent Resistant Hypertension, Hypertension, High Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT07260370

    The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy

    Chang Gung Memorial Hospital 300 participants Est. completion 2026-04-30 1 site
    Other conditions: microRNA, Circulating Tumor Cells, Immunotherapy
    View official trial listing →
  • Recruiting NCT NCT07261657

    N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

    Not yet reported Seth Pollack 8 participants Est. completion 2032-09-02 1 site
    Obstructive sleep apnea Other conditions: Synovial Sarcoma
    View official trial listing →
  • Recruiting NCT NCT07265674

    A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

    Not yet reported J-Pharma Co., Ltd. 480 participants Est. completion 2027-10 18 sites
    Other conditions: Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
    View official trial listing →
  • Recruiting NCT NCT07266142

    Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker

    Universitaire Ziekenhuizen KU Leuven 7500 participants Est. completion 2051-01 1 site
    Other conditions: Skin Cancer, Non-Melanoma, Skin Cancer Melanoma
    View official trial listing →
  • Recruiting NCT NCT07269561

    Headache Registration and Followup Initiated by Tongji Hospital, HUST

    Tongji Hospital 50000 participants Est. completion 2028-12-31 1 site
    Other conditions: Headache, Comorbidities
    View official trial listing →
  • Recruiting NCT NCT07270666

    ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2027-11 7 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT07271342

    Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China

    Beijing Tiantan Hospital 10000 participants Est. completion 2029-06-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07271355

    Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

    Not yet reported City of Hope Medical Center 129 participants Est. completion 2031-02-28 5 sites
    Other conditions: Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum, Stage IV Appendix Carcinoma AJCC v8, Stage IVC Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07275697

    Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

    Not yet reported Emma Svennberg 200 participants Est. completion 2028-12-30 1 site
    Other conditions: Atrial Fibrillation (AF), Obesity & Overweight
    View official trial listing →
  • Recruiting NCT NCT07277114

    DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR

    Not yet reported Shanghai Zhongshan Hospital 656 participants Est. completion 2030-12-31 1 site
    Other conditions: Coronary Calcification
    View official trial listing →
  • Recruiting NCT NCT07277387

    Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

    Instituto de Investigación Biomédica de Salamanca 350 participants Est. completion 2029-01 3 sites
    Other conditions: Febrile Neutropenia
    View official trial listing →
  • Recruiting NCT NCT07284563

    Ultralow Dose PET Imaging for 18F-NaF Uptake

    Not yet reported Akiva Mintz 200 participants Est. completion 2030-06-30 2 sites
    Other conditions: Healthy Volunteer, Bone Alteration, Bone and Joint Cancer, Bone and Joint Infection, Arthritis
    View official trial listing →
  • Recruiting NCT NCT07291765

    Blood Flow Restriction Training in Acute Geriatric Rehabilitation

    Not yet reported University Hospital, Bonn 60 participants Est. completion 2027-03-31 1 site
    Other conditions: Sarcopenia in Elderly
    View official trial listing →
  • Recruiting NCT NCT07293403

    Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

    Not yet reported City of Hope Medical Center 25 participants Est. completion 2027-11-23 1 site
    Other conditions: Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
    View official trial listing →
  • Recruiting NCT NCT07294131

    Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electromyography-driven Serious Game.

    Not yet reported Vrije Universiteit Brussel 120 participants Est. completion 2029-01-01 3 sites
    Other conditions: Hospital Associated Disability, Immobility, Older Adults (65 Years and Older)
    View official trial listing →
  • Recruiting NCT NCT07294521

    Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers

    Not yet reported Pak Emirates Military Hospital 40 participants Est. completion 2026-05-12 1 site
    Other conditions: Chronic Leg Ulcer
    View official trial listing →
  • Recruiting NCT NCT07296965

    Oral Microbiome in Carotid Atherosclerosis

    Semmelweis University Heart and Vascular Center 200 participants Est. completion 2029-11-01 1 site
    Cardiovascular disease Other conditions: Atherosclerosis of Artery, Carotid Artery Plaque, Periodontitis, Carotid Artery Diseases
    View official trial listing →
  • Recruiting NCT NCT07299695

    Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

    Not yet reported Argyrios Tzouvelekis 196 participants Est. completion 2028-12 1 site
    Other conditions: Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis
    View official trial listing →
  • Recruiting NCT NCT07301801

    Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10 participants Est. completion 2026-09-30 1 site
    Other conditions: Malignant Tumors, SSTR2, PET
    View official trial listing →
  • Recruiting NCT NCT07302425

    High-intensity Resistance Training in Post-exacerbation COPD

    Not yet reported Istituti Clinici Scientifici Maugeri SpA 64 participants Est. completion 2028-05 1 site
    Other conditions: COPD Exacerbation
    View official trial listing →
  • Recruiting NCT NCT07304323

    Prepare II - Predictive Model Training and External Validation

    I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 400 participants Est. completion 2026-10-31 1 site
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT07304440

    Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study

    Not yet reported Adia Med of Winter Park LLC 100 participants Est. completion 2028-06-15 2 sites
    Other conditions: Autism Spectrum Disorder, Autism, ASD, Autism Spectrum Disorder (ASD)
    View official trial listing →
  • Recruiting NCT NCT07304856

    Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

    University of Milan 80 participants Est. completion 2026-08-20 1 site
    Other conditions: Lymphangioleiomyomatosis (LAM), Extracellular Vesicles; Generation and Function
    View official trial listing →
  • Recruiting NCT NCT07308132

    A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies

    Not yet reported Janssen Research & Development, LLC 340 participants Est. completion 2029-10-31 19 sites
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Recruiting NCT NCT07310316

    Efficacy and Safety of Variceal Embolization Combined With Partial Splenic Artery Embolization for Variceal Bleeding in Cavernous Transformation of Portal Vein.

    Not yet reported Air Force Military Medical University, China 26 participants Est. completion 2026-09-30 1 site
    Other conditions: Cavernous Transformation of Portal Vein, Gastroesophageal Varices Bleeding
    View official trial listing →
  • Recruiting NCT NCT07315750

    A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

    Not yet reported RemeGen Co., Ltd. 555 participants Est. completion 2030-12-31 1 site
    Other conditions: Gastric Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07318610

    Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

    Not yet reported Regeneron Pharmaceuticals 7050 participants Est. completion 2029-11-16 20 sites
    Other conditions: Peripheral Artery Disease (PAD)
    View official trial listing →
  • Recruiting NCT NCT07322133

    Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

    Not yet reported University of California, Davis 30 participants Est. completion 2027-06-30 1 site
    Other conditions: Hypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN), Hypoxemic Respiratory Failure
    View official trial listing →
  • Recruiting NCT NCT07322406

    Kaempferol Absorption and Pharmacokinetics Evaluation

    Not yet reported University of Pittsburgh 120 participants Est. completion 2027-12-22 3 sites
    Other conditions: No Disease, Mitochondria Health, Longevity, Pharmacokinetics and Biological Absorption of Kaempferol in Healthy Adult, Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07322419

    Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine

    Not yet reported Mansoura University 200 participants Est. completion 2026-12-31 1 site
    Other conditions: Cesarean Delivery, Spinal Anesthesia for Cesarean Section
    View official trial listing →
  • Recruiting NCT NCT07323641

    Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

    Not yet reported Jonsson Comprehensive Cancer Center 60 participants Est. completion 2028-02-01 1 site
    Other conditions: Lung Non-Small Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07328035

    Remission in Adults With Severe Asthma in Thailand

    Thammasat University 230 participants Est. completion 2026-12-31 1 site
    Other conditions: Severe Asthma, Asthma Control Level
    View official trial listing →
  • Recruiting NCT NCT07339111

    Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

    Not yet reported Medipost, Inc. 300 participants Est. completion 2029-06-30 30 sites
    Other conditions: Knee Cartilage Defects
    View official trial listing →
  • Recruiting NCT NCT07342634

    Effect of Blood Flow Restriction on Recovery After Maximal Resistance Exercise

    Not yet reported Paulista University 80 participants Est. completion 2026-12 1 site
    Other conditions: Recovery, Recovery Time
    View official trial listing →
  • Recruiting NCT NCT07342803

    Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

    Not yet reported Longbio Pharma 200 participants Est. completion 2029-09-30 1 site
    Other conditions: Allergic Asthma
    View official trial listing →
  • Recruiting NCT NCT07343752

    To Evaluate the Efficiency and Results of Adding BFR to the Physical Therapy Program fo Managing Adolescents Presented With Spasmotic Flatfoot Deformities Compared to the Standard Physical Therapy Program Without BFR

    Not yet reported Assiut University 40 participants Est. completion 2026-12 1 site
    Other conditions: Flat Foot; Spastic
    View official trial listing →
  • Recruiting NCT NCT07345091

    Feasibility Performance Study of ABL90 FLEX PLUS HEM

    Radiometer Medical ApS 95 participants Est. completion 2026-06-10 1 site
    Other conditions: Hemolysis
    View official trial listing →
  • Recruiting NCT NCT07350785

    Prediction of Mortality and Morbidity After Hip Fracture Using Monocyte Distribution Width (MDW)

    National and Kapodistrian University of Athens 100 participants Est. completion 2026-03-01 1 site
    Other conditions: Sepsis, Osteoporotic Hip Fracture, Hip Fracture
    View official trial listing →
  • Recruiting NCT NCT07352215

    PRP Plus Fractional CO₂ Laser for Acne Scars

    Not yet reported Gujranwala medical college District Headquarters Hospital, Gujranwala 70 participants Est. completion 2026-04-30 1 site
    Other conditions: Post-Acne Atrophic Scars, Carbon Dioxide Lasers, Platelet-Rich Plasma
    View official trial listing →
  • Recruiting NCT NCT07356245

    Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

    Not yet reported Jonathan Brammer 44 participants Est. completion 2027-01-31 1 site
    Other conditions: T-cell Lymphoma, Graft Versus Host Disease, Lymphoma, T-Cell, Peripheral T Cell Lymphoma, T-cell Prolymphocytic Leukemia, Cutaneous T Cell Lymphoma, Adult T-cell Leukemia/Lymphoma, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07356570

    Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

    Hospices Civils de Lyon 150 participants Est. completion 2026-06 2 sites
    Other conditions: Post-Acute COVID-19 Syndrome
    View official trial listing →
  • Recruiting NCT NCT07357324

    A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate

    Not yet reported The Fourth Affiliated Hospital of Zhejiang University School of Medicine 136 participants Est. completion 2026-12-31 1 site
    Other conditions: Benign Prostatic Hyperplasia, Nocturia Associated With Nocturnal Polyuria
    View official trial listing →
  • Recruiting NCT NCT07361380

    Non-Invasive Testing Device for Anaemia

    University of Oxford 300 participants Est. completion 2026-10-01 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Recruiting NCT NCT07362225

    MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

    MPN Research Foundation 5000 participants Est. completion 2035-09-08 2 sites
    Other conditions: Polycythemia Vera, ET (Essential Thrombocythemia), Polycythemia Vera (PV), Essential Thrombocythemia (ET), Primary Myelofibrosis (MF), Primary Myelofibrosis (PMF), Myelofibrosis, Myelofibrosis (MF), Myelofibrosis, Primary, Myelofibrosis, Post ET, Myelofibrosis, Post PV, Myelofibrosis (PMF), Myelofibrosis,MF, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis, Myelofibrosis Due to and Following Polycythemia Vera, Myelofibrosis Transformation in Essential Thrombocythemia, Myelofibrosis With High Molecular Risk Mutations, MF, Secondary Myelofibrosis, Secondary Myelofibrosis in Myeloproliferative Disease, Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis), Post-Polycythemia Vera Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), Post-polycythemia Vera Myelofibrosis(Post-PV MF), Post-PV MF, Post-Essential Thrombocythemia Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis (PET-MF), Post-essential Thrombocythemia Myelofibrosis(Post-ET MF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF), Post-ET MF, Pre-fibrotic Myelofibrosis, Myeloproliferative Disorder, Myeloproliferative Disorders, Myeloproliferative Disorders (MPD), Myeloproliferative Neoplasms (MPNs), Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis, Myeloproliferative Neoplasm With 10% Blasts or Higher, Myeloproliferative Neoplasms, MPN, MPN (Myeloproliferative Neoplasms), MPN-associated Myelofibrosis, Myeloproliferative Neoplasm, Unclassifiable, Myeloproliferative Neoplasm, Not Otherwise Specified, Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Blast Phase MPN, Blast Phase Myeloproliferative Neoplasm, Thrombocythemia Myelofibrosis (PET-MF), Thrombocythemia, Essential, Thrombocythemia, Hemorrhagic, Agnogenic Myeloid Metaplasia, Chronic Idiopathic Myelofibrosis, Idiopathic Myelofibrosis, MDS/MPN Crossover Syndromes
    View official trial listing →
  • Recruiting NCT NCT07366086

    Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

    Not yet reported Amgen 71 participants Est. completion 2028-04-19 4 sites
    Other conditions: Osteogenesis Imperfecta
    View official trial listing →
  • Recruiting NCT NCT07368621

    Effectiveness of Connective Tissue Graft With and Without Leukocyte Platelet Rich Fibrin on Peri-implant Soft Tissue Thickness Around Delayed Implants in Patients With Thin Gingival Phenotype: A Randomized Controlled Clinical Trial

    Not yet reported British University In Egypt 38 participants Est. completion 2026-07-31 1 site
    Other conditions: Soft Tissue Thickness Around Delayed Implants in Patients With Thin Gingival Phenotype
    View official trial listing →
  • Recruiting NCT NCT07369128

    Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

    Not yet reported Boston Children's Hospital 105 participants Est. completion 2028-03 1 site
    Obstructive sleep apnea Other conditions: MRI Sedation, Pediatric Sedation, Emergence Delirium, Anesthesia, Recovery Time, Dexmedetomidine
    View official trial listing →
  • Recruiting NCT NCT07375953

    Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)

    Not yet reported General Hospital of Shenyang Military Region 120 participants Est. completion 2027-12-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07375966

    Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)

    Not yet reported General Hospital of Shenyang Military Region 198 participants Est. completion 2027-12-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07376837

    Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study

    Not yet reported University Health Network, Toronto 30 participants Est. completion 2027-07-01 1 site
    Other conditions: Thyroid Papillary Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07377162

    HYPER MIND - Hyperoxia Effects on Cerebral Hemodynamics

    Not yet reported Erasme University Hospital 80 participants Est. completion 2028-12-31 1 site
    Other conditions: Hyperoxemia, Cerebrovascular Circulation, Cerebral Autoregulation, Critical Illness, Mechanical Ventilation
    View official trial listing →
  • Recruiting NCT NCT07380217

    Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures

    Not yet reported Amsterdam UMC, location VUmc 98 participants Est. completion 2027-03-01 8 sites
    Cardiovascular disease Other conditions: High-risk PCI
    View official trial listing →
  • Recruiting NCT NCT07389616

    A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

    Not yet reported, Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 40 participants Est. completion 2029-08-01 1 site
    Other conditions: Peripheral T Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07390279

    Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia

    Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization 35 participants Est. completion 2026-08-03 1 site
    Other conditions: Postherpetic Neuralgia, Chronic Pain, Neuropathy
    View official trial listing →
  • Recruiting NCT NCT07392684

    Optimisation of the Blood Culture Pathway Utilising Behaviour Change

    Gloucestershire Hospitals NHS Foundation Trust 24 participants Est. completion 2026-09-30 1 site
    Other conditions: Microbiology, Blood Culture
    View official trial listing →
  • Recruiting NCT NCT07396246

    Comparison Between Transarterial Musculoskeletal Embolization and Platelet-Rich Plasma Injection for the Treatment of Greater Trochanteric Pain Syndrome

    Not yet reported Unidade Local de Saúde do Alto Ave, EPE 30 participants Est. completion 2027-12-31 1 site
    Other conditions: Trochanteric Syndrome
    View official trial listing →
  • Recruiting NCT NCT07398599

    Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study

    Not yet reported Second Affiliated Hospital of Nanchang University 30 participants Est. completion 2027-12-30 1 site
    Other conditions: Leptomeningeal Metastasis, Lung Neoplasms, Non-Small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT07399652

    Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures

    Not yet reported Asian Institute of Gastroenterology, India 20 participants Est. completion 2026-04-30 1 site
    Other conditions: Achalasia Cardia, Tumor
    View official trial listing →
  • Recruiting NCT NCT07401316

    Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors

    Not yet reported Indiana University 130 participants Est. completion 2032-12 1 site
    Other conditions: Germ Cell Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT07404332

    5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors

    Not yet reported Mohammed Milhem 35 participants Est. completion 2031-02-28 1 site
    Other conditions: Solid Tumor, Locally Advanced Solid Tumor, Metastatic Tumor
    View official trial listing →
  • Recruiting NCT NCT07404969

    Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility

    Not yet reported BEYOND GENOMiX SA, AG, Ltd 15 participants Est. completion 2026-12-01 1 site
    Other conditions: Idiopathic Infertility, Infertility Unexplained, Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Infertility Female
    View official trial listing →
  • Recruiting NCT NCT07405086

    Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

    Not yet reported OHSU Knight Cancer Institute 160 participants Est. completion 2028-12-31 1 site
    Other conditions: Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hepatocellular Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Melanoma, Advanced Renal Cell Carcinoma, Metastatic Biliary Tract Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hepatocellular Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Metastatic Renal Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07405710

    Use of the Electronic Medical Record to Screen Code Status Preference Using Death Language

    Not yet reported Rutgers, The State University of New Jersey 118 participants Est. completion 2027-06-30 1 site
    Other conditions: Code Status Discussions With Medical In-patients
    View official trial listing →
  • Recruiting NCT NCT07410520

    PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 50 participants Est. completion 2029-12-31 1 site
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)
    View official trial listing →
  • Recruiting NCT NCT07411599

    Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 28 participants Est. completion 2030-11-15 1 site
    Other conditions: Colorectal Cancer, Peritoneal Metastases, Carcinomatosis
    View official trial listing →
  • Recruiting NCT NCT07412470

    A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

    Not yet reported, Not yet reported Sanofi 526 participants Est. completion 2033-08-15 63 sites
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Recruiting NCT NCT07413159

    The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.

    Not yet reported Texas Southern University 480 participants Est. completion 2030-05-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT07417072

    GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients

    Not yet reported Meyer Children's Hospital IRCCS 50 participants Est. completion 2026-10 1 site Stand-alone
    Other conditions: Pediatric Brain Tumors, Genomics, Epigenetic
    View official trial listing →
  • Recruiting NCT NCT07419932

    Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

    Fujian Medical University 120 participants Est. completion 2029-06-30 1 site
    Other conditions: Thyroid Cancer, Thyroid Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07420023

    The Satiety Control Optimization by Nutritional Enhancement Study

    Not yet reported University College Cork 24 participants Est. completion 2026-05 1 site
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07420153

    Remote Ischemic Preconditioning and Postoperative Neuronal Injury

    Not yet reported University of Hamburg-Eppendorf 216 participants Est. completion 2027-09 1 site
    Other conditions: Postoperative Neuronal Injury
    View official trial listing →
  • Recruiting NCT NCT07423065

    The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and Obesity

    Not yet reported University of Primorska 34 participants Est. completion 2027-11-01 3 sites
    Other conditions: Pre Diabetic, Obesity & Overweight
    View official trial listing →
  • Recruiting NCT NCT07424833

    A Study of APG-3288 in Relapsed/Refractory Blood Cancers

    Not yet reported Ascentage Pharma Group Inc. 180 participants Est. completion 2031-12 6 sites
    Other conditions: Relapsed/Refractory Hematological Malignancies, Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL, Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation), Relapsed/Refractory Mantle Cell Lymphoma (MCL), Relapsed/Refractory Waldenström Macroglobulinemia (WM), Relapsed/Refractory Marginal Zone Lymphoma (MZL), Relapsed/Refractory Follicular Lymphoma (FL)
    View official trial listing →
  • Recruiting NCT NCT07425639

    ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

    Celltrion HealthCare France 225 participants Est. completion 2028-09 1 site
    Other conditions: Chronic Spontaneous Urticaria (CSU), Allergic Asthma
    View official trial listing →
  • Recruiting NCT NCT07430124

    Flow-Controlled Versus Volume-Controlled Ventilation During Balloon Dilatation Under Direct Laryngoscopy

    Not yet reported Ankara Etlik City Hospital 40 participants Est. completion 2026-08-20 1 site
    Other conditions: Airway Stenosis, Upper Airway Obstruction
    View official trial listing →
  • Recruiting NCT NCT07431281

    Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

    Not yet reported AstraZeneca 2130 participants Est. completion 2031-10-27 311 sites
    Other conditions: Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer
    View official trial listing →
  • Recruiting NCT NCT07431580

    Effect of Acute Hypoxia on RIght VEntRicular Function in Asthma.

    Not yet reported Mona Lichtblau 18 participants Est. completion 2030-01 1 site
    Other conditions: Hypoxia, Altitude, Hypoxia, Normobaric Hypoxia, Right Ventricular Function
    View official trial listing →
  • Recruiting NCT NCT07432373

    Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection

    National University of Malaysia 80 participants Est. completion 2028-07-01 1 site
    Other conditions: Pleural Infection
    View official trial listing →
  • Recruiting NCT NCT07432425

    Effects of Different Exercise Protocols on Physical and Cognitive Changes in People With Chronic Neck Pain

    Not yet reported Hacettepe University 21 participants Est. completion 2026-03-30 1 site
    Other conditions: Neck Pain, Chronic Neck Pain
    View official trial listing →
  • Recruiting NCT NCT07438535

    High-Load, Low-Load, and Passive Blood Flow Restriction in Competitive Sprinters

    Not yet reported Riphah International University 18 participants Est. completion 2026-09-01 1 site
    Other conditions: Blood Flow Restriction
    View official trial listing →
  • Recruiting NCT NCT07439133

    Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)

    Not yet reported Sinotau Pharmaceutical Group 395 participants Est. completion 2027-10 5 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07439991

    Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

    The First Hospital of Jilin University 900 participants Est. completion 2029-11-30 1 site
    Other conditions: Lung Cancer (Diagnosis), Deep Vein Thrombosis (DVT), Venous Thromboembolism (VTE)
    View official trial listing →
  • Recruiting NCT NCT07441720

    Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

    Not yet reported Zhejiang Cancer Hospital 25 participants Est. completion 2027-12-30 1 site
    Other conditions: Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia
    View official trial listing →
  • Recruiting NCT NCT07442552

    Perioperative Sepsis. An Epigenetic Perspective

    Carol Davila University of Medicine and Pharmacy 40 participants Est. completion 2026-04-10 1 site
    Other conditions: Sepsis Abdominal
    View official trial listing →
  • Recruiting NCT NCT07442669

    Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration

    Not yet reported Hackensack Meridian Health 100 participants Est. completion 2028-08-17 1 site
    Other conditions: Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant
    View official trial listing →
  • Recruiting NCT NCT07444060

    Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease

    Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2029-12-31 1 site
    Other conditions: CD - Crohn's Disease, Stricture; Bowel, IBD - Inflammatory Bowel Disease
    View official trial listing →
  • Recruiting NCT NCT07446179

    Blood Glucose Response to Test Foods Containing Brewer's Spent Grain

    Not yet reported Universidad Católica del Uruguay 20 participants Est. completion 2026-12 1 site
    Other conditions: Glycemic Responses
    View official trial listing →
  • Recruiting NCT NCT07454161

    Bleeding Disorder of Unknown Cause in the Netherlands

    Maastricht University Medical Center 500 participants Est. completion 2039-03-01 8 sites
    Other conditions: Hemorrhagic Disorders, Bleeding Disorder of Unknown Cause
    View official trial listing →
  • Recruiting NCT NCT07460700

    Mesenteric Ischemia Markers Study

    Not yet reported Belarusian State Medical University 120 participants Est. completion 2026-12-12 1 site
    Other conditions: Mesenteric Vascular Disease
    View official trial listing →
  • Recruiting NCT NCT07462650

    Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

    Not yet reported, Not yet reported Beijing Biotech 48 participants Est. completion 2028-12-22 1 site
    Other conditions: Colorectal Cancer Metastatic, Adenocarcinoma of Colon
    View official trial listing →
  • Recruiting NCT NCT07463508

    Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

    Not yet reported University Hospital, Clermont-Ferrand 20 participants Est. completion 2029-01-01 1 site
    Other conditions: Testicular Germ Cell Cancer
    View official trial listing →
  • Recruiting NCT NCT07463898

    A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With Preeclampsia

    Washington University School of Medicine 172 participants Est. completion 2027-12 1 site
    Other conditions: Cardiovascular Biomarkers, Preeclampsia (PE) Risk, Preeclampsia (PE)
    View official trial listing →
  • Recruiting NCT NCT07465159

    Multimodal Prehabilitation of Frail Patients Undergoing Elective Knee or Hip Replacement

    Not yet reported University of Iceland 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Frailty Syndrome, Prehabilitation, Arthroplasties, Knee Replacement, Arthroplasties, Hip Replacement
    View official trial listing →
  • Recruiting NCT NCT07465848

    Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis

    Not yet reported Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe) 1200 participants Est. completion 2026-12-31 12 sites
    Other conditions: Lung Cancer (Diagnosis), Health Adult Subjects, Patient
    View official trial listing →
  • Recruiting NCT NCT07467863

    Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

    Not yet reported, Not yet reported Beijing Biotech 48 participants Est. completion 2028-02-17 1 site
    Other conditions: Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC
    View official trial listing →
  • Recruiting NCT NCT07468097

    The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational Study

    Marmara University 59 participants Est. completion 2027-03-01 1 site
    Other conditions: Central Sensitization, Lipedema, Pain, HOMA-IR
    View official trial listing →
  • Recruiting NCT NCT07472738

    Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases

    Beijing Chao Yang Hospital 950 participants Est. completion 2027-12 1 site
    Other conditions: Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Chronic Airway Diseases
    View official trial listing →
  • Recruiting NCT NCT07473687

    Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room

    Taipei Veterans General Hospital, Taiwan 315 participants Est. completion 2030-06-30 1 site
    Other conditions: Cholecystitis, Liver Neoplasms, Cholelithiasis, Inguinal Hernia
    View official trial listing →
  • Recruiting NCT NCT07476365

    A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)

    University Medical Center Goettingen 70 participants Est. completion 2026-09-30 1 site
    Other conditions: CMT, CMT (Charcot Marie Tooth Disease), CMT - Charcot-Marie-Tooth Disease, CMT1A, CMT 1A
    View official trial listing →
  • Recruiting NCT NCT07479134

    Production of Stem Cells for the Generation of Pancreatic Cells

    Not yet reported Ospedale San Raffaele 100 participants Est. completion 2036-02-28 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Recruiting NCT NCT07480265

    Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

    Necmettin Erbakan University 500 participants Est. completion 2028-03 1 site
    Other conditions: Hypertension (HTN), Hyperhomocysteinemia, Diastolic Dysfunction
    View official trial listing →
  • Recruiting NCT NCT07482371

    Comparative Effects of Scooping Mobilization and Dynamic Cupping Therapy on Elbow Stiffness

    Not yet reported Riphah International University 28 participants Est. completion 2026-06-16 1 site
    Other conditions: Children, Adults
    View official trial listing →
  • Recruiting NCT NCT07483151

    Venous Congestion And Cognitive Dysfunction After Cardiac Surgery

    Zhuan Zhang 110 participants Est. completion 2026-10-31 1 site
    Other conditions: Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
    View official trial listing →
  • Recruiting NCT NCT07486102

    A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

    Not yet reported Boehringer Ingelheim 44 participants Est. completion 2027-02-27 1 site
    Other conditions: Healthy, Hepatic Impairment
    View official trial listing →
  • Recruiting NCT NCT07489274

    Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial).

    Not yet reported Ole Hyldegaard 1480 participants Est. completion 2033-06-30 2 sites
    Other conditions: Necrotizing Soft Tissue Infection
    View official trial listing →
  • Recruiting NCT NCT07491354

    The Biopsychosocial Model to Identify Risk Factors for Chronic Post-traumatic Pain in ICU Patients

    University Hospital, Montpellier 400 participants Est. completion 2027-07-29 1 site
    Other conditions: Post Traumatic Chronic Pain
    View official trial listing →
  • Recruiting NCT NCT07501117

    Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

    Not yet reported Inge Marie Svane 15 participants Est. completion 2029-06-01 1 site
    Other conditions: Uveal Melanoma
    View official trial listing →
  • Recruiting NCT NCT07501325

    Recombinant Tropomyosin- and Hemocyanin-Specific IgE in Children With Suspected Shrimp Allergy

    Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 129 participants Est. completion 2028-04 1 site
    Other conditions: Food Hypersensitivity, Shellfish Allergy
    View official trial listing →
  • Recruiting NCT NCT07502287

    Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

    Not yet reported, Not yet reported Beijing Biotech 36 participants Est. completion 2028-06-17 1 site
    Other conditions: Relapsed Neuroblastoma, Refractory Neuroblastoma, High-Risk Neuroblastoma, Ganglioneuroblastoma
    View official trial listing →
  • Recruiting NCT NCT07502742

    Pain in Aging Former Athletes, Master's Athletes, and Nonathletes

    Not yet reported Marquette University 90 participants Est. completion 2028-05 1 site
    Other conditions: Pain, Pain Management, Athlete, Exercise Training, Sports Medicine, Strength Training Effects, Aerobic Exercise, Strength Training, Aging, Quality of Life, Sports
    View official trial listing →
  • Recruiting NCT NCT07504588

    Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

    Not yet reported National Cancer Institute (NCI) 87 participants Est. completion 2029-04-12 7 sites Stand-alone
    Other conditions: Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Primary Peritoneal High Grade Serous Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07510321

    FL-261 Imaging for Cancer Diagnosis and Staging

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12 participants Est. completion 2026-12-31 1 site
    Other conditions: Non-Small Cell Lung Cancer, Colorectal Cancer, Head & Neck Cancer, Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT07512921

    Matching Primary Tumor and Blood Gene Expression Analysis of HPV-negative Squamous Head and Neck Cancers

    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 300 participants Est. completion 2027-12-31 2 sites
    Other conditions: Head and Neck (HNSCC)
    View official trial listing →
  • Recruiting NCT NCT07514832

    VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial

    Not yet reported Beijing 302 Hospital 48 participants Est. completion 2028-12-31 1 site
    Other conditions: AML (Acute Myeloid Leukemia)
    View official trial listing →
  • Recruiting NCT NCT07516366

    Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

    Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2028-12-31 1 site
    Other conditions: Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07518784

    Accurate Point of Care Liver Disease Diagnostics (Phase 2)

    University of California, San Diego 26 participants Est. completion 2026-06-30 1 site
    MASLD
    View official trial listing →
  • Recruiting NCT NCT07519356

    A Comprehensive Register Of Lymphoproliferative Disorders (ReLy)

    Fondazione IRCCS Policlinico San Matteo di Pavia 9000 participants Est. completion 2030-12-30 1 site
    Other conditions: Lymphoproliferative Disease
    View official trial listing →
  • Recruiting NCT NCT07527858

    Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

    Not yet reported Gilead Sciences 170 participants Est. completion 2028-12 14 sites
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT07529197

    Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS

    Charite University, Berlin, Germany 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), ME/CFS Following COVID-19
    View official trial listing →
  • Recruiting NCT NCT07529236

    Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,

    Not yet reported Centre Hospitalier Universitaire de Nice 40 participants Est. completion 2027-10-01 1 site
    Other conditions: Chronic Inflammatory Bowel Diseases
    View official trial listing →
  • Recruiting NCT NCT07529821

    Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive Patients

    Not yet reported Foundation University Islamabad 45 participants Est. completion 2026-05-15 1 site
    Other conditions: PRE-HYPERTENSION
    View official trial listing →
  • Recruiting NCT NCT07532161

    Comparison Between Liquid Fibrin and Soft Laser Effects on Healing and Relapse After Lip Repositioning Surgery

    Not yet reported Damascus University 22 participants Est. completion 2027-01-31 1 site
    Other conditions: Gummy Smile
    View official trial listing →
  • Recruiting NCT NCT07534319

    Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy

    University of Zurich 100 participants Est. completion 2027-12-01 1 site
    Other conditions: Acute Cerebrovascular Accident, Thrombectomy, Cerebral Revascularization, No Reflow Phenomenon
    View official trial listing →
  • Recruiting NCT NCT07535112

    A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

    Not yet reported Bayer 130 participants Est. completion 2030-07-09 21 sites
    Other conditions: Advanced/Metastatic Colorectal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07535372

    ASO Treatment for Syndromic Craniosynostoses

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 12 participants Est. completion 2028-04-20 1 site
    Other conditions: Craniosynostoses, Crouzon Syndrome, Saethre Chotzen Syndrome, Muenke Syndrome, Pfeiffer Syndrome, Apert Syndrome
    View official trial listing →
  • Recruiting NCT NCT07536516

    Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

    Not yet reported Medical University of Vienna 20 participants Est. completion 2026-06-01 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT07538115

    Advanced vs Standard Hemodynamic Monitoring During Propofol Sedation for ERCP: A Prospective Study

    Not yet reported Hitit University 32 participants Est. completion 2026-07-15 1 site
    Other conditions: Hemodynamic Instability
    View official trial listing →
  • Recruiting NCT NCT07542366

    The Feasibility of Pulmonary Perfusion Assessment Using Sodium Bicarbonate Contrast With Electrical Impedance Tomography: A Prospective Pilot Study

    First Affiliated Hospital of Wannan Medical College 41 participants Est. completion 2026-09-25 1 site
    Other conditions: Acute Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Critical Illness, Feasibility of Contrast-enhanced Electrical Impedance Tomography (EIT) for Pulmonary Perfusion Assessment in Mechanically Ventilated Adults
    View official trial listing →
  • Recruiting NCT NCT07543705

    Glucose-Level During Endurance Exercise

    University of Ulm 100 participants Est. completion 2028-06 1 site
    Other conditions: Glucose Metabolism
    View official trial listing →
  • Recruiting NCT NCT07550114

    PVI vs ESP Block for Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery.

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 62 participants Est. completion 2028-03-01 2 sites
    Other conditions: Surgical Blood Loss, Postoperative Pain, Lumbar Spinal Fusion Surgery
    View official trial listing →
  • Recruiting NCT NCT07550673

    Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE)

    Not yet reported Xijing Hospital of Digestive Diseases 226 participants Est. completion 2028-11-01 4 sites
    Other conditions: Acute Severe Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT07553845

    A Multimodal Prospective Cohort Study of Parkinsonism

    Ruijin Hospital 640 participants Est. completion 2029-05 1 site
    Other conditions: Parkinsonism, REM Sleep Behavior Disorder
    View official trial listing →
  • Recruiting NCT NCT07556185

    MedlyPeds Feasibility Study

    Not yet reported The Hospital for Sick Children 30 participants Est. completion 2029-12 1 site
    Heart failure Other conditions: Congenital Heart Disease (CHD), Acquired Heart Disease, Pulmonary Hypertension, Post Cardiac Surgery
    View official trial listing →
  • Recruiting NCT NCT07559760

    New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer

    Not yet reported The First Hospital of Jilin University 30 participants Est. completion 2029-05-31 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07562022

    A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

    Not yet reported Sinocelltech Ltd. 93 participants Est. completion 2029-06 1 site
    Other conditions: Follicular Lymphoma (FL)
    View official trial listing →
  • Recruiting NCT NCT07562490

    A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer

    Not yet reported Fudan University 100 participants Est. completion 2027-12-31 1 site
    Other conditions: ctDNA, Chemotherapy, Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07563985

    Effect of Lemon Juice and Apple Cider Vinegar on Postprandial Blood Glucose and Satiety in Healthy Individuals

    Not yet reported Alanya Alaaddin Keykubat University 15 participants Est. completion 2026-07-01 1 site
    Other conditions: Satiety, Postprandial Glycemia
    View official trial listing →
  • Recruiting NCT NCT07565844

    Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic Neuralgia

    Not yet reported Zagazig University 45 participants Est. completion 2026-11-11 1 site
    Other conditions: Postherpetic Neuralgia ( PHN )
    View official trial listing →
  • Recruiting NCT NCT07570407

    Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

    University Hospital Pilsen 75 participants Est. completion 2029-01-31 1 site
    Other conditions: Allogeneic HSCT, Posttransplant Complications, GvHD, Relapse, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07572032

    Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

    Not yet reported Kyungsub Song 80 participants Est. completion 2028-12-20 4 sites
    Cardiovascular diseaseHeart failure Other conditions: Valvular Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT07577752

    Quantifying Blood Flow in the Aorta

    University of Twente 70 participants Est. completion 2027-07-31 1 site
    Other conditions: Healthy Aortic Blood Flow
    View official trial listing →
  • Recruiting NCT NCT07579195

    Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

    Not yet reported, Not yet reported University of Washington 12 participants Est. completion 2030-02-01 1 site
    Other conditions: Muscle Invasive Bladder Carcinoma, Stage III Bladder Cancer AJCC v8, Stage IV Bladder Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT07580716

    Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

    Not yet reported Enlivex Therapeutics Ltd. 270 participants Est. completion 2028-04 17 sites
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT07581210

    Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy

    Not yet reported Shanghai QuietD Biotechnology Co., Ltd. 120 participants Est. completion 2026-12 14 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07587905

    Effects of Calamansi on Blood Glucose and Insulin Levels

    Not yet reported Burapha University 54 participants Est. completion 2027-01-31 1 site
    Other conditions: Calamansi Powder Capsule Supplementation
    View official trial listing →
  • Recruiting NCT NCT07588256

    New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases

    Not yet reported New Taipei City Medical Association 4162 participants Est. completion 2029-02-05 1 site
    Cardiovascular disease Other conditions: Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR, Digital Medicine, Hypertension, Hyperglycaemia (Diabetic), Hyperlipidemia
    View official trial listing →
  • Recruiting NCT NCT07588503

    FES Cycling With BFR in the Spinal Cord Injury Population

    Not yet reported Dr. B. Catharine. Craven 6 participants Est. completion 2027-09-30 1 site
    Type 2 diabetesCardiovascular disease Other conditions: Spinal Cord Injury, Cardio Vascular Disease
    View official trial listing →
  • Recruiting NCT NCT07590323

    BFR Training and Knee Osteoarthritis

    Not yet reported University of Hail 90 participants Est. completion 2026-12-30 1 site
    Other conditions: Knee Osteoarthristis
    View official trial listing →
  • Recruiting NCT NCT07597850

    TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status

    Not yet reported Tri-Service General Hospital (TSGH) 90 participants Est. completion 2026-12-31 1 site
    Other conditions: Pre-Frailty, Sarcopenia, Muscle Atrophy or Weakness, Osteoporosis, Aging
    View official trial listing →
  • Recruiting NCT NCT07602283

    Music for Pain and Dementia

    Not yet reported Yale University 60 participants Est. completion 2027-02 1 site
    Other conditions: Alzheimer Disease, Dementia, Mild Cognitive Impairment, Peer-bonded Caregiver, Caregiver
    View official trial listing →
  • Recruiting NCT NCT07602920

    Gut Leakage' in Dengue

    University of Oxford 190 participants Est. completion 2028-01-31 1 site
    Other conditions: Dengue, Dengue Hemorrhagic Fever, Intestinal Disease, Ascites, Dengue With Warning Signs, Gut Microbiome
    View official trial listing →
  • Recruiting NCT NCT07603583

    Assessment of Heart Rate Variability for Predicting Obstructive Sleep Apnea in Patients With Hypertension

    Kaohsiung Armed Forces General Hospital 100 participants Est. completion 2026-12-31 1 site
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT07605416

    Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

    Not yet reported National Cancer Institute (NCI) 74 participants Est. completion 2032-11-06 10 sites Stand-alone
    Other conditions: Plasma Cell Leukemia
    View official trial listing →
  • Recruiting NCT NCT07606014

    No Guts No Glory Probiotics

    Not yet reported, Not yet reported University Medical Center Groningen 112 participants Est. completion 2029-05-01 3 sites
    Other conditions: Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine
    View official trial listing →
  • Recruiting NCT NCT07608835

    IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy

    Not yet reported Institut Paoli-Calmettes 200 participants Est. completion 2033-05-12 1 site
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT07609966

    IVR ON UPPER-LIMB REHABILITATION IN STROKE PATIENTS: A CLINICAL TRIAL

    Not yet reported Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta 120 participants Est. completion 2026-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07610720

    Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 57 participants Est. completion 2029-11-01 1 site
    Other conditions: Advanced/Metastatic Breast Cancer, HER2-Positive Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07611526

    Investigation of the Individual Fatigue Response During Blood Flow Restriction Training

    Not yet reported University Hospital, Bonn 20 participants Est. completion 2027-03-31 1 site
    Other conditions: Total Knee Anthroplasty
    View official trial listing →
  • Recruiting NCT NCT07611825

    Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma

    Not yet reported Jinling Hospital, China 33 participants Est. completion 2028-12-31 2 sites
    Other conditions: Advanced RCC
    View official trial listing →
  • Recruiting NCT NCT07612722

    Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo

    Not yet reported Wen-zhao ZHONG 585 participants Est. completion 2034-05-31 1 site
    Other conditions: NSCLC
    View official trial listing →
  • Recruiting NCT NCT07614659

    Uppsala Self-Screening of Cardiovascular Health

    Not yet reported Johan Sundström 45000 participants Est. completion 2037-12 1 site
    Cardiovascular diseaseChronic kidney disease Other conditions: Hypertension, Dyslipidemias, Diabetes Mellitus, Atrial Fibrillation
    View official trial listing →
  • Recruiting NCT NCT07615673

    Exploration of Potential Biomarkers of Polyphenol Intake From Artichoke By-product Supplements

    Not yet reported Iziar Amaia Ludwig Sanz Orrio 16 participants Est. completion 2026-06-25 1 site Stand-alone
    Other conditions: Healthy Adult Participants, ADME, Polyphenols Absorption Profile, Polyphenolic Compounds and Metabolism
    View official trial listing →
  • Recruiting NCT NCT07616349

    Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.

    Nicolas Brogly 85 participants Est. completion 2027-05-01 1 site
    Other conditions: Thrombocytopenia, Postpartum Haemorrhage (PPH)
    View official trial listing →
  • Recruiting NCT NCT07616427

    Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2033-05-20 3 sites
    Other conditions: HR+/HER2+ Early Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07616921

    A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant

    Not yet reported University of Washington 30 participants Est. completion 2028-04-03 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07617259

    UltraSound Guided Distal Radial Artery vS Conventional Transradial Access for Interventional Coronary Angiography

    Not yet reported University Hospital of Patras 1400 participants Est. completion 2028-11-01 1 site
    Other conditions: Radial Artery Access, Distal Radial Artery Access (dTRA)
    View official trial listing →
  • Recruiting NCT NCT07617610

    Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

    Swiss Cancer Institute 30 participants Est. completion 2030-09 13 sites
    Other conditions: Metastatic Colorectal Cancer, BRAF V600E Mutation
    View official trial listing →
  • Recruiting NCT NCT07623265

    Improving the Use of Immunotherapy to Treat Liver Cancer

    Not yet reported Universitaire Ziekenhuizen KU Leuven 300 participants Est. completion 2032-01 4 sites
    Other conditions: Hepatocellular Carcinoma (HCC)
    View official trial listing →
  • Recruiting NCT NCT07625579

    Collaboration for Down Syndrome Progress (CDP)

    RTI International 1400 participants Est. completion 2029-08-31 16 sites
    Other conditions: Down Syndrome, Chromosome Disorders, Intellectual and Developmental Disabilities
    View official trial listing →
  • Recruiting NCT NCT07631663

    Satiety Evaluation of Mature Okra Flour-incorporated Biscuit

    Not yet reported Universiti Putra Malaysia 30 participants Est. completion 2026-06-25 1 site
    Other conditions: Appetite Regulation, Healthy Young Adults
    View official trial listing →
  • Recruiting NCT NCT07634562

    TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation

    Not yet reported, Not yet reported Stanford University 12 participants Est. completion 2031-08 1 site
    Other conditions: Liver Failure
    View official trial listing →
  • Recruiting NCT NCT07636785

    A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

    Not yet reported, Not yet reported VM Discovery, Inc. 111 participants Est. completion 2031-12 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC), Nonsmall Cell Lung Cancer, Colorectal Cancer (CRC)
    View official trial listing →
  • Recruiting NCT NCT07637266

    Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging

    Not yet reported Klinički Bolnički Centar Zagreb 60 participants Est. completion 2027-06-01 2 sites
    Other conditions: CABG, Myocardial Viability
    View official trial listing →
  • Recruiting NCT NCT07638670

    Effect of Mycobacterial Infection on Immune Status

    First Affiliated Hospital of Ningbo University 120 participants Est. completion 2026-07-20 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT07641582

    Prediction of Atrial Fibrillation Using Polygenic Risk Score

    Not yet reported Seoul St. Mary's Hospital 800 participants Est. completion 2027-06-30 5 sites
    Other conditions: Atrial Fibrillation (AF)
    View official trial listing →
  • Recruiting NCT NCT07644117

    Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease

    Shmuel Kivity, MD 40 participants Est. completion 2028-12 1 site
    Other conditions: IBD (Inflammatory Bowel Disease), Crohn Disease (CD), Ulcerative Colitis (UC)
    View official trial listing →
  • Recruiting NCT NCT07653048

    Personality Traits and Biochemical Risk Phenotypes

    Medical Center TOPMED 1000 participants Est. completion 2027-09-01 1 site
    PrediabetesMetabolic syndrome Other conditions: Hyperglycemia
    View official trial listing →
  • Recruiting NCT NCT07658170

    Evaluation of the Efficacy and Safety of Using Platelet-rich Fibrin (PRF)-Based Lipobolus for the Immediate Reconstruction of Defects After Breast-conserving Resection for Breast Cancer (Minimally Invasive Primary Immediate Grafting)

    Not yet reported The Leningrad Regional Clinical Hospital 30 participants Est. completion 2028-06-03 1 site
    Other conditions: Breast Cancer, Lipofilling, Fat Graft, Platelet Rich Plasma
    View official trial listing →
  • Recruiting NCT NCT07664358

    Fibrinogen-to-Albumin Ratio as a Predictor of Acute Respiratory Distress Syndrome in Traumatic Brain Injury

    Tanta University 350 participants Est. completion 2027-01-01 1 site
    Other conditions: Fibrinogen, Albumin, ARDS, TBI (Traumatic Brain Injury)
    View official trial listing →
  • Recruiting NCT NCT07664904

    Relationship of Periostin and ODI, EQ-5D

    Keimyung University Dongsan Medical Center 53 participants Est. completion 2027-02-27 2 sites
    Other conditions: Intervertebral Disc Disease
    View official trial listing →
  • Recruiting NCT NCT07675148

    Cooking Classes as a Family-based Intervention for Weight Reduction: Effects on Dietary Quality and Weight Management in Abu Dhabi (United Arab Emirates)

    Not yet reported Institute for Healthier Living Abu Dhabi 250 participants Est. completion 2026-10-31 1 site
    Other conditions: Obesity & Overweight, Culinary Medicine
    View official trial listing →
  • Recruiting NCT NCT07676773

    Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients

    Not yet reported Sichuan Academy of Medical Sciences 80 participants Est. completion 2026-12-31 1 site
    Other conditions: Diabete Type 2, Cardio Respiratory Fitness
    View official trial listing →
  • Recruiting NCT NCT07677007

    Evaluation of Lateral Sinus Floor Elevation Using Xenograft Versus L-PRF Block Combined With Xenograft

    Not yet reported Gulf Medical University 30 participants Est. completion 2027-02-01 1 site
    Other conditions: Sinus Floor Augmentation, Maxillary Sinus Floor Elevation, Sinus Lift, Xenograft
    View official trial listing →
  • Recruiting NCT NCT07680439

    Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

    Not yet reported BrainChild Bio, Inc 75 participants Est. completion 2030-07 6 sites
    Other conditions: Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor, CNS Tumor, Central Nervous System Tumor, Pediatric Cancer, Adult Cancer Patients, CNS Tumor, Childhood, CNS Tumor, Adult, Brainstem Glioma, Diffuse Midline Glioma, DMG
    View official trial listing →
  • Recruiting NCT NCT07682389

    Etiologic Diagnosis Algorithm in Infective Endocarditis

    Not yet reported I.M. Sechenov First Moscow State Medical University 128 participants Est. completion 2027-02-20 3 sites
    Other conditions: Infective Endocarditis, Microbiology
    View official trial listing →
  • Recruiting NCT NCT07685730

    Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight

    Ohio State University 327 participants Est. completion 2029-08-06 1 site
    Other conditions: Anesthesia, Pregnancy Related, Blockades Neuromuscular
    View official trial listing →
  • Recruiting NCT NCT07690358

    Concentrations of Nitrous Oxide in Blood, Exhaled Air and Urine After Various Types of Exposure.

    Not yet reported University of Aarhus 40 participants Est. completion 2026-12-31 1 site
    Other conditions: Intoxication by Drug
    View official trial listing →
  • Recruiting NCT NCT07692646

    The Effect of Fasting on Peak Fat Oxidation, Mitochondrial Coupling and Extracellular Matrix

    Not yet reported University of Copenhagen 40 participants Est. completion 2033-12 1 site
    Other conditions: Fasting, Obesity (BMI>30), Sex Difference
    View official trial listing →
  • Recruiting NCT NCT07694648

    Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens

    Huashan Hospital 2398 participants Est. completion 2028-09-30 31 sites
    Other conditions: Respiratory Tract Infections (RTI), Respiratory Syndrome, Acute, Severe, Acute Respiratory Infections (ARIs)
    View official trial listing →
  • Recruiting NCT NCT07702032

    Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

    Not yet reported Genmab 960 participants Est. completion 2031-09 6 sites
    Other conditions: Left-sided Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07706413

    Plasma Exchange in Children With Severe Sepsis and Septic Shock

    Not yet reported Menoufia University 22 participants Est. completion 2027-03-31 1 site
    Other conditions: Severe Sepsis
    View official trial listing →
  • Recruiting NCT NCT07707245

    Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

    Not yet reported Fondazione Don Carlo Gnocchi ETS 120 participants Est. completion 2028-10-30 1 site
    Other conditions: COPD, Idiopathic Pulmonary Fibrosis (IPF), Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT07707609

    Neural Sensitisation and Neuropsychological Alterations in Painful Chronic Pancreatitis

    Asian Institute of Gastroenterology, India 200 participants Est. completion 2026-11-30 1 site
    Other conditions: Chronic Pancreatitis, Pain Management
    View official trial listing →
  • Recruiting NCT NCT07707739

    Plasma Exchange in Pediatric Autoimmune Encephalitis

    Not yet reported Menoufia University 22 participants Est. completion 2027-03-31 1 site
    Other conditions: Autoimmune Encephalitis (AE)
    View official trial listing →
  • Recruiting NCT NCT07710495

    Exercise to Improve Outcomes in Pancreatic Cancer

    Not yet reported University of Surrey 60 participants Est. completion 2030-06-01 1 site
    Other conditions: Pancreas Adenocarcinoma (MSI-H), Deconditioning
    View official trial listing →
  • Recruiting NCT NCT07712393

    A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2027-04-26 1 site
    Other conditions: Asthma
    View official trial listing →
  • Recruiting NCT NCT07713615

    Blood Clotting Markers and Heart Ultrasound in People With Device-Detected Atrial Fibrillation

    Andreas Sjøholm-Christensen 222 participants Est. completion 2037-09 1 site
    Other conditions: Device-detected Atrial Fibrillation, Subclinical Atrial Fibrillation, Atrial High Rate Episodes
    View official trial listing →
  • Recruiting NCT NCT07716813

    The Effect of Breast Milk, 10% and 20% Dextrose on Pain and Physiological Variables During Heel Puncture in Infants

    Not yet reported Mersin University 96 participants Est. completion 2026-09-30 1 site
    Other conditions: Newborn Care, Pain Management, Physiological Parameters During Newborn Care İn Newborn's, Breast Milk, Premature
    View official trial listing →
  • Recruiting NCT NCT07718815

    HLA B Leader in Patients With Psoriatic Arthritis

    Not yet reported Centre Hospitalier Universitaire, Amiens 658 participants Est. completion 2026-09 1 site
    Other conditions: Psoriatic Arthritis, HLA b Leader, HLA B27
    View official trial listing →
  • Recruiting NCT NCT07718958

    Biomarkers for Diagnosis and Treatment Response in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

    University of Cagliari 80 participants Est. completion 2027-02-28 5 sites
    Other conditions: PANS, Pediatric Acute-Onset Neuropsychiatric Syndrome
    View official trial listing →
  • Recruiting NCT NCT07725809

    A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity

    Not yet reported Pfizer 57 participants Est. completion 2027-01-13 1 site
    Other conditions: Overweight, Obesity, Healthy
    View official trial listing →
  • Recruiting NCT NCT07726563

    Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)

    Not yet reported National Taiwan University Hospital 20 participants Est. completion 2029-07-31 1 site
    Other conditions: Amyotrophic Lateral Sclerosis (ALS), Autoantibody, Plasmapheresis
    View official trial listing →
  • Recruiting NCT NCT07728175

    Effects of Sirolimus on Asymptomatic ApoE4 Carriers

    Not yet reported University of Missouri-Columbia 225 participants Est. completion 2028-07-07 1 site
    Other conditions: Genetic Predisposition to Disease, Healthy Volunteer, APOE-4 Positive
    View official trial listing →
  • Recruiting NCT NCT07729891

    Real-time Evaluation and Continuous Observation of Vital Signs for Enhanced Recovery: a Study for the Early Identification of Complications in the Surgical Ward Following Surgery in Patients Not Eligible for Intensive Care Admission.

    Azienda Ospedaliero-Universitaria di Parma 150 participants Est. completion 2027-02 1 site
    Other conditions: Postoperative Complication, Respiratory Complications, Cardiac Complications
    View official trial listing →
  • Recruiting NCT NCT07734636

    A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury

    Not yet reported University of California, San Francisco 60 participants Est. completion 2029-03 1 site
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Recruiting NCT NCT07737561

    Blood Pressure Response to Exercise and Aortic Stiffness in Patients With Cardiovascular-Kidney-Metabolic Syndrome

    Karamanoğlu Mehmetbey University 80 participants Est. completion 2027-01-01 1 site
    Metabolic syndrome Other conditions: Cardiovascular-kidney-metabolic (CKM)
    View official trial listing →
  • Recruiting NCT NCT07740018

    Factors Affecting Clinical and Radiological Outcome in Endovascular Management of Acute Ischemic Stroke Due to Large Vessel Occlusion

    Not yet reported Sohag University 40 participants Est. completion 2028-08-01 1 site
    Other conditions: Endovascular Thrombectomy
    View official trial listing →
  • Recruiting NCT NCT07745244

    Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System

    Not yet reported SiBionics, Co, Ltd 36 participants Est. completion 2027-12-01 1 site
    Other conditions: type1diabetes, CGM, T1D
    View official trial listing →
  • Recruiting NCT NCT07747454

    Isometric Strengthening Exercises Versus Tens in Diabetic Population

    Not yet reported Kafrelsheikh University 75 participants Est. completion 2027-01-01 1 site
    Other conditions: Diabetes Complications
    View official trial listing →
  • Recruiting NCT NCT07750223

    Cognitive Effects of Hesperidin in Overweight/Obese Older Adults

    Not yet reported Min Hou 105 participants Est. completion 2027-03-30 1 site Stand-alone
    Other conditions: Cognitive Dysfunction, Overweight and Obesity
    View official trial listing →
  • Recruiting NCT NCT07755397

    First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

    Not yet reported Jubilant Therapeutics India Limited 30 participants Est. completion 2028-04 6 sites
    Other conditions: NSCLC Patients With EGFR Activating Mutation, Adenoid Cystic Carcinoma Metastatic, Adenoid Cystic Carcinoma of the Head and Neck
    View official trial listing →
  • Recruiting NCT NCT07756437

    Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

    AZ Sint-Lucas Gent 70 participants Est. completion 2029-06-01 1 site
    Other conditions: Muscle-Invasive Bladder Cancer (MIBC), Upper Tract Urothelial Carcinoma, Urothelial Carcinoma (UC)
    View official trial listing →
  • Recruiting NCT NCT07758270

    Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

    Washington University School of Medicine 15 participants Est. completion 2030-08-29 1 site
    Other conditions: Multiple Sclerosis (MS) - Relapsing-remitting
    View official trial listing →
  • Recruiting NCT NCT07763197

    Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)

    Natera, Inc. 400 participants Est. completion 2032-07 1 site
    Other conditions: Non-Muscle Invasive Bladder Cancer, NMIBC, High-risk Non-Muscle Invasive Bladder Cancer
    View official trial listing →
  • Recruiting NCT NCT07769151

    BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

    Henry Ford Health System 124 participants Est. completion 2031-12-30 1 site
    Other conditions: Mortality Prediction
    View official trial listing →
  • Recruiting NCT NCT07769892

    A Multicenter Prospective Observational Cohort Study for Digestive Tract Tumor Screening Using Multi-Target Blood and Fecal Biomarkers

    Xijing Hospital 5000 participants Est. completion 2035-12-31 7 sites
    Other conditions: Gastrointestinal Cancers
    View official trial listing →
  • Recruiting NCT NCT07775287

    Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)

    Not yet reported Genmab 600 participants Est. completion 2030-01-31 4 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07776314

    Are There Any Clinical Benefits to Screening for Late -Onset Gestational Diabetes Mellitus?"

    Izmir Ataturk Training and Research Hospital 128 participants Est. completion 2026-11-10 1 site
    Other conditions: Pregnancy in Diabetes, Pregnancy, Pregnancy Outcomes
    View official trial listing →
  • Recruiting NCT NCT07782203

    Establishment of a Biological Collection to Develop Translational Preclinical Models for the Study of Tumors and Diseases of the Gastrointestinal Tract

    Not yet reported University Hospital, Strasbourg, France 400 participants Est. completion 2027-12-30 1 site
    Other conditions: Gastrointestinal Cancer, IBD
    View official trial listing →
  • Recruiting NCT NCT07784907

    Efficacy of Platelet-Rich Plasma Combined With Hyaluronic Acid in Knee Osteoarthritis

    Not yet reported Implai Sp z o.o 100 participants Est. completion 2028-07 1 site
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT07785401

    Efficacy of Platelet-Rich Plasma Added to Hyaluronic Acid in Knee Osteoarthritis

    Not yet reported Implai Sp z o.o 50 participants Est. completion 2028-07 1 site
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT07785635

    Evaluation of the Relation Between Patient Fasting Time and the Occurrence of PIH (Post Induction Hypotension)

    University Hospital Ostrava 100 participants Est. completion 2026-09 1 site
    Other conditions: Post-induction Hypotension
    View official trial listing →
  • Recruiting NCT NCT07787975

    RNA to the RESCUE: Evaluation to Assess the Clinical Utility of RNA Sequencing in Establishing a Genetic Diagnosis or Adjudicating a Previously Established Genetic Diagnosis.

    University of California, San Francisco 100 participants Est. completion 2030-12 1 site
    Other conditions: Genetic Conditions, Genetic Disorders
    View official trial listing →
  • Recruiting NCT NCT07795502

    Dynamic Infection Kinetics for Early Diagnosis, Monitoring, and Prognostication of Sepsis in Adult Oncology Patients: Evaluating Serial Infection Biomarkers, Blood Culture Kinetics, Treatment Response, Disease Severity, and Clinical Outcomes

    Sohag University 100 participants Est. completion 2027-08-15 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Recruiting NCT NCT07796672

    Feasibility Study of Blood Biomarker Identification in Cervical Cancer

    Queensland Centre for Gynaecological Cancer 100 participants Est. completion 2032-09-15 1 site
    Other conditions: Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07807839

    Study of Correlation Between Serum BDNF Levels and Pfirmann Grading and IL- 1β

    Keimyung University Dongsan Medical Center 59 participants Est. completion 2027-08-30 1 site
    Other conditions: Chronic Low Back Pain (CLBP)
    View official trial listing →
  • Recruiting NCT NCT07814235

    Human Sperm Cryopreservation as an Alternative to the Decline of Sperm Quality With Aging

    IVI Murcia 45 participants Est. completion 2027-09-30 1 site
    Other conditions: Aging, Epigenetic Aging, Infertility, Assisted Reproduction Technologies, Male Fertility
    View official trial listing →
  • Recruiting NCT NCT07819630

    Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation

    Not yet reported Beijing Chao Yang Hospital 90 participants Est. completion 2027-03-30 1 site
    Other conditions: Postoperative Pain
    View official trial listing →
  • Recruiting NCT NCT07820072

    A Prospective Multi-center Single Arm Study Evaluating the Safety and Performance of the SPIKE FLOW Endocardial Lead

    Not yet reported FIAB SpA 131 participants Est. completion 2027-08 3 sites
    Other conditions: The Objective of This Study is to Assess the Safety and Performance of the SPIKE FLOW Endocardial Lead
    View official trial listing →
  • Recruiting NCT NCT07823335

    Acute Endocrine Responses to Aerobic and Anaerobic Exercise in Sedentary Women: A Comparative Analysis of Thyroid Hormones and Cortisol

    Not yet reported Assoc. Prof. Dr. Özgür EKEN 30 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Sedentary Behavior, Acute Exercise, Endocrine Response
    View official trial listing →
  • Recruiting NCT NCT07841574

    HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC

    Not yet reported Lianghe Lu 35 participants Est. completion 2029-06-30 1 site
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07842835

    Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China

    Xiaohui Ren 400 participants Est. completion 2031-07-31 3 sites
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL)
    View official trial listing →
  • Recruiting NCT NCT07849738

    Molecular Autopsy in Young Individuals With Sudden Cardiac Death

    University of Sao Paulo 200 participants Est. completion 2028-07 1 site
    Other conditions: Tachycardia
    View official trial listing →
  • Completed NCT NCT00000190

    Cocaine in Parotid Saliva, Blood and Urine - 4

    Not yet reported University of Pennsylvania Est. completion 1992-02 1 site
    Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Withdrawn NCT NCT00000372

    Glycine and D-Cycloserine in Schizophrenia

    Not yet reported Massachusetts General Hospital Est. completion 2005-11 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00000509

    Potassium and Sodium to Control Blood Pressure in Hypertensives

    Not yet reported University of Minnesota Est. completion 2003-09
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Vascular Diseases
    View official trial listing →
  • Completed NCT NCT00000608

    Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-07
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Vascular Diseases
    View official trial listing →
  • Completed NCT NCT00000611

    Women's Health Initiative (WHI)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI)
    Cardiovascular disease Other conditions: Bone Diseases, Breast Neoplasms, Colonic Neoplasms, Coronary Disease, Heart Diseases, Myocardial Ischemia, Osteoporosis, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000647

    An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 6 participants Est. completion 1994-12 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00000916

    A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 399 participants Est. completion 2004-08 34 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00000941

    A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 56 participants Est. completion 2002-03 13 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00001210

    Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

    National Cancer Institute (NCI) 60 participants Est. completion 2000-09 1 site
    Other conditions: HIV Infections, Healthy
    View official trial listing →
  • Completed NCT NCT00001336

    In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

    National Cancer Institute (NCI) 1000 participants Est. completion 2003-02 1 site
    Other conditions: Immunologic Deficiency Syndrome, Leukemia, Lymphoma, Neoplasm
    View official trial listing →
  • Completed NCT NCT00001364

    Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities

    National Institute of Neurological Disorders and Stroke (NINDS) 120 participants Est. completion 2007-12-10 1 site
    Other conditions: Arteriovenous Fistula, Arteriovenous Malformation, Spinal Cord Disease
    View official trial listing →
  • Completed NCT NCT00001461

    Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme

    National Heart, Lung, and Blood Institute (NHLBI) 209 participants Est. completion 2001-04 1 site
    Other conditions: Atherosclerosis, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00001498

    A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

    Not yet reported National Cancer Institute (NCI) 55 participants Est. completion 2000-12 1 site
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00001566

    A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

    Not yet reported National Cancer Institute (NCI) 42 participants Est. completion 2008-09 1 site
    Obstructive sleep apnea Other conditions: Ewing's Sarcoma
    View official trial listing →
  • Completed NCT NCT00001586

    Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

    Not yet reported National Cancer Institute (NCI) 105 participants Est. completion 2011-11 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00001629

    The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 49 participants Est. completion 2000-09 1 site
    Heart failureCardiovascular disease Other conditions: Atherosclerosis, Hypertension
    View official trial listing →
  • Completed NCT NCT00001715

    Evaluation of Patients With Blood Disorders

    National Institutes of Health Clinical Center (CC) 898 participants Est. completion 2017-08-23 1 site
    Other conditions: Hematologic Disease
    View official trial listing →
  • Completed NCT NCT00001741

    Study of Inherited Changes of Receptors Located on Blood Vessels

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 200 participants Est. completion 2003-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00001827

    p53 Vaccine for Ovarian Cancer

    Not yet reported National Cancer Institute (NCI) 21 participants Est. completion 2013-01-25 1 site
    Other conditions: Ovarian Neoplasm
    View official trial listing →
  • Completed NCT NCT00001839

    A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

    Not yet reported National Institutes of Health Clinical Center (CC) 182 participants Est. completion 2000-05 1 site
    Other conditions: Hematologic Diseases, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00001921

    Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings

    National Institute of Mental Health (NIMH) 1386 participants Est. completion 2018-06-08 1 site
    Other conditions: Healthy, Schizophrenia
    View official trial listing →
  • Completed NCT NCT00001932

    Serotonin Receptors in Seizure Disorders

    National Institute of Neurological Disorders and Stroke (NINDS) 95 participants Est. completion 2007-08-15 1 site
    Other conditions: Partial Epilepsy
    View official trial listing →
  • Completed NCT NCT00002050

    A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients

    Not yet reported Immunobiology Research Institute 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT00002531

    Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

    Not yet reported Johann Wolfgang Goethe University Hospital 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00002549

    Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1520 participants 75 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002572

    Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

    Not yet reported University of Colorado, Denver 10 participants Est. completion 1999-12 3 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00002594

    Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors

    Not yet reported Children's Oncology Group 31 participants Est. completion 2007-03 118 sites
    Other conditions: Brain Tumor, Central Nervous System Tumor
    View official trial listing →
  • Completed NCT NCT00002596

    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 270 participants Est. completion 2006-07 153 sites
    Other conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00002600

    Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23 participants Est. completion 2001-07-25 2 sites
    Other conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00002601

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

    Not yet reported City of Hope Medical Center 13 participants Est. completion 2014-09 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Status unknown NCT NCT00002658

    Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

    Not yet reported Medical Research Council 2000 participants 1 site
    Other conditions: Leukemia, Neutropenia
    View official trial listing →
  • Completed NCT NCT00002674

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported Fred Hutchinson Cancer Center 30 participants Est. completion 2000-03 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002718

    T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

    Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2008-10 1 site
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT00002761

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported, Not yet reported Columbia University Est. completion 2007-10
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002788

    High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

    Not yet reported Fred Hutchinson Cancer Center 15 participants Est. completion 2002-09 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002798

    Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not yet reported National Cancer Institute (NCI) 880 participants 1 site
    Other conditions: Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Ringed Sideroblasts, Secondary Myelodysplastic Syndromes, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    View official trial listing →
  • Completed NCT NCT00002838

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 13 participants Est. completion 2002-07 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002868

    Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

    Not yet reported Eastern Cooperative Oncology Group 744 participants 3 sites
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00003056

    Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

    Not yet reported Baxalta now part of Shire 105 participants Est. completion 2003-06-01 13 sites
    Other conditions: Leukemia, Lymphoma, Graft Versus Host Disease
    View official trial listing →
  • Terminated NCT NCT00003086

    Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer

    Not yet reported, Not yet reported Louisiana State University Health Sciences Center Shreveport 12 participants Est. completion 2001-01-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003101

    Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

    Not yet reported Memorial Sloan Kettering Cancer Center 60 participants Est. completion 2002-01 7 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00003116

    High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Case Comprehensive Cancer Center 66 participants Est. completion 2009-06 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003131

    CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse

    Not yet reported Pfizer 55 participants Est. completion 2002-02 13 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00003146

    Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-06 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003173

    High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 36 participants Est. completion 2003-05 2 sites
    Other conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Retinoblastoma, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00003195

    Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2000-11 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003204

    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 515 participants 1 site
    Other conditions: Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00003211

    Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor

    Not yet reported St. Jude Children's Research Hospital 94 participants Est. completion 2007-06 4 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00003243

    Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 site
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Status unknown NCT NCT00003284

    High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 30 participants 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00003297

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer

    Not yet reported, Not yet reported Georgetown University 50 participants Est. completion 2001-01 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00003335

    Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

    Not yet reported Case Comprehensive Cancer Center 44 participants Est. completion 2012-01 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003353

    High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

    Not yet reported Eastern Cooperative Oncology Group 17 sites
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003400

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer

    Not yet reported University of Maryland, Baltimore 45 participants Est. completion 2000-03 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003413

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

    Not yet reported University of Maryland, Baltimore 32 participants Est. completion 2001-02 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00003539

    Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 50 participants Est. completion 2003-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00003552

    Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-10 1 site
    Other conditions: Stage IV Melanoma, Recurrent Melanoma
    View official trial listing →
  • Terminated NCT NCT00003567

    Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

    Not yet reported Case Comprehensive Cancer Center 8 participants Est. completion 2007-02 1 site
    Other conditions: Brain and Central Nervous System Tumors, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00003572

    Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20 participants Est. completion 2002-04 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00003578

    High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

    Not yet reported Lymphoma Trials Office 500 participants 72 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003595

    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 120 participants 13 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003648

    Genetic Study of Patients and Families With a History of Colorectal Cancer

    Alliance for Clinical Trials in Oncology 1500 participants Est. completion 2006-05 12 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00003662

    Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

    Not yet reported Roswell Park Cancer Institute 90 participants Est. completion 2001-01 15 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Thymic Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT00003663

    Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma

    Not yet reported Hoag Memorial Hospital Presbyterian Est. completion 2000-01 3 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003673

    CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

    Not yet reported Pfizer 55 participants Est. completion 1999-03 10 sites
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00003680

    Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

    Not yet reported Scottish Cancer Therapy Network 300 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003735

    Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

    Not yet reported Children's Oncology Group 11 participants Est. completion 2006-09 38 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00003757

    Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

    Not yet reported Swiss Cancer Institute 25 participants Est. completion 2007-07 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00003789

    Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

    Not yet reported National Cancer Institute (NCI) 216 participants 1 site
    Other conditions: Recurrent Melanoma, Stage III Melanoma
    View official trial listing →
  • Completed NCT NCT00003809

    Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

    Not yet reported Eastern Cooperative Oncology Group 76 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00003849

    Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

    Not yet reported Alliance for Clinical Trials in Oncology 39 participants Est. completion 2008-02 21 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003868

    Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2005-03 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00003877

    Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

    Not yet reported, Not yet reported Roswell Park Cancer Institute 30 participants Est. completion 2000-12 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003942

    Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Systemix 15 participants 6 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003944

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet reported Fox Chase Cancer Center 3 participants Est. completion 2003-02 1 site
    Other conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00003972

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 280 participants Est. completion 2003-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003992

    Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

    Not yet reported National Cancer Institute (NCI) 200 participants Est. completion 2009-03 45 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004013

    Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 60 participants Est. completion 2001-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00004040

    Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

    Not yet reported Hoag Memorial Hospital Presbyterian Est. completion 1999-06 3 sites
    Other conditions: Leukemia, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00004158

    Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2006-01 4 sites
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00004162

    Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma

    Not yet reported University of Alabama at Birmingham 48 participants Est. completion 2001-01 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00004221

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer

    Not yet reported Gynecologic Oncology Group 12 participants 1 site
    Other conditions: Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Carcinoma, Stage III Ovarian Cancer, Undifferentiated Ovarian Carcinoma
    View official trial listing →
  • Completed NCT NCT00004231

    Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

    Not yet reported Northwestern University Est. completion 2006-08 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00004255

    Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

    Not yet reported, Not yet reported Chimeric Therapies Est. completion 2003-05 15 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00004286

    Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

    Not yet reported National Center for Research Resources (NCRR) 120 participants Est. completion 1999-11
    Other conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
    View official trial listing →
  • Completed NCT NCT00004474

    Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia

    Not yet reported Roswell Park Cancer Institute 224 participants Est. completion 2007-08 4 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00004865

    Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

    Not yet reported Jonsson Comprehensive Cancer Center 3 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00004888

    Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 84 participants Est. completion 2009-05 1 site
    Other conditions: Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004900

    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

    Not yet reported Hackensack Meridian Health Est. completion 2004-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004906

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

    Not yet reported Hackensack Meridian Health Est. completion 2001-06 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004907

    Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Northwestern University Est. completion 2004-08 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00005124

    National Heart, Lung, and Blood Institute Twin Study

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1998-11
    Cardiovascular disease Other conditions: Heart Diseases, Lung Diseases, Hypertension, Diabetes Mellitus, Obesity, Coronary Disease, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00005164

    Insulin Resistance and Blood Pressure Regulation in Blacks

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1991-08
    Cardiovascular disease Other conditions: Hypertension, Heart Diseases, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00005206

    Calcium Intake, Metabolism, and Gestational Blood Pressure

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1991-08
    Cardiovascular disease Other conditions: Heart Diseases
    View official trial listing →
  • Completed NCT NCT00005363

    Ambulatory Blood Pressure and Prognosis

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1994-07
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00005606

    Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

    Not yet reported Northwestern University Est. completion 2003-09 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00005619

    Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia

    Northwestern University 16 participants Est. completion 2001-08 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00005783

    A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50 participants Est. completion 2000-10 1 site
    Other conditions: Hemoglobin SC Disease, Sickle Cell Anemia
    View official trial listing →
  • Completed NCT NCT00005799

    Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

    Not yet reported Fred Hutchinson Cancer Center 55 participants 7 sites
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), B-cell Chronic Lymphocytic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Childhood Renal Cell Carcinoma, Chronic Phase Chronic Myelogenous Leukemia, Clear Cell Renal Cell Carcinoma, de Novo Myelodysplastic Syndromes, Nodal Marginal Zone B-cell Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Splenic Marginal Zone Lymphoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, T-cell Large Granular Lymphocyte Leukemia, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00005803

    Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 76 participants Est. completion 2018-10 5 sites
    Other conditions: Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Childhood Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Small Lymphocytic Lymphoma, T-Cell Chronic Lymphocytic Leukemia, T-Cell Prolymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00005824

    Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma

    Not yet reported AIDS Malignancy Consortium Est. completion 2006-04 2 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00005835

    N99-02: Melphalan and Buthionine Sulfoximine

    Not yet reported New Approaches to Neuroblastoma Therapy Consortium 31 participants Est. completion 2016-04 9 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00005851

    Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 11 participants Est. completion 2018-09-27 6 sites
    Other conditions: Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    View official trial listing →
  • Terminated NCT NCT00005852

    Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2007-07
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005866

    S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

    Not yet reported SWOG Cancer Research Network 240 participants Est. completion 2006-03 66 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005907

    Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers

    National Institute of Allergy and Infectious Diseases (NIAID) 55 participants Est. completion 2002-05 1 site
    Other conditions: Active Immunity, Healthy, Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00005946

    Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

    Not yet reported University of Maryland, Baltimore Est. completion 2002-06 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005947

    Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Dendreon 127 participants Est. completion 2004-09 34 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005978

    N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma

    Not yet reported New Approaches to Neuroblastoma Therapy Consortium 15 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00005986

    Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Withdrawn NCT NCT00005998

    Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

    Not yet reported Masonic Cancer Center, University of Minnesota Est. completion 2003-03
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00006032

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2001-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00006055

    Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

    Not yet reported Fairview University Medical Center 10 participants 1 site
    Obstructive sleep apnea Other conditions: Purpura, Schoenlein-Henoch, Graft Versus Host Disease, Anemia, Hemolytic, Autoimmune, Rheumatoid Arthritis, Churg-Strauss Syndrome, Hypersensitivity Vasculitis, Wegener's Granulomatosis, Systemic Lupus Erythematosus, Giant Cell Arteritis, Pure Red Cell Aplasia, Juvenile Rheumatoid Arthritis, Autoimmune Thrombocytopenic Purpura, Takayasu Arteritis
    View official trial listing →
  • Status unknown NCT NCT00006072

    A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies

    Not yet reported National Center for Research Resources (NCRR)
    Other conditions: Peripheral Neuropathy
    View official trial listing →
  • Status unknown NCT NCT00006100

    Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

    Not yet reported Milton S. Hershey Medical Center 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00006126

    Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

    Not yet reported Northwestern University Est. completion 2001-04
    Other conditions: Breast Cancer, Kidney Cancer, Lung Cancer, Melanoma (Skin), Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00006148

    Spleen Size in Peripheral Blood Stem Cell Donors

    National Institutes of Health Clinical Center (CC) 49 participants Est. completion 2004-06 1 site
    Other conditions: Splenomegaly
    View official trial listing →
  • Completed NCT NCT00006320

    Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 20 participants Est. completion 2004-07 1 site
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT00006379

    Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

    Not yet reported Case Comprehensive Cancer Center 58 participants Est. completion 2011-10 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant Condition, Small Intestine Cancer
    View official trial listing →
  • Completed NCT NCT00006381

    Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2004-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00006390

    Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

    Not yet reported Eastern Cooperative Oncology Group 14 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00006412

    Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 630 participants Est. completion 2003-05 58 sites
    Other conditions: HIV Infections, Lipodystrophy
    View official trial listing →
  • Completed NCT NCT00006437

    Pathophysiology of Chronic Wounds

    National Institute of Dental and Craniofacial Research (NIDCR) 999 participants Est. completion 2002-10 1 site
    Other conditions: Healthy, Skin Ulcer
    View official trial listing →
  • Withdrawn NCT NCT00006669

    Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma

    Not yet reported Medstar Health Research Institute Est. completion 2000-01 2 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00006708

    S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported SWOG Cancer Research Network 7 participants Est. completion 2006-11 85 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00007813

    Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21 participants Est. completion 2005-02-01 1 site
    Other conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00008151

    Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2002-07 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00008203

    Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center Est. completion 2008-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00008216

    Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Columbia University 48 participants Est. completion 2009-01 1 site
    Other conditions: Adult Langerhans Cell Histiocytosis, Childhood Langerhans Cell Histiocytosis, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00010361

    Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders

    Not yet reported Fred Hutchinson Cancer Center 20 participants 1 site
    Other conditions: Metabolism, Inborn Errors, Granulomatous Disease, Chronic
    View official trial listing →
  • Completed NCT NCT00014495

    Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 32 participants Est. completion 2009-12 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00014508

    Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

    Not yet reported Eastern Cooperative Oncology Group Est. completion 2011-05-27 12 sites
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00014573

    Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

    Not yet reported Barbara Ann Karmanos Cancer Institute Est. completion 2004-10 1 site
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Terminated NCT NCT00016029

    Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer

    Not yet reported Duke University 775 participants Est. completion 2005-08 14 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00017368

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

    Not yet reported Children's Oncology Group 42 participants Est. completion 2012-01 9 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00017394

    Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) 56 participants 1 site
    Other conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00017589

    Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia

    Not yet reported Genta Incorporated Est. completion 2006-05 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00017628

    Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

    Not yet reported Northwestern Memorial Hospital 20 participants 2 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT00017654

    Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia

    Not yet reported Northwestern Memorial Hospital 3 participants 1 site
    Other conditions: Graft Versus Host Disease, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00017680

    Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

    Not yet reported Herbert Irving Comprehensive Cancer Center 25 participants Est. completion 2004-04 1 site
    Other conditions: Amyloidosis
    View official trial listing →
  • Completed NCT NCT00018070

    Identification and Treatment of Feeder Vessels in Macular Degeneration

    Not yet reported National Eye Institute (NEI) 20 participants Est. completion 2006-08-30 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00019097

    Vaccine Therapy in Treating Patients With Multiple Myeloma

    Not yet reported National Cancer Institute (NCI) Est. completion 2007-03 3 sites
    Other conditions: Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00020176

    Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) Est. completion 2007-08 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00020722

    Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

    Not yet reported Barbara Ann Karmanos Cancer Institute 7 participants Est. completion 2013-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00020917

    Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2004-02 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00022321

    Gemtuzumab in Treating Patients With Myelodysplastic Syndrome

    Not yet reported Jonsson Comprehensive Cancer Center 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00022672

    A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 208 participants Est. completion 2009-10 132 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00022737

    Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 220 participants 1 site
    Other conditions: Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00023491

    Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells

    National Institute of Dental and Craniofacial Research (NIDCR) 10 participants Est. completion 2004-10 1 site
    Other conditions: Graft vs Host Disease, Sjogren's Syndrome
    View official trial listing →
  • Completed NCT NCT00024154

    Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 132 participants 1 site
    Other conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00026000

    Brain Activation in Vocal and Motor Tics

    National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2005-01 1 site
    Other conditions: Tourette's Syndrome, Chronic Motor Tic Disorder, Chronic Motor Vocal Disorder
    View official trial listing →
  • Completed NCT NCT00026182

    Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 99 participants 1 site
    Obstructive sleep apnea Other conditions: Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma
    View official trial listing →
  • Completed NCT NCT00026221

    Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

    Not yet reported National Cancer Institute (NCI) 57 participants Est. completion 2013-11 2 sites
    Other conditions: Recurrent Melanoma, Stage IV Skin Melanoma
    View official trial listing →
  • Completed NCT NCT00026832

    Examination of Brain Serotonin Receptors in Patients With Mood Disorders

    National Institute of Mental Health (NIMH) 214 participants Est. completion 2012-11-27 1 site
    Other conditions: Mood Disorder, Bipolar Disorder, Depression
    View official trial listing →
  • Completed NCT NCT00027547

    Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2004-07 3 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00027846

    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma

    Not yet reported Children's Oncology Group 378 participants Est. completion 2016-03-31 165 sites
    Other conditions: Brain Tumor, Central Nervous System Tumor
    View official trial listing →
  • Completed NCT NCT00027937

    Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2007-11 1 site
    Other conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00028665

    Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma

    Not yet reported Case Comprehensive Cancer Center 37 participants 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00028834

    Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer

    Not yet reported National Cancer Institute (NCI) 50 participants 1 site
    Other conditions: Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00029107

    Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 47 participants Est. completion 2011-05 1 site
    Other conditions: Hepatitis C, Vasculitis
    View official trial listing →
  • Completed NCT NCT00029926

    Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20 participants Est. completion 2002-11 1 site
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00031681

    7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

    Not yet reported National Cancer Institute (NCI) 41 participants 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer, Extensive Stage Small Cell Lung Cancer, Gastrointestinal Stromal Tumor, HER2-negative Breast Cancer, Metastatic Gastrointestinal Carcinoid Tumor, Ovarian Sarcoma, Ovarian Stromal Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Adult Primary Liver Cancer, Recurrent Anal Cancer, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor, Recurrent Breast Cancer, Recurrent Cervical Cancer, Recurrent Colon Cancer, Recurrent Endometrial Carcinoma, Recurrent Esophageal Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Recurrent Gastric Cancer, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Pancreatic Cancer, Recurrent Prostate Cancer, Recurrent Rectal Cancer, Recurrent Salivary Gland Cancer, Recurrent Small Cell Lung Cancer, Recurrent Small Intestine Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Small Intestine Adenocarcinoma, Small Intestine Lymphoma, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Anal Cancer, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor, Stage IV Breast Cancer, Stage IV Colon Cancer, Stage IV Endometrial Carcinoma, Stage IV Esophageal Cancer, Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IV Gastric Cancer, Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Stage IV Pancreatic Cancer, Stage IV Prostate Cancer, Stage IV Rectal Cancer, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer, Triple-negative Breast Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    View official trial listing →
  • Completed NCT NCT00032045

    Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

    Not yet reported National Cancer Institute (NCI) Est. completion 2006-08 1 site
    Other conditions: Intraocular Melanoma, Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00032734

    Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

    Not yet reported Sanofi 35 participants Est. completion 2003-07 4 sites
    Other conditions: Syndrome of Inappropriate ADH (SIADH) Secretion, Hyponatremia
    View official trial listing →
  • Terminated NCT NCT00032773

    Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

    Not yet reported, Not yet reported Astex Pharmaceuticals, Inc. 36 participants Est. completion 2005-11-03 1 site
    Other conditions: Acute Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00032786

    Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

    Not yet reported Biogen Est. completion 2004-03
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00034021

    Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction

    Not yet reported National Center for Complementary and Integrative Health (NCCIH) Est. completion 2004-09 1 site
    Other conditions: Hypoactive Sexual Desire Disorder, Sexual Dysfunctions, Psychological
    View official trial listing →
  • Completed NCT NCT00035555

    Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney

    Not yet reported Bristol-Myers Squibb 230 participants Est. completion 2012-07 12 sites
    Other conditions: Graft Rejection, Kidney Transplantation, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00035776

    Blood Factors and Peripheral Arterial Disease Outcomes

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2005-12
    Cardiovascular disease Other conditions: Arterial Occlusive Diseases, Peripheral Vascular Diseases, Coronary Disease
    View official trial listing →
  • Terminated NCT NCT00035958

    Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 75 participants Est. completion 2002-08 1 site
    Other conditions: Dermatomyositis
    View official trial listing →
  • Completed NCT NCT00036374

    A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis

    Not yet reported Centocor, Inc. 123 participants Est. completion 2006-12
    Other conditions: Rheumatoid Arthritis, Juvenile
    View official trial listing →
  • Completed NCT NCT00036387

    A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.

    Not yet reported Centocor, Inc. 347 participants Est. completion 2003-11
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00036491

    Anti-CD20 in Systemic Lupus Erythematosus

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2006-01 3 sites
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00036738

    Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

    Not yet reported Fred Hutchinson Cancer Center 28 participants Est. completion 2018-05 3 sites
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blastic Phase, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase of Disease, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Disease
    View official trial listing →
  • Completed NCT NCT00038402

    Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 74 participants Est. completion 2011-07 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00038623

    Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 35 participants Est. completion 2010-02 1 site
    Other conditions: Lymphoma, Mantle-Cell
    View official trial listing →
  • Completed NCT NCT00038935

    Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2003-02
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT00039650

    Pilot Study: Effects of G-CSF on T Cell Function

    National Institutes of Health Clinical Center (CC) 15 participants Est. completion 2004-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00040651

    Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15 participants Est. completion 2007-03 1 site
    Other conditions: Scleroderma, Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT00040846

    Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

    Not yet reported Fred Hutchinson Cancer Center 60 participants Est. completion 2009-12 7 sites
    Obstructive sleep apnea Other conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Hepatosplenic T-cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Peripheral T-cell Lymphoma, Previously Treated Myelodysplastic Syndromes, Progressive Hairy Cell Leukemia, Initial Treatment, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Splenic Marginal Zone Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Terminated NCT NCT00041288

    Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

    Not yet reported University of Texas Southwestern Medical Center 10 participants Est. completion 2003-01 23 sites
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00042809

    Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 40 participants 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00043823

    Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 41 participants Est. completion 2006-05-15 2 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00044057

    A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

    Not yet reported Astellas Pharma Inc Est. completion 2003-01 118 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00045981

    The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)

    Not yet reported Synvista Therapeutics, Inc 450 participants Est. completion 2006-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00046293

    ReoPro and Retavase to Treat Acute Stroke

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 72 participants Est. completion 2007-07-20 3 sites
    Other conditions: Cerebrovascular Accident
    View official trial listing →
  • Completed NCT NCT00046683

    Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

    Not yet reported Genzyme, a Sanofi Company 284 participants Est. completion 2006-06 20 sites
    Other conditions: B Cell Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00047021

    Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

    Not yet reported Case Comprehensive Cancer Center 3 participants Est. completion 2005-09 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00047060

    Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 5 participants Est. completion 2019-01-24 1 site
    Other conditions: Mycosis Fungoides, Sezary Syndrome
    View official trial listing →
  • Status unknown NCT NCT00047268

    Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

    Not yet reported European Working Group of MDS in Childhood 1 site
    Other conditions: Leukemia, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00047762

    Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

    Not yet reported Genentech, Inc. 3 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00047866

    Brain Function in Response to Motivational Stimuli

    National Institute on Alcohol Abuse and Alcoholism (NIAAA) 38 participants Est. completion 2010-06-25 1 site
    Other conditions: Drug Dependence
    View official trial listing →
  • Completed NCT NCT00048412

    Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

    Not yet reported, Not yet reported Baylor College of Medicine 40 participants Est. completion 2004-11-12 2 sites
    Other conditions: Myelodysplastic Disorders, Leukemia, Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoproliferative Disorders
    View official trial listing →
  • Completed NCT NCT00048737

    Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 70 participants Est. completion 2011-12 1 site
    Other conditions: Lymphoma, Leukemia
    View official trial listing →
  • Completed NCT NCT00048971

    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

    Alliance for Clinical Trials in Oncology 308 participants Est. completion 2006-11 84 sites
    Other conditions: Colorectal Cancer, Diarrhea, Neutropenia
    View official trial listing →
  • Terminated NCT NCT00049088

    Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 24 participants 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00050648

    To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris

    Not yet reported, Not yet reported Rockefeller University 20 participants Est. completion 2008-04 3 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00051597

    A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

    Not yet reported, Not yet reported Seagen Inc. 70 participants Est. completion 2003-08 10 sites
    Other conditions: Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell
    View official trial listing →
  • Completed NCT NCT00051636

    Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

    Not yet reported Novartis Pharmaceuticals 172 participants Est. completion 2011-04 34 sites
    Other conditions: Paget's Disease of Bone
    View official trial listing →
  • Completed NCT NCT00052390

    Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2005-10 3 sites
    Other conditions: Sarcoma
    View official trial listing →
  • Withdrawn NCT NCT00052403

    Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

    Not yet reported Barbara Ann Karmanos Cancer Institute
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00053027

    Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 30 participants Est. completion 2009-11
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00054236

    Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

    Not yet reported Case Comprehensive Cancer Center 55 participants Est. completion 2011-03 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00054353

    Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 16 participants Est. completion 2012-10-14 2 sites
    Other conditions: Refractory Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00054600

    Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease

    Not yet reported Mallinckrodt 60 participants Est. completion 2004-06 21 sites
    Other conditions: Graft-versus-Host Disease
    View official trial listing →
  • Completed NCT NCT00055159

    Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

    Not yet reported National Institutes of Health Clinical Center (CC) 50 participants Est. completion 2007-12-10 1 site
    Other conditions: Thrombosis
    View official trial listing →
  • Completed NCT NCT00055536

    Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease

    Not yet reported Biogen 60 participants Est. completion 2003-07 18 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00055653

    Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

    Not yet reported Roswell Park Cancer Institute Est. completion 2005-09 25 sites
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT00056979

    Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases

    Not yet reported, Not yet reported Baylor College of Medicine 2 participants Est. completion 2003-06 2 sites
    Other conditions: Inherited Metabolic Storage Diseases
    View official trial listing →
  • Completed NCT NCT00057005

    Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation

    Not yet reported Baylor College of Medicine 6 participants Est. completion 2009-10 2 sites
    Other conditions: LEUKEMIA
    View official trial listing →
  • Completed NCT NCT00057681

    Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

    Not yet reported Washington University School of Medicine 379 participants Est. completion 2008-12 5 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00057889

    Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

    Not yet reported National Institutes of Health Clinical Center (CC) Est. completion 2008-02 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00061815

    Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

    Not yet reported Eli Lilly and Company 102 participants Est. completion 2005-11 39 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00062296

    Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

    Not yet reported Fox Chase Cancer Center 5 participants Est. completion 2005-08 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00063141

    Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

    Not yet reported Eli Lilly and Company 1302 participants Est. completion 2007-10 188 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00065156

    Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality

    Not yet reported Celgene 148 participants Est. completion 2008-08-01 32 sites
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00065260

    Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 54 participants Est. completion 2016-02-05 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00067080

    Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

    Not yet reported Novartis Pharmaceuticals 195 participants 34 sites
    Other conditions: Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT00067925

    A School-Based Osteoporosis Prevention Program for Adolescent Girls

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 718 participants Est. completion 2002-06
    Other conditions: Osteoporosis
    View official trial listing →
  • Enrolling by invitation NCT NCT00068003

    Harvesting Cells for Experimental Cancer Treatments

    National Cancer Institute (NCI) 7000 participants 1 site
    Other conditions: Melanoma, Gastrointestinal Cancer, Metastatic Cancer, Breast Cancer, Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00068315

    Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

    Not yet reported National Cancer Institute (NCI) 18 participants 7 sites
    Obstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00068458

    Survival TRaining for ENhancing Total Health (STRENGTH)

    Not yet reported Duke University 39 participants Est. completion 2005-01 4 sites
    Other conditions: Breast Cancer, Depression, Weight Changes
    View official trial listing →
  • Completed NCT NCT00068757

    Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 23 participants 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00069095

    A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 2035 participants Est. completion 2009-04 236 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00070291

    Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma

    Not yet reported Eastern Cooperative Oncology Group 4 participants Est. completion 2011-05 23 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Enrolling by invitation NCT NCT00071045

    Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

    National Heart, Lung, and Blood Institute (NHLBI) 6000 participants 1 site
    Other conditions: Neoplasms, Hematologic Neoplasms, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00071227

    Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders

    Not yet reported National Eye Institute (NEI) 16 participants Est. completion 2007-08-15 1 site
    Other conditions: Macular Degeneration, Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT00071396

    Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders

    Not yet reported M.D. Anderson Cancer Center 48 participants Est. completion 2007-08 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00072592

    An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2005-08 1 site
    Other conditions: Wegener's Granulomatosis
    View official trial listing →
  • Completed NCT NCT00072761

    Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial

    Not yet reported Washington University School of Medicine 196 participants Est. completion 2013-12 1 site
    Cardiovascular disease Other conditions: Sickle Cell Anemia
    View official trial listing →
  • Terminated NCT NCT00074490

    Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

    Not yet reported National Cancer Institute (NCI) 442 participants Est. completion 2017-08-16 2 sites
    Other conditions: Lymphoma, Leukemia, Myeloproliferative Disorders, Multiple Myleoma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00075075

    Infliximab to Treat Non-Infectious Scleritis

    Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2007-09-06 1 site
    Other conditions: Scleritis
    View official trial listing →
  • Completed NCT NCT00075621

    Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis

    Not yet reported Boston Medical Center 62 participants Est. completion 2020-09-04 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00075803

    Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)

    Not yet reported Medical College of Wisconsin 600 participants Est. completion 2007-09 33 sites
    Other conditions: Lymphoma, Infection, Leukemia
    View official trial listing →
  • Completed NCT NCT00076349

    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)

    Not yet reported Cephalon 66 participants Est. completion 2008-03 34 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00076752

    Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus

    Not yet reported National Cancer Institute (NCI) 9 participants Est. completion 2013-10-15 1 site
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00077298

    Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2007-07 1 site
    Other conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00077324

    Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions

    Alliance for Clinical Trials in Oncology 1000 participants Est. completion 2011-11 73 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00078195

    Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 168 participants Est. completion 2005-05 3 sites
    Other conditions: Hay Fever, Hypersensitivity, Allergy, Rhinitis
    View official trial listing →
  • Status unknown NCT NCT00078221

    Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)

    Not yet reported OccuLogix 180 participants Est. completion 2005-12 8 sites
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00079040

    Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer

    Not yet reported National Cancer Institute (NCI) 65 participants Est. completion 2009-01 1 site
    Other conditions: Extensive Stage Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00079937

    Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

    Not yet reported Novartis Pharmaceuticals 628 participants Est. completion 2008-03 56 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00080353

    Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

    Not yet reported National Cancer Institute (NCI) 58 participants Est. completion 2008-12 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00086567

    Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

    National Cancer Institute (NCI) 119 participants 11 sites
    Other conditions: Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT00086606

    A Safety and Efficacy Study of Xolair in Peanut Allergy

    Not yet reported Genentech, Inc. 150 participants Est. completion 2006-04 1 site
    Other conditions: Allergy
    View official trial listing →
  • Completed NCT NCT00089947

    A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

    Not yet reported Genzyme, a Sanofi Company 150 participants Est. completion 2005-12 19 sites
    Other conditions: Renal Transplantation, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00090038

    Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

    Not yet reported Biogen 168 participants Est. completion 2007-11 45 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00090623

    A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

    Not yet reported Genentech, Inc. 180 participants Est. completion 2007-03 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00091104

    Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma

    Not yet reported National Institutes of Health Clinical Center (CC) 136 participants Est. completion 2010-10 2 sites
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00093483

    Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

    Not yet reported Roswell Park Cancer Institute 61 participants Est. completion 2009-12 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00093925

    Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)

    Not yet reported The Medicines Company 739 participants Est. completion 2006-09 9 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00094068

    The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients

    National Institutes of Health Clinical Center (CC) 76 participants Est. completion 2006-05 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00094653

    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

    Not yet reported Bristol-Myers Squibb 1783 participants Est. completion 2009-10 209 sites
    Other conditions: Melanoma, Metastases
    View official trial listing →
  • Completed NCT NCT00094783

    MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the Legs

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 24 participants Est. completion 2008-06-17 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00096590

    Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

    National Cancer Institute (NCI) 60 participants 1 site
    Other conditions: Thromboembolism, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00097747

    Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

    Not yet reported Affymax 28 participants Est. completion 2005-01 1 site
    Chronic kidney disease Other conditions: Anemia, Chronic Renal Failure, Cancer
    View official trial listing →
  • Completed NCT NCT00099476

    Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure

    Not yet reported National Center for Complementary and Integrative Health (NCCIH) 65 participants Est. completion 2009-04-16 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00099554

    Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)

    Not yet reported Amgen 200 participants
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00101348

    Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2008-05 1 site
    Other conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Colon Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Non-small Cell Lung Cancer, Recurrent Pancreatic Cancer, Recurrent Rectal Cancer, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage III Adenoid Cystic Carcinoma of the Oral Cavity, Stage III Basal Cell Carcinoma of the Lip, Stage III Colon Cancer, Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Lymphoepithelioma of the Oropharynx, Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage III Mucoepidermoid Carcinoma of the Oral Cavity, Stage III Pancreatic Cancer, Stage III Rectal Cancer, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IIIB Non-small Cell Lung Cancer, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Colon Cancer, Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Non-small Cell Lung Cancer, Stage IV Pancreatic Cancer, Stage IV Rectal Cancer, Stage IV Renal Cell Cancer, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    View official trial listing →
  • Completed NCT NCT00102011

    Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 4952 participants Est. completion 2026-03-05 4 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00102141

    Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

    Not yet reported Bayer 750 participants Est. completion 2005-07
    Other conditions: Hypertension, Postmenopause
    View official trial listing →
  • Completed NCT NCT00102271

    Nitrite Infusion Studies

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 36 participants Est. completion 2011-04-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00103740

    Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

    Not yet reported Novartis Pharmaceuticals 185 participants Est. completion 2011-04 41 sites
    Other conditions: Paget's Disease of Bone
    View official trial listing →
  • Completed NCT NCT00104975

    Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Yale University 20 participants Est. completion 2008-05 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00105001

    Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 210 participants Est. completion 2015-05-08 11 sites
    Other conditions: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic Lymphocytic Leukemia, Refractory Plasma Cell Myeloma, Waldenstrom Macroglobulinemia, Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA, Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Lymphoma, Childhood Myelodysplastic Syndrome, Stage II Contiguous Adult Burkitt Lymphoma, Stage II Contiguous Adult Diffuse Large Cell Lymphoma, Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma, Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Contiguous Immunoblastic Lymphoma, Stage II Contiguous Adult Lymphoblastic Lymphoma, Stage II Grade 1 Contiguous Follicular Lymphoma, Stage II Grade 2 Contiguous Follicular Lymphoma, Stage II Grade 3 Contiguous Follicular Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Adult Burkitt Lymphoma, Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma, Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma, Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Non-Contiguous Immunoblastic Lymphoma, Stage II Non-Contiguous Adult Lymphoblastic Lymphoma, Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Stage II Grade 2 Non-Contiguous Follicular Lymphoma, Stage II Grade 3 Non-Contiguous Follicular Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma, Stage II Small Lymphocytic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Burkitt Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Secondary Myelodysplastic Syndrome, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Immunoblastic Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Burkitt Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Burkitt Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Burkitt Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Burkitt Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00105066

    The Effects of Metformin on Blood Vessel Structure and Function

    Not yet reported National Institute on Aging (NIA) 77 participants Est. completion 2008-05 1 site
    Other conditions: Obesity, Hypertension, Hypercholesterolemia, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT00106678

    Typology of Adherence in Adolescents: Phase II

    University of North Carolina, Chapel Hill 1200 participants Est. completion 2005-04 17 sites
    Other conditions: HIV Infection
    View official trial listing →
  • Terminated NCT NCT00107315

    Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer

    Not yet reported Roswell Park Cancer Institute 16 participants 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00108797

    Trial of NovoSeven® in Haemophilia - Joint Bleeds

    Not yet reported Novo Nordisk A/S 42 participants Est. completion 2006-02 20 sites
    Other conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
    View official trial listing →
  • Completed NCT NCT00109057

    An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

    Not yet reported Genentech, Inc. 56 participants Est. completion 2004-02
    Other conditions: Cancer
    View official trial listing →
  • Terminated NCT NCT00109850

    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

    Not yet reported SWOG Cancer Research Network 22 participants Est. completion 2012-05 132 sites
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00109967

    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2012-03 195 sites
    Other conditions: Recurrent Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00110058

    Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2006-07 3 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00110617

    Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients

    Not yet reported Novartis Pharmaceuticals 212 participants Est. completion 2008-04 59 sites
    Other conditions: Sickle Cell Disease, Iron Overload, Hemolytic Anemia
    View official trial listing →
  • Status unknown NCT NCT00110708

    Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism

    Not yet reported PediaMed Pharmaceuticals 120 participants Est. completion 2006-06 22 sites
    Other conditions: Autism, Autistic Disorder, Child Development Disorders, Pervasive, Gastrointestinal Diseases, Signs and Symptoms, Digestive
    View official trial listing →
  • Completed NCT NCT00111124

    Enbrel® in Psoriatic Arthritis

    Not yet reported Amgen
    Other conditions: Psoriasis
    View official trial listing →
  • Terminated NCT NCT00111917

    Beryllium Infliximab Study: Clinical Interventional Trial

    Not yet reported, Not yet reported Maier, Lisa, M.D. 13 participants Est. completion 2009-01 1 site
    Other conditions: Berylliosis, Beryllium Disease
    View official trial listing →
  • Completed NCT NCT00111956

    Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

    Not yet reported, Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 56 participants Est. completion 2005-05 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00112294

    Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

    Not yet reported Eli Lilly and Company 755 participants Est. completion 2008-08 124 sites
    Other conditions: Non-Small-Cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT00114010

    Experimental Vaccine for Malaria

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 13 participants Est. completion 2006-12-22 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT00115128

    Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors

    Amgen 309 participants Est. completion 2007-09
    Other conditions: Normal PBPC Donors
    View official trial listing →
  • Terminated NCT NCT00115336

    Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease

    Not yet reported Children's Hospital Medical Center, Cincinnati 10 participants Est. completion 2008-12 1 site
    Other conditions: Hematologic Diseases, Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT00115518

    Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

    Not yet reported Heidelberg University 30 participants Est. completion 2010-08 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT00115778

    Intravenous Immunoglobulin (IVIG) in Lung Transplantation

    Not yet reported Columbia University 11 participants Est. completion 2010-08 1 site
    Other conditions: Hypogammaglobulinemia, Lung Transplantation
    View official trial listing →
  • Status unknown NCT NCT00116311

    Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood

    Groningen Research Institute for Asthma and COPD 20 participants Est. completion 2007-02 1 site
    Other conditions: Asthma, Healthy
    View official trial listing →
  • Completed NCT NCT00119392

    Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported Fred Hutchinson Cancer Center 42 participants Est. completion 2016-04-23 1 site
    Other conditions: B-cell Chronic Lymphocytic Leukemia, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00119678

    Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone

    Not yet reported Bristol-Myers Squibb 183 participants Est. completion 2008-11 52 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT00120198

    Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

    Not yet reported Geriatric Oncology Consortium 50 participants Est. completion 2006-09 5 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00121056

    REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations

    Amgen
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00122005

    GVAX in Advanced Prostate Cancer Patients Made Lymphopenic

    Not yet reported, Not yet reported Providence Health & Services 18 participants Est. completion 2005-07 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00122382

    Remission and Joint Damage Progression in Early Rheumatoid Arthritis

    Not yet reported Bristol-Myers Squibb 1052 participants Est. completion 2009-02 89 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00123058

    Comparison of Two Programs to Improve Blood Pressure Treatment Adherence

    Not yet reported Duke University 777 participants Est. completion 2007-06 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00124618

    Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 58 participants Est. completion 2015-03 175 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00124826

    SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points

    Not yet reported University of Glasgow 45 participants 1 site
    Cardiovascular disease Other conditions: Hyperglycemia
    View official trial listing →
  • Terminated NCT NCT00126191

    Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma

    Not yet reported Dana-Farber Cancer Institute 10 participants Est. completion 2011-06 2 sites
    Other conditions: Burkitt Lymphoma, Non-Hodgkins Lymphoma, Atypical Burkitt Lymphoma
    View official trial listing →
  • Completed NCT NCT00126672

    RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

    Not yet reported Dana-Farber Cancer Institute 36 participants Est. completion 2010-04 7 sites
    Other conditions: Nonmalignant Neoplasm, Tuberous Sclerosis, Lymphangioleimyomatosis, Kidney Angiomyolipoma
    View official trial listing →
  • Completed NCT NCT00127283

    Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

    Not yet reported Novo Nordisk A/S 829 participants Est. completion 2007-01 167 sites
    Other conditions: Acquired Bleeding Disorder, Intracerebral Haemorrhage
    View official trial listing →
  • Completed NCT NCT00128518

    IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs

    Not yet reported Hospices Civils de Lyon 139 participants Est. completion 2010-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00128739

    Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

    Not yet reported Rafa Laboratories 24 participants Est. completion 2005-08 1 site
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Completed NCT NCT00129727

    Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

    Not yet reported Massachusetts General Hospital 62 participants Est. completion 2009-02
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00130156

    Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

    Not yet reported Eisai Inc. 93 participants Est. completion 2009-03 1 site
    Other conditions: High Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT00131313

    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

    Not yet reported East Valley Hematology and Oncology Medical Group 180 participants Est. completion 2009-04 52 sites
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00132418

    Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders

    Not yet reported Amgen 564 participants Est. completion 2004-02
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00132691

    Multicenter Uveitis Steroid Treatment (MUST) Trial

    Not yet reported JHSPH Center for Clinical Trials 255 participants Est. completion 2010-12 23 sites
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT00133653

    The Double Exposure Study: The Impact of Job Strain and Marital Cohesion on Blood Pressure

    Sunnybrook Health Sciences Centre 250 participants Est. completion 2004-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00134680

    Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

    Not yet reported Duke University 33 participants Est. completion 2005-07 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00135135

    Therapy for Children With Neuroblastoma

    Not yet reported St. Jude Children's Research Hospital 23 participants Est. completion 2007-06 1 site
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00135720

    Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

    Not yet reported Massachusetts General Hospital 12 participants Est. completion 2007-11 1 site
    Other conditions: Pemphigus Vulgaris
    View official trial listing →
  • Completed NCT NCT00135798

    Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79 participants Est. completion 2009-12 8 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00135941

    Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

    Not yet reported Sanofi 582 participants Est. completion 2007-09 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00136084

    Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

    Not yet reported St. Jude Children's Research Hospital 238 participants Est. completion 2012-06 8 sites
    Other conditions: Leukemia, Myelocytic, Acute
    View official trial listing →
  • Completed NCT NCT00136539

    Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer

    Not yet reported Harold J. Burstein, MD, PhD 41 participants Est. completion 2012-03 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00137969

    A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

    Not yet reported, Not yet reported Genentech, Inc. 262 participants Est. completion 2008-08-25 65 sites
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00137995

    R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

    Not yet reported Lymphoma Study Association 481 participants Est. completion 2008-10 10 sites
    Other conditions: Lymphoma, Large-Cell, Diffuse
    View official trial listing →
  • Terminated NCT NCT00138125

    Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

    Not yet reported Translational Oncology Research International 2 participants Est. completion 2009-12 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00139490

    Home-Based Program to Treat High Blood Pressure in African Americans

    Not yet reported Visiting Nurse Service of New York 846 participants Est. completion 2009-09
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00139984

    Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance

    Not yet reported University Hospital, Basel, Switzerland 170 participants Est. completion 2007-05 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00140036

    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

    Not yet reported Pfizer 137 participants Est. completion 2005-08 34 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00140556

    Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

    Not yet reported David M. Brizel, MD 28 participants Est. completion 2010-04 1 site
    Other conditions: Head and Neck Cancer, Pharynx Cancer
    View official trial listing →
  • Completed NCT NCT00141037

    Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 130 participants Est. completion 2010-11 12 sites
    Other conditions: Kidney Diseases, Kidney Transplantation, Kidney Transplant, Renal Transplantation, Renal Transplant
    View official trial listing →
  • Completed NCT NCT00142155

    Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

    Not yet reported Dana-Farber Cancer Institute 300 participants Est. completion 2007-03 1 site
    Other conditions: Waldenstrom's Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00142181

    Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

    Not yet reported Dana-Farber Cancer Institute 27 participants Est. completion 2008-06 3 sites
    Other conditions: Lymphoplasmacytic Lymphoma, Waldenstrom's Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00142428

    Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2008-10 3 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT00142480

    Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

    Not yet reported Massachusetts General Hospital 8 participants Est. completion 2011-04 3 sites
    Other conditions: Biliary Tract Cancer, Gallbladder Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00143195

    Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 200 participants Est. completion 2005-01 12 sites
    Other conditions: Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00143234

    Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1825 participants Est. completion 2005-07 118 sites
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00143988

    Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers

    University of Medicine and Dentistry of New Jersey 36 participants Est. completion 2007-03 1 site
    Other conditions: Heart Rate, Blood Pressure
    View official trial listing →
  • Completed NCT NCT00145626

    HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 40 participants Est. completion 2016-07 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia, Histiocytosis
    View official trial listing →
  • Completed NCT NCT00147043

    Adult Stem Cell Therapy in Liver Insufficiency

    Not yet reported Imperial College London 5 participants Est. completion 2005-06 1 site
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT00147121

    Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

    Not yet reported, Not yet reported Haruhiko Fukuda 300 participants Est. completion 2010-02 45 sites
    Other conditions: Lymphoma, B-Cell
    View official trial listing →
  • Completed NCT NCT00147862

    Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?

    Not yet reported Tata Memorial Hospital 240 participants Est. completion 2007-01 1 site
    Other conditions: Head and Neck Neoplasms
    View official trial listing →
  • Completed NCT NCT00148044

    Uremic Toxins of Patients With Acute Kidney Failure

    University Hospital, Ghent 30 participants Est. completion 2004-02 1 site
    Other conditions: Kidney Failure, Acute
    View official trial listing →
  • Completed NCT NCT00148070

    Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer

    Not yet reported University of Michigan Rogel Cancer Center 45 participants Est. completion 2006-02 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00148109

    Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

    Not yet reported University of Michigan Rogel Cancer Center 36 participants Est. completion 2009-12 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00148226

    ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial

    Not yet reported University of Sydney Est. completion 2005-09 1 site
    Other conditions: Colorectal Cancer Screening
    View official trial listing →
  • Completed NCT NCT00148681

    Preoperative Herceptin and Navelbine for Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 49 participants Est. completion 2003-05 3 sites
    Other conditions: Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
    View official trial listing →
  • Completed NCT NCT00149175

    Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment

    Institut National de la Santé Et de la Recherche Médicale, France 2256 participants Est. completion 2020-12-31 12 sites
    Other conditions: Alzheimer's Disease, Dementia, Neurodegenerative Disorders
    View official trial listing →
  • Completed NCT NCT00152386

    A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

    Not yet reported UCB Pharma 950 participants Est. completion 2006-10 76 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00154141

    Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

    Not yet reported Ethicon, Inc. 150 participants Est. completion 2006-03 17 sites
    Other conditions: Peripheral Vascular Disease
    View official trial listing →
  • Completed NCT NCT00154271

    Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)

    Not yet reported Novartis 1677 participants Est. completion 2005-06
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00154310

    Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

    Not yet reported Novartis 300 participants Est. completion 2008-09 3 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00155402

    The Application of Fibrin Glue in Ocular Surface Diseases

    Not yet reported National Taiwan University Hospital 30 participants Est. completion 2008-03 1 site
    Other conditions: Pterygium, Corneal Ulcer
    View official trial listing →
  • Completed NCT NCT00156143

    Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents

    Not yet reported Pfizer 90 participants Est. completion 2005-04
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00157040

    Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A

    Not yet reported, Not yet reported Baxalta now part of Shire 50 participants Est. completion 2005-01-04 12 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT00157079

    Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

    Not yet reported Baxalta now part of Shire 61 participants Est. completion 2003-12-16 11 sites
    Other conditions: Primary Immunodeficiency Diseases (PID), Immune Thrombocytopenic Purpura (ITP), Kawasaki Syndrome
    View official trial listing →
  • Completed NCT NCT00157105

    Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery

    Not yet reported, Not yet reported Baxalta now part of Shire 59 participants Est. completion 2004-08-03 10 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT00157131

    Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

    Not yet reported Baxter Healthcare Corporation 150 participants Est. completion 2007-02 17 sites
    Other conditions: Deep Partial or Full Thickness Wounds
    View official trial listing →
  • Status unknown NCT NCT00157274

    Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

    Not yet reported Latin American Cooperative Onco-Haematology Group - Peru 20 participants Est. completion 2008-07 1 site
    Other conditions: Mycosis Fungoides, Sezary Syndrome
    View official trial listing →
  • Completed NCT NCT00157326

    Tadalafil in Subjects With Mild to Moderate Hypertension

    Not yet reported Eli Lilly and Company 180 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00158639

    Electronic Communications and Home Blood Pressure Monitoring

    Not yet reported Kaiser Permanente 778 participants Est. completion 2007-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00158743

    Efficacy Study of Digibind for Treatment of Severe Preeclampsia

    Not yet reported BTG International Inc. 51 participants Est. completion 2007-12 8 sites
    Other conditions: Pre-eclampsia
    View official trial listing →
  • Completed NCT NCT00162851

    Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia

    Not yet reported Karolinska University Hospital 20 participants Est. completion 2006-07 1 site
    Other conditions: B-CLL
    View official trial listing →
  • Completed NCT NCT00165334

    Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer

    Not yet reported Dana-Farber Cancer Institute 53 participants Est. completion 2007-11 3 sites
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00165568

    Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

    Not yet reported Dana-Farber Cancer Institute 20 participants Est. completion 2006-10 2 sites
    Other conditions: Colorectal Cancer, Neoplasm Metastasis
    View official trial listing →
  • Terminated NCT NCT00167661

    Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation

    Not yet reported, Not yet reported University of Wisconsin, Madison 33 participants Est. completion 2012-05 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00168077

    Prothrombin Complex Concentrate for Anticoagulant Reversal

    Not yet reported CSL Behring 40 participants Est. completion 2006-11 15 sites
    Other conditions: Acquired Coagulation Factor Deficiency
    View official trial listing →
  • Completed NCT NCT00168168

    ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

    Not yet reported Alberta Health services 60 participants Est. completion 2007-02 1 site
    Other conditions: Peripheral Stem Cell/Marrow Transplant
    View official trial listing →
  • Completed NCT NCT00169208

    Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

    Not yet reported Lymphoma Study Association 50 participants Est. completion 2006-12 16 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT00169247

    Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation

    Not yet reported Groupe Oncologie Radiotherapie Tete et Cou 156 participants 3 sites
    Other conditions: Larynx Cancer, Hypopharynx Cancer
    View official trial listing →
  • Completed NCT NCT00171353

    A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure

    Not yet reported Novartis 109 participants Est. completion 2005-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00172263

    The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes

    Not yet reported National Taiwan University Hospital 1 site
    Other conditions: Severe Acute Respiratory Syndrome
    View official trial listing →
  • Status unknown NCT NCT00173628

    Autoantibodies in Patients With Type 1 Diabetes Mellitus

    National Taiwan University Hospital 150 participants Est. completion 2006-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00175084

    Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers

    Not yet reported Tufts University 30 participants Est. completion 2012-12 1 site
    Metabolic syndromeCardiovascular disease Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT00176852

    Stem Cell Transplant for Hemoglobinopathy

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2020-01 1 site
    Other conditions: Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia, Diamond-Blackfan Anemia, Shwachman-Diamond Syndrome
    View official trial listing →
  • Completed NCT NCT00176878

    Stem Cell Transplant for Bone Marrow Failure Syndromes

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 10 participants Est. completion 2009-03 1 site
    Other conditions: Diamond-Blackfan Anemia, Kostmann's Neutropenia, Shwachman-Diamond Syndrome
    View official trial listing →
  • Completed NCT NCT00176917

    Stem Cell Transplantation for Hurler

    Not yet reported Masonic Cancer Center, University of Minnesota 41 participants Est. completion 2010-05 1 site
    Other conditions: Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Mannosidosis, Mucolipidosis Type II (I-cell Disease)
    View official trial listing →
  • Completed NCT NCT00178659

    Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)

    The University of Texas Health Science Center, Houston 260 participants Est. completion 2026-06-08 1 site
    Other conditions: Brain Injuries, Traumatic, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT00178919

    Nitric Oxide and the Autonomic Nervous System

    Not yet reported Vanderbilt University 112 participants Est. completion 2008-08 1 site
    Other conditions: Hypertension, Pure Autonomic Failure
    View official trial listing →
  • Completed NCT NCT00179868

    C-Reactive Protein as a Predictor of Stem Cell Transplant Complications

    Ann & Robert H Lurie Children's Hospital of Chicago 70 participants Est. completion 2008-02 1 site
    Other conditions: Cancer, Leukemia, Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00180011

    Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

    Not yet reported, Not yet reported DiMango, Emily, M.D. 18 participants Est. completion 2012-02 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00181142

    The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation

    Not yet reported, Not yet reported Johns Hopkins University 60 participants Est. completion 2004-12 1 site
    Other conditions: Patients Active and Listed for Lung Transplantation
    View official trial listing →
  • Completed NCT NCT00182793

    Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

    Not yet reported City of Hope Medical Center 32 participants Est. completion 2014-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00182923

    Forearm Vascular Relaxation

    National Institute on Aging (NIA) 400 participants Est. completion 2006-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00184392

    Cleaning of the Nose After Sinus Surgery: Necessary or Only Bothersome?

    Not yet reported Norwegian University of Science and Technology 60 participants Est. completion 2007-09 2 sites
    Other conditions: Acute Recurrent Rhinosinusitis
    View official trial listing →
  • Terminated NCT NCT00184548

    Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

    Not yet reported Novo Nordisk A/S 554 participants Est. completion 2008-09 14 sites
    Other conditions: Acquired Bleeding Disorder, Trauma
    View official trial listing →
  • Completed NCT NCT00185068

    An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

    Not yet reported Daiichi Sankyo 110 participants Est. completion 2004-10 16 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185172

    Olmesartan in Essential Hypertension

    Not yet reported Sankyo Pharma Gmbh 2333 participants Est. completion 2005-06 8 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00185562

    A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis

    Not yet reported Stanford University 12 participants Est. completion 2006-01 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT00185796

    TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

    Not yet reported Stanford University 77 participants Est. completion 2015-02 1 site
    Other conditions: Myeloproliferative Disorders, Blood Cancer, Myelodysplastic Syndromes
    View official trial listing →
  • Enrolling by invitation NCT NCT00186147

    Bone Marrow Grafting for Leukemia and Lymphoma

    Stanford University 9999 participants Est. completion 2069-12 1 site
    Other conditions: Leukemia, Lymphoma, Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT00186641

    High Dose Chemotherapy and Autologous Transplant for Breast Cancer

    Not yet reported Stanford University 203 participants Est. completion 2008-02-08 1 site
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Terminated NCT NCT00186745

    Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

    Not yet reported St. Joseph's Healthcare Hamilton 148 participants Est. completion 2016-02 1 site
    Other conditions: Venous Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00190970

    The Effect of Ruboxistaurin on Small Fiber Function

    Not yet reported Chromaderm, Inc. 52 participants Est. completion 2005-11 1 site
    Other conditions: Diabetic Neuropathy
    View official trial listing →
  • Status unknown NCT NCT00192829

    Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

    Rambam Health Care Campus 100 participants 2 sites
    Other conditions: Non-Small Cell Lung Carcinoma, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT00193440

    Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma

    Not yet reported SCRI Development Innovations, LLC 40 participants Est. completion 2009-01
    Other conditions: Non-Hodgkins Lymphoma
    View official trial listing →
  • Completed NCT NCT00193492

    A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

    Not yet reported SCRI Development Innovations, LLC 60 participants Est. completion 2013-03 22 sites
    Other conditions: Lymphoma, Follicular
    View official trial listing →
  • Completed NCT NCT00194129

    Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder

    Not yet reported University Hospitals Cleveland Medical Center 31 participants Est. completion 2006-09 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00195273

    Study Evaluating Sirolimus in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 61 participants Est. completion 2008-07 3 sites
    Other conditions: Graft vs Host Disease, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00195338

    Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

    Pfizer 25 participants Est. completion 2010-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00195416

    Study Investigating Enbrel Treatment for Ankylosing Spondylitis

    Wyeth is now a wholly owned subsidiary of Pfizer 526 participants Est. completion 2008-08 3 sites
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00197886

    Dose of Norepinephrine and the Concentration of L-Lactate in the Rectum and Stomach in Patients With Septic Shock.

    Not yet reported Herlev Hospital 10 participants Est. completion 2005-12 1 site
    Other conditions: Septic Shock
    View official trial listing →
  • Status unknown NCT NCT00198562

    Hypertension Control Based on Home Blood Pressure

    Not yet reported Ministry of Health, Labour and Welfare, Japan 2600 participants Est. completion 2012-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00199030

    Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

    Not yet reported Goethe University 8 participants Est. completion 2008-04 1 site
    Other conditions: Adult Acute Lymphocytic Leukemia T-cell, Lymphoma, Lymphoblastic
    View official trial listing →
  • Completed NCT NCT00199082

    Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

    Not yet reported Nicola Goekbuget 650 participants Est. completion 2010-06 1 site
    Other conditions: Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Neoplasms, Lymphoblastic Lymphoma, Large Cell Anaplastic Lymphoma
    View official trial listing →
  • Completed NCT NCT00199810

    Hemodynamic Measurements in Women With Serious Preeclampsia

    Oslo University Hospital 68 participants Est. completion 2008-08 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Completed NCT NCT00200460

    A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

    Not yet reported Mylan Bertek Pharmaceuticals 825 participants Est. completion 2003-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00200694

    Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

    Not yet reported Nantes University Hospital 18 participants Est. completion 2007-03 1 site
    Other conditions: Heavy Proteinuria
    View official trial listing →
  • Completed NCT NCT00201045

    Team Management of High Blood Pressure

    Not yet reported University of Iowa 179 participants Est. completion 2006-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00201149

    Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence

    Not yet reported Boston Medical Center 870 participants Est. completion 2015-12 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00201682

    Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

    Not yet reported, Not yet reported John Byrd 36 participants Est. completion 2009-08 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00202553

    S90652 in Paediatric Hypertension

    Not yet reported Institut de Recherches Internationales Servier 50 participants Est. completion 2006-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00202865

    Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)

    Not yet reported Merck Sharp & Dohme LLC 76 participants Est. completion 2007-05-01
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT00204451

    Human Ovarian Follicular Dynamics and Emergency Contraception

    Not yet reported University of Saskatchewan 40 participants Est. completion 2006-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00205335

    Free Test Strips and Blood Glucose Control

    Not yet reported University of Wisconsin, Madison 22 participants Est. completion 2007-11 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00206726

    Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)

    Not yet reported Genzyme, a Sanofi Company 60 participants Est. completion 2008-04 27 sites
    Other conditions: Leukemia, Lymphocytic, Chronic, B-Cell
    View official trial listing →
  • Completed NCT NCT00207077

    Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors

    Not yet reported Eli Lilly and Company 33 participants Est. completion 2007-05 1 site
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT00207116

    An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma

    Not yet reported Eli Lilly and Company 120 participants Est. completion 2006-03 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00207272

    Use of MCT Oil for Enhancement of Weight Loss in Obese Patients

    Not yet reported Boston Medical Center 24 participants Est. completion 2008-02 1 site
    Other conditions: Obesity, Weight Loss
    View official trial listing →
  • Completed NCT NCT00207558

    Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification

    Not yet reported Centers for Disease Control and Prevention 1100 participants 1 site
    Other conditions: Neural Tube Defects - Spina Bifida and Anencephaly
    View official trial listing →
  • Completed NCT NCT00207688

    A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

    Janssen Research & Development, LLC 505 participants Est. completion 2015-09-09 102 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT00209222

    Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

    Not yet reported European Mantle Cell Lymphoma Network 360 participants Est. completion 2014-12 3 sites
    Other conditions: Lymphoma, Mantle-Cell
    View official trial listing →
  • Completed NCT NCT00210262

    Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes

    Not yet reported Institute for Clinical Evaluative Sciences Est. completion 2005-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT00211120

    Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1432 participants Est. completion 2005-08
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00213915

    L-arginine Supplementation and Exercise; L-arginine Supplementation and Renal Function

    Not yet reported University Hospital, Strasbourg, France 30 participants Est. completion 2004-12 3 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Status unknown NCT NCT00214448

    Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples

    Abbott Molecular 4 participants
    Other conditions: Genetic Disorders
    View official trial listing →
  • Terminated NCT NCT00216073

    Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer

    Not yet reported Hoosier Cancer Research Network 11 participants Est. completion 2006-10 11 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00216541

    A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

    Not yet reported Janssen-Cilag B.V. 110 participants Est. completion 2006-09
    Other conditions: Anemia, Neoplasms
    View official trial listing →
  • Completed NCT NCT00217334

    Community Hypertension Assessment Trial (CHAT)

    Not yet reported Hamilton Health Sciences Corporation 28 participants Est. completion 2005-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00217386

    Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

    Not yet reported Fred Hutchinson Cancer Center 30 participants 4 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00217425

    Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

    Not yet reported Eastern Cooperative Oncology Group 46 participants Est. completion 2014-03 110 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00217672

    Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer

    Not yet reported Translational Oncology Research International 76 participants Est. completion 2010-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00217737

    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

    Not yet reported National Cancer Institute (NCI) 2431 participants Est. completion 2026-05-26 928 sites
    Other conditions: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7, Stage IIB Colon Cancer AJCC v7, Stage IIC Colon Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT00220766

    Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

    Not yet reported Grifols Therapeutics LLC 100 participants Est. completion 2004-03 13 sites
    Other conditions: Immunologic Deficiency Syndrome, Agammaglobulinemia, Severe Combined Immunodeficiency, Wiskott-Aldrich Syndrome, Common Variable Immunodeficiency
    View official trial listing →
  • Completed NCT NCT00220805

    Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

    Not yet reported Grifols Therapeutics LLC 96 participants Est. completion 2005-05 7 sites
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00222729

    Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer

    Not yet reported University of Pittsburgh 42 participants Est. completion 2013-10 1 site
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT00223600

    Special Turku Atherosclerosis Risk Factor Intervention Project for Children (STRIP)

    Not yet reported University of Turku 1062 participants Est. completion 2005-08 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00224874

    Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 180 participants Est. completion 2012-06 19 sites
    Other conditions: Graft vs Host Disease, Immune System Disorders
    View official trial listing →
  • Withdrawn NCT NCT00225342

    Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina

    Not yet reported University of Glasgow 60 participants 1 site
    Type 2 diabetes Other conditions: Angina Pectoris
    View official trial listing →
  • Withdrawn NCT NCT00226083

    Study of Blood Platelets in Sickle Cell Disease

    Rockefeller University Est. completion 2007-09 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00231439

    Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)

    Not yet reported, Not yet reported Haukeland University Hospital 40 participants Est. completion 2004-07
    Other conditions: Post-Polio Syndrome
    View official trial listing →
  • Completed NCT NCT00232622

    A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots

    Not yet reported All India Institute of Medical Sciences 120 participants Est. completion 2007-03
    Other conditions: Prosthetic Valve Thrombosis
    View official trial listing →
  • Completed NCT NCT00233428

    Study to Determine Racial and Gender Differences in Platelet Aggregation

    Texas Tech University Health Sciences Center 60 participants Est. completion 2006-05 1 site
    Other conditions: Platelet Aggregation
    View official trial listing →
  • Completed NCT NCT00233571

    A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

    Not yet reported Abbott 796 participants Est. completion 2006-06
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00234169

    A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

    Not yet reported, Not yet reported Peter MacCallum Cancer Centre, Australia 30 participants Est. completion 2008-01 1 site
    Other conditions: Multiple Myeloma, Lymphoma
    View official trial listing →
  • Completed NCT NCT00234845

    Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis

    Not yet reported Abbott 148 participants 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00234897

    Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

    Not yet reported Abbott 1938 participants 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00235391

    Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

    Not yet reported Novartis Pharmaceuticals 1683 participants Est. completion 2008-10 141 sites
    Other conditions: Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00235573

    Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption

    Not yet reported University of Florida 21 participants Est. completion 2005-11 1 site
    Other conditions: Disorder of Vitamin B12
    View official trial listing →
  • Completed NCT NCT00235859

    Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

    Not yet reported Abbott 128 participants
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00238238

    Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab

    Not yet reported Alliance for Clinical Trials in Oncology 97 participants Est. completion 2015-08 79 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00238290

    Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer

    Not yet reported Swiss Cancer Institute 13 participants Est. completion 2011-04 14 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00238420

    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2022-05-20 184 sites
    Other conditions: Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7, Stage III Bladder Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT00238433

    Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

    Not yet reported OHSU Knight Cancer Institute 37 participants Est. completion 2016-12 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00243243

    Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

    Not yet reported United States Army Institute of Surgical Research 20 participants Est. completion 2011-07 1 site
    Other conditions: Burns
    View official trial listing →
  • Completed NCT NCT00243906

    Interventional Management of Stroke (IMS) II Study

    Not yet reported University of Cincinnati 81 participants Est. completion 2007-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT00244127

    Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

    Not yet reported Zeneus Pharma 75 participants 5 sites
    Other conditions: Aggressive Non-Hodgkin's Lymphoma in the Elderly.
    View official trial listing →
  • Completed NCT NCT00244361

    Effectiveness of Rituximab in Pediatric OMS Patients.

    Not yet reported, Not yet reported National Pediatric Neuroinflammation Organization, Inc. 25 participants Est. completion 2007-12 1 site
    Other conditions: Opsoclonus-myoclonus Syndrome, Opsoclonus, Myoclonus, Ataxia
    View official trial listing →
  • Completed NCT NCT00244855

    Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

    Not yet reported Fred Hutchinson Cancer Center 32 participants Est. completion 2011-08-29 1 site
    Obstructive sleep apnea Other conditions: Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Marginal Zone Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Marginal Zone Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00244985

    Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Roswell Park Cancer Institute 42 participants Est. completion 2012-12 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00245115

    Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7 participants Est. completion 2012-01 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00247949

    Accuracy of Non-invasive Continuous CO2-Monitoring

    University Hospital, Basel, Switzerland 150 participants Est. completion 2006-02 1 site
    Other conditions: Blood Gas Monitoring, Transcutaneous
    View official trial listing →
  • Completed NCT NCT00248807

    A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.

    Not yet reported VA Office of Research and Development 30 participants Est. completion 2012-04 1 site
    Other conditions: Orthostatic Hypotension, Spinal Cord Injuries
    View official trial listing →
  • Terminated NCT NCT00250718

    Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach

    Not yet reported New Mexico Cancer Research Alliance 17 participants Est. completion 2014-05 1 site
    Other conditions: Non-Hodgkin's Lymphoma, Cancer
    View official trial listing →
  • Completed NCT NCT00250991

    Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial

    Not yet reported, Not yet reported University of Cincinnati 94 participants Est. completion 2007-07 19 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00251069

    Glucosamine Sulphate and Increased Level of Blood Cholesterol

    Not yet reported Slidgigtinstituttet 66 participants Est. completion 2005-08 1 site
    Osteoarthritis
    View official trial listing →
  • Terminated NCT NCT00251186

    First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

    Not yet reported University of Medicine and Dentistry of New Jersey 18 participants Est. completion 2006-04 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00251394

    Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma

    Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2009-07 3 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Terminated NCT NCT00252239

    Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

    Not yet reported University of Virginia 112 participants Est. completion 2009-09 9 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00253786

    Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy

    Not yet reported Okayama University 312 participants Est. completion 2014-11-27 1 site
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT00253929

    Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia

    Not yet reported Radboud University Medical Center 100 participants Est. completion 2006-02 1 site
    Other conditions: Blood Flow in Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00254592

    Neoadjuvant Treatment of Breast Cancer

    Not yet reported University of California, Irvine 43 participants Est. completion 2013-09-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00255593

    Safety and Efficacy Study of Rituximab in Renal Transplantation

    Not yet reported Karolinska University Hospital 140 participants Est. completion 2007-10 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00256022

    The Effect of Prophylactic Pre Operative Probiotic Therapy on Endotoxin Levels in Cardiac Surgery Patients

    Not yet reported Melbourne Health Est. completion 2007-12
    Other conditions: Preoperative Cardiac Surgery Patients
    View official trial listing →
  • Completed NCT NCT00257608

    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

    Not yet reported Genentech, Inc. 1145 participants Est. completion 2014-11 247 sites
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00257777

    Intermittent Cold Blood vs Crystalloid Cardioplegia in Aortic Valve Surgery

    Not yet reported Oslo University Hospital 350 participants Est. completion 2007-11 1 site
    Cardiovascular disease Other conditions: Aortic Valve Disease
    View official trial listing →
  • Completed NCT NCT00258349

    Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2010-09 25 sites
    Other conditions: Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00258960

    Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

    Not yet reported Spanish Breast Cancer Research Group 49 participants Est. completion 2009-07-14 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00259610

    Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

    Not yet reported University of Alabama at Birmingham 755 participants Est. completion 2009-06 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00260208

    Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

    Not yet reported Novartis Pharmaceuticals 361 participants 2 sites
    Other conditions: Liver Transplant, Hepatitis C
    View official trial listing →
  • Completed NCT NCT00261274

    Safety Study of ECO Conversion System For Red Blood Cells.

    Not yet reported Velico Medical 60 participants 6 sites
    Other conditions: Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT00262470

    Treatment of Orthostatic Intolerance

    Not yet reported, Not yet reported Satish R. Raj 150 participants Est. completion 2029-12 1 site
    Other conditions: Tachycardia, Chronic Orthostatic Intolerance
    View official trial listing →
  • Completed NCT NCT00262717

    Can Resistance Enhance Selection of Treatment? (CREST)

    Not yet reported Kirby Institute 338 participants Est. completion 2006-07-31 19 sites
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT00262886

    Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

    Not yet reported University of Rochester 35 participants 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00263731

    Metabolomic Analysis of Lung Cancer

    University of Louisville 249 participants Est. completion 2020-09-24 1 site
    Other conditions: Carcinoma, Non-Small Cell Lung, Carcinoma, Small Cell Lung
    View official trial listing →
  • Completed NCT NCT00264095

    An Observational Study of Blood Management Techniques in Oncology Surgical Treatment

    Janssen-Cilag B.V. 488 participants Est. completion 2006-02 11 sites
    Other conditions: Anemia, Blood Loss, Surgical, Neoplasms
    View official trial listing →
  • Terminated NCT NCT00265005

    Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants

    Not yet reported University of Louisville 12 participants Est. completion 2012-12 1 site
    Other conditions: Thrombosis
    View official trial listing →
  • Completed NCT NCT00265850

    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 2334 participants Est. completion 2018-01 683 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00267865

    Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

    Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2019-09-19 1 site
    Other conditions: AIDS-Related-Primary Central Nervous System Lymphoma
    View official trial listing →
  • Completed NCT NCT00267969

    A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis

    Not yet reported Centocor Research & Development, Inc. 766 participants Est. completion 2011-05 42 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00269477

    Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

    Not yet reported Sanofi Pasteur, a Sanofi Company 145 participants Est. completion 2007-12 8 sites Stand-alone
    Other conditions: Meningitis, Meningococcal Infection
    View official trial listing →
  • Completed NCT NCT00269867

    Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis

    Not yet reported Centocor, Inc. 428 participants Est. completion 2000-03
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00269880

    A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.

    Not yet reported Centocor, Inc. 2792 participants Est. completion 1995-12
    Other conditions: Angioplasty, Transluminal, Percutaneous Coronary
    View official trial listing →
  • Withdrawn NCT NCT00269971

    A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.

    Not yet reported Janssen-Ortho Inc., Canada Est. completion 1999-04
    Other conditions: Anemia, Blood Transfusion, Orthopedic Surgery
    View official trial listing →
  • Completed NCT NCT00270075

    A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

    Not yet reported, Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 1992-05
    Other conditions: Blood Transfusion, Blood Transfusion, Autologous, Orthopedic Procedures, Orthopedic Surgery, Cardiovascular Surgical Procedure
    View official trial listing →
  • Completed NCT NCT00270894

    Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

    Not yet reported Accelerated Community Oncology Research Network 30 participants Est. completion 2011-08 7 sites
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Terminated NCT NCT00271011

    A Study of Mitomycin C, Irinotecan, and Cetuximab

    Not yet reported University of Michigan Rogel Cancer Center 13 participants Est. completion 2009-07 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00273585

    Study of Using Computerized Education to Increase Patients' Confidence in Their Ability to Be Screened for Colon Cancer

    Not yet reported University of California, Davis 100 participants Est. completion 2006-02 1 site
    Other conditions: Colorectal Cancer Screening
    View official trial listing →
  • Completed NCT NCT00274534

    A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

    Not yet reported Boehringer Ingelheim 36 participants Est. completion 2003-07 2 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00275509

    Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

    Not yet reported Johns Hopkins University 56 participants Est. completion 2010-06 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00275678

    Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies

    Not yet reported Mayo Clinic 15 participants 1 site
    Other conditions: Blood Stem Cell Transplant
    View official trial listing →
  • Completed NCT NCT00275821

    Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

    Not yet reported Novartis 353 participants Est. completion 2008-01 1 site
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00275951

    Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer

    Not yet reported National Taiwan University Hospital 39 participants Est. completion 2009-06 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00276055

    Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma

    Not yet reported New Mexico Cancer Research Alliance 38 participants Est. completion 2010-11 4 sites
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00277199

    Comparability DE vs CD-CHO1

    Not yet reported Bristol-Myers Squibb 30 participants Est. completion 2002-12 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00277277

    In-Home Weight Loss Program for Adults With Type 2 Diabetes Delivered by Interactive Cable Television Technology

    Not yet reported Bastyr University 19 participants Est. completion 2005-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00278889

    Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)

    Not yet reported AstraZeneca 215 participants Est. completion 2009-10 43 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00280085

    The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

    Not yet reported Pfizer 29 participants Est. completion 2007-07 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00280462

    Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade

    Not yet reported Medical University of Vienna 21 participants Est. completion 2006-04 1 site
    Other conditions: Ocular Physiology, Regional Blood Flow
    View official trial listing →
  • Terminated NCT NCT00281528

    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer

    Not yet reported Celgene 208 participants Est. completion 2011-03-01 40 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Terminated NCT NCT00281931

    Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia

    Not yet reported German CLL Study Group 21 participants Est. completion 2006-10 1 site
    Other conditions: Prolymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00281983

    Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

    Not yet reported, Not yet reported German CLL Study Group 100 participants Est. completion 2010-07 13 sites
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00282347

    A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis

    Not yet reported Genentech, Inc. 144 participants Est. completion 2013-01
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00282659

    The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

    Not yet reported Hartford Hospital 240 participants Est. completion 2008-06 1 site
    Cardiovascular disease Other conditions: Hypertension, Dyslipidemia, Diabetes
    View official trial listing →
  • Completed NCT NCT00283088

    Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke

    Not yet reported University of California, San Diego 130 participants Est. completion 2009-05 7 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00283465

    A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

    Not yet reported Janssen-Cilag B.V. 316 participants Est. completion 2004-04
    Other conditions: Anemia, Neoplasm
    View official trial listing →
  • Completed NCT NCT00284180

    Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 32 participants Est. completion 2010-11 10 sites
    Other conditions: Breast Neoplasms, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00284453

    Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm

    University of Pittsburgh 65 participants Est. completion 2018-12 2 sites
    Other conditions: Arrhythmias
    View official trial listing →
  • Status unknown NCT NCT00286416

    Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma

    Not yet reported Scripps Clinic 60 participants Est. completion 2008-07 1 site
    Other conditions: Asthma, Allergic Rhinitis
    View official trial listing →
  • Withdrawn NCT NCT00287456

    Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2006-02-02 1 site
    Other conditions: Cystic Fibrosis Related Diabetes
    View official trial listing →
  • Completed NCT NCT00287547

    Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris

    Not yet reported Bristol-Myers Squibb 144 participants Est. completion 1998-01 10 sites
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Completed NCT NCT00287586

    Testosterone Replacement in Older Men and Atherosclerosis Progression

    Not yet reported Brigham and Women's Hospital 308 participants Est. completion 2012-05-12 3 sites
    Other conditions: Hypogonadism, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00287690

    Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease

    Not yet reported, Not yet reported Imperial College London 71 participants Est. completion 2003-08-18 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00288743

    Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

    Not yet reported University Hospital, Ghent 30 participants Est. completion 2002-12 1 site
    Other conditions: Critically Ill Patients
    View official trial listing →
  • Terminated NCT NCT00288808

    Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.

    Not yet reported University of Rochester 200 participants Est. completion 2006-06 1 site
    Other conditions: Blood Coagulation Disorder
    View official trial listing →
  • Completed NCT NCT00289627

    A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

    Not yet reported Bristol-Myers Squibb 155 participants Est. completion 2007-07 53 sites
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00289640

    Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

    Not yet reported Bristol-Myers Squibb 210 participants Est. completion 2007-07 62 sites
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00289744

    Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

    Not yet reported GlaxoSmithKline 178 participants Est. completion 2009-04-15 1 site
    Other conditions: Hepatitis B, Hepatitis A
    View official trial listing →
  • Terminated NCT NCT00290082

    Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients

    Not yet reported University Hospital, Rouen 120 participants Est. completion 2007-10 21 sites
    Other conditions: Acute Agitated Patients
    View official trial listing →
  • Status unknown NCT NCT00292955

    Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma

    Not yet reported University of Virginia 30 participants 2 sites
    Other conditions: Cancer of the Cervix
    View official trial listing →
  • Completed NCT NCT00293514

    TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)

    Not yet reported Nycomed Est. completion 2007-10 1 site
    Other conditions: Pulmonary Diseases, Intraoperative Complications
    View official trial listing →
  • Completed NCT NCT00293709

    Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

    Pfizer 129 participants Est. completion 2013-02 1 site
    Other conditions: Arthritis, Psoriatic, Psoriasis, Skin Diseases, Papulosquamous
    View official trial listing →
  • Completed NCT NCT00293748

    Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease

    National Institute of Neurological Disorders and Stroke (NINDS) 200 participants Est. completion 2008-12-15 1 site
    Other conditions: Vascular Disease, Vascular Disease Risk
    View official trial listing →
  • Completed NCT NCT00295932

    Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 79 participants Est. completion 2018-03-11 8 sites
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00296855

    Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

    Not yet reported Bayer 261 participants Est. completion 2007-02 26 sites
    Other conditions: Peripheral Vascular Diseases
    View official trial listing →
  • Completed NCT NCT00297310

    Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation

    Not yet reported Janssen-Cilag Pty Ltd 89 participants Est. completion 2007-04
    Other conditions: Kidney Transplantation, Transplantation
    View official trial listing →
  • Completed NCT NCT00297596

    Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 25 participants Est. completion 2010-10 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00298129

    Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

    Yokohama City University Medical Center 278 participants Est. completion 2006-12 1 site
    Other conditions: Diabetes Mellitus, Essential Hypertension, Renal Failure, Chronic Nephropathy
    View official trial listing →
  • Terminated NCT NCT00298272

    Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

    Not yet reported Biogen 54 participants Est. completion 2011-07 18 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00299806

    SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension

    Not yet reported Novartis 39 participants Est. completion 2006-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00301301

    A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

    Royal Marsden NHS Foundation Trust 39 participants 1 site
    Other conditions: Non-Hodgkins Lymphoma
    View official trial listing →
  • Completed NCT NCT00301366

    The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

    Not yet reported Grifols Therapeutics LLC 38 participants Est. completion 2007-03 10 sites
    Other conditions: Alpha 1-Antitrypsin Deficiency
    View official trial listing →
  • Terminated NCT NCT00301860

    Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer

    Not yet reported University of California, San Francisco 8 participants Est. completion 2007-11 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00302497

    EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 50 participants Est. completion 2008-04 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Terminated NCT NCT00303719

    Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    Not yet reported Masonic Cancer Center, University of Minnesota 342 participants Est. completion 2019-05-08 1 site
    Other conditions: Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00304226

    Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

    Not yet reported Novartis 1288 participants Est. completion 2007-01 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00305825

    Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

    Not yet reported University of California, San Francisco 43 participants Est. completion 2016-05-24 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00306254

    Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

    Not yet reported Pfizer 1225 participants Est. completion 2007-07 134 sites
    Other conditions: Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00307086

    Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 30 participants Est. completion 2012-03 1 site
    Other conditions: Multiple Myeloma, Plasma Cell Leukemia
    View official trial listing →
  • Terminated NCT NCT00307723

    Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Massachusetts General Hospital 52 participants Est. completion 2009-07
    Other conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00308581

    Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab

    Not yet reported UCB Pharma 539 participants Est. completion 2008-04 107 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00308607

    Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

    Not yet reported University of Turku 27 participants Est. completion 2009-04 3 sites
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT00309465

    Perioperative Insulin Glargine Dosing Study

    Not yet reported Tamra Dukatz 402 participants Est. completion 2009-10 2 sites
    Other conditions: Diabetes, Surgery
    View official trial listing →
  • Completed NCT NCT00309842

    Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 213 participants Est. completion 2019-11-22 2 sites
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelofibrosis, MDS, Refractory Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Non-Hodgkin's Lymphoma, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00309907

    Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

    Not yet reported Children's Oncology Group 39 participants Est. completion 2011-09 26 sites
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Disseminated Neuroblastoma, Juvenile Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndromes, Pulmonary Complications, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00311155

    Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

    Not yet reported Sankyo Pharma Gmbh 694 participants Est. completion 2008-04 79 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT00311857

    Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

    Not yet reported, Not yet reported Heidelberg University 46 participants 1 site
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Withdrawn NCT NCT00312390

    Amblyopia and Neurovascular Coupling in the Retina of Humans

    Not yet reported Medical University of Vienna 1 site
    Other conditions: Amblyopia, Regional Blood Flow
    View official trial listing →
  • Completed NCT NCT00312728

    A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)

    Not yet reported Genentech, Inc. 115 participants Est. completion 2009-06
    Other conditions: Non-Small Cell Lung Cancer, Brain Neoplasms
    View official trial listing →
  • Completed NCT NCT00312884

    Home-HF: Evaluation of Patients With Heart Failure Using Home Telemonitoring

    Not yet reported Imperial College London 182 participants Est. completion 2008-09 3 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00314574

    A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)

    Not yet reported Genentech, Inc. 850 participants Est. completion 2009-11
    Other conditions: Asthma
    View official trial listing →
  • Terminated NCT NCT00314691

    Development of New Prenatal Diagnostic Tests From Maternal Blood

    Not yet reported University Hospital, Strasbourg, France 10 participants Est. completion 2006-09 1 site
    Other conditions: Hereditary Diseases
    View official trial listing →
  • Completed NCT NCT00317200

    A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer

    Not yet reported Hoosier Cancer Research Network 34 participants Est. completion 2007-11 17 sites
    Other conditions: Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00317538

    Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept

    Not yet reported Centocor Ortho Biotech Services, L.L.C. 28 participants Est. completion 2004-11
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00318136

    A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)

    Not yet reported Genentech, Inc. 47 participants Est. completion 2009-07
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00318227

    Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 73 participants Est. completion 2010-02-23 1 site
    Other conditions: Anemia, Coronary Artery Bypass Surgery
    View official trial listing →
  • Status unknown NCT NCT00320008

    Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria

    Not yet reported Peter Gæde 160 participants Est. completion 2025-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00320099

    Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock

    Not yet reported University of Versailles 508 participants Est. completion 2009-02 8 sites
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT00320164

    Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals

    Weill Medical College of Cornell University 8 participants Est. completion 2008-01
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00320658

    Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 60 participants Est. completion 2007-07 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT00322101

    Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

    Not yet reported Fred Hutchinson Cancer Center 25 participants Est. completion 2014-10 8 sites
    Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00322842

    Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

    Not yet reported Genzyme, a Sanofi Company 35 participants Est. completion 2007-02 3 sites
    Other conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00323531

    Thoracoscopy Versus Fibrinolysis in Children With Empyema

    Not yet reported, Not yet reported Children's Mercy Hospital Kansas City 36 participants Est. completion 2007-10 1 site
    Other conditions: Empyema
    View official trial listing →
  • Completed NCT NCT00324155

    Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma

    Not yet reported Bristol-Myers Squibb 681 participants Est. completion 2013-10 127 sites
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00324207

    Molecular Quantification of Insulin mRNA

    Children's Mercy Hospital Kansas City 400 participants Est. completion 2009-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00324805

    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

    Not yet reported National Cancer Institute (NCI) 1501 participants Est. completion 2025-01-31 1169 sites
    Other conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT00325624

    Diabetes Risk Evaluation and Management Tele-monitoring Study (DREAM-Tel)

    Not yet reported Sunnybrook Health Sciences Centre 40 participants Est. completion 2008-04 2 sites
    Other conditions: Hypertension, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00326495

    BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 51 participants Est. completion 2014-11-07 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00327093

    Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases

    Not yet reported Hospices Civils de Lyon 31 participants Est. completion 2008-10 1 site
    Other conditions: Colorectal Cancer, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00327119

    Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer

    Not yet reported Amgen 50 participants
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00327210

    Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet

    Not yet reported University of Virginia 35 participants Est. completion 2009-07 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00327678

    Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

    Not yet reported Assistance Publique - Hôpitaux de Paris 1080 participants Est. completion 2014-04 1 site
    Other conditions: Leukemia, Lymphocytic
    View official trial listing →
  • Completed NCT NCT00328016

    Breathe: Slow Paced Breathing to Lower Blood Pressure

    Not yet reported National Institute on Aging (NIA) 44 participants Est. completion 2009-12 1 site
    Other conditions: High Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT00328029

    Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population

    Not yet reported University Hospital, Strasbourg, France 35 participants Est. completion 2012-06 2 sites
    Other conditions: Signs and Symptoms, Respiratory
    View official trial listing →
  • Completed NCT NCT00328497

    A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

    Not yet reported CASI pharmaceuticals, Inc. 31 participants Est. completion 2009-12 1 site
    Other conditions: Carcinoid Tumor
    View official trial listing →
  • Completed NCT NCT00328666

    The Penn Lifestyle Modification and Blood Pressure Study

    Not yet reported University of Pennsylvania 60 participants Est. completion 2007-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00330421

    Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

    Not yet reported National Cancer Institute (NCI) 15 participants Est. completion 2008-07 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Adult Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT00330460

    A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.

    Not yet reported Amgen 1189 participants Est. completion 2008-01
    Other conditions: Osteoporosis, Osteopenia
    View official trial listing →
  • Completed NCT NCT00330746

    CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer

    Not yet reported National Cancer Institute, Naples 100 participants Est. completion 2008-06 25 sites
    Other conditions: Advanced Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00330889

    Effects Of Prednisolone On Rheumatoid Arthritis Patients

    GlaxoSmithKline 32 participants Est. completion 2006-12 6 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00331071

    Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 334 participants Est. completion 2006-03
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00331851

    Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 584 participants Est. completion 2007-04 116 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT00332085

    Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

    Not yet reported Bastyr University 40 participants Est. completion 2007-03 2 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00332371

    COMPACT - COMbining Plasma-filtration and Adsorption Clinical Trial

    Not yet reported Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva 184 participants Est. completion 2011-07 19 sites
    Other conditions: Shock, Septic
    View official trial listing →
  • Completed NCT NCT00332761

    Caduet in an Untreated Subject Population

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2007-09 34 sites
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00333034

    Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2007-05 23 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00333775

    A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 736 participants Est. completion 2013-10 114 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00336024

    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

    Not yet reported Children's Oncology Group 91 participants Est. completion 2025-09-30 145 sites
    Other conditions: Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    View official trial listing →
  • Enrolling by invitation NCT NCT00338065

    External Influences Upon Ocular Homeostasis

    Not yet reported Vanderbilt University Medical Center 200 participants Est. completion 2027-12 1 site
    Other conditions: Intraocular Pressure
    View official trial listing →
  • Completed NCT NCT00339898

    Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma

    National Cancer Institute (NCI) 414 participants Est. completion 2015-01-13 1 site
    Other conditions: Non-Metastatic Ewings Sarcoma
    View official trial listing →
  • Completed NCT NCT00340574

    Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2008-07-02 2 sites
    Other conditions: Healthy Volunteer, HV
    View official trial listing →
  • Terminated NCT NCT00341042

    Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research

    National Institute of Allergy and Infectious Diseases (NIAID) 253 participants Est. completion 2013-05-01 1 site
    Other conditions: Tuberculosis, HIV
    View official trial listing →
  • Completed NCT NCT00342849

    Treatment of Lead-Exposed Children Trial

    Not yet reported National Institute of Environmental Health Sciences (NIEHS) 780 participants Est. completion 2015-06-10 4 sites
    Other conditions: Lead Exposure
    View official trial listing →
  • Completed NCT NCT00343044

    Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers

    Not yet reported Benaroya Research Institute 40 participants Est. completion 2011-08 2 sites
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT00343707

    PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients

    Not yet reported GlaxoSmithKline 72 participants Est. completion 2005-11 1 site
    Other conditions: Depressive Disorder and Anxiety Disorders
    View official trial listing →
  • Completed NCT NCT00344539

    AMA1-C1/Alhydrogel + CpG 7909 for Malaria

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2007-01 1 site
    Other conditions: Plasmodium Falciparum Malaria
    View official trial listing →
  • Completed NCT NCT00345163

    A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)

    Not yet reported Genentech, Inc. 167 participants Est. completion 2007-09
    Other conditions: Glioblastoma
    View official trial listing →
  • Withdrawn NCT NCT00346879

    Study to Determine Effective Dosing of Fondaparinux in Obese Persons

    Not yet reported Indiana University Est. completion 2009-01 1 site
    Other conditions: Morbid Obesity
    View official trial listing →
  • Completed NCT NCT00348426

    Botulism Outbreak in Thailand (Episode II)

    Department of Medical Services Ministry of Public Health of Thailand 200 participants Est. completion 2006-09 1 site
    Other conditions: Botulism
    View official trial listing →
  • Status unknown NCT NCT00348998

    Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

    Not yet reported Virginia Mason Hospital/Medical Center 18 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00349557

    Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer

    Not yet reported Benaroya Research Institute 18 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00349921

    Clonidine Versus Adenosine to Treat Neuropathic Pain

    Not yet reported Wake Forest University Health Sciences 24 participants Est. completion 2008-01 2 sites
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT00350168

    Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

    Not yet reported Novartis 647 participants Est. completion 2007-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00350220

    Transfusion Strategies in Pediatric Cardiothoracic Surgery

    Not yet reported University of Rochester 60 participants Est. completion 2009-09 1 site
    Other conditions: Congenital Heart Disease
    View official trial listing →
  • Completed NCT NCT00350545

    A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease

    Not yet reported Stanford University 37 participants Est. completion 2014-10 1 site
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Terminated NCT NCT00350766

    Cell Therapy in Myocardial Infarction

    Not yet reported, Not yet reported Ministry of Health, Brazil 166 participants Est. completion 2014-07-14 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00351156

    Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease

    Amicus Therapeutics 50 participants Est. completion 2007-03 7 sites
    Other conditions: Gaucher Disease
    View official trial listing →
  • Completed NCT NCT00353613

    Prevention of Surgical Site Infections

    Not yet reported The University of Texas Health Science Center, Houston 900 participants Est. completion 2012-12 2 sites
    Other conditions: Surgical Wound Infection
    View official trial listing →
  • Status unknown NCT NCT00353717

    Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

    Not yet reported, Not yet reported Hadassah Medical Organization 25 participants Est. completion 2009-09 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00353834

    The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes

    Not yet reported Joslin Diabetes Center 72 participants Est. completion 2010-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00354978

    Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients

    Not yet reported M.D. Anderson Cancer Center 49 participants Est. completion 2011-03 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00356031

    Bevacizumab and Radiation Therapy for Sarcomas

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2010-03 1 site
    Obstructive sleep apnea Other conditions: Soft Tissue Sarcoma, Fibrous Histiocytoma, Synovial Sarcoma
    View official trial listing →
  • Withdrawn NCT NCT00357461

    Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma

    Not yet reported Bristol-Myers Squibb
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00357565

    Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 34 participants Est. completion 2025-03-11 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Childhood Acute Myeloid Leukemia in Remission, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Previously Treated Myelodysplastic Syndrome, Secondary Myelodysplastic Syndrome, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Excess Blasts, Refractory Anemia, De Novo Myelodysplastic Syndrome, Childhood Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT00357591

    Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation

    Not yet reported Orqis Medical Corporation 200 participants Est. completion 2008-01 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00357656

    Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

    Not yet reported Baxalta now part of Shire 85 participants Est. completion 2015-12-09 36 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Terminated NCT NCT00359398

    Sequestration of Platelets Prior to Bypass Reduces Bleeding After Cardiac Surgery

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 30 participants Est. completion 2009-07 1 site
    Other conditions: Cardiac Surgical Procedures, Cardiopulmonary Bypass, Blood Platelet Disorders, Blood Coagulation Disorders
    View official trial listing →
  • Terminated NCT NCT00359424

    Interventional Management of Stroke (IMS) III Trial

    Not yet reported Joseph Broderick 656 participants Est. completion 2013-04 71 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00359918

    Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI)

    Not yet reported Holger Thiele 162 participants Est. completion 2009-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00360737

    Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses

    Not yet reported Emergent BioSolutions 40 participants Est. completion 2010-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00360919

    Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion

    Not yet reported Physicians Committee for Responsible Medicine 28 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Food Habits
    View official trial listing →
  • Completed NCT NCT00362115

    Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

    Not yet reported Takeda 449 participants Est. completion 2006-12 54 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00364819

    Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

    Not yet reported, Not yet reported University of California, Davis 6 participants Est. completion 2009-12 1 site
    Other conditions: Primary Biliary Cirrhosis
    View official trial listing →
  • Terminated NCT NCT00365274

    SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 6 participants Est. completion 2010-05 1 site
    Other conditions: Anaplastic Large Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00366275

    Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 64 participants Est. completion 2007-09 1 site
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT00368875

    Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 54 participants Est. completion 2011-12 1 site
    Other conditions: Male Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00369070

    A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

    Not yet reported Amgen 186 participants Est. completion 2011-08-03
    Other conditions: Advanced Non-squamous NSCLC
    View official trial listing →
  • Status unknown NCT NCT00370721

    Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

    Not yet reported Shahid Beheshti University of Medical Sciences 1 site
    Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Withdrawn NCT NCT00371228

    Timing of Cord Clamping and Neonatal Hemoglobin

    Not yet reported Oklahoma State University Center for Health Sciences Est. completion 2009-06 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00373256

    A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

    Not yet reported Pfizer 488 participants Est. completion 2011-08 250 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00373854

    Study of How Low Blood Sugar Affects the Way Blood Vessels Work

    Ohio State University 13 participants Est. completion 2006-09 1 site
    Other conditions: Hypoglycemia
    View official trial listing →
  • Completed NCT NCT00374530

    Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2

    Not yet reported Danish Headache Center 12 participants 1 site
    Other conditions: Headache, Migraine
    View official trial listing →
  • Completed NCT NCT00374894

    The Combined Effect of 2,3-Dimercaptosuccinic Acid and Multi-Nutrients on Children in Lead Poisoning

    China Medical University, China 500 participants Est. completion 2004-08 1 site
    Other conditions: Lead Poisoning
    View official trial listing →
  • Completed NCT NCT00374933

    Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation

    Not yet reported Abramson Cancer Center at Penn Medicine 18 participants Est. completion 2009-12 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00376701

    Combination Therapy for Age-Related Macular Degeneration.

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103 participants Est. completion 2009-04 5 sites
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00377169

    Collection of Blood Samples From SMART Study Participants for Future Genetic Studies

    National Institute of Allergy and Infectious Diseases (NIAID) 3261 participants Est. completion 2006-01 42 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00377208

    Individually Tailored Web-Based Program to Improve Blood Pressure Control

    Not yet reported Milton S. Hershey Medical Center 500 participants Est. completion 2010-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00377390

    ICATA Asthma Mechanistic Study

    National Institute of Allergy and Infectious Diseases (NIAID) 224 participants Est. completion 2009-12 4 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00377988

    A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 423 participants Est. completion 2008-10
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00378066

    Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer

    Not yet reported Asan Medical Center 49 participants Est. completion 2008-10 6 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00378599

    Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 125 participants Est. completion 2009-07
    Other conditions: Liver Transplantation, Hepatitis C, Chronic, Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT00378768

    Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center 12 participants Est. completion 2007-06 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00379418

    Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients

    Emory University 220 participants Est. completion 2009-12 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00379652

    Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes

    Not yet reported Harvard Medical School (HMS and HSDM) 1204 participants Est. completion 2010-05 2 sites
    Other conditions: Hypertension, Diabetes Mellitis
    View official trial listing →
  • Terminated NCT NCT00381836

    Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

    Not yet reported, Not yet reported University of Aarhus 140 participants Est. completion 2007-02 1 site
    Other conditions: Prostatic Neoplasms, Anemia
    View official trial listing →
  • Completed NCT NCT00381888

    Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 44 participants Est. completion 2009-01 2 sites
    Other conditions: Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma, Thromboembolism, Vaginal Cancer, Vulvar Cancer
    View official trial listing →
  • Completed NCT NCT00384176

    First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

    Not yet reported, Not yet reported AstraZeneca 1814 participants Est. completion 2015-08-19 280 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00384241

    Evaluating the Relationship Between Inflammation, Genetics, and Stress in the Development of High Blood Pressure

    Augusta University 1099 participants Est. completion 2009-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00385021

    ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

    Not yet reported Southwestern Regional Medical Center 20 participants Est. completion 2007-09 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00387634

    Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults

    Not yet reported Novartis Vaccines 323 participants Est. completion 2011-10 1 site
    Other conditions: Tick Born Encephalitis
    View official trial listing →
  • Completed NCT NCT00388323

    Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human

    Not yet reported Assistance Publique - Hôpitaux de Paris 47 participants Est. completion 2011-01 1 site
    Other conditions: Alcoholic Hepatitis, Alcoholic Cirrhosis
    View official trial listing →
  • Completed NCT NCT00388427

    Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies

    Not yet reported University of Pittsburgh 31 participants Est. completion 2013-02 1 site
    Other conditions: Malignant Solid Tumour
    View official trial listing →
  • Completed NCT NCT00389467

    Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy

    Not yet reported University of California, Los Angeles 127 participants Est. completion 2012-04 22 sites
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT00389766

    High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma

    Not yet reported Children's Cancer and Leukaemia Group
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00390156

    Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

    Not yet reported University of California, San Francisco 35 participants Est. completion 2011-01 1 site
    Other conditions: Unspecified Adult Solid Tumor
    View official trial listing →
  • Completed NCT NCT00391092

    A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

    Not yet reported Hoffmann-La Roche 424 participants Est. completion 2014-08 89 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00392665

    Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck

    Not yet reported Massachusetts General Hospital 36 participants Est. completion 2013-12 2 sites
    Other conditions: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    View official trial listing →
  • Status unknown NCT NCT00392886

    Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

    Not yet reported Children's Hospital Los Angeles 120 participants 37 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00393107

    Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab

    Not yet reported Gruppo Italiano Studio Linfomi 54 participants Est. completion 2006-08 9 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT00393783

    Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity

    Not yet reported Memorial Sloan Kettering Cancer Center 13 participants Est. completion 2027-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00396032

    A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters

    Not yet reported Genentech, Inc. 150 participants
    Other conditions: Dysfunctional Hemodialysis Catheters
    View official trial listing →
  • Completed NCT NCT00396266

    AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF

    Not yet reported Genzyme, a Sanofi Company 22 participants Est. completion 2007-12 2 sites
    Other conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Terminated NCT NCT00396383

    Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

    Not yet reported Genzyme, a Sanofi Company 9 participants Est. completion 2007-05 2 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00396656

    Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

    Not yet reported Novartis 30 participants Est. completion 2007-12 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00396695

    Neuroimmunological Model of Traumatic Memory

    Ziv Hospital 40 participants Est. completion 2007-12 1 site
    Other conditions: Stress Disorders, Post-Traumatic
    View official trial listing →
  • Withdrawn NCT NCT00397501

    BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

    Not yet reported, Not yet reported OHSU Knight Cancer Institute Est. completion 2013-10
    Other conditions: Brain and Central Nervous System Tumors, Breast Cancer, Cognitive/Functional Effects, Drug/Agent Toxicity by Tissue/Organ, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Completed NCT NCT00398216

    A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

    Not yet reported Daiichi Sankyo 903 participants Est. completion 2007-06 29 sites
    Other conditions: Thrombosis, Hip Replacement
    View official trial listing →
  • Completed NCT NCT00399711

    Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 560 participants Est. completion 2007-11 103 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00399724

    A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus

    Not yet reported Sanofi 7376 participants Est. completion 2003-08
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00401232

    Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

    Not yet reported Pfizer 955 participants Est. completion 2017-12 2 sites
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00402545

    C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck

    Not yet reported Dana-Farber Cancer Institute 29 participants Est. completion 2009-07 1 site
    Other conditions: Head and Neck Neoplasms
    View official trial listing →
  • Completed NCT NCT00402558

    Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2014-04 1 site
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Withdrawn NCT NCT00403156

    Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

    Not yet reported Vitreous -Retina- Macula Consultants of New York 1 site
    Other conditions: Choroidal Neovascularization
    View official trial listing →
  • Status unknown NCT NCT00404404

    ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer

    Not yet reported Premiere Oncology 35 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00405938

    Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 79 participants Est. completion 2011-06 11 sites
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT00406380

    Effect of Avastin in Juxtafoveal Telangiectasias

    Not yet reported Asociación para Evitar la Ceguera en México Est. completion 2006-11 1 site
    Other conditions: Telangiectasis
    View official trial listing →
  • Completed NCT NCT00406614

    Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans

    Not yet reported University of Texas at Austin 360 participants Est. completion 2011-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00407381

    The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study

    Not yet reported Johns Hopkins University 126 participants Est. completion 2011-08 20 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Withdrawn NCT NCT00407641

    Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis

    Not yet reported Anemia Working Group Romania Est. completion 2017-01 13 sites
    Other conditions: Diabetes Mellitus, Hemodialysis
    View official trial listing →
  • Completed NCT NCT00407888

    Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

    Not yet reported University of Washington 60 participants Est. completion 2012-07 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00408447

    Stem Cell Transplant in Sickle Cell Disease and Thalassemia

    Not yet reported Columbia University 53 participants Est. completion 2025-02 1 site
    Other conditions: Sickle Cell Disease, Beta Thalassemia
    View official trial listing →
  • Completed NCT NCT00408499

    Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported University of California, Davis 64 participants Est. completion 2013-01 1 site
    Other conditions: Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00408629

    Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

    Not yet reported Abbott 518 participants Est. completion 2010-03 108 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00408694

    Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

    Not yet reported National Cancer Institute (NCI) 46 participants Est. completion 2011-12-15 108 sites
    Other conditions: Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7, Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
    View official trial listing →
  • Completed NCT NCT00409656

    Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients

    Not yet reported University Hospital Freiburg Est. completion 2005-12
    Other conditions: Corneal Transplantation
    View official trial listing →
  • Completed NCT NCT00409682

    Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

    Not yet reported Abbott 192 participants Est. completion 2010-05 45 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00410657

    Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 53 participants 1 site
    Other conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00414440

    Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

    Not yet reported Novartis Pharmaceuticals 431 participants Est. completion 2013-10 24 sites
    Other conditions: Autosomal Dominant Polycystic Kidney Disease
    View official trial listing →
  • Status unknown NCT NCT00414713

    Transfusion Requirements in Gastrointestinal (GI) Bleeding

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 860 participants Est. completion 2007-12 1 site
    Other conditions: Upper Gastrointestinal Bleeding, Cirrhosis, Portal Hypertension
    View official trial listing →
  • Completed NCT NCT00415051

    Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

    Not yet reported U.S. Army Medical Research and Development Command 20 participants Est. completion 2009-05 1 site
    Other conditions: Rift Valley Fever
    View official trial listing →
  • Completed NCT NCT00417625

    Validation of MRI Measurement of Cardiac Blood Flow

    National Heart, Lung, and Blood Institute (NHLBI) 34 participants Est. completion 2010-07-19 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00418301

    Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain

    Not yet reported Boston Scientific Corporation 15 participants Est. completion 2009-04 1 site
    Other conditions: Pain, Low Back Pain, Leg Pain
    View official trial listing →
  • Completed NCT NCT00419341

    Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

    Not yet reported CSL Behring 49 participants Est. completion 2008-10 13 sites
    Other conditions: Primary Immune Deficiency
    View official trial listing →
  • Completed NCT NCT00419796

    Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

    Not yet reported Novartis 78 participants Est. completion 2007-09 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT00420173

    Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)

    European Society of Cutaneous Lupus Erythematosus e.V. 45 participants Est. completion 2008-06 1 site
    Other conditions: Cutaneous Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00421174

    Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 37 participants Est. completion 2013-07 12 sites
    Other conditions: Pneumonia, Idiopathic Pneumonia Syndrome
    View official trial listing →
  • Completed NCT NCT00422773

    Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Technische Universität Dresden 21 participants 3 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00423852

    Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 26 participants Est. completion 2013-02 1 site
    Other conditions: Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer, Teratoma, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00423865

    Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2011-09 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00424788

    A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

    Not yet reported Biogen 12 participants Est. completion 2007-10 2 sites
    Other conditions: Relapsing Forms of Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00424827

    A Trial of Chemo & Radiation Therapy for Pancreatic Cancer

    Not yet reported University of Massachusetts, Worcester 11 participants Est. completion 2014-12
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00425204

    Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

    Not yet reported Amgen 31 participants Est. completion 2008-03
    Other conditions: Colorectal Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Solid Tumors, Advanced Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00426842

    A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride

    Not yet reported James J. Peters Veterans Affairs Medical Center 11 participants Est. completion 2011-03 1 site
    Other conditions: Orthostatic Hypotension, Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT00427232

    Endothelin-Receptor Blockade in Coronary Heart Disease

    Not yet reported Medical University of Vienna 26 participants Est. completion 2006-08 1 site
    Other conditions: Coronary Vessels, Endothelins, Vascular Resistance
    View official trial listing →
  • Completed NCT NCT00428233

    Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

    Not yet reported Dana-Farber Cancer Institute 65 participants Est. completion 2014-06 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00428896

    A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer

    Not yet reported University Hospital of Crete 24 participants Est. completion 2008-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00428922

    Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

    Not yet reported Bhuvaneswari Ramaswamy 26 participants Est. completion 2017-02-07 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00429065

    Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

    Instituto Nacional de Cancerologia de Mexico 30 participants Est. completion 2007-01 1 site
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT00429416

    Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14 participants Est. completion 2009-05 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT00430001

    Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer

    Not yet reported Danish Breast Cancer Cooperative Group 300 participants Est. completion 2008-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00431288

    A Nutrition Intervention to Lower Blood Pressure in Adolescents

    Not yet reported University of Cincinnati 54 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00433095

    Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer

    Not yet reported Ludwig-Maximilians - University of Munich 1 site
    Other conditions: Carcinoma Breast Stage IV
    View official trial listing →
  • Completed NCT NCT00433537

    Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 77 participants Est. completion 2013-06 1 site
    Other conditions: Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage I Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma, Stage IV Mantle Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT00433953

    Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients

    Not yet reported Children's Hospital Medical Center, Cincinnati 44 participants Est. completion 2010-02 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00434434

    A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma

    Not yet reported Genentech, Inc. 61 participants Est. completion 2009-06
    Other conditions: Allergic Asthma
    View official trial listing →
  • Completed NCT NCT00434811

    Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2014-05 8 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00434850

    Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT00435422

    Neuroaxial Blokade and Blood Pressure

    Not yet reported Rigshospitalet, Denmark 16 participants Est. completion 2010-05 1 site
    Other conditions: Hypovolemia
    View official trial listing →
  • Status unknown NCT NCT00436709

    Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 75 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00436787

    Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

    Not yet reported University of Pittsburgh 21 participants Est. completion 2007-12 2 sites
    Other conditions: Venous Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00436956

    AZD2171 to Treat Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 59 participants Est. completion 2014-02-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00437268

    A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer

    Not yet reported Eli Lilly and Company 26 participants Est. completion 2009-05 20 sites
    Other conditions: Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumor
    View official trial listing →
  • Completed NCT NCT00437632

    Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809

    Not yet reported GlaxoSmithKline 104 participants Est. completion 2008-08-22 1 site
    Other conditions: Substance Dependence
    View official trial listing →
  • Completed NCT NCT00437645

    Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 1183 participants Est. completion 2007-11 12 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00438893

    Effects of a Long Term Dietary Portfolio and of Sequential Removal of Food Components From the Diet

    Not yet reported University of Toronto 66 participants Est. completion 2009-05 1 site
    Cardiovascular disease Other conditions: Hyperlipidemia, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00439465

    Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

    Not yet reported Dartmouth-Hitchcock Medical Center 23 participants Est. completion 2012-11-30 1 site
    Other conditions: Myeloma, Transplant-eligible Patients
    View official trial listing →
  • Status unknown NCT NCT00439933

    Weight Loss in Obese Children and Adolescents and Its Effect on Improvement of Destructive Changes in Blood Vessels

    Not yet reported Heidelberg University 180 participants 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00440609

    Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema

    Not yet reported, Not yet reported Philip J. ferrone, M.D. 50 participants Est. completion 2012-12 2 sites
    Other conditions: Clinically Significant Diabetic Macular Edema
    View official trial listing →
  • Withdrawn NCT NCT00440921

    Clinical Trial for Fibrin Sealant in Knee Surgery

    Not yet reported Sanquin Research & Blood Bank Divisions Est. completion 2010-06
    Other conditions: Total Knee-replacement, Total Hip-replacement
    View official trial listing →
  • Withdrawn NCT NCT00441038

    A Trial on the Effect on Low Back Pain Related Disability of Different Health Education Programs for Retired Persons

    Not yet reported Kovacs Foundation Est. completion 2008-09 1 site
    Other conditions: Low Back Pain
    View official trial listing →
  • Completed NCT NCT00441129

    Obtain a Good Blood Glucose Control With the Paradigm Real Time System

    Not yet reported Medtronic MiniMed, Inc. 115 participants Est. completion 2008-05 8 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT00442507

    Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction

    Not yet reported Washington University School of Medicine 6 participants Est. completion 2009-01 1 site
    Other conditions: Esophageal Neoplasms, Esophageal Diseases
    View official trial listing →
  • Completed NCT NCT00443027

    Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.

    Not yet reported Pfizer 12 participants Est. completion 2008-10 2 sites
    Other conditions: Sexual Dysfunction, Physiological
    View official trial listing →
  • Completed NCT NCT00443651

    A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis

    Not yet reported Genentech, Inc. 578 participants Est. completion 2013-02
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00444327

    Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy

    Min-Sheng General Hospital 900 participants 2 sites
    Other conditions: Atopy, Allergic Disease
    View official trial listing →
  • Completed NCT NCT00444340

    An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 70 participants Est. completion 2007-07
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00444587

    A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

    Not yet reported Hoffmann-La Roche 114 participants Est. completion 2011-08 30 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00444600

    Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema

    Not yet reported Jaeb Center for Health Research 691 participants Est. completion 2014-02 50 sites
    Other conditions: Diabetic Retinopathy, Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT00445848

    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer

    Not yet reported SWOG Cancer Research Network 89 participants Est. completion 2014-01 153 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00446251

    Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

    Not yet reported University of Washington 14 participants Est. completion 2008-12
    Other conditions: Kidney Failure, Chronic, Diabetic Nephropathies, Glomerulonephritis, IGA, Hypertension, Renal
    View official trial listing →
  • Completed NCT NCT00446264

    Islet Allotransplantation With Steroid Free Immunosuppression

    Not yet reported University Hospital, Lille 14 participants Est. completion 2009-02 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia, Metabolic Diseases
    View official trial listing →
  • Completed NCT NCT00446511

    Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension

    Not yet reported Novartis Pharmaceuticals 250 participants Est. completion 2009-06 9 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00446524

    Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

    Not yet reported Novartis 403 participants Est. completion 2008-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00446563

    Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

    Not yet reported Novartis 90 participants Est. completion 2010-03 1 site
    Other conditions: Hypertension; Hypertrophy, Left Ventricular
    View official trial listing →
  • Completed NCT NCT00447408

    Impact of a Personal Digital Assistant (PDA) - Based Dietary Adherence Intervention on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients

    Not yet reported University of Pittsburgh 22 participants Est. completion 2009-01 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00447915

    Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis

    Not yet reported Chugai Pharmaceutical 1265 participants Est. completion 2011-12 4 sites
    Other conditions: Primary Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00448097

    Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

    Not yet reported The Methodist Hospital Research Institute 7 participants Est. completion 2008-08 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00448201

    Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 71 participants Est. completion 2012-05-23 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00449839

    Changes of the Infusion Rate in Insulin Pump Treatment

    Not yet reported Aarhus University Hospital 10 participants Est. completion 2008-10 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00453531

    Model System for Transient Forearm Blood Vessel Dysfunction

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 6 participants Est. completion 2009-02-11 1 site
    Other conditions: Limb Ischemia, Ischemic Preconditioning
    View official trial listing →
  • Completed NCT NCT00454285

    Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing

    Not yet reported Wake Forest University Health Sciences 290 participants Est. completion 2006-06 1 site
    Other conditions: Bacteremia
    View official trial listing →
  • Completed NCT NCT00455013

    A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation

    Not yet reported Bristol-Myers Squibb 93 participants Est. completion 2012-08 17 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT00455871

    Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

    Not yet reported Barnes Retina Institute 30 participants Est. completion 2010-10 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00456261

    First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC

    Not yet reported SCRI Development Innovations, LLC 110 participants Est. completion 2012-09 18 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00457145

    Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

    Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2007-10-24 1 site
    Other conditions: Telangiectasia
    View official trial listing →
  • Withdrawn NCT NCT00457678

    Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself

    Not yet reported Vitreous -Retina- Macula Consultants of New York Est. completion 2007-12-04
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00458185

    Study Evaluating Etanercept in Patients With Ankylosing Spondylitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 40 participants Est. completion 2007-04
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00458848

    Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

    Not yet reported Gruppo Italiano Malattie EMatologiche dell'Adulto 470 participants Est. completion 2014-03 66 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00459017

    The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension

    Not yet reported Sheba Medical Center 150 participants Est. completion 2005-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00459563

    Vitamin D and Blood Pressure

    Not yet reported Atlanta VA Medical Center Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00459914

    Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment

    Not yet reported Fundacio Catalana de Pneumologia 130 participants Est. completion 2008-12 1 site
    Other conditions: Hypertension, Sleep Apnea
    View official trial listing →
  • Completed NCT NCT00460213

    Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research(VOYAGER)Study

    Not yet reported Kitakyushu-Tsuyazaki Hospital 103 participants Est. completion 2013-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00460356

    Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes

    Gynecologic Oncology Group 159 participants Est. completion 2016-07-16 18 sites
    Other conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    View official trial listing →
  • Status unknown NCT NCT00460447

    Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation

    Not yet reported, Not yet reported University Hospital Carl Gustav Carus 30 participants 1 site
    Other conditions: Acute Myeloid Leukemia, Allogeneic Transplantation
    View official trial listing →
  • Completed NCT NCT00460603

    Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Pfizer 187 participants Est. completion 2012-11 106 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00462501

    Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 35 participants Est. completion 2014-02 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00462878

    Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

    PETHEMA Foundation 392 participants Est. completion 2009-04 64 sites
    Other conditions: Allogenic Blood Stem Cell Transplantation, Febrile Neutropenia
    View official trial listing →
  • Completed NCT NCT00463645

    Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients

    Medical University of Graz 10 participants Est. completion 2006-01 1 site
    Other conditions: Severe Sepsis
    View official trial listing →
  • Terminated NCT NCT00464386

    Continuous Glucose Monitoring (POC) in the ICU

    Not yet reported United States Army Institute of Surgical Research 23 participants Est. completion 2013-12 1 site
    Other conditions: Burns, Trauma
    View official trial listing →
  • Terminated NCT NCT00464490

    Use of Dexmedetomidine to Facilitate Extubation in Surgical ICU Patients Who Failed Previous Weaning Attempts

    Not yet reported University of California, San Francisco 42 participants Est. completion 2012-12 1 site
    Other conditions: Intubation; Difficult, Respiration Disorders
    View official trial listing →
  • Completed NCT NCT00464555

    Strategies to Improve Islet Survival

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-02 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00466843

    Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

    Not yet reported Office of Rare Diseases (ORD) 54 participants Est. completion 2010-02 4 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00466934

    Measuring Blood Flow in the Brain

    National Institute of Neurological Disorders and Stroke (NINDS) 31 participants Est. completion 2011-12-29 1 site
    Other conditions: Traumatic Brain Injury, Healthy
    View official trial listing →
  • Completed NCT NCT00467012

    Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer

    Not yet reported Chugai Pharmaceutical 122 participants Est. completion 2011-09 5 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00467051

    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors

    Not yet reported Children's Oncology Group 20 participants Est. completion 2018-06-30 95 sites
    Other conditions: Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Malignant Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Ovarian Choriocarcinoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor, Testicular Choriocarcinoma, Testicular Embryonal Carcinoma, Testicular Mixed Choriocarcinoma and Embryonal Carcinoma, Testicular Mixed Choriocarcinoma and Yolk Sac Tumor, Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor, Testicular Yolk Sac Tumor
    View official trial listing →
  • Completed NCT NCT00468273

    A Clinical Study of Intravenous Immunoglobulin

    Not yet reported FFF Enterprises 57 participants Est. completion 2009-08 10 sites
    Other conditions: Immunologic Deficiency Syndromes
    View official trial listing →
  • Completed NCT NCT00470444

    Transfusion Triggers in Cardiac Surgery

    Not yet reported Unity Health Toronto 50 participants Est. completion 2009-05 1 site
    Other conditions: Cardiac Surgery
    View official trial listing →
  • Status unknown NCT NCT00470769

    The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR

    University of Roma La Sapienza 2006 participants Est. completion 2007-05 3 sites
    Other conditions: Hypertension, Renal Failure
    View official trial listing →
  • Completed NCT NCT00470977

    Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

    Not yet reported, Not yet reported Manhattan Eye, Ear & Throat Hospital 18 participants Est. completion 2010-12 2 sites
    Other conditions: Coats' Disease, Idiopathic Retinal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Choroidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-focal Choroiditis, Rubeosis Iridis, Von Hippel Lindau Disease, BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
    View official trial listing →
  • Completed NCT NCT00473200

    Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine

    Not yet reported Baylor Research Institute 27 participants Est. completion 2013-07 1 site
    Other conditions: Hyperhomocysteinemia
    View official trial listing →
  • Completed NCT NCT00473590

    A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)

    Not yet reported Genentech, Inc. 102 participants Est. completion 2009-11
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00475293

    Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC

    Not yet reported Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 85 participants Est. completion 2010-03 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00477191

    Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis

    Not yet reported Massachusetts General Hospital 18 participants Est. completion 2013-12 1 site
    Metabolic syndrome Other conditions: Psoriasis, Hyperlipidemia, Obesity, Hypertension
    View official trial listing →
  • Completed NCT NCT00477711

    A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer

    Not yet reported Peking University 41 participants Est. completion 2009-02 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00479115

    Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 1 participants Est. completion 2010-12 1 site
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Terminated NCT NCT00479258

    Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents

    Not yet reported Pfizer 2 participants Est. completion 2007-10 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00479752

    Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer

    Not yet reported Central European Cooperative Oncology Group 151 participants Est. completion 2015-11 24 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00480129

    The Anti-allergic Effects of Specific Probiotics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 36 participants Est. completion 2007-10 1 site
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT00480259

    Hyperproteic Nutrition:Correlation of BUN to Nitrogen Balance

    Not yet reported Milton S. Hershey Medical Center 8 participants Est. completion 2009-04-21
    Other conditions: Enteral Feeding
    View official trial listing →
  • Completed NCT NCT00481208

    Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma

    Yonsei University 70 participants Est. completion 2006-11 1 site
    Other conditions: Open-Angle Glaucoma
    View official trial listing →
  • Terminated NCT NCT00482053

    Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

    Not yet reported Stanford University 3 participants Est. completion 2010-05 1 site
    Other conditions: Lymphoma, B-cell, Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma (DLBCL), Malignant Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00482248

    Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

    Not yet reported Novartis 132 participants Est. completion 2006-06
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00482508

    Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

    Not yet reported Novartis 95 participants Est. completion 2005-10
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00483782

    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

    Not yet reported Medical Research Council 1520 participants 142 sites
    Other conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Withdrawn NCT NCT00484172

    Genomic Search for Childhood Obesity Genes-A Pilot Study

    Children's Mercy Hospital Kansas City Est. completion 2008-06 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00484939

    A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 280 participants Est. completion 2013-03 55 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00486837

    Deposition of Inhaled Prolastin in Cystic Fibrosis Patients

    Not yet reported Grifols Therapeutics LLC 72 participants Est. completion 2004-06
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00486967

    Insulin Resistance : Heart Failure

    University of Dundee 147 participants Est. completion 2008-07-31 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00488358

    Hemodynamic Changes After Aortic Aneurysm Treatment With Stent-Graft

    University of California, San Francisco 10 participants Est. completion 2012-08 1 site
    Other conditions: Abdominal Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT00489463

    IUD Uterine Vascularization and Side Effects

    Not yet reported Hospital de Clinicas de Porto Alegre 63 participants Est. completion 2006-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00489970

    Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

    Not yet reported GlaxoSmithKline 1954 participants Est. completion 2016-03-01 37 sites Stand-alone
    Other conditions: Acellular Pertussis, Tetanus, Diphtheria
    View official trial listing →
  • Completed NCT NCT00490529

    Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

    Not yet reported Ronald Levy 59 participants Est. completion 2017-12-14 1 site
    Other conditions: Lymphoma, Mantle-Cell
    View official trial listing →
  • Completed NCT NCT00490646

    A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer

    Not yet reported R-Pharm 50 participants Est. completion 2011-11 19 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00491855

    Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

    Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2012-12 1 site
    Other conditions: Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT00492089

    Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

    Not yet reported National Cancer Institute (NCI) 11 participants Est. completion 2010-08 1 site
    Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma, Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma, Adult Central Nervous System Germ Cell Tumor, Adult Choroid Plexus Tumor, Adult Diffuse Astrocytoma, Adult Ependymoma, Adult Grade II Meningioma, Adult Grade III Meningioma, Adult Malignant Hemangiopericytoma, Adult Mixed Glioma, Adult Oligodendroglioma, Adult Papillary Meningioma, Adult Pineocytoma, Malignant Neoplasm, Meningeal Melanocytoma, Radiation Toxicity, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Adult Brain Tumor, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage I Adenoid Cystic Carcinoma of the Oral Cavity, Stage I Basal Cell Carcinoma of the Lip, Stage I Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage I Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage I Lymphoepithelioma of the Nasopharynx, Stage I Lymphoepithelioma of the Oropharynx, Stage I Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage I Mucoepidermoid Carcinoma of the Oral Cavity, Stage I Salivary Gland Cancer, Stage I Squamous Cell Carcinoma of the Hypopharynx, Stage I Squamous Cell Carcinoma of the Larynx, Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Oropharynx, Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage I Verrucous Carcinoma of the Larynx, Stage I Verrucous Carcinoma of the Oral Cavity, Stage III Adenoid Cystic Carcinoma of the Oral Cavity, Stage III Basal Cell Carcinoma of the Lip, Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage III Mucoepidermoid Carcinoma of the Oral Cavity, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity
    View official trial listing →
  • Completed NCT NCT00492284

    Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

    Not yet reported QLT Inc. 162 participants Est. completion 2010-05 26 sites
    Other conditions: Choroidal Neovascularization, Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00493298

    Tysabri Observational Program

    Biogen 6620 participants Est. completion 2023-11-01 419 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00493467

    Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2022-08-11 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00493597

    Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

    University Hospital, Antwerp 124 participants Est. completion 2020-10-26 1 site
    Other conditions: Atherosclerosis, Restenosis
    View official trial listing →
  • Completed NCT NCT00495755

    Campath in Chronic GVHD

    Not yet reported Dana-Farber Cancer Institute 13 participants Est. completion 2012-10 1 site
    Other conditions: Chronic Graft-vs.-Host Disease
    View official trial listing →
  • Completed NCT NCT00496587

    Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma

    Not yet reported M.D. Anderson Cancer Center 34 participants Est. completion 2016-05 1 site
    Other conditions: Renal Cell Carcinoma, Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00496808

    Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

    Not yet reported M.D. Anderson Cancer Center 69 participants Est. completion 2010-11 1 site
    Other conditions: Ductal Carcinoma In Situ
    View official trial listing →
  • Status unknown NCT NCT00498147

    Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program

    Group Health Centre 1213 participants Est. completion 2010-07 1 site
    Chronic kidney disease Other conditions: Disease Management, Diabetes Complications, Diabetic Vascular Complications, Diabetic Neuropathy, Diabetic Retinopathy
    View official trial listing →
  • Status unknown NCT NCT00499018

    Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

    Not yet reported Fondazione Italiana Linfomi - ETS 399 participants Est. completion 2013-09 75 sites
    Other conditions: Diffuse Large B-Cell Lymphoma, IPI≥2
    View official trial listing →
  • Completed NCT NCT00499070

    Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment

    University Hospital Freiburg 119 participants Est. completion 2012-08 10 sites
    Other conditions: Dyskeratosis Congenita, Fanconi Anemia, Myelodysplastic Syndromes, Pearson Marrow-pancreas Syndrome, Shwachman-diamond Syndrome
    View official trial listing →
  • Completed NCT NCT00499811

    Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

    Not yet reported National Cancer Institute (NCI) 15 participants 11 sites Stand-alone
    Obstructive sleep apnea Other conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    View official trial listing →
  • Terminated NCT NCT00499889

    Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

    Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2009-11 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00500617

    Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree

    CardioDx 4350 participants Est. completion 2011-09 10 sites
    Cardiovascular disease Other conditions: Angina Pectoris, Chest Pain, Coronary Heart Disease, CAD, CVD, CHD
    View official trial listing →
  • Completed NCT NCT00500760

    Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

    Not yet reported Amgen 153 participants Est. completion 2011-04-26
    Other conditions: Head and Neck Cancer, Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00502853

    A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.

    Not yet reported Hoffmann-La Roche 10 participants Est. completion 2010-07-23 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00503139

    Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

    Pfizer 684 participants Est. completion 2013-04 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00503503

    Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan

    Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-10
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT00505882

    Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2008-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00506129

    Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2015-06 1 site
    Other conditions: Lymphoma, Disorder Related to Bone Marrow Transplantation
    View official trial listing →
  • Completed NCT NCT00506194

    Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control

    Not yet reported Taipei Veterans General Hospital, Taiwan 60 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00506844

    Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer

    Not yet reported National Cancer Center, Korea 40 participants Est. completion 2010-05 4 sites
    Other conditions: Rectal Neoplasms, Neoadjuvant Treatment
    View official trial listing →
  • Terminated NCT NCT00506948

    Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

    Not yet reported M.D. Anderson Cancer Center 13 participants Est. completion 2010-10 1 site
    Other conditions: Hematological Malignancies, Myelodysplastic Syndrome, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00507260

    Nutritional Assessment Intervention to Improve Cancer-Related Fatigue

    Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2014-12 1 site
    Other conditions: Leukemia, Lymphoma, Fatigue
    View official trial listing →
  • Completed NCT NCT00508014

    Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes

    Not yet reported University of Rochester 727 participants Est. completion 2010-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00508612

    Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 259 participants Est. completion 2010-03 3 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00508664

    Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)

    Not yet reported ClinAssess 180 participants Est. completion 2015-02 27 sites
    Other conditions: Squamous Cell Carcinoma of the Hypopharynx, Larynx Carcinoma
    View official trial listing →
  • Completed NCT NCT00508820

    An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP

    Not yet reported Amgen 407 participants Est. completion 2011-03-01
    Other conditions: Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura
    View official trial listing →
  • Terminated NCT NCT00508872

    Folfox-B Study for Patients With Colorectal Liver Metastases

    Not yet reported M.D. Anderson Cancer Center 2 participants Est. completion 2009-06 1 site
    Other conditions: Colorectal Liver Metastases
    View official trial listing →
  • Suspended NCT NCT00511394

    Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis

    Not yet reported Govind Ballabh Pant Hospital 16 participants Est. completion 2008-12 1 site
    Other conditions: Cirrhosis, Ascites
    View official trial listing →
  • Completed NCT NCT00512499

    Strategies to Treat Osteoporosis Following a Fragility Fracture

    Not yet reported Université de Sherbrooke 1410 participants Est. completion 2016-07 1 site
    Other conditions: Osteoporosis, Fractures
    View official trial listing →
  • Terminated NCT NCT00512577

    Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)

    Not yet reported NHS Blood and Transplant 70 participants Est. completion 2011-03 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Terminated NCT NCT00513318

    Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies

    University of California, San Francisco 15 participants Est. completion 2009-06 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplasia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Lymphomas, Low-grade NHL and Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00513383

    Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

    Not yet reported Massachusetts General Hospital 34 participants Est. completion 2012-10 2 sites
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT00515476

    Effect of Exercise Training on the Function of the High Density Lipoprotein (HDL)-Cholesterol, Endothelial Function and Endothelial Progenitor Cells in Patients With Metabolic Syndrome(HERMET-Study)

    Not yet reported Hannover Medical School 24 participants Est. completion 2008-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00515632

    Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy

    Not yet reported Rheoscience A/S 409 participants Est. completion 2009-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00517049

    A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)

    Not yet reported Genentech, Inc. 49 participants Est. completion 2009-12
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00517829

    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

    Not yet reported US Oncology Research 150 participants Est. completion 2012-04 47 sites
    Other conditions: Gastric Cancer Adenocarcinoma Metastatic
    View official trial listing →
  • Terminated NCT NCT00518193

    Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix

    Not yet reported ARCAGY/ GINECO GROUP 44 participants Est. completion 2008-09 4 sites
    Other conditions: Cervix Cancer
    View official trial listing →
  • Status unknown NCT NCT00518544

    Hemostatic Effect of Various Colloid Solutions

    Not yet reported Samsung Medical Center 1 site
    Other conditions: Laminectomy
    View official trial listing →
  • Status unknown NCT NCT00518583

    Phase II Study in Patients With Operable Breast Cancer

    Not yet reported Aptium Oncology Research Network 30 participants Est. completion 2009-09 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00518882

    Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 467 participants Est. completion 2009-04 125 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00520013

    Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors

    Not yet reported Dana-Farber Cancer Institute 60 participants Est. completion 2013-11 3 sites
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Papillary Serous Mullerian Tumor, Clear Cell Mullerian Tumor
    View official trial listing →
  • Completed NCT NCT00521014

    GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center 14 participants Est. completion 2013-07 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00521287

    Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection

    Not yet reported Mackay Memorial Hospital 150 participants Est. completion 2009-12 1 site
    Other conditions: Neoplasms
    View official trial listing →
  • Terminated NCT NCT00521924

    Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)

    Not yet reported Merck Sharp & Dohme LLC 8 participants Est. completion 2008-04
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00522704

    Correlation Between Access Blood Flow and Extracorporeal Blood Flow

    Instituto Nacional de Cardiologia Ignacio Chavez 30 participants Est. completion 2015-06 1 site
    Other conditions: Arteriovenous Fistula
    View official trial listing →
  • Completed NCT NCT00522821

    Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response

    Not yet reported Prothya Biosolutions 55 participants Est. completion 2014-07 9 sites
    Other conditions: IgG Deficiency, Infections
    View official trial listing →
  • Completed NCT NCT00523354

    Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis

    Not yet reported Swiss EE Study Group Est. completion 2007-10 1 site
    Other conditions: Esophagitis
    View official trial listing →
  • Terminated NCT NCT00523640

    A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma

    Not yet reported University of Chicago 30 participants Est. completion 2011-04 1 site
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT00523731

    ACPs in Severe PAD/CLI by Direct Intramuscular Injection

    Not yet reported TheraVitae Ltd. 6 participants Est. completion 2007-03 1 site
    Other conditions: Peripheral Arterial Disease, Critical Limb Ischemia
    View official trial listing →
  • Completed NCT NCT00524017

    Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2011-12 10 sites
    Other conditions: Head and Neck Cancer, Precancerous Condition
    View official trial listing →
  • Completed NCT NCT00524472

    Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery

    Not yet reported The Cleveland Clinic 1439 participants Est. completion 2015-04 2 sites
    Other conditions: Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT00525876

    Non-Myeloablative Allogeneic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 49 participants Est. completion 2010-09 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00525902

    Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis

    Not yet reported Oregon Health and Science University 31 participants Est. completion 2010-09 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT00527475

    Ranibizumab and Reduced Fluence PDT for AMD

    Not yet reported Texas Retina Associates 60 participants Est. completion 2010-01 3 sites
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00528138

    Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation

    Cirujanos la Serena 132 participants Est. completion 2008-09 1 site
    Other conditions: Perforated Appendicitis
    View official trial listing →
  • Terminated NCT NCT00528203

    Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)

    National Heart, Lung, and Blood Institute (NHLBI) 3640 participants Est. completion 2008-09 13 sites
    Other conditions: Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT00528567

    BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

    Not yet reported Hoffmann-La Roche 2591 participants Est. completion 2014-06 403 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00529165

    The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin

    Not yet reported University of Jena 100 participants Est. completion 2009-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00529815

    Continuous Glucose Monitoring in Patients With Type 2 Diabetes

    Not yet reported Walter Reed Army Medical Center 50 participants Est. completion 2010-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00530868

    Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

    Not yet reported University of Alabama at Birmingham 75 participants Est. completion 2022-03-31 7 sites
    Other conditions: Breast Cancer, Cancer of the Breast, Breast Neoplasm
    View official trial listing →
  • Terminated NCT NCT00531115

    Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

    Not yet reported Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28 participants Est. completion 2009-04 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00531336

    MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen

    Not yet reported The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 60 participants Est. completion 2008-12 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00531960

    A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.

    Not yet reported Hoffmann-La Roche 124 participants Est. completion 2010-01 57 sites
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00532909

    Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

    Not yet reported Branimir Sikic 13 participants Est. completion 2010-05 1 site
    Other conditions: Anal, Colon, and Rectal Cancers, Colorectal Neoplasms, Colon/Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00533104

    Cell Therapy in Chronic Limb Ischemia

    Not yet reported, Not yet reported CHU de Reims 40 participants Est. completion 2009-02 1 site
    Other conditions: Peripheral Vascular Diseases
    View official trial listing →
  • Completed NCT NCT00533429

    Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy

    Not yet reported Eli Lilly and Company 40 participants Est. completion 2009-02 12 sites
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00533702

    A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

    Not yet reported Eli Lilly and Company 106 participants Est. completion 2011-05 17 sites
    Other conditions: Metastatic Malignant Melanoma
    View official trial listing →
  • Status unknown NCT NCT00533936

    Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

    Not yet reported Instituto Nacional de Cancerologia, Columbia 160 participants 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00534313

    Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

    Not yet reported Bristol-Myers Squibb 191 participants Est. completion 2011-05 44 sites
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00536601

    High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

    Not yet reported Roswell Park Cancer Institute 174 participants Est. completion 2018-07-09 1 site
    Obstructive sleep apnea Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET), Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Plasma Cell Neoplasm, Primary Systemic Amyloidosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Neuroblastoma, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Regional Neuroblastoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    View official trial listing →
  • Terminated NCT NCT00537173

    Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

    Hoosier Cancer Research Network 11 participants Est. completion 2009-08 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00537316

    Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)

    Not yet reported Merck Sharp & Dohme LLC 242 participants Est. completion 2010-02
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Terminated NCT NCT00537823

    Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement

    Not yet reported Washington University School of Medicine 9 participants Est. completion 2011-07 1 site
    Other conditions: Colorectal Cancer, Metastases
    View official trial listing →
  • Completed NCT NCT00537901

    First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

    Not yet reported King Faisal Specialist Hospital & Research Center 100 participants Est. completion 2013-10
    Other conditions: Colonic Neoplasms, Rectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00538083

    Cocoa and Endothelial Function in Adults With Elevated BMI

    Not yet reported Griffin Hospital 45 participants Est. completion 2006-05 1 site
    Other conditions: Cardioprotection
    View official trial listing →
  • Completed NCT NCT00538265

    Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation

    Not yet reported University Hospital, Toulouse 100 participants Est. completion 2011-01 8 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT00538291

    Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

    Not yet reported City of Hope Medical Center 13 participants 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00540995

    Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

    Not yet reported, Not yet reported City of Hope Medical Center 25 participants Est. completion 2011-08-09 1 site
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts
    View official trial listing →
  • Terminated NCT NCT00541112

    Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

    Not yet reported UNICANCER 19 participants Est. completion 2010-01-29 10 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00541879

    Obesity and Diabetes Prevention Through Science Enrichment

    Not yet reported Colorado State University 2909 participants Est. completion 2011-09 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00542776

    Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

    Boston Children's Hospital 146 participants Est. completion 2008-02 1 site
    Other conditions: Inflammatory Bowel Disease (IBD), Immunosuppressed or Non-Immunosuppressed, Influenza Vaccine, Antibody Titers, Seroprotective Titers
    View official trial listing →
  • Completed NCT NCT00543504

    Bevacizumab in Multiple Phase I Combinations

    Not yet reported M.D. Anderson Cancer Center 343 participants Est. completion 2020-04-29 1 site
    Other conditions: Advanced Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00544115

    Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

    Not yet reported City of Hope Medical Center 260 participants Est. completion 2027-03-29
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant Condition
    View official trial listing →
  • Completed NCT NCT00544284

    Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

    Not yet reported City of Hope Medical Center 25 participants Est. completion 2012-01 2 sites
    Other conditions: Brain and Central Nervous System Tumors, Lymphoma, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00544362

    Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery

    Not yet reported, Not yet reported Federation Francophone de Cancerologie Digestive 33 participants Est. completion 2013-03 13 sites
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00544570

    High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma

    Not yet reported City of Hope Medical Center 30 participants Est. completion 2007-12
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00545545

    Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma

    Not yet reported, Not yet reported HiberCell, Inc. 32 participants Est. completion 2009-12 2 sites
    Other conditions: Recurrent Colorectal Carcinoma, Progressive Colorectal Carcinoma
    View official trial listing →
  • Completed NCT NCT00546195

    Infant Immune Response to Bacterial Infection

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 45 participants Est. completion 2011-03-29 1 site
    Other conditions: Prematurity, Histologic Chorioamnionitis
    View official trial listing →
  • Completed NCT NCT00548444

    T-Cell Turnover Following Vaccination With MVA85A

    Not yet reported University of Oxford 12 participants Est. completion 2010-01 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00548808

    A Study for Type 2 Diabetic Patients

    Not yet reported Eli Lilly and Company 426 participants Est. completion 2009-08 25 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00548977

    Genetic Studies Spermatogenic Failure

    National Cheng-Kung University Hospital 283 participants Est. completion 2005-02 1 site
    Other conditions: Oligospermia, Azoospermia, Male Infertility
    View official trial listing →
  • Completed NCT NCT00549302

    Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

    Not yet reported Eli Lilly and Company 357 participants Est. completion 2012-02 10 sites
    Other conditions: Hypertension, Pulmonary
    View official trial listing →
  • Completed NCT NCT00549536

    The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure

    Not yet reported Aristotle University Of Thessaloniki 31 participants Est. completion 2008-05 1 site
    Other conditions: Hypertension, Diabetes, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00551460

    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

    Not yet reported SWOG Cancer Research Network 78 participants Est. completion 2018-02-05 192 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00552149

    Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 150 participants Est. completion 2012-04 1 site
    Other conditions: Advanced Biliary Cancer
    View official trial listing →
  • Completed NCT NCT00552214

    Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

    Not yet reported Novartis 10290 participants Est. completion 2008-07-01 1 site
    Other conditions: Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations
    View official trial listing →
  • Completed NCT NCT00552734

    Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software

    University of Colorado, Denver 123 participants Est. completion 2007-05 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00553202

    Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

    Not yet reported Children's Oncology Group 158 participants Est. completion 2020-03-31 52 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00553488

    Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

    Not yet reported Becton, Dickinson and Company 30 participants Est. completion 2008-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00553839

    Pharmacokinetics of Ketamine in Infants and Children

    Not yet reported Stanford University 21 participants Est. completion 2009-01 2 sites
    Other conditions: The Pk of IV Ketamine in Children With Heart Disease
    View official trial listing →
  • Completed NCT NCT00554710

    Top Down Versus Step Up Strategies in Crohn's Disease

    Not yet reported Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW 129 participants Est. completion 2004-01 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00554788

    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma

    Not yet reported Children's Oncology Group 60 participants Est. completion 2024-12-31 73 sites
    Other conditions: Extraocular Retinoblastoma
    View official trial listing →
  • Suspended NCT NCT00555126

    Forced Air Versus Endovascular Warming in Polytrauma Patients

    Not yet reported Medical University of Vienna 100 participants Est. completion 2011-01 2 sites
    Other conditions: Polytrauma, Hypothermia
    View official trial listing →
  • Completed NCT NCT00556933

    Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

    Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 site
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00557193

    Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported Children's Oncology Group 218 participants Est. completion 2024-06-30 170 sites
    Other conditions: Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT00558506

    Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

    Not yet reported Charite University, Berlin, Germany 30 participants Est. completion 2009-12 2 sites
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00560261

    Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease

    Not yet reported Assistance Publique - Hôpitaux de Paris 120 participants Est. completion 2012-02 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00560534

    Whole Body Magnetic Resonance Angiography With Subsystolic Venous Compression

    Copenhagen University Hospital at Herlev 36 participants Est. completion 2009-03 1 site
    Alcohol use disorder Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00562328

    Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia

    Not yet reported Mayo Clinic 33 participants Est. completion 2014-12-18 2 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00562952

    Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients

    Not yet reported, Not yet reported Medical University of Vienna 300 participants Est. completion 2011-12 2 sites
    Heart failureCardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00564187

    Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

    Not yet reported Sanofi 115 participants Est. completion 2004-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00564395

    Detemir: Role in Type 1 Diabetes

    Not yet reported Montefiore Medical Center 18 participants Est. completion 2010-05 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00564538

    A Study of Thymoglobulin and Tacrolimus in Liver Transplant

    Not yet reported University of Nebraska 100 participants Est. completion 2009-12 1 site
    Other conditions: Liver Transplantation, Liver Disease, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00567476

    Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

    Not yet reported Novartis 116 participants Est. completion 2010-04 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00567567

    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

    Not yet reported Children's Oncology Group 665 participants Est. completion 2022-03-31 190 sites
    Other conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00569049

    Molecular Analysis of Breast Cancer

    Stanford University 788 participants Est. completion 2011-07-01 1 site
    Other conditions: Breast Cancer, Breast Cancer Non-invasive Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Completed NCT NCT00569322

    Admission Glucose ICU Study

    HealthPartners Institute Est. completion 2004-09 1 site
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT00569803

    Subcutaneous Pharmacokinetics of Belatacept

    Not yet reported Bristol-Myers Squibb 153 participants Est. completion 2008-08 1 site
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT00570193

    Photodynamic and Pharmacologic Treatment of CNV

    Not yet reported, Not yet reported Mid-Atlantic Retina Consultations, Inc. 41 participants Est. completion 2011-06
    Other conditions: Choroidal Neovascularization, Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00570726

    Treatment of Failing Blebs With Ranibizumab

    Not yet reported The New York Eye & Ear Infirmary 6 participants Est. completion 2007-11 1 site
    Other conditions: Glaucoma, Open-Angle, Failing Bleb Following Trabeculectomy
    View official trial listing →
  • Withdrawn NCT NCT00570999

    Palifermin After Haploidentical PBSCT

    Not yet reported European Society for Blood and Marrow Transplantation Est. completion 2013-01 1 site
    Other conditions: Non-Hodgkin's Lymphoma or Hodgkin's Disease, Acute Leukaemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia, Osteomyelofibrosis
    View official trial listing →
  • Completed NCT NCT00571818

    The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients

    Not yet reported University of Nebraska 31 participants Est. completion 2010-06-01 1 site
    Other conditions: Transplant, Diabetes
    View official trial listing →
  • Completed NCT NCT00572312

    Optimalization of Nephroprotection Using Atorvastatin (Sortis)

    Not yet reported Medical University of Gdansk
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00572338

    Therapeutic Research in Multiple Myeloma

    University of Arkansas 6388 participants Est. completion 2015-03 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00572351

    The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels

    Not yet reported Cedars-Sinai Medical Center 44 participants Est. completion 2007-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00572793

    A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk

    Carl Weiner, MD 431 participants Est. completion 2014-07 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Completed NCT NCT00572806

    Initiation of Insulin Aspart in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 6 participants Est. completion 2004-02-02 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00572858

    Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women

    Cedars-Sinai Medical Center 75 participants Est. completion 2020-10 1 site
    Other conditions: Estrogen Deficiency
    View official trial listing →
  • Completed NCT NCT00575120

    Endothelial Function Assessed With BOLD-MRI

    Not yet reported University of Calgary 15 participants Est. completion 2011-09 1 site
    Other conditions: Endothelial Function
    View official trial listing →
  • Completed NCT NCT00575809

    Incidence and Factors Associated With the Development and Severity of Oral Mucositis

    The University of Texas Health Science Center at San Antonio 633 participants Est. completion 2021-07-15 2 sites
    Other conditions: Peripheral Blood Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00576693

    Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis

    Not yet reported Medical University of South Carolina 451 participants Est. completion 2013-04 50 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00576979

    Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

    Not yet reported, Not yet reported City of Hope Medical Center 51 participants Est. completion 2026-01-07 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00577369

    A Pilot Study to Measure Blood Levels of Desflurane in Children

    Not yet reported Children's Hospital of Philadelphia 7 participants Est. completion 2008-06 1 site
    Other conditions: Desflurane Levels
    View official trial listing →
  • Terminated NCT NCT00577694

    Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported UNC Lineberger Comprehensive Cancer Center 21 participants Est. completion 2015-08 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00578149

    Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer

    Not yet reported Dana-Farber Cancer Institute 45 participants Est. completion 2007-08 2 sites
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00578630

    Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients

    Memorial Sloan Kettering Cancer Center 128 participants Est. completion 2018-11 1 site
    Other conditions: Neoplasms
    View official trial listing →
  • Terminated NCT NCT00578903

    Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

    Not yet reported Baylor College of Medicine 22 participants Est. completion 2012-07 2 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT00579163

    Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

    Memorial Sloan Kettering Cancer Center 992 participants Est. completion 2026-12 1 site
    Other conditions: Breast Neoplasms, Ovarian Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Uterine Cervical Neoplasms, Leukemia, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00579527

    Phase I/II Thymus Transplantation With Immunosuppression #950

    Not yet reported, Not yet reported Sumitomo Pharma Switzerland GmbH 14 participants Est. completion 2017-12-31 1 site
    Other conditions: DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly, Complete DiGeorge Syndrome, Complete Atypical DiGeorge Syndrome
    View official trial listing →
  • Terminated NCT NCT00579592

    Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2007-04 1 site
    Other conditions: Acute Rejection, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00579709

    Thymus Transplantation With Immunosuppression

    Not yet reported Sumitomo Pharma Switzerland GmbH 15 participants Est. completion 2019-12 1 site
    Other conditions: DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete DiGeorge Syndrome
    View official trial listing →
  • Completed NCT NCT00580047

    Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

    Not yet reported University of Nebraska 59 participants Est. completion 2014-07-29 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT00580073

    Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum

    Not yet reported University of Wisconsin, Madison 6 participants Est. completion 2009-11 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00580840

    Dosing Flexibility Study in Patients With Rheumatoid Arthritis

    Not yet reported UCB Pharma 333 participants Est. completion 2011-03 66 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00581100

    Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 136 participants Est. completion 2009-10
    Other conditions: Nail Psoriasis, Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00581126

    Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 14 participants Est. completion 2004-07
    Other conditions: Hemophilia B
    View official trial listing →
  • Active, not recruiting NCT NCT00581321

    Oral Water Ingestion in Heart Transplant Patients

    Not yet reported Satish R. Raj 40 participants Est. completion 2029-12 2 sites
    Other conditions: Blood Pressure, Cardiac Transplantation
    View official trial listing →
  • Terminated NCT NCT00581477

    Treatment of Orthostatic Hypotension

    Not yet reported, Not yet reported Vanderbilt University 8 participants Est. completion 2020-12 1 site
    Other conditions: Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency, Orthostatic Intolerance
    View official trial listing →
  • Completed NCT NCT00582257

    Early Onset and Familial Gastric Cancer Registry

    Memorial Sloan Kettering Cancer Center 971 participants Est. completion 2024-09-30 10 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00582296

    Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

    Memorial Sloan Kettering Cancer Center 1530 participants Est. completion 2026-12 8 sites
    Other conditions: Lynch Syndrome
    View official trial listing →
  • Completed NCT NCT00582530

    Men Undergoing Radical Prostatectomy

    Memorial Sloan Kettering Cancer Center 513 participants Est. completion 2022-06-21 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00583999

    The Role of Leptin Receptors in NASH

    University of California, Davis 104 participants Est. completion 2009-06 1 site
    MASHMetabolic syndrome
    View official trial listing →
  • Withdrawn NCT NCT00585403

    Exercise Changes to Peripheral Blood Mononuclear Cells in Children

    University of California, Irvine Est. completion 2004-12 1 site
    Other conditions: Physical Fitness, Obesity, Child Development, Growth
    View official trial listing →
  • Completed NCT NCT00586092

    A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors

    Not yet reported Herbert Hurwitz 45 participants Est. completion 2013-02 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Terminated NCT NCT00586274

    Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT

    Not yet reported Baylor College of Medicine 1 participants Est. completion 2009-07 2 sites
    Other conditions: FANCONI ANEMIA
    View official trial listing →
  • Completed NCT NCT00587158

    Oral Paricalcitol in Kidney Transplant Recipients

    Not yet reported Mayo Clinic 100 participants Est. completion 2011-11 2 sites
    Other conditions: Transplant; Failure, Kidney, Renal Disease, End Stage, Hyperparathyroidism, Secondary
    View official trial listing →
  • Completed NCT NCT00588042

    Remote Myocardial Ischemic Preconditioning in Humans

    Not yet reported Mayo Clinic 156 participants Est. completion 2009-06 1 site
    Other conditions: Coronary Artery Ischemia
    View official trial listing →
  • Status unknown NCT NCT00588718

    A Biologic Validation of Biomarkers of Progressive NEC & Sepsis

    R. Lawrence Moss 740 participants Est. completion 2019-12 1 site
    Other conditions: Necrotizing Enterocolitis
    View official trial listing →
  • Terminated NCT NCT00588822

    Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

    Not yet reported Mayo Clinic 21 participants Est. completion 2011-02 3 sites
    Other conditions: Precancerous Condition
    View official trial listing →
  • Completed NCT NCT00590512

    Dietary Salt Intake and Vascular Function

    Not yet reported Brigham and Women's Hospital 133 participants Est. completion 2012-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00590694

    Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

    Not yet reported, Not yet reported Pacific Eye Associates 15 participants Est. completion 2009-12 1 site
    Other conditions: Age-related Macular Degeneration, Pigment Epithelial Detachment, Neovascular Macular Degeneration, Wet Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00591201

    Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies

    Not yet reported, Not yet reported Hospital General de Mexico 26 participants Est. completion 2007-09 1 site
    Other conditions: Spondylarthropathies
    View official trial listing →
  • Completed NCT NCT00591253

    Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

    Not yet reported Takeda 413 participants Est. completion 2009-04 64 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00592397

    Prestudy: Lifestyle and Cardiovascular Disease

    Not yet reported Norwegian University of Science and Technology 5 participants Est. completion 2006-04 1 site
    Cardiovascular disease Other conditions: Obesity, Diabetes Mellitus
    View official trial listing →
  • Active, not recruiting NCT NCT00593268

    Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage

    Vanderbilt University Medical Center 150 participants Est. completion 2028-12 1 site
    Other conditions: Subarachnoid Hemorrhage
    View official trial listing →
  • Terminated NCT NCT00594308

    In-Vivo Activated T-Cell Depletion to Prevent GVHD

    Not yet reported Indiana University 10 participants 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Myelodysplasia, Lymphoma, Non-Hodgkin's, Mantle-Cell Lymphoma, Hodgkin's Disease, Multiple Myeloma, Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00595413

    Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

    Not yet reported EMD Serono 311 participants Est. completion 2009-10 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00596154

    Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center 33 participants Est. completion 2023-02-02 3 sites
    Other conditions: CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00596167

    Intradialytic Drug Removal by Short-daily Hemodialysis

    Not yet reported Indiana University 6 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: End Stage Renal Disease, Infection
    View official trial listing →
  • Completed NCT NCT00596245

    Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets

    Not yet reported GlaxoSmithKline 42 participants Est. completion 2007-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00596999

    A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

    Celgene Corporation 6 participants Est. completion 2013-12 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Terminated NCT NCT00597441

    Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

    Not yet reported Sumitomo Pharma Switzerland GmbH 6 participants Est. completion 2010-05 1 site
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00597584

    Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

    Not yet reported Affymax 823 participants Est. completion 2010-01 84 sites
    Chronic kidney disease Other conditions: Chronic Renal Failure, Anemia
    View official trial listing →
  • Terminated NCT NCT00599131

    Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)

    Not yet reported University of Michigan Rogel Cancer Center 4 participants Est. completion 2010-10 1 site
    Other conditions: Cancer of Larynx
    View official trial listing →
  • Completed NCT NCT00599170

    Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

    Not yet reported University of Southern California 52 participants Est. completion 2021-01-10 1 site
    Other conditions: Diffuse, Large B-Cell, Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00600210

    Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

    Not yet reported Leo W. Jenkins Cancer Center Est. completion 2011-04 1 site
    Other conditions: Cervical Cancer
    View official trial listing →
  • Withdrawn NCT NCT00600236

    HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

    Not yet reported Asociación para Evitar la Ceguera en México Est. completion 2008-01 1 site
    Type 2 diabetes Other conditions: Proliferative Diabetic Retinopathy
    View official trial listing →
  • Withdrawn NCT NCT00600301

    Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

    Not yet reported Asociación para Evitar la Ceguera en México Est. completion 2008-01 1 site
    Other conditions: Diffuse Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT00600522

    Alternative Surgical Policy for Central Liver Tumors

    University of Milan 15 participants Est. completion 2007-05 1 site
    Other conditions: Colorectal Liver Metastases, Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT00601198

    A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer

    Not yet reported University of Cincinnati 4 participants Est. completion 2010-01-13 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT00603460

    DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer

    Not yet reported, Not yet reported University of Pennsylvania Est. completion 2013-03 1 site
    Other conditions: Ovarian Cancer, Primary Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT00604786

    The Effect of Omalizumab on Responses to Cat Allergen Challenge

    Not yet reported Johns Hopkins University 18 participants Est. completion 2009-01 1 site
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Withdrawn NCT NCT00605800

    Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function

    Memorial Sloan Kettering Cancer Center Est. completion 2009-03
    Other conditions: Liver Cancer
    View official trial listing →
  • Terminated NCT NCT00607061

    Synthesis of Glutathione From Low Birth Weight Newborn Babies

    Not yet reported Nantes University Hospital 35 participants Est. completion 2010-07 1 site
    Other conditions: Low Birth Weight
    View official trial listing →
  • Completed NCT NCT00608972

    Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

    Not yet reported Rutgers, The State University of New Jersey 31 participants Est. completion 2015-09-25 7 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00609219

    T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC

    Not yet reported Baylor College of Medicine 25 participants Est. completion 2012-06 2 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00609284

    Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux

    Not yet reported Groupe Oncologie Radiotherapie Tete et Cou 406 participants Est. completion 2019-03-26 5 sites
    Other conditions: HNSCC
    View official trial listing →
  • Completed NCT NCT00609609

    Photopheresis for the Treatment of Acute Graft Versus Host Disease

    Not yet reported M.D. Anderson Cancer Center 81 participants Est. completion 2016-01 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Terminated NCT NCT00609622

    Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer

    Not yet reported Pfizer 191 participants Est. completion 2011-07 97 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Terminated NCT NCT00610311

    Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

    Not yet reported National Cancer Institute (NCI) 3 participants Est. completion 2011-02 1 site
    Other conditions: Metastatic Melanoma, Skin Cancer
    View official trial listing →
  • Completed NCT NCT00611000

    Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia

    Not yet reported Rockefeller University 20 participants
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00611104

    Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women

    Mayo Clinic 20 participants Est. completion 2014-08-22 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00615797

    Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea

    Not yet reported University of Cape Town 20 participants Est. completion 2009-12 1 site
    Other conditions: Sydenham Chorea, Post Streptococcal Movement Disorder
    View official trial listing →
  • Completed NCT NCT00617942

    Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer

    Not yet reported William Sikov MD 60 participants Est. completion 2015-12 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00619372

    Oral OKT3 in Combination With Beta-D-Glucosylceramide

    Not yet reported Hadassah Medical Organization 20 participants Est. completion 2008-06 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00619645

    Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

    Not yet reported University of California, Davis 8 participants Est. completion 2013-11 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00620139

    Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma

    Memorial Sloan Kettering Cancer Center 17 participants Est. completion 2013-10 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00620971

    Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC

    Not yet reported Hellenic Oncology Research Group 77 participants Est. completion 2010-04 9 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00621062

    Prospective Randomized Trial Comparing the New Endovenous Procedures Versus Conventional Surgery for Varicose Veins Due to Great Saphenous Vein Incompetence

    Not yet reported Uppsala University 540 participants Est. completion 2014-01 1 site
    Other conditions: Varicose Veins
    View official trial listing →
  • Completed NCT NCT00622453

    Arrhythmias in Myotonic Muscular Dystrophy

    Indiana University 448 participants Est. completion 2015-02 1 site
    Substance use disorder Other conditions: Muscular Dystrophy, Arrhythmia
    View official trial listing →
  • Completed NCT NCT00623480

    Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

    Not yet reported Bayer 84 participants Est. completion 2013-11 38 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT00623935

    Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia

    Not yet reported University of Michigan Rogel Cancer Center 56 participants Est. completion 2015-11 1 site
    Other conditions: Acute Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT00624065

    Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure

    Not yet reported GlaxoSmithKline 348 participants Est. completion 2008-08 76 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00624559

    The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

    Not yet reported University of Delaware 12 participants Est. completion 2009-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00625820

    Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria

    Not yet reported University of Michigan 17 participants Est. completion 2008-09 1 site
    Other conditions: Kidney Disease, Albuminuria
    View official trial listing →
  • Completed NCT NCT00626782

    Lucentis Versus Mitomycin C During Glaucoma Surgery

    Not yet reported, Not yet reported Wills Eye 24 participants Est. completion 2011-04 1 site
    Other conditions: Glaucoma
    View official trial listing →
  • Completed NCT NCT00627445

    Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 441 participants Est. completion 2009-01 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT00627861

    Combined Renin Inhibition/Beta-blockade

    Not yet reported The Rogosin Institute 1 participants Est. completion 2010-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00629499

    Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 63 participants Est. completion 2010-09 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00629668

    Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital Est. completion 2007-12 1 site
    Other conditions: Chronic Liver Disease, Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT00629837

    Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980

    Not yet reported Bayer 27 participants Est. completion 2006-03 2 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Status unknown NCT NCT00630006

    Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver Disease

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital Est. completion 2008-12 3 sites
    Other conditions: Hepatitis C Virus Infection, Chronic Liver Disease
    View official trial listing →
  • Completed NCT NCT00630721

    Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells

    Not yet reported University of North Carolina, Chapel Hill 56 participants Est. completion 2011-03-15 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00630786

    Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

    Not yet reported, Not yet reported Amgen 53 participants Est. completion 2010-11
    Other conditions: Colon Cancer, Colorectal Cancer, Rectal Cancer, Metastatic Colorectal Cancer, Oncology
    View official trial listing →
  • Terminated NCT NCT00631059

    Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients

    Not yet reported University of California, Irvine 40 participants Est. completion 2010-06 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00631553

    Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound

    Not yet reported University of Virginia 20 participants Est. completion 2009-12 1 site
    Other conditions: Kidney
    View official trial listing →
  • Withdrawn NCT NCT00632437

    Intraoperative Optical Imaging of Brain Function

    M.D. Anderson Cancer Center Est. completion 2010-06 1 site
    Other conditions: Brain Tumor
    View official trial listing →
  • Terminated NCT NCT00632541

    A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

    Not yet reported Hoosier Cancer Research Network 18 participants Est. completion 2009-03 10 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00633334

    Development of Early Detection Signs for Gastrointestinal Cancer

    University of Pittsburgh 2499 participants Est. completion 2016-02-17 1 site
    Other conditions: GI Cancer
    View official trial listing →
  • Completed NCT NCT00633464

    Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

    Not yet reported R-Pharm 79 participants Est. completion 2011-05 19 sites
    Other conditions: Triple Negative Locally Advanced Non-resectable Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00634920

    Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 204 participants Est. completion 2013-05 8 sites
    Other conditions: Renal Function
    View official trial listing →
  • Withdrawn NCT NCT00636298

    Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

    Not yet reported Emory University Est. completion 2012-03
    Other conditions: Esophageal Carcinoma
    View official trial listing →
  • Completed NCT NCT00637052

    A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia

    Not yet reported, Not yet reported Pfizer 36 participants Est. completion 2010-06-21 2 sites
    Other conditions: Advanced MDS, Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00637351

    A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays

    GlaxoSmithKline 21 participants Est. completion 2009-02 2 sites
    Other conditions: Infections, Streptococcal
    View official trial listing →
  • Terminated NCT NCT00637390

    A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

    Not yet reported University of Michigan Rogel Cancer Center 3 participants Est. completion 2010-10 1 site
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    View official trial listing →
  • Terminated NCT NCT00637858

    Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects

    Not yet reported Soroka University Medical Center 130 participants Est. completion 2011-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00639158

    Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

    Not yet reported Abbott 543 participants 118 sites
    Other conditions: Dyslipidemias, Coronary Heart Disease, Combined (Atherogenic) Dyslipidemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00639691

    A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy

    Not yet reported Novartis 48 participants Est. completion 2011-12 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00640393

    Safety and Efficacy of Combining nbUVB to Etanercept in Patients

    Not yet reported Innovaderm Research Inc. 99 participants Est. completion 2010-03 10 sites
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Completed NCT NCT00646178

    Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

    Not yet reported Abbott 102 participants
    Other conditions: Arthritis, Psoriatic
    View official trial listing →
  • Completed NCT NCT00647868

    NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers

    Not yet reported Acerus Pharmaceuticals Corporation 32 participants Est. completion 2009-03 1 site
    Other conditions: Hypogonadism
    View official trial listing →
  • Completed NCT NCT00648037

    Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

    Not yet reported Memorial Sloan Kettering Cancer Center 26 participants Est. completion 2008-12 1 site
    Other conditions: Hodgkin's Disease, Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00648206

    Testing Alcohol Only Samples for Drugs and Drugs Only Samples for Alcohol

    Finnish Institute for Health and Welfare 250 participants Est. completion 2011-10 1 site
    Other conditions: Driving Under the Influence
    View official trial listing →
  • Terminated NCT NCT00648414

    Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

    Not yet reported Mylan Pharmaceuticals Inc 12 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Approved For Marketing NCT NCT00650390

    Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab

    Abbott
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00650858

    Clinical Trial on Treatment of Intraventricular Hemorrhage

    Not yet reported Johns Hopkins University 52 participants Est. completion 2008-08 25 sites
    Other conditions: Intraventricular Hemorrhage
    View official trial listing →
  • Completed NCT NCT00653822

    A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers

    Not yet reported Astellas Pharma Inc 75 participants Est. completion 2008-07 1 site
    Other conditions: Pharmacokinetics of Alefacept
    View official trial listing →
  • Completed NCT NCT00654368

    CAMEO: Canadian Methotrexate and Etanercept Outcome Study

    Not yet reported Amgen 258 participants Est. completion 2013-02 28 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00654589

    Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload

    Not yet reported Novartis Pharmaceuticals 75 participants Est. completion 2012-01 1 site
    Other conditions: Iron Overload
    View official trial listing →
  • Status unknown NCT NCT00655460

    Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1

    Not yet reported Intermountain Health Care, Inc. 200 participants Est. completion 2018-12 11 sites
    Other conditions: Critically Ill, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT00656435

    Bevacizumab and Long Acting Gas in Diabetic Vitrectomy

    Not yet reported National Taiwan University Hospital 16 participants Est. completion 2008-02 1 site
    Other conditions: Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT00657202

    Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

    Not yet reported Massachusetts General Hospital 11 participants Est. completion 2013-12 1 site
    Other conditions: Neurofibromatosis Type 1, Cutaneous Neurofibromas
    View official trial listing →
  • Completed NCT NCT00657566

    SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection

    Not yet reported University of Virginia 518 participants Est. completion 2014-08 23 sites
    Other conditions: Peritonitis
    View official trial listing →
  • Completed NCT NCT00659724

    Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

    Vantive Health LLC 33 participants Est. completion 2008-05 2 sites
    Other conditions: Chronic Kidney Failure
    View official trial listing →
  • Completed NCT NCT00661817

    Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study)

    Not yet reported Washington University School of Medicine 365 participants Est. completion 2011-04 1 site
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Completed NCT NCT00661986

    Effect of Different Dosages of Dark Chocolate on Arterial Blood Pressure in Cardiovascular High-risk Patients

    Not yet reported University of Leipzig 102 participants Est. completion 2009-05
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00662129

    Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 50 participants Est. completion 2013-08 92 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00664599

    Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

    Not yet reported Tehran University of Medical Sciences 20 participants Est. completion 2008-01 1 site
    Other conditions: Behcet's Syndrome
    View official trial listing →
  • Completed NCT NCT00666263

    Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy

    Not yet reported Baxalta now part of Shire 50 participants Est. completion 2011-08-11 17 sites
    Other conditions: Multifocal Motor Neuropathy
    View official trial listing →
  • Terminated NCT NCT00667420

    Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma

    Not yet reported, Not yet reported Massachusetts General Hospital 17 participants Est. completion 2014-06 2 sites
    Other conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT00668421

    CEP-701 (Lestaurtinib) in Myelofibrosis

    Not yet reported, Not yet reported Ronald Hoffman 60 participants Est. completion 2015-01 7 sites
    Other conditions: Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    View official trial listing →
  • Completed NCT NCT00669279

    Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure

    Not yet reported University of Florida 41 participants Est. completion 2010-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00669305

    Bone Marrow for Hemoglobinopathy Research

    St. Jude Children's Research Hospital 26 participants Est. completion 2019-08-29 1 site
    Other conditions: Sickle Cell Anemia, Thalassemia
    View official trial listing →
  • Terminated NCT NCT00670228

    Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction

    Not yet reported Sanofi 34 participants Est. completion 2009-11 5 sites
    Other conditions: AMI
    View official trial listing →
  • Completed NCT NCT00671021

    Duration of Platelet Inhibition by Aspirin

    Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 10 participants Est. completion 2009-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00671931

    Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine

    Not yet reported Children's Hospital Medical Center, Cincinnati 44 participants Est. completion 2009-01 1 site
    Other conditions: Scoliosis
    View official trial listing →
  • Status unknown NCT NCT00673218

    The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils

    Not yet reported Creighton University 25 participants Est. completion 2012-11 1 site
    Other conditions: Allergy
    View official trial listing →
  • Terminated NCT NCT00673439

    Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

    Not yet reported University of Louisville 3 participants Est. completion 2011-09 1 site
    Other conditions: Heparin-Induced Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00673556

    A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

    Not yet reported Astellas Pharma Inc 195 participants Est. completion 2005-05 34 sites
    Other conditions: Chronic Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00673673

    FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

    Not yet reported Yale University 39 participants Est. completion 2014-07 2 sites
    Other conditions: Gastroesophageal Cancer, Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00674882

    Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant

    St. Jude Children's Research Hospital 637 participants Est. completion 2022-10-03 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00675181

    Effects of Melatonin and Oxygen Consumption and Choroidal Blood Flow

    Not yet reported University Hospital, Basel, Switzerland 16 participants Est. completion 2010-01 1 site
    Other conditions: Vasospastic Syndrome
    View official trial listing →
  • Completed NCT NCT00675259

    Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 33 participants Est. completion 2014-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00676325

    Surgical Treatment To Greater Anterior Vaginal Prolapse

    Not yet reported Federal University of São Paulo 70 participants Est. completion 2009-12 1 site
    Other conditions: Hernia, Cystocele
    View official trial listing →
  • Completed NCT NCT00676741

    Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

    Novo Nordisk A/S 3809 participants Est. completion 2010-05 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00678782

    Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis

    Not yet reported University of Padova 31 participants Est. completion 2007-12 1 site
    Other conditions: Persistent Knee Joint Synovitis
    View official trial listing →
  • Completed NCT NCT00680043

    Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

    Not yet reported Affymax 114 participants Est. completion 2009-08 11 sites
    Chronic kidney disease Other conditions: Anemia, Chronic Renal Failure
    View official trial listing →
  • Status unknown NCT NCT00681616

    Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg

    Not yet reported Twin Star Medical, Inc. 90 participants Est. completion 2010-12 13 sites
    Other conditions: Compartment Syndrome
    View official trial listing →
  • Completed NCT NCT00682916

    Compare Effects of a Soluble Fiber on Weight and Blood Cholesterol

    Not yet reported University of California, Davis 42 participants Est. completion 2008-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00684008

    Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

    Not yet reported Cytheris, Inc. 12 participants Est. completion 2011-04 1 site
    Other conditions: AML, CML, MDS
    View official trial listing →
  • Completed NCT NCT00685061

    Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation

    Not yet reported University of Miami 90 participants Est. completion 2005-09 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00685854

    Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth

    Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2011-03-24 1 site
    Other conditions: Macular Telangiectasia
    View official trial listing →
  • Completed NCT NCT00686556

    Total Marrow Irradiation for Refractory Acute Leukemia

    Not yet reported Masonic Cancer Center, University of Minnesota 12 participants Est. completion 2016-12 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00686595

    A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)

    Not yet reported Merck Sharp & Dohme LLC 48 participants Est. completion 2009-10-01
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00687973

    Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

    Not yet reported Novartis Pharmaceuticals 393 participants Est. completion 2009-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00688636

    Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery

    Not yet reported University of Pittsburgh 24 participants Est. completion 2009-01 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Status unknown NCT NCT00689702

    Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer

    Not yet reported Institute of Oncology Ljubljana 43 participants Est. completion 2013-05 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00691379

    Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer

    Not yet reported, Not yet reported Hellenic Oncology Research Group 46 participants Est. completion 2016-03 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00691652

    Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

    Not yet reported, Not yet reported OHSU Knight Cancer Institute 2 participants Est. completion 2009-04 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00692211

    Interventions to Improve Colorectal Cancer Screening

    Not yet reported US Department of Veterans Affairs 404 participants Est. completion 2009-04 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00693329

    Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy

    Abbott RDx Cardiometabolic 260 participants Est. completion 2009-12 3 sites
    Other conditions: Cardiovascular Surgery With Coronary Angiography
    View official trial listing →
  • Completed NCT NCT00693524

    Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX

    Not yet reported Astellas Pharma Inc 94 participants Est. completion 2004-03 8 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT00694200

    Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

    Not yet reported Hellenic Oncology Research Group 13 participants Est. completion 2009-12 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00695201

    Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 52 participants Est. completion 2021-06-28 1 site
    Other conditions: Colon Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00695279

    Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

    St. Jude Children's Research Hospital 41 participants Est. completion 2024-10-17 1 site
    Other conditions: Severe Combined Immunodeficiency, Malignancy, Hematologic, Neuroblastoma, Neoplasm, Mucopolysaccharidosis I
    View official trial listing →
  • Completed NCT NCT00697684

    Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

    Not yet reported Beth Israel Deaconess Medical Center 29 participants Est. completion 2023-11 2 sites
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia, Relapsed/Refractory Non Hodgkin's Lymphoma, Hodgkins Disease, Relapsed Refractory Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT00698685

    Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported University of Arizona 14 participants Est. completion 2011-04-26 2 sites
    Other conditions: Leukemia, Lymphoma, Hodgkin's Disease, Hematologic Neoplasms, Multiple Myeloma, Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT00698841

    Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors

    Not yet reported Eli Lilly and Company 79 participants Est. completion 2010-02 16 sites
    Other conditions: Advanced Cancer
    View official trial listing →
  • Status unknown NCT NCT00699621

    Platelet Transfusion in Acute Intracerebral Hemorrhage

    Not yet reported University of Oulu 100 participants Est. completion 2014-12 1 site
    Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Completed NCT NCT00699907

    Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer

    Not yet reported University of Arizona 127 participants Est. completion 2014-11 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00700466

    Intravenous Beta-blockade for Improvement of Autonomic Activity

    University Hospital Schleswig-Holstein 100 participants Est. completion 2009-11 1 site
    Other conditions: Hypertension, Tachycardia, Heart Rate Variability
    View official trial listing →
  • Completed NCT NCT00700726

    Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma

    Ohio State University 26 participants Est. completion 2013-12 1 site
    Other conditions: Asthma, Allergies
    View official trial listing →
  • Completed NCT NCT00701389

    Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)

    Not yet reported Merck Sharp & Dohme LLC 24 participants Est. completion 2008-04-10
    Other conditions: Migraine Disorders
    View official trial listing →
  • Status unknown NCT NCT00704548

    Antihypertensive Effect of Simvastatin in Hypertensive Patients

    Not yet reported Hospital de Clinicas de Porto Alegre 92 participants Est. completion 2009-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Enrolling by invitation NCT NCT00704626

    Serum Auto-Antibodies in Neurological Diseases

    University of California, Davis 120 participants Est. completion 2031-03 1 site
    Other conditions: Multiple Sclerosis, Myasthenia Gravis, Transverse Myelitis
    View official trial listing →
  • Completed NCT NCT00704639

    Chemoradiation Treatment for Head and Neck Cancer

    Not yet reported, Not yet reported Trans Tasman Radiation Oncology Group 60 participants Est. completion 2015-12 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00704834

    Gene Expression Profiles in Multiple Sclerosis (MS)

    University of California, Davis 46 participants Est. completion 2017-07-05 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00705042

    Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2008-11 3 sites
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00705367

    Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

    Not yet reported Bristol-Myers Squibb 13 participants Est. completion 2011-07 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT00706797

    Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 141 participants Est. completion 2010-05 45 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00709358

    Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections

    Not yet reported Assistance Publique - Hôpitaux de Paris 2000 participants Est. completion 2010-09 1 site
    Other conditions: Febrile Neutropenia, Endocarditis, Severe Sepsis
    View official trial listing →
  • Terminated NCT NCT00709397

    HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

    Brigham and Women's Hospital 3 participants Est. completion 2009-12 2 sites
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT00710580

    Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

    Not yet reported AbbVie (prior sponsor, Abbott) 350 participants Est. completion 2009-04 42 sites
    Other conditions: Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00710957

    Vitamin D and Physical Function in Older Adults

    Wake Forest University Health Sciences 1100 participants Est. completion 2011-02
    Other conditions: Vitamin D, Physical Function
    View official trial listing →
  • Status unknown NCT NCT00711789

    Angiotensin in Septic Kidney Injury Trial

    Not yet reported Austin Health 12 participants 2 sites
    Other conditions: Acute Renal Failure, Sepsis, Septic Shock
    View official trial listing →
  • Terminated NCT NCT00712998

    X-Ray Computed Tomography and Blood Reactive Oxygen Species Level

    National Taiwan University Hospital 60 participants Est. completion 2008-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00713011

    Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients

    Not yet reported Bayer Est. completion 2009-03
    Other conditions: Diabetic Nephropathies, Hypertension
    View official trial listing →
  • Completed NCT NCT00714493

    RESTART C0168Z05 Rheumatoid Arthritis Study

    Not yet reported Centocor Ortho Biotech Services, L.L.C. 203 participants Est. completion 2010-06 76 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00714662

    High Flux Hemodialysis Thrice Versus Once

    Not yet reported National Taiwan University Hospital 80 participants Est. completion 2009-03 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Withdrawn NCT NCT00715065

    fMRI in Blood Phobia Syncope

    Vanderbilt University Est. completion 2010-06 1 site
    Other conditions: Syncope, Blood Injury Phobia, Autonomic Dysfunction
    View official trial listing →
  • Completed NCT NCT00715078

    To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

    Not yet reported Dendreon 122 participants Est. completion 2015-05 12 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00715208

    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma

    Not yet reported Millennium Pharmaceuticals, Inc. 55 participants Est. completion 2011-03 43 sites
    Other conditions: Relapsed Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT00715312

    Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study

    Not yet reported Malaysia Palm Oil Board 43 participants Est. completion 2008-06 1 site
    Other conditions: Inflammation
    View official trial listing →
  • Withdrawn NCT NCT00715715

    Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients

    Not yet reported Maimonides Medical Center Est. completion 2011-02 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT00715910

    The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

    Not yet reported GlaxoSmithKline 818 participants Est. completion 2013-10 10 sites Stand-alone
    Other conditions: Infections, Meningococcal
    View official trial listing →
  • Completed NCT NCT00715988

    Methadone Pharmacokinetics and Cardiac Effects in Newborns

    Not yet reported University of Utah 7 participants Est. completion 2017-02-10 2 sites
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT00716079

    The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

    Not yet reported The George Institute 2839 participants Est. completion 2012-12 62 sites
    Cardiovascular disease Other conditions: Intracerebral Hemorrhage, Hypertension
    View official trial listing →
  • Completed NCT NCT00716911

    Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

    Not yet reported City of Hope Medical Center 100 participants Est. completion 2007-07
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nonneoplastic Condition
    View official trial listing →
  • Terminated NCT NCT00717990

    Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment

    Not yet reported University Hospital of Crete 15 participants Est. completion 2012-12 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00718042

    Evaluation of Chagas Blood Screening and Confirmatory Assays

    Not yet reported Abbott Diagnostics Division 41862 participants Est. completion 2009-09 7 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00718939

    Rheos® Diastolic Heart Failure Trial

    Not yet reported CVRx, Inc. 6 participants Est. completion 2012-07 4 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00720135

    Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 9 participants Est. completion 2014-07 1 site
    Obstructive sleep apnea Other conditions: Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00720304

    Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

    Not yet reported Case Comprehensive Cancer Center 43 participants Est. completion 2015-11-13 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • No Longer Available NCT NCT00720603

    This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

    Genzyme, a Sanofi Company
    Other conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00720876

    Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 30 participants Est. completion 2017-06-08 3 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00723346

    Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia

    Not yet reported, Not yet reported ERYtech Pharma 25 participants Est. completion 2009-03 1 site
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00723814

    Blood Pressure Monitor Clinical Test

    Andon Health Co., Ltd
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT00724022

    Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation

    Not yet reported University Hospital Freiburg 600 participants Est. completion 2014-07 25 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT00724360

    Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)

    Not yet reported Nantes University Hospital 15 participants Est. completion 2011-11 8 sites
    Other conditions: Relapsed/Refractory Leukemia
    View official trial listing →
  • Completed NCT NCT00724958

    Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)

    Merck Sharp & Dohme LLC 348 participants Est. completion 2010-07
    Other conditions: Crohn's Disease
    View official trial listing →
  • Withdrawn NCT NCT00725400

    Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma

    Not yet reported American Scitech International 450 participants Est. completion 2014-02 1 site
    Other conditions: Colorectal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT00725829

    Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects

    Not yet reported Jagiellonian University 100 participants Est. completion 2009-12 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00727636

    Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy

    Not yet reported Boston Children's Hospital 53 participants Est. completion 2011-04 1 site
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT00728026

    Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea

    Medical College of Wisconsin 19 participants Est. completion 2016-09-16
    Other conditions: Vomiting Syndrome, Irritable Bowel Syndrome, Postural Orthostatic Tachycardia Syndrome, Abdominal Pain, Chronic Nausea
    View official trial listing →
  • Completed NCT NCT00730626

    Dose Response Study of a Fermented Yogurt on the Immune System and Gut Health

    Not yet reported Laval University 58 participants Est. completion 2009-05 1 site
    Other conditions: Immune System
    View official trial listing →
  • Status unknown NCT NCT00734123

    Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

    Not yet reported Hospital Arnau de Vilanova 2948 participants Est. completion 2013-05 1 site
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00734201

    Safety and Efficacy of Low Doses of V24343 in Obese Subjects

    Not yet reported Vernalis (R&D) Ltd 32 participants Est. completion 2009-03 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00736983

    Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's

    Not yet reported Foundation for Liver Research 76 participants Est. completion 2011-12 13 sites
    Other conditions: Crohn's Disease With Perianal Fistulas
    View official trial listing →
  • Completed NCT NCT00737243

    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

    Not yet reported SCRI Development Innovations, LLC 289 participants Est. completion 2012-12 21 sites
    Other conditions: Carcinoma
    View official trial listing →
  • Terminated NCT NCT00737321

    Mechanisms Regulating Wound Vascularization

    Gayle Gordillo 36 participants Est. completion 2018-12 2 sites
    Other conditions: Wounds and Injuries
    View official trial listing →
  • Completed NCT NCT00737438

    Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

    Not yet reported Memorial Sloan Kettering Cancer Center 22 participants Est. completion 2015-02 5 sites
    Other conditions: Esophageal Cancer, Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00737516

    Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

    Not yet reported National Marrow Donor Program 3621 participants Est. completion 2011-10 19 sites
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00738452

    Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2018-02-07 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00738829

    Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

    Not yet reported, Not yet reported Arbeitsgemeinschaft medikamentoese Tumortherapie 45 participants Est. completion 2012-01 7 sites
    Other conditions: Leukemia, Lymphocytic, Chronic, B-Cell
    View official trial listing →
  • Completed NCT NCT00739921

    The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA

    Not yet reported University of California, San Francisco 260 participants Est. completion 2015-05 1 site
    Other conditions: Sinusitis, Nasal Polyps
    View official trial listing →
  • Completed NCT NCT00741390

    Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose

    Not yet reported Becton, Dickinson and Company 250 participants Est. completion 2008-09 4 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00741455

    Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

    Not yet reported Dartmouth-Hitchcock Medical Center 18 participants Est. completion 2020-05-01 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00741585

    Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

    Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites
    Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
    View official trial listing →
  • Terminated NCT NCT00742339

    Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

    Not yet reported, Not yet reported University of Padova 49 participants Est. completion 2013-10 1 site
    Other conditions: Cirrhosis, Hepatorenal Syndrome
    View official trial listing →
  • Completed NCT NCT00742521

    Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3

    Not yet reported Vanderbilt University 22 participants Est. completion 2009-06 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00742729

    Increasing Colorectal Cancer Screening Among Filipino Americans

    Not yet reported Jonsson Comprehensive Cancer Center 906 participants Est. completion 2009-06 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00742989

    Effect of Osteopathic Lymphatic Treatment on Plasma Volume, Protein Concentration and Albumin Concentration.

    Not yet reported Kansas City University of Medicine and Biosciences 15 participants Est. completion 2006-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00743782

    Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism

    Not yet reported National Institutes of Health Clinical Center (CC) 21 participants Est. completion 2014-04-07 1 site
    Other conditions: Hypoparathyroidism, Hypocalcemia, Autoimmune Polyendocrine Syndrome Type 1, Autosomal Dominant Hypocalcemia Type 1 (ADH1)
    View official trial listing →
  • Withdrawn NCT NCT00745953

    Regression of Fatty Heart by Valsartan Therapy

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2009-08 1 site
    Metabolic syndrome Other conditions: Lipotoxicity
    View official trial listing →
  • Completed NCT NCT00746473

    Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART

    UPECLIN HC FM Botucatu Unesp 73 participants Est. completion 2005-10 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00747344

    A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

    Not yet reported Centocor, Inc. 121 participants Est. completion 2010-03 5 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT00748137

    Bolus Insulin Card Calculator Randomised Controlled Study

    Not yet reported John Hunter Children's Hospital 150 participants Est. completion 2011-01 5 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00748657

    Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary

    Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2013-01-31 36 sites
    Obstructive sleep apnea Other conditions: Malignant Ovarian Epithelial Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor, Ovarian Sex Cord Tumor With Annular Tubules, Ovarian Sex Cord-Stromal Tumor, Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types, Ovarian Steroid Cell Tumor
    View official trial listing →
  • Completed NCT NCT00749320

    Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)

    Not yet reported Beth Israel Deaconess Medical Center 32 participants Est. completion 2019-12 2 sites
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00749372

    MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions

    Not yet reported Weill Medical College of Cornell University 15 participants Est. completion 2013-03-29 1 site
    Other conditions: Myelodysplastic Syndrome (MDS)
    View official trial listing →
  • Completed NCT NCT00750984

    A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing

    Not yet reported Zimmer Biomet 49 participants Est. completion 2017-02 1 site
    Other conditions: Arthritis, Avascular Necrosis
    View official trial listing →
  • Withdrawn NCT NCT00751608

    Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients

    Not yet reported Novartis Pharmaceuticals Est. completion 2009-02
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00751621

    Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

    Not yet reported CSL Behring 40 participants Est. completion 2011-12 13 sites
    Other conditions: Primary Immunodeficiency (PID)
    View official trial listing →
  • Completed NCT NCT00751751

    Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 441 participants Est. completion 2005-06 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00753909

    Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer

    Not yet reported Hellenic Oncology Research Group 50 participants Est. completion 2016-10 10 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00753948

    Exhaled Levels of Nitric Oxide

    Not yet reported, Not yet reported VA Office of Research and Development 23 participants Est. completion 2010-08 1 site
    Other conditions: Tetraplegia, Asthma
    View official trial listing →
  • Completed NCT NCT00754351

    Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer

    Not yet reported University Hospital of Crete 48 participants Est. completion 2012-02 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00754650

    A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia

    Not yet reported Hoffmann-La Roche 2 participants Est. completion 2009-03 1 site
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Completed NCT NCT00757172

    Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

    Not yet reported Alliance for Clinical Trials in Oncology 70 participants Est. completion 2014-12 21 sites
    Other conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00757484

    Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery

    University of Rochester 528 participants Est. completion 2010-09 1 site
    Other conditions: Urogynecology
    View official trial listing →
  • Completed NCT NCT00757939

    A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 40 participants Est. completion 2010-10
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Status unknown NCT NCT00759343

    Stone Centre Urine and Serum Bank

    University of British Columbia 500 participants Est. completion 2023-12 2 sites
    Other conditions: Kidney Stones
    View official trial listing →
  • Completed NCT NCT00760448

    Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia

    Not yet reported Novo Nordisk A/S 25 participants Est. completion 2005-10 1 site
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00760552

    Trial of Low and High Intensity Strategies to Maintain BP Control

    Not yet reported US Department of Veterans Affairs 249 participants Est. completion 2013-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00760630

    Measurements to Assess Severity of Epicardial Stenoses

    University of Cincinnati 10 participants Est. completion 2012-02-24 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00761657

    Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis

    Not yet reported Kyntra Bio 117 participants Est. completion 2010-06-21 34 sites
    Chronic kidney disease Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00762034

    A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer

    Not yet reported Eli Lilly and Company 939 participants Est. completion 2014-12 67 sites
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00762697

    Obtaining and Storing Blood Samples and Debridement Samples for Wound Related Research

    Southwest Regional Wound Care Center 20 participants Est. completion 2012-04 1 site
    Other conditions: Venous Insufficiency
    View official trial listing →
  • Completed NCT NCT00764192

    Influence of Hemodialysis on Endothel-Depending Dilatation of Peripheral Arteries

    Not yet reported RWTH Aachen University 14 participants Est. completion 2007-10 1 site
    Other conditions: Hemodialysis
    View official trial listing →
  • Completed NCT NCT00764725

    Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)

    Not yet reported Karolinska Institutet 487 participants Est. completion 2008-12
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00765726

    Study Evaluating The Safety Of Xyntha In Usual Care Settings

    Not yet reported Pfizer 12 participants Est. completion 2011-08 6 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT00766116

    Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)

    Not yet reported, Not yet reported University of California, San Diego 50 participants Est. completion 2014-09-26 3 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT00767065

    Early Cardiac Computed Tomography (CT) In Patients Admitted With Acute Chest Pain

    Not yet reported Chelsea and Westminster NHS Foundation Trust 250 participants Est. completion 2011-12 1 site
    Other conditions: Acute Chest Pain
    View official trial listing →
  • Completed NCT NCT00767325

    A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

    Not yet reported Bristol-Myers Squibb 104 participants Est. completion 2011-10 21 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00768053

    Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 108 participants Est. completion 2010-04 17 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00769145

    Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery

    Not yet reported University of Miami 5 participants Est. completion 2012-03 1 site
    Other conditions: Corneal Neovascularization
    View official trial listing →
  • Completed NCT NCT00770224

    S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

    Not yet reported SWOG Cancer Research Network 87 participants Est. completion 2019-08 114 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00773084

    Aliskiren and Renin Inhibition in Diastolic Heart Failure

    Not yet reported Texas Tech University Health Sciences Center Est. completion 2009-08 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00773747

    Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)

    Not yet reported Merck Sharp & Dohme LLC 637 participants Est. completion 2015-06-30
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00775034

    Drainage Versus Sealant in Double Blinded Monocentric Open Incisional Hernia Repair

    Not yet reported University Hospital, Ghent 57 participants Est. completion 2018-05-24 2 sites
    Other conditions: Incisional Hernia
    View official trial listing →
  • Completed NCT NCT00775073

    Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

    Not yet reported Gerhard Treiber 33 participants Est. completion 2012-04 10 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT00775437

    Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use

    Not yet reported AbbVie (prior sponsor, Abbott) 32 participants Est. completion 2013-03
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT00775632

    Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

    Not yet reported University Health Network, Toronto 78 participants Est. completion 2010-09 1 site
    Other conditions: Graft Versus Host Disease, Bone Marrow Transplantation
    View official trial listing →
  • Completed NCT NCT00776035

    Sex and Obesity: Effects on Heart Failure Study

    Washington University School of Medicine 19 participants Est. completion 2011-04-02 1 site
    Heart failure Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT00776295

    Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 2 participants Est. completion 2010-08 1 site
    Other conditions: Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00776412

    Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

    National Institute of Allergy and Infectious Diseases (NIAID) 310 participants 1 site
    Other conditions: Inflammation, Pathologic Processes
    View official trial listing →
  • Terminated NCT NCT00776555

    Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution

    Not yet reported Shire 3 participants Est. completion 2009-03-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00778102

    A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

    Not yet reported Hoffmann-La Roche 80 participants Est. completion 2013-10 19 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00778869

    Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 10 participants Est. completion 2005-08
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT00778986

    Effects of Remote Patient Monitoring on Heart Failure Management

    Not yet reported University Health Network, Toronto 100 participants Est. completion 2010-09 1 site
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT00780637

    Brachial Artery t-PA Release in Heart Transplant Recipients

    Not yet reported Vanderbilt University Est. completion 2011-05 1 site Stand-alone
    Other conditions: Heart Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT00781612

    A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

    Not yet reported Genentech, Inc. 378 participants Est. completion 2027-06-30 179 sites
    Other conditions: Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00782106

    Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

    Not yet reported, Not yet reported Baxalta now part of Shire 11 participants Est. completion 2007-11-01 3 sites
    Other conditions: Primary Immunodeficiency Diseases (PID)
    View official trial listing →
  • Completed NCT NCT00783029

    Measurement of the Eye's Blood Vessels Using the Dynamic Vessel Analyzer (DVA)

    Penn State University 87 participants Est. completion 2011-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00783497

    Evaluating the Relationship Between Stress, Ethnicity, and Blood Pressure

    University of California, San Diego 203 participants Est. completion 2010-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00783510

    Juvenile Idiopathic Arthritis (JIA) Registry

    AbbVie 849 participants Est. completion 2024-02-01 92 sites
    Other conditions: Juvenile Idiopathic Arthritis, JIA
    View official trial listing →
  • Status unknown NCT NCT00784667

    Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib

    Not yet reported Austin Health 50 participants Est. completion 2011-02 4 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00784927

    Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma

    Not yet reported Mayo Clinic 36 participants Est. completion 2016-02 2 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00785512

    A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy

    Not yet reported Forest Laboratories 207 participants 26 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00786162

    Blood Pressure Self Management for Hypertension & Prehypertension Using an Internet Enabled, Automated Self Management Program

    Not yet reported Massachusetts General Hospital 404 participants Est. completion 2008-12 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT00787670

    Impact of GBS on CVD in Type 2 Diabetes Mellitus

    Not yet reported Duke University 84 participants Est. completion 2011-08 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00787969

    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 74 participants Est. completion 2017-06-15 144 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00788307

    Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy

    Not yet reported Mayo Clinic 8 participants Est. completion 2018-02-07 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00788957

    Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

    Not yet reported, Not yet reported NantBioScience, Inc. 177 participants Est. completion 2010-07-23
    Other conditions: Colon Cancer, Colorectal Cancer, Gastrointestinal Cancer, Metastatic Colorectal Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00789451

    The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man

    Not yet reported University of Edinburgh 12 participants Est. completion 2010-10 1 site
    Other conditions: Ischaemic Heart Diseases
    View official trial listing →
  • Completed NCT NCT00790335

    Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

    Not yet reported Washington University School of Medicine 692 participants Est. completion 2017-01 56 sites
    Other conditions: Deep Vein Thrombosis, Venous Thrombosis, Postphlebitic Syndrome, Venous Thromboembolism, Post Thrombotic Syndrome
    View official trial listing →
  • Completed NCT NCT00791999

    Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

    Not yet reported, Not yet reported Otsuka Pharmaceutical Co., Ltd. 316 participants Est. completion 2011-01 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00792636

    A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period

    Not yet reported GlaxoSmithKline 407 participants Est. completion 2009-11 49 sites
    Other conditions: Migraine Disorders
    View official trial listing →
  • Completed NCT NCT00793572

    Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center 32 participants Est. completion 2016-10 1 site
    Other conditions: Refractory Plasma Cell Myeloma
    View official trial listing →
  • Terminated NCT NCT00793650

    Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

    Not yet reported, Not yet reported Emory University 39 participants Est. completion 2011-09 1 site
    Other conditions: Cancer, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00794820

    Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline

    Not yet reported M.D. Anderson Cancer Center 66 participants Est. completion 2014-12 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00795132

    Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

    Not yet reported University of Utah 47 participants Est. completion 2009-07 1 site
    Other conditions: Acute Leukaemia, Chronic Disease, Leukemia, Myelodysplasia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00796042

    Interdisciplinary Pressure Management & Mobility Program as an Alternative to Usual Care: A Pilot Study

    Not yet reported University of Western Ontario, Canada 14 participants Est. completion 2010-01 2 sites
    Other conditions: Pressure Ulcer
    View official trial listing →
  • Completed NCT NCT00796822

    Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications

    Not yet reported Indiana University 26 participants Est. completion 2011-10 1 site
    Cardiovascular disease Other conditions: HIV, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00797212

    A New Glucose Meter With Alternative Site Testing

    Not yet reported Ascensia Diabetes Care 50 participants Est. completion 2008-11 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00797316

    Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension

    Not yet reported Novartis 532 participants Est. completion 2009-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00797563

    Evaluation of a New Blood Glucose Meter System With Capillary and Venous Blood

    Not yet reported Ascensia Diabetes Care 102 participants Est. completion 2008-11 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00797758

    Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

    Not yet reported Assistance Publique - Hôpitaux de Paris 76 participants Est. completion 2011-12 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT00797784

    The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

    Not yet reported Florida Academic Dermatology Centers 20 participants Est. completion 2011-04 1 site
    Other conditions: Discoid Lupus Erythematosus (DLE)
    View official trial listing →
  • Completed NCT NCT00797836

    Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers

    Not yet reported Assistance Publique - Hôpitaux de Paris 1024 participants Est. completion 2010-11 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00799383

    Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia

    Not yet reported Chadi A. Calarge 47 participants Est. completion 2014-03 1 site
    Other conditions: Risperidone-induced Hyperprolactinemia
    View official trial listing →
  • Completed NCT NCT00800202

    A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis

    Not yet reported Hoffmann-La Roche 91 participants Est. completion 2012-10 25 sites
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT00800644

    Pelvic Fractures and Radiation Therapy for Cervical Cancer

    M.D. Anderson Cancer Center 239 participants Est. completion 2020-11-30 1 site
    Other conditions: Cervical Cancer, Endometrial Cancer, Vaginal Cancer
    View official trial listing →
  • Withdrawn NCT NCT00801125

    Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy

    Not yet reported Biogen
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00801632

    Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-11 1 site
    Other conditions: Kidney Transplantation, Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00801671

    Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension

    Not yet reported Russian Cardiology Research and Production Center 50 participants Est. completion 2011-06 1 site
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00804206

    Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

    Not yet reported Asociación para Evitar la Ceguera en México 15 participants Est. completion 2008-07 1 site
    Other conditions: Macular Edema
    View official trial listing →
  • Completed NCT NCT00804596

    Evaluation of Labeling Comprehension and Performance of a New Blood Glucose Meter System

    Not yet reported Ascensia Diabetes Care 74 participants Est. completion 2009-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00806598

    Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 53 participants Est. completion 2012-06 1 site
    Other conditions: Myelodysplastic Syndrome, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00806767

    Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

    Not yet reported Institut Paoli-Calmettes 82 participants 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00807092

    Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 145 participants Est. completion 2009-10 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT00808210

    A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab

    Not yet reported Genentech, Inc. 28 participants Est. completion 2012-11-14 53 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00808652

    Prevalence and Outcome of Brachial Artery Endothelial Function in Morbidly Obese Patients Undergoing Bariatric Surgery

    Sheba Medical Center 13 participants Est. completion 2014-11 1 site
    Other conditions: Obesity, Morbid, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00809133

    Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours

    Not yet reported Boehringer Ingelheim 83 participants Est. completion 2015-02 2 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Terminated NCT NCT00810017

    Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer

    Not yet reported Medstar Health Research Institute 2 participants Est. completion 2010-06 1 site
    Other conditions: HER-2 Positive Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00810095

    Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical Study

    Not yet reported MindFrame, Inc. 40 participants Est. completion 2011-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00811317

    Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

    Not yet reported Boston University Charles River Campus 11 participants Est. completion 2009-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00812526

    Regulation of Choroidal Blood Flow During Combined Changes in Intraocular Pressure and Arterial Blood Pressure

    Not yet reported Medical University of Vienna 18 participants Est. completion 2004-09 1 site
    Other conditions: Autoregulation
    View official trial listing →
  • Completed NCT NCT00812734

    Epidemiologic Multicentre Study of Neuropathic Post-surgical Pain

    University Hospital, Clermont-Ferrand 3322 participants Est. completion 2011-09 1 site
    Other conditions: Neuropathic Pain
    View official trial listing →
  • Completed NCT NCT00813124

    Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

    Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2014-09 1 site
    Other conditions: Stem Cell Transplantation, Leukemia
    View official trial listing →
  • Completed NCT NCT00814242

    Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels

    Not yet reported, Not yet reported Eastern Hepatobiliary Surgery Hospital 120 participants Est. completion 2011-11 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT00815230

    Effect of Cardiac Computed Tomography Angiography on the Blood Reactive Oxygen Species Level

    National Taiwan University Hospital 20 participants Est. completion 2009-03 1 site
    Other conditions: Radiation Injury
    View official trial listing →
  • Completed NCT NCT00816283

    Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

    Not yet reported City of Hope Medical Center 5 participants Est. completion 2011-06 2 sites
    Other conditions: Leukemia
    View official trial listing →
  • Withdrawn NCT NCT00816413

    Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

    Not yet reported, Not yet reported University of Nebraska Est. completion 2010-02 Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Nonmalignant Neoplasm
    View official trial listing →
  • Completed NCT NCT00817752

    Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

    Not yet reported National University of Natural Medicine 25 participants Est. completion 2008-02 1 site
    Other conditions: Inflammation, Cancer, Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT00818220

    Protective Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants

    Not yet reported University of Rhode Island 211 participants Est. completion 2014-03 1 site
    Other conditions: Intraventricular Hemorrhage, Sepsis
    View official trial listing →
  • Terminated NCT NCT00818961

    Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

    Not yet reported Northside Hospital, Inc. 36 participants Est. completion 2012-03 1 site
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00819598

    Pilot Study to Determine the Optimal Technique for Measurement of Ankle Blood Pressures

    Summit Doppler Systems, Inc. 70 participants Est. completion 2009-10 1 site
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT00819767

    Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

    Not yet reported Novartis 68 participants Est. completion 2009-10 8 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00820547

    Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients

    Not yet reported UNICANCER 100 participants Est. completion 2019-09 28 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00821665

    Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of Saccharose

    Not yet reported Maastricht University Medical Center 39 participants Est. completion 2008-09 1 site
    Type 2 diabetes Other conditions: Glycemic Control
    View official trial listing →
  • Completed NCT NCT00822042

    Corticosteroid-induced Lipodystrophy and Adipokines

    Assistance Publique - Hôpitaux de Paris 32 participants Est. completion 2008-11 1 site
    Other conditions: Lipodystrophy
    View official trial listing →
  • Completed NCT NCT00823147

    Pain Catastrophizing as a Cause for Systemic Inflammation

    Not yet reported Beth Darnall, PhD 93 participants Est. completion 2014-09 1 site
    Other conditions: Musculoskeletal Pain
    View official trial listing →
  • Completed NCT NCT00823160

    Surgical Management of Blood in the Pericardial Sac After Penetrating Trauma

    Not yet reported University of Cape Town 111 participants Est. completion 2009-02 1 site
    Other conditions: Heart Injuries
    View official trial listing →
  • Completed NCT NCT00823589

    Immune Status of Elderly Population Admitted in an Acute Geriatric Unit

    Not yet reported Assistance Publique Hopitaux De Marseille 78 participants Est. completion 2012-02 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT00824148

    Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus

    Not yet reported Norwegian University of Science and Technology 30 participants Est. completion 2009-09 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00824993

    Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

    Not yet reported M.D. Anderson Cancer Center 78 participants Est. completion 2017-04-07 1 site
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT00825695

    Flavanol-Rich Cocoa and Cerebral Blood Flow

    Not yet reported Brigham and Women's Hospital 60 participants Est. completion 2013-06 1 site
    Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Completed NCT NCT00826085

    Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall

    Not yet reported, Not yet reported Imunon 17 participants Est. completion 2016-06 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00828009

    BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

    Not yet reported ECOG-ACRIN Cancer Research Group 70 participants Est. completion 2019-05-22 88 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Withdrawn NCT NCT00829205

    Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

    Not yet reported, Not yet reported Cancer Research UK 5 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00833053

    Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)

    Not yet reported Merck Sharp & Dohme LLC 39 participants Est. completion 2011-04
    Other conditions: Psoriasis
    View official trial listing →
  • Enrolling by invitation NCT NCT00833599

    Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

    The University of Texas Health Science Center, Houston 283 participants Est. completion 2030-12-01 3 sites
    Other conditions: Lymphedema, Lymphatic Disorders, Lipedema, Vascular Malformation, Vascular Anomaly, Dercum Disease
    View official trial listing →
  • Completed NCT NCT00834600

    Renin Profiling in Selection of Initial Antihypertensive Drug

    Not yet reported The Louis & Rachel Rudin Foundation 185 participants Est. completion 2011-10 5 sites
    Other conditions: Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT00835133

    Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma

    Mayo Clinic 1122 participants Est. completion 2027-09-30 1 site
    Other conditions: Familial Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00835224

    Safety and Efficacy of L-NAME and Midodrine to Increase MAP

    Not yet reported US Department of Veterans Affairs 34 participants Est. completion 2013-08 1 site
    Other conditions: Orthostatic Hypotension, Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT00836329

    Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 133 participants Est. completion 2014-05 1 site
    Cardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00838331

    Adverse Effects of RBC Transfusions: A Unifying Hypothesis

    Not yet reported Emory University 24 participants Est. completion 2013-10 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00838747

    Measurement of the Folate Receptor in Blood

    Royal Marsden NHS Foundation Trust 7 participants Est. completion 2011-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00839241

    A Clinical Study to Investigate if Transfusion of Patients Own Shed Blood Improves the Immunological Status in Comparison to Transfusion of Donor Blood ("Bank Blood")

    Not yet reported Wellspect HealthCare 45 participants Est. completion 2009-06 1 site
    Other conditions: Arthroplasty, Replacement, Knee, Blood Transfusion, Autologous, Blood Transfusion
    View official trial listing →
  • Status unknown NCT NCT00841308

    Home Blood Pressure in Hypertension Management

    Not yet reported University of Athens 150 participants Est. completion 2012-12 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00841373

    Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

    Not yet reported, Not yet reported Southern New England Retina Associates 1 participants Est. completion 2010-01 1 site
    Other conditions: Retinal Ischemia
    View official trial listing →
  • Completed NCT NCT00841672

    Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

    Not yet reported Novartis 485 participants Est. completion 2009-09 6 sites
    Other conditions: Moderate to Severe Hypertension
    View official trial listing →
  • Completed NCT NCT00841958

    Endocardial Stem Cells Approach Efficacy

    Not yet reported Meshalkin Research Institute of Pathology of Circulation 250 participants Est. completion 2011-12 1 site
    Other conditions: Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00842465

    Prolactin Receptor and Breast Diseases

    Assistance Publique - Hôpitaux de Paris 735 participants Est. completion 2012-06 1 site
    Other conditions: Benign Breast Disease, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00842595

    Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas

    Not yet reported French Innovative Leukemia Organisation 50 participants Est. completion 2010-05 1 site
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00842712

    Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

    Not yet reported Merck KGaA, Darmstadt, Germany 232 participants Est. completion 2013-07 44 sites
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT00843453

    Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly

    Not yet reported University of Delaware 36 participants Est. completion 2008-04 2 sites
    Other conditions: Vitamin B12 Deficiency
    View official trial listing →
  • Terminated NCT NCT00843791

    Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin

    Not yet reported Oregon Health and Science University 6 participants Est. completion 2011-05 1 site
    Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00844298

    Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported Asan Medical Center 91 participants Est. completion 2014-07 16 sites
    Other conditions: Leukemia
    View official trial listing →
  • Withdrawn NCT NCT00845104

    Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

    Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    Other conditions: B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00845169

    The Role of Nitric Oxide Synthase Isoforms in the Cardiovascular Effects of Air Pollution

    Not yet reported University of Edinburgh 16 participants Est. completion 2013-06 1 site
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Terminated NCT NCT00845832

    A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate

    Not yet reported Hoffmann-La Roche 24 participants Est. completion 2013-03 24 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00845910

    A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 22 participants Est. completion 2011-05 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00846612

    Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

    Not yet reported NYU Langone Health 15 participants Est. completion 2012-06 4 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00846898

    Is There a Metabolic Effect of Cinnamon on HbA1c, Blood Pressure and Serum Lipids in Type 2 Diabetes Mellitus?

    Not yet reported Thames Valley University 58 participants Est. completion 2009-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00847899

    Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance

    Not yet reported Arete Therapeutics 150 participants Est. completion 2009-11 30 sites
    Prediabetes Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00849810

    Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate

    Not yet reported University of Mississippi Medical Center 1 participants Est. completion 2010-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00850252

    Use of a Lifeline Graft in the A-V Shunt Model

    Not yet reported, Not yet reported Cytograft Tissue Engineering Est. completion 2012-12 2 sites
    Other conditions: ESRD, Hemodialysis
    View official trial listing →
  • Terminated NCT NCT00850499

    Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab

    Not yet reported Millennium Pharmaceuticals, Inc. 12 participants Est. completion 2011-10 43 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00851474

    Measurement of Cardiac Output and Blood Volumes

    Transonic Systems Inc. Est. completion 2011-05 1 site
    Other conditions: Cardiac Output
    View official trial listing →
  • Status unknown NCT NCT00852228

    Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

    Not yet reported Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60 participants Est. completion 2015-12 14 sites
    Other conditions: Metastatic Colorectal Cancer, Liver Metastases, Hepatic Lesions
    View official trial listing →
  • Completed NCT NCT00854321

    Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital

    Kuopio University Hospital 49 participants Est. completion 2008-07 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT00855127

    New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients

    University of Colorado, Denver Est. completion 2013-07 2 sites
    Other conditions: Renal Insufficiency, Acute
    View official trial listing →
  • Completed NCT NCT00855348

    PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening

    Epigenomics, Inc 7929 participants Est. completion 2010-04 23 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00855712

    Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation

    Not yet reported TransMedics 128 participants Est. completion 2013-11 11 sites
    Heart failure
    View official trial listing →
  • Terminated NCT NCT00855907

    Fatty Liver in Inflammatory Bowel Disease (IBD) Patients

    Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2011-03 1 site
    Other conditions: Inflammatory Bowel Disease, Fatty Liver
    View official trial listing →
  • Completed NCT NCT00856934

    Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing

    Not yet reported Centre Hospitalier Universitaire Vaudois 45 participants 1 site
    Other conditions: Skin Graft
    View official trial listing →
  • Completed NCT NCT00857883

    A First-Time-In-Human Study in Healthy Subjects

    Not yet reported GlaxoSmithKline 56 participants Est. completion 2009-08-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00858702

    Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

    Not yet reported Daiichi Sankyo Co., Ltd. 105 participants Est. completion 2005-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00859222

    LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

    Not yet reported, Not yet reported Patrick Y. Wen, MD 51 participants Est. completion 2015-12 5 sites
    Other conditions: Malignant Glioma
    View official trial listing →
  • Terminated NCT NCT00860535

    Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 9 participants Est. completion 2010-06
    Other conditions: Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML), Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
    View official trial listing →
  • Completed NCT NCT00860574

    Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

    Not yet reported Fred Hutchinson Cancer Center 96 participants 3 sites
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00860821

    A Methodology Study in Healthy Subjects to Evaluate the Effect of AZD8309 After Nasal Administration of Lipopolysaccharide (LPS)

    Not yet reported AstraZeneca 20 participants Est. completion 2009-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00862719

    Sitagliptin Umbilical Cord Blood Transplant Study

    Not yet reported Indiana University 29 participants Est. completion 2015-02 1 site
    Other conditions: Leukemia, Myeloid, Acute, Acute Lymphoblastic Leukemia, Myelodysplasia, Leukemia, Myelogenous, Chronic, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Status unknown NCT NCT00864773

    The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy

    Not yet reported Hallym University Medical Center 10 participants Est. completion 2010-03
    Other conditions: Central Serous Chorioretinopathy
    View official trial listing →
  • Completed NCT NCT00864942

    Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)

    Not yet reported Georgetown University 28 participants Est. completion 2014-10 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00865345

    An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance

    Not yet reported Medtronic MiniMed, Inc. 63 participants Est. completion 2010-01 3 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00866463

    A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 18 participants Est. completion 2008-10 1 site
    Other conditions: Erectile Dysfunction
    View official trial listing →
  • Completed NCT NCT00866957

    Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)

    Northwestern University 180 participants Est. completion 2019-07 1 site
    Other conditions: Liver Cancer
    View official trial listing →
  • Completed NCT NCT00867321

    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

    Not yet reported, Not yet reported Alliance for Clinical Trials in Oncology 24 participants Est. completion 2013-05 177 sites
    Other conditions: Liver Cancer
    View official trial listing →
  • Completed NCT NCT00868062

    Responses to Colloid Infusions

    Not yet reported University of Nottingham 24 participants Est. completion 2011-11 1 site
    Other conditions: Laparoscopic Cholecystectomy
    View official trial listing →
  • Completed NCT NCT00869193

    Effect of Grape Seed Extract on Blood Pressure

    Not yet reported Unilever R&D 70 participants Est. completion 2009-07 1 site
    Other conditions: Elevated Blood Pressure
    View official trial listing →
  • Completed NCT NCT00869999

    Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

    Not yet reported Massachusetts General Hospital 26 participants Est. completion 2011-11 2 sites
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00870584

    Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

    Not yet reported Novartis Pharmaceuticals 271 participants Est. completion 2010-03 50 sites
    Other conditions: Persistent Allergic Asthma
    View official trial listing →
  • Status unknown NCT NCT00874913

    Study of Ocular Blood Flow in Patients With Glaucoma and/or Obstructive Sleep Apnea Syndrome (OSAS)

    Not yet reported University Hospital, Grenoble 90 participants Est. completion 2014-01 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00874926

    EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS

    Bayer 405 participants Est. completion 2013-04 17 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT00874978

    The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality

    Not yet reported King's College Hospital NHS Trust 36 participants Est. completion 2016-05 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00875667

    A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

    Not yet reported Celgene 254 participants Est. completion 2018-10-09 97 sites
    Other conditions: Mantle Cell Lymphoma, Lymphoma, Mantle-Cell
    View official trial listing →
  • Terminated NCT NCT00876915

    A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

    Not yet reported University of Rochester 218 participants Est. completion 2014-12 7 sites
    Other conditions: Venous Thromboembolism, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00876993

    Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors

    Not yet reported Johns Hopkins All Children's Hospital 26 participants Est. completion 2015-09 1 site
    Other conditions: Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00877006

    Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 447 participants Est. completion 2012-03-31 128 sites
    Other conditions: Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00877136

    A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®

    St. Joseph Hospital of Orange 18 participants Est. completion 2021-03 1 site
    Other conditions: Liver Tumors, Hepatocellular Carcinoma, Hepatoma, Neoplasms
    View official trial listing →
  • Completed NCT NCT00879385

    KRAS Wild-type Metastatic Colorectal Cancer Trial

    Not yet reported University of Utah 21 participants Est. completion 2013-01 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00881829

    Hypoxia Blood Validation in Multiple Pulse Oximeters

    Clinimark, LLC 500 participants Est. completion 2021-12-21 1 site
    Other conditions: Hypoxia
    View official trial listing →
  • Status unknown NCT NCT00881933

    Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)

    Not yet reported, Not yet reported The Korean Society of Pediatric Hematology Oncology 5 participants Est. completion 2012-09 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT00883714

    Exercise During the Allogeneic Stem Cell Transplantation

    Not yet reported Charite University, Berlin, Germany 60 participants Est. completion 2011-08 1 site
    Other conditions: Fatigue, Allogeneic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT00884338

    Cognitive Function After Stem Cell Transplantation

    Not yet reported Charite University, Berlin, Germany 60 participants Est. completion 2011-09 1 site
    Other conditions: Fatigue, Cognitive Impairment, Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00884481

    Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS

    Biogen 195 participants Est. completion 2011-06-30 27 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis, Fatigue
    View official trial listing →
  • Completed NCT NCT00885170

    A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)

    Not yet reported Merck Sharp & Dohme LLC 246 participants Est. completion 2011-09-15
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00885794

    Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)

    Not yet reported, Not yet reported The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 40 participants Est. completion 2012-05 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT00887809

    Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

    Not yet reported Memorial Sloan Kettering Cancer Center 47 participants Est. completion 2014-11 1 site
    Obstructive sleep apnea Other conditions: Sarcoma, Malignant Fibrous, Histiocytoma
    View official trial listing →
  • Completed NCT NCT00889096

    Effects of Propranolol on the Encoding and Retrieval of Emotional Material After Single Dose Administration in Healthy Young Subjects

    Not yet reported University Medicine Greifswald 46 participants 1 site
    Other conditions: Memory, Heart Rate, Skin Electric Conductance, Amylase, Propanolol
    View official trial listing →
  • Completed NCT NCT00889278

    Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

    Dartmouth-Hitchcock Medical Center 30 participants Est. completion 2016-01-05 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00889616

    Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 154 participants Est. completion 2012-07-18 2 sites
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT00889811

    Effect of Remote Preconditioning in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery

    Not yet reported Seoul National University Hospital 68 participants Est. completion 2009-08 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00889980

    Melanoma Molecular Profiling Analysis

    University of Pittsburgh 237 participants Est. completion 2019-07-22 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00890500

    Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

    Not yet reported Fate Therapeutics 12 participants Est. completion 2013-10 2 sites
    Other conditions: Hematologic Malignancies, Allogeneic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00891735

    A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)

    Not yet reported Genentech, Inc. 1097 participants Est. completion 2012-08 99 sites
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00891839

    Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma

    Not yet reported Cephalon 45 participants Est. completion 2014-05 13 sites
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00892229

    Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in Erbil

    Not yet reported Hawler Medical University 100 participants Est. completion 2008-03 1 site
    Other conditions: Missed Abortion
    View official trial listing →
  • Completed NCT NCT00892710

    Trial of Poor Performance Status Patients (ToPPS)

    Not yet reported SCRI Development Innovations, LLC 172 participants Est. completion 2015-05 27 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT00893477

    GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

    Not yet reported French Innovative Leukemia Organisation 60 participants
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00893984

    Alternative in Beta Blocker Intolerance: The ABBI Trial

    Not yet reported Minneapolis Heart Institute Foundation 6 participants Est. completion 2012-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00894504

    Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 71 participants Est. completion 2014-09 17 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00895362

    Erlotinib in Combination With Cetuximab

    Not yet reported M.D. Anderson Cancer Center 65 participants 1 site
    Other conditions: Advanced Cancers
    View official trial listing →
  • Completed NCT NCT00897182

    Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia

    Alliance for Clinical Trials in Oncology 96 participants Est. completion 2014-03 2 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00897650

    Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

    Vanderbilt-Ingram Cancer Center 204 participants Est. completion 2017-07 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT00897728

    Study of Tumor and Blood Samples From Women With Breast Cancer

    Institut Curie 180 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00897910

    Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

    Barbara Ann Karmanos Cancer Institute 6 participants Est. completion 2012-09 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00898014

    Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

    Institut Curie 216 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00898079

    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

    Children's Oncology Group 2545 participants Est. completion 2018-06-30 192 sites
    Other conditions: Acute Undifferentiated Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Solid Neoplasm, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, Juvenile Myelomonocytic Leukemia, Mast Cell Leukemia, Neoplasm of Uncertain Malignant Potential, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, T-Cell Large Granular Lymphocyte Leukemia
    View official trial listing →
  • Status unknown NCT NCT00898118

    Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

    European Working Group of MDS in Childhood 125 participants 10 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00898274

    Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants

    Case Comprehensive Cancer Center 40 participants Est. completion 2011-05 3 sites
    Other conditions: Precancerous Condition, Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00898456

    Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia

    Alliance for Clinical Trials in Oncology 600 participants 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00899847

    Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

    Not yet reported Stanford University 9 participants Est. completion 2014-12 1 site
    Other conditions: Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma, Blood and Marrow Transplant (BMT)
    View official trial listing →
  • Completed NCT NCT00900133

    Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer

    Case Comprehensive Cancer Center 60 participants Est. completion 2006-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00900302

    OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

    OHSU Knight Cancer Institute 98 participants Est. completion 2011-03 1 site
    Other conditions: Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT00900497

    A Study Using White Blood Cells From Healthy Donors To Treat Solid Cancers

    Not yet reported, Not yet reported Dipnarine Maharaj 29 participants Est. completion 2030-12 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00901355

    Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population

    Central Hospital, Nancy, France 1130 participants Est. completion 2013-12 6 sites
    Other conditions: Hypertension, Elderly, Cardiovascular Mortality, Cognitive Impairment, Morbidity
    View official trial listing →
  • Terminated NCT NCT00901927

    Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma

    Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2016-01 1 site
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT00902512

    Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 30 participants Est. completion 2009-04 1 site
    Other conditions: Healthy Males
    View official trial listing →
  • Completed NCT NCT00904241

    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

    Children's Oncology Group 10000 participants Est. completion 2026-03-31 259 sites
    Other conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00904501

    Bone Marrow Autograft in Limb Ischemia

    Not yet reported CHU de Reims 40 participants Est. completion 2015-01 15 sites
    Other conditions: Peripheral Vascular Diseases
    View official trial listing →
  • Completed NCT NCT00904722

    Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma

    Not yet reported M.D. Anderson Cancer Center 32 participants Est. completion 2015-04 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00904839

    BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

    Not yet reported Boehringer Ingelheim 128 participants Est. completion 2012-01 47 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00904995

    Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis

    Not yet reported M.D. Anderson Cancer Center 23 participants Est. completion 2010-07 1 site
    Other conditions: Leukemia, Fungal Infection
    View official trial listing →
  • Completed NCT NCT00905996

    Primary Prophylaxis of Gastric Varix Bleed

    Not yet reported Govind Ballabh Pant Hospital 74 participants Est. completion 2009-01 1 site
    Other conditions: Cirrhosis
    View official trial listing →
  • Status unknown NCT NCT00906516

    Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme

    Not yet reported Bradmer Pharmaceuticals Inc. 60 participants Est. completion 2010-12 1 site
    Other conditions: Brain Tumors
    View official trial listing →
  • Status unknown NCT NCT00907036

    Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

    Not yet reported Cancer Research UK 49 participants
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00907751

    Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

    Not yet reported Assistance Publique - Hôpitaux de Paris 12 participants Est. completion 2013-08 1 site
    Other conditions: Thrombotic Thrombocytopenic Purpura
    View official trial listing →
  • Withdrawn NCT NCT00908986

    Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis

    Not yet reported Northwell Health Est. completion 2009-11
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT00909363

    Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients

    Not yet reported Weill Medical College of Cornell University 24 participants Est. completion 2017-06-30 1 site
    Other conditions: Wiskott-Aldrich Syndrome, Thrombocytopenia, Bleeding
    View official trial listing →
  • Completed NCT NCT00909480

    Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 457 participants Est. completion 2010-06 88 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Suspended NCT NCT00909558

    Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

    Not yet reported Envita Medical Center, Inc. 24 participants 1 site
    Other conditions: Breast Cancer, Glioma, Hepatocellular Cancer, Squamous Cell Lung Cancer, Pancreatic Cancer, Colon Cancer, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00911417

    A Study to Collect Intravascular Ultrasound Images Before and After Treatment With the Jetstream System

    Not yet reported Pathway Medical Technologies Inc. 40 participants Est. completion 2011-08 5 sites
    Other conditions: Peripheral Arterial Disease, Peripheral Vascular Disease
    View official trial listing →
  • Completed NCT NCT00911599

    RCT Comparing Ion Levels and Clinical Outcomes of A-Class BFH to Metal on Polyethylene Total Hip Replacement

    Not yet reported Ottawa Hospital Research Institute 60 participants Est. completion 2013-05 1 site
    Osteoarthritis Other conditions: Hip Joint, Arthroplasty
    View official trial listing →
  • Completed NCT NCT00911716

    TC Avastin. ICORG 08-10, V6

    Not yet reported Cancer Trials Ireland 106 participants Est. completion 2015-09 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00911820

    Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

    Not yet reported Dana-Farber Cancer Institute 88 participants Est. completion 2013-08 4 sites
    Other conditions: Esophageal Cancer, Gastric Cancer, Stomach Cancer
    View official trial listing →
  • Completed NCT NCT00912340

    Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer

    Not yet reported Emory University 70 participants Est. completion 2017-07 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00913913

    Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

    Not yet reported Dartmouth-Hitchcock Medical Center 8 participants Est. completion 2013-01 1 site
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00914407

    Measurement of Retinal Blood Flow, Retinal Oxygenation and Retinal Oxygen Extraction in Healthy Subjects During Normoxia and Systemic Hyperoxia

    Not yet reported Medical University of Vienna 48 participants Est. completion 2017-03-01 1 site
    Other conditions: Healthy, Normoxia, Systemic Hypoxia
    View official trial listing →
  • Status unknown NCT NCT00914784

    The Incidence of TRALI in Patients Undergoing Orthopedic-Oncology Surgery

    Tel-Aviv Sourasky Medical Center 550 participants Est. completion 2011-09 1 site
    Other conditions: Dyspnea, Pulmonary Edema
    View official trial listing →
  • Status unknown NCT NCT00915044

    Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)

    Tel-Aviv Sourasky Medical Center 40 participants 1 site
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT00916188

    Effects of Black Tea on Type 2 Diabetes

    Not yet reported National Nutrition and Food Technology Institute 45 participants Est. completion 2007-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00916643

    Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy

    Not yet reported B. Braun Medical Inc. 113 participants Est. completion 2009-09
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00916721

    Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence

    Not yet reported Massachusetts General Hospital 113 participants Est. completion 2011-01 1 site
    Other conditions: Smoking Cessation
    View official trial listing →
  • Completed NCT NCT00917384

    Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

    Not yet reported Eli Lilly and Company 355 participants Est. completion 2015-12 161 sites
    Other conditions: Gastric Cancer, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00918723

    Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2016-10 2 sites
    Other conditions: Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Small Lymphocytic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00919711

    Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

    Not yet reported Amgen 870 participants Est. completion 2012-03-05
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00919724

    Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People

    Indiana University 89 participants Est. completion 2013-05 1 site
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT00920114

    Estimate of the Activity and the Forecast of the Lupus Disease of the Adult by a Transcriptomic Score (STUDY LU-PUCE)

    Not yet reported Assistance Publique Hopitaux De Marseille 80 participants Est. completion 2012-03 1 site
    Other conditions: Lupus Disease
    View official trial listing →
  • Terminated NCT NCT00920569

    Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation

    Transonic Systems Inc. 8 participants Est. completion 2008-08 1 site
    Other conditions: Recirculation, Oxygenator Blood Volume, Cardiac Output, Venoarterial Extracorporeal Membrane Oxygenation, Venovenous Extracorporeal Membrane Oxygenation
    View official trial listing →
  • Completed NCT NCT00920894

    Effect of Plant Stanol Esters on Blood Lipids

    Not yet reported Clinical Life Sciences Ltd. 112 participants Est. completion 2009-11 1 site
    Other conditions: Elevated Blood Lipids
    View official trial listing →
  • Completed NCT NCT00920907

    Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

    Not yet reported Bristol-Myers Squibb 99 participants Est. completion 2012-10 7 sites
    Other conditions: Advanced Melanoma
    View official trial listing →
  • Completed NCT NCT00921167

    A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas

    Not yet reported Clinical Research Center for Solid Tumor, Korea 32 participants Est. completion 2013-12 1 site
    Other conditions: Glioblastoma, Astrocytoma
    View official trial listing →
  • Completed NCT NCT00921271

    The Application of Near Infrared Spectroscopy (NIRS) in the Detection of Lower Limb Compartment Syndrome

    University Hospital Birmingham NHS Foundation Trust 120 participants Est. completion 2011-04 1 site
    Other conditions: Compartment Syndrome
    View official trial listing →
  • Completed NCT NCT00923182

    A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

    Not yet reported Genzyme, a Sanofi Company 6 participants Est. completion 2011-08 6 sites
    Other conditions: Leukemia, Lymphocytic, Chronic, B-Cell
    View official trial listing →
  • Terminated NCT NCT00924209

    A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

    Not yet reported National Cancer Institute (NCI) 7 participants Est. completion 2011-09 2 sites
    Other conditions: NSCLC, Stage IIIA (N2)
    View official trial listing →
  • Completed NCT NCT00924833

    Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects.

    Not yet reported Istituto Auxologico Italiano 27 participants Est. completion 2006-11 1 site
    Heart failure Other conditions: Hypoxia, Altitude
    View official trial listing →
  • Completed NCT NCT00925600

    Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

    Not yet reported Amgen 769 participants Est. completion 2016-05-12 172 sites
    Other conditions: Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporosis, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00925847

    Effect of Lithium Carbonate in Patients With Amyotrophic Lateral Sclerosis

    Not yet reported Assistance Publique - Hôpitaux de Paris 23 participants Est. completion 2011-04 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Status unknown NCT NCT00926770

    Cerebral Near Infrared Spectroscopy During Blood Sampling From a Peripheral Artery Catheter in Preterm Infants

    University of Cologne 20 participants 1 site
    Other conditions: Cerebral Oxygenation, Cerebral Blood Flow, Prematurity
    View official trial listing →
  • Completed NCT NCT00927069

    Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

    Not yet reported Innovaderm Research Inc. 85 participants Est. completion 2008-12 12 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00927589

    A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable Cancer

    Not yet reported Genentech, Inc. 59 participants Est. completion 2013-02 20 sites
    Other conditions: Solid Cancers
    View official trial listing →
  • Status unknown NCT NCT00928616

    Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes

    Not yet reported University Hospital, Saarland 16 participants Est. completion 2009-06 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00928824

    Can Japanese Traditional Foods Lower Blood Pressure in Healthy Volunteers

    Not yet reported Kyorin University 25 participants Est. completion 2008-09 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT00929526

    Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

    Not yet reported GlaxoSmithKline 752 participants Est. completion 2011-02 13 sites Stand-alone
    Other conditions: Infections, Papillomavirus
    View official trial listing →
  • Completed NCT NCT00929864

    Abatacept Versus Adalimumab Head-to-Head

    Not yet reported Bristol-Myers Squibb 869 participants Est. completion 2012-11 83 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00930137

    Ruminant Trans Fats and the Risk of Cardiovascular Disease in Women

    Not yet reported Laval University 64 participants Est. completion 2011-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00931905

    Homeopathic Preparation Plumbum Metallicum for Lead Poisoning

    Not yet reported Federal University of São Paulo 113 participants 1 site
    Other conditions: Lead Poisoning
    View official trial listing →
  • Completed NCT NCT00932555

    EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

    Bayer 82 participants Est. completion 2011-12 1 site
    Other conditions: Hemophilia A
    View official trial listing →
  • Terminated NCT NCT00933322

    Trial to Assess the Effects of Different Trans-fatty Acids on Endothelial Function in Humans

    Not yet reported Insel Gruppe AG, University Hospital Bern 142 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00933387

    A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

    Not yet reported National Health Research Institutes, Taiwan 47 participants Est. completion 2013-11 1 site
    Other conditions: Oral Cancer
    View official trial listing →
  • Completed NCT NCT00934024

    Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers

    Not yet reported Medical University of South Carolina 21 participants Est. completion 2012-01 1 site
    Other conditions: Nicotine Dependence
    View official trial listing →
  • Withdrawn NCT NCT00934518

    Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma

    Not yet reported Milton S. Hershey Medical Center Est. completion 2011-07 1 site
    Other conditions: Squamous Cell Cancer of the Head and Neck
    View official trial listing →
  • Completed NCT NCT00934856

    A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 98 participants Est. completion 2013-10 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00934986

    Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia

    Not yet reported Institut Paoli-Calmettes 70 participants Est. completion 2010-09 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT00935324

    The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)

    Heidelberg University 120 participants Est. completion 2011-05 1 site
    Other conditions: Allo-SCT
    View official trial listing →
  • Completed NCT NCT00936065

    Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

    Not yet reported Pfizer 60 participants Est. completion 2011-04 10 sites
    Other conditions: Moderate to Severe Psoriasis
    View official trial listing →
  • Completed NCT NCT00936078

    The Living Kidney Donor Safety Study

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1438 participants Est. completion 2022-03 13 sites
    Other conditions: Living Kidney Donation
    View official trial listing →
  • Terminated NCT NCT00936585

    NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease

    Not yet reported National Institutes of Health Clinical Center (CC) 2 participants Est. completion 2011-02 1 site
    Other conditions: Colitis, Crohn's Disease, Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT00939003

    Study of Adalimumab in Patients With Axial Spondyloarthritis

    Not yet reported AbbVie (prior sponsor, Abbott) 192 participants Est. completion 2013-08 38 sites
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Withdrawn NCT NCT00939328

    S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment

    Not yet reported SWOG Cancer Research Network Est. completion 2010-09
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00939627

    Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

    Not yet reported National Cancer Institute (NCI) 55 participants Est. completion 2014-01 8 sites
    Other conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    View official trial listing →
  • Completed NCT NCT00940316

    Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

    Not yet reported Northwestern University 28 participants Est. completion 2015-01 10 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00940342

    Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia

    Not yet reported M.D. Anderson Cancer Center 130 participants Est. completion 2017-01-05 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00941499

    Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

    Not yet reported M.D. Anderson Cancer Center 140 participants Est. completion 2014-05 1 site
    Other conditions: Advanced Cancers
    View official trial listing →
  • Terminated NCT NCT00942058

    Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

    Centre Hospitalier Universitaire de Saint Etienne 16 participants Est. completion 2013-11 3 sites
    Other conditions: Metastatic Kidney Cancer, Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00942331

    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

    Not yet reported National Cancer Institute (NCI) 506 participants Est. completion 2021-06-15 873 sites
    Other conditions: Advanced Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma, Metastatic Prostate Carcinoma, Metastatic Renal Pelvis Urothelial Carcinoma, Metastatic Ureter Urothelial Carcinoma, Metastatic Urethral Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7, Stage IV Prostate Cancer AJCC v7, Stage IV Renal Pelvis Cancer AJCC v7, Stage IV Ureter Cancer AJCC v7, Stage IV Urethral Cancer AJCC v7, Unresectable Urothelial Carcinoma
    View official trial listing →
  • Completed NCT NCT00942500

    Effects of Postconditioning On Myocardial Reperfusion

    Not yet reported Samsung Medical Center 700 participants Est. completion 2012-08 1 site
    Cardiovascular disease Other conditions: Myocardial Reperfusion
    View official trial listing →
  • Completed NCT NCT00942955

    Point-Of-Care Chemistry Test (POCT) Effect on the Emergency Department (ED)

    Seoul National University Hospital Est. completion 2009-03
    Other conditions: Emergency Department, Length of Stay, Turnaround-time
    View official trial listing →
  • Completed NCT NCT00943267

    Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS)

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 52 participants Est. completion 2011-03 1 site
    Other conditions: Pneumonia, Lipopolysaccharides
    View official trial listing →
  • Completed NCT NCT00943319

    Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies

    Not yet reported, Not yet reported University of Chicago 50 participants Est. completion 2018-12 1 site
    Other conditions: Leukemia, Lymphoma, Myeloma
    View official trial listing →
  • Completed NCT NCT00943787

    Counter-Regulatory Impairment and the Effect of Microvascular Insulin Transfer in Type 1 Diabetes Mellitus

    Not yet reported University of Virginia 41 participants Est. completion 2009-05 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00943800

    Combined Haploidentical-Cord Blood Transplantation for Adults and Children

    Not yet reported University of Chicago 87 participants Est. completion 2018-09 1 site
    Other conditions: Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, Lymphoma
    View official trial listing →
  • Completed NCT NCT00944385

    Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement

    Not yet reported Yonsei University Est. completion 2011-04 1 site
    Other conditions: Abnormal Aortic Valve
    View official trial listing →
  • Completed NCT NCT00944983

    Clinical Validation of the Tiba Medical Ambulo 2400 ABPM According to the ISO 80601-2-30 Standard in Adults, Adolescents, and Children

    Tiba Medical, Inc. 105 participants Est. completion 2009-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00945139

    Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)

    Not yet reported New Mexico Cancer Research Alliance 46 participants Est. completion 2011-08 3 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00945724

    Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of Testis

    Not yet reported International Extranodal Lymphoma Study Group (IELSG) 54 participants Est. completion 2023-09-26 22 sites
    Other conditions: Large B-cell Diffuse Lymphoma of Testis
    View official trial listing →
  • Status unknown NCT NCT00946374

    Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma

    Not yet reported Heidelberg University 20 participants Est. completion 2011-06 1 site
    Other conditions: Mantle-Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT00946712

    S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

    Not yet reported SWOG Cancer Research Network 1333 participants Est. completion 2022-02-08 798 sites
    Other conditions: Recurrent Large Cell Lung Carcinoma, Recurrent Lung Adenocarcinoma, Recurrent Squamous Cell Lung Carcinoma, Stage IV Large Cell Lung Carcinoma, Stage IV Lung Adenocarcinoma, Stage IV Squamous Cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT00948454

    Research Study on the Effects of Smoking on Arteries

    University of Pennsylvania 105 participants Est. completion 2006-06 1 site
    Other conditions: Smoking
    View official trial listing →
  • Completed NCT NCT00948727

    Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation

    Not yet reported Assistance Publique - Hôpitaux de Paris 39 participants Est. completion 2008-06 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00949260

    Hemodynamic Assessment of Healthy and Hypertensive Pregnant Women by Non-Invasive Bio-Reactance

    Samuel Lunenfeld Research Institute, Mount Sinai Hospital 30 participants Est. completion 2009-12 1 site
    Other conditions: Hypertension, Pregnancy-Induced
    View official trial listing →
  • Completed NCT NCT00949663

    Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function

    Not yet reported Washington University School of Medicine 38 participants Est. completion 2014-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00951626

    A Standardized Nursing Intervention Protocol for HCT Patients

    Not yet reported City of Hope Medical Center 282 participants Est. completion 2011-09 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Psychosocial Effects of Cancer and Its Treatment, Therapy-related Toxicity
    View official trial listing →
  • Completed NCT NCT00952003

    Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients

    Not yet reported Arbeitsgemeinschaft medikamentoese Tumortherapie 40 participants Est. completion 2020-06 7 sites
    Other conditions: Gastric Cancer, Unresectable
    View official trial listing →
  • Withdrawn NCT NCT00953797

    Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension

    Not yet reported Albert Einstein Healthcare Network Est. completion 2011-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00954473

    Study of Blood Samples From Patients With Osteosarcoma

    Children's Oncology Group 1000 participants 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00954733

    A Comparison of the Detection of Hypoventilation During Deep Sedation Utilizing Nasal End Title CO@ Versus Transcutaneous CO2 Measurement Techniques

    Not yet reported Northwestern University 40 participants Est. completion 2009-08 1 site
    Other conditions: Surgery, Hypoventilation
    View official trial listing →
  • Terminated NCT NCT00955305

    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

    Not yet reported National Cancer Institute (NCI) 175 participants Est. completion 2016-11 165 sites
    Other conditions: Large Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer, Bronchioloalveolar Lung Carcinoma
    View official trial listing →
  • Status unknown NCT NCT00955435

    Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15

    Cancer Trials Ireland 60 participants 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00957606

    Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer

    Not yet reported Odense University Hospital 100 participants Est. completion 2013-09 2 sites
    Other conditions: Prostate Cancer, Androgen Deprivation Therapy, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00957853

    Preoperative Treatment With Cetuximab and/or IMC-A12

    Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2018-08-15 1 site
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00957931

    Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs

    Not yet reported Stanford University 6 participants Est. completion 2013-08 2 sites
    Other conditions: Sickle Cell Disease, Thalassemia, Diamond-Blackfan Anemia
    View official trial listing →
  • Status unknown NCT NCT00959023

    Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer

    Institute of Cancer Research, United Kingdom 21000 participants 135 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00959491

    A Prospective Study of a New Immunological Fecal Occult Blood Test

    National Institute of Gastroenterology, Cuba 160 participants Est. completion 2010-11 1 site
    Other conditions: Colonoscopy, Occult Blood, Immunologic Tests
    View official trial listing →
  • Status unknown NCT NCT00960518

    TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

    Not yet reported Tongji University 216 participants Est. completion 2015-08 2 sites
    Other conditions: Hepatitis B Virus, Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT00960817

    "Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up

    Not yet reported Hillel Yaffe Medical Center 1 site
    Other conditions: Coronary Angiography
    View official trial listing →
  • Completed NCT NCT00965666

    Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia

    Not yet reported Children's Hospital Medical Center, Cincinnati 3 participants Est. completion 2010-10 1 site
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Status unknown NCT NCT00967239

    Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

    NSABP Foundation Inc 1881 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00968071

    Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 71 participants Est. completion 2012-08 1 site
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00968214

    Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

    Alliance for Clinical Trials in Oncology 364 participants Est. completion 2018-09
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00968409

    Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)

    Not yet reported Washington University School of Medicine 20 participants Est. completion 2011-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00968630

    Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 9 participants Est. completion 2017-03-17 1 site
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection
    View official trial listing →
  • Completed NCT NCT00968929

    Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)

    Not yet reported Beijing Chao Yang Hospital 83 participants Est. completion 2009-05 8 sites
    Other conditions: Pulmonary Embolism, Pulmonary Thromboembolism
    View official trial listing →
  • Terminated NCT NCT00968968

    Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

    Not yet reported Novartis Pharmaceuticals 37 participants Est. completion 2018-03-30 116 sites
    Other conditions: Cancer
    View official trial listing →
  • Terminated NCT NCT00970541

    Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome

    Not yet reported Pennington Biomedical Research Center 8 participants Est. completion 2013-06 1 site
    Other conditions: Polycystic Ovary Syndrome, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00970957

    Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

    Not yet reported Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 107 participants Est. completion 2013-02 13 sites
    Other conditions: Macular Edema, Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT00971672

    Incidence of Iron Deficiency Anemia in Toddlers

    HaEmek Medical Center, Israel 260 participants Est. completion 2014-08 1 site
    Other conditions: Healthy Infants
    View official trial listing →
  • Status unknown NCT NCT00973492

    Impact of Functional Insulinotherapy on Blood Glucose Variability Indicators in Patients With Type 1 Diabetes

    Association Grenobloise pour le Developpement D'etudes et de Recherches en Physiopathologie Endocrinienne, Diabetologie et Maladies de la Nutrition 30 participants Est. completion 2009-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT00973726

    The Retinal Function in Relation to Glucose Changes

    Not yet reported Glostrup University Hospital, Copenhagen 80 participants Est. completion 2009-10 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00974363

    Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

    Not yet reported GlaxoSmithKline 697 participants Est. completion 2013-05 5 sites
    Other conditions: Infections, Meningococcal
    View official trial listing →
  • Completed NCT NCT00975364

    Folate Gene Polymorphisms and Cellular Folate Speciation Pilot Study

    Quadram Institute Bioscience 100 participants Est. completion 2010-12 1 site
    Other conditions: Single Nucleotide Polymorphism
    View official trial listing →
  • Status unknown NCT NCT00975793

    Australasian Resuscitation In Sepsis Evaluation Randomised Controlled Trial

    Not yet reported Belinda Howe 1600 participants Est. completion 2015-04 51 sites
    Other conditions: Severe Sepsis
    View official trial listing →
  • Completed NCT NCT00976196

    Platelet Hyperreactivity Project

    Pierre Fontana 110 participants Est. completion 2010-01 1 site
    Other conditions: Platelet Reactivity
    View official trial listing →
  • Completed NCT NCT00976222

    Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

    Not yet reported University Hospital Muenster 40 participants Est. completion 2015-12 2 sites
    Other conditions: Pigment Epithelial Detachment
    View official trial listing →
  • Completed NCT NCT00976989

    A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer

    Not yet reported Hoffmann-La Roche 225 participants Est. completion 2016-01 55 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00977509

    Gene Mutations in Non-Small Cell Lung Cancer Cells

    National Taiwan University Hospital 200 participants Est. completion 2014-12 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT00977769

    Carbetocin Versus Oxytocin and Hemodynamic Effects

    Not yet reported Oslo University Hospital 76 participants Est. completion 2011-10 2 sites
    Other conditions: Effects of; Anesthesia, in Pregnancy
    View official trial listing →
  • Completed NCT NCT00977808

    Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)

    Not yet reported University of Virginia 12 participants Est. completion 2009-02 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT00979641

    Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer

    Not yet reported Tampere University Hospital 65 participants Est. completion 2014-12 1 site
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT00980239

    HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

    Not yet reported M.D. Anderson Cancer Center 115 participants Est. completion 2015-08 1 site
    Other conditions: Liver Cancer, Advanced Cancer
    View official trial listing →
  • Terminated NCT NCT00981370

    Clinical Importance of Treating Iron Overload in Sickle Cell Disease

    Not yet reported Children's Hospital Los Angeles 1 participants Est. completion 2010-12 1 site
    Other conditions: Anemia, Sickle Cell, Transfusion Hemosiderosis
    View official trial listing →
  • Completed NCT NCT00983164

    Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial

    Not yet reported Universidade do Sul de Santa Catarina 32 participants Est. completion 2009-04 3 sites
    Other conditions: Hepatitis C, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT00983190

    BeneMACS Study:HeartMate 2 (HM2)Left Ventricular Assist Device (LVAD) Survival in Non Transplant Patients is Equal/Better Than Results in Medical Literature

    Not yet reported Abbott Medical Devices 10 participants Est. completion 2013-05 2 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00983216

    Drug-Drug Interaction Study Between Colchicine and Ketoconazole

    Not yet reported Mutual Pharmaceutical Company, Inc. 24 participants Est. completion 2008-08 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Status unknown NCT NCT00983398

    Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

    Not yet reported, Not yet reported OHSU Knight Cancer Institute 17 participants Est. completion 2022-12-31 2 sites
    Other conditions: Central Nervous System Embryonal Neoplasm, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered, Germ Cell Tumor, Medulloblastoma, Medulloepithelioma, Primitive Neuroectodermal Tumor, Recurrent Childhood Central Nervous System Embryonal Neoplasm, Recurrent Malignant Germ Cell Tumor, Recurrent Medulloblastoma, Recurrent Primitive Neuroectodermal Tumor
    View official trial listing →
  • Completed NCT NCT00983931

    Drug-Drug Interaction Study Between Colchicine and Cyclosporine

    Not yet reported Mutual Pharmaceutical Company, Inc. 24 participants Est. completion 2008-09 1 site
    Other conditions: Pharmacokinetics, Healthy
    View official trial listing →
  • Completed NCT NCT00984048

    Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer

    Jewish General Hospital 160 participants Est. completion 2019-08 15 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00984568

    Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)

    Not yet reported Merck Sharp & Dohme LLC 28 participants Est. completion 2012-03
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Completed NCT NCT00985322

    Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis

    Not yet reported Mario Negri Institute for Pharmacological Research 269 participants Est. completion 2016-04 29 sites
    Other conditions: Left Ventricular Hypertrophy, Hypertension
    View official trial listing →
  • Completed NCT NCT00986050

    Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction

    Not yet reported Catharina Ziekenhuis Eindhoven 907 participants Est. completion 2009-07 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00986154

    Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

    Not yet reported Daiichi Sankyo 8292 participants Est. completion 2013-04 454 sites
    Other conditions: Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Thromboembolism, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00986518

    T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 5 participants Est. completion 2013-02 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT00987662

    Irbesartan Versus Amlodipine: The OBI Study

    Not yet reported Aristotle University Of Thessaloniki Est. completion 2014-01 1 site
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Status unknown NCT NCT00989352

    Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma

    Not yet reported University Hospital Freiburg 56 participants Est. completion 2011-09 1 site
    Other conditions: Primary Non Hodgkin Lymphoma of the Central Nervous System
    View official trial listing →
  • Completed NCT NCT00990249

    Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 120 participants Est. completion 2016-05 1 site
    Other conditions: Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Suspended NCT NCT00990444

    A Two Part Study of Peroral Insulin in Type 2 Diabetes

    Not yet reported, Not yet reported Bows Pharmaceuticals AG 32 participants Est. completion 2010-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00990678

    Study of Vitamin D Supplementation to Male HIV Sero-positive Patients

    Not yet reported Hvidovre University Hospital 60 participants Est. completion 2011-01 1 site
    Other conditions: HIV Seropositive
    View official trial listing →
  • Completed NCT NCT00991042

    Study of Cytokines Serum Levels in Chronic Low Back Pain

    Not yet reported Federal University of São Paulo 23 participants Est. completion 2005-03 1 site
    Other conditions: Interleukines
    View official trial listing →
  • Completed NCT NCT00991341

    Red Cell Storage Duration Study

    Not yet reported Carelon Research 1481 participants Est. completion 2014-03 33 sites
    Other conditions: Cardiac Surgery, Erythrocyte Transfusion
    View official trial listing →
  • Completed NCT NCT00991627

    Different Approaches to Maternal Hypotension During Cesarean Section

    Not yet reported University of Parma 36 participants Est. completion 2010-08 1 site
    Other conditions: Pregnancy, Cesarean Section, Anesthesia,Spinal, Hypotension
    View official trial listing →
  • Completed NCT NCT00991731

    A Program to Increase Physical Activity Among Blacks

    Not yet reported Melicia Whitt-Glover 496 participants Est. completion 2014-12 1 site
    Other conditions: Physical Activity
    View official trial listing →
  • Completed NCT NCT00992394

    Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept

    Not yet reported Pfizer 174 participants Est. completion 2013-04 46 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00993187

    Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)

    Not yet reported Merck Sharp & Dohme LLC 292 participants Est. completion 2013-10-29
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00993473

    6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes

    Not yet reported Sanofi 125 participants Est. completion 2011-03 61 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00993603

    Lifestyle Intervention in Obese Non-diabetic Adults With a Family History of Diabetes.

    Not yet reported The Royal Bournemouth Hospital 66 participants Est. completion 2012-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00994643

    Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 11 participants Est. completion 2015-06-25 1 site
    Other conditions: High Risk Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00995072

    Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function

    Not yet reported East Coast Institute for Research 29 participants Est. completion 2013-04 1 site
    Other conditions: Hypertension, Female Sexual Dysfunction
    View official trial listing →
  • Completed NCT NCT00995527

    Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine

    National Heart, Lung, and Blood Institute (NHLBI) 26 participants Est. completion 2014-06-25 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00996437

    Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)

    Not yet reported, Not yet reported Jaeb Center for Health Research 261 participants Est. completion 2013-01 67 sites
    Other conditions: Vitreous Hemorrhage, Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT00996567

    A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

    Not yet reported University Hospital, Ghent 22 participants Est. completion 2015-09 4 sites
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT00997009

    Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer

    Not yet reported National Cancer Institute, Naples 108 participants Est. completion 2024-12 15 sites
    Other conditions: Cervical Cancer
    View official trial listing →
  • Completed NCT NCT00997217

    The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery

    Not yet reported Seoul National University Hospital 1200 participants Est. completion 2010-11 1 site
    Other conditions: Myocardium; Injury, Cardiac Surgical Procedures
    View official trial listing →
  • Withdrawn NCT NCT00998101

    Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

    Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2009-11
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00999102

    Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life

    Not yet reported Weill Medical College of Cornell University 37 participants Est. completion 2011-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00999700

    Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin

    Not yet reported Gruppo Oncologico del Nord-Ovest 282 participants Est. completion 2021-12 21 sites
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT01000051

    Eltrombopag for Post Transplant Thrombocytopenia

    Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2018-04-04 1 site
    Other conditions: Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT01000766

    Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury

    University of North Carolina, Chapel Hill 25 participants Est. completion 2013-12 1 site
    Other conditions: Drug Induced Liver Injury
    View official trial listing →
  • Completed NCT NCT01000935

    Impact of Autologous Platelet Rich Plasma on Healing of Rotator Cuff Repairs

    Not yet reported Sunnybrook Health Sciences Centre 82 participants Est. completion 2015-05 2 sites
    Other conditions: Rotator Cuff Pathology
    View official trial listing →
  • Completed NCT NCT01002482

    Computerized Glucose Control in Critically Ill Patients

    Not yet reported Centre Hospitalier of Chartres 2684 participants Est. completion 2013-04 35 sites
    Other conditions: Hyperglycemia, Critical Illness
    View official trial listing →
  • Completed NCT NCT01003301

    The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge

    Not yet reported Johns Hopkins University 19 participants Est. completion 2013-09 1 site
    Other conditions: Cat Allergy
    View official trial listing →
  • Completed NCT NCT01003613

    Evaluation of Tranilast to Treat Pterygium Before Excision

    Not yet reported Gildasio Castello de Almeida Junior 32 participants Est. completion 2012-03 1 site
    Other conditions: Pterygium
    View official trial listing →
  • Withdrawn NCT NCT01005147

    Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding

    Not yet reported University of Oklahoma Est. completion 2011-10
    Other conditions: Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT01005745

    Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 19 participants Est. completion 2025-08-18 1 site
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT01007292

    A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

    Not yet reported Astellas Pharma Inc 43 participants Est. completion 2015-06 19 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01007942

    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 569 participants Est. completion 2015-06 161 sites
    Other conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01009086

    A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis

    Not yet reported Janssen Research & Development, LLC 615 participants Est. completion 2013-05 102 sites
    Other conditions: Arthritis, Psoriatic
    View official trial listing →
  • Completed NCT NCT01009138

    Evaluation of a Diabetes-specific Cognitive Behavioural Treatment for Subthreshold Depression

    Not yet reported Forschungsinstitut der Diabetes Akademie Mergentheim 214 participants Est. completion 2012-05 1 site
    Other conditions: Depressive Symptoms, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01009359

    Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

    Not yet reported Bayer 22 participants Est. completion 2010-10 2 sites
    Other conditions: Diagnostic Imaging
    View official trial listing →
  • Completed NCT NCT01009437

    Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 28 participants Est. completion 2014-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01010035

    Cholesterol Metabolism and Lipid Transfer in Diabetes

    University of Sao Paulo General Hospital 26 participants Est. completion 2009-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01012323

    A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

    Not yet reported Octapharma 51 participants Est. completion 2012-06 7 sites
    Other conditions: Primary Immunodeficiency Diseases
    View official trial listing →
  • Completed NCT NCT01012609

    External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas

    Not yet reported Memorial Sloan Kettering Cancer Center 47 participants Est. completion 2018-01-15 12 sites
    Other conditions: Brain Cancer
    View official trial listing →
  • Completed NCT NCT01013402

    Investigating the Accuracy of the Home Glucose Monitors in Hypoglycemia

    Not yet reported Gulhane School of Medicine 51 participants Est. completion 2009-08 1 site
    Other conditions: Hypoglycemia
    View official trial listing →
  • Completed NCT NCT01015248

    Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

    Not yet reported Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 60 participants Est. completion 2013-12 19 sites
    Other conditions: MALT LYMPHOMA
    View official trial listing →
  • Terminated NCT NCT01015664

    Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Not yet reported, Not yet reported University of Tennessee Cancer Institute 11 participants Est. completion 2012-12 1 site
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT01018641

    An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

    Not yet reported Pfizer 449 participants Est. completion 2011-07 5 sites
    Other conditions: Bacterial Infections, Staphylococcal Vaccines, Immunotherapy, Active, Staphylococcal Skin Infections, Staphylococcal Infections
    View official trial listing →
  • Completed NCT NCT01019330

    Radial Versus Femoral Arterial Access for Cardiac Catheterization: Comparison of Complications at 30 Days

    Creighton University 243 participants Est. completion 2015-08 2 sites
    Other conditions: Radial Artery Occlusion
    View official trial listing →
  • Status unknown NCT NCT01021098

    Acute Respiratory Infection Consortium

    Henry M. Jackson Foundation for the Advancement of Military Medicine 2018 participants Est. completion 2023-12 5 sites
    Other conditions: Influenza
    View official trial listing →
  • Status unknown NCT NCT01022086

    Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

    Unity Health Toronto 50 participants Est. completion 2019-12 2 sites
    Other conditions: Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)
    View official trial listing →
  • Completed NCT NCT01022125

    TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435

    Not yet reported Tibotec Pharmaceuticals, Ireland 28 participants Est. completion 2010-04
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01023945

    A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

    Not yet reported Astellas Pharma Inc 30 participants Est. completion 2010-03-26 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01024933

    Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)

    Not yet reported Weill Medical College of Cornell University 238 participants Est. completion 2014-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01025024

    Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients

    Chungnam National University 1224 participants Est. completion 2009-11 1 site
    Other conditions: Single-nucleotide Polymorphism (SNP) for Glaucoma
    View official trial listing →
  • Completed NCT NCT01025934

    Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

    Not yet reported University of Campania Luigi Vanvitelli
    Other conditions: Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT01026233

    Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

    Not yet reported Seagen Inc. 52 participants Est. completion 2011-08 9 sites
    Other conditions: Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT01026714

    CYP2C9 Activity Evaluated With a Simple Finger Prick

    Not yet reported, Not yet reported University Hospital, Geneva 10 participants Est. completion 2010-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01026753

    Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba

    Not yet reported University of Manitoba 2395 participants Est. completion 2011-12 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT01026961

    Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers

    Not yet reported, Not yet reported Novartis 1 site
    Other conditions: Heart Rate, Blood Pressure, Arrhythmias
    View official trial listing →
  • Completed NCT NCT01026987

    Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

    Not yet reported Washington University School of Medicine 29 participants Est. completion 2016-06-08 1 site
    Other conditions: Stem Cell Transplant Patients
    View official trial listing →
  • Completed NCT NCT01027871

    A Study for Patients With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 289 participants Est. completion 2011-01 25 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01028716

    Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Fred Hutchinson Cancer Center 46 participants Est. completion 2021-10-07 1 site
    Other conditions: Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(3)(Q21Q26.2); RPN1-EVI1, Acute Myeloid Leukemia With Multilineage Dysplasia, Acute Myeloid Leukemia With t(6;9), Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia With T(1;19)(Q23;P13.3); E2A-PBX1 (TCF3-PBX1), Ph+ ALL, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Complete Remission, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Recurrent Anaplastic Large Cell Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Recurrent Follicular Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Secondary Acute Myeloid Leukemia, T Lymphoblastic Lymphoma, Hematopoietic Cell Transplant Recipient
    View official trial listing →
  • Completed NCT NCT01029119

    Clinical Test for Blood Pressure Meter of CH-101

    Citizen Systems Japan Co., Ltd. 85 participants Est. completion 2007-02 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT01029327

    Effects of Curcumin on Postprandial Blood Glucose, and Insulin in Healthy Subjects

    Skane University Hospital Est. completion 2009-09 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01030016

    Study of Atenolol Influence on Blood Pressure During Resistance Exercise

    Not yet reported University of Sao Paulo 10 participants Est. completion 2009-05 1 site
    Other conditions: Blood Pressure, Exercise
    View official trial listing →
  • Completed NCT NCT01030445

    Cardiac Function as Measured by Non-invasive Electrical Velocimetry Cardiac Monitor in Hospitalized Children

    Boston Children's Hospital 83 participants Est. completion 2011-06 1 site
    Other conditions: Cardiac Output, Blood Pressure
    View official trial listing →
  • Completed NCT NCT01030458

    Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial

    Not yet reported KU Leuven 183 participants Est. completion 2012-03 7 sites
    Other conditions: Blood Pressure
    View official trial listing →
  • Withdrawn NCT NCT01030744

    Evaluation of the Gestational Diabetes Self-Management Education Program and Quality Improvement Plan

    Vanderbilt University Medical Center Est. completion 2015-12 1 site
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT01031381

    Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

    Not yet reported University of Pittsburgh 50 participants Est. completion 2014-12 1 site
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01032278

    Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

    Not yet reported M.D. Anderson Cancer Center 597 participants Est. completion 2021-01 2 sites
    Other conditions: Cardiac Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Status unknown NCT NCT01032746

    Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer

    Not yet reported Harvard University 1000 participants 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01034007

    A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery

    Not yet reported Christopher Breuer 4 participants Est. completion 2018-01-23 1 site
    Other conditions: Single Ventricle Cardiac Anomaly
    View official trial listing →
  • Completed NCT NCT01034306

    Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis

    Not yet reported Can-Fite BioPharma 79 participants Est. completion 2013-12 5 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01034579

    The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial

    Not yet reported EMD Serono 324 participants Est. completion 2010-11 1 site
    Other conditions: Relapsing Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT01034592

    Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

    Not yet reported Jason Robert Gotlib 2 participants Est. completion 2012-12 1 site
    Other conditions: Anemia, Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
    View official trial listing →
  • Completed NCT NCT01035060

    Blood Flow, Muscle Regeneration and Sarcopenia

    University of Florida 68 participants Est. completion 2011-12 1 site
    Other conditions: Sarcopenia
    View official trial listing →
  • Completed NCT NCT01035463

    Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma

    Not yet reported, Not yet reported University of Nebraska 74 participants Est. completion 2018-07-27 3 sites
    Other conditions: Anaplastic Large Cell Lymphoma, ALK-Negative, Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01035645

    First Time in Human Study of Intravenous Interleukin-18 Antibody

    Not yet reported GlaxoSmithKline 78 participants Est. completion 2012-07-11 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT01036971

    Screening Protocol for the Evaluation of Potential Research Subjects

    National Institute on Drug Abuse (NIDA) 6967 participants 1 site
    Other conditions: Addiction
    View official trial listing →
  • Completed NCT NCT01038401

    Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

    Not yet reported ANRS, Emerging Infectious Diseases 30 participants Est. completion 2010-05 1 site
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT01041001

    Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury

    Not yet reported Medipost Co Ltd. 104 participants Est. completion 2011-01 8 sites
    Osteoarthritis Other conditions: Cartilage Injury
    View official trial listing →
  • Completed NCT NCT01041040

    LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

    Not yet reported PETHEMA Foundation 200 participants Est. completion 2013-01 1 site
    Other conditions: Acute Myeloblastic Leukemia
    View official trial listing →
  • Completed NCT NCT01042262

    Maternal Oxygen Use During Delivery and Cord Blood Superoxide Dismutase

    Not yet reported George Washington University 60 participants Est. completion 2009-08 1 site
    Other conditions: Oxidative Stress, Fetal Distress
    View official trial listing →
  • Completed NCT NCT01042288

    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC

    Not yet reported SCRI Development Innovations, LLC 70 participants Est. completion 2015-07 13 sites
    Other conditions: Non-Small-Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01042405

    Nutrition Based Computerized Predictive Method for Morbidity & Mortality Risk in HD Patients. Assisng NIR for Blood Cr

    Wolfson Medical Center 130 participants Est. completion 2021-10 1 site
    Other conditions: Malnutrition, Inflammation, Morbidity, Mortality
    View official trial listing →
  • Status unknown NCT NCT01042717

    Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

    Not yet reported Shi, Patricia, M.D. 10 participants Est. completion 2011-12 1 site
    Other conditions: Multiple Myeloma, Non-Hodgkins Lymphoma
    View official trial listing →
  • Completed NCT NCT01043484

    Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer

    Not yet reported Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 90 participants Est. completion 2016-08 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Suspended NCT NCT01044368

    Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on Monotherapy

    Not yet reported Endocrine Research Society 50 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01046266

    A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

    Not yet reported Hoffmann-La Roche 62 participants Est. completion 2012-06 7 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01046786

    Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord

    Not yet reported, Not yet reported China Spinal Cord Injury Network 8 participants Est. completion 2013-12 2 sites
    Other conditions: Spinal Cord Injuries
    View official trial listing →
  • Withdrawn NCT NCT01047072

    Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

    Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1 site
    Other conditions: Systemic Scleroderma
    View official trial listing →
  • Completed NCT NCT01047631

    Role of Exercise in Diastolic Heart Failure

    Not yet reported University of Michigan 50 participants Est. completion 2012-03 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01049087

    Plasma Volume Determination by 99mTc-labeled Albumin and 125I-labeled Albumin

    Not yet reported Zealand University Hospital 15 participants Est. completion 2012-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01049204

    Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens

    Not yet reported St Stephens Aids Trust 48 participants Est. completion 2011-06 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT01049542

    Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers

    Not yet reported University of Edinburgh 6 participants Est. completion 2010-07 1 site
    Other conditions: Vascular Disease, Heart Disease
    View official trial listing →
  • Completed NCT NCT01050036

    Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia

    Not yet reported Asan Medical Center 20 participants Est. completion 2018-10-30 11 sites
    Other conditions: Leukemia, Myeloid
    View official trial listing →
  • Completed NCT NCT01051349

    Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis

    Not yet reported Biogen 410 participants Est. completion 2016-08-25 65 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01051609

    Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients

    Jonsson Comprehensive Cancer Center 27 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01052363

    OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

    Not yet reported West Virginia University 1 site
    Other conditions: Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT01053078

    Naltrexone and Hypoglycemia in Type 1 Diabetes

    Not yet reported, Not yet reported University of Minnesota 29 participants Est. completion 2014-06 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia Unawareness
    View official trial listing →
  • Completed NCT NCT01054781

    Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

    Not yet reported Samsung Medical Center 91 participants 1 site
    Other conditions: Diffuse Large B-cell Lymphoma (DLBCL)
    View official trial listing →
  • Terminated NCT NCT01055028

    Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

    Not yet reported Stanford University 18 participants Est. completion 2016-06-24 3 sites
    Obstructive sleep apnea Other conditions: Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT01055795

    Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors

    Not yet reported Herbert Hurwitz 14 participants Est. completion 2012-05 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT01056510

    A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

    Not yet reported Hoffmann-La Roche 357 participants Est. completion 2014-03 85 sites
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Completed NCT NCT01057264

    HAI Abraxane With Gemcitabine and Bevacizumab

    Not yet reported M.D. Anderson Cancer Center 78 participants Est. completion 2014-05 1 site
    Other conditions: Advanced Cancers
    View official trial listing →
  • Completed NCT NCT01057537

    UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

    Not yet reported Imperial College London 2004 participants Est. completion 2012-09 7 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01057628

    A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients

    Not yet reported Astellas Pharma Inc 130 participants Est. completion 2010-11-06 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01059474

    Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion

    Not yet reported Banner Health 9 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Toxicity
    View official trial listing →
  • Completed NCT NCT01059773

    A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

    Not yet reported Janssen-Cilag International NV 490 participants Est. completion 2011-08 76 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Active, not recruiting NCT NCT01061515

    Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer

    Not yet reported Washington University School of Medicine 21 participants Est. completion 2027-09-27 1 site
    Other conditions: Carcinoma
    View official trial listing →
  • Completed NCT NCT01062035

    Study of a Screening Blood Test to Determine Patients' Potential Risk of Adenomatous or Advanced Colon Polyps (ACPs)

    Mayo Clinic 72 participants Est. completion 2013-09 1 site
    Other conditions: Colonic Polyp
    View official trial listing →
  • Terminated NCT NCT01062698

    Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke

    Not yet reported Central Hospital, Nancy, France 412 participants Est. completion 2016-03 1 site
    Cardiovascular disease Other conditions: Cerebrovascular Accident
    View official trial listing →
  • Completed NCT NCT01062763

    The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension

    Not yet reported Ib Abildgaard Jacobsen 119 participants Est. completion 2012-05
    Other conditions: Arterial Hypertension, Hypertension, Resistant to Conventional Therapy, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01064856

    Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)

    Not yet reported AbbVie (prior sponsor, Abbott) 165 participants Est. completion 2014-05
    Other conditions: Peripheral Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT01065155

    Relationship of Central Blood Pressure and Pulse Wave Velocity With Target Organ Damage

    Fundacion para la Investigacion y Formacion en Ciencias de la Salud 110 participants Est. completion 2016-03 1 site
    Cardiovascular disease Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01066572

    Paramedic Initiated Lisinopril For Acute Stroke Treatment

    Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 14 participants Est. completion 2011-12 4 sites
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT01067118

    A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.

    Not yet reported Stanford University Est. completion 2011-06 2 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01067469

    Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

    Not yet reported M.D. Anderson Cancer Center 83 participants Est. completion 2016-10 1 site
    Other conditions: Brain Cancer, Glioblastoma
    View official trial listing →
  • Completed NCT NCT01067638

    The Effect of Tranexamic Acid on Postoperative Blood Loss and Coagulation in Patients With Preoperative Anemia Undergoing Off-Pump Coronary Artery Bypass Graft; Double Blind Randomized Control Study

    Not yet reported Yonsei University 90 participants Est. completion 2010-09 1 site
    Other conditions: Coronary Artery Occlusive Disease
    View official trial listing →
  • Completed NCT NCT01068301

    A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

    Not yet reported St. Jude Children's Research Hospital 12 participants Est. completion 2013-10 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01068691

    Arterial Properties of Thoracic Aorta Disease

    University Hospital, Grenoble 180 participants Est. completion 2010-06 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT01070316

    Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 20 participants Est. completion 2016-04 2 sites
    Other conditions: Epilepsy, Tuberous Sclerosis Complex
    View official trial listing →
  • Completed NCT NCT01070836

    JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

    Biogen 35895 participants Est. completion 2015-11 478 sites
    Other conditions: Relapsing Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01071083

    Treatment Interruption of Natalizumab

    Not yet reported Biogen 175 participants Est. completion 2011-11 33 sites
    Other conditions: Relapsing Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01071122

    FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

    Not yet reported Bayer 365 participants Est. completion 2012-02 15 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01071525

    The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker

    Not yet reported Rambam Health Care Campus 30 participants Est. completion 2010-10 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01071798

    An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis

    Hoffmann-La Roche 1653 participants Est. completion 2014-10 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01072669

    Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet

    Not yet reported Soumya Chatterjee 20 participants Est. completion 2010-12 1 site
    Other conditions: Ischemia
    View official trial listing →
  • Completed NCT NCT01074762

    Randomised Controlled Trial of Structured Personal Care of Type 2 Diabetes Mellitus

    Not yet reported Research Unit Of General Practice, Copenhagen 1470 participants Est. completion 1996-02 1 site
    Other conditions: Diabetes Mellitus, Quality of Health Care, Health Services Research
    View official trial listing →
  • Completed NCT NCT01075698

    A Trial of Telmisartan Prevention of Cardiovascular Disease

    Not yet reported Kumamoto University 1228 participants Est. completion 2016-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01075997

    The Impact of a Video Cell Phone Reminder System on Glycemic Control in Patients With Diabetes Mellitus

    Not yet reported Walter Reed Army Medical Center 170 participants Est. completion 2010-10 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01076270

    Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Fred Hutchinson Cancer Center 1 participants Est. completion 2011-02 1 site
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, BCR-ABL Negative, Blastic Phase Chronic Myelogenous Leukemia, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT01077401

    Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

    Not yet reported Johns Hopkins University 152 participants Est. completion 2013-03 13 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01077648

    Brain Metastasis in Breast Cancer Patients

    GlaxoSmithKline 1 participants Est. completion 2013-08
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01079494

    Clinical Pharmacists Role in the Management of Hypertension in Jordan

    Not yet reported University of Jordan 266 participants Est. completion 2009-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT01081262

    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

    Not yet reported National Cancer Institute (NCI) 50 participants Est. completion 2027-03-12 248 sites
    Other conditions: Borderline Ovarian Mucinous Tumor, Ovarian Mucinous Cystadenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Stage IA Fallopian Tube Cancer AJCC v6 and v7, Stage IA Ovarian Cancer AJCC v6 and v7, Stage IB Fallopian Tube Cancer AJCC v6 and v7, Stage IB Ovarian Cancer AJCC v6 and v7, Stage IC Fallopian Tube Cancer AJCC v6 and v7, Stage IC Ovarian Cancer AJCC v6 and v7, Stage IIA Fallopian Tube Cancer AJCC v6 and v7, Stage IIA Ovarian Cancer AJCC V6 and v7, Stage IIB Fallopian Tube Cancer AJCC v6 and v7, Stage IIB Ovarian Cancer AJCC v6 and v7, Stage IIC Fallopian Tube Cancer AJCC v6 and v7, Stage IIC Ovarian Cancer AJCC v6 and v7, Stage IIIA Fallopian Tube Cancer AJCC v7, Stage IIIA Ovarian Cancer AJCC v6 and v7, Stage IIIB Fallopian Tube Cancer AJCC v7, Stage IIIB Ovarian Cancer AJCC v6 and v7, Stage IIIC Fallopian Tube Cancer AJCC v7, Stage IIIC Ovarian Cancer AJCC v6 and v7, Stage IV Fallopian Tube Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01081730

    Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

    Janssen Biotech, Inc. 2040 participants Est. completion 2017-09-29
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01082939

    Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

    Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2011-01 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01084863

    Evaluate Safety, Efficacy and Pharmacokinetics

    Not yet reported, Not yet reported Celltrion 143 participants Est. completion 2023-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01085526

    Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

    Not yet reported Aarhus University Hospital 30 participants Est. completion 2014-09
    Other conditions: Allergic Rhinoconjunctivitis
    View official trial listing →
  • Completed NCT NCT01085617

    Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

    University College, London Est. completion 2025-02-24
    Other conditions: Leukemia, Mucositis, Oral Complications
    View official trial listing →
  • Terminated NCT NCT01086345

    Radiosurgery Plus Bevacizumab in Glioblastoma

    Not yet reported Case Comprehensive Cancer Center 9 participants Est. completion 2014-12 1 site
    Obstructive sleep apnea Other conditions: Glioblastoma, Brain Tumor
    View official trial listing →
  • Status unknown NCT NCT01087398

    Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis

    Not yet reported, Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2012-12 1 site
    Other conditions: Osteopetrosis
    View official trial listing →
  • Completed NCT NCT01087515

    Pilot Study for Cell Based Therapies in Patients With Asthma

    Not yet reported Fraunhofer-Institute of Toxicology and Experimental Medicine 20 participants Est. completion 2011-11
    Other conditions: Asthma, Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT01087762

    Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis

    Not yet reported UCB BIOSCIENCES GmbH 325 participants Est. completion 2015-08 104 sites
    Other conditions: Spondyloarthropathies
    View official trial listing →
  • Completed NCT NCT01088100

    Study of the Correlation Between Specific Genes and Cognitive Dysfunction After Surgery

    Herlev Hospital 279 participants Est. completion 2011-01 1 site
    Other conditions: Genotype, Cognitive Impairment
    View official trial listing →
  • Suspended NCT NCT01088620

    Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer

    Not yet reported WiSP Wissenschaftlicher Service Pharma GmbH 134 participants Est. completion 2014-01 20 sites
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Withdrawn NCT NCT01089738

    A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals

    Not yet reported Pfizer Est. completion 2011-04-25
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01090063

    Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis

    Not yet reported Tufts Medical Center 26 participants Est. completion 2012-04 1 site
    Other conditions: Moderate to Severe Palmar Plantar Psoriasis
    View official trial listing →
  • Completed NCT NCT01090232

    Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection

    Not yet reported Assistance Publique Hopitaux De Marseille 17 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection
    View official trial listing →
  • Completed NCT NCT01090297

    Continuous Positive Airway Pressure (CPAP) Mode Impact on Clinical Blood Arterial Pressure

    Not yet reported AGIR à Dom 322 participants Est. completion 2012-11 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT01091714

    Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent?

    Not yet reported Bucci Laser Vision Institute 60 participants Est. completion 2011-07 1 site
    Other conditions: Cardioprotective Levels
    View official trial listing →
  • Completed NCT NCT01091792

    Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)

    Not yet reported Dartmouth-Hitchcock Medical Center 13 participants Est. completion 2015-04-02 1 site
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Status unknown NCT NCT01091896

    Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage

    Not yet reported University of Sao Paulo 1 participants Est. completion 2011-03 1 site
    Other conditions: Vitreous Hemorrhage Secondary to PDR
    View official trial listing →
  • Status unknown NCT NCT01093235

    Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 800 participants 1 site
    Other conditions: Breast Cancer, Cardiac Toxicity, Perioperative/Postoperative Complications
    View official trial listing →
  • Completed NCT NCT01094184

    A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer

    Not yet reported Hoffmann-La Roche 49 participants Est. completion 2015-12 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01096381

    Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

    Vanderbilt-Ingram Cancer Center 8 participants Est. completion 2011-08 2 sites
    Other conditions: Breast Cancer, Cardiovascular Complications, Colorectal Cancer, Fallopian Tube Cancer, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Peritoneal Cavity Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01096706

    Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3)

    Not yet reported University of Edinburgh 10 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Vascular Disease, Heart Disease
    View official trial listing →
  • Completed NCT NCT01096784

    IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity

    Not yet reported Shire 121 participants Est. completion 2016-03-30 24 sites
    Other conditions: Retinopathy of Prematurity (ROP)
    View official trial listing →
  • Completed NCT NCT01097746

    First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2022-09-13 5 sites
    Other conditions: Fallopian Tube Carcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, FIGO Stage III Ovarian Cancer, FIGO Stage IIIA Ovarian Cancer, FIGO Stage IIIA1 Ovarian Cancer, FIGO Stage IIIA1(i) Ovarian Cancer, FIGO Stage IIIA1(ii) Ovarian Cancer, FIGO Stage IIIA2 Ovarian Cancer, FIGO Stage IIIB Ovarian Cancer, FIGO Stage IIIC Ovarian Cancer, FIGO Stage IVA Ovarian Cancer, FIGO Stage IVB Ovarian Cancer, Malignant Ovarian Brenner Tumor, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Adenocarcinoma, Ovarian Transitional Cell Carcinoma, Ovarian Undifferentiated Carcinoma, Primary Peritoneal Carcinoma, Primary Peritoneal Serous Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01099397

    Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study

    University of Florida 26 participants Est. completion 2010-12 1 site
    Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT01100502

    A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

    Not yet reported Seagen Inc. 329 participants Est. completion 2020-04-27 87 sites
    Other conditions: Disease, Hodgkin
    View official trial listing →
  • Completed NCT NCT01100892

    Cystic Fibrosis - Insulin Deficiency, Early Action

    Not yet reported Sydney Children's Hospitals Network 100 participants Est. completion 2023-02 6 sites
    Other conditions: Cystic Fibrosis, Diabetes
    View official trial listing →
  • Status unknown NCT NCT01101503

    The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes

    Not yet reported Xiang Guang-da 1000 participants Est. completion 2020-12 1 site
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT01103440

    Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

    Not yet reported Icahn School of Medicine at Mount Sinai 36 participants Est. completion 2009-06 1 site
    Other conditions: Stable Angina
    View official trial listing →
  • Completed NCT NCT01105273

    Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia

    Not yet reported, Not yet reported Asan Medical Center 12 participants Est. completion 2012-07 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01105403

    Exploratory Study on POL6326 in Stem Cell Mobilization

    Not yet reported Polyphor Ltd. 21 participants Est. completion 2014-04 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT01105702

    Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

    Not yet reported NYU Langone Health 28 participants Est. completion 2015-04 2 sites
    Other conditions: Brain Cancer
    View official trial listing →
  • Completed NCT NCT01106482

    An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

    Not yet reported Novartis Vaccines 126 participants Est. completion 2011-05 10 sites
    Other conditions: Tick Borne Encephalitis (TBE)
    View official trial listing →
  • Completed NCT NCT01106898

    Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery

    Not yet reported University of Nebraska 112 participants Est. completion 2015-09-28 2 sites
    Other conditions: Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer
    View official trial listing →
  • Completed NCT NCT01107535

    Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

    Abbott 82 participants Est. completion 2011-02 4 sites
    Other conditions: Respiratory Syncytial Virus Infection
    View official trial listing →
  • Completed NCT NCT01108159

    Integrated Whole-Genome Analysis of Hematologic Disorders

    Stanford University 35 participants Est. completion 2013-08-02 1 site
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT01109602

    Strength, Flexibility, And Balance Therapy After Stroke

    Not yet reported, Not yet reported VA Office of Research and Development 47 participants Est. completion 2011-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01110239

    Preconditioning for Aneurismal Subarachnoid Hemorrhage

    Not yet reported University of Miami 34 participants Est. completion 2010-07
    Other conditions: Subarachnoid Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT01110655

    The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia

    Not yet reported Western States Endurance Run Research Foundation 100 participants Est. completion 2010-06 1 site
    Other conditions: Exercise-associated Hyponatremia
    View official trial listing →
  • Completed NCT NCT01111604

    A Study of Ramucirumab or Icrucumab in Colorectal Cancer

    Not yet reported Eli Lilly and Company 158 participants Est. completion 2013-12 17 sites
    Other conditions: Colon Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01114386

    Clinical Assessment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and/or Chronic Heart Failure (CHF)

    University of Modena and Reggio Emilia 100 participants Est. completion 2011-12 1 site
    Heart failure Other conditions: COPD
    View official trial listing →
  • Suspended NCT NCT01114750

    A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)

    Not yet reported Bows Pharmaceuticals AG 8 participants Est. completion 2010-10 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01115140

    Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women

    Not yet reported University Magna Graecia 50 participants Est. completion 2011-05 1 site
    Other conditions: Pregnancy, Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT01116232

    Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

    Not yet reported Barbara Ann Karmanos Cancer Institute 4 participants Est. completion 2013-06 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT01116596

    Paracetamol and Glutathion

    Not yet reported University Hospital, Clermont-Ferrand 18 participants Est. completion 2008-05 1 site
    Other conditions: Chronic Pain, Elderly
    View official trial listing →
  • Completed NCT NCT01117506

    Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)

    CardioDx 581 participants Est. completion 2012-05 7 sites
    Cardiovascular disease Other conditions: Chest Pain, Coronary Heart Disease, Angina Pectoris, CAD, CVD, CHD
    View official trial listing →
  • Completed NCT NCT01118520

    AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)

    Not yet reported Imperial College London 224 participants Est. completion 2015-04 9 sites
    Other conditions: Abdominal Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT01119859

    A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

    Not yet reported Hoffmann-La Roche 326 participants Est. completion 2012-01 82 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01119911

    Blood Sampling Through Peripheral Venous Catheter in Infants

    Meir Medical Center 50 participants Est. completion 2012-06 1 site
    Other conditions: Pain
    View official trial listing →
  • Terminated NCT NCT01120158

    Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

    Not yet reported Hellenic Oncology Research Group 46 participants Est. completion 2017-01 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01120613

    Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study

    Not yet reported Northwell Health 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01121120

    Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients

    Not yet reported Tarix Pharmaceuticals 75 participants Est. completion 2020-12 10 sites
    Other conditions: Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma
    View official trial listing →
  • Withdrawn NCT NCT01123122

    A Comparison of Strict Glucose Control With Usual Care at the Time of Islet Cell Transplantation

    Not yet reported Vancouver Coastal Health Est. completion 2015-09 1 site
    Other conditions: Diabetes Mellitus, Type 1, Islet Transplantation
    View official trial listing →
  • Status unknown NCT NCT01123564

    Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

    Not yet reported University of Pecs 40 participants Est. completion 2011-09 2 sites
    Other conditions: Retinal Vein Occlusion, Macular Edema
    View official trial listing →
  • Completed NCT NCT01123759

    Healthful Seafood Consumption for Sensitive Populations

    Not yet reported Purdue University 71 participants Est. completion 2009-12 2 sites
    Other conditions: Infant Brain Health
    View official trial listing →
  • Completed NCT NCT01123837

    A Closer Look at the Effect of Dextrose on Postoperative Nausea and Vomiting

    Not yet reported Loma Linda University 202 participants Est. completion 2013-09 1 site
    Other conditions: Postoperative Nausea and Vomiting
    View official trial listing →
  • Status unknown NCT NCT01124136

    Neurostimulation of Spinal Nerves That Affect the Heart

    Not yet reported Jerry Estep, MD 40 participants Est. completion 2018-11 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01124526

    Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma

    Not yet reported Asociacion Espanola de Hematologia y Hemoterapia 75 participants Est. completion 2008-07 20 sites
    Other conditions: Non Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01124669

    Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate

    ECOG-ACRIN Cancer Research Group 80 participants Est. completion 2010-07-13
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT01124838

    Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis

    Not yet reported AbbVie (prior sponsor, Abbott) 261 participants Est. completion 2015-05
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT01125176

    Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL

    Not yet reported Weill Medical College of Cornell University 15 participants Est. completion 2020-12-29 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT01125293

    Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 46 participants Est. completion 2014-08 1 site
    Other conditions: Waldenstrom's Macroglobulinemia
    View official trial listing →
  • Status unknown NCT NCT01125644

    Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis

    Not yet reported Proaparts srl 10 participants Est. completion 2011-12 1 site
    Other conditions: Cryptococcosis or Aspergillosis Infections
    View official trial listing →
  • Completed NCT NCT01125813

    Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

    Not yet reported Octapharma 32 participants Est. completion 2012-01 11 sites
    Other conditions: Severe Hemophilia A
    View official trial listing →
  • Terminated NCT NCT01126866

    Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

    Not yet reported National Center for Tumor Diseases, Heidelberg 35 participants Est. completion 2011-06 1 site
    Other conditions: Colorectal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01127841

    Trial of Rituximab, Bendamustine (RB) for Patients With Follicular Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line

    Not yet reported Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas 60 participants Est. completion 2015-12 18 sites
    Other conditions: Follicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.
    View official trial listing →
  • Completed NCT NCT01128270

    Pharmacotoxicology of Trichloroethylene Metabolites

    Not yet reported, Not yet reported University of Florida 27 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01131169

    Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

    Not yet reported Memorial Sloan Kettering Cancer Center 66 participants Est. completion 2020-05-15 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01131195

    Metronomic Therapy in Metastatic Breast Cancer.

    Not yet reported Swiss Cancer Institute 139 participants Est. completion 2018-02-28 23 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01131247

    PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab

    Not yet reported Nevada Cancer Institute 37 participants 1 site
    Other conditions: Chronic Lymphocytic Leukemia (CLL)
    View official trial listing →
  • Status unknown NCT NCT01131741

    Comparison of Perfusion Index, T Wave Amplitude, Systolic Blood Pressure and Heart Rate

    Not yet reported Seoul National University Hospital 50 participants Est. completion 2011-04 1 site
    Other conditions: Injections, Intravenous
    View official trial listing →
  • Withdrawn NCT NCT01133223

    Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

    Not yet reported Hospital de Clinicas de Porto Alegre Est. completion 2015-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01133990

    FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Eisai Inc. 5 participants Est. completion 2011-02-18 34 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01134510

    Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

    Not yet reported, Not yet reported Stanley Jordan, MD 20 participants Est. completion 2013-11 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01135498

    A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.

    Not yet reported Hoffmann-La Roche 90 participants Est. completion 2010-04 12 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01135537

    Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

    Not yet reported The Hospital for Sick Children 30 participants Est. completion 2014-01 1 site
    Other conditions: Malignancy, Metabolic Disease, Genetic Disorder
    View official trial listing →
  • Completed NCT NCT01135771

    Performance Study Using the OptiScanner on Healthy Diabetics

    Not yet reported Profil Institut für Stoffwechselforschung GmbH 60 participants Est. completion 2010-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01136395

    Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

    Not yet reported University of Giessen 85 participants Est. completion 2019-06-18 1 site
    Other conditions: Kidney Transplantation, Rituximab (RTx), Living Donors, Immunology, Virus
    View official trial listing →
  • Completed NCT NCT01139463

    Study of Blood Lactate Levels in Patients Treated With Antipsychotics

    University of Split 60 participants Est. completion 2009-10 1 site
    Other conditions: Movement Disorders, Lactic Acidosis
    View official trial listing →
  • Completed NCT NCT01139567

    Tissue Perfusion and Blood Flow Monitoring Technology

    CW Optics, Inc. 56 participants Est. completion 2013-04 1 site
    Other conditions: Wounds and Injuries
    View official trial listing →
  • Terminated NCT NCT01141218

    Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked Cigarettes

    Vanderbilt-Ingram Cancer Center 88 participants Est. completion 2012-09 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Withdrawn NCT NCT01142414

    Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01142726

    Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

    Not yet reported Bristol-Myers Squibb 511 participants Est. completion 2014-10 73 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01142869

    An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

    Merck KGaA, Darmstadt, Germany 133 participants Est. completion 2014-08-05 28 sites
    Other conditions: Carcinoma, Squamous Cell
    View official trial listing →
  • Completed NCT NCT01143831

    Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplementation

    Not yet reported Stephan Moll, MD 8 participants Est. completion 2012-03 1 site
    Other conditions: Thrombosis
    View official trial listing →
  • Status unknown NCT NCT01144156

    Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy

    Not yet reported Rabin Medical Center 30 participants 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Status unknown NCT NCT01144988

    Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma

    Not yet reported Medical University Innsbruck 35 participants Est. completion 2013-03 2 sites
    Other conditions: Recurrent Malignant Glioma
    View official trial listing →
  • Completed NCT NCT01145352

    Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]

    Pfizer 113 participants Est. completion 2013-10 1 site
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT01145495

    Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2022-01-15 91 sites
    Other conditions: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, Ann Arbor Stage IV Grade 1 Follicular Lymphoma, Ann Arbor Stage IV Grade 2 Follicular Lymphoma, Ann Arbor Stage IV Grade 3 Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT01146470

    The Influence of Red Grape Cells on Blood Pressure Vascular Function in People With Hypertension

    Not yet reported Tel-Aviv Sourasky Medical Center 50 participants Est. completion 2012-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01147341

    Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

    Not yet reported Michael Schiff, MD 37 participants Est. completion 2012-01 12 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01149083

    Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) 77 participants Est. completion 2024-09-30 23 sites
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Unresectable Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT01149395

    Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn

    Not yet reported University of North Carolina, Chapel Hill 40 participants Est. completion 2012-04 1 site
    Other conditions: Heartburn, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01149850

    Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

    Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2023-12-08 3 sites
    Obstructive sleep apnea Other conditions: Giant Cell Glioblastoma, Glioblastoma
    View official trial listing →
  • Withdrawn NCT NCT01150266

    Study for the Use of Alteplase in Patients Who Awaken With Stroke

    Not yet reported University of California, San Diego 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01150305

    Epidemiology of Non-syndromic Dominant Deafness

    Assistance Publique - Hôpitaux de Paris 183 participants Est. completion 2012-04 1 site
    Other conditions: Hearing Impairment
    View official trial listing →
  • Terminated NCT NCT01150617

    Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty

    Not yet reported IRCCS San Raffaele 46 participants Est. completion 2011-05 1 site
    Type 2 diabetes Other conditions: Peripheral Vascular Disease
    View official trial listing →
  • Completed NCT NCT01152190

    A Study in Benign Prostatic Hyperplasia

    Not yet reported Eli Lilly and Company 97 participants Est. completion 2012-07 5 sites
    Other conditions: Benign Prostatic Hyperplasia
    View official trial listing →
  • Withdrawn NCT NCT01152658

    Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF)

    Not yet reported Meir Medical Center Est. completion 2012-06 1 site Stand-alone
    Other conditions: Partial Supraspinatus Tear
    View official trial listing →
  • Status unknown NCT NCT01154387

    Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

    Not yet reported, Not yet reported Tolera Therapeutics, Inc 85 participants Est. completion 2013-06 12 sites
    Other conditions: End Stage Renal Disease, Renal Transplant
    View official trial listing →
  • Completed NCT NCT01155700

    Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

    Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2012-02 17 sites
    Other conditions: Allergic Asthma
    View official trial listing →
  • Completed NCT NCT01156597

    Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes

    Not yet reported University of Miami 30 participants Est. completion 2010-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01157052

    Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

    Not yet reported AHS Cancer Control Alberta 15 participants Est. completion 2015-09 1 site
    Other conditions: Neoplasms, Colorectal, Colorectal Cancer, Colorectal Carcinoma
    View official trial listing →
  • Completed NCT NCT01157520

    Study to Detect Hypotensive Episodes During Spinal Anesthesia for Cesarean Section Using a Noninvasive Continuous Device

    University Hospital Schleswig-Holstein Est. completion 2010-06
    Other conditions: Hypotension
    View official trial listing →
  • Completed NCT NCT01158261

    The Evicel Post-Authorization Surveillance Study

    Ethicon, Inc. 300 participants Est. completion 2014-05 2 sites
    Other conditions: Peripheral Vascular Disease, Hemorrhage
    View official trial listing →
  • Completed NCT NCT01158508

    Remote Ischemic Preconditioning in Subarachnoid Hemorrhage

    Not yet reported University of California, Los Angeles 20 participants Est. completion 2014-07 1 site
    Other conditions: Subarachnoid Hemorrhage, Aneurysmal, Subarachnoid Hemorrhage, Cerebral Vasospasm, Intracranial Aneurysm
    View official trial listing →
  • Completed NCT NCT01158716

    Remote Ischemic Preconditioning in ad Hoc Percutaneous Coronary Interventions

    Not yet reported Cardiovascular Research Society, Greece 94 participants Est. completion 2012-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01158729

    Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates

    Not yet reported Medical College of Wisconsin 8 participants Est. completion 2013-12 1 site
    Other conditions: Postoperative Hemorrhage
    View official trial listing →
  • Completed NCT NCT01160744

    A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

    Not yet reported Eli Lilly and Company 280 participants Est. completion 2018-04 53 sites
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT01162499

    Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia

    Not yet reported Diva De Leon 7 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Postprandial Hypoglycemia
    View official trial listing →
  • Status unknown NCT NCT01162824

    Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries

    Not yet reported St George's Healthcare NHS Trust 50 participants Est. completion 2011-12 1 site
    Other conditions: Endothelial Dysfunction, Atherosclerosis, Inflammation, Myocardial Ischemia
    View official trial listing →
  • Withdrawn NCT NCT01163201

    T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota Est. completion 2015-01 1 site
    Other conditions: Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia in Blast Crisis, Anemia, Refractory, With Excess of Blasts, Chronic Myeloproliferative Disease, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Lymphoma, Large Cell Non-Hodgkin's Lymphoma, Lymphoblastic Lymphoma, Burkitt's Lymphoma, High Grade Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01163396

    First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

    Not yet reported Gruppo Oncologico del Nord-Ovest 57 participants Est. completion 2010-04
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT01164007

    A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

    Not yet reported Hoffmann-La Roche 40 participants Est. completion 2012-05-31 1 site
    Other conditions: Malignant Melanoma
    View official trial listing →
  • Withdrawn NCT NCT01166529

    Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic Malignancies

    Not yet reported Northwestern University Est. completion 2013-07 1 site
    Other conditions: Pain, Cancer
    View official trial listing →
  • Completed NCT NCT01168089

    Near Infrared Spectroscopy for Blood Glucose Measurement in Critical Care Settings

    InLight Solutions 50 participants Est. completion 2008-04 1 site
    Other conditions: Critical Care
    View official trial listing →
  • Completed NCT NCT01169558

    A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.

    Not yet reported Hoffmann-La Roche 168 participants Est. completion 2009-07 28 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01169974

    Use of Laser Speckle to Study Post Occlusive Reactive Hyperhemia in Healthy Subjects

    University Hospital, Angers 41 participants Est. completion 2012-12-04 1 site
    Other conditions: Microcirculation
    View official trial listing →
  • Completed NCT NCT01170312

    Arthroscopic Surgery and Platelet Rich Plasma In Rotator Cuff Tear Evaluation

    Not yet reported McMaster University 25 participants Est. completion 2012-08 3 sites
    Other conditions: Rotator Cuff Tear
    View official trial listing →
  • Completed NCT NCT01170663

    A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma

    Not yet reported Eli Lilly and Company 665 participants Est. completion 2017-02 167 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01171131

    A Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury

    The University of Texas Health Science Center, Houston 96 participants Est. completion 2016-03-03 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT01171209

    REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients

    Not yet reported Melinda Magyari 10 participants Est. completion 2011-08
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01171248

    Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 Diabetes

    Steno Diabetes Center Copenhagen 650 participants Est. completion 2011-08 1 site
    Other conditions: Type 1 Diabetes, Hypertension
    View official trial listing →
  • Completed NCT NCT01172015

    NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults

    Not yet reported Assistance Publique Hopitaux De Marseille 80 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Immunologic Thrombcytopenic Purpura (ITP) Adults
    View official trial listing →
  • Completed NCT NCT01172418

    Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols

    Not yet reported University of Miami 200 participants Est. completion 2010-05 1 site
    Other conditions: Transplant; Failure, Kidney
    View official trial listing →
  • Withdrawn NCT NCT01172717

    Study of Panitumumab in the Treatment of Carcinoid Syndrome

    Not yet reported Boston Medical Center Est. completion 2013-07 2 sites
    Other conditions: Carcinoid Syndrome
    View official trial listing →
  • Completed NCT NCT01174277

    Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.

    University of Kansas Medical Center 23 participants Est. completion 2016-02 2 sites
    Other conditions: Blood Stem Cell Transplant Failure, Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT01175356

    Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

    Not yet reported Children's Oncology Group 99 participants Est. completion 2025-12-31 25 sites
    Other conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01175408

    Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin

    Not yet reported Endocrine Research Society 100 participants Est. completion 2012-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01175733

    Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Amsterdam UMC, location VUmc 18 participants Est. completion 2016-05 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01175824

    Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

    Not yet reported Eli Lilly and Company 478 participants Est. completion 2012-11 18 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01176149

    Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin

    Not yet reported Consorzio Mario Negri Sud 62 participants Est. completion 2010-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT01176422

    Telomere and Telomerase

    University of Kansas Medical Center Est. completion 2011-02 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01176461

    Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 127 participants Est. completion 2016-12-12 1 site
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT01176474

    Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 73 participants Est. completion 2023-01-06 1 site
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Terminated NCT NCT01176565

    Antihypertensive Treatment of Acute Cerebral Hemorrhage-II

    Not yet reported University of Minnesota 1000 participants Est. completion 2016-03-08 171 sites
    Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT01176708

    Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion

    Not yet reported University Hospital, Gentofte, Copenhagen 30 participants Est. completion 2012-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01176968

    Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1012 participants Est. completion 2012-10 75 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01177956

    A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck

    Not yet reported Merck KGaA, Darmstadt, Germany 73 participants Est. completion 2012-11 14 sites
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT01178086

    A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

    Hoffmann-La Roche 681 participants Est. completion 2015-06-30 1 site
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Completed NCT NCT01178281

    Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence

    Not yet reported Celgene 267 participants Est. completion 2018-05-15 87 sites
    Other conditions: Primary Myelofibrosis, MPN-associated Myelofibrosis
    View official trial listing →
  • Completed NCT NCT01180127

    Mars Flavanol Exercise and Cognitive Function Study

    Not yet reported New York State Psychiatric Institute 41 participants Est. completion 2013-10
    Other conditions: Cognitive Function
    View official trial listing →
  • Completed NCT NCT01181154

    Rituximab in Auto-Immune Hemolytic Anemia

    Not yet reported Assistance Publique - Hôpitaux de Paris 32 participants Est. completion 2016-01-08 1 site
    Other conditions: Warm Autoimmune Hemolytic Anemia
    View official trial listing →
  • Completed NCT NCT01181401

    InductionChemo-Radio-Antibody-Treatment

    Not yet reported Charite University, Berlin, Germany 94 participants Est. completion 2015-08 5 sites
    Other conditions: Squamous Cell Carcinoma of the Head, Squamous Cell Carcinoma of the Neck
    View official trial listing →
  • Completed NCT NCT01181609

    A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum

    Not yet reported Hoffmann-La Roche 54 participants Est. completion 2010-05 16 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01181947

    VALIANT CAPTIVIA Post-market Registry

    Medtronic Cardiovascular 100 participants Est. completion 2013-08 15 sites
    Other conditions: Aortic Aneurysm, Thoracic
    View official trial listing →
  • Terminated NCT NCT01183637

    Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions Pilot Trial

    Not yet reported Kensey Nash Corporation 2 participants Est. completion 2014-05 2 sites
    Other conditions: Articular Cartilage Injury
    View official trial listing →
  • Completed NCT NCT01184092

    A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)

    Not yet reported Pfizer 24 participants Est. completion 2010-09 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01184339

    Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

    MicroPhage, Inc. 1165 participants Est. completion 2010-08
    Other conditions: Bacteremia
    View official trial listing →
  • Completed NCT NCT01185600

    Microparticles in Stored RBC as Potential Mediators of Transfusion Complications

    Not yet reported University of Miami 177 participants Est. completion 2015-05 1 site
    Other conditions: Coronary Artery Bypass
    View official trial listing →
  • Status unknown NCT NCT01185886

    Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

    European Organisation for Research and Treatment of Cancer - EORTC 1200 participants Est. completion 2021-06 21 sites
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01187953

    Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx

    Not yet reported Veloxis Pharmaceuticals 543 participants Est. completion 2014-03 86 sites
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT01188655

    Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

    Pfizer 89 participants Est. completion 2010-03
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT01189188

    Ultrasound Guidance for Radial Arterial Blood Sampling

    Not yet reported Centre Hospitalier Universitaire de Nīmes 74 participants Est. completion 2010-09-25 1 site
    Other conditions: Radial Artery, Ultrasonography
    View official trial listing →
  • Completed NCT NCT01189331

    CT Coronary Angiography and Computational Fluid Dynamics

    Not yet reported Seoul National University Hospital 103 participants Est. completion 2020-12-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01190683

    Vitamin D and Muscle Strength and Surface (Electromyography) EMG

    Not yet reported Indian Council of Medical Research 170 participants Est. completion 2011-04
    Other conditions: Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT01192061

    Autonomic Nervous System Activity and Normal Tension Glaucoma

    Military Institute od Medicine National Research Institute 97 participants Est. completion 2011-01 1 site
    Other conditions: Normal Tension Glaucoma
    View official trial listing →
  • Terminated NCT NCT01192685

    Transcranial Magnetic Stimulation in Major Depression With EEG and Near Infrared Spectroscopy (NIRS) Monitoring

    Not yet reported Boston University 2 participants Est. completion 2013-12 1 site
    Other conditions: Depression
    View official trial listing →
  • Terminated NCT NCT01192763

    RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

    Not yet reported National Cancer Institute (NCI) 30 participants 6 sites Stand-alone
    Other conditions: Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01194024

    Scoring System for Inhalation Injury

    American Burn Association 108 participants Est. completion 2019-09-29 9 sites
    Other conditions: Inhalation Injury
    View official trial listing →
  • Completed NCT NCT01196390

    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

    Not yet reported National Cancer Institute (NCI) 203 participants Est. completion 2023-08-15 634 sites
    Other conditions: Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Esophageal Cancer AJCC v7, Stage IIA Esophageal Cancer AJCC v7, Stage IIB Esophageal Cancer AJCC v7, Stage IIIA Esophageal Cancer AJCC v7, Stage IIIB Esophageal Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT01196715

    Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes

    Not yet reported Barts & The London NHS Trust 360 participants Est. completion 2015-10-31 4 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01198262

    Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections

    Michael E. DeBakey VA Medical Center 260 participants Est. completion 2010-08 1 site
    Other conditions: Staphylococcus Aureus, Staphylococcal Skin Infections, Bacteremia
    View official trial listing →
  • Terminated NCT NCT01198548

    High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer

    Not yet reported Roswell Park Cancer Institute 10 participants Est. completion 2012-06 1 site
    Other conditions: Stage IV Colon Cancer, Stage IV Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01199627

    Tranexamic Acid Versus Placebo for the Reduction of Blood Loss in Total Hip Replacement Surgery

    Not yet reported Basque Health Service 114 participants Est. completion 2013-02 1 site
    Other conditions: Hip Replacement, Total
    View official trial listing →
  • Completed NCT NCT01200433

    The Effects of Dexmedetomidine and Propofol on Cerebral Blood Flow and Brain Oxygenation During Deep Brain Stimulation

    Not yet reported The Cleveland Clinic 44 participants Est. completion 2013-08 1 site
    Other conditions: Intracranial Neurosurgery
    View official trial listing →
  • Completed NCT NCT01201265

    A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 40 participants Est. completion 2015-04 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01201460

    DPBRN Blood Sugar Testing in Dental Patients

    Dental Practice-Based Research Network 498 participants Est. completion 2010-07 7 sites
    Other conditions: Diabetes Mellitus, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01202903

    Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

    Not yet reported Novartis Pharmaceuticals 616 participants Est. completion 2013-10 39 sites
    Other conditions: Persistent Allergic Asthma
    View official trial listing →
  • Completed NCT NCT01203514

    The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

    Not yet reported, Not yet reported NICHD Neonatal Research Network 318 participants Est. completion 2000-08 9 sites
    Other conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Anemia, Neonatal
    View official trial listing →
  • Completed NCT NCT01203800

    Evaluation of Blood Brain Barrier Permeability in Chronic Stroke

    Wolfson Medical Center 30 participants Est. completion 2011-11 1 site
    Other conditions: A Positive or a Negative Brain SPECT
    View official trial listing →
  • Completed NCT NCT01205022

    Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-01 1 site
    Other conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT01206439

    An Advanced Echocardiographic Evaluation of Nebivolol

    Not yet reported Jack Rubinstein 2 participants Est. completion 2012-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01207037

    Prognostic Factors of Acute Splenic Sequestration

    Not yet reported Assistance Publique - Hôpitaux de Paris 58 participants Est. completion 2017-11-07 1 site
    Other conditions: Anemia; Drepanocytic
    View official trial listing →
  • Completed NCT NCT01207687

    Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

    Not yet reported National Cancer Institute (NCI) 14 participants Est. completion 2014-03 3 sites
    Other conditions: Vestibular Schwannoma, Neurofibromatosis Type 2
    View official trial listing →
  • Terminated NCT NCT01208402

    Esmolol for Treatment of Perioperative Tachycardia

    Not yet reported Duke University 76 participants Est. completion 2013-07 3 sites
    Other conditions: High-risk, Non-cardiovascular Surgeries
    View official trial listing →
  • Withdrawn NCT NCT01209013

    Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE)

    Not yet reported Pinnacle Biologics Inc. Stand-alone
    Other conditions: Barrett Esophagus
    View official trial listing →
  • Completed NCT NCT01210430

    Local Vasoconstriction in Postural Tachycardia Syndrome

    Not yet reported New York Medical College 74 participants Est. completion 2015-06 1 site
    Other conditions: Postural Tachycardia Syndrome
    View official trial listing →
  • Terminated NCT NCT01211314

    Antihypertensive Efficacy of Fixed Combination Drug

    Not yet reported Meir Medical Center 10 participants Est. completion 2012-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01211925

    Distal Venous Arterialisation of Ischemic Limb

    Not yet reported, Not yet reported Clinical Centre of Serbia 30 participants Est. completion 2011-07 1 site
    Other conditions: Critical Limb Ischemia
    View official trial listing →
  • Completed NCT NCT01212510

    Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer

    Not yet reported University Hospital, Rouen 200 participants Est. completion 2016-07 4 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01213017

    The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients

    Not yet reported Oklahoma Medical Research Foundation 20 participants Est. completion 2012-04 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01213043

    Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency

    Not yet reported Grifols Therapeutics LLC 30 participants Est. completion 2012-01 5 sites
    Other conditions: Emphysema, Alpha 1-antitrypsin Deficiency (AATD)
    View official trial listing →
  • Status unknown NCT NCT01213667

    Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD

    Not yet reported University of Cologne 110 participants Est. completion 2017-12 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01214317

    Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis

    Not yet reported Isfahan University of Medical Sciences 40 participants Est. completion 2012-02 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT01216631

    Seronegative Oligoarthritis of the Knee Study (SOKS)

    Not yet reported University of Leeds 1 participants Est. completion 2011-08 1 site
    Other conditions: Spondylarthropathies
    View official trial listing →
  • Completed NCT NCT01217671

    International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema

    Not yet reported, Not yet reported Kamada, Ltd. 168 participants Est. completion 2015-06 12 sites
    Other conditions: Emphysema
    View official trial listing →
  • Status unknown NCT NCT01218061

    Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)

    Not yet reported Nantes University Hospital 366 participants Est. completion 2023-06 1 site
    Prediabetes
    View official trial listing →
  • Completed NCT NCT01219972

    Pulmonary Complications of Allografts

    Assistance Publique - Hôpitaux de Paris 245 participants Est. completion 2016-12 1 site
    Other conditions: Pulmonary Complications
    View official trial listing →
  • Completed NCT NCT01220856

    Reparixin in Pancreatic Islet Transplantation

    Not yet reported Dompé Farmaceutici S.p.A 9 participants Est. completion 2013-04-30 2 sites
    Other conditions: Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01221129

    Zinc and the Synthesis of Zinc Binding Proteins (Protocol B)

    University of Florida 10 participants Est. completion 2010-03 1 site
    Other conditions: Zinc Deficiency
    View official trial listing →
  • Completed NCT NCT01224093

    An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)

    Hoffmann-La Roche 219 participants Est. completion 2014-02 55 sites
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Completed NCT NCT01226173

    Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol

    Bio-Rad Laboratories 182353 participants Est. completion 2012-08 2 sites
    Other conditions: Mass Screening
    View official trial listing →
  • Completed NCT NCT01226719

    FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

    Not yet reported SCRI Development Innovations, LLC 15 participants Est. completion 2014-03 15 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01230216

    Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound

    Not yet reported Takeshi Morimoto 8 participants Est. completion 2015-04 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01230229

    Primary Stenting vs Conservative Treatment in Claudicants - a Study on Quality of Life

    Not yet reported Lund University 100 participants Est. completion 2017-08 2 sites
    Alcohol use disorder Other conditions: Superficial Femoral Artery Disease, Best Medical Treatment, Quality of Life Scores at 12 and 24 Months
    View official trial listing →
  • Terminated NCT NCT01230502

    Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT01231412

    Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 174 participants Est. completion 2017-06-30 11 sites
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Plasma Cell Myeloma, Refractory Chronic Lymphocytic Leukemia, Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Hodgkin Lymphoma, Small Lymphocytic Lymphoma, T-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01231633

    Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)

    Not yet reported Long Island Vitreoretinal Consultants 27 participants Est. completion 2014-09 4 sites
    Other conditions: Macular Edema, Central Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT01232387

    Identification of Early Predictors of Fetomaternal Hemorrhage

    Icahn School of Medicine at Mount Sinai 39 participants Est. completion 2013-09 1 site
    Other conditions: Fetomaternal Hemorrhage, Neonatal Anemia
    View official trial listing →
  • Completed NCT NCT01232530

    Pharmacovigilance for ACTs in Africa

    Centre Muraz 3176 participants Est. completion 2013-12 1 site
    Other conditions: Malaria
    View official trial listing →
  • Withdrawn NCT NCT01232777

    Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)

    Not yet reported Vision Research Foundation Est. completion 2018-07 19 sites
    Other conditions: Retinopathy of Prematurity
    View official trial listing →
  • Withdrawn NCT NCT01233479

    Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

    Not yet reported Pediatric Brain Tumor Consortium Est. completion 2017-08-24 11 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT01235598

    Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)

    Not yet reported UCB Pharma 41 participants Est. completion 2013-05 10 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01235624

    Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes

    Not yet reported University Hospital, Montpellier 1161 participants Est. completion 2013-04 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT01237262

    Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy

    Not yet reported University of Padova 20 participants 1 site
    Other conditions: Moderate to Severe Psoriasis., Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.
    View official trial listing →
  • Completed NCT NCT01237717

    Relationship of Urine Sodium Excretion to Central Blood Pressure and Aortic Pulse Wave Velocity

    DongGuk University 200 participants Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01243476

    Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome

    Not yet reported Fundación General de la Universidad de Salamanca 61 participants Est. completion 2022-06-06 25 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT01243840

    Japan Central Aortic Pressure Prospective Study

    Yoshio Matsui 3000 participants Est. completion 2019-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01244282

    A Study of Two Methodologies for Measuring Blood Flow in the Brain in Response to Non-Drug Stimuli (P08085/MK-0000-180)

    Not yet reported Merck Sharp & Dohme LLC 10 participants Est. completion 2011-04
    Other conditions: Functional Magnetic Resonance Imaging
    View official trial listing →
  • Completed NCT NCT01245361

    A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit

    Not yet reported Patrick Durez 30 participants Est. completion 2012-12 1 site
    Other conditions: Undifferentiated Arthritis
    View official trial listing →
  • Withdrawn NCT NCT01246492

    The Effect of Artificial Sweeteners on Blood Glucose Response

    Not yet reported Northumbria University Est. completion 2011-05 1 site
    Other conditions: Taste Receptors, Nutrient Sensing, Intestinal Absorption, Blood Glucose, Appetite
    View official trial listing →
  • Completed NCT NCT01246960

    A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

    Not yet reported Eli Lilly and Company 168 participants Est. completion 2014-05 58 sites
    Other conditions: Stomach Cancer, Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT01247129

    Delaying the Superficial Inferior Epigastric Artery (SIEA) Flap and Determining the Change in SIEA Diameter and Blood Flow

    Not yet reported University Medical Centre Ljubljana 26 participants Est. completion 2010-09 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01247311

    Vitamin D and the Health of Blood Vessels in Kidney Disease

    Not yet reported University of British Columbia 129 participants Est. completion 2014-08 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01247545

    Effect of Remote Ischaemic Preconditioning on Clinical Outcomes in CABG Surgery

    Not yet reported University College, London 1612 participants Est. completion 2015-03 28 sites
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT01248104

    Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery

    Not yet reported Loma Linda University 100 participants Est. completion 2015-02 1 site
    Other conditions: Cardiopulmonary Bypass
    View official trial listing →
  • Status unknown NCT NCT01249937

    Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

    Not yet reported University Health Network, Toronto 30 participants Est. completion 2011-10 1 site
    Other conditions: Wet Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01250132

    Ante-hypophyseal Dysfunctions in Children Following Moderate to Severe Traumatic Brain Injuries

    Not yet reported Hospices Civils de Lyon 110 participants Est. completion 2018-04-13 2 sites
    Other conditions: Moderate to Severe Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT01251042

    Comparison Between Return and Wastage of Your Own Blood, Collected During Spinal Surgery, for Verification of Safety When Returning Blood

    Not yet reported Wellspect HealthCare 51 participants Est. completion 2011-12 1 site
    Other conditions: Spinal Surgery
    View official trial listing →
  • Completed NCT NCT01251523

    Improving Asthma Outcomes Through Cultural Competence Training for Physicians

    Not yet reported University of Michigan 1176 participants Est. completion 2015-06 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01251744

    Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

    Not yet reported GlaxoSmithKline 160 participants Est. completion 2015-06-17 9 sites
    Other conditions: Infections, Cytomegalovirus, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01252628

    Phase 1 and 2 Study of PX-866 and Cetuximab

    Not yet reported, Not yet reported Cascadian Therapeutics Inc. 178 participants Est. completion 2014-01 40 sites
    Other conditions: Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT01252667

    Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 44 participants Est. completion 2019-03 4 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Withdrawn NCT NCT01253694

    Ranibizumab as a Rescue Therapy for Diabetic Macular Edema

    Not yet reported New England Retina Associates Est. completion 2012-07 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01254968

    Influence of Direction of Movement While Walking

    Medical University of Silesia 1 participants Est. completion 2009-04 1 site
    Other conditions: Changes in Blood Flow to the Brain, Changes Depending on the Form of Walking
    View official trial listing →
  • Completed NCT NCT01255358

    Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients

    Not yet reported Quince Therapeutics S.p.A. 22 participants Est. completion 2011-12 2 sites
    Other conditions: Nervous System Disorder, Genetic Syndrome
    View official trial listing →
  • Completed NCT NCT01256567

    A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer

    Not yet reported Eli Lilly and Company 7 participants Est. completion 2013-02 4 sites
    Other conditions: Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01258660

    Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate

    Not yet reported Bayer 172 participants Est. completion 2008-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01260272

    Study of Raisins Versus Alternative Snacks on Cardiovascular Risk Factors In Generally Healthy Subjects

    Not yet reported Louisville Metabolic and Atherosclerosis Research Center 49 participants Est. completion 2011-09 1 site
    Other conditions: Cardiovascular Risk Factors
    View official trial listing →
  • Completed NCT NCT01260415

    A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases

    Not yet reported University Health Network, Toronto 11 participants Est. completion 2013-06 4 sites
    Other conditions: Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Completed NCT NCT01260506

    Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

    Not yet reported, Not yet reported Vascular Biogenics Ltd. operating as VBL Therapeutics 75 participants Est. completion 2018-12-20 4 sites
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT01262066

    Effects of Lifeskills Workshop on BP in Hypertensive Employees

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 181 participants Est. completion 2006-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01263704

    A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

    Not yet reported Hoffmann-La Roche 42 participants Est. completion 2017-04-03 12 sites
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Completed NCT NCT01263834

    Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome

    Not yet reported, Not yet reported Prince of Songkla University 39 participants Est. completion 2014-01 1 site
    Other conditions: Glaucoma
    View official trial listing →
  • Completed NCT NCT01264016

    Performance of a New Glucose Meter System

    Not yet reported Ascensia Diabetes Care 96 participants Est. completion 2010-12 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT01264341

    Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma

    Not yet reported Hellenic Cooperative Oncology Group 39 participants Est. completion 2015-07 8 sites
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT01265004

    Identification of Microcirculation After Surgical Treatment of Rupture of the Achilles Tendon

    RWTH Aachen University 20 participants Est. completion 2012-11 1 site
    Other conditions: Microcirculation, Achilles Tendon Rupture
    View official trial listing →
  • Completed NCT NCT01265927

    A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer

    Not yet reported Indiana University 10 participants Est. completion 2015-10 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01267487

    Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass

    Not yet reported SANE-Society of Anesthesiology 240 participants Est. completion 2010-11 1 site
    Other conditions: Cardiac Surgery, Cardiopulmonary Bypass, Anticoagulation
    View official trial listing →
  • Completed NCT NCT01267812

    Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

    Not yet reported City of Hope Medical Center 23 participants Est. completion 2020-11-02 2 sites
    Other conditions: Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Stage I Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma, Stage IV Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01268488

    Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting

    Not yet reported Ascensia Diabetes Care 98 participants Est. completion 2010-12 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01270542

    Avastin for PDR (Proliferative Diabetic Retinopathy)

    Not yet reported University of Southern California 20 participants Est. completion 2012-07 1 site
    Other conditions: Retinal Detachment, Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT01270867

    Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke

    Not yet reported Stryker Neurovascular 178 participants Est. completion 2012-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01270919

    A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device

    Not yet reported Stryker Orthopaedics 1 participants Est. completion 2011-05 3 sites
    Other conditions: Knee Meniscus Tear
    View official trial listing →
  • Completed NCT NCT01271023

    Inpatient Evaluation of an Automated Closed-Loop Control-to-Range System

    Not yet reported Jaeb Center for Health Research 57 participants Est. completion 2012-08 7 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT01271283

    Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia

    Not yet reported National Cancer Institute (NCI) Est. completion 2011-08 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01271543

    Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope

    Not yet reported Milton S. Hershey Medical Center 60 participants Est. completion 2012-03 1 site
    Other conditions: Anesthesia
    View official trial listing →
  • Completed NCT NCT01271556

    Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients

    Not yet reported University of Milan 20 participants Est. completion 2009-07 1 site
    Other conditions: Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients, Chronic Obstructive Pulmonary Disease, Bronchodilator Agents, Salmeterol
    View official trial listing →
  • Terminated NCT NCT01271907

    Drosophila-generated CTL

    Not yet reported National Cancer Institute (NCI) 3 participants Est. completion 2011-12-08 1 site
    Other conditions: Metastatic Cutaneous Melanoma
    View official trial listing →
  • Completed NCT NCT01272375

    This Study Is To Estimate The Time Course Of Pf-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

    Not yet reported Pfizer 48 participants Est. completion 2011-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01272986

    Trial of Screening for ALOA-IgG AtheroAbzyme Test

    Not yet reported Omicron Pharmaceuticals 100 participants Est. completion 2011-03 1 site
    Other conditions: Myocardial Ischemia, Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01273753

    Effects of Intradialytic Exercise as Assessed by Bioimpedance Analysis and Blood Volume Monitoring

    Not yet reported University of Michigan 17 participants Est. completion 2012-08 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT01274481

    Iloprost Effects on Gas Exchange and Pulmonary Mechanics

    Not yet reported University of Oklahoma 20 participants Est. completion 2012-07 1 site
    Other conditions: Acute Respiratory Distress Syndrome, Acute Lung Injury, Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT01275820

    A Study to Evaluate Glucose and Insulin Response to Nutralin

    Avera McKennan Hospital & University Health Center 10 participants Est. completion 2010-09 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT01275976

    Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

    Not yet reported UMC Utrecht 11 participants Est. completion 2015-02 1 site
    Other conditions: Trauma, Inflammation, Sepsis, Multiple Organ Dysfunction Syndrome
    View official trial listing →
  • Completed NCT NCT01276262

    Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female Subjects

    Not yet reported AstraZeneca 22 participants Est. completion 2011-11 1 site
    Other conditions: Scientific Terminology Rheumatoid Arthritis, Healthy Female Volunteers, Pharmacokinetics, Oral Contraceptive, Drug-drug Interaction, Laymen Terminology Level of Oral Contraceptive in Blood, Oral Contraceptive, Rheumatoid Arthritis, Drug -Drug Interaction
    View official trial listing →
  • Status unknown NCT NCT01278602

    R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma

    Not yet reported Fudan University 50 participants Est. completion 2014-02 1 site
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01279278

    Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

    Not yet reported University of Paris 5 - Rene Descartes 2700 participants Est. completion 2011-04 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01279928

    Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot Study

    John Hunter Hospital 26 participants Est. completion 2010-10 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01280006

    Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans

    Not yet reported, Not yet reported University of Calgary 12 participants Est. completion 2011-12 1 site
    Obstructive sleep apneaCardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01280266

    Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

    Not yet reported, Not yet reported Seoul National University Hospital 29 participants Est. completion 2011-06 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT01280942

    Early Warning System for Clinical Deterioration on General Hospital Wards

    Not yet reported Washington University School of Medicine 20031 participants Est. completion 2012-05 1 site
    Other conditions: Escalation of Care, Cardiopulmonary Arrest, Respiratory Arrest, Severe Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT01281306

    An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

    Not yet reported Novartis Pharmaceuticals 910 participants Est. completion 2011-12 90 sites
    Other conditions: Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT01281345

    SIHAM Candidemia Network:An Observational Study

    Society of Indian Human & Animal Mycologist 1400 participants Est. completion 2012-12 1 site
    Other conditions: Candidemia
    View official trial listing →
  • Completed NCT NCT01281605

    Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes

    Not yet reported Mackay Memorial Hospital 181 participants Est. completion 2016-05 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01282021

    Molecular Immunohematology in Ethiopian Sub-Populations

    National Institutes of Health Clinical Center (CC) 95 participants 1 site
    Other conditions: Immunohematology
    View official trial listing →
  • Terminated NCT NCT01282333

    Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

    Not yet reported National Cancer Institute (NCI) 44 participants 3 sites
    Other conditions: Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Regional Transitional Cell Cancer of the Renal Pelvis and Ureter, Stage III Bladder Cancer, Stage III Pancreatic Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Bladder Cancer, Stage IV Non-small Cell Lung Cancer, Stage IV Pancreatic Cancer, Transitional Cell Carcinoma of the Bladder, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    View official trial listing →
  • Completed NCT NCT01282567

    Study for the Artificial Pancreas Project : Determination of a Tuning Strategy of Metabolic Profiles

    Not yet reported Rennes University Hospital 3 participants Est. completion 2011-09 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01282957

    Way to Health, Healthy Measures

    Not yet reported University of Pennsylvania 75 participants Est. completion 2012-08 1 site
    Other conditions: Diabetes, Hypertension
    View official trial listing →
  • Terminated NCT NCT01283386

    A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status

    Not yet reported Hoffmann-La Roche 26 participants Est. completion 2016-03-16 8 sites
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Completed NCT NCT01284582

    Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)

    Not yet reported Affiris AG 36 participants Est. completion 2012-07 1 site
    Other conditions: HDL, Drug Safety
    View official trial listing →
  • Status unknown NCT NCT01285193

    Treating Hypertension With Breath Control

    Not yet reported Penang Hospital, Malaysia 84 participants Est. completion 2012-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01286506

    Observational Study of Blood Pressure Measurements and Continuous Dialysis

    University of Chicago 7 participants Est. completion 2015-12 1 site
    Other conditions: Kidney Failure, Respiratory Failure, Critical Illness, Shock
    View official trial listing →
  • Completed NCT NCT01287195

    Oral OKT3 for the Treatment of Active Ulcerative Colitis

    Not yet reported, Not yet reported Brigham and Women's Hospital 6 participants Est. completion 2013-05-02 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01287689

    Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study

    Technische Universität Dresden 685 participants Est. completion 2016-12-31 7 sites
    Other conditions: Primary Immunodeficiency (PID), Secondary Immunodeficiency (SID), Neurological Autoimmune Disease
    View official trial listing →
  • Completed NCT NCT01288404

    Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium

    Not yet reported Ramathibodi Hospital 80 participants Est. completion 2010-11 1 site
    Other conditions: Pterygium of the Conjunctiva and Cornea
    View official trial listing →
  • Completed NCT NCT01288898

    Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941

    Not yet reported Astellas Pharma Inc 48 participants Est. completion 2008-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01290770

    Search a Correlation Between Lp(a) Rate and TFPI Activity in Obese Patients With Chest Pain Like Angina

    Centre Hospitalier Universitaire de Saint Etienne 40 participants Est. completion 2014-04 3 sites
    Other conditions: Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT01290887

    Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 1052 participants Est. completion 2015-01 219 sites
    Other conditions: Eosinophilic Asthma
    View official trial listing →
  • Completed NCT NCT01290913

    Xolair Enhances Oral Desensitization in Peanut Allergic Patients

    Not yet reported, Not yet reported Lynda Schneider 13 participants Est. completion 2013-09 1 site
    Other conditions: Peanut Allergy
    View official trial listing →
  • Completed NCT NCT01290952

    On Versus Off Pump Myocardial Revascularization Study

    Not yet reported Medtronic Italia 411 participants Est. completion 2011-06 8 sites
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT01291719

    Insulin Balanced Infusion System

    Not yet reported, Not yet reported Admetsys Corporation 40 participants Est. completion 2026-11 1 site
    Other conditions: Hyperglycemia, Diabetes
    View official trial listing →
  • Completed NCT NCT01292356

    Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response

    Not yet reported Poitiers University Hospital 28 participants Est. completion 2016-03-03 1 site
    Other conditions: Metastatic Colon Cancer
    View official trial listing →
  • Completed NCT NCT01292798

    Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab

    Not yet reported, Not yet reported California Retina Consultants 43 participants Est. completion 2013-04 5 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01293266

    Effect of Propofol and Sevoflurane on Lactate During Anesthesia for Pediatric Heart Catheterisation

    Not yet reported University Hospital Schleswig-Holstein 40 participants Est. completion 2010-08 1 site
    Other conditions: Metabolic Acidosis
    View official trial listing →
  • Completed NCT NCT01293344

    Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women

    Not yet reported Laval University 70 participants Est. completion 2010-10 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01294865

    Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal Sepsis

    Ankara University 120 participants Est. completion 2012-06 1 site
    Other conditions: Neonatal Sepsis
    View official trial listing →
  • Status unknown NCT NCT01295762

    Immunomonitoring of Children With Neuroblastoma

    Not yet reported Centre Leon Berard 35 participants Est. completion 2019-07 4 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01296815

    Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

    Not yet reported Centro de Investigación en. Enfermedades Infecciosas, Mexico 14 participants Est. completion 2013-12 1 site
    Other conditions: Kaposi´s Sarcoma
    View official trial listing →
  • Completed NCT NCT01297205

    Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia

    Not yet reported Medipost Co Ltd. 9 participants Est. completion 2011-12 1 site
    Other conditions: Bronchopulmonary Dysplasia
    View official trial listing →
  • Withdrawn NCT NCT01297231

    Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI

    Memorial Sloan Kettering Cancer Center Est. completion 2014-02
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01297569

    Ranibizumab "Treat and Extend" in Diabetic Macular Edma

    Not yet reported Novartis Pharmaceuticals 7 participants Est. completion 2012-11 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01299376

    MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

    Not yet reported Merck Sharp & Dohme LLC 286 participants Est. completion 2012-09-20
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01300572

    Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

    Not yet reported Fred Hutchinson Cancer Center 16 participants Est. completion 2019-11-22 1 site
    Other conditions: Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts, Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01300728

    Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment

    Not yet reported Sutter Health 52 participants Est. completion 2020-03-12 1 site
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Status unknown NCT NCT01301053

    Pilot Study of Intensive Care Unit Continuous Glucose Monitoring

    Not yet reported University of Virginia 20 participants Est. completion 2013-09 1 site
    Other conditions: Hyperglycemia, Hypoglycemia
    View official trial listing →
  • Withdrawn NCT NCT01302236

    Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients

    Not yet reported Jichi Medical University Est. completion 2012-07
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01302535

    The Impact of Yoga on Blood Pressure and Quality of Life in Patients With Hypertension

    Not yet reported Region Skane 83 participants Est. completion 2011-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01303042

    Efficacy of Insulin Lispro Mix 50/50 Therapy

    Not yet reported Aichi Gakuin University 80 participants Est. completion 2014-12 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01305213

    Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

    Not yet reported National Cancer Institute (NCI) 107 participants Est. completion 2016-11-03 51 sites
    Other conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma
    View official trial listing →
  • Completed NCT NCT01305941

    A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases

    Not yet reported UNC Lineberger Comprehensive Cancer Center 32 participants Est. completion 2017-10-16 4 sites
    Other conditions: HER-2 Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01307137

    Peer-led and Telehealth Comparative Effectiveness Research (CER) Adoption for Diabetes Prevention and Management

    Not yet reported South Florida Veterans Affairs Foundation for Research and Education 85 participants Est. completion 2013-09 2 sites
    Prediabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01307267

    A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

    Not yet reported Pfizer 190 participants Est. completion 2019-02-20 42 sites
    Other conditions: Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell of Head and Neck, Malignant Melanoma
    View official trial listing →
  • Completed NCT NCT01307657

    Impact of a High-fat Meal on Assessment of Clopidogrel-induced Platelet Inhibition in Healthy Subjects

    Not yet reported University of Nebraska 12 participants Est. completion 2012-03-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01308346

    ABSORB PHYSIOLOGY Clinical Investigation

    Not yet reported Abbott Medical Devices 1 participants Est. completion 2013-04 6 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01308684

    A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

    Not yet reported Hoffmann-La Roche 22 participants Est. completion 2013-02 4 sites
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Terminated NCT NCT01309126

    Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer

    Not yet reported HiberCell, Inc. 217 participants Est. completion 2017-02 53 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01310322

    A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

    Not yet reported AstraZeneca 12 participants Est. completion 2011-10 1 site
    Other conditions: Healthy, Asthma
    View official trial listing →
  • Withdrawn NCT NCT01312493

    Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

    Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2018-12
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01312714

    Vitamin D3 Supplementation in Dialysis Patients

    Not yet reported Regional Hospital Holstebro 64 participants Est. completion 2012-09 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01313208

    Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)

    Not yet reported Amgen 210 participants Est. completion 2013-05 47 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01314391

    Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor

    Children's Oncology Group 20 participants
    Other conditions: Kidney Cancer, Renal Failure
    View official trial listing →
  • Status unknown NCT NCT01315834

    Couples Coping With Coronary Heart Disease

    Meir Medical Center 130 participants Est. completion 2014-12 1 site
    Other conditions: Coronary Heart Disease (CHD)
    View official trial listing →
  • Completed NCT NCT01315938

    Abatacept Treatment in Polymyositis and Dermatomyositis

    Not yet reported Karolinska Institutet 20 participants Est. completion 2013-11-28 2 sites
    Other conditions: Polymyositis, Dermatomyositis
    View official trial listing →
  • Completed NCT NCT01316757

    Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

    Not yet reported Fox Chase Cancer Center 24 participants Est. completion 2017-10-03 3 sites
    Other conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    View official trial listing →
  • Terminated NCT NCT01318915

    Research Study of ATG and Rituximab in Renal Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2017-08-25 6 sites
    Other conditions: Renal Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01320137

    Study in Allergic Adults to Support the Development of Immunological Assays

    Not yet reported GlaxoSmithKline 80 participants Est. completion 2011-05-11 2 sites
    Other conditions: Immunologic Tests
    View official trial listing →
  • Status unknown NCT NCT01321775

    Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer

    Not yet reported Hospital Universitario Madrid Sanchinarro 44 participants Est. completion 2013-11 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01324245

    Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

    Not yet reported Georgetown University 45 participants Est. completion 2006-05 1 site
    Other conditions: Salt-sensitive Hypertension
    View official trial listing →
  • Completed NCT NCT01324388

    A Study of the Effect of LY2189265 on Two Blood Pressure Drugs

    Not yet reported Eli Lilly and Company 51 participants Est. completion 2011-08 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01326000

    A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 169 participants Est. completion 2013-12 69 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01326104

    Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

    Not yet reported University of Florida 26 participants Est. completion 2025-03-28 3 sites
    Other conditions: Medulloblastoma, Neuroectodermal Tumor
    View official trial listing →
  • Withdrawn NCT NCT01326468

    Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2016-12
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01326559

    Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

    Not yet reported Hong Kong Nasopharyngeal Cancer Study Group Limited 33 participants Est. completion 2017-03 4 sites
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Completed NCT NCT01327209

    Blood Glucose Monitoring System Clinical Study

    Intuity Medical, Inc 202 participants Est. completion 2011-04 4 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01331343

    Effectiveness Study of the Guardian RT in Type 1 Diabetics

    Not yet reported Medtronic MiniMed, Inc. 156 participants Est. completion 2005-06 8 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01331499

    Salient Aquamantys Spine Trial

    Not yet reported Salient Surgical Technologies 12 participants Est. completion 2013-04 3 sites
    Other conditions: Blood Loss
    View official trial listing →
  • Completed NCT NCT01331525

    The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer

    Not yet reported University Hospital Southampton NHS Foundation Trust 42 participants Est. completion 2015-06 7 sites
    Other conditions: Extensive Stage Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01331837

    A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

    Not yet reported Hoffmann-La Roche 3080 participants Est. completion 2016-03-25 428 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01332968

    A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

    Not yet reported Hoffmann-La Roche 1401 participants Est. completion 2021-07-30 183 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01332994

    A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid Arthritis

    Not yet reported Hoffmann-La Roche 519 participants Est. completion 2014-02 83 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01333358

    Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients

    Not yet reported Central Texas Neurology Consultants 30 participants Est. completion 2014-03
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01333657

    The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney Injuries

    Chinese PLA General Hospital 104 participants Est. completion 2011-04 1 site
    Other conditions: SIRS, Sepsis
    View official trial listing →
  • Completed NCT NCT01334008

    Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

    Not yet reported Institut Curie 40 participants Est. completion 2012-05 1 site
    Other conditions: Choroidal Melanoma, Diffuse
    View official trial listing →
  • Completed NCT NCT01334502

    Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 26 participants Est. completion 2017-08 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT01334515

    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

    Not yet reported Children's Oncology Group 52 participants Est. completion 2019-09-30 76 sites
    Other conditions: Recurrent Neuroblastoma
    View official trial listing →
  • Withdrawn NCT NCT01335919

    Neonatal Non-Invasive Hemoglobin Determination

    Children's Hospital of Philadelphia Est. completion 2012-12
    Other conditions: Surgical Procedures, Infant, Newborn, Infant, Low Birth Weight
    View official trial listing →
  • Completed NCT NCT01335984

    Effects of Telemonitoring and Telemedicine Service for Hypertensive Care

    Not yet reported Chang Hee, Lee 440 participants Est. completion 2013-08 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01336426

    Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery Disease

    Vermillion, Inc. 1033 participants Est. completion 2011-08 10 sites
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Withdrawn NCT NCT01336478

    CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

    Not yet reported Imperial College London Est. completion 2014-06 1 site
    Other conditions: Haematological Malignancies, Allogeneic Stem Cell Transplant, CD56+CD3- NK Cells
    View official trial listing →
  • Completed NCT NCT01336712

    Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases

    Not yet reported Northside Hospital, Inc. 30 participants Est. completion 2015-07 1 site
    Other conditions: Chronic Leukemia, Acute Leukemia, Hodgkin's Disease, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01336751

    Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment

    Not yet reported Sanofi 212 participants Est. completion 2002-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01337947

    The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes

    University of Virginia 32 participants Est. completion 2013-11 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT01337999

    Human Epididymis Protein 4 in Normal Menstruating Women

    Women and Infants Hospital of Rhode Island 60 participants 1 site
    Other conditions: Healthy Premenopausal Women
    View official trial listing →
  • Completed NCT NCT01338116

    Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections

    Not yet reported Rabin Medical Center 600 participants Est. completion 2019-05-13 1 site
    Other conditions: Community-associated Infections, Health-care Acquired Infections, Nosocomial Infections
    View official trial listing →
  • Completed NCT NCT01338441

    Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood Samples

    Not yet reported Ectycell SASU 130 participants Est. completion 2011-08 1 site
    Other conditions: Cardiology: RR / QT
    View official trial listing →
  • Completed NCT NCT01341002

    Red Blood Cells (RBC) Transfusion Related to Central Venous O2 Saturation (ScvO2) Measurement

    Not yet reported University Hospital, Lille 100 participants Est. completion 2014-05 1 site
    Other conditions: Postoperative Complications, Erythrocyte Transfusion, Oxygen Disorders
    View official trial listing →
  • Completed NCT NCT01344824

    Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

    Not yet reported UNC Lineberger Comprehensive Cancer Center 38 participants Est. completion 2016-07-20 4 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT01344863

    A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe

    Not yet reported Hoffmann-La Roche 119 participants Est. completion 2012-01 2 sites
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01344941

    Human Immune Responses Toward HIV-1 Envelope Antigens

    St. Jude Children's Research Hospital 8 participants Est. completion 2015-11 1 site
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT01346735

    Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER)

    Indian Society of Critical Care Medicine 381 participants Est. completion 2012-10 1 site
    Other conditions: Nosocomial Infections
    View official trial listing →
  • Completed NCT NCT01347203

    A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting

    Not yet reported Diakron Pharmaceuticals 12 participants Est. completion 2011-06 1 site
    Other conditions: Deep Vein Thrombosis Leg
    View official trial listing →
  • Status unknown NCT NCT01347398

    Validity of a Supersimplified Device for Diagnosis of Patients With Suspected Obstructive Sleep Apnoea-hypopnoea (OSAH)

    Not yet reported Basque Health Service 815 participants Est. completion 2014-04
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT01349712

    Study to Test the Accuracy of a Prototype Handheld PT/INR Device

    Universal Biosensors Pty Ltd 200 participants Est. completion 2011-11 1 site
    Other conditions: Blood Coagulation Disorders
    View official trial listing →
  • Completed NCT NCT01349842

    Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer

    Not yet reported Institut Curie 265 participants Est. completion 2018-11-06 7 sites
    Other conditions: Breast Cancer Ductal Infiltrating Metastatic
    View official trial listing →
  • Status unknown NCT NCT01350219

    Stem Cell Educator Therapy in Type 1 Diabetes

    Not yet reported Throne Biotechnologies Inc. 100 participants Est. completion 2019-09 4 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01352884

    Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

    Not yet reported MedImmune LLC 44 participants Est. completion 2014-01 4 sites
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT01354821

    Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms

    Not yet reported Assistance Publique - Hôpitaux de Paris 49 participants Est. completion 2015-12 1 site
    Other conditions: Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT01355094

    Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/Injury

    Not yet reported University of Calgary 50 participants Est. completion 2022-06 1 site
    Other conditions: Abdominal Compartment Syndrome, Intra-abdominal Hypertension
    View official trial listing →
  • Completed NCT NCT01356615

    Low Molecular Weight Heparin for Hemodialysis Anticoagulation

    Not yet reported Tehran University of Medical Sciences 27 participants Est. completion 2011-03
    Other conditions: End Stage Renal Failure on Dialysis
    View official trial listing →
  • Completed NCT NCT01359891

    Clinical Evaluation of Novel Biomarkers in Patients With Septicemia

    Medical University of Graz 750 participants Est. completion 2021-08 1 site
    Other conditions: Sepsis, Bacteremia, Fungemia
    View official trial listing →
  • Completed NCT NCT01360203

    Better Effectiveness After Transition - Heart Failure

    Not yet reported University of California, Los Angeles 1437 participants Est. completion 2014-03 6 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT01360333

    Oral Fluid Volume Expansion

    Not yet reported University Hospital, Linkoeping 10 participants Est. completion 2011-12 1 site
    Other conditions: Dehydration, Hydration
    View official trial listing →
  • Completed NCT NCT01361997

    Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination

    Not yet reported Universidad de Guanajuato 1102 participants Est. completion 2012-08 1 site
    Other conditions: Infectious Diseases
    View official trial listing →
  • Completed NCT NCT01362595

    Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

    Not yet reported, Not yet reported Northwell Health 55 participants Est. completion 2020-11-30 11 sites
    Other conditions: Diamond Blackfan Anemia, Blackfan Diamond Syndrome, DBA, Congenital Hypoplastic Anemia, Pure Red Cell Aplasia
    View official trial listing →
  • Completed NCT NCT01365481

    Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

    Not yet reported Novartis Pharmaceuticals 150 participants Est. completion 2015-09 28 sites
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01366911

    Stem Cells Predicting Orthopedic Outcomes

    University of Nebraska 203 participants Est. completion 2014-01-10 1 site
    Other conditions: Hip Arthroplasty
    View official trial listing →
  • Completed NCT NCT01369550

    Efficacy Study of Stearidonic Acid (SDA) Soybean Oil-containing Foods on Red Blood Cell Fatty Acid Content

    Not yet reported Monsanto Company, LLC 127 participants Est. completion 2011-01 2 sites
    Other conditions: Healthy Volunteers, Markers of Cardiovascular Risk
    View official trial listing →
  • Status unknown NCT NCT01372566

    Effect of Platelet Rich Plasma on Photoaged Skin

    Not yet reported, Not yet reported Northwestern University 23 participants Est. completion 2025-12 1 site
    Other conditions: Photoaging
    View official trial listing →
  • Completed NCT NCT01373229

    Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

    Not yet reported David Rizzieri, MD 21 participants Est. completion 2015-03 1 site
    Other conditions: Leukemia, Lymphocytic, Chronic, B-Cell
    View official trial listing →
  • Completed NCT NCT01373359

    Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin

    Not yet reported Jawaharlal Nehru Medical College 652 participants Est. completion 2008-01 1 site
    Other conditions: Postpartum Hemorrhage
    View official trial listing →
  • Completed NCT NCT01373489

    Technology-assisted Case Management in Adults With Type 2 Diabetes

    Not yet reported State University of New York at Buffalo 113 participants Est. completion 2016-06 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01375569

    TRC105 for Liver Cancer That Has Not Responded to Sorafenib

    Not yet reported National Cancer Institute (NCI) 11 participants Est. completion 2015-12-01 1 site
    Other conditions: Hepatocellular Carcinoma, Hepatocellular Cancer, Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT01377155

    A Comparison of Two Initial Dosing Formulas

    Not yet reported Diabetes Care Center 20 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01377285

    Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

    Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 site
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Withdrawn NCT NCT01377961

    Effect of Lycopene and Isoflavones on Glucose Metabolism

    Not yet reported The University of Texas Medical Branch, Galveston Est. completion 2015-08 2 sites
    Metabolic syndrome Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT01378169

    SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICU

    Fondation Hôpital Saint-Joseph 300 participants Est. completion 2013-06-01 1 site
    Other conditions: SIRS, Sepsis, Severe Sepsis, Septic Shock
    View official trial listing →
  • Status unknown NCT NCT01379807

    Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported Grupo Gallego de Investigaciones Oncologicas 55 participants Est. completion 2015-12 9 sites
    Other conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01381601

    Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

    GlaxoSmithKline 1 participants Est. completion 2011-10
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT01381614

    Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

    GlaxoSmithKline 1 participants Est. completion 2011-12
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT01382160

    Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)

    Not yet reported University Hospital, Tours 69 participants Est. completion 2013-07 7 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01384812

    Prostaglandin E2 in Migraine Suffers Without Aura.

    Not yet reported Troels Wienecke 12 participants Est. completion 2011-07 1 site
    Other conditions: "Migraine-like" Headache
    View official trial listing →
  • Completed NCT NCT01386268

    Kogenate FS Regulatory Post-Marketing Surveillance

    Bayer 64 participants Est. completion 2013-08 1 site
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT01386892

    Immunological Characterization of Blood of Normal Individuals

    Ohio State University 1300 participants Est. completion 2015-01-05 1 site
    Other conditions: Heathly Volunteers
    View official trial listing →
  • Completed NCT NCT01387295

    Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

    Not yet reported Dorte Nielsen 38 participants Est. completion 2017-09-01 1 site
    Other conditions: Metastatic Breast Cancer, Liver Metastases
    View official trial listing →
  • Status unknown NCT NCT01388127

    Minocycline Treatment in Acute Hemorrhagic Stroke

    Wolfson Medical Center 150 participants Est. completion 2012-07 1 site
    Other conditions: Poor Performance Status
    View official trial listing →
  • Completed NCT NCT01388491

    A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 293 participants Est. completion 2012-09-30 27 sites
    Other conditions: Hemostasis, Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT01388569

    Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

    Eastern Cooperative Oncology Group 48 participants Est. completion 2011-09-28
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Status unknown NCT NCT01388621

    Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer

    Not yet reported WiSP Wissenschaftlicher Service Pharma GmbH 140 participants Est. completion 2015-07 18 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT01388725

    Comparison the Value of Several Biomarkers of Sepsis

    Chinese PLA General Hospital 130 participants Est. completion 2011-07 1 site
    Other conditions: Systemic Inflammatory Response Syndrome, Sepsis
    View official trial listing →
  • Completed NCT NCT01388998

    Fluid Management Study to Evaluate Changes in Intravascular Volume After Applying Various Pressure Levels on the Caval Vein

    Not yet reported Johannes Gutenberg University Mainz 24 participants Est. completion 2012-01 1 site
    Other conditions: Intravascular Volume, Respiratory Changes
    View official trial listing →
  • Status unknown NCT NCT01390532

    Rest/Stress Quantification Of Left Ventricular Dyssynchrony By 3D Gated Blood Pool D-SPECT

    Not yet reported University Hospital, Clermont-Ferrand 30 participants Est. completion 2011-10 1 site
    Other conditions: Left Ventricular Dyssynchrony
    View official trial listing →
  • Completed NCT NCT01390610

    Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition

    HealthPartners Institute 27 participants Est. completion 2013-01 1 site
    Type 2 diabetes Other conditions: Diabetic Blood Glucose Monitoring
    View official trial listing →
  • Completed NCT NCT01390649

    A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)

    Not yet reported CSL Behring 57 participants Est. completion 2014-09 17 sites
    Other conditions: Immune Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT01391182

    Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)

    Not yet reported Mayo Clinic 60 participants Est. completion 2015-01 1 site
    Osteoarthritis Other conditions: Degenerative Joint Disease
    View official trial listing →
  • Completed NCT NCT01393249

    PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL

    Copenhagen University Hospital, Rigshospitalet 31 participants Est. completion 2014-06 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Pancreatitis
    View official trial listing →
  • Completed NCT NCT01393496

    Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants

    Not yet reported University Hospital Tuebingen 1013 participants Est. completion 2018-10-31 32 sites
    Other conditions: Anemia of Prematurity
    View official trial listing →
  • Completed NCT NCT01395498

    Prevalence of Pneumocystis Jirovecii and of Cytomegalovirus in Bronchial Wash Fluid of Patients Undergoing Bronchoscopy

    Carmel Medical Center 93 participants Est. completion 2013-12 1 site
    Other conditions: Patients Scheduled for Bronchoscopy
    View official trial listing →
  • Completed NCT NCT01396070

    Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

    Not yet reported Youn Kim 36 participants Est. completion 2016-05 1 site
    Other conditions: Non-Hodgkin Lymphoma (NHL), Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides, Sezary Syndrome
    View official trial listing →
  • Completed NCT NCT01396382

    68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 97 participants Est. completion 2014-12 1 site
    Other conditions: Neuroendocrine Carcinoma
    View official trial listing →
  • Completed NCT NCT01397409

    Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

    Not yet reported Allergan 271 participants Est. completion 2014-04-30 8 sites
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01397825

    MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine

    Not yet reported, Not yet reported Millennium Pharmaceuticals, Inc. 45 participants Est. completion 2016-10-05 25 sites
    Other conditions: Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, Mantle Cell Lymphoma, Burkitt's Lymphoma
    View official trial listing →
  • Completed NCT NCT01398280

    Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation

    Not yet reported University of California, San Diego 15 participants Est. completion 2012-12 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT01398722

    Effect of Intensive Insulin Therapy on Clinical Prognosis of Infants Undergoing Cardiac Surgery

    Not yet reported Xijing Hospital 800 participants Est. completion 2012-07 1 site
    Other conditions: Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT01398943

    Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Augusta University 60 participants Est. completion 2015-06 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01399489

    Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients

    Not yet reported Springfield College 51 participants Est. completion 2012-12 1 site
    Chronic kidney disease Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Status unknown NCT NCT01400061

    Relation of Blood-boron Levels With Body Mass Index

    SB Istanbul Education and Research Hospital 80 participants Est. completion 2011-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Withdrawn NCT NCT01400256

    Blood Pressure Lowering in Acute Stroke Trial

    Not yet reported Stanford University Est. completion 2009-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01402037

    Beta Cell Function in (Pre)Type 1 Diabetes

    Not yet reported Universitair Ziekenhuis Brussel 100 participants Est. completion 2016-07 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT01403012

    BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis

    Technical University of Munich 34 participants Est. completion 2015-12-04 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT01403363

    Use of Fentanyl Patch in Partial Doses Than the Original

    Not yet reported Meir Medical Center 95 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Chronic Pain
    View official trial listing →
  • Status unknown NCT NCT01403519

    Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized

    Rambam Health Care Campus 70 participants Est. completion 2014-01 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT01404806

    GSK1349572 Exposure in Blood, Cervicovaginal Fluid, and Cervical and Vaginal Tissue in Healthy Female Subjects

    Not yet reported University of North Carolina, Chapel Hill 10 participants Est. completion 2012-09 1 site
    Other conditions: Healthy Adult Females
    View official trial listing →
  • Completed NCT NCT01404897

    Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals

    Not yet reported UCSF Benioff Children's Hospital Oakland 36 participants Est. completion 2013-12 1 site
    Cardiovascular disease Other conditions: Dyslipidemia, Blood Pressure
    View official trial listing →
  • Completed NCT NCT01406470

    Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

    Not yet reported Green Cross Corporation 45 participants Est. completion 2013-07 11 sites
    Other conditions: Immunologic Deficiency Syndrome
    View official trial listing →
  • Completed NCT NCT01406821

    Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma

    Not yet reported Stanford University 30 participants Est. completion 2019-03-15 2 sites
    Other conditions: Tendinopathy
    View official trial listing →
  • Completed NCT NCT01407315

    Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor

    Not yet reported Medical University of Graz 20 participants Est. completion 2010-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01408810

    Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

    Not yet reported Grupo de Estudo da Doença Inflamatória Intestinal 21 participants Est. completion 2012-11 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01411670

    Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.

    Not yet reported University of Roma La Sapienza 60 participants Est. completion 2015-04 1 site
    Other conditions: Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT01412346

    Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish

    Not yet reported Finnish Institute for Health and Welfare 111 participants Est. completion 2014-09 1 site
    Other conditions: Prehypertension, Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01412437

    Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria

    Not yet reported Children's National Research Institute Est. completion 2012-12 1 site
    Other conditions: PKU
    View official trial listing →
  • Completed NCT NCT01412957

    Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer

    Not yet reported Amgen 377 participants Est. completion 2016-11 78 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01413126

    Peanuts Second Meal Glycemic Response

    Not yet reported Federal University of Vicosa 15 participants Est. completion 2011-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01413542

    Pharmacogenetics of Ace Inhibitor-Associated Angioedema

    Not yet reported Vanderbilt University 44 participants Est. completion 2014-07 1 site
    Other conditions: Hypertension, Diabetes Type 2
    View official trial listing →
  • Completed NCT NCT01418079

    Accuracy of the O2 MedTech PMS-3000 Monitor

    Not yet reported O2 MedTech, Inc. 42 participants Est. completion 2012-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01418222

    FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer

    Not yet reported Genentech, Inc. 194 participants Est. completion 2013-03-18 23 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01418495

    Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

    National Cancer Institute (NCI) 12 participants 1 site
    Other conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neurotoxicity Syndrome, Pain, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT01418521

    Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery

    Not yet reported Rambam Health Care Campus 300 participants Est. completion 2013-08 1 site
    Other conditions: Elective Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT01418755

    Study of Platelet-rich Plasma in Treating Patients With Tibiofemoral Cartilage Degeneration

    Not yet reported Komzak Martin, M.D. 50 participants Est. completion 2011-07 1 site
    Other conditions: Cartilage Degeneration
    View official trial listing →
  • Completed NCT NCT01419197

    A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

    Not yet reported Hoffmann-La Roche 602 participants Est. completion 2015-08 184 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01419249

    First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study

    Not yet reported Merck KGaA, Darmstadt, Germany 458 participants Est. completion 2012-10 31 sites
    Other conditions: Idiopathic Growth Hormone Deficiency, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT01419509

    DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma

    Children's Oncology Group 170 participants Est. completion 2016-05
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT01420198

    Efficiency and Cost-effectiveness of a Culturally Adopted Lifestyle Intervention Program - the MEDIM Study.

    Not yet reported Region Skane 96 participants Est. completion 2015-06 1 site
    Type 2 diabetesPrediabetes Other conditions: Obesity, Physical Activity
    View official trial listing →
  • Completed NCT NCT01421147

    A Study in Adults With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 536 participants Est. completion 2013-04 52 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01421667

    A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

    Not yet reported Seagen Inc. 176 participants Est. completion 2015-06 34 sites
    Other conditions: Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    View official trial listing →
  • Withdrawn NCT NCT01422343

    Microparticles and the Risk of Re-stenosis Following Balloon Angioplasty in Patients With Peripheral Arterial Disease

    Insel Gruppe AG, University Hospital Bern Est. completion 2011-07
    Other conditions: Peripheral Vascular Diseases
    View official trial listing →
  • Completed NCT NCT01422681

    Extracorporeal CO2 Removal in COPD Exacerbation

    Not yet reported University of Turin, Italy 30 participants Est. completion 2013-12 1 site
    Other conditions: COPD Exacerbation
    View official trial listing →
  • Status unknown NCT NCT01423591

    Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica

    Not yet reported Hospital Universitario Marqués de Valdecilla 23 participants Est. completion 2011-12 1 site
    Other conditions: Polymyalgia Rheumatica
    View official trial listing →
  • Active, not recruiting NCT NCT01426529

    Caveolin-1 and Vascular Dysfunction

    Not yet reported Brigham and Women's Hospital 120 participants Est. completion 2026-10-15 1 site
    Other conditions: Hypertension, Insulin Resistance
    View official trial listing →
  • Withdrawn NCT NCT01426724

    Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease

    Not yet reported University of Virginia Est. completion 2013-08 1 site
    Chronic kidney disease Other conditions: Secondary Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT01427335

    Calcium for Prevention of Ovarian Hyperstimulation Syndrome

    Not yet reported Cairo University 200 participants Est. completion 2013-09 1 site
    Other conditions: Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT01427751

    Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

    Not yet reported Allergan 307 participants Est. completion 2014-11-04 6 sites
    Other conditions: Retinal Vein Occlusion, Macular Edema
    View official trial listing →
  • Completed NCT NCT01428609

    Blood Mercury Levels Following Retrograde Amalgam Surgeries

    Not yet reported Masoud Saatchi 14 participants Est. completion 2010-12 1 site
    Other conditions: Blood Mercury Concentration
    View official trial listing →
  • Completed NCT NCT01428778

    Berlin Beat of Running Study

    Charite University, Berlin, Germany 110 participants Est. completion 2012-09 1 site
    Cardiovascular disease Other conditions: Cardiac Arrhythmia, Brain Lesion
    View official trial listing →
  • Completed NCT NCT01429155

    Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B

    Henry Ford Health System 36 participants Est. completion 2013-03 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Terminated NCT NCT01430273

    Assessment of Blood Loss With a Point Of Care Device

    Assistance Publique - Hôpitaux de Paris 28 participants Est. completion 2015-12 3 sites
    Other conditions: Acute or Programmed Hip Replacement (Gamma Nail, Total Prosthesis or Throuhg DHS) / Knee Surgery
    View official trial listing →
  • Active, not recruiting NCT NCT01430390

    In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

    Not yet reported Memorial Sloan Kettering Cancer Center 19 participants Est. completion 2026-09 1 site
    Other conditions: Acute Lymphocytic Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01430910

    A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately

    Not yet reported Pfizer 43 participants Est. completion 2012-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01431118

    Iron Metabolism in Dragon Boat Athletes

    Not yet reported University of Giessen 40 participants Est. completion 2012-04
    Other conditions: Anaemia
    View official trial listing →
  • Completed NCT NCT01431404

    Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects

    Not yet reported Hanwha Chemical 44 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01431443

    Consumption of Chocolate in Pregnant Women.

    Not yet reported Laval University 160 participants Est. completion 2014-09 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Completed NCT NCT01432275

    Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study

    Not yet reported Abbott Diabetes Care 179 participants Est. completion 2012-04 7 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01433289

    Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

    Not yet reported Baylor College of Medicine 23 participants Est. completion 2015-07 2 sites Stand-alone
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT01434147

    Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

    Not yet reported Austrian Breast & Colorectal Cancer Study Group 25 participants Est. completion 2013-08 7 sites
    Other conditions: Rectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT01434550

    Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2015-08
    Other conditions: Pancreatic Tumor
    View official trial listing →
  • Completed NCT NCT01434706

    Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection

    Not yet reported University of California, San Diego 22607 participants Est. completion 2015-04-07 5 sites
    Other conditions: Acute HIV Infection
    View official trial listing →
  • Terminated NCT NCT01434953

    Prehypertension Labeling

    Not yet reported Columbia University 100 participants Est. completion 2012-07-09 1 site
    Other conditions: Prehypertension
    View official trial listing →
  • Terminated NCT NCT01436305

    Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2015-04 3 sites
    Other conditions: Kidney Transplantation, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01437488

    Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14 participants Est. completion 2017-03-30 3 sites
    Other conditions: Urothelial Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01438593

    Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke

    Not yet reported China Medical University Hospital 6 participants Est. completion 2013-12 1 site
    Cardiovascular disease Other conditions: Ischaemic Cerebral Infarction, Infarction, Middle Cerebral Artery, Ischemia, Brain Ischemia
    View official trial listing →
  • Completed NCT NCT01440075

    Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease

    Not yet reported Hospices Civils de Lyon 43 participants Est. completion 2015-04-13 1 site
    Other conditions: Kawasaki Disease
    View official trial listing →
  • Completed NCT NCT01440946

    Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B

    Not yet reported Bioverativ Therapeutics Inc. 30 participants Est. completion 2014-11 15 sites
    Other conditions: Hemophilia B
    View official trial listing →
  • Status unknown NCT NCT01441609

    Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination

    Beijing Municipal Science & Technology Commission 94 participants Est. completion 2012-05 1 site
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT01442051

    Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 52 participants Est. completion 2019-07-01 4 sites
    Other conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    View official trial listing →
  • Completed NCT NCT01442532

    A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam

    Not yet reported Janssen Research & Development, LLC 94 participants Est. completion 2012-07 1 site
    Other conditions: Healthy Male Volunteer
    View official trial listing →
  • Completed NCT NCT01442883

    Renal Nerve Ablation in Chronic Kidney Disease Patients

    University of Erlangen-Nürnberg Medical School 27 participants Est. completion 2019-06 2 sites
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01442935

    Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

    Not yet reported UNICANCER 256 participants Est. completion 2021-01 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01443312

    Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia

    HaEmek Medical Center, Israel 28 participants Est. completion 2014-12 1 site
    Other conditions: Thalassemia
    View official trial listing →
  • Completed NCT NCT01444664

    Aneurysm Wall Histology Registry

    Not yet reported Medical University of South Carolina 24 participants Est. completion 2015-06 10 sites
    Other conditions: Brain Aneurysm
    View official trial listing →
  • Completed NCT NCT01445405

    Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

    Not yet reported National Cancer Institute (NCI) 3 participants Est. completion 2010-08-27 1 site
    Other conditions: Carcinoma, Squamous, Head and Neck Cancer, Oral Cancer, Laryngeal Cancer, Pharyngeal Cancer
    View official trial listing →
  • Completed NCT NCT01445535

    Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

    Not yet reported National Cancer Institute (NCI) 15 participants Est. completion 2020-10-22 1 site
    Other conditions: T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma, NK T-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01446029

    Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)

    Not yet reported Minneapolis Veterans Affairs Medical Center 601 participants Est. completion 2013-10 1 site
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT01446900

    R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma

    Not yet reported European Institute of Oncology 25 participants Est. completion 2017-12 1 site
    Other conditions: Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT01447121

    User Study of an Investigational Blood Glucose Monitoring System

    Not yet reported Ascensia Diabetes Care 118 participants Est. completion 2011-09 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01448096

    Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

    Not yet reported Chonbuk National University Hospital 33 participants Est. completion 2019-07-10 1 site
    Other conditions: Large B Cell Diffuse Lymphoma
    View official trial listing →
  • Completed NCT NCT01448343

    Effect of Rapid Transfusion With Fluid Management System 2000® (FMS)

    Not yet reported Seoul National University Hospital 10 participants Est. completion 2012-03 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01448694

    Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss

    University of Colorado, Denver 320 participants Est. completion 2014-09 1 site
    Other conditions: Hemorrhage
    View official trial listing →
  • Completed NCT NCT01449266

    Safety and Dialysability of Dotarem® in Dialysed Patients

    Not yet reported Guerbet 10 participants Est. completion 2012-06 1 site
    Other conditions: End-stage Renal Failure
    View official trial listing →
  • Completed NCT NCT01449305

    Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea

    Not yet reported Chen Yi Enterprise, Co., Ltd. 44 participants Est. completion 2012-06 1 site
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT01450371

    Interferential Electrical Stimulation and Vasodilatation in Healthy Individuals

    Hospital de Clinicas de Porto Alegre 11 participants Est. completion 2012-10 3 sites
    Other conditions: Decreased Vascular Flow
    View official trial listing →
  • Withdrawn NCT NCT01451060

    Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for Cesarean

    Not yet reported Instituto Materno Infantil Prof. Fernando Figueira Est. completion 2014-07 1 site
    Other conditions: Preeclampsia, Pregnancy Toxemias
    View official trial listing →
  • Completed NCT NCT01451203

    Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis

    Not yet reported Astellas Pharma Inc 319 participants Est. completion 2014-10-20 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01452880

    Remifentanil in Extracorporeal Shock Wave Lithotripsy

    Not yet reported University of Roma La Sapienza 228 participants Est. completion 2010-07 1 site
    Other conditions: Kidney Calculi
    View official trial listing →
  • Terminated NCT NCT01453088

    Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

    Not yet reported Hackensack Meridian Health 63 participants Est. completion 2022-05-01 2 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01453270

    Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial

    Not yet reported National University Hospital, Singapore 122 participants Est. completion 2014-03 1 site
    Other conditions: Sepsis, Shock, Septic
    View official trial listing →
  • Status unknown NCT NCT01453309

    Cost Effectiveness and Clinical Utility of Cell Saver Use for Two to Three Level Lumbar Fusions

    Not yet reported Norton Leatherman Spine Center 240 participants Est. completion 2013-10 1 site
    Other conditions: Low Back Pain Unresponsive to Non-surgical Care
    View official trial listing →
  • Completed NCT NCT01454284

    A Study in Participants With Type I Diabetes Mellitus

    Not yet reported Eli Lilly and Company 1114 participants Est. completion 2014-02 119 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01454804

    Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

    Not yet reported M.D. Anderson Cancer Center 43 participants Est. completion 2015-03 1 site
    Other conditions: Advanced Cancers
    View official trial listing →
  • Status unknown NCT NCT01455207

    From Uncomplicated Alcoholism to Korsakoff's Syndrome

    Not yet reported University Hospital, Caen 220 participants Est. completion 2015-01 1 site
    Other conditions: Alcoholism, Alcohol Amnestic Disorder
    View official trial listing →
  • Status unknown NCT NCT01455935

    Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention

    Not yet reported Jacobs Neurological Institute 90 participants Est. completion 2014-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01456169

    A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

    Not yet reported Takeda 507 participants Est. completion 2013-01 108 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01457235

    The Effects of Cognitive Remediation on Cognitive Function in Remitted Bipolar Disorder - a Proof of Concept Study

    Not yet reported Copenhagen University Hospital, Rigshospitalet 46 participants Est. completion 2014-01 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01458171

    Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

    Not yet reported CSL Behring 23 participants Est. completion 2012-04 9 sites
    Other conditions: Primary Immune Deficiency Disorder
    View official trial listing →
  • Completed NCT NCT01461018

    Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

    Not yet reported CSL Behring 22 participants Est. completion 2014-07 9 sites
    Other conditions: Primary Immune Deficiency
    View official trial listing →
  • Completed NCT NCT01461057

    A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer

    Not yet reported Hoffmann-La Roche 30 participants Est. completion 2017-10-31 24 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01462734

    MicroRNA Expression in Human Blood Serum and Vitreous Body

    Kyorin University 8 participants 1 site
    Other conditions: MicroRNA Expression Profile in Human Vitreous
    View official trial listing →
  • Status unknown NCT NCT01463085

    Clinical Trial to Assess the Effects of Low-fat Dairy on Systolic Blood Pressure

    Not yet reported Dairy Research Institute 65 participants Est. completion 2012-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01463345

    Blood Conservation in Cardiac Surgery

    Not yet reported Hackensack Meridian Health Est. completion 2013-05 1 site
    Other conditions: Transfusion Reactions, Post Cardiac Surgery
    View official trial listing →
  • Terminated NCT NCT01464788

    Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke

    Not yet reported Andrew D. Barreto, MD 90 participants Est. completion 2015-06-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01465360

    Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

    Exonhit 160 participants 3 sites
    Other conditions: Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, Fronto-temporal Dementia, Primary Progressive Aphasia, Parkinson' Disease Dementia, Mixed Dementia
    View official trial listing →
  • Completed NCT NCT01467687

    Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions

    Not yet reported Synerx Pharma, LLC 58 participants Est. completion 2007-08
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01468363

    Hypervolemia in ESRD Patients in Zonguldak (Prospective Study)

    Not yet reported Zonguldak Bulent Ecevit University 550 participants Est. completion 2012-11 10 sites
    Other conditions: Hemodialysis Fluid Allergy
    View official trial listing →
  • Completed NCT NCT01469156

    Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy

    Not yet reported, Not yet reported Southeast Retina Center, Georgia 20 participants Est. completion 2015-02 1 site
    Other conditions: Polypoidal Choroidal Vasculopathy
    View official trial listing →
  • Completed NCT NCT01469572

    Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

    Not yet reported Emory University 13 participants Est. completion 2018-10 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT01470976

    Goal-directed Resuscitation in High-risk Patients Undergoing Cardiac Surgery

    Not yet reported University of Sao Paulo 126 participants Est. completion 2014-07 1 site
    Other conditions: Perioperative Hemodynamic Optimization, Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT01471522

    International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

    Not yet reported NYU Langone Health 5179 participants Est. completion 2023-05-30 320 sites
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT01472562

    Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma

    Not yet reported Weill Medical College of Cornell University 38 participants Est. completion 2023-07-30 4 sites
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01472627

    Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

    Dana-Farber Cancer Institute 11 participants Est. completion 2018-01 2 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01474213

    Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation

    Not yet reported Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 42 participants Est. completion 2012-01 2 sites
    Other conditions: Intubation; Difficult
    View official trial listing →
  • Completed NCT NCT01474785

    RYGB and the Gastric Adipose Axis

    Not yet reported Vanderbilt University 49 participants Est. completion 2015-07 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT01475422

    Effectiveness of the Self Monitoring of Capillary Blood Glucose at Home

    Not yet reported University of Sao Paulo 91 participants Est. completion 2012-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01476449

    Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

    Not yet reported Retina Vitreous Associates of Florida 20 participants Est. completion 2016-09 2 sites
    Other conditions: Diabetic Retinopathy, Macular Edema
    View official trial listing →
  • Completed NCT NCT01476839

    Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 25 participants Est. completion 2024-05-31 1 site
    Other conditions: Recurrent Adult Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01476969

    Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace

    Not yet reported Central South University 90 participants Est. completion 2012-11 1 site
    Other conditions: Rheumatic Disease of Heart Valve, Ischemic Reperfusion Injury
    View official trial listing →
  • Status unknown NCT NCT01477216

    Determination of Glycemic and Insulinemic Indices

    Not yet reported Finnish Institute for Health and Welfare 142 participants Est. completion 2013-12
    Other conditions: Glucose Metabolism
    View official trial listing →
  • Completed NCT NCT01478347

    A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults

    Not yet reported Novartis Vaccines 18 participants Est. completion 2014-11 1 site
    Other conditions: Meningococcal Disease, Meningococcal Meningitis
    View official trial listing →
  • Withdrawn NCT NCT01480531

    Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection

    Not yet reported Duke University Est. completion 2012-12 1 site
    Other conditions: Aorta Aneurysm, Dissection of Aorta
    View official trial listing →
  • Completed NCT NCT01480908

    Right Bundle Branch Block After Surgical Closure of Ventricular Septal Defect

    Not yet reported University of Aarhus 60 participants Est. completion 2014-12 1 site
    Other conditions: Bundle-Branch Block, Heart Septal Defects, Ventricular
    View official trial listing →
  • Completed NCT NCT01484470

    Umbilical Cord Transplantation for the Elderly Population

    Not yet reported Loyola University 18 participants Est. completion 2018-11-21 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01484782

    Developing Accessible Telehealth Programs for Hypertensive Patients in Latin America

    Not yet reported University of Michigan 200 participants Est. completion 2012-01 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01485731

    Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

    Not yet reported University of Miami 8 participants Est. completion 2015-02 1 site
    Other conditions: Cervical Cancer
    View official trial listing →
  • Status unknown NCT NCT01487746

    Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls

    Meir Medical Center 207 participants Est. completion 2012-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01487837

    Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.

    Not yet reported University Children's Hospital, Zurich 57 participants Est. completion 2014-10 1 site
    Other conditions: Blood Coagulation Disorders, Hemorrhage
    View official trial listing →
  • Completed NCT NCT01488084

    Assessing Vein Graft Properties Between Conventional & No-Touch Harvesting Technique - (PATENT SVG)

    Not yet reported Sunnybrook Health Sciences Centre 15 participants Est. completion 2012-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01491958

    Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

    Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2016-06-27 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT01492127

    Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

    Not yet reported University Hospital, Montpellier 64 participants Est. completion 2016-03 1 site
    Other conditions: Hepatocellular Carcinoma, Cirrhosis
    View official trial listing →
  • Completed NCT NCT01493219

    Biomarkers for Prognosis of Glioblastoma (GBM)

    University of Nebraska 19 participants Est. completion 2017-09-01 1 site
    Other conditions: Glioblastoma
    View official trial listing →
  • Terminated NCT NCT01493323

    Functional Imaging of Psychic Pain

    Not yet reported University Hospital, Montpellier 123 participants Est. completion 2014-12 1 site
    Other conditions: Suicide, Attempted, Mood Disorder
    View official trial listing →
  • Status unknown NCT NCT01493492

    Urinary Proteomics Analysis for Sepsis and Prognosis

    Chinese PLA General Hospital 60 participants Est. completion 2012-01 1 site
    Other conditions: SIRS, Sepsis
    View official trial listing →
  • Status unknown NCT NCT01494389

    The Changes of CD4+T Lymphocyte Subsets in Septic Patients

    Chinese PLA General Hospital Est. completion 2012-03 1 site
    Other conditions: Sepsis, SIRS(Systemic Inflammatory Response Syndrome)
    View official trial listing →
  • Completed NCT NCT01496053

    Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)

    Not yet reported, Not yet reported Oslo University Hospital 100 participants Est. completion 2016-01 1 site
    Other conditions: Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT01497184

    Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

    Not yet reported M.D. Anderson Cancer Center 95 participants Est. completion 2021-03-08 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01498978

    Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

    Not yet reported OHSU Knight Cancer Institute 10 participants Est. completion 2019-01-19 2 sites
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT01500161

    Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

    Not yet reported Texas Oncology Cancer Center 1 participants Est. completion 2013-11 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Hodgkins Disease, Non-Hodgkins Lymphoma, Aplastic Anemia, Multiple Myeloma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01500681

    Maintenance Plasma Exchange for Neuromyelitis Optica

    Mayo Clinic 9 participants Est. completion 2015-07-09 2 sites
    Other conditions: Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis
    View official trial listing →
  • Completed NCT NCT01502917

    Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy

    Not yet reported Y-mAbs Therapeutics 50 participants Est. completion 2022-01 2 sites
    Other conditions: Brain Cancer, Brain Stem Glioma
    View official trial listing →
  • Completed NCT NCT01502943

    Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index

    Not yet reported Liaoning University of Traditional Chinese Medicine 480 participants Est. completion 2011-12 10 sites
    Other conditions: Coronary Heart Disease, Stable Angina Pectoris
    View official trial listing →
  • Completed NCT NCT01503463

    Remote Monitoring of Patients With CHF in Central Greece

    Not yet reported Regional Health Authority of Sterea & Thessaly 60 participants Est. completion 2014-01 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT01504945

    Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)

    Not yet reported, Not yet reported Beth Israel Deaconess Medical Center 60 participants Est. completion 2017-12 1 site
    Other conditions: Acute Coronary Syndrome, Anemia
    View official trial listing →
  • Status unknown NCT NCT01506102

    Thromboelastography During and After Delivery

    Not yet reported Città di Roma Hospital 120 participants Est. completion 2012-05 1 site
    Other conditions: Delivery Uterine
    View official trial listing →
  • Completed NCT NCT01506466

    Weight Variation During Chemotherapy in Breast Cancer Patients

    Not yet reported Centre Jean Perrin 52 participants Est. completion 2014-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01506921

    Racemic Ketamine Versus S-ketamine With Arterial Spin Labeling (ASL)-MRI in Healthy Volunteers

    Not yet reported Lund University 14 participants Est. completion 2012-02 1 site
    Other conditions: Healthy, Abnormal Vascular Flow
    View official trial listing →
  • Status unknown NCT NCT01510548

    ADALISKIAS: Adalimumab for Acute Disc Prolapse

    Not yet reported Kuopio University Hospital 90 participants Est. completion 2014-07 1 site
    Other conditions: Disc Prolapse, Pain
    View official trial listing →
  • Completed NCT NCT01511315

    The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment

    Not yet reported University of California, San Francisco 36 participants Est. completion 2014-12 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01511445

    Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome

    Not yet reported Amedica Corporation 100 participants Est. completion 2015-11 1 site
    Other conditions: Radiating Pain, Myelopathy, Cervicobrachial Syndrome
    View official trial listing →
  • Status unknown NCT NCT01511861

    Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device

    GlucoVista 137 participants Est. completion 2021-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01512199

    Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)

    Not yet reported, Not yet reported Daiichi Sankyo 29 participants Est. completion 2015-01-28 8 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01513083

    A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

    Not yet reported Hoffmann-La Roche 28 participants Est. completion 2014-09 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01513213

    Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient

    Swedish Medical Center 65 participants Est. completion 2016-12 1 site
    Other conditions: Neurosurgery
    View official trial listing →
  • Completed NCT NCT01514344

    Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma

    Not yet reported Andres J. M. Ferreri 20 participants Est. completion 2019-10 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Active, not recruiting NCT NCT01514643

    Inflammatory Response Following Intraarticular Fracture

    University of Utah 60 participants Est. completion 2028-12 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT01515189

    Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

    Not yet reported Bristol-Myers Squibb 831 participants Est. completion 2017-08-17 88 sites
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT01516021

    How Fat Influences the Brain

    Not yet reported University Hospital Tuebingen 11 participants Est. completion 2011-03 1 site
    Other conditions: Fat Processing in the Brain
    View official trial listing →
  • Completed NCT NCT01516216

    Study of Vitamin D in Untreated Metastatic Colorectal Cancer

    Not yet reported Dana-Farber Cancer Institute 139 participants Est. completion 2019-11-09 18 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01516385

    Detection of Peripheral Blood Biomarkers in Intermediate Phase Spinal Cord Injury: Correlation With Neurological and Functional Outcomes, and Comparison to Other Central and Peripheral Neurological Conditions.

    Sheba Medical Center 150 participants 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT01516580

    Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 482 participants Est. completion 2022-11-16 10 sites
    Other conditions: B-cell Non Hodgkin Lymphoma, Mature B-cell Leukemia Burkitt-type
    View official trial listing →
  • Terminated NCT NCT01517347

    Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

    Not yet reported Peking University People's Hospital 90 participants Est. completion 2015-08 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT01520025

    Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

    Not yet reported Ottawa Heart Institute Research Corporation 18 participants Est. completion 2015-01 1 site
    Other conditions: Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT01520493

    Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension

    Not yet reported Laval University 20 participants Est. completion 2015-03 2 sites
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01521039

    Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

    Ohio State University Comprehensive Cancer Center 259 participants Est. completion 2024-12-30 1 site
    Other conditions: Acute Graft-versus-Host Disease, Allogeneic Stem Cell Transplant
    View official trial listing →
  • Completed NCT NCT01523808

    Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer

    Not yet reported ERYtech Pharma 12 participants Est. completion 2011-03
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01525407

    Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center 83 participants Est. completion 2016-02 3 sites
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT01525836

    rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

    Not yet reported Shandong University 123 participants Est. completion 2014-06 1 site
    Other conditions: Purpura, Idiopathic Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT01526213

    Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?

    Not yet reported University of North Carolina, Chapel Hill 18 participants Est. completion 2011-04 1 site
    Other conditions: Food-drug Interaction
    View official trial listing →
  • Status unknown NCT NCT01527058

    68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients

    Not yet reported Peking Union Medical College Hospital 100 participants Est. completion 2017-12 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT01528267

    Bronchoscopic Lung Volume Reduction Using Blood

    Not yet reported Chelsea and Westminster NHS Foundation Trust 10 participants Est. completion 2013-03 1 site
    Other conditions: Emphysema
    View official trial listing →
  • Completed NCT NCT01528449

    Babesia Testing in Blood Donors

    Not yet reported Imugen 90116 participants Est. completion 2014-09 1 site
    Other conditions: Transfusion Transmitted Babesiosis
    View official trial listing →
  • Completed NCT NCT01528644

    Iron & Alginate Study

    Not yet reported University of East Anglia 16 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Iron Deficiency, Anaemia
    View official trial listing →
  • Terminated NCT NCT01530399

    Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery

    Not yet reported The Medicines Company 44 participants Est. completion 2012-11 5 sites
    Other conditions: Bleeding
    View official trial listing →
  • Terminated NCT NCT01532206

    IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction

    Not yet reported Johns Hopkins University 1 participants Est. completion 2014-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01532375

    Kochujang, a Fermented Soybean-based Red Pepper Paste, Decreases Visceral Fat and Improves Blood Lipid Profiles in Overweight Adults

    Not yet reported Chonbuk National University Hospital 60 participants Est. completion 2010-03
    Other conditions: Overweight
    View official trial listing →
  • Completed NCT NCT01534117

    Platelet Function Analysis in Head Trauma: ASA/Plavix

    Not yet reported Chang, Steve S., M.D. 97 participants Est. completion 2011-11 1 site
    Other conditions: Head Injury Trauma Blunt
    View official trial listing →
  • Completed NCT NCT01534247

    A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

    Not yet reported Pfizer 28 participants Est. completion 2012-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01537575

    Intravenous Immunoglobulins for Post-Polio Syndrome

    Not yet reported Azienda Ospedaliera Universitaria Integrata Verona 50 participants
    Other conditions: Post-polio Syndrome
    View official trial listing →
  • Status unknown NCT NCT01538264

    Blood Flow MRI for Monitoring Brain Tumors

    Beth Israel Deaconess Medical Center 125 participants Est. completion 2025-12-31 1 site
    Other conditions: Brain Tumors
    View official trial listing →
  • Completed NCT NCT01538472

    Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2011-11 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT01539343

    Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2016-04 1 site
    Other conditions: Infection
    View official trial listing →
  • Withdrawn NCT NCT01539395

    A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis

    MSDx, Inc. Est. completion 2012-07 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01539512

    A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

    Not yet reported Gilead Sciences 220 participants Est. completion 2014-04 72 sites
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01540123

    The Time Effects of a Berry Extract Upon Cerebral Blood Flow.

    Not yet reported Northumbria University 20 participants Est. completion 2013-05 1 site
    Other conditions: Cerebral Blood Flow
    View official trial listing →
  • Completed NCT NCT01540175

    Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant

    St. Jude Children's Research Hospital 31 participants Est. completion 2015-06 1 site
    Other conditions: Solid Tumor, Brain Tumor, Lymphoma
    View official trial listing →
  • Completed NCT NCT01541319

    Mechanism and Repository Study for the Red Cell Storage Duration Study

    Carelon Research 92 participants Est. completion 2016-08 13 sites
    Other conditions: Cardiac Surgery, Erythrocyte Transfusion
    View official trial listing →
  • Withdrawn NCT NCT01541527

    Non Neutralizing Antibodies: Prevalence and Characterization

    University Hospital, Montpellier Est. completion 2013-08 1 site
    Other conditions: Hemophilia A
    View official trial listing →
  • Terminated NCT NCT01541670

    Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis

    Not yet reported Baxalta now part of Shire 4 participants Est. completion 2012-12-31 24 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01542749

    Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer

    Daxor Corporation 20 participants Est. completion 2012-01
    Heart failure Other conditions: Hypoalbuminemia, Nephrosis, Cirrhosis, Shock
    View official trial listing →
  • Terminated NCT NCT01543126

    IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer

    Fudan University 9 participants Est. completion 2013-02 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01544036

    Monitoring Renal Blood Flow With Contrast Enhanced Ultrasound During Coronary Angiogram

    Not yet reported University of Virginia 150 participants 2 sites
    Other conditions: Contrast Induced Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT01544348

    A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

    Not yet reported MedImmune LLC 295 participants Est. completion 2013-06 7 sites
    Other conditions: Allergic Asthma, Atopic Dermatitis, Allergic Rhinitis, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01544686

    Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients

    Not yet reported University of Cologne 630 participants Est. completion 2015-10 5 sites
    Other conditions: Bloodstream Infection
    View official trial listing →
  • Terminated NCT NCT01545635

    RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma

    Not yet reported Medical University Innsbruck 100 participants Est. completion 2016-02 1 site
    Other conditions: Major Trauma
    View official trial listing →
  • Completed NCT NCT01546545

    Insulin Variance Throughout the Day

    Pennington Biomedical Research Center 11 participants Est. completion 2013-05 1 site
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Terminated NCT NCT01547923

    Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines

    Not yet reported Institut Cancerologie de l'Ouest 1142 participants Est. completion 2013-03-04 25 sites
    Other conditions: Colorectal Cancer, Intravenous 5 Fluorouracile
    View official trial listing →
  • Terminated NCT NCT01549886

    Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma

    Not yet reported Spectrum Pharmaceuticals, Inc 5 participants Est. completion 2015-05 9 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01550965

    A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

    Not yet reported AbbVie (prior sponsor, Abbott) 463 participants Est. completion 2015-04
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01551667

    Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds

    Centre Hospitalier Universitaire de Nīmes 69 participants Est. completion 2016-03 6 sites
    Other conditions: Diabetic Foot, Foot Ulcer, Leg Ulcer, Bacteremia, Infection
    View official trial listing →
  • Completed NCT NCT01552070

    Recruitment on Extravascular Lung Water in Acute Respiratory Distress Syndrome (ARDS)

    Not yet reported Chang Gung Memorial Hospital 30 participants Est. completion 2013-07 2 sites Stand-alone
    Other conditions: Acute Respiratory Distress Syndrome, Acute Lung Injury
    View official trial listing →
  • Completed NCT NCT01552408

    Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)

    Not yet reported, Not yet reported David M. Brown, M.D. 29 participants Est. completion 2017-05-18 3 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01552759

    Appetite Hormones in Binge Eating Disorder

    Not yet reported New York Obesity and Nutrition Research Center 96 participants Est. completion 2012-01 1 site
    Other conditions: Binge Eating Disorder
    View official trial listing →
  • Completed NCT NCT01553058

    Vascular Inflammation in Psoriasis Trial (The VIP Trial)

    Not yet reported University of Pennsylvania 97 participants Est. completion 2016-10-27 9 sites
    Cardiovascular disease Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01553409

    Effect of Blood Donation on Blood Pressure, Iron Metabolism, Oxidative Stress

    Charite University, Berlin, Germany 300 participants Est. completion 2014-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01555021

    Pharmacogenomics for Antidepressant Guidance and Education

    Massachusetts General Hospital 4 participants Est. completion 2012-07 1 site
    Other conditions: Treatment Resistant Depression
    View official trial listing →
  • Completed NCT NCT01556100

    Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression

    Not yet reported Chang Gung Memorial Hospital 40 participants Est. completion 2015-12
    Other conditions: Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT01556347

    Multi-Drug Desensitization Protocol for Heart Transplant Candidates

    Not yet reported Providence Health & Services 2 participants Est. completion 2016-05 1 site
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT01556672

    Adalimumab-psoriasis and Small Bowel Lesions

    Not yet reported Innovaderm Research Inc. 100 participants Est. completion 2016-04 3 sites
    Other conditions: Plaque Psoriasis, Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01557088

    Lp-PLA2 and Coronary Atherosclerosis in Humans

    Not yet reported Mayo Clinic 166 participants Est. completion 2015-06 1 site
    Other conditions: Coronary Atherosclerosis, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT01558089

    Good EULAR Response In Patients With Early Rheumatoid Arthritis

    Pfizer 76 participants Est. completion 2015-05 9 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01558596

    Remote Ischemic Preconditioning Prior to Vascular Surgery

    Not yet reported, Not yet reported VA Office of Research and Development 201 participants Est. completion 2016-09 1 site
    Other conditions: Peripheral Arterial Disease, Vascular Surgery
    View official trial listing →
  • Completed NCT NCT01559402

    Oxygenation Test During General Anesthesia

    Not yet reported Region Västmanland 40 participants Est. completion 2014-03 1 site
    Other conditions: Morbid Obesity
    View official trial listing →
  • Completed NCT NCT01559636

    Diarrhea and Bivalent Oral Polio Vaccine Immunity

    Not yet reported Centers for Disease Control and Prevention 699 participants Est. completion 2013-10 1 site
    Other conditions: Seroimmunity, Diarrhea, Polio
    View official trial listing →
  • Completed NCT NCT01560052

    Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)

    Not yet reported The George Institute 503 participants Est. completion 2021-07-23 66 sites
    Other conditions: IgA Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT01560702

    Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers

    Not yet reported Zagazig University 100 participants Est. completion 2013-09 1 site
    Other conditions: Blood, Injection, Injury Type Phobia, Gastrointestinal Ulcer Haemorrhage, Adverse Reaction to Epinephrine
    View official trial listing →
  • Completed NCT NCT01561131

    The Effect of Protein and Calcium on Weight Change and Blood Lipid Profile

    Not yet reported University of Copenhagen 223 participants Est. completion 2015-01 1 site
    Other conditions: Prevention of Obesity
    View official trial listing →
  • Completed NCT NCT01561313

    Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.

    Not yet reported AbbVie (prior sponsor, Abbott) 64 participants Est. completion 2012-11 6 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT01561482

    Study of Metformin With Simvastatin for Men With Prostate Carcinoma

    Not yet reported Nicholas Mitsiades Est. completion 2014-07 3 sites
    Other conditions: Prostate Carcinoma
    View official trial listing →
  • Completed NCT NCT01561924

    Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

    Not yet reported Novo Nordisk A/S 17 participants Est. completion 2006-05 7 sites Stand-alone
    Other conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
    View official trial listing →
  • Completed NCT NCT01562028

    BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)

    Not yet reported ETOP IBCSG Partners Foundation 109 participants Est. completion 2018-10-31 48 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01562353

    Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction

    Analgesic Solutions 30 participants Est. completion 2013-12 1 site
    Other conditions: Usage of Prescription Opioids
    View official trial listing →
  • Completed NCT NCT01562977

    Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL

    Not yet reported Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 82 participants Est. completion 2015-04 28 sites
    Other conditions: Aggressive Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01564108

    The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema

    Not yet reported Moorfields Eye Hospital NHS Foundation Trust 10 participants Est. completion 2014-06 1 site
    Other conditions: Uveitis Related Cystoid Macular Edema, Steroid-induced Glaucoma - Borderline
    View official trial listing →
  • Completed NCT NCT01564784

    A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

    Not yet reported Pfizer 326 participants Est. completion 2017-01-04 198 sites
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Terminated NCT NCT01565148

    A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)

    Not yet reported Johns Hopkins University 185 participants Est. completion 2014-10 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01565616

    Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

    Not yet reported Emory University 22 participants Est. completion 2016-06-30 8 sites
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT01565837

    Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

    Not yet reported Wolfram Samlowski 50 participants Est. completion 2017-11 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT01565941

    Heart And Lung Failure - Pediatric INsulin Titration Trial

    Not yet reported Boston Children's Hospital 713 participants Est. completion 2018-02 35 sites
    Heart failure Other conditions: Respiratory Failure
    View official trial listing →
  • Completed NCT NCT01566695

    The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

    Not yet reported Celgene 216 participants Est. completion 2023-12-21 196 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01567163

    A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors

    Not yet reported Eli Lilly and Company 22 participants Est. completion 2014-03 6 sites
    Other conditions: Malignant Solid Tumor
    View official trial listing →
  • Completed NCT NCT01567657

    Safety Study of Two Regimen for Sedation for Transesophageal Echocardiography

    Not yet reported Kantonsspital Münsterlingen 200 participants Est. completion 2013-01 1 site
    Other conditions: Hypotension
    View official trial listing →
  • Completed NCT NCT01568944

    Role of Infected Blood Dendritic Cells in Heart Disease Risk

    Not yet reported Augusta University 18 participants Est. completion 2014-09 1 site
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT01568983

    The Effects of Polyphenol-rich Berry Juice on Blood Pressure in Hypertensive Subjects

    Not yet reported University of Oslo 153 participants Est. completion 2012-06 1 site
    Other conditions: Pre-hypertension, Hypertension
    View official trial listing →
  • Completed NCT NCT01570608

    Lucentis KAV Study

    Not yet reported The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 51 participants Est. completion 2011-08 3 sites
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01571687

    Pik Lenin High Altitude Research Expedition 2009

    Not yet reported Insel Gruppe AG, University Hospital Bern 30 participants Est. completion 2009-08 1 site
    Other conditions: Oxidative Stress, Cell-derived Microparticles
    View official trial listing →
  • Completed NCT NCT01572545

    Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

    Not yet reported Aristotle University Of Thessaloniki 91 participants Est. completion 2013-01 3 sites
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT01572818

    Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients

    Not yet reported Rennes University Hospital 13 participants Est. completion 2015-10 2 sites
    Other conditions: Insulin Resistance, Iron Overload
    View official trial listing →
  • Completed NCT NCT01578434

    Role of Calcium And Vitamin D In Nutritional Rickets And It's Management

    Not yet reported Lady Hardinge Medical College 67 participants Est. completion 2009-04
    Other conditions: Nutritional Rickets
    View official trial listing →
  • Completed NCT NCT01578629

    NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event

    Not yet reported, Not yet reported Andrew Slivka 210 participants Est. completion 2018-12 1 site
    Cardiovascular disease Other conditions: Transient Ischemic Attack (TIA)
    View official trial listing →
  • Completed NCT NCT01579656

    Effect of Flax, Poppy, Sesame & Salba on Postprandial Blood Glucose Response, Vascular, Appetite & Sensory Parameters

    Not yet reported Unity Health Toronto 21 participants Est. completion 2012-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01580150

    Effects of Berries on Post-meal Blood Sugar

    Not yet reported Marjukka Kolehmainen 20 participants Est. completion 2012-01 1 site
    Other conditions: Blood Glucose, Postprandial, Blood Insulin, Postprandial, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01580293

    A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

    Not yet reported, Not yet reported Bayer 145 participants Est. completion 2019-11-21 59 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Terminated NCT NCT01580618

    Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

    Not yet reported, Not yet reported Kaiser Permanente 20 participants Est. completion 2011-09 1 site
    Other conditions: Pleural Effusion
    View official trial listing →
  • Completed NCT NCT01580865

    Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis

    Not yet reported Ramathibodi Hospital 84 participants Est. completion 2017-03 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01581411

    Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion

    Not yet reported Weill Medical College of Cornell University 1 participants Est. completion 2015-11 1 site
    Other conditions: Central Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT01583582

    Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp

    Not yet reported Marealis AS 74 participants Est. completion 2012-12 1 site
    Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Completed NCT NCT01583634

    Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin

    Mespere Lifesciences Inc. 9 participants Est. completion 2014-10 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT01584687

    mRNA Expression as a Biomarker of Omalizumab Response

    Not yet reported Instituto de Investigação em Imunologia 6 participants Est. completion 2012-12
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01584778

    Behçet's Disease and Eosinophil Cationic Protein

    Cukurova University 47 participants Est. completion 2002-12 1 site
    Other conditions: Behçet's Disease
    View official trial listing →
  • Completed NCT NCT01585987

    An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

    Not yet reported Bristol-Myers Squibb 143 participants Est. completion 2015-04 36 sites
    Other conditions: Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction
    View official trial listing →
  • Completed NCT NCT01586702

    Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients

    Not yet reported Charite University, Berlin, Germany 2082 participants Est. completion 2019-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01588457

    Sequential Multiple Assignment Treatment for Bipolar Disorder

    Not yet reported The University of Texas Health Science Center at San Antonio 112 participants Est. completion 2016-12 2 sites
    Other conditions: Bipolar I Disorder, Bipolar II Disorder
    View official trial listing →
  • Completed NCT NCT01588561

    Nicotine Related Brain Activity: The Influence of Smoking History and Blood Nicotine Levels

    Not yet reported Mclean Hospital 15 participants Est. completion 2015-09 1 site
    Other conditions: Nicotine Dependence
    View official trial listing →
  • Completed NCT NCT01588704

    Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma

    Not yet reported Si-Yu Wang 42 participants Est. completion 2014-04 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT01589822

    The EVICEL® Gastrointestinal Study

    Not yet reported Ethicon, Inc. 214 participants Est. completion 2014-09 22 sites
    Other conditions: Gastrointestinal Diseases
    View official trial listing →
  • Completed NCT NCT01590823

    An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients

    Not yet reported Nova Scotia Health Authority 10 participants Est. completion 2012-09 1 site
    Other conditions: Blood Coagulation Disorders
    View official trial listing →
  • Status unknown NCT NCT01590849

    Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone

    Not yet reported Instituto do Coracao 69 participants 1 site
    Other conditions: Contraceptive Affecting the Autonomic Nervous System, Contraceptive Affecting Blood Pressure
    View official trial listing →
  • Completed NCT NCT01592539

    Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

    Creighton University 78 participants Est. completion 2013-08 1 site
    Other conditions: Type 1 Diabetes,, Bone
    View official trial listing →
  • Completed NCT NCT01592669

    Passive Leg Raising Attenuates and Delays Tourniquet Deflation-induced Hypotension and Tachycardia

    Not yet reported Tri-Service General Hospital (TSGH) 35 participants Est. completion 2011-08 1 site
    Other conditions: Hypotension, Tachycardia
    View official trial listing →
  • Completed NCT NCT01594177

    Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy

    Not yet reported GBG Forschungs GmbH 65 participants Est. completion 2014-03 1 site
    Other conditions: Unilateral HER2 Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01594229

    A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported AbbVie 60 participants Est. completion 2020-07-14 8 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01595659

    Influence of Alcohol and Peer Passengers on Risky Driving Behavior in Young Adults

    Not yet reported Centre de recherche du Centre hospitalier universitaire de Sherbrooke 240 participants Est. completion 2015-06-03 1 site
    Other conditions: Accidents, Traffic
    View official trial listing →
  • Terminated NCT NCT01596699

    Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

    Not yet reported University of California, San Francisco 16 participants Est. completion 2019-06 1 site
    Other conditions: Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect, Congenital Immunodeficiency, Metabolic Disease, Severe Immune Dysregulation
    View official trial listing →
  • Completed NCT NCT01596790

    COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

    Not yet reported University Hospital, Montpellier 168 participants Est. completion 2019-09 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01596998

    Plasma Concentrations of Levobupivacaine With and Without Epinephrine in Transversus Abdominis Plane Blocks

    Not yet reported Pontificia Universidad Catolica de Chile 11 participants Est. completion 2012-04 1 site
    Other conditions: Transversus Abdominis Plane Block
    View official trial listing →
  • Completed NCT NCT01597011

    Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh Fixation

    Herlev Hospital 2340 participants Est. completion 2014-09 1 site
    Other conditions: Hernia, Inguinal, Recurrence, Chronic Pain
    View official trial listing →
  • Completed NCT NCT01597414

    Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 80 participants Est. completion 2022-11 30 sites
    Other conditions: Elderly Metastatic Breast Cancer Population
    View official trial listing →
  • Terminated NCT NCT01598025

    Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    Not yet reported Memorial Sloan Kettering Cancer Center 3 participants Est. completion 2017-10-16 1 site
    Other conditions: Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma
    View official trial listing →
  • Completed NCT NCT01600118

    Effect of Shock Waves on Dental Parameters

    Not yet reported, Not yet reported Medical University of Vienna 72 participants Est. completion 2013-12 1 site
    Other conditions: Tooth Stability, Blood Flow
    View official trial listing →
  • Status unknown NCT NCT01600911

    Establish a Vegetable Signature Database From Human Metabolomics Responses

    Not yet reported National Health Research Institutes, Taiwan 50 participants Est. completion 2013-12 1 site
    Other conditions: Human Metabolomic Responses to Plant Foods, Blood Pressure
    View official trial listing →
  • Terminated NCT NCT01602302

    Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis

    Not yet reported Medical University of Graz 40 participants Est. completion 2020-11-19 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01602315

    A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Not yet reported, Not yet reported Novartis Pharmaceuticals 179 participants Est. completion 2016-09-16 29 sites
    Other conditions: Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01602445

    Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

    Ottawa Hospital Research Institute 700 participants Est. completion 2016-10 5 sites
    Other conditions: Venous Thromboembolism, Deep-Vein Thrombosis, Pulmonary Embolism, Cancer
    View official trial listing →
  • Completed NCT NCT01603940

    Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

    Not yet reported Hospital Universitario Pedro Ernesto 30 participants Est. completion 2015-01 1 site
    Other conditions: Hypertension, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01604993

    Acute Effect of Nitrate From Natural Dietary Sources on Arterial Stiffness and Blood Pressures in Healthy Individuals

    Not yet reported Unity Health Toronto 31 participants Est. completion 2013-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01605318

    Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Gilead Sciences 92 participants Est. completion 2017-01-03 7 sites
    Other conditions: Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01608594

    Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma

    Not yet reported Diwakar Davar 30 participants Est. completion 2017-02-27 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT01608971

    Protamine in Cardiac Surgery and Haemostasis

    Heart and Diabetes Center North-Rhine Westfalia 30 participants Est. completion 2012-03 1 site
    Other conditions: Bleeding, Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT01608984

    Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary Artery Bypass Grafting(RIPCON)

    Not yet reported Heinrich-Heine University, Duesseldorf 100 participants Est. completion 2015-12 1 site
    Other conditions: Myocardial Injury
    View official trial listing →
  • Completed NCT NCT01609010

    A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma

    Not yet reported Hoffmann-La Roche 313 participants Est. completion 2011-07 31 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT01609023

    A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia

    Hoffmann-La Roche 67 participants Est. completion 2015-11 9 sites
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Status unknown NCT NCT01609699

    Effectiveness Study of the UltraShape® Contour I-Y for Non-Invasive Reduction in Abdominal Circumference

    Not yet reported UltraShape 30 participants Est. completion 2012-12 1 site
    Other conditions: Reduction in Abdominal Circumference
    View official trial listing →
  • Completed NCT NCT01610154

    Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics

    Not yet reported Guangwei Li 85 participants Est. completion 2015-06 1 site
    Other conditions: Insulin Secretion, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01610947

    Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity

    Not yet reported University Hospital, Montpellier 398 participants Est. completion 2018-10-18 1 site
    Other conditions: Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT01613027

    An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

    Hoffmann-La Roche 135 participants Est. completion 2015-09 14 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01613495

    Ghrelin Suppression by Octreotide in Prader-Willi

    Not yet reported Oregon Health and Science University 2 participants Est. completion 2024-11
    Other conditions: Prader Willis Syndrome
    View official trial listing →
  • Completed NCT NCT01613807

    Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes

    Not yet reported Sansum Diabetes Research Institute 40 participants Est. completion 2010-10
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT01614223

    Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis

    Not yet reported University of Western Ontario, Canada 140 participants Est. completion 2015-09 1 site
    Other conditions: Chronic Plantar Fasciitis
    View official trial listing →
  • Completed NCT NCT01614951

    The Pulmonary Protection Trial

    Not yet reported Copenhagen University Hospital, Rigshospitalet 90 participants Est. completion 2013-11 1 site
    Other conditions: Chronic Obstructive Lung Disease
    View official trial listing →
  • Terminated NCT NCT01615146

    Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot

    Not yet reported Ottawa Hospital Research Institute 9 participants Est. completion 2015-06 1 site
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Status unknown NCT NCT01615302

    Is the Use of Blood Platelets Effective in the Treatment of Difficult Fistulas Related to the Anal Sphincter?

    Not yet reported Maastricht University Medical Center 120 participants Est. completion 2016-04 6 sites
    Other conditions: Rectal Fistula
    View official trial listing →
  • Withdrawn NCT NCT01616680

    Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease

    Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Withdrawn NCT NCT01617473

    Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant

    Not yet reported Peking University People's Hospital Est. completion 2017-10 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT01619761

    NK Cells in Cord Blood Transplantation

    Not yet reported M.D. Anderson Cancer Center 13 participants Est. completion 2021-11 1 site
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, ISS Stage II Plasma Cell Myeloma, ISS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Small Lymphocytic Lymphoma, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01622101

    Thermogenic Properties of Zantrex-3

    Not yet reported University of Copenhagen 23 participants Est. completion 2007-08 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT01622179

    Outcome of Two Different Suture Methods for Achilles Tendon Rupture

    Not yet reported Peifu Tang 40 participants Est. completion 2013-06 1 site
    Other conditions: Achilles Tendon Rupture
    View official trial listing →
  • Completed NCT NCT01624766

    Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

    Not yet reported M.D. Anderson Cancer Center 57 participants Est. completion 2021-02-24 1 site
    Other conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm, Refractory Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT01625351

    A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

    Not yet reported St. Jude Children's Research Hospital 23 participants Est. completion 2020-02-10 1 site
    Obstructive sleep apnea Other conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT01625741

    Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6 participants Est. completion 2015-05 15 sites
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01625936

    CRLX101 Plus Bevacizumab in Advanced RCC

    Not yet reported Abramson Cancer Center at Penn Medicine 22 participants Est. completion 2018-07-16 1 site
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01626092

    Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders

    Not yet reported Masonic Cancer Center, University of Minnesota 3 participants Est. completion 2013-11 1 site
    Other conditions: Lysosomal Storage Disease, Peroxisomal Disorder
    View official trial listing →
  • Status unknown NCT NCT01626469

    Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic Patients

    Not yet reported, Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2020-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01627379

    Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer

    Not yet reported AIO-Studien-gGmbH 300 participants Est. completion 2017-05 1 site
    Other conditions: Esophageal Squamous Cell Cancer
    View official trial listing →
  • Completed NCT NCT01628133

    Packed Red Blood Cell Transfusion and Intestinal Blood Flow in Preterm Neonates

    St. Louis University 25 participants Est. completion 2014-01 1 site
    Other conditions: Intestinal Blood Flow
    View official trial listing →
  • Completed NCT NCT01628354

    Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

    Not yet reported University of Melbourne 49 participants Est. completion 2010-04 1 site
    Other conditions: Choroidal Neovascularization, Retinal Pigment Epithelial Detachment
    View official trial listing →
  • Completed NCT NCT01629004

    Increasing Uptake of Colorectal Cancer Screening in Ontario

    Not yet reported Sunnybrook Health Sciences Centre 5155 participants Est. completion 2013-12 1 site
    Other conditions: Colorectal Disorders
    View official trial listing →
  • Terminated NCT NCT01629511

    Allogeneic Stem Cell Transplant for CLL

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2018-04-25 1 site
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Richter Syndrome
    View official trial listing →
  • Completed NCT NCT01629758

    Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

    Not yet reported Bristol-Myers Squibb 33 participants Est. completion 2014-12 5 sites
    Other conditions: Neoplasms by Site
    View official trial listing →
  • Status unknown NCT NCT01633359

    The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients

    Not yet reported Ji Huang 300 participants Est. completion 2013-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01633541

    Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

    Not yet reported University of Michigan Rogel Cancer Center 55 participants Est. completion 2021-11-06 1 site
    Other conditions: Laryngeal Cancer
    View official trial listing →
  • Completed NCT NCT01634217

    Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Masonic Cancer Center, University of Minnesota 16 participants Est. completion 2018-12-01 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01634568

    A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

    Not yet reported Vernalis (R&D) Ltd 49 participants Est. completion 2012-02 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT01634815

    Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization

    Not yet reported University Hospital, Strasbourg, France 12 participants Est. completion 2015-08-21 2 sites
    Other conditions: Chronic Critical Ischemia
    View official trial listing →
  • Completed NCT NCT01635764

    Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa

    Not yet reported AbbVie (prior sponsor, Abbott) 508 participants Est. completion 2016-08
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT01636154

    Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations

    Not yet reported Yunling Zhang 120 participants Est. completion 2016-08 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01637194

    Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

    Not yet reported Fox Chase Cancer Center 12 participants Est. completion 2011-07 1 site
    Other conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Colon Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Stage IVA Colon Cancer, Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Colon Cancer, Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Tongue Cancer
    View official trial listing →
  • Completed NCT NCT01637623

    Study of Cardiovascular Disease and Obstructive Sleep Apnea

    Not yet reported University of Wisconsin, Madison 87 participants Est. completion 2015-06 4 sites
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01638715

    A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action

    Not yet reported Medical University of Vienna 115 participants Est. completion 2018-08-01 9 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01638819

    Autologous Cord Blood Stem Cells for Autism

    Not yet reported Sutter Health 30 participants Est. completion 2016-12 1 site
    Other conditions: Autism
    View official trial listing →
  • Completed NCT NCT01638858

    Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

    Not yet reported University of Luebeck 25 participants 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01639404

    Umbilical Cord Blood Therapy for Children With Cerebral Palsy

    Not yet reported MinYoung Kim, M.D. 17 participants Est. completion 2013-03 1 site
    Other conditions: Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT01640171

    Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

    Not yet reported Retina Vitreous Associates of Florida 57 participants Est. completion 2013-10 1 site
    Other conditions: Age-related Macular Degeneration, Central Retinal Vein Occlusion, Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01642836

    Clinic, Family & Community Intervention for Children With Overweight and Obesity (Stanford GOALS)

    Not yet reported Stanford University 241 participants Est. completion 2016-12-19 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01646385

    Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

    Pfizer 6393 participants Est. completion 2012-08
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01646671

    Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 35 participants Est. completion 2013-02 9 sites
    Other conditions: Severe Hypertension
    View official trial listing →
  • Completed NCT NCT01647555

    Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer

    Centre Oscar Lambret 57 participants Est. completion 2014-10 7 sites
    Other conditions: Epidermoid Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT01647620

    A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

    Not yet reported Diakron Pharmaceuticals 30 participants Est. completion 2012-09 1 site
    Cardiovascular disease Other conditions: Deep Vein Thrombosis Leg
    View official trial listing →
  • Completed NCT NCT01648166

    Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

    Susanne Arnold 520 participants Est. completion 2019-09-04 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01648946

    Transfusion Requirements in Critically Ill Oncologic Patient

    Not yet reported Instituto do Cancer do Estado de São Paulo 300 participants Est. completion 2013-06 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01651351

    GLASSIA Infusion Rate Study

    Not yet reported Baxalta now part of Shire 30 participants Est. completion 2013-01-16 1 site
    Other conditions: Alpha1-antitrypsin Deficiency, Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT01653678

    Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)

    Not yet reported Brigham and Women's Hospital 25875 participants Est. completion 2026-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01654380

    A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

    Not yet reported Eli Lilly and Company 22 participants Est. completion 2013-10 1 site
    Other conditions: Healthy Volunteers, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01654445

    TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion

    Not yet reported University of Calgary 50 participants Est. completion 2014-07 1 site
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT01654835

    A Effectiveness Trial of Early Hemodynamic Support in Patients Demonstrating a Low Systolic Blood Pressure

    Not yet reported The Cleveland Clinic Est. completion 2013-12 1 site
    Other conditions: Intraoperative Low Blood Pressure
    View official trial listing →
  • Completed NCT NCT01654913

    Influence of Oxygen on Non-invasive Measurement of Hemoglobin

    Not yet reported Hopital Foch 47 participants Est. completion 2014-11 2 sites
    Other conditions: Anesthesia
    View official trial listing →
  • Status unknown NCT NCT01655472

    Schizophrenia Imaging

    Not yet reported Tel-Aviv Sourasky Medical Center 80 participants Est. completion 2015-07 8 sites
    Other conditions: Foetal Differences Between Healthy and Schizophernic Parents
    View official trial listing →
  • Completed NCT NCT01656304

    Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported Barbara Ann Karmanos Cancer Institute 16 participants Est. completion 2012-06 2 sites
    Other conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT01657513

    TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

    Not yet reported University Hospital, Gentofte, Copenhagen 60 participants 2 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01657773

    Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm

    Wenzhou Medical University 2315 participants Est. completion 2012-07 1 site
    MASLD Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT01658787

    Global Registry for Endovascular Aortic Treatment (GREAT)

    W.L.Gore & Associates 4600 participants Est. completion 2027-06 6 sites
    Other conditions: Multiple Pathologies
    View official trial listing →
  • Completed NCT NCT01660698

    Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic Individuals

    Not yet reported Société des Produits Nestlé (SPN) 20 participants Est. completion 2012-01 1 site
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Status unknown NCT NCT01661361

    Optimalisation of Therapeutic Drug Monitoring (TDM) of Vancomycin in Patients With Central Venous Port Devices

    Universitaire Ziekenhuizen KU Leuven 15 participants Est. completion 2012-12
    Other conditions: Catheter-related Infection
    View official trial listing →
  • Completed NCT NCT01661790

    Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

    Not yet reported Chinese PLA General Hospital 72 participants Est. completion 2012-10 1 site
    Other conditions: Malignant Pleural Effusion
    View official trial listing →
  • Withdrawn NCT NCT01663584

    Multi-disease Carrier Screening Test Validation

    Natera, Inc. 1 site
    Other conditions: Spinal Muscular Atrophy (SMA), Carrier Screening, Genetic Testing
    View official trial listing →
  • Completed NCT NCT01664182

    Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

    Not yet reported National Cancer Institute (NCI) 41 participants Est. completion 2020-12-07 12 sites
    Other conditions: Advanced Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7
    View official trial listing →
  • Terminated NCT NCT01664988

    Effect of Muscular Relaxation and Breathing Technique on Blood Pressure in Pregnancy

    Not yet reported, Not yet reported Mashhad University of Medical Sciences 60 participants Est. completion 2012-02
    Other conditions: Blood Pressure in Pregnancy
    View official trial listing →
  • Completed NCT NCT01665768

    Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56 participants Est. completion 2020-08 1 site
    Other conditions: CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL), Transformed Lymphoma/DLBCL/PMBCL, Hodgkin's Disease, Gray Zone Lymphoma
    View official trial listing →
  • Completed NCT NCT01666899

    Effect of Radiation on Tissue for Delayed Breast Reconstruction

    Not yet reported University of Michigan Rogel Cancer Center 10 participants Est. completion 2015-06-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01668225

    Impact of Follicular and Blood G-CSF During a Natural Cycle of IVF

    Clinique Ovo 152 participants Est. completion 2017-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT01669759

    The Study in the Correlation Between the Severity of Post-stroke Fatigue and the Severity of qi Deficiency and Blood Stasis

    China Medical University Hospital 90 participants Est. completion 2013-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01669928

    Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control

    Not yet reported Imperial College London 103 participants Est. completion 2015-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01670084

    Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

    Not yet reported Mayo Clinic Est. completion 2017-09 2 sites
    Other conditions: B-cell Adult Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT01670370

    Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2019-12
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01674491

    Effects of Black Soy Peptide Supplementation on Blood Pressure

    Not yet reported Yonsei University 100 participants Est. completion 2012-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01676454

    Serum Vasopressin Levels and Severe Hemorrhagic Shock

    Poudre Valley Health System Est. completion 2013-01 1 site
    Other conditions: Injury
    View official trial listing →
  • Completed NCT NCT01677208

    Danhong Injection in the Treatment of Acute Ischemic Stroke

    Not yet reported China Academy of Chinese Medical Sciences 1503 participants Est. completion 2019-03-27 62 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01677572

    Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease

    Not yet reported Biogen 197 participants Est. completion 2019-07-31 32 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT01677884

    Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 10 participants Est. completion 2016-02 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT01678469

    Lipophilic Micronutrients, Adipokines and Gestational Diabetes Mellitus

    Not yet reported Assistance Publique Hopitaux De Marseille 348 participants Est. completion 2022-10-27 1 site
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01679041

    High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment

    Not yet reported Seah Lim M.D. 1 participants Est. completion 2013-11 3 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01681394

    Effect of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression

    Not yet reported Technological Centre of Nutrition and Health, Spain 25 participants Est. completion 2013-02 1 site
    Other conditions: Cardiovascular Function, Gene Expression
    View official trial listing →
  • Status unknown NCT NCT01682122

    Frequency and Persistence of Wide Pulse Pressure in the Neonatal Population

    Staten Island University Hospital 196 participants 1 site
    Other conditions: Blood Pressure, Pediatrics, Infant, Newborn, Cardiology
    View official trial listing →
  • Completed NCT NCT01682564

    To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure

    Not yet reported Chong Kun Dang Pharmaceutical 169 participants Est. completion 2014-10 14 sites
    Heart failure Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01682629

    Examining the Effect of a Scripted Debriefing on Resuscitation Performance in Pediatrics

    Not yet reported KidSIM Simulation Program 443 participants Est. completion 2011-02 1 site
    Other conditions: Pediatric Cardiac Arrest (Simulated)
    View official trial listing →
  • Terminated NCT NCT01682928

    Hydrotherapy for the Reversal of Oligohydramnios

    Not yet reported Pediatrix 4 participants Est. completion 2014-12 1 site
    Other conditions: Oligohydramnios
    View official trial listing →
  • Completed NCT NCT01683357

    Prognosis of One-stage Hepatectomy for Bilobar Colorectal Metastases

    University of Milan 58 participants Est. completion 2012-07 1 site
    Other conditions: Liver Metastases
    View official trial listing →
  • Terminated NCT NCT01684462

    The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke

    Not yet reported Seoul St. Mary's Hospital 2 participants Est. completion 2014-09 4 sites
    Other conditions: Cerebral Infarction
    View official trial listing →
  • Status unknown NCT NCT01686269

    Endothelial Progenitor Cells

    Not yet reported Far Eastern Memorial Hospital 50 participants 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01687439

    Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)

    Not yet reported Fudan University 15 participants Est. completion 2009-10 1 site
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01688505

    Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function

    Hallym University Medical Center 140 participants Est. completion 2013-02 5 sites
    Other conditions: Cerebral Small Vessel Diseases
    View official trial listing →
  • Withdrawn NCT NCT01689870

    Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma

    Not yet reported, Not yet reported Ludwig Institute for Cancer Research Est. completion 2014-08
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT01690104

    The Effect of PXR Activation on Blood Pressure Regulation

    Not yet reported University of Oulu 22 participants Est. completion 2013-12 1 site
    Other conditions: Blood Pressure Regulation
    View official trial listing →
  • Terminated NCT NCT01692002

    Oral Propionate to Treat and Prevent Diabetes

    Not yet reported Imperial College London 6 participants Est. completion 2019-08 3 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01692119

    Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure

    Not yet reported Federal Union of German Associations of Pharmacists 258 participants Est. completion 2019-03 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01692353

    Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers

    R.J. Reynolds Tobacco Company 168 participants Est. completion 2009-04 1 site
    Cardiovascular disease Other conditions: Cigarette Smoking
    View official trial listing →
  • Completed NCT NCT01692561

    MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters

    Wake Forest University Health Sciences 22 participants Est. completion 2013-06-11 1 site
    Other conditions: Dysautonomia
    View official trial listing →
  • Completed NCT NCT01693016

    Validation of Non-invasive Hemoglobin (SpHb) Measurement in Children

    Not yet reported Johannes Gutenberg University Mainz 81 participants Est. completion 2013-01 1 site
    Other conditions: Non-invasive Hb Measurement in Children
    View official trial listing →
  • Status unknown NCT NCT01695499

    Diagnostic Study of Biomarkers in BAL of ICU Patients With Lung Infiltrates

    Heidelberg University 200 participants Est. completion 2020-12 1 site
    Other conditions: INvasive Aspergillosis, Mechanical Ventilation, Lung Infiltrates, Diagnostics, Biomarker
    View official trial listing →
  • Completed NCT NCT01696097

    The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults

    Not yet reported Purdue University 19 participants Est. completion 2014-10 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01696461

    A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

    Not yet reported Center for International Blood and Marrow Transplant Research 127 participants Est. completion 2016-08 12 sites
    Other conditions: Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01696500

    Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

    Not yet reported Nihon Pharmaceutical Co., Ltd 10 participants Est. completion 2014-06 1 site
    Other conditions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
    View official trial listing →
  • Active, not recruiting NCT NCT01696994

    Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

    Not yet reported National Cancer Institute (NCI) 78216 participants Est. completion 2027-06-30 1 site
    Other conditions: Ovarian Carcinoma, Ovarian Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT01698307

    Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy

    Not yet reported Alimentiv Inc. 1095 participants Est. completion 2020-04-16 22 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Status unknown NCT NCT01698853

    Difference Between Central and Peripheral Arterial Blood Oxygen Saturation With Different CPB Strategy

    Xijing Hospital 60 participants Est. completion 2013-05 1 site
    Other conditions: Bypass Complications, Disorder of Blood Gas
    View official trial listing →
  • Status unknown NCT NCT01700218

    Integrated Telemonitoring and Nurse Support Evaluation

    Not yet reported Medical University of Graz 350 participants Est. completion 2015-10 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01700751

    Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

    Not yet reported Washington University School of Medicine 17 participants Est. completion 2016-11-21 1 site
    Other conditions: Leukemia, Acute Myeloid, Leukemia, Lymphoblastic,Acute, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT01701050

    Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index

    Janssen Diagnostics, LLC 121 participants Est. completion 2016-11-10 20 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01701674

    Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 13 participants Est. completion 2025-08-21 1 site
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT01701986

    Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2024-06-05 1 site
    Other conditions: Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01702272

    Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS

    Gen-Probe, Incorporated 150000 participants Est. completion 2014-01 1 site
    Other conditions: Dengue
    View official trial listing →
  • Completed NCT NCT01704703

    Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques

    Not yet reported Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 72 participants Est. completion 2016-07 1 site
    Other conditions: Stage IV Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01705041

    Preliminary Evaluation of a Point-Of-Care Liver Function Test

    Not yet reported PATH 700 participants Est. completion 2012-12 1 site
    Other conditions: HIV, Tuberculosis, Drug-Induced Liver Injury
    View official trial listing →
  • Withdrawn NCT NCT01705470

    Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction

    Not yet reported Tel-Aviv Sourasky Medical Center Est. completion 2013-06
    Other conditions: Anemia Treatment Among Patients Suffering From Left Ventricular Systolic Dysfunction
    View official trial listing →
  • Completed NCT NCT01706432

    Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

    University of Chicago 4 participants Est. completion 2024-01-22 1 site
    Other conditions: Central Nervous System Metastases, Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma With Predominant Intraductal Component, Invasive Lobular Breast Carcinoma, Invasive Lobular Breast Carcinoma With Predominant in Situ Component, Liver Metastases, Lobular Breast Carcinoma in Situ, Lung Metastases, Male Breast Cancer, Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate, Mucinous Ductal Breast Carcinoma, Papillary Ductal Breast Carcinoma, Recurrent Breast Cancer, Stage IV Breast Cancer, Tubular Ductal Breast Carcinoma, Tumors Metastatic to Brain
    View official trial listing →
  • Completed NCT NCT01706718

    Beetroot Enriched Bread, Blood Pressure and Vascular Function

    Not yet reported University of Reading 24 participants Est. completion 2010-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01707225

    Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

    Not yet reported Virginia Commonwealth University 10 participants Est. completion 2014-10 1 site
    Other conditions: Gastrointestinal Bleeding
    View official trial listing →
  • Withdrawn NCT NCT01707758

    Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence

    University of Kansas Est. completion 2013-02
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01708941

    Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 88 participants Est. completion 2026-05-26 276 sites
    Other conditions: Recurrent Melanoma, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
    View official trial listing →
  • Terminated NCT NCT01709136

    Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

    Not yet reported, Not yet reported University of Pittsburgh 3 participants Est. completion 2010-01
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01709162

    Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

    Not yet reported Bristol-Myers Squibb 31 participants Est. completion 2014-07 17 sites
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT01709539

    Clinical Evaluation of a New Cancer Diagnosis Center at Kristianstad General Hospital, Sweden

    Not yet reported Region Skane 388 participants Est. completion 2021-12 2 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01710358

    A Study in Moderate to Severe Rheumatoid Arthritis

    Not yet reported Eli Lilly and Company 1307 participants Est. completion 2015-09 213 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01711164

    The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis

    University Health Network, Toronto 106 participants Est. completion 2016-09 1 site
    Other conditions: Chronic Hepatitis C Infection
    View official trial listing →
  • Completed NCT NCT01711593

    Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma

    Not yet reported Andrew D. Luster, M.D.,Ph.D. 43 participants Est. completion 2016-09 1 site
    Other conditions: Asthma, Allergies
    View official trial listing →
  • Completed NCT NCT01712841

    Non-exudative Age-related Macular Degeneration

    Oregon Health and Science University 30 participants Est. completion 2018-01-18 1 site
    Other conditions: Non-exudative Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01712919

    Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

    Not yet reported, Not yet reported Jiangsu Cancer Institute & Hospital 61 participants Est. completion 2014-03 1 site
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Completed NCT NCT01713478

    Subclinical Myocardial Dysfunction in Patients With Hepatic Cirrhosis

    Not yet reported Carol Davila University of Medicine and Pharmacy 100 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Cirrhosis, Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01714232

    Evaluation of Blood Glucose Meter Systems

    Not yet reported Ascensia Diabetes Care 106 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT01715220

    Treatment of Suspected Cholelithiasis With Nitroglycerin

    Not yet reported United States Naval Medical Center, San Diego 62 participants Est. completion 2019-03 1 site
    Other conditions: COLIC, BILIARY TRACT DISEASES
    View official trial listing →
  • Completed NCT NCT01715480

    Effect of Broccoli Sprouts Homogenate on SS RBC

    Not yet reported Duke University 21 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Sickle Red Blood Cell, Fetal Hemoglobin, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT01715597

    Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma

    Not yet reported Seoul National University Hospital 50 participants Est. completion 2017-10 1 site
    Other conditions: Uterine Leiomyoma
    View official trial listing →
  • Completed NCT NCT01716312

    Omalizumab for Lupus

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 17 participants Est. completion 2017-08-24 1 site
    Other conditions: Systemic Lupus Erthematosus, Sjogren's Syndrome
    View official trial listing →
  • Completed NCT NCT01716416

    Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)

    Not yet reported Washington University School of Medicine 32 participants Est. completion 2017-08-31 1 site
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Status unknown NCT NCT01716442

    Rituximab Trial for Pediatric Nephrotic Syndrome

    Not yet reported, Not yet reported Seoul National University Childrens Hospital 88 participants Est. completion 2013-11 1 site
    Other conditions: Steroid Resistant Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT01716533

    Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

    Not yet reported GlaxoSmithKline 57 participants Est. completion 2015-06-01 5 sites
    Other conditions: Infections, Clostridium Difficile
    View official trial listing →
  • Completed NCT NCT01716923

    Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia

    Not yet reported Cerus Corporation 81 participants Est. completion 2014-10 2 sites
    Other conditions: Focus:Use of S303 RBCs in Patients With Acute Anemia
    View official trial listing →
  • Status unknown NCT NCT01717612

    A Prospective, Randomized Trial of Histoacryl Injection Versus Thrombin in the Control of Acute Gastric Variceal Bleeding

    Not yet reported National Science and Technology Council, Taiwan 62 participants 1 site
    Other conditions: Ulcer, on Gastric Varices, Rebleeding From Gastric Varices
    View official trial listing →
  • Completed NCT NCT01717742

    Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

    Not yet reported The Hospital for Sick Children 97 participants Est. completion 2017-12 6 sites
    Other conditions: Pleural Empyema
    View official trial listing →
  • Completed NCT NCT01718470

    Proseal Laryngeal Mask Airway or Endotracheal Tube for Emergence From Neuroanesthesia

    Not yet reported Ricard Valero 42 participants Est. completion 2012-03 1 site
    Other conditions: Hypertension on Emergence
    View official trial listing →
  • Completed NCT NCT01720264

    Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    Not yet reported Sherif S. Farag 15 participants Est. completion 2017-12-15 2 sites
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Hematopoetic Myelodysplasia, Leukemia, Myelogenous, Chronic, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT01721759

    Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

    Not yet reported Bristol-Myers Squibb 117 participants Est. completion 2021-04-22 33 sites
    Other conditions: Squamous Cell Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01722162

    Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer

    Not yet reported Washington University School of Medicine 47 participants Est. completion 2015-10 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT01722214

    Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

    Not yet reported Innovaderm Research Inc. 107 participants Est. completion 2016-01 5 sites
    Other conditions: Psoriasis, Vascular Inflammation, Coronary Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01723839

    Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide

    Not yet reported Hackensack Meridian Health 21 participants Est. completion 2021-06-08 1 site
    Other conditions: Chronic Lymphocytic Leukemia (CLL)
    View official trial listing →
  • Status unknown NCT NCT01724034

    Lung Ultrasound Assisting Weaning in Difficult-to-wean Patients

    Not yet reported Hospital Ernesto Dornelles 128 participants Est. completion 2014-06 1 site
    Other conditions: Difficult-to-wean Adult Patients
    View official trial listing →
  • Completed NCT NCT01725438

    Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells

    Not yet reported Assistance Publique - Hôpitaux de Paris 150 participants Est. completion 2021-12-31 1 site
    Other conditions: Trisomy 21
    View official trial listing →
  • Completed NCT NCT01725633

    Aerobic Training in Metastatic Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 27 participants Est. completion 2023-04-04 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01726114

    A Clinical Study of the C8 MediSensors Optical Glucose Monitor™

    Not yet reported C8 MediSensors, Inc. 86 participants Est. completion 2013-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT01726868

    Clinical Study to Evaluate the Efficacy of Blood Purification Therapy on Cholesterol Crystal Embolism

    Not yet reported Japan Community Health Care Organization Sendai Hospital 35 participants Est. completion 2020-12 1 site
    Other conditions: Cholesterol Embolism
    View official trial listing →
  • Terminated NCT NCT01727843

    Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures

    Not yet reported Dr. Jeff Yach 15 participants Est. completion 2017-11-03 1 site
    Other conditions: Femoral Neck Fracture
    View official trial listing →
  • Withdrawn NCT NCT01728649

    Reperfusion With Cooling in Cerebral Acute Ischemia II

    Not yet reported WellStar Health System Est. completion 2015-06 1 site
    Cardiovascular disease Other conditions: Hypothermia
    View official trial listing →
  • Completed NCT NCT01728831

    Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury

    Unity Health Toronto 20 participants Est. completion 2015-11 1 site
    Other conditions: TBI (Traumatic Brain Injury), Acute Brain Injuries
    View official trial listing →
  • Terminated NCT NCT01729104

    Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2018-10-03 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT01731938

    Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries

    Not yet reported Grifols Biologicals, LLC 327 participants Est. completion 2015-06 25 sites
    Other conditions: Soft Tissue Surgical Bleeding
    View official trial listing →
  • Status unknown NCT NCT01732328

    Effect of Calcium Plus Vitamin D Supplementation on Adolescent Mother and Infant Bone Health

    Not yet reported Universidade Federal do Rio de Janeiro 76 participants Est. completion 2013-06
    Other conditions: Lactation Bone Loss, Infant Bone Growth
    View official trial listing →
  • Withdrawn NCT NCT01734174

    Left Ventricular Volume and Ejection Fraction: Validation of Real Time 3 Dimensional Transesophageal Echocardiography

    Weill Medical College of Cornell University Est. completion 2013-11 1 site
    Other conditions: 3D Transesophageal and Transthoracic Echocardiogram
    View official trial listing →
  • Completed NCT NCT01734590

    Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood

    Not yet reported Unilever R&D 12 participants Est. completion 2012-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01735227

    Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)

    Not yet reported Yaling Han 620 participants Est. completion 2013-10 2 sites
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT01736436

    APG101 in Myelodysplastic Syndrome

    Not yet reported Apogenix GmbH 20 participants Est. completion 2015-12 2 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01736475

    Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)

    Not yet reported, Not yet reported Baxalta now part of Shire 159 participants Est. completion 2014-07-17 72 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT01740297

    Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

    Not yet reported, Not yet reported Amgen 217 participants Est. completion 2021-03-09 40 sites
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT01741896

    Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?

    Not yet reported Mid Western Regional Hospital, Ireland 100 participants Est. completion 2013-03 1 site
    Other conditions: Contrast Induced Nephropathy, Remote Ischaemic Preconditioning
    View official trial listing →
  • Status unknown NCT NCT01742533

    Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure

    Not yet reported, Not yet reported Shenzhen Beike Bio-Technology Co., Ltd. 40 participants Est. completion 2014-03 1 site
    Other conditions: Premature Ovarian Failure,
    View official trial listing →
  • Suspended NCT NCT01743170

    Telemonitoring of Hypertensive Patients

    Not yet reported KU Leuven 240 participants Est. completion 2022-12-31 7 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01744392

    Medication Adherence With Polyglot Meducation

    Not yet reported Durham VA Medical Center 23 participants Est. completion 2014-07 1 site
    Other conditions: Hypertension, Diabetes, Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT01744821

    Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

    Not yet reported Northwestern University 7 participants Est. completion 2015-04 2 sites
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT01745757

    Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer

    UNICANCER 510 participants Est. completion 2022-12 19 sites
    Other conditions: Metastatic, Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01745913

    Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

    Not yet reported Weill Medical College of Cornell University 2 participants Est. completion 2015-04-29 1 site
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Terminated NCT NCT01746173

    CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

    Not yet reported Dana-Farber Cancer Institute 5 participants Est. completion 2014-10 2 sites
    Other conditions: T-cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01746693

    Neurovascular Coupling in Subjects With Amblyopia

    Not yet reported Medical University of Vienna 60 participants Est. completion 2023-09-02 1 site
    Other conditions: Amblyopia ex Strabismus, Amblyopia ex Anisometropia
    View official trial listing →
  • Completed NCT NCT01746771

    A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer

    Not yet reported, Not yet reported Hanmi Pharmaceutical Company Limited 44 participants Est. completion 2015-08 1 site
    Other conditions: HER-2 Positive Advanced Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01746953

    The Effect of Red Blood Cells Transfusion in Trauma Patients

    Progress 20211 participants Est. completion 2010-03
    Other conditions: Trauma
    View official trial listing →
  • Terminated NCT NCT01747408

    Treatment of Subarachnoid Hemorrhage With Human Albumin

    Not yet reported Baylor College of Medicine 47 participants Est. completion 2011-05 1 site
    Other conditions: Subarachnoid Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT01748006

    The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure

    Finn Gustafsson 30 participants Est. completion 2016-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01748084

    Rituximab in Systemic Sclerosis

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 22 participants Est. completion 2016-04-18 1 site
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT01749202

    Effects of Stearidonic Acid-Containing Foods on Eicosapentaenoic Acid Levels in Red Blood Cells and Omega-3 Index

    Not yet reported Solae, LLC 126 participants Est. completion 2011-12 1 site
    Substance use disorderCardiovascular disease
    View official trial listing →
  • Completed NCT NCT01749761

    Blood Pressure Guided Biofeedback on Hemodialysis and the Reduction of IntraDialytic Hypotension

    Not yet reported University of Calgary 25 participants Est. completion 2013-12 1 site
    Other conditions: Hypotension
    View official trial listing →
  • Terminated NCT NCT01751139

    An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil

    Not yet reported GlaxoSmithKline 3300 participants Est. completion 2018-12-20 5 sites
    Other conditions: Dengue
    View official trial listing →
  • Completed NCT NCT01751932

    Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24 participants Est. completion 2013-09 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01752413

    Iron Depletion and Replacement in Blood Donors

    Not yet reported Memorial Blood Centers, Minnesota 197 participants Est. completion 2014-11 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01753856

    Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis

    Not yet reported Eli Lilly and Company 69 participants Est. completion 2014-06 6 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01756157

    Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

    Not yet reported Shire 47 participants Est. completion 2013-09-13 23 sites
    Other conditions: Hereditary Angioedema (HAE)
    View official trial listing →
  • Completed NCT NCT01756274

    Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates

    Not yet reported Ascensia Diabetes Care 162 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01757639

    Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 42 participants 9 sites
    Other conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01757782

    Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns

    Not yet reported Sir Takhtasinhji General Hospital 96 participants Est. completion 2012-09 1 site
    Other conditions: Meconium Aspiration Syndrome, Persistent Pulmonary Hypertension of Newborn
    View official trial listing →
  • Completed NCT NCT01758432

    Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4)

    Not yet reported Portola Pharmaceuticals 54 participants Est. completion 2015-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Enrolling by invitation NCT NCT01758653

    Carbon Monoxide Blood and DNA Biorepository

    Intermountain Health Care, Inc. 300 participants Est. completion 2032-12 2 sites
    Other conditions: Carbon Monoxide Poisoning
    View official trial listing →
  • Completed NCT NCT01758874

    Study to Explore the Effect of Lowering Blood Viscosity in Patients With Treatment-resistant Critical Limb Ischemia

    Not yet reported Seoul Veterans Hospital 20 participants Est. completion 2012-04 1 site
    Other conditions: Critical Limb Ischemia
    View official trial listing →
  • Completed NCT NCT01759641

    Observational Study to Assess Oxygen Saturation Predictive Power Related to Intradialytic Acute Hypotension

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 51 participants Est. completion 2012-08 1 site
    Other conditions: Acute Intradialytic Hypotension
    View official trial listing →
  • Completed NCT NCT01760226

    Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

    Not yet reported Baylor College of Medicine 4 participants Est. completion 2016-12 1 site
    Other conditions: Diffuse Large B Cell Lymphoma, Post Transplant Lymphoproliferative Disorder, Primary Mediastinal (Thymic) Large B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01760811

    CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT

    Not yet reported, Not yet reported Rabin Medical Center 25 participants Est. completion 2017-12 1 site
    Other conditions: Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01763099

    Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure

    Not yet reported Nanfang Hospital, Southern Medical University 60 participants Est. completion 2016-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cells, Umbilical Cord Blood, Graft Failure, Hematological Diseases
    View official trial listing →
  • Completed NCT NCT01763645

    A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer

    Not yet reported Biocad 353 participants Est. completion 2014-11 44 sites
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01763671

    Paclitaxel-bevacizumab in Advanced Lung Cancer

    Not yet reported Intergroupe Francophone de Cancerologie Thoracique 166 participants Est. completion 2017-04 55 sites
    Other conditions: Non-squamous Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01764529

    Modifiers of Disease Severity in Cerebral Cavernous Malformations

    University of California, San Francisco 789 participants Est. completion 2025-06-30 7 sites
    Other conditions: Cavernous Angioma, Familial, Cerebral Cavernous Malformations, Cerebral Cavernous Hemangioma
    View official trial listing →
  • Completed NCT NCT01765205

    Newborn Screening for Critical Congenital Heart Disease

    University of Florida 20 participants Est. completion 2014-01 1 site
    Other conditions: Congenital Cardiovascular Malformation
    View official trial listing →
  • Terminated NCT NCT01766505

    The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

    Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2014-03 9 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01767649

    Inflammatory Signature of Human Chorionic Cells

    Assistance Publique - Hôpitaux de Paris 24 participants Est. completion 2014-11 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT01768845

    Unrelated Umbilical Cord Blood (UBC)Transplantation

    Not yet reported West Virginia University 34 participants Est. completion 2021-04-06 1 site
    Other conditions: Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01769924

    A Prospective UK Multicentre Study of Kidney Donors

    Cambridge University Hospitals NHS Foundation Trust 463 participants Est. completion 2017-03 1 site
    Other conditions: Living Kidney Donors
    View official trial listing →
  • Terminated NCT NCT01770756

    FSU Hypertension Self-Care Training Study

    Not yet reported Florida State University 88 participants Est. completion 2018-04-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01771029

    Technical Evaluation of Brahms PCT Direct

    Philipp Schuetz 150 participants Est. completion 2014-09 3 sites
    Other conditions: Infection
    View official trial listing →
  • Completed NCT NCT01771458

    A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer

    Not yet reported Institut Curie 742 participants Est. completion 2016-12 8 sites
    Other conditions: Reccurent/Metastatic Solid Tumor Disease
    View official trial listing →
  • Completed NCT NCT01773681

    Novel Imaging Markers for Rheumatoid Arthritis

    University of California, San Francisco 30 participants Est. completion 2018-03 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01774656

    Remission From Stage D Heart Failure

    Not yet reported University of Louisville 40 participants Est. completion 2017-12 6 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT01776138

    Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer

    UNC Lineberger Comprehensive Cancer Center 103 participants Est. completion 2021-09-02 1 site
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT01776294

    Prehypertension Among Medical Students in Visakhapatnam and Association With Cardiovascular Risk Factors

    Andhra Medical College 275 participants Est. completion 2009-12 1 site
    Other conditions: Prehypertension, Cardiovascular Risk Factors
    View official trial listing →
  • Completed NCT NCT01776840

    A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

    Not yet reported Janssen Research & Development, LLC 523 participants Est. completion 2024-06-24 201 sites
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01778907

    Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)

    Not yet reported University of Groningen 202 participants Est. completion 2017-06 11 sites
    Other conditions: Depression, Depressive Disorder, Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant, Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant, Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant
    View official trial listing →
  • Completed NCT NCT01779245

    Effect of High-calcium Intake on Substrate Metabolism During Exercise

    Not yet reported Northumbria University 13 participants Est. completion 2013-02 1 site
    Other conditions: Lipid Metabolism
    View official trial listing →
  • Completed NCT NCT01780857

    Immune Signature of Palmoplantar Pustulosis

    Baylor Research Institute 30 participants Est. completion 2014-07 1 site
    Other conditions: Palmoplantar Pustulosis
    View official trial listing →
  • Completed NCT NCT01781520

    Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Capital Medical University 47 participants Est. completion 2017-06-13 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01785043

    Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

    Not yet reported Anna Cruceta 13 participants Est. completion 2014-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01785238

    Nephronic Reduction After Neonatal Acute Renal Failure in Preterm

    Not yet reported Nantes University Hospital 75 participants Est. completion 2013-10 1 site
    Other conditions: Neonatal Acute Renal Failure in Preterm
    View official trial listing →
  • Withdrawn NCT NCT01788280

    Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab

    Not yet reported University of Utah Est. completion 2022-01 1 site
    Other conditions: Glioblastoma Multiforme (GBM)
    View official trial listing →
  • Status unknown NCT NCT01788956

    Comparison of Central Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter

    Mespere Lifesciences Inc. 40 participants Est. completion 2016-10 1 site
    Cardiovascular disease Other conditions: Sepsis, Post Cardiac Surgery Low Output Syndrome Requiring Inotropic/Vasopressor Therapy, Hypoxemic Respiratory Failure.
    View official trial listing →
  • Completed NCT NCT01791491

    Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients

    Not yet reported Bristol-Myers Squibb 16 participants Est. completion 2016-12-06 8 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01794819

    Usefulness of C-reactive Protein Testing in Acute Cough

    Not yet reported Northern State Medical University 179 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Respiratory Tract Infections
    View official trial listing →
  • Completed NCT NCT01796197

    Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

    Not yet reported Dana-Farber Cancer Institute 23 participants Est. completion 2026-01 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01799720

    Oxidized Omega-3 Supplements With Different Oxidation

    Not yet reported Universidad Miguel Hernandez de Elche 71 participants Est. completion 2011-04 1 site
    Other conditions: Overweight
    View official trial listing →
  • Completed NCT NCT01799837

    Norepinephrine Transporter Availability in PTSD

    Not yet reported Emory University 9 participants Est. completion 2013-07 1 site
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Terminated NCT NCT01801046

    Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    Not yet reported University of Southern California 10 participants Est. completion 2017-08-20 1 site
    Other conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myeloid Leukemia in Remission, Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    View official trial listing →
  • Completed NCT NCT01801891

    Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers

    Not yet reported Professor Stewart Walsh 25 participants Est. completion 2014-10 2 sites
    Other conditions: Chronic Venous Disease
    View official trial listing →
  • Completed NCT NCT01802372

    Task Shifting and Blood Pressure Control in Ghana

    Not yet reported NYU Langone Health 757 participants Est. completion 2016-10-01 1 site
    Cardiovascular disease Other conditions: Hypertension, High Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT01802749

    Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer

    Not yet reported National Cancer Institute, Naples 406 participants Est. completion 2023-12 82 sites
    Other conditions: Recurrent Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT01803347

    Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells

    Not yet reported Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 80 participants Est. completion 2017-10 5 sites
    Other conditions: Anal Fistula
    View official trial listing →
  • Completed NCT NCT01804660

    Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population

    GeNeuro Innovation SAS 25 participants Est. completion 2013-12 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT01806051

    A Pilot Study on Diurnal Variation

    Not yet reported Dr. Linda Randolph 6 participants Est. completion 2014-05 1 site
    Other conditions: Phenylketonuria (PKU)
    View official trial listing →
  • Completed NCT NCT01807702

    13C-Pyruvate Breath Test

    Not yet reported University of Florida 5 participants Est. completion 2013-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01809145

    Testing Hypersensitivity to Metals in Sarcoidosis Patients by Applying the MELISA Test.

    Not yet reported Tel-Aviv Sourasky Medical Center 10 participants Est. completion 2013-12 1 site
    Other conditions: Sarcoidosis
    View official trial listing →
  • Completed NCT NCT01809821

    Sleep to Lower Elevated Blood Pressure

    Not yet reported University College Hospital Galway 134 participants Est. completion 2014-06 1 site
    Cardiovascular disease Other conditions: Hypertension, Sleep Disorders, Insomnia
    View official trial listing →
  • Completed NCT NCT01810458

    Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)

    University of Florida 109 participants Est. completion 2019-09 1 site
    Other conditions: Liver Fibrosis, Alpha-1 Antitrypsin Deficiency, AAT Deficiency, AATD
    View official trial listing →
  • Completed NCT NCT01811498

    Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM

    Not yet reported, Not yet reported Northwell Health 31 participants Est. completion 2021-10 1 site
    Other conditions: Glioblastoma Multiforme, Brain Tumor
    View official trial listing →
  • Terminated NCT NCT01811693

    Field Administration of Stroke Therapy-Blood Pressure Lowering

    Not yet reported University of California, Los Angeles 4 participants Est. completion 2013-12-09 2 sites
    Cardiovascular disease Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Completed NCT NCT01812291

    Evaluation of a Stepped Care Approach to Manage Depression in Diabetes

    Not yet reported Forschungsinstitut der Diabetes Akademie Mergentheim 260 participants Est. completion 2015-11 1 site
    Other conditions: Major Depressive Disorder, Minor Depressive Disorder, Sub-Threshold Depression, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01813500

    Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients

    Boston Medical Center 400 participants Est. completion 2016-04 1 site
    Other conditions: Crohn's Disease, Ulcerative Colitis, Clostridium Difficile, Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT01814683

    IMPROV (Improving the Radical Cure of Vivax Malaria)

    Not yet reported University of Oxford 2388 participants Est. completion 2018-02-28 8 sites
    Other conditions: Uncomplicated Vivax Malaria
    View official trial listing →
  • Completed NCT NCT01814800

    Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

    Not yet reported ADMA Biologics, Inc. 59 participants Est. completion 2015-01 9 sites
    Other conditions: Primary Immune Deficiency Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT01815749

    Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 30 participants Est. completion 2027-05-31 1 site
    Obstructive sleep apnea Other conditions: Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01815931

    Hemolysis in Blood Samples in the ER

    University Hospital, Geneva 2800 participants Est. completion 2013-10 1 site
    Other conditions: Hemolysis, Emergency Service, Hospital, Emergencies, Blood Specimen Collection
    View official trial listing →
  • Completed NCT NCT01816646

    Intravesical Cidofovir for Hemorrhagic Cystitis

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2016-12 1 site
    Other conditions: Blood And Marrow Transplantation
    View official trial listing →
  • Status unknown NCT NCT01816737

    Fetal Blood Flow Response to Partial Occlusion by External Compression

    Meir Medical Center 50 participants
    Other conditions: Gestational Age
    View official trial listing →
  • Completed NCT NCT01818284

    Plerixafor for Stem Cell Mobilization in Normal Donors

    Not yet reported M.D. Anderson Cancer Center 22 participants Est. completion 2016-06 1 site
    Other conditions: Blood And Marrow Transplantation
    View official trial listing →
  • Status unknown NCT NCT01818830

    Amino Acids Expression Profiling of Patients With Sepsis

    Chinese PLA General Hospital 100 participants 1 site
    Other conditions: Sepsis, Amino Acids
    View official trial listing →
  • Completed NCT NCT01819220

    Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

    Not yet reported Yonsei University 16 participants Est. completion 2014-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01819636

    Effects Of Consumption Of A Highly Mineralized Sodium Bicarbonated Water On Blood Lipid Profile

    Not yet reported Neptune 162 participants Est. completion 2014-06 3 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01820117

    Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

    St. Jude Children's Research Hospital 416 participants Est. completion 2018-02-20 1 site
    Other conditions: Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01820572

    A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

    Not yet reported Bristol-Myers Squibb 446 participants Est. completion 2019-10-24 117 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT01820832

    Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD

    Not yet reported Huashan Hospital 60 participants Est. completion 2015-06 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT01821144

    A School-based Education Programme to Reduce Salt Intake in Children and Their Families

    Not yet reported Queen Mary University of London 832 participants Est. completion 2014-02 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01823198

    Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 63 participants Est. completion 2022-05-10 1 site
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts Under 20 Percent of Bone Marrow Nucleated Cells, Blasts Under 20 Percent of Peripheral Blood White Cells, Chronic Myelomonocytic Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Therapy-Related Acute Myeloid Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01823588

    Nurse-led Reminder Program for the Prevention of Cardiovascular Diseases

    Not yet reported Università degli Studi 'G. d'Annunzio' Chieti e Pescara 203 participants Est. completion 2013-05 2 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01824277

    DCI: A Community Based Pre-cardiac Surgery Diabetes Care Project

    Not yet reported Dr. Rakesh C. Arora 33 participants Est. completion 2018-07 2 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01824368

    Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.

    Not yet reported, Not yet reported Red de Terapia Celular 10 participants Est. completion 2016-04 1 site
    Other conditions: Liver Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01826500

    VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations

    Rennes University Hospital 163 participants Est. completion 2017-01 2 sites
    Other conditions: IVF, Endometriosis
    View official trial listing →
  • Completed NCT NCT01826773

    CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects

    Not yet reported Fluoropharma, Inc. 34 participants Est. completion 2016-09 5 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01830049

    Differential Plasma MicroRNA Profiles in ED and Normal Erectile Function in Older Males

    Nanjing Medical University 30 participants Est. completion 2013-08 1 site
    Other conditions: Erectile Dysfunction
    View official trial listing →
  • Completed NCT NCT01830335

    Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Environmental Stress

    Not yet reported Brock University 8 participants Est. completion 2016-12 1 site
    Other conditions: Healthy Males, Neuromuscular Function
    View official trial listing →
  • Completed NCT NCT01830517

    Diurnal Variation in Hypertensive Stroke Patients

    Not yet reported Hanmi Pharmaceutical Company Limited 84 participants Est. completion 2012-02 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01830712

    A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors

    Novo Nordisk A/S 15 participants Est. completion 2011-08 1 site
    Other conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
    View official trial listing →
  • Status unknown NCT NCT01830894

    Feasibility Study of New MRI Protocol in Assessing Early Blood Brain Barrier Disruption (BBBD)in Related to Delay Brain Edema

    Not yet reported, Not yet reported Sheba Medical Center 30 participants Est. completion 2014-06 1 site
    Other conditions: Intra Cerebral Hemorrhage
    View official trial listing →
  • Active, not recruiting NCT NCT01831570

    DIGItal Cohort Osteoarthritis Design

    Not yet reported Assistance Publique - Hôpitaux de Paris 500 participants Est. completion 2027-06 1 site
    Other conditions: Arthrosis of Hand
    View official trial listing →
  • Completed NCT NCT01831622

    Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

    Not yet reported Mats Fredriksen 131 participants Est. completion 2015-06 2 sites
    Other conditions: Attention Deficit-Hyperactivity Disorder
    View official trial listing →
  • Completed NCT NCT01831908

    The "Know Your Numbers" Program in Atahualpa

    Not yet reported Hospital Clínica Kennedy 350 participants Est. completion 2019-08-02 1 site
    Cardiovascular disease Other conditions: Cardiovascular Risk Factors, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT01831947

    Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

    Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40 participants Est. completion 2013-03 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT01832285

    Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients

    Not yet reported Sha'ar Menashe Mental Health Center 40 participants Est. completion 2013-12 1 site
    Other conditions: SCHIZOPHRENIA 1 (Disorder)
    View official trial listing →
  • Completed NCT NCT01832415

    First Line Ovarian Cancer Treatment - Cohort Study

    ARCAGY/ GINECO GROUP 500 participants Est. completion 2016-03 14 sites
    Other conditions: Epithelial Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT01832753

    Treatment Trial of Subclinical Hypothyroidism in Down Syndrome

    Not yet reported Children's Hospital of Philadelphia 12 participants Est. completion 2017-10-18 2 sites
    Other conditions: Down Syndrome, Subclinical Hypothyroidism
    View official trial listing →
  • Completed NCT NCT01834014

    Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

    Not yet reported EPS Corporation 110 participants Est. completion 2017-03 1 site
    Other conditions: Liver Metastasis, Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01835470

    Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

    Not yet reported Bristol-Myers Squibb 23 participants Est. completion 2018-07-30 13 sites
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT01835600

    Transient Apnea During Flexible Ureteroscopic Lithotripsy

    Not yet reported Chinese Medical Association 150 participants Est. completion 2025-04-16 1 site
    Other conditions: Renal Calculi, Kidney Stones
    View official trial listing →
  • Completed NCT NCT01838005

    Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services

    Not yet reported University of North Carolina, Chapel Hill 433 participants Est. completion 2015-04 1 site
    Other conditions: HIV
    View official trial listing →
  • Withdrawn NCT NCT01838265

    Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management

    University of Miami 1 site
    Other conditions: Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01840956

    Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease

    Not yet reported Humacyte, Inc. 20 participants Est. completion 2016-04-28 3 sites
    Other conditions: End-stage Renal Disease, Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT01841619

    IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

    Not yet reported University of California, Irvine 16 participants Est. completion 2014-11 2 sites
    Other conditions: Cutaneous Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT01843114

    Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects

    Not yet reported Medical University of Vienna 48 participants Est. completion 2017-03-01 1 site
    Other conditions: Type I Diabetes
    View official trial listing →
  • Status unknown NCT NCT01843686

    Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns

    Not yet reported Arteriocyte, Inc. 42 participants Est. completion 2018-03 3 sites
    Other conditions: Acute Burns
    View official trial listing →
  • Completed NCT NCT01844219

    Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in Patients Who Underwent Aortic Surgery Using a Gray Zone Approach

    Samsung Medical Center 375 participants Est. completion 2013-09 1 site
    Other conditions: Aortic Surgery, Postoperative Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT01844271

    Low Level Laser Therapy in Muscle Fatigue and Muscle Recovery

    Not yet reported University of Nove de Julho 28 participants Est. completion 2013-12 1 site
    Other conditions: Muscle; Fatigue, Heart, Skeletal Muscle Recovery
    View official trial listing →
  • Terminated NCT NCT01845012

    Evaluation of Daily HemoDialysis at Low Dialysate Flow in Patients Previously Treated With Conventional Hemodialysis

    Not yet reported Association Pour L'utilisation Rein Artificiel Région Lyonnaise 2 participants Est. completion 2015-01 13 sites
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01846767

    Exogenous Glucose Oxidation Breath Test

    Not yet reported National University of Ireland, Galway, Ireland 46 participants Est. completion 2014-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01846975

    Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday

    Not yet reported Rüdiger B. Müller 49 participants Est. completion 2015-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01847651

    Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate

    Not yet reported Imperial College London 42 participants Est. completion 2015-06 1 site
    Other conditions: Hepatic Encephalopathy, Minimal Hepatic Encephalopathy, Cirrhosis
    View official trial listing →
  • Terminated NCT NCT01847677

    Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin

    Not yet reported Grupo Español de Investigación en Cáncer de Ovario 71 participants Est. completion 2019-05-17 13 sites
    Other conditions: Cancer, Ovarian
    View official trial listing →
  • Withdrawn NCT NCT01848431

    Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer

    University of Zurich Est. completion 2018-01 1 site
    Other conditions: Open Fracture of Foot, Tumor
    View official trial listing →
  • Completed NCT NCT01849614

    Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart

    UNC Lineberger Comprehensive Cancer Center 25 participants Est. completion 2016-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01849939

    Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia

    Not yet reported University Hospital, Clermont-Ferrand 43 participants Est. completion 2017-09 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT01850121

    Remicade in the Treatment of Patients With Active Ankylosing Spondylitis

    Göteborg University 19 participants Est. completion 2008-05 1 site
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Terminated NCT NCT01850771

    Regenexx™ PL-Disc Versus Steroid Epidurals for Lumbar Radiculopathy

    Not yet reported Regenexx, LLC 8 participants Est. completion 2016-05 1 site
    Other conditions: Radiculopathy, Herniated Disc, Disc Degeneration
    View official trial listing →
  • Completed NCT NCT01851382

    Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research

    National Cancer Institute (NCI) 29 participants Est. completion 2015-02-12 1 site
    Other conditions: Graft vs Host Disease, Healthy Volunteer, Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT01851733

    MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme

    Not yet reported Washington University School of Medicine 37 participants Est. completion 2018-05-30 1 site
    Other conditions: Glioblastoma
    View official trial listing →
  • Completed NCT NCT01852708

    Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood

    Natera, Inc. 1059 participants Est. completion 2020-10 9 sites
    Other conditions: Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Abnormalities, Microdeletion Syndromes
    View official trial listing →
  • Completed NCT NCT01853553

    Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Not yet reported University of Colorado, Denver 61 participants Est. completion 2017-01 1 site
    Other conditions: ADPKD
    View official trial listing →
  • Completed NCT NCT01853839

    Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients

    Boehringer Ingelheim 1674 participants Est. completion 2014-07 132 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01854190

    Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension

    Rio de Janeiro State University 40 participants Est. completion 2013-05 1 site
    Obstructive sleep apnea Other conditions: Secondary Hypertension
    View official trial listing →
  • Completed NCT NCT01854294

    GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)

    Not yet reported Genervon Biopharmaceuticals, LLC 12 participants Est. completion 2014-07 2 sites
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Status unknown NCT NCT01855451

    Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma

    Not yet reported Trans Tasman Radiation Oncology Group 189 participants Est. completion 2023-08-23 16 sites
    Other conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT01856192

    Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 349 participants Est. completion 2026-12-31 502 sites
    Other conditions: Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01857154

    A Study of Changes in Bone Mineral Density as a Function of Consuming Two Different Forms of Calcium Carbonate

    Not yet reported Integrative Health Technologies, Inc. 160 participants Est. completion 2014-10 1 site
    Other conditions: Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT01857258

    Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction

    Not yet reported Ohio State University 15 participants Est. completion 2016-04 1 site
    Cardiovascular disease Other conditions: Hyperglycemia
    View official trial listing →
  • Status unknown NCT NCT01858207

    Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient

    Not yet reported Shi-Ming Lin 60 participants Est. completion 2014-12 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT01859494

    Evaluation of an Investigational Blood Glucose Monitoring System

    Not yet reported Ascensia Diabetes Care 219 participants Est. completion 2013-05 2 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01860586

    Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.

    Not yet reported Wills Eye 20 participants Est. completion 2014-11 1 site
    Other conditions: Retinal Detachment, Vitreoretinopathy Proliferative
    View official trial listing →
  • Status unknown NCT NCT01862237

    Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Replacement Surgery.

    Not yet reported Hospices Civils de Lyon 100 participants Est. completion 2017-01 1 site
    Other conditions: Type II Diabetes
    View official trial listing →
  • Completed NCT NCT01864057

    Pharmacokinetics of Thiamine in Breastfeeding Mothers and Infants

    Not yet reported Mayo Clinic 24 participants Est. completion 2012-09 2 sites
    Other conditions: Beriberi
    View official trial listing →
  • Withdrawn NCT NCT01865630

    Safety and Efficacy Study of Etanercept for Aneurysmal Subarachnoid Hemorrhage

    Not yet reported Unity Health Toronto Est. completion 2022-01 1 site
    Other conditions: Subarachnoid Hemorrhage, Aneurysmal
    View official trial listing →
  • Completed NCT NCT01868698

    Effects of High Voltage Electrical Stimulation, Shortwave Diathermy and Kinesiotherapy on Arterial Blood Flow in the Lower Limbs of Diabetic Women

    Not yet reported University of Sao Paulo 15 participants Est. completion 2012-01 1 site
    Other conditions: Diabetes, Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT01869608

    Postpartum Screening of Type 2 Diabetes

    Not yet reported Université de Sherbrooke 121 participants Est. completion 2018-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Approved For Marketing NCT NCT01869803

    Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia

    Wake Forest University Health Sciences 1 site
    Other conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Promyelocytic Leukemia (M3), Childhood Acute Promyelocytic Leukemia (M3), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01870739

    A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2015-06 4 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01870986

    Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)

    Not yet reported Pfizer 210 participants Est. completion 2014-02 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT01872273

    Blood Cell Response to Exercise

    USDA Grand Forks Human Nutrition Research Center Est. completion 2016-06
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT01873833

    Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer

    Not yet reported University of Southern California 10 participants Est. completion 2021-03-02 1 site
    Other conditions: HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01874054

    Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

    Not yet reported, Not yet reported Seagen Inc. 55 participants Est. completion 2018-02-20 13 sites
    Other conditions: Hodgkin Disease
    View official trial listing →
  • Status unknown NCT NCT01874639

    Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study (HEPACOLL)

    Not yet reported University Hospital, Clermont-Ferrand 140 participants Est. completion 2016-12 1 site
    Other conditions: Hepatectomy
    View official trial listing →
  • Completed NCT NCT01874769

    Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

    Institut National de la Santé Et de la Recherche Médicale, France 30 participants Est. completion 2017-08 3 sites
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT01875224

    Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

    Not yet reported University of Arizona 32 participants Est. completion 2016-08 1 site
    Other conditions: New Onset Diabetes After Transplant, Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01875237

    Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2017-03-07 1 site
    Other conditions: Leukemia, Myeloma, Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT01875458

    Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use

    University of Pennsylvania 314 participants Est. completion 2022-10-30 1 site
    Other conditions: Osteoporosis, With or Without Treatment, Bisphosphonate Treatment, Atypical Femur Fracture, Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ), Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01875666

    Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib

    Not yet reported UNC Lineberger Comprehensive Cancer Center 26 participants Est. completion 2016-12-19 5 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01875809

    Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation

    University of Witten/Herdecke 80 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01876394

    Comparison of Dietary Fats on Vascular Parameters

    Not yet reported Unity Health Toronto 24 participants Est. completion 2016-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT01878136

    Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage

    Not yet reported, Not yet reported Rush University Medical Center Est. completion 2016-09 1 site
    Other conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm, Cerebral Aneurysm, Hydrocephalus
    View official trial listing →
  • Status unknown NCT NCT01878539

    Oral Anticoagulation and Self-management

    Not yet reported Osakidetza 333 participants Est. completion 2014-12 1 site
    Other conditions: Atrial Fibrillation, Embolism
    View official trial listing →
  • Completed NCT NCT01880346

    Comparison of Absorption of Vitamin D in Cystic Fibrosis

    Not yet reported Emory University 17 participants Est. completion 2015-10 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT01883466

    Health Effects of Biodiesel Exhaust Exposure

    Not yet reported Umeå University 19 participants Est. completion 2013-04 1 site
    Other conditions: Vascular Endothelium
    View official trial listing →
  • Completed NCT NCT01884935

    PK and PD Study of Natalizumab in Pediatric Subjects With RRMS

    Not yet reported Biogen 13 participants Est. completion 2014-09 5 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01885845

    Excellent BRASSS-V Drape™ Versus Indirect Measurement Protocol for Measurement of Postpartum Blood Loss

    Not yet reported Gynuity Health Projects 900 participants Est. completion 2007-09 1 site
    Other conditions: Postpartum Hemorrhage
    View official trial listing →
  • Active, not recruiting NCT NCT01886872

    Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Not yet reported National Cancer Institute (NCI) 547 participants Est. completion 2027-06-24 937 sites
    Other conditions: Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01887093

    The Influence of Walking at Different Times of Day on Blood Lipids and Inflammatory Markers

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 330 participants Est. completion 2013-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01888432

    Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants

    Not yet reported Novartis Pharmaceuticals 285 participants Est. completion 2018-04-21 42 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT01889446

    The Effects of the Food Preservative Propionic Acid in Post-prandial Metabolism

    Not yet reported Brigham and Women's Hospital 20 participants Est. completion 2015-06 1 site
    Other conditions: Obesity, Insulin Resistance, Diabetes
    View official trial listing →
  • Completed NCT NCT01890473

    Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe

    Not yet reported Bristol-Myers Squibb 356 participants Est. completion 2014-11 25 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01890707

    Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery

    Not yet reported Northwestern University 19 participants Est. completion 2014-04-17 1 site
    Other conditions: Surgery, Anesthesia, Pain
    View official trial listing →
  • Completed NCT NCT01891110

    Prevention of Orthostatic Hypotension With Electric Stimulation in Persons With Acute SCI

    Not yet reported Swiss Paraplegic Research, Nottwil 20 participants Est. completion 2014-05 1 site
    Other conditions: Spinal Cord Injury, Orthostatic Hypotension
    View official trial listing →
  • Withdrawn NCT NCT01891500

    Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure

    Not yet reported University of Florida Est. completion 2019-09-19 1 site
    Other conditions: Persistent Fetal Circulation Syndrome, Hypertension, Pulmonary, of Newborn, Persistent, Persistent Pulmonary Hypertension of Newborn
    View official trial listing →
  • Status unknown NCT NCT01891708

    VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer

    Li Liu 40 participants Est. completion 2018-12 1 site
    Other conditions: Non Small Cell Lung Cancer, Brain Metastasis
    View official trial listing →
  • Completed NCT NCT01891864

    Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

    Not yet reported Sandoz 531 participants Est. completion 2015-03 74 sites
    Other conditions: Chronic Stable Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT01892215

    Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad,

    Not yet reported Saint Thomas Hospital, Panama 839 participants Est. completion 2013-06 1 site
    Other conditions: Blunt Expansion of the Uterine Incision
    View official trial listing →
  • Withdrawn NCT NCT01893658

    Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)

    Not yet reported Mayo Clinic Est. completion 2018-09-28 1 site
    Other conditions: Acute Interstitial Nephritis
    View official trial listing →
  • Status unknown NCT NCT01893840

    Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg

    Not yet reported Otivio AS 20 participants Est. completion 2013-12 1 site
    Other conditions: Periferal Arterial Occlusive Disease, PAOD
    View official trial listing →
  • Completed NCT NCT01893996

    Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease

    Not yet reported Jonathan Graf 63 participants Est. completion 2017-07 1 site
    Cardiovascular disease Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01894906

    Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients

    Not yet reported, Not yet reported Rockwell Medical Technologies, Inc. 12 participants Est. completion 2013-09 1 site
    Other conditions: Kidney Failure
    View official trial listing →
  • Completed NCT NCT01895231

    A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors

    Not yet reported Pharmacosmos A/S 107 participants Est. completion 2016-12 1 site
    Other conditions: Iron-deficiency
    View official trial listing →
  • Completed NCT NCT01895387

    Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes

    Not yet reported Yonsei University 100 participants Est. completion 2012-10 1 site
    PrediabetesType 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01895582

    Performance of IGRAs for TB Infection Diagnosis in Elderly

    Assistance Publique - Hôpitaux de Paris 160 participants Est. completion 2019-03-17 3 sites
    Other conditions: Ageing, Tuberculosis
    View official trial listing →
  • Completed NCT NCT01896167

    Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia

    Not yet reported Danish Headache Center 34 participants Est. completion 2014-09 1 site
    Other conditions: Headache, Migraine, Aura
    View official trial listing →
  • Completed NCT NCT01897857

    Influence of DM on Artery Blood Flow and Complications After Radial Artery Cannulation

    Not yet reported Yonsei University 80 participants Est. completion 2016-01 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01897909

    The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana

    Bernhard Nocht Institute for Tropical Medicine 1100 participants Est. completion 2021-07-29 1 site
    Other conditions: HIV, Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
    View official trial listing →
  • Completed NCT NCT01897987

    Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial

    Not yet reported Medipost Co Ltd. 62 participants Est. completion 2020-03 2 sites
    Other conditions: Bronchopulmonary Dysplasia
    View official trial listing →
  • Terminated NCT NCT01898793

    Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

    Not yet reported, Not yet reported Washington University School of Medicine 89 participants Est. completion 2022-04-04 1 site
    Other conditions: Leukemia, Myeloid, Acute
    View official trial listing →
  • Completed NCT NCT01899196

    Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

    Not yet reported ANRS, Emerging Infectious Diseases 24 participants Est. completion 2016-03 1 site
    Other conditions: Hiv Infection
    View official trial listing →
  • Completed NCT NCT01899755

    A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

    Not yet reported GlaxoSmithKline 45 participants Est. completion 2014-04-03 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01900769

    Calculating Blood Volume by Dilution of Hemoglobin - Pilot Study

    Not yet reported Kai Schoenhage 20 participants Est. completion 2013-09 1 site
    Other conditions: Determine Validity of Concept of Using Hemoglobin Dilution to Assess/Measure Blood Volume.
    View official trial listing →
  • Terminated NCT NCT01902771

    Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

    Not yet reported Edward Ziga 1 participants Est. completion 2017-01-26 1 site
    Other conditions: Glioma, Brain Cancer, Brain Tumor, Glioblastoma Multiforme, High Grade Glioma
    View official trial listing →
  • Terminated NCT NCT01904708

    Moderate Intensity Exercise and Phenylketonuria

    Not yet reported Oregon Health and Science University 2 participants Est. completion 2014-06 1 site
    Other conditions: Phenylketonuria, PKU
    View official trial listing →
  • Completed NCT NCT01904994

    Link4Health: A Combination Strategy for Linkage and Retention, Swaziland

    Not yet reported Columbia University 2201 participants Est. completion 2021-10-12 20 sites
    Other conditions: HIV (Human Immunodeficiency Virus)
    View official trial listing →
  • Status unknown NCT NCT01906281

    Influence of Adipocytokines in Osteoarthritis

    Parc Taulí Hospital Universitari 105 participants Est. completion 2014-12 2 sites
    Osteoarthritis Other conditions: Endocrine System Diseases, Cardiovascular Risk Factors
    View official trial listing →
  • Completed NCT NCT01907906

    Inactivation of Whole Blood With Mirasol

    Not yet reported Terumo BCTbio 29 participants Est. completion 2014-05 2 sites
    Other conditions: Focus of Study: Radiolabel Recovery and Survival of RBCs
    View official trial listing →
  • Completed NCT NCT01909063

    A Randomized Controlled Trial Testing The Effect Of A Multi-Nutrient Fortified Juice

    Not yet reported Boston University 180 participants Est. completion 2008-01 1 site
    Other conditions: Vitamin D Deficiency, Hypovitaminosis A, Vitamin E Deficiency
    View official trial listing →
  • Completed NCT NCT01909960

    Flow MRI in Normal Pressure Hydrocephalus

    Not yet reported Centre Hospitalier Universitaire, Amiens 144 participants Est. completion 2020-08-18 2 sites
    Other conditions: Normal Pressure Hydrocephalus
    View official trial listing →
  • Completed NCT NCT01910376

    Cancer in Nursing Home Residents

    European Organisation for Research and Treatment of Cancer - EORTC 125 participants Est. completion 2017-12 1 site
    Other conditions: Armonea Nursing Homes Residents
    View official trial listing →
  • Completed NCT NCT01910467

    Avoiding Hypotension in Preterm Neonates

    Not yet reported Medical University of Graz 98 participants Est. completion 2016-12 1 site
    Other conditions: Hypotension
    View official trial listing →
  • Completed NCT NCT01911689

    Magnetic Resonance Imaging Study of Acute Pancreatitis

    Affiliated Hospital of North Sichuan Medical College 168 participants Est. completion 2015-03 1 site
    Other conditions: Acute Pancreatitis
    View official trial listing →
  • Completed NCT NCT01911871

    Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations

    Assistance Publique - Hôpitaux de Paris 110 participants Est. completion 2015-03 1 site
    Other conditions: Thalassemia, Sickle Cell Disease, Myelodysplasia
    View official trial listing →
  • Completed NCT NCT01911897

    Controlling and Lowering Blood Pressure With The MOBIUS HD™ (CALM-FIM_EUR)

    Not yet reported Vascular Dynamics, Inc. 30 participants Est. completion 2020-02-28 6 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01913093

    N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors

    The Hospital for Sick Children 204 participants Est. completion 2019-06 1 site
    Other conditions: Childhood Leukemia Survivors
    View official trial listing →
  • Completed NCT NCT01914588

    Multiparametric Telemonitoring In Elderly People With Chronic Heart Failure

    Not yet reported Campus Bio-Medico University 100 participants Est. completion 2013-07
    Heart failure
    View official trial listing →
  • Completed NCT NCT01915433

    Wahls Paleo Diet and Progressive Multiple Sclerosis

    Not yet reported Terry L. Wahls 15 participants Est. completion 2016-11 2 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01918891

    Center for Stroke Disparities Solution - Community Transitions Intervention

    Not yet reported Visiting Nurse Service of New York 495 participants Est. completion 2018-06 1 site
    Cardiovascular disease Other conditions: Hypertension, Transient Ischemic Attack
    View official trial listing →
  • Status unknown NCT NCT01918969

    Reference Values of Circulating Endothelial Progenitor Cells

    Hopital Jean Minjoz 120 participants Est. completion 2014-03 1 site
    Other conditions: Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT01920191

    Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma

    Not yet reported, Not yet reported University Hospital, Geneva 19 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: CNS Tumor, Adult
    View official trial listing →
  • Completed NCT NCT01920906

    Comparative Analysis of Small and Large Plaque Psoriasis

    Not yet reported Rockefeller University 13 participants Est. completion 2015-06 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01921283

    Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring

    Not yet reported Yonsei University 180 participants Est. completion 2012-02 1 site
    Other conditions: Early Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT01921699

    Macrophages Effect on Chemoresistance

    Not yet reported Rambam Health Care Campus 2 participants
    Other conditions: the Focus of the Study is Macrophage-induced Chemoresistance in Pancreatic Carcinoma Cells During Chemotherapy.
    View official trial listing →
  • Completed NCT NCT01921725

    The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing

    Not yet reported Bio-medical Carbon Technology Co., Ltd. 60 participants 2 sites
    Other conditions: Wounds
    View official trial listing →
  • Completed NCT NCT01922037

    A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)

    Not yet reported Hoffmann-La Roche 806 participants Est. completion 2016-03-31 145 sites
    Other conditions: Asthma
    View official trial listing →
  • Withdrawn NCT NCT01922141

    Aliskiren Study of Safety and Efficacy in Senior Hypertensives

    Not yet reported Novartis Pharmaceuticals Est. completion 2018-06
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01922921

    Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy

    Not yet reported, Not yet reported University of Washington 31 participants Est. completion 2021-09-01 1 site
    Other conditions: HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01922973

    Effect of Fasting on Ghrelin and Growth Hormone in Healthy Young and Older Adults

    University of Virginia 21 participants Est. completion 2004-12
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT01924312

    Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease

    Not yet reported Gregory Jicha, 323-5550 80 participants Est. completion 2019-06-30 1 site
    Other conditions: Cerebrovascular Disease, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT01924572

    Placental Transfusion in Term Infants: A Pilot Study

    Not yet reported University of Rhode Island 32 participants Est. completion 2011-05 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01926457

    Treating Prediabetes in the First Trimester

    Not yet reported University of California, San Diego 202 participants Est. completion 2017-06-15 1 site
    Prediabetes Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT01926639

    Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma

    Not yet reported Oslo University Hospital 14 participants Est. completion 2014-10 1 site
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT01927237

    Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide

    Not yet reported Beth Israel Deaconess Medical Center Est. completion 2014-08 1 site
    Other conditions: Low Tidal Volume Ventilation, Acute Respiratory Distress Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01928966

    Effect of Pumpkin Seeds on the Dietary Fatty Acid Intake and Blood Pressure in Women

    Not yet reported Texas Woman's University Est. completion 2014-11 1 site
    Cardiovascular disease Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT01929785

    BIIR Gene to Manage Heart Allograft Patients

    Baylor Research Institute 56 participants Est. completion 2013-11 1 site
    Other conditions: Cardiac Transplant Failure
    View official trial listing →
  • Completed NCT NCT01930162

    Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant

    Not yet reported Novartis Pharmaceuticals 9 participants Est. completion 2016-08-29 1 site
    Other conditions: Single Umbilical Cord Blood Transplantation, Non-myeloablative Conditioning, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01930487

    The Effects of an Antioxidant Formulation on Ocular Blood Flow

    Not yet reported ScienceBased Health 47 participants Est. completion 2015-08 1 site
    Other conditions: Primary Open Angle Glaucoma
    View official trial listing →
  • Completed NCT NCT01932125

    An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

    Not yet reported Hoffmann-La Roche 100 participants Est. completion 2025-06-18 13 sites
    Other conditions: Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms
    View official trial listing →
  • Completed NCT NCT01932710

    A Feasibility Study of Prophylactic White Blood Cell Transfusions

    Not yet reported M.D. Anderson Cancer Center 45 participants Est. completion 2016-11-30 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT01933516

    GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma

    Not yet reported Sandoz 6 participants Est. completion 2014-08 1 site
    Other conditions: Indolent B-cell Non-Hodgkin's Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT01934842

    A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate

    Not yet reported Seventh Sense Biosystems Est. completion 2013-09 1 site
    Other conditions: Diabetes, Anemia
    View official trial listing →
  • Completed NCT NCT01935362

    Impact of Oranges on Cardiovascular Health

    Not yet reported, Not yet reported University of Leeds 25 participants Est. completion 2014-03 1 site
    Cardiovascular disease Other conditions: Blood Pressure, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT01935895

    Exercise and Blood Pressure Reactivity

    Universidade Federal do vale do São Francisco 20 participants Est. completion 2011-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT01937117

    Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88 participants Est. completion 2027-06 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01939327

    Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma

    Not yet reported Institut Paoli-Calmettes 34 participants Est. completion 2020-01 1 site
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01939860

    A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment

    Not yet reported University of Warwick 56 participants Est. completion 2014-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01940354

    Comparison of AccuCath IV Catheter and Conventional IV Catheter in Interventional Radiology

    Not yet reported C. R. Bard 220 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Vascular Access Complications
    View official trial listing →
  • Terminated NCT NCT01940887

    A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

    Not yet reported Ophthotech Corporation 645 participants Est. completion 2017-09 207 sites
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01941407

    First Line Metastatic Breast Cancer Treatment (ESMERALDA)

    Not yet reported ARCAGY/ GINECO GROUP 61 participants Est. completion 2016-03 40 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01941615

    Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel

    Not yet reported Boehringer Ingelheim 18 participants Est. completion 2014-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01942356

    Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor

    Not yet reported The University of Texas Health Science Center at San Antonio 4 participants Est. completion 2014-08 1 site
    Other conditions: Acute Cholecystitis, Chronic Cholecystitis
    View official trial listing →
  • Completed NCT NCT01942655

    IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection

    Not yet reported ANRS, Emerging Infectious Diseases 26 participants Est. completion 2018-03-01 1 site
    Other conditions: HIV Reservoirs
    View official trial listing →
  • Active, not recruiting NCT NCT01943695

    Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 144 participants Est. completion 2027-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01943916

    The PIONEER-01 Study of the Imagio Breast Imaging System

    Not yet reported Seno Medical Instruments Inc. 2105 participants Est. completion 2015-09-09 16 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01944111

    Plicated Laparoscopic Adjustable Gastric Banding Study

    Not yet reported Tenet Healthcare Corporation 100 participants Est. completion 2014-09 1 site
    Other conditions: Weight Loss
    View official trial listing →
  • Terminated NCT NCT01944618

    forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

    AstraZeneca 5000 participants Est. completion 2015-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01944839

    A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

    Not yet reported Ophthotech Corporation 619 participants Est. completion 2016-12 115 sites
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01945086

    A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis

    Not yet reported Janssen Pharmaceutical K.K. 79 participants Est. completion 2014-12 13 sites
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT01945866

    Phase II Combination Steroid and Anti-VEGF for Persistent DME

    Not yet reported Jaeb Center for Health Research 129 participants Est. completion 2017-06-05 56 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Active, not recruiting NCT NCT01947023

    Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 23 participants Est. completion 2027-05-12 1 site
    Other conditions: Metastatic Thyroid Gland Carcinoma, Unresectable Thyroid Gland Carcinoma
    View official trial listing →
  • Completed NCT NCT01949948

    Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke

    Not yet reported Lars Thomassen 1050 participants Est. completion 2016-12-31 13 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01950364

    A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

    Not yet reported Millennium Pharmaceuticals, Inc. 20 participants Est. completion 2015-06 6 sites
    Other conditions: Hodgkin Lymphoma, Anaplastic Large-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01950390

    Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 169 participants Est. completion 2025-01-31 482 sites
    Other conditions: Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma
    View official trial listing →
  • Completed NCT NCT01950819

    Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

    Not yet reported Novartis Pharmaceuticals 2037 participants Est. completion 2018-01-17 184 sites
    Chronic kidney disease Other conditions: End Stage Renal Disease (ESRD), Hemodialysis, Renal Replacement Therapy, Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01950910

    Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)

    Wake Forest University Health Sciences 766 participants Est. completion 2020-10-29 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Completed NCT NCT01951313

    Effects of Egg Consumption on Carotenoid Absorption From Co-consumed, Non-Egg Food

    Not yet reported Purdue University 17 participants Est. completion 2014-05 1 site
    Other conditions: Will Consuming Eggs With a Mixed Vegetable Salad Increase Carotenoid Absorption
    View official trial listing →
  • Completed NCT NCT01951586

    Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

    Not yet reported Amgen 226 participants Est. completion 2017-11-28 74 sites
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01953120

    Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)

    Not yet reported University of California, Los Angeles 20 participants Est. completion 2021-04-21 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT01953159

    Assessment of Paclitaxel-Induced Neuropathy

    University of Chicago 43 participants Est. completion 2027-12 1 site
    Other conditions: Cancer, Breast Cancer, Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT01953692

    A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)

    Not yet reported Merck Sharp & Dohme LLC 197 participants Est. completion 2020-06-26
    Other conditions: Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Primary Mediastinal B-Cell Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT01954446

    A Novel Non-interfering Arterial Blood Pressure Monitoring Device

    Not yet reported Sense A/S Est. completion 2013-12
    Other conditions: Hypertension, Hypotension, Healthy
    View official trial listing →
  • Completed NCT NCT01955187

    Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

    Not yet reported Hospital Universitario 12 de Octubre 86 participants Est. completion 2019-06-26 1 site
    Other conditions: MEMBRANOUS NEPHROPATHY
    View official trial listing →
  • Completed NCT NCT01955252

    Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea

    Not yet reported Lihir Medical Centre 16000 participants Est. completion 2017-05 1 site
    Other conditions: Yaws
    View official trial listing →
  • Completed NCT NCT01955811

    Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion

    Not yet reported Medical University Innsbruck 130 participants Est. completion 2014-08 5 sites
    Other conditions: Blood Platelet Transfusion, Blood Clotting
    View official trial listing →
  • Completed NCT NCT01956019

    MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study

    Not yet reported The Christie NHS Foundation Trust 15 participants Est. completion 2017-01 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT01956695

    Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma

    Not yet reported Institut Curie 45 participants Est. completion 2018-01-11 12 sites
    Other conditions: Lymphoma, Relapse
    View official trial listing →
  • Terminated NCT NCT01957514

    Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer Therapy

    University of Washington 31 participants Est. completion 2018-06-30 2 sites
    Other conditions: Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT01960530

    An Investigational Study of Hydrocortisone

    Not yet reported Neurocrine UK Limited 14 participants Est. completion 2014-11 1 site
    Other conditions: Adrenal Insufficiency
    View official trial listing →
  • Terminated NCT NCT01962636

    Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 200 participants Est. completion 2026-05-14 1 site
    Other conditions: Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelofibrosis, Myelodysplasia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Lymphoblastic Lymphoma, Burkitt's Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01963221

    Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients

    Not yet reported Central Hospital, Nancy, France 30 participants Est. completion 2013-09 1 site
    Other conditions: Aging, Inflammation
    View official trial listing →
  • Completed NCT NCT01964742

    Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients

    Not yet reported Assistance Publique Hopitaux De Marseille 68 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: HIV-HCV Co-infected Patients
    View official trial listing →
  • Active, not recruiting NCT NCT01966367

    CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

    Not yet reported, Not yet reported Diane George 37 participants Est. completion 2030-02 1 site
    Other conditions: Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia, Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Schwachman Diamond Syndrome, Primary Immunodeficiency Syndromes, Acquired Immunodeficiency Syndromes, Histiocytic Syndrome, Familial Hemophagocytic Lymphocytosis, Lymphohistiocytosis, Macrophage Activation Syndrome, Langerhans Cell Histiocytosis (LCH), Hemoglobinopathies, Sickle Cell Disease, Sickle Cell-beta-thalassemia
    View official trial listing →
  • Completed NCT NCT01968109

    An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

    Not yet reported, Not yet reported Bristol-Myers Squibb 1482 participants Est. completion 2025-02-03 54 sites
    Other conditions: Neoplasms by Site
    View official trial listing →
  • Completed NCT NCT01969084

    The Effect of Linagliptin on Mitochondrial and Endothelial Function

    Not yet reported Beth Israel Deaconess Medical Center 45 participants Est. completion 2016-07 1 site
    Other conditions: Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01969617

    Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

    Not yet reported H. Lundbeck A/S 22 participants 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT01969708

    Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)

    Not yet reported The Emmes Company, LLC 362 participants Est. completion 2021-03 72 sites
    Other conditions: Central Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT01969877

    A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.

    Not yet reported Lund University Hospital 298 participants Est. completion 2018-04 9 sites
    Other conditions: Locally Advanced Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT01970345

    A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder

    Not yet reported Icahn School of Medicine at Mount Sinai 3 participants Est. completion 2017-09-13 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT01970969

    THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring

    Scripps Translational Science Institute 928 participants Est. completion 2017-12 1 site
    Other conditions: Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01971346

    The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

    Not yet reported University of Michigan 50 participants Est. completion 2017-11-01 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01971515

    First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

    Not yet reported EMD Serono 101 participants Est. completion 2018-08-09 15 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT01971762

    Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology

    Fundación Pública Andaluza Progreso y Salud 600 participants Est. completion 2012-01 16 sites
    Other conditions: Staphylococcus Aureus Bacteremia
    View official trial listing →
  • Completed NCT NCT01971970

    Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD)

    Erasmus Medical Center 45 participants Est. completion 2017-01-30 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT01972763

    Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.

    Not yet reported, Not yet reported Northern California Retina Vitreous Associates 12 participants Est. completion 2018-07 1 site
    Other conditions: Recalcitrant Wet Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01973387

    A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma

    Not yet reported Janssen Research & Development, LLC 160 participants Est. completion 2017-08-11 26 sites
    Other conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT01973868

    Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination

    Not yet reported Bayer 42 participants Est. completion 2018-04-03 4 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT01974401

    Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia

    Not yet reported Mashhad University of Medical Sciences 20 participants Est. completion 2012-06 1 site
    Other conditions: Severe Neutropenia, Thrombocytopenia, Chemotherapy, Blood Dyscrasia Patients
    View official trial listing →
  • Completed NCT NCT01974947

    Metabolic Syndrome and Male Infertility

    Assistance Publique - Hôpitaux de Paris 170 participants Est. completion 2016-01-20 1 site
    Other conditions: Male Infertility
    View official trial listing →
  • Completed NCT NCT01975883

    Glycemic Instability After Spine Surgery

    Beaujon Hospital 91 participants Est. completion 2011-01 1 site
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01976013

    Prediction of Major Bleeding in ELBW-infants (<1000g) by Sequential Coagulation Monitoring

    Not yet reported Medical University of Vienna 126 participants Est. completion 2016-02 1 site
    Other conditions: Intraventricular Haemorrhage, Pulmonary Haemorrhage
    View official trial listing →
  • Completed NCT NCT01976078

    Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents

    Children's Hospital Los Angeles 45 participants Est. completion 2015-04-22 1 site
    Other conditions: Pharmacokinetics, Voriconazole
    View official trial listing →
  • Completed NCT NCT01976338

    Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

    Not yet reported Novartis Pharmaceuticals 283 participants Est. completion 2016-03-28 33 sites
    Other conditions: Macular Edema Secondary to Branch Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT01977547

    Age of Blood in Children in Pediatric Intensive Care Units

    Not yet reported Washington University School of Medicine 1538 participants Est. completion 2018-12 37 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01978925

    Pharmaceutical Care in Emergency Department

    Not yet reported Hospital Moinhos de Vento 380 participants Est. completion 2014-12 1 site
    Other conditions: Medication Adherence, Hypertension, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01979211

    Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

    Not yet reported University of Cincinnati 24 participants Est. completion 2022-01-19 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01979471

    The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH

    Not yet reported University of Alberta 723 participants Est. completion 2015-12 1 site
    Chronic kidney disease Other conditions: Diabetes, Established Atherosclerotic Vascular Disease, Framingham Risk Score More Than 20 Percent
    View official trial listing →
  • Status unknown NCT NCT01980472

    Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients

    Not yet reported Grupo de Investigación y Divulgación Oncológica 50 participants Est. completion 2017-08 10 sites
    Other conditions: Non-small Cell Lung Cancer (NSCLC)
    View official trial listing →
  • Completed NCT NCT01980823

    Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

    Not yet reported Columbia University 23 participants Est. completion 2022-12 1 site
    Other conditions: Breast Cancer, Breast Tumors, Cancer of Breast
    View official trial listing →
  • Completed NCT NCT01980862

    Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes

    Fujirebio Diagnostics, Inc. 48 participants Est. completion 2013-11 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01982669

    Spicy Diet on Salty Taste and Salt Intake

    Zhiming Zhu 606 participants Est. completion 2013-12 1 site
    Other conditions: Salty Taste, Spicy Diet
    View official trial listing →
  • Status unknown NCT NCT01983475

    Denosumab Administration After Spinal Cord Injury

    Not yet reported James J. Peters Veterans Affairs Medical Center 24 participants Est. completion 2020-05 2 sites
    Other conditions: Osteoporosis, Spinal Cord Injury
    View official trial listing →
  • Status unknown NCT NCT01983761

    Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

    Not yet reported, Not yet reported Targazyme, Inc. 25 participants 4 sites
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL), Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01983813

    Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care

    Not yet reported Korey Kennelty 302 participants Est. completion 2018-04 12 sites
    Cardiovascular disease Other conditions: Diabetes Mellitus, Hypertension, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01984593

    Impact of Yoga on Blood Pressure, Quality of Life and Stress in Patients With Hypertension

    Not yet reported Region Skane 190 participants Est. completion 2014-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01985139

    Pleasure for Food and Endocannabinoids in Obesity

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 20 participants Est. completion 2019-11-21 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01985360

    ISCHEMIA-Chronic Kidney Disease Trial

    Not yet reported NYU Langone Health 777 participants Est. completion 2020-07 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Myocardial Ischemia, Kidney Disease, End Stage Renal Failure on Dialysis
    View official trial listing →
  • Status unknown NCT NCT01985633

    Mesenchymal Stem Cells Enhanced With PRP Versus PRP In OA Knee

    Not yet reported, Not yet reported Aditya K Aggarwal 24 participants Est. completion 2014-06 1 site
    Osteoarthritis
    View official trial listing →
  • Terminated NCT NCT01986127

    Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients

    Not yet reported Sara Varea 26 participants Est. completion 2018-06-30 13 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01987726

    Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors

    Ohio State University Comprehensive Cancer Center 150 participants Est. completion 2021-06-28 1 site
    Other conditions: Recurrent Breast Cancer, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Breast Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01988675

    MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier

    University of Michigan Rogel Cancer Center 91 participants Est. completion 2014-06-03 1 site
    Other conditions: Brain Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT01988805

    Gene Polymorphism Study of Normal Individual Inflammasome Genes

    Ohio State University Est. completion 2014-02 1 site
    Other conditions: Healthy Individuals
    View official trial listing →
  • Completed NCT NCT01989312

    The Simultaneous Use of Supraclavicular and Distal Blocks

    Not yet reported Ankara University 75 participants Est. completion 2013-02 1 site
    Other conditions: Orthopaedic Disorders, Nerve Block, Anaesthesia
    View official trial listing →
  • Completed NCT NCT01991145

    Allogeneic UCB Therapy With EPO in Children With CP

    Not yet reported MinYoung Kim, MD, PhD 92 participants Est. completion 2017-06-24 1 site
    Other conditions: Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT01992653

    A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Genentech, Inc. 85 participants Est. completion 2018-12-19 11 sites
    Other conditions: Lymphoma, Non Hodgkin
    View official trial listing →
  • Completed NCT NCT01992666

    GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus

    Not yet reported Hospices Civils de Lyon 271 participants Est. completion 2016-10 26 sites
    Other conditions: Systemic Lupus Erythematosus (SLE)
    View official trial listing →
  • Completed NCT NCT01992939

    The Effect of Heat on Blood and Oxygen Flow Readings Part 2

    Not yet reported VA Pittsburgh Healthcare System 51 participants Est. completion 2015-12 1 site
    Other conditions: Healthy, Peripheral Vascular Disease, Vasoconstriction
    View official trial listing →
  • Completed NCT NCT01994850

    Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 32 participants Est. completion 2019-01 1 site
    Other conditions: CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30-Positive Diffuse Large B-Cell Lymphoma, CD30-Positive Gray Zone Lymphoma
    View official trial listing →
  • Completed NCT NCT01996306

    A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC

    Not yet reported Epidemiological and Clinical Research Information Network 650 participants Est. completion 2018-06-30 1 site
    Other conditions: Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms
    View official trial listing →
  • Completed NCT NCT01996553

    The Prevalence of Radial Artery Occlusion in Diagnostic Cardiac Catheterization and Percutaneous Intervention

    Jesse Brown VA Medical Center 172 participants Est. completion 2017-07 1 site
    Other conditions: Coronary Angiography, Radial Artery Occlusion
    View official trial listing →
  • Completed NCT NCT01996826

    A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

    Not yet reported, Not yet reported Reza Dana, MD 75 participants Est. completion 2019-04 3 sites
    Other conditions: Corneal Neovascularization, Corneal Graft Failure
    View official trial listing →
  • Completed NCT NCT01996956

    Prediction of Fluid Responsiveness by NICOM (Non-invasive Cardiac Output Monitoring) in Children With Congenital Heart Disease After Cardiac Surgery

    Not yet reported Seoul National University Hospital 30 participants Est. completion 2013-10 1 site
    Other conditions: Fluid Responsiveness
    View official trial listing →
  • Completed NCT NCT01997554

    Validation of a New TSH Test

    Not yet reported Hospices Civils de Lyon 1654 participants Est. completion 2014-08 2 sites
    Other conditions: Sub-clinical Hypothyroidism, Hypothyroidism, Euthyroidism
    View official trial listing →
  • Terminated NCT NCT01997840

    ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma

    Not yet reported, Not yet reported Celgene 103 participants Est. completion 2024-02-29 2 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01998009

    Study of In-home Tests for Colorectal Cancer

    Not yet reported Centers for Disease Control and Prevention 1382 participants Est. completion 2014-09 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01998906

    A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer

    Not yet reported Hoffmann-La Roche 330 participants Est. completion 2012-07 36 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02000869

    Impact of Arterial Stiffness and Central Aortic Blood Pressure on Kidney Transplant Outcomes

    Louisiana State University Health Sciences Center Shreveport 40 participants Est. completion 2016-01 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02001090

    Vascular Function on the First Day After Cardiac Surgery

    Norwegian University of Science and Technology 25 participants Est. completion 2014-04-29 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02005224

    Effect of Low-carbohydrate/High-fat Diet on Glucose Tolerance and Lipid Profile in Lean, Healthy Women

    Not yet reported Atlantis Medical University College 17 participants Est. completion 2013-03 1 site
    Other conditions: Insulin Sensitivity, Weight
    View official trial listing →
  • Completed NCT NCT02005939

    Effect of Biophenol-rich Pomegranate Extract Intake on Blood Pressure, Hormones, Body Composition and Quality of Life in Healthy Volunteers.

    Not yet reported Queen Margaret University 29 participants Est. completion 2012-07 1 site
    Other conditions: Cardiovascular Risk Factors
    View official trial listing →
  • Completed NCT NCT02006784

    Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)

    Vanderbilt University 17 participants Est. completion 2017-04 1 site
    Other conditions: Systemic Lupus Erythematosus (SLE)
    View official trial listing →
  • Completed NCT NCT02007174

    Bevacizumab Injection for Recurrent Pterygium

    Instituto de Oftalmología Fundación Conde de Valenciana 38 participants Est. completion 2013-08 1 site
    Other conditions: Recurrent Pterygium
    View official trial listing →
  • Completed NCT NCT02007603

    Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients

    Not yet reported Medical University of Vienna 16 participants Est. completion 2017-05 1 site
    Other conditions: Infection During Hemodialysis
    View official trial listing →
  • Completed NCT NCT02007629

    Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor

    Not yet reported Bayer 61 participants Est. completion 2016-12-29 27 sites
    Other conditions: Hypertension, Pulmonary
    View official trial listing →
  • Completed NCT NCT02007642

    Evaluation of High Throughput Sequencing for Screening of Pathogens in Immunocompromised Patients With Suspected Infectious Disease.

    Pathoquest 250 participants Est. completion 2014-10 2 sites
    Other conditions: Immunodeficiency and Suspected Infection
    View official trial listing →
  • Completed NCT NCT02007902

    Plasma Protein Levels and Very Preterm Birth

    Centre Hospitalier Universitaire de la Réunion 125 participants Est. completion 2015-03 2 sites
    Other conditions: Very Preterm Infants
    View official trial listing →
  • Completed NCT NCT02008240

    Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET

    Not yet reported Aljazeera Hospital 160 participants Est. completion 2014-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02008552

    Study of the Effect of the Benfluorex

    Not yet reported University Hospital, Brest 346 participants Est. completion 2021-10-18 7 sites
    Other conditions: Blood Sample
    View official trial listing →
  • Status unknown NCT NCT02010541

    The Influence of Technology, Education and Psychological Support on Metabolic Control in Children With T1D

    University Medical Centre Ljubljana 40 participants Est. completion 2014-05 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02010632

    Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

    Not yet reported Khon Kaen University 32 participants Est. completion 2014-12 1 site
    Other conditions: Pharmacodynamics
    View official trial listing →
  • Completed NCT NCT02012478

    Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients.

    Not yet reported University of Pennsylvania 54 participants Est. completion 2014-12 1 site
    Other conditions: Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02012569

    Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting

    Not yet reported Thrombotargets Europe S.L 78 participants Est. completion 2015-07 1 site
    Other conditions: Burns, Traumatic Lesions
    View official trial listing →
  • Completed NCT NCT02012621

    Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy

    University of Colorado, Denver 807 participants Est. completion 2017-07 1 site
    Other conditions: HIV/AIDS
    View official trial listing →
  • Completed NCT NCT02014519

    A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary

    Not yet reported GlaxoSmithKline 2000 participants Est. completion 2015-04-24 5 sites
    Other conditions: Pertussis, Pertussis Vaccines
    View official trial listing →
  • Completed NCT NCT02015156

    A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)

    Not yet reported Pfizer 162 participants Est. completion 2014-04 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02015793

    Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

    Not yet reported AbbVie 30 participants Est. completion 2015-02
    Other conditions: Crohn's Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02016599

    Effects of Transitional Circulation in ELBW Infants

    University of Iowa 200 participants Est. completion 2032-12 1 site
    Other conditions: Neonatal Prematurity, Hypotension
    View official trial listing →
  • Completed NCT NCT02016833

    Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

    PX Biosolutions 15 participants Est. completion 2014-12 1 site
    Other conditions: Ovarian Serous Adenocarcinoma, Undifferentiated Carcinoma of Ovary, Cervical Cancer, Cervical Intraepithelial Neoplasia, Grade 3, Acute Myeloid Leukemia, Chronic Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT02017522

    Non-Invasive Characterization in Cardiac Sarcoidosis

    Not yet reported University of Michigan 3 participants Est. completion 2015-07-07 1 site
    Other conditions: Cardiac Sarcoidosis
    View official trial listing →
  • Status unknown NCT NCT02017587

    Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection

    Vaccine and Gene Therapy Institute, Florida 40 participants Est. completion 2015-12 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Withdrawn NCT NCT02018419

    Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients

    Not yet reported, Not yet reported Mirror Biologics, Inc. Est. completion 2014-03 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02018497

    Essential Hypotension and Allostasis Registry

    CES University 5000 participants Est. completion 2024-06-30 1 site
    Cardiovascular diseaseHeart failure Other conditions: Blood Pressure, Depression, Panic Attack, Fibromyalgia, POTS, Inappropriate Sinus Tachycardia, Coronary Heart Disease, Acute Coronary Syndrome (ACS), Cerebrovascular Disease (CVD), Transient Ischemic Attack (TIA), Atrial Fibrillation, Diabetes Mellitus, Cancer, Chronic Fatigue Syndrome, Syncope, Vasovagal Syncope
    View official trial listing →
  • Completed NCT NCT02020369

    Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors

    Not yet reported rEVO Biologics 27 participants Est. completion 2015-08 17 sites
    Other conditions: Hemophilia A With Inhibitors, Hemophilia B With Inhibitors
    View official trial listing →
  • Completed NCT NCT02020707

    Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

    Not yet reported Mayo Clinic 43 participants Est. completion 2024-07-18 4 sites
    Obstructive sleep apnea Other conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Squamous Cell Carcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, Malignant Female Reproductive System Neoplasm, Malignant Ovarian Clear Cell Tumor, Malignant Ovarian Endometrioid Tumor, Malignant Ovarian Epithelial Tumor, Malignant Ovarian Mucinous Tumor, Malignant Peritoneal Neoplasm, Malignant Solid Neoplasm, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian High Grade Serous Adenocarcinoma, Ovarian Mucinous Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Transitional Cell Carcinoma, Ovarian Undifferentiated Carcinoma, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Platinum-Sensitive Ovarian Carcinoma, Primary Peritoneal Clear Cell Adenocarcinoma, Primary Peritoneal Serous Adenocarcinoma, Primary Peritoneal Transitional Cell Carcinoma, Primary Peritoneal Undifferentiated Carcinoma, Unresectable Melanoma
    View official trial listing →
  • Completed NCT NCT02021682

    CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

    Washington University School of Medicine 58 participants Est. completion 2017-07 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02021760

    Reduction in Infarct Size by Remote Per-postconditioning in Patients With ST-elevation Myocardial Infarction

    Not yet reported John Pernow 120 participants Est. completion 2015-11 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02022540

    Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

    Not yet reported PanOptica, Inc. 50 participants Est. completion 2016-05 22 sites
    Other conditions: Age-Related Macular Degeneration (AMD)
    View official trial listing →
  • Status unknown NCT NCT02023424

    An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome

    Not yet reported Sheba Medical Center 10 participants Est. completion 2015-02 1 site
    Other conditions: Rett Syndrome
    View official trial listing →
  • Completed NCT NCT02023502

    Proteomic Pattern in Female Stress Urinary Incontinence: a Pilot Study

    Medical University of Vienna 40 participants Est. completion 2015-09 1 site
    Other conditions: Female Stress Urinary Incontinence
    View official trial listing →
  • Status unknown NCT NCT02023710

    Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

    Not yet reported Peking University Cancer Hospital & Institute 182 participants Est. completion 2017-12 3 sites
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT02027753

    Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

    Not yet reported Sanofi 109 participants Est. completion 2015-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02028195

    Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme

    Not yet reported University of Aarhus 11000 participants Est. completion 2019-12 1 site
    Cardiovascular disease Other conditions: Health Promotion, Physical Inactivity, Selfreported Quality of Health, Mental Health
    View official trial listing →
  • Status unknown NCT NCT02029456

    Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism

    Not yet reported Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital 30 participants Est. completion 2014-08 1 site
    Other conditions: Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT02029807

    Comparison of Physiological Variables During Blood Donation

    University of Colorado, Denver 50 participants Est. completion 2016-06 1 site
    Other conditions: Hemorrhage
    View official trial listing →
  • Completed NCT NCT02031809

    Multicentric Study VATS Major Introperative Complications

    University Hospital, Gasthuisberg 3076 participants Est. completion 2015-10 9 sites
    Other conditions: Lung Neoplasms
    View official trial listing →
  • Completed NCT NCT02034396

    Clinical Implications of Genetic Variations of Venous Stasis Ulceration

    Not yet reported University of Pittsburgh 377 participants Est. completion 2022-03-31 1 site
    Other conditions: Venous Ulcers
    View official trial listing →
  • Completed NCT NCT02034422

    Understanding the Exercise-Hypertension Paradox

    Not yet reported VA Office of Research and Development 75 participants Est. completion 2021-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02034877

    13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India

    Not yet reported Pfizer 1200 participants Est. completion 2015-07 16 sites
    Other conditions: Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC
    View official trial listing →
  • Completed NCT NCT02035046

    Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter

    Not yet reported Assistance Publique - Hôpitaux de Paris 250 participants Est. completion 2016-09 5 sites
    Other conditions: Heterozygous Carriers of Gitelman Syndrome
    View official trial listing →
  • Completed NCT NCT02035527

    Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Not yet reported Ohio State University Comprehensive Cancer Center 3 participants Est. completion 2017-04-20 1 site
    Other conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Oral Cavity Squamous Cell Carcinoma, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    View official trial listing →
  • Completed NCT NCT02036424

    Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema

    Not yet reported Raj K. Maturi, MD 45 participants Est. completion 2015-08 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Terminated NCT NCT02037373

    Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation

    Octapharma 43 participants Est. completion 2018-02 4 sites
    Other conditions: Coagulopathy, Endstage Liver Disease
    View official trial listing →
  • Completed NCT NCT02038179

    Center of Research Translation (CORT) Project 2

    Not yet reported, Not yet reported University of Alabama at Birmingham 99 participants Est. completion 2018-08 1 site
    Other conditions: Pre-hypertension, JNC 7 Stage I Hypertension
    View official trial listing →
  • Completed NCT NCT02038270

    Accuracy of Nexfin® and NIBP to Predict IBP

    University Medical Center Groningen 110 participants Est. completion 2012-03 1 site
    Other conditions: Bloodpressure
    View official trial listing →
  • Completed NCT NCT02039440

    6-year Antibody Check After Third Vaccination Against Japanese Encephalitis

    Not yet reported Medical University of Vienna 67 participants Est. completion 2014-06 1 site
    Other conditions: Post Other Specified Vaccination Encephalitis
    View official trial listing →
  • Completed NCT NCT02039557

    Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

    Gamida Cell ltd 33 participants Est. completion 2023-06-29 10 sites
    Other conditions: Patients Transplanted With NiCord/CordIn (Omidubicel)
    View official trial listing →
  • Completed NCT NCT02039674

    A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)

    Not yet reported, Not yet reported Merck Sharp & Dohme LLC 267 participants Est. completion 2021-10-18
    Other conditions: Non-small Cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT02040584

    A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

    Not yet reported Novartis Pharmaceuticals 217 participants Est. completion 2016-02-10 20 sites
    Other conditions: Liver Transplant
    View official trial listing →
  • Enrolling by invitation NCT NCT02040714

    Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

    Texas Scottish Rite Hospital for Children 1500 participants Est. completion 2032-09 46 sites
    Other conditions: Legg Calve Perthes Disease
    View official trial listing →
  • Status unknown NCT NCT02042066

    Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension

    Not yet reported Medispec 10 participants 1 site
    Other conditions: Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT02043379

    Post-bypass Prophylactic IVIG in Infants and Neonates

    Not yet reported University of Alabama at Birmingham 50 participants Est. completion 2015-06 1 site
    Other conditions: Hypogammaglobulinemia, Congenital Heart Disease
    View official trial listing →
  • Terminated NCT NCT02043587

    Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

    Not yet reported University of California, San Diego 31 participants Est. completion 2022-04-14 4 sites
    Other conditions: Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma
    View official trial listing →
  • Completed NCT NCT02046993

    Effect of Smart Phone Based Telemonitoring on Blood Pressure Among Hypertensive Patients in Primary Care

    Not yet reported Kwong Wah Hospital 210 participants Est. completion 2015-03 1 site
    Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Withdrawn NCT NCT02047552

    RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone

    Not yet reported Denver Health and Hospital Authority Est. completion 2017-12 1 site
    Other conditions: Functional Iron Deficiency, Trauma, Anemia
    View official trial listing →
  • Completed NCT NCT02048059

    ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

    Not yet reported Angiochem Inc 72 participants Est. completion 2017-09 19 sites
    Other conditions: Breast Cancer, Brain Metastases
    View official trial listing →
  • Completed NCT NCT02049541

    Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma

    Not yet reported Kami Maddocks, MD 18 participants Est. completion 2019-04-09 2 sites
    Obstructive sleep apnea Other conditions: Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT02050035

    Exercise and Vascular Function in Chronic Kidney Disease

    Not yet reported University of Delaware 76 participants Est. completion 2017-07-31 1 site
    Other conditions: Chronic Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT02050581

    A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

    Weill Medical College of Cornell University 72 participants 1 site
    Other conditions: Idiopathic Thrombocytopenia Purpura
    View official trial listing →
  • Completed NCT NCT02050594

    Ipilimumab 12-month Intensive Pharmacovigilance Protocol

    Bristol-Myers Squibb 6 participants Est. completion 2015-02 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Status unknown NCT NCT02050984

    Effect of Bariatric Surgery on Blood Pressure

    Zhiming Zhu 40 participants Est. completion 2018-12 1 site
    Other conditions: Obesity, Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT02051218

    Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

    Not yet reported Swiss Cancer Institute 1380 participants Est. completion 2028-12-31 50 sites
    Other conditions: Metastatic Breast Cancer, Metastatic Prostate Cancer, Bone Metastases
    View official trial listing →
  • Active, not recruiting NCT NCT02051257

    Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 51 participants Est. completion 2027-03-02 1 site
    Other conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Mantle Cell Lymphoma, Transformed Recurrent Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02052986

    An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels

    Not yet reported New York Hospital Queens 100 participants 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02053584

    Dario™ Blood Glucose Monitoring System - User Performance Evaluation

    Not yet reported LabStyle Innovations Ltd. 230 participants Est. completion 2013-06 Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02053610

    CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)

    Not yet reported Hoffmann-La Roche 787 participants Est. completion 2017-08-23 261 sites
    Other conditions: Lymphocytic Leukemia, Chronic
    View official trial listing →
  • Withdrawn NCT NCT02056613

    Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products

    National Institutes of Health Clinical Center (CC) Est. completion 2018-11-01
    Other conditions: Induced Pluripotent Stem Cells
    View official trial listing →
  • Completed NCT NCT02056730

    The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid

    Not yet reported Chulalongkorn University 60 participants Est. completion 2015-02 1 site
    Other conditions: Hyperparathyroidism, Secondary
    View official trial listing →
  • Completed NCT NCT02057107

    SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN

    Not yet reported Heath Skinner 40 participants Est. completion 2019-12-31 1 site
    Other conditions: Previously-Irradiated, Squamous Cell Carcinoma of the Head and Neck Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02057133

    A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

    Not yet reported Eli Lilly and Company 198 participants Est. completion 2026-12 13 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02058095

    Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)

    Not yet reported, Not yet reported Mayo Clinic 22 participants Est. completion 2019-12 1 site
    Other conditions: Cardiomyopathy, Renal Impairment
    View official trial listing →
  • Completed NCT NCT02058784

    Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects

    Not yet reported Helsinn Healthcare SA 28 participants Est. completion 2014-03 1 site
    Other conditions: Healthy Volunteers, Moderate to Heavy Smokers, Non-smokers
    View official trial listing →
  • Completed NCT NCT02059239

    Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma

    Not yet reported, Not yet reported Weill Medical College of Cornell University 34 participants Est. completion 2020-06-15 1 site
    Other conditions: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT02059512

    Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease

    Not yet reported St. Petersburg State Pavlov Medical University 117 participants Est. completion 2018-01 1 site
    Heart failure Other conditions: Ischemic Heart Disease, Bone Marrow Cells, Coronary Artery Bypass Grafting (CABG)
    View official trial listing →
  • Status unknown NCT NCT02060656

    Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)

    Not yet reported Royal Marsden NHS Foundation Trust 92 participants Est. completion 2023-08 1 site
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02060955

    Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

    Not yet reported CytoVac A/S 25 participants Est. completion 2015-07 4 sites
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT02061761

    A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

    Not yet reported, Not yet reported Bristol-Myers Squibb 106 participants Est. completion 2022-02-16 10 sites
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02062970

    Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock

    Not yet reported Assistance Publique Hopitaux De Marseille 230 participants Est. completion 2019-09 1 site
    Other conditions: the Coagulolytic Balance, the Mortality Rate, the Performance Used to Evaluate the Principal Objective Are Technical Performances, Sensibility and Specificity of the Tests
    View official trial listing →
  • Completed NCT NCT02063035

    Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery

    Not yet reported Massachusetts General Hospital 29 participants Est. completion 2015-04-22 1 site
    Other conditions: Lumbar Spinal Stenosis, Thoracic Spinal Stenosis
    View official trial listing →
  • Completed NCT NCT02063477

    Effect of Oligopin® on Blood Pressure.

    Not yet reported Technological Centre of Nutrition and Health, Spain 24 participants Est. completion 2014-10 1 site
    Other conditions: Blood Pressure, Hypertension
    View official trial listing →
  • Completed NCT NCT02063685

    Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

    Not yet reported Fondazione Italiana Linfomi - ETS 807 participants Est. completion 2021-12 48 sites
    Other conditions: Follicular Non-Hodgkin's Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02065466

    Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

    Not yet reported, Not yet reported University of Arizona Est. completion 2015-08 2 sites
    Other conditions: Metastatic Melanoma, Brain Metastases
    View official trial listing →
  • Completed NCT NCT02065635

    Effect of Type of General Anesthesia Maintenance on Exhaled Nitric Oxide and Eosinophil Blood Count

    Not yet reported Aretaieion University Hospital 60 participants Est. completion 2018-04 1 site
    Other conditions: Anesthesia, Exhaled Nitric Oxide, Eosinophil Blood Count
    View official trial listing →
  • Completed NCT NCT02066532

    Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer

    Not yet reported, Not yet reported Dawn L. Hershman 32 participants Est. completion 2020-10-14 4 sites
    Other conditions: Metastatic Breast Cancer, Breast Carcinoma, HER-2 Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02066831

    Diabetes Coaching Study

    Not yet reported West German Center of Diabetes and Health 202 participants Est. completion 2015-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02068183

    World Trade Center Adolescent Health Study

    NYU Langone Health 402 participants Est. completion 2016-03 1 site
    Other conditions: Asthma, Hypertension, Cardiovascular Risk Factor, Insulin Resistance, Stress Disorders, Post-Traumatic, Exposure to Toxic Dust
    View official trial listing →
  • Completed NCT NCT02068755

    Blood Products in Cardiac Surgery

    University of Turku 31000 participants Est. completion 2012-12
    Other conditions: Anemia, Renal Impairment, Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT02069015

    Achieving Blood Pressure Control Through Enhanced Discharge

    Not yet reported Wayne State University 139 participants Est. completion 2016-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02069210

    The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients

    Mahidol University 40 participants Est. completion 2015-12 1 site
    Other conditions: Infection After Transfusion
    View official trial listing →
  • Completed NCT NCT02069561

    Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 25 participants 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02070848

    Muscle Blood Flow During Exercise

    University Hospital, Strasbourg, France 20 participants Est. completion 2018-10-19 1 site
    Other conditions: Skeletal Muscle Blood Flow
    View official trial listing →
  • Status unknown NCT NCT02071407

    A Clinical Trial of the Effect of Midazolam on the Cerebral Metabolism and Inflammatory Response in Patients With Moderate and Severe Traumatic Brain Injury

    Not yet reported Subei People's Hospital of Jiangsu Province 60 participants 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT02072967

    Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

    Astellas Pharma Europe B.V. 97 participants Est. completion 2015-10 35 sites
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT02073396

    Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis

    East and North Hertfordshire NHS Trust 140 participants Est. completion 2018-09 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02073487

    Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel

    Not yet reported The Methodist Hospital Research Institute 32 participants Est. completion 2019-01 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02073526

    Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

    Oslo University Hospital 1230 participants Est. completion 2016-11 1 site
    Other conditions: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02074423

    A Human Clinical Trial Evaluating the Effect of MealShape™ on Blood Glucose Level Following Consumption of Standard Meal

    Not yet reported Dialpha 18 participants Est. completion 2014-02 1 site
    Other conditions: Postprandial Glycemia, Postprandial Insulinemia
    View official trial listing →
  • Completed NCT NCT02075333

    The Effect of Ingesting or Rinsing Sucrose and Sucralose on Self-control, Cognitive Performance, and Blood Glucose

    Not yet reported University of Leeds 40 participants Est. completion 2014-08 1 site
    Other conditions: Self-control, Cognitive Performance, Blood Glucose Response
    View official trial listing →
  • Completed NCT NCT02077556

    Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients

    Not yet reported National Taiwan University Hospital 14 participants Est. completion 2019-01-15 1 site
    Other conditions: Drug Interaction Potentiation
    View official trial listing →
  • Completed NCT NCT02077751

    BioRBC Survival in Adults With Prior Antibody Response to BioRBCs

    Not yet reported John A Widness 3 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Anemia
    View official trial listing →
  • Status unknown NCT NCT02078778

    Central and Peripheral Blood Pressure in Treatment of Obstructive Sleep Apnea.

    Not yet reported Erling Bjerregaard Pedersen 20 participants Est. completion 2017-03 1 site
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT02078804

    Colonoscopy and FIT as Colorectal Cancer Screening Test in the Average Risk Population

    Not yet reported Uppsala University Hospital 278000 participants Est. completion 2030-12-31
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02079532

    A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor

    Not yet reported Hoffmann-La Roche 302 participants Est. completion 2010-11 69 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT02081339

    Cohort Study of the Clinical Course of Macular Diseases in Japanese

    Kyoto University, Graduate School of Medicine 1000 participants Est. completion 2024-03 1 site
    Other conditions: Macular Disease
    View official trial listing →
  • Completed NCT NCT02082184

    An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes

    Not yet reported Abbott Diabetes Care 302 participants Est. completion 2015-12 26 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02082275

    OB Nest; Redefining Continuity of Care for Expectant Mothers

    Not yet reported Mayo Clinic 300 participants Est. completion 2015-11 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT02083432

    Cognitive Behavioural Treatment of Intra-oral Injection-phobia in 10-16 Year Old Children and Adolescents

    Not yet reported University of Bergen 60 participants Est. completion 2016-06-30 1 site
    Other conditions: Dental Anxiety
    View official trial listing →
  • Completed NCT NCT02083549

    Evaluating URMC's Massive Transfusion Protocol

    University of Rochester 2 participants Est. completion 2014-12-16 1 site
    Other conditions: Blood Coagulation Disorders, Trauma, Acute Coagulopathy
    View official trial listing →
  • Completed NCT NCT02084407

    Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients

    Not yet reported Institut de Myologie, France 12 participants Est. completion 2014-08 1 site
    Other conditions: DM1
    View official trial listing →
  • Withdrawn NCT NCT02084810

    Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects

    Not yet reported Novo Nordisk A/S Est. completion 2014-07
    Other conditions: Congenital Bleeding Disorder, Haemophilia A, Haemophilia A With Inhibitors, Haemophilia B, Haemophilia B With Inhibitors, Healthy
    View official trial listing →
  • Completed NCT NCT02086773

    Red Cell Transfusion Goals in Patients With Acute Leukemias

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 90 participants Est. completion 2015-09 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Acute Promyelocytic Leukemia (APL)
    View official trial listing →
  • Active, not recruiting NCT NCT02086890

    Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa

    Not yet reported Nova Southeastern University 21 participants Est. completion 2027-12 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02087514

    Duration of Red Blood Cell Storage Prior to Transfusion

    Not yet reported Columbia University 60 participants Est. completion 2016-02 1 site
    Other conditions: Iron, Blood Level Abnormal
    View official trial listing →
  • Completed NCT NCT02088541

    Selinexor (KPT-330) in Older Patients With Relapsed AML

    Not yet reported Karyopharm Therapeutics Inc 317 participants Est. completion 2018-01-08 78 sites
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Completed NCT NCT02089035

    Replacement of Saturated Fat in Dairy on Total Cholesterol

    Not yet reported University of Reading 54 participants Est. completion 2016-04 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02089841

    Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.

    Not yet reported Richard Mwaiswelo 140 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Plasmodium Falciparum Malaria
    View official trial listing →
  • Status unknown NCT NCT02090166

    Lung Cancer Detection by Measuring Monocyte Activity

    Not yet reported Carmel Medical Center 950 participants Est. completion 2021-01 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT02092467

    Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

    Not yet reported Pfizer 4372 participants Est. completion 2020-07-22 345 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT02093351

    To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

    Not yet reported AstraZeneca 79 participants Est. completion 2019-04-29 14 sites
    Other conditions: Solid Tumours
    View official trial listing →
  • Terminated NCT NCT02093494

    Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters

    Not yet reported Magnolia Medical Technologies, Inc. 200 participants Est. completion 2015-05 1 site
    Other conditions: Septicemia
    View official trial listing →
  • Completed NCT NCT02094755

    Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)

    University of Southern California 100 participants Est. completion 2017-01-31 1 site
    Other conditions: Critical Limb Ischemia
    View official trial listing →
  • Active, not recruiting NCT NCT02094794

    Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML

    Not yet reported City of Hope Medical Center 108 participants Est. completion 2027-05-04 1 site
    Other conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT02095444

    Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection

    Not yet reported, Not yet reported S-Evans Biosciences Co., Ltd. 20 participants Est. completion 2016-12 1 site
    Other conditions: Acute Lung Injury, Acute Respiratory Distress Syndrome (ARDS), Multiple Organ Failure
    View official trial listing →
  • Completed NCT NCT02096354

    A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer

    Not yet reported EpicentRx, Inc. 62 participants Est. completion 2020-10-08 5 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT02096874

    Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema

    Not yet reported King Khaled Eye Specialist Hospital 50 participants Est. completion 2015-06 1 site
    Other conditions: Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema
    View official trial listing →
  • Withdrawn NCT NCT02097264

    A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

    Not yet reported Novo Nordisk A/S Est. completion 2015-09
    Other conditions: Inflammation, Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02098447

    Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds

    Not yet reported Medical University of Vienna 24 participants Est. completion 2015-04-13 1 site
    Other conditions: Chronic Diabetic Foot Ulcers
    View official trial listing →
  • Completed NCT NCT02099266

    Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment

    Not yet reported University of Kansas Medical Center 15 participants Est. completion 2016-02 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS), Hodgkins Lymphoma, Non-Hodgkins Lymphoma
    View official trial listing →
  • Completed NCT NCT02099461

    Effect of Denosumab on Cellular Biomarkers in the Human Breast

    Not yet reported Amgen 82 participants Est. completion 2014-07 3 sites
    Other conditions: Healthy Volunteer, Female, Breast
    View official trial listing →
  • Completed NCT NCT02099877

    μ-opioid Receptor Polymorphism and Opioid Analgesia

    American University of Beirut Medical Center 250 participants Est. completion 2017-06 1 site
    Other conditions: Pharmacogenetic and Duration of Labor Fentanyl Analgesia
    View official trial listing →
  • Completed NCT NCT02100228

    Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

    Not yet reported Pfizer 1500 participants Est. completion 2017-02-08 165 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Withdrawn NCT NCT02100618

    Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

    Not yet reported GlaxoSmithKline Est. completion 2015-04 Stand-alone
    Other conditions: Infections, Papillomavirus
    View official trial listing →
  • Completed NCT NCT02100969

    Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

    Not yet reported Mazen Dimachkie, MD 23 participants Est. completion 2018-01 5 sites
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Withdrawn NCT NCT02101164

    Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

    Not yet reported Amgen Est. completion 2014-11
    Other conditions: Solid Tumor, Metastatic Bone Disease
    View official trial listing →
  • Completed NCT NCT02103582

    Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans

    Not yet reported Georgetown University 40 participants Est. completion 2017-11 1 site
    Other conditions: Smoking Cessation
    View official trial listing →
  • Completed NCT NCT02105532

    Transfusion in Gastrointestinal Bleeding

    Not yet reported, Not yet reported Dr Vipul Jairath 936 participants Est. completion 2013-08 1 site
    Other conditions: Gastrointestinal Hemorrhage
    View official trial listing →
  • Active, not recruiting NCT NCT02105766

    Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 56 participants Est. completion 2027-12-31 1 site
    Other conditions: Sickle Cell Disease, Thalassemia, Stem Cell Transplantation, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02106039

    Pulmonary Tuberculosis Patients With Diabetes Mellitus

    Not yet reported Universitas Padjadjaran 350 participants Est. completion 2017-12-21 3 sites
    Other conditions: Diabetes Mellitus, Pulmonary Tuberculosis
    View official trial listing →
  • Withdrawn NCT NCT02107222

    The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)

    Not yet reported Maquet Cardiopulmonary GmbH 1 site
    Other conditions: COPD, Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02107833

    Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers

    Not yet reported Protalix 18 participants Est. completion 2014-12 1 site
    Other conditions: Human Volunteer
    View official trial listing →
  • Completed NCT NCT02107976

    Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes

    Not yet reported National Institutes of Health Clinical Center (CC) 28 participants Est. completion 2025-03-05 1 site
    Other conditions: Diabetes Type 2
    View official trial listing →
  • Completed NCT NCT02108639

    To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

    Not yet reported Bristol-Myers Squibb 41 participants Est. completion 2014-06 4 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02108860

    Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

    Not yet reported University of South Florida 65 participants Est. completion 2023-12-20 20 sites
    Other conditions: Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis, Wegener's Granulomatosis, ANCA-Associated Vasculitis
    View official trial listing →
  • Completed NCT NCT02109575

    Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)

    Medical College of Wisconsin 540 participants Est. completion 2020-03-30 8 sites
    Cardiovascular disease Other conditions: Acute Rejection of Cardiac Transplant, Cardiac Transplant Rejection, Heart Transplant Failure and Rejection
    View official trial listing →
  • Completed NCT NCT02109666

    Long Term Experience With Abatacept in Routine Clinical Practice

    Bristol-Myers Squibb 2364 participants Est. completion 2016-02 13 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02109926

    A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor

    Centre Leon Berard 1367 participants Est. completion 2018-04 22 sites
    Other conditions: Testicular Germ Cell Tumor
    View official trial listing →
  • Status unknown NCT NCT02111226

    Detecting and Treating High Blood Pressure in Aboriginal Population and Low and Middle Income Countries

    Not yet reported Sunnybrook Health Sciences Centre 360 participants Est. completion 2018-03 1 site
    Cardiovascular disease Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Status unknown NCT NCT02112097

    ASIS for Enbrel in Plaque Psoriasis

    Not yet reported, Not yet reported ASIS Corporation 60 participants Est. completion 2017-06 2 sites
    Other conditions: Plaque Psoriasis.
    View official trial listing →
  • Completed NCT NCT02112825

    Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease

    Not yet reported University of Minnesota 40 participants Est. completion 2015-06 1 site
    Chronic kidney disease
    View official trial listing →
  • Active, not recruiting NCT NCT02113384

    Locally Advanced Rectal Cancer - Exfoliated Peritoneal Tumor Cells

    Oslo University Hospital 231 participants Est. completion 2028-01 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT02113904

    Clinical Trial Using Humira in Netherton Syndrome

    Not yet reported Assistance Publique - Hôpitaux de Paris 11 participants Est. completion 2017-09-21 1 site
    Other conditions: Netherton Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT02116335

    Endothelin Receptor Function and Acute Stress

    Not yet reported Augusta University 320 participants Est. completion 2026-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02116504

    Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 156 participants Est. completion 2017-11 1 site
    Other conditions: Rheumatoid Arthritis, Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT02117037

    Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes

    Not yet reported Assistance Publique Hopitaux De Marseille 180 participants Est. completion 2018-08 1 site
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT02117310

    ICG Use in Angiography for Nasoseptal Flap Harvest

    Not yet reported Ohio State University 5 participants Est. completion 2015-11 1 site
    Other conditions: Skull Base Neoplasms
    View official trial listing →
  • Terminated NCT NCT02117349

    Topical Raplixa for Surgical Bleeding in Children

    Not yet reported Mallinckrodt 55 participants Est. completion 2018-03-06 13 sites
    Other conditions: Surgical Bleeding
    View official trial listing →
  • Terminated NCT NCT02117466

    Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Amsterdam UMC, location VUmc 85 participants Est. completion 2021-01 3 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT02118311

    Treg Cells for AGVHD in Non-myeloablative UCB Transplant

    Not yet reported Masonic Cancer Center, University of Minnesota Est. completion 2018-09 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT02118337

    A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

    Not yet reported, Not yet reported MedImmune LLC 97 participants Est. completion 2020-03-17 27 sites
    Other conditions: Select Advanced Malignancies, Kidney Cancer, Clear Cell Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02118883

    Dehydration, Rehydration, and Blood Viscosity

    Not yet reported Essentia Water, LLC 100 participants Est. completion 2014-07 1 site
    Other conditions: Dehydration
    View official trial listing →
  • Completed NCT NCT02119026

    Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer

    Not yet reported Prof. Dr. Werner Scheithauer 120 participants Est. completion 2017-08-31 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02119351

    A Study Evaluating the Clinical Performance of the ViaValve™ Safety IV Catheter

    Not yet reported Smiths Medical, ASD, Inc. 150 participants Est. completion 2013-12 1 site
    Other conditions: Peripheral Intravenous Catheter
    View official trial listing →
  • Completed NCT NCT02120222

    Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

    Not yet reported Kari Kendra 8 participants Est. completion 2018-04-08 1 site
    Other conditions: Recurrent Melanoma
    View official trial listing →
  • Completed NCT NCT02120287

    Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme

    Not yet reported Ajay Niranjan 16 participants Est. completion 2018-03-31 1 site
    Other conditions: Glioblastoma Multiforme, Glioblastoma - Category
    View official trial listing →
  • Completed NCT NCT02120365

    Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence

    Not yet reported, Not yet reported Virginia Commonwealth University 22 participants Est. completion 2022-02-16 4 sites
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT02120651

    Fibrin Monomer Compared With Hemostatic Sponge in the Integrity of the Graft During Tympanoplasty

    Not yet reported CLOTILDE FUENTES OROZCO 80 participants Est. completion 2014-01 1 site
    Other conditions: Tympanic Membrane Perforation
    View official trial listing →
  • Completed NCT NCT02122081

    Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    Not yet reported Sumithira Vasu 33 participants Est. completion 2022-09-06 1 site
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT02122107

    Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History

    Memorial Sloan Kettering Cancer Center 499 participants Est. completion 2027-04 2 sites
    Other conditions: Breast Cancer Survivors
    View official trial listing →
  • Completed NCT NCT02123069

    Vascular Function and Uterine Fibroids

    Mayo Clinic 28 participants Est. completion 2018-03-01 1 site
    Other conditions: Leiomyoma
    View official trial listing →
  • Status unknown NCT NCT02123615

    ASIS for GAMMAGARD in Primary Immunodeficiency

    Not yet reported, Not yet reported ASIS Corporation 60 participants Est. completion 2016-06 1 site
    Other conditions: Primary Immunodeficiency
    View official trial listing →
  • Completed NCT NCT02123914

    The Effect of Exercises on Physiological Changes and Clinical Symptoms in Allergic Rhinitis Patients

    Not yet reported Chulalongkorn University 27 participants Est. completion 2014-08 1 site
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Withdrawn NCT NCT02124785

    Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®

    Not yet reported GlaxoSmithKline Est. completion 2019-07 1 site
    Other conditions: Hepatitis A
    View official trial listing →
  • Completed NCT NCT02125695

    Pilot Tape Harvesting Study

    Biogen 37 participants Est. completion 2016-08 2 sites
    Other conditions: Atopic Dermatitis, Healthy, Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02128854

    Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills

    Not yet reported Medical University of South Carolina 60 participants Est. completion 2016-08-31 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Noninsulin Dependent, Diabetes Mellitus, Type II
    View official trial listing →
  • Completed NCT NCT02130271

    PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients

    Massachusetts General Hospital 42 participants Est. completion 2018-12 1 site
    Other conditions: Sciatica
    View official trial listing →
  • Completed NCT NCT02130505

    Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

    Not yet reported Sint Franciscus Gasthuis 51 participants Est. completion 2008-06
    Type 2 diabetes Other conditions: Atherosclerosis, Leukocyte Activation Disorder, Familial Combined Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT02130752

    Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery

    Not yet reported West China Hospital 430 participants Est. completion 2022-10 9 sites
    Other conditions: Gastric Cancer, Surgery, Ultrasonic Scalpel, Monopolar Electrocautery, Operation Time, Blood Loss, Surgical, Quality of Life, External Causes of Morbidity and Mortality
    View official trial listing →
  • Status unknown NCT NCT02130973

    The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

    Not yet reported Health Research, Inc. 60 participants Est. completion 2018-08 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02131766

    USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes

    Not yet reported University of Virginia 33 participants Est. completion 2015-03 4 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02132858

    Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

    Fox Chase Cancer Center 43 participants Est. completion 2022-10 1 site
    Other conditions: Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer, Stage IIC Rectal Cancer, Stage IIIA Rectal Cancer, Stage IIIB Rectal Cancer, Stage IIIC Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT02132884

    Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

    Not yet reported Fox Chase Cancer Center 1 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Malignant Pericardial Effusion, Malignant Pleural Effusion, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02133222

    Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

    Not yet reported Centre Hospitalier Universitaire de Nice 22 participants Est. completion 2016-08 1 site
    Other conditions: Metastatic (Stage IV) Melanoma
    View official trial listing →
  • Completed NCT NCT02134119

    Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes

    Not yet reported University of Georgia 45 participants Est. completion 2013-07 1 site
    Other conditions: Ineffective Erythropoiesis
    View official trial listing →
  • Completed NCT NCT02134171

    Early Predictive Factors of Cardiac and Cerebral Involvement in TMA

    Not yet reported Assistance Publique - Hôpitaux de Paris 119 participants Est. completion 2017-07-30 1 site
    Other conditions: Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura
    View official trial listing →
  • Withdrawn NCT NCT02138175

    Continuous Hemoglobin Monitoring: Detection of Acute Blood Loss - Accurate, Timely and Cost-effective

    Wake Forest University Health Sciences Est. completion 2017-01 1 site
    Other conditions: Bleeding, Acute Blood Loss Anemia
    View official trial listing →
  • Status unknown NCT NCT02138331

    Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM)

    Not yet reported, Not yet reported General Committee of Teaching Hospitals and Institutes, Egypt 20 participants Est. completion 2014-09 3 sites
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Withdrawn NCT NCT02138591

    Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.

    Not yet reported University of Missouri, Kansas City Est. completion 2016-05 1 site
    Other conditions: Vitamin d Deficiency
    View official trial listing →
  • Completed NCT NCT02138617

    Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

    Not yet reported UNC Lineberger Comprehensive Cancer Center 100 participants Est. completion 2024-08-01 7 sites
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT02140203

    Effects of Yoga on Metabolic Syndrome

    Not yet reported Angus Yu 182 participants Est. completion 2013-08 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02140372

    Anti-platelet Effects of Colchicine in Healthy Volunteers

    Not yet reported NYU Langone Health 10 participants Est. completion 2015-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02141633

    Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment

    Not yet reported University of Miami 31 participants Est. completion 2015-12 1 site
    Other conditions: Smoking
    View official trial listing →
  • Completed NCT NCT02141906

    A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin

    Not yet reported University of Texas Southwestern Medical Center 20 participants Est. completion 2022-05-16 1 site
    Other conditions: Hepatocellular Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02143414

    Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 53 participants Est. completion 2027-06-06 195 sites
    Other conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT02143934

    Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity

    Not yet reported Papua New Guinea Institute of Medical Research 524 participants Est. completion 2014-05 1 site
    Other conditions: Plasmodium Vivax Infection, Plasmodium Vivax Clinical Episode, Plasmodium Falciparum Infection, Plasmodium Falciparum Clinical Episode
    View official trial listing →
  • Completed NCT NCT02144454

    Impact of Meal Fatty Acids on Postprandial Vascular Reactivity

    Not yet reported University of Reading 32 participants Est. completion 2015-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02144571

    Sistas Inspiring Sistas Through Activity and Support

    Not yet reported University of South Carolina 350 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Prevention Harmful Effects
    View official trial listing →
  • Completed NCT NCT02144740

    Effect of NWT-03 on Blood Pressure

    Not yet reported Newtricious R&D BV 63 participants 1 site
    Other conditions: Blood Pressure, Albuminuria
    View official trial listing →
  • Completed NCT NCT02147327

    Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities

    Zekai Tahir Burak Women's Health Research and Education Hospital 120 participants Est. completion 2014-05
    Other conditions: Neonatal Hypocalcemia, Neonatal Sepsis
    View official trial listing →
  • Completed NCT NCT02147535

    Impact of CES1 Genotype on Metabolism of Methylphenidate

    Not yet reported Bispebjerg Hospital 78 participants 1 site
    Other conditions: Carboxylesterase 1 (CES1) Genotype, CES1 Activity
    View official trial listing →
  • Completed NCT NCT02148198

    Effect of NWT-03 on Blood Pressure - Part 1

    Not yet reported Newtricious R&D BV 92 participants
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT02148523

    Social Forces to Improve Statin Adherence (Study B)

    Not yet reported University of Pennsylvania 201 participants Est. completion 2015-01 1 site
    Other conditions: Medication Adherence, High Blood Pressure, Diabetes
    View official trial listing →
  • Completed NCT NCT02148653

    An Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Subjects

    Not yet reported Lund University 47 participants Est. completion 2015-11 1 site
    Metabolic syndrome Other conditions: Insulin Resistance, Overweight
    View official trial listing →
  • Status unknown NCT NCT02149069

    Blood Management Program in the Post - Operative Period.

    Azienda USL Reggio Emilia - IRCCS 200 participants Est. completion 2016-01 1 site
    Other conditions: Excessive Amount of Blood / Fluid Transfusion
    View official trial listing →
  • Completed NCT NCT02150031

    Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols

    Not yet reported University of Santiago de Compostela 208 participants Est. completion 2012-06 2 sites
    Other conditions: Bacteremia, Tooth Extraction Status Nos
    View official trial listing →
  • Completed NCT NCT02150720

    Prevention of Postoperative Bleeding in Subcapital Femoral Fractures

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 161 participants Est. completion 2016-03 6 sites
    Other conditions: Hip Fracture, Blood Loss
    View official trial listing →
  • Completed NCT NCT02154412

    Mechanisms of Arterial Hypotension in Chronic Spinal Cord Injury

    Not yet reported University of Louisville 1 participants Est. completion 2019-04-30 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Status unknown NCT NCT02154997

    The Effect of Different Food Products on Post Prandial Blood Glucose in Pregnant Woman With Diabetes

    Uri Elchalal 100 participants Est. completion 2017-12 1 site
    Type 2 diabetes Other conditions: Type 1 Diabetes, Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT02155868

    Role of Cerebral Oximetry in Reducing Postoperative Morbidity Following Cardiac Surgery

    Not yet reported Meshalkin Research Institute of Pathology of Circulation 120 participants Est. completion 2016-12 1 site
    Other conditions: Postoperative Complications
    View official trial listing →
  • Completed NCT NCT02157181

    Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab

    Not yet reported Jurgen Barth 89 participants Est. completion 2013-01 47 sites
    Other conditions: Hairy Cell Leukemia (HCL)
    View official trial listing →
  • Completed NCT NCT02157883

    Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

    Not yet reported AstraZeneca 39 participants Est. completion 2023-05-17 16 sites Stand-alone
    Other conditions: Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02157948

    A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

    Not yet reported Amgen 394 participants Est. completion 2015-07 23 sites
    Other conditions: Postmenopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT02158052

    Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2021-06-22 1 site
    Other conditions: Multiple Myeloma, Amyloidosis
    View official trial listing →
  • Completed NCT NCT02158845

    Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis

    Not yet reported University of Sao Paulo 44 participants Est. completion 2012-09 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02159521

    Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

    Not yet reported Boston Scientific Corporation 81 participants Est. completion 2017-11-30 22 sites
    Other conditions: Deep Vein Thrombosis, Post-thrombotic Syndrome
    View official trial listing →
  • Completed NCT NCT02159638

    Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes

    Not yet reported Vastra Gotaland Region 38 participants Est. completion 2014-09-01 2 sites
    Other conditions: Diabetes Mellitus, Type 1, Blood Glucose
    View official trial listing →
  • Completed NCT NCT02159846

    Effects of Mixed Herbs on Blood Glucose and Lipid Profile in T2DM Patients

    International Islamic University Malaysia 20 participants Est. completion 2013-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02160366

    Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients

    M.D. Anderson Cancer Center 2000 participants Est. completion 2020-09-27 1 site
    Other conditions: Advanced Cancers
    View official trial listing →
  • Status unknown NCT NCT02161055

    Intensive Versus Nonintensive Insulin Therapy for Hyperglycemia After Traumatic Brain Injury

    Not yet reported Lianyungang Oriental Hospital 144 participants Est. completion 2016-12 2 sites
    Other conditions: Brain Injuries, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02161575

    Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD

    Not yet reported Novartis Pharmaceuticals 103 participants Est. completion 2017-09-14 28 sites
    Other conditions: Neovascular Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02162563

    Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

    Not yet reported Dutch Colorectal Cancer Group 530 participants Est. completion 2025-01 56 sites
    Other conditions: Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Completed NCT NCT02162667

    Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer

    Not yet reported Celltrion 562 participants Est. completion 2018-10 98 sites
    Other conditions: HER2-positive Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT02163759

    A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

    Not yet reported Hoffmann-La Roche 358 participants Est. completion 2020-03-19 88 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT02166463

    Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma

    Not yet reported National Cancer Institute (NCI) 600 participants Est. completion 2026-10-03 199 sites
    Other conditions: Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma, Ann Arbor Stage IVB Hodgkin Lymphoma, Childhood Hodgkin Lymphoma, Classic Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT02167464

    Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study

    Not yet reported Medical University of South Carolina 70 participants Est. completion 2015-01 8 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02167958

    Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

    Not yet reported Rafic Farah, MD 28 participants Est. completion 2019-09-21 1 site
    Other conditions: Leukemia, MDS, Myelofibrosis, Lymphoma
    View official trial listing →
  • Completed NCT NCT02169713

    Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

    Not yet reported Astellas Pharma Europe B.V. 20 participants Est. completion 2014-08 1 site
    Other conditions: Healthy Subjects, Pharmacokinetics, Drug-Drug Interaction (DDI)
    View official trial listing →
  • Status unknown NCT NCT02172937

    Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study

    Not yet reported, Not yet reported Karolinska Institutet 50 participants Est. completion 2016-12 1 site
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Status unknown NCT NCT02173951

    An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients

    Not yet reported, Not yet reported Ain Shams University 64 participants Est. completion 2015-07 1 site
    Other conditions: Beta Thalassemia Major
    View official trial listing →
  • Completed NCT NCT02174172

    A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors

    Not yet reported Hoffmann-La Roche 158 participants Est. completion 2019-11-25 9 sites
    Other conditions: Solid Cancers
    View official trial listing →
  • Completed NCT NCT02175017

    ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

    Not yet reported Ono Pharmaceutical Co., Ltd. 104 participants Est. completion 2021-02 10 sites
    Other conditions: Advanced Non-small Cell Lung Cancer (NSCLC)
    View official trial listing →
  • Completed NCT NCT02176031

    Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD

    Not yet reported Dana-Farber Cancer Institute 21 participants Est. completion 2019-02 2 sites
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT02176317

    Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)

    Not yet reported Duke University 25 participants Est. completion 2015-12 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT02177409

    Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension

    Not yet reported Boehringer Ingelheim 431 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177981

    Impact of Remote Ischemic Preconditioning Preceding Coronary Artery Bypass Grafting on Inducing nEuroprotection

    Not yet reported University of Zagreb 70 participants Est. completion 2016-03 1 site
    Other conditions: Brain Ischemia, Postoperative Confusion
    View official trial listing →
  • Completed NCT NCT02178306

    Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

    Not yet reported Boehringer Ingelheim 82 participants
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02179840

    Assessment of Cerebral Microvascular Circulation

    Not yet reported University of California, San Francisco Est. completion 2016-03 1 site
    Other conditions: Cerebral Microvascular Circulation
    View official trial listing →
  • Completed NCT NCT02181244

    Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects

    Not yet reported University of Connecticut 33 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Inflammation
    View official trial listing →
  • Completed NCT NCT02183818

    Integrative-omics of the Disordered COPD Small Airway Epithelium

    Weill Medical College of Cornell University 42 participants Est. completion 2020-10-15 1 site
    Other conditions: Smoking, COPD
    View official trial listing →
  • Completed NCT NCT02184507

    Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress

    Not yet reported Mohammad Hassan Eftekhari 92 participants Est. completion 2014-07
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02184858

    Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension

    Not yet reported University Ghent 13 participants Est. completion 2018-09-17 1 site
    Other conditions: Primary Hypertension, Secondary Hypertension
    View official trial listing →
  • Completed NCT NCT02185755

    Internet Monitoring vs Medication to Control Blood Sugar in Type 2 Diabetes

    Not yet reported Endocrine Research Society 60 participants Est. completion 2016-08 1 site
    Type 2 diabetes
    View official trial listing →
  • No Longer Available NCT NCT02186249

    Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma

    Bristol-Myers Squibb 66 sites
    Other conditions: Malignant Melanoma
    View official trial listing →
  • Completed NCT NCT02187133

    Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

    Not yet reported University of California, San Francisco 10 participants Est. completion 2021-03-31 3 sites
    Other conditions: Lymphoma, Non-Hodgkin, Lymphoma
    View official trial listing →
  • Completed NCT NCT02187302

    CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

    Not yet reported NewLink Genetics Corporation 115 participants Est. completion 2017-01 43 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02187861

    A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)

    Not yet reported Hoffmann-La Roche 163 participants Est. completion 2018-03-16 71 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT02188771

    A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis

    Not yet reported, Not yet reported ProCore Ltd. 11 participants Est. completion 2015-10 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02189135

    Making Ramadhan Fasting a Safer Experience With Technology Study

    Not yet reported Monash University 85 participants Est. completion 2016-09 1 site
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Status unknown NCT NCT02189512

    Study on the Effect of Surgical Intestinal Manipulation

    Not yet reported Universitaire Ziekenhuizen KU Leuven 20 participants Est. completion 2016-06 1 site
    Other conditions: Intestinal Manipulation
    View official trial listing →
  • Completed NCT NCT02189525

    Evaluation of Mild TBI in Collegiate Athletes

    Banyan Biomarkers, Inc 500 participants Est. completion 2018-07-25 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Status unknown NCT NCT02189928

    REmote iSchemic Conditioning in acUtE BRAin INfarction Study

    Not yet reported Versailles Hospital 200 participants Est. completion 2019-01 9 sites
    Other conditions: Cerebral Infarction
    View official trial listing →
  • Completed NCT NCT02193724

    Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma

    St. Jude Children's Research Hospital 15 participants Est. completion 2019-08-23 1 site
    Other conditions: Retinoblastoma
    View official trial listing →
  • Status unknown NCT NCT02194101

    Supernormal Goal for Proximal Femur Fracture

    Guangzhou First People's Hospital 30 participants Est. completion 2015-06 1 site
    Other conditions: Femoral Fractures
    View official trial listing →
  • Completed NCT NCT02194569

    Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose.

    Not yet reported Ziekenhuis Oost-Limburg 36 participants Est. completion 2017-06 1 site
    Other conditions: Critically Ill, Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT02194907

    Emotion Study -- A Neurofeedback Approach

    Not yet reported University of Florida 19 participants Est. completion 2020-01-08 1 site
    Other conditions: Aging, Emotion
    View official trial listing →
  • Status unknown NCT NCT02195336

    dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.

    Not yet reported Karl Kölbeck 20 participants Est. completion 2018-06 1 site
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02196701

    Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

    Not yet reported AbbVie 46 participants Est. completion 2017-03-17
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02196961

    Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation

    Not yet reported Prof. Dr. med. Dirk Schadendorf 180 participants Est. completion 2024-08-31 20 sites
    Other conditions: Merkel Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02197416

    Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

    Not yet reported Boehringer Ingelheim 214 participants Est. completion 2019-11-19 62 sites
    Other conditions: Venous Thromboembolism, Secondary Prevention
    View official trial listing →
  • Completed NCT NCT02198144

    Cut Your Pressure Too: The Altadena Barbershop Blood Pressure Study, Phase 2 (Intervention Pilot Study)

    Not yet reported Cedars-Sinai Medical Center 14 participants Est. completion 2013-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT02199041

    Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen

    Not yet reported St. Jude Children's Research Hospital 24 participants Est. completion 2017-05-23 1 site
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT02200419

    POC - Transfusion Algorithm Cardiac Study

    Not yet reported University Health Network, Toronto 7402 participants Est. completion 2016-09 12 sites
    Other conditions: Heart Diseases
    View official trial listing →
  • Completed NCT NCT02203292

    Transfusion Requirements After Head Trauma

    Not yet reported University of Sao Paulo 44 participants Est. completion 2016-06 1 site
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Terminated NCT NCT02204982

    Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma

    Not yet reported SecuraBio 13 participants Est. completion 2017-03 5 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT02205047

    Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 172 participants Est. completion 2024-12-31 48 sites
    Other conditions: Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach, Epidermal Growth Factor Receptor (EGFR) Protein Overexpression
    View official trial listing →
  • Status unknown NCT NCT02208791

    Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

    Not yet reported University of Sao Paulo General Hospital 45 participants Est. completion 2017-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02209142

    Blood Biomarkers in Major Depression

    Not yet reported Assistance Publique Hopitaux De Marseille 275 participants Est. completion 2022-11-10 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT02210741

    Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease

    National Taiwan University Hospital 200 participants Est. completion 2024-02 1 site
    Other conditions: Graves Disease
    View official trial listing →
  • Completed NCT NCT02212262

    Role of Osteocytes in Myeloma Bone Disease

    Attaya Suvannasankha 67 participants Est. completion 2022-02-05 2 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02212548

    Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose

    Not yet reported Royal North Shore Hospital 30 participants Est. completion 2016-12 1 site
    Other conditions: Cancer of the Prostate
    View official trial listing →
  • Completed NCT NCT02212626

    Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion

    Not yet reported Flanders Medical Research Program 30 participants Est. completion 2017-01 5 sites
    Other conditions: Peripheral Vascular Disease
    View official trial listing →
  • Terminated NCT NCT02213341

    Impact of Vaccination on Th2 Immunity in Infancy

    National Institute of Allergy and Infectious Diseases (NIAID) 77 participants Est. completion 2016-06-14 1 site
    Other conditions: Food Hypersensitivity
    View official trial listing →
  • Terminated NCT NCT02213744

    MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients

    Not yet reported, Not yet reported Merrimack Pharmaceuticals 113 participants Est. completion 2017-06 109 sites
    Other conditions: Breast Cancer, HER2 Positive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02213952

    PRP ULCERAS: Clinical Trial Phase III

    Not yet reported Basque Health Service Est. completion 2017-12 2 sites
    Other conditions: Ulcer
    View official trial listing →
  • Status unknown NCT NCT02214004

    Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women

    Not yet reported Gangnam Severance Hospital 132 participants Est. completion 2019-06 14 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02214394

    Detection of Propofol in Exhaled Breath

    Not yet reported Xhale Assurance 15 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02218177

    Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

    University Health Network, Toronto 30 participants Est. completion 2016-12 1 site
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02218268

    Arterial Stiffness in Type I Diabetes Mellitus

    University of Florida 60 participants Est. completion 2015-08 1 site
    Other conditions: Arterial Stiffness in Youth With Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT02218554

    Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay

    Not yet reported Micromedic Technologies Ltd 150 participants Est. completion 2014-12 2 sites
    Other conditions: Bisphosphonate-related Osteonecrosis of the Jaw
    View official trial listing →
  • Completed NCT NCT02218931

    ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes

    Not yet reported Queen Mary University of London 3442 participants Est. completion 2017-04-30 1 site
    Other conditions: Pre-eclampsia, Obesity, Raised Lipids, High Blood Pressure, Insulin Resistance, Gestational Diabetes, Small for Gestational Age, Stillbirth
    View official trial listing →
  • Completed NCT NCT02219659

    Pilot Study on Pairing Sedation Strategies and Weaning

    Not yet reported MemorialCare Health System 90 participants Est. completion 2018-05-18 1 site
    Other conditions: Acute Respiratory Failure
    View official trial listing →
  • Completed NCT NCT02220608

    Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

    Not yet reported Washington University School of Medicine 10 participants Est. completion 2016-11-30 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02221258

    Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)

    Not yet reported Kang Stem Biotech Co., Ltd. 9 participants Est. completion 2015-10 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02222155

    Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

    Not yet reported Amgen 42 participants Est. completion 2016-07-19 43 sites
    Other conditions: ANCA-associated Vasculitis
    View official trial listing →
  • Status unknown NCT NCT02222311

    Influence of Vitamin D Deficiency on the Development of Autism

    Hillel Yaffe Medical Center 300 participants Est. completion 2018-04 1 site
    Other conditions: Autism
    View official trial listing →
  • Completed NCT NCT02222610

    Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.

    Not yet reported Greater Houston Retina Research 40 participants Est. completion 2019-03 4 sites
    Other conditions: Radiation Retinopathy
    View official trial listing →
  • Completed NCT NCT02224417

    Trial to Incentivise Adherence for Diabetes

    Not yet reported Duke-NUS Graduate Medical School 240 participants Est. completion 2018-10-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT02224781

    Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

    Not yet reported National Cancer Institute (NCI) 267 participants Est. completion 2026-12-19 838 sites Stand-alone
    Other conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Recurrent Melanoma, Unresectable Melanoma
    View official trial listing →
  • Withdrawn NCT NCT02225795

    Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.

    Not yet reported TriStar Health Est. completion 2019-12
    Other conditions: Crohn's Disease
    View official trial listing →
  • Withdrawn NCT NCT02228512

    Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

    Not yet reported, Not yet reported National Cancer Institute (NCI) Est. completion 2015-05-05
    Other conditions: Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma
    View official trial listing →
  • Completed NCT NCT02229487

    The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers

    Not yet reported Ramathibodi Hospital 51 participants Est. completion 2017-03-31 1 site
    Prediabetes
    View official trial listing →
  • Completed NCT NCT02229513

    Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage

    Not yet reported Baylor Research Institute 200 participants Est. completion 2014-08 1 site
    Other conditions: Postpartum Hemorrhage, Uterine Atony
    View official trial listing →
  • Completed NCT NCT02230098

    Effects of Remote Ischemic Conditioning on Myocardial Perfusion in Humans

    Not yet reported University of Aarhus 50 participants Est. completion 2014-10 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT02232113

    Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

    Not yet reported Taipei Veterans General Hospital, Taiwan 67 participants Est. completion 2013-01 1 site
    Other conditions: Anemia, Inflammation, Malnutrition
    View official trial listing →
  • Terminated NCT NCT02232568

    Trial of Feedback on Blood Use

    Not yet reported Brigham and Women's Hospital 426 participants Est. completion 2017-11-01 5 sites
    Other conditions: Compliance With Restrictive RBC Transfusion Guideline
    View official trial listing →
  • Completed NCT NCT02233322

    Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.

    Not yet reported Indiana University 8 participants Est. completion 2019-11-12 1 site
    Other conditions: Autosomal Dominant Hypophosphatemic Rickets
    View official trial listing →
  • Withdrawn NCT NCT02233829

    Dopamine Rhythms in Health and Addiction

    Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) Est. completion 2024-04-23 1 site
    Other conditions: Cocaine Abuse
    View official trial listing →
  • Completed NCT NCT02234947

    Pancreas Volume in Preclinical Type 1 Diabetes

    University of Florida 246 participants Est. completion 2023-04-04 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT02235389

    A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®)

    Boehringer Ingelheim 59 participants
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02236936

    Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck

    Not yet reported Arbeitsgemeinschaft medikamentoese Tumortherapie 8 participants Est. completion 2019-07-10 7 sites
    Other conditions: Squamous Cell Carcinoma of the Hypopharynx Stage III, Squamous Cell Carcinoma of the Hypopharynx Stage IV, Laryngeal Squamous Cell Carcinoma Stage III, Laryngeal Squamous Cell Carcinoma Stage IV, Oropharyngeal Squamous Cell Carcinoma Stage III, Oropharyngeal Squamous Cell Carcinoma Stage IV, Squamous Cell Carcinoma of the Oral Cavity Stage III, Squamous Cell Carcinoma of the Oral Cavity Stage IV, Locally Advanced Malignant Neoplasm
    View official trial listing →
  • Status unknown NCT NCT02240342

    Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve

    Not yet reported Hospital Universitario La Fe 20 participants Est. completion 2016-03 1 site
    Other conditions: Ovarian Reserve
    View official trial listing →
  • Status unknown NCT NCT02240394

    TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure

    Shanghai Jiao Tong University Affiliated Sixth People's Hospital 400 participants Est. completion 2015-03 1 site
    Other conditions: Traumatic Brain Injury, Cerebral Hemorrhage, Increased Intracranial Pressure
    View official trial listing →
  • Completed NCT NCT02241187

    Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

    Not yet reported Memorial Sloan Kettering Cancer Center 2 participants Est. completion 2016-09-13 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT02241343

    Venous Occlusion and Limb Swelling

    Not yet reported Imperial College London 1 participants Est. completion 2014-06 1 site
    Other conditions: Venous Occlusion
    View official trial listing →
  • Completed NCT NCT02242864

    Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

    Boehringer Ingelheim 1527 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02246842

    A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.

    Not yet reported Bio Products Laboratory 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02247739

    A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor

    Not yet reported Pharming Technologies B.V. 32 participants Est. completion 2016-09 10 sites
    Other conditions: Hereditary Angioedema
    View official trial listing →
  • Completed NCT NCT02247765

    Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion

    Not yet reported Medtronic - MITG 18 participants Est. completion 2014-12 2 sites
    Other conditions: Healthy, Hypoxia
    View official trial listing →
  • Completed NCT NCT02247843

    Stem Cell Gene Therapy for Sickle Cell Disease

    Not yet reported, Not yet reported Donald B. Kohn, M.D. 4 participants Est. completion 2025-09-24 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02250287

    New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease

    Mayo Clinic 20 participants Est. completion 2016-03 1 site
    Other conditions: Autosomal Dominant Polycystic Kidney Disease, Kidney Disease
    View official trial listing →
  • Completed NCT NCT02250482

    An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.

    Not yet reported Bio Products Laboratory 8 sites
    Other conditions: Haemophilia A
    View official trial listing →
  • Status unknown NCT NCT02250729

    Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure

    Not yet reported Central Hospital, Nancy, France 1020 participants Est. completion 2020-07 24 sites
    Other conditions: Neuromuscular Blocking Agents Anaphylaxis
    View official trial listing →
  • Status unknown NCT NCT02252952

    The Effect of Sugar Sweetened and Diet Beverages Consumed as Part of a Weight-Maintenance Diet on Fat Storage

    Not yet reported Rippe Lifestyle Institute 99 participants 1 site
    Other conditions: Focus: Understanding the Obesogenic Potential of Sugars and Non-caloric Sweeteners
    View official trial listing →
  • Completed NCT NCT02253121

    Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

    Not yet reported Slotervaart Hospital 46 participants Est. completion 2017-05 4 sites
    Other conditions: Hyperglycemia Steroid-induced
    View official trial listing →
  • Active, not recruiting NCT NCT02253238

    Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients

    Not yet reported M.D. Anderson Cancer Center 427 participants Est. completion 2027-04-30 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Status unknown NCT NCT02255006

    Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury

    Not yet reported Kyunghee University Medical Center 36 participants Est. completion 2014-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02257567

    A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma

    Not yet reported, Not yet reported Hoffmann-La Roche 331 participants Est. completion 2021-10-21 62 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02258009

    Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

    Not yet reported Novartis Pharmaceuticals Est. completion 2016-10 1 site
    Other conditions: Visual Impairment Due to Diabetic Macular Edema
    View official trial listing →
  • Status unknown NCT NCT02258282

    Safety and Efficacy of Etanercept in Patients With Psoriasis

    Not yet reported Chengdu PLA General Hospital 80 participants Est. completion 2022-12 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02259101

    RCT of CBT for Insomnia With PLWHA

    Not yet reported Emory University 34 participants Est. completion 2016-02 1 site
    Other conditions: Insomnia, HIV, Aids
    View official trial listing →
  • Status unknown NCT NCT02260739

    Sequential Analysis in Patients With an Hemopathy

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 246 participants Est. completion 2026-01 1 site
    Other conditions: Hemopathy
    View official trial listing →
  • Completed NCT NCT02261506

    Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT

    Not yet reported Sunnybrook Health Sciences Centre 115 participants Est. completion 2017-10-05 17 sites
    Other conditions: Bacteremia
    View official trial listing →
  • Terminated NCT NCT02263235

    In Vivo Alzheimer Proteomics

    Not yet reported University Hospital, Montpellier 89 participants Est. completion 2018-05-22 1 site
    Other conditions: Probable Alzheimer Disease, Parkinson Disease, Neurological Disease Without Cognitive Degradation, Brain Trauma, Acute Hydrocephaly
    View official trial listing →
  • Completed NCT NCT02265016

    Regulation and Signaling of Red Blood Cell (RBC) Endothelial Nitric Oxide Synthase (eNOS) in Patients With Stable and Unstable Coronary Artery Disease

    Heinrich-Heine University, Duesseldorf 300 participants Est. completion 2020-12-31 1 site
    Cardiovascular disease Other conditions: Endothelial NO-synthase
    View official trial listing →
  • Status unknown NCT NCT02265562

    Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy

    Not yet reported Cairo University 220 participants Est. completion 2015-06 1 site
    Other conditions: Blood Loss
    View official trial listing →
  • Withdrawn NCT NCT02266654

    Early Goal Directed Therapy in Sepsis by Emergency Medical Services

    Not yet reported Massachusetts General Hospital Est. completion 2017-05 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Completed NCT NCT02268695

    Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

    Not yet reported Groupe Oncologie Radiotherapie Tete et Cou 541 participants Est. completion 2021-12-31 17 sites
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02269163

    Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

    Not yet reported Prometic Biotherapeutics, Inc. 82 participants Est. completion 2019-01-11 13 sites
    Other conditions: Primary Immunodeficiency
    View official trial listing →
  • Withdrawn NCT NCT02270164

    The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study

    Not yet reported University of Mississippi Medical Center Est. completion 2016-02 1 site
    Other conditions: Lipid Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT02270216

    Cardiovascular Responses to Static and Dynamic Exercise in Elderly With Isolated Systolic Hypertension

    Not yet reported Sahachat Aueyingsak 30 participants 1 site
    Other conditions: Cardiovascular Responses in Elderly With Isolated Systolic Hypertension
    View official trial listing →
  • Terminated NCT NCT02271178

    Multi-cap for Increase Adherence After Acute Myocardial Infarction

    Not yet reported Hospital El Cruce 100 participants Est. completion 2016-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02271477

    Can Vena Cava Ultrasound Guided Volume Repletion Prevent Spinal Induced Significant Hypotension in Elective Patients?

    Not yet reported Ente Ospedaliero Cantonale, Bellinzona 160 participants Est. completion 2014-12 1 site
    Other conditions: Fluid Overload, Anesthesia; Adverse Effect, Spinal and Epidural, Regional Anesthesia Morbidity
    View official trial listing →
  • Status unknown NCT NCT02271724

    sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN

    University of Aarhus 85 participants Est. completion 2016-11 1 site
    Other conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
    View official trial listing →
  • Completed NCT NCT02272413

    Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

    Not yet reported Boehringer Ingelheim 671 participants Est. completion 2018-11-16 189 sites
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT02274064

    Motivating Type O- Blood Donors to Return

    Not yet reported Ohio University 598 participants Est. completion 2016-08 1 site
    Other conditions: Blood Donors
    View official trial listing →
  • Completed NCT NCT02274402

    Pharmacokinetics of Prednisone in Adults

    Assistance Publique - Hôpitaux de Paris 114 participants Est. completion 2016-06 1 site
    Other conditions: Patients Receiving Prednisone
    View official trial listing →
  • Withdrawn NCT NCT02274506

    Infusion of Allogeneic, 3rd Party CD19-specific T Cells

    Not yet reported M.D. Anderson Cancer Center Est. completion 2014-10-20
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT02274792

    Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis

    Not yet reported Amgen 132 participants Est. completion 2015-11 45 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Status unknown NCT NCT02275598

    Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma

    Not yet reported University of Modena and Reggio Emilia 12 participants Est. completion 2015-03 3 sites
    Other conditions: Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT02277197

    Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

    Not yet reported James J Lee 14 participants Est. completion 2018-02 3 sites
    Other conditions: Carcinoma, Squamous Cell of Head and Neck, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head And Neck
    View official trial listing →
  • Completed NCT NCT02278536

    Multiple Gestation Study

    Natera, Inc. 354 participants Est. completion 2019-03 8 sites
    Other conditions: Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities
    View official trial listing →
  • Completed NCT NCT02278874

    High Risk Multiple Gestation Study

    Natera, Inc. 99 participants Est. completion 2019-03 4 sites
    Other conditions: Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities
    View official trial listing →
  • Completed NCT NCT02280486

    Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 388 participants Est. completion 2017-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02280785

    Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas

    Not yet reported Samsung Medical Center 33 participants Est. completion 2018-09 4 sites
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT02281474

    Nilotinib in Cognitively Impaired Parkinson Disease Patients 001

    Not yet reported Georgetown University 12 participants 1 site
    Other conditions: Parkinson's Disease, Parkinson's Disease Dementia, Diffuse Lewy Body Disease
    View official trial listing →
  • Withdrawn NCT NCT02281695

    PEEP Influence on Gas Exchange During Early Weaning

    Not yet reported Marienhospital Osnabrück Est. completion 2018-12 1 site
    Other conditions: Respiratory Failure
    View official trial listing →
  • Terminated NCT NCT02281838

    The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II

    Not yet reported University of Alberta 142 participants Est. completion 2021-12 2 sites
    Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Completed NCT NCT02282033

    Safety and Performance Study of the Moderato System

    Not yet reported BackBeat Medical Inc 57 participants Est. completion 2017-08 10 sites
    Other conditions: Hypertension Resistant to Conventional Therapy, Bradycardia, Atrioventricular Block
    View official trial listing →
  • Completed NCT NCT02282254

    Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia

    Not yet reported Institut de Recherches Cliniques de Montreal 35 participants Est. completion 2016-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT02282267

    Blood Detection of EGFR Mutation For Iressa Treatment

    Not yet reported Peking University Cancer Hospital & Institute 188 participants Est. completion 2018-02 1 site
    Other conditions: Lung Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02282371

    Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)

    Not yet reported Memorial Sloan Kettering Cancer Center 16 participants Est. completion 2021-10-22 6 sites
    Other conditions: Head and Neck Squamous Cell Cancer
    View official trial listing →
  • Completed NCT NCT02282657

    Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS

    Not yet reported, Not yet reported European Society of Intensive Care Medicine 95 participants Est. completion 2017-07-30 1 site
    Other conditions: Moderate Acute Respiratory Distress Syndrome
    View official trial listing →
  • Status unknown NCT NCT02282995

    Effect of Genetic Association With Functional Dyspepsia and Mood Disorders

    Chinese University of Hong Kong 1200 participants Est. completion 2017-12 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT02283450

    Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients

    Harbin Medical University 30 participants Est. completion 2014-04
    Heart failure
    View official trial listing →
  • Completed NCT NCT02284256

    A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery

    Not yet reported Mallinckrodt 150 participants Est. completion 2015-08 15 sites
    Other conditions: Surgical Bleeding
    View official trial listing →
  • Completed NCT NCT02286102

    A Prospective Randomized Study on the Clinical Benefits of OrthoPAT Drains

    Not yet reported Hospital for Special Surgery, New York 70 participants Est. completion 2016-10-17 1 site
    Other conditions: Spine Deformity
    View official trial listing →
  • Terminated NCT NCT02286401

    Functional Assessment of Coronary Artery Disease by CTA Flow Encoding

    Johns Hopkins University 19 participants Est. completion 2016-12-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02287064

    An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias

    Not yet reported University of South Florida 10 participants 1 site
    Other conditions: Spinocerebellar Ataxias
    View official trial listing →
  • Completed NCT NCT02287753

    Relationship Between Parameters of VOT Using NIRS and Clinical Outcomes in Pediatric Cardiac Surgery

    Not yet reported Seoul National University Hospital 130 participants Est. completion 2016-12 1 site
    Other conditions: Congenital Heart Disease
    View official trial listing →
  • Withdrawn NCT NCT02288351

    Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass

    Not yet reported Duke University Est. completion 2015-04
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT02288663

    Renal Function Assessment in the Elderly Using Plasma Creatinine Assay and Lean Body Mass Measurement

    Not yet reported University Hospital, Strasbourg, France 220 participants Est. completion 2022-11-02 1 site
    Other conditions: Renal Function
    View official trial listing →
  • Completed NCT NCT02291081

    A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients

    University Hospital, Essen 1519 participants Est. completion 2017-01 7 sites
    Cardiovascular diseaseHeart failure Other conditions: HIV-infection, Coronary Heart Disease, HIV-encephalopathy, Aging
    View official trial listing →
  • Terminated NCT NCT02291965

    Blood Samples to Identify Biomarkers of Busulfan

    Fred Hutchinson Cancer Center 139 participants Est. completion 2024-10-07 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma, Immunodeficiency, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02294292

    Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its Impact on Morbidity and Mortality

    Not yet reported Institute of Liver and Biliary Sciences, India 189 participants Est. completion 2016-08-31 1 site
    Other conditions: Diastolic Dysfunction, Chronic Liver Disease
    View official trial listing →
  • Status unknown NCT NCT02295085

    Fernald Community Cohort -18 Year Observational Study

    University of Cincinnati 9782 participants Est. completion 2025-12 1 site
    Cardiovascular disease Other conditions: Cancer, Renal Failure, Diabetes
    View official trial listing →
  • Completed NCT NCT02295488

    Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy

    Not yet reported University Hospital, Rouen 29 participants Est. completion 2018-04-12 1 site
    Other conditions: Hymenoptera Allergy
    View official trial listing →
  • Completed NCT NCT02296593

    Continuous MONItoring of Blood LActate and Glucose Levels Using a New Central Veinous Microdialysis Catheter Device

    University Hospital, Caen 20 participants Est. completion 2016-11 1 site
    Other conditions: Other Functional Disturbances Following Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT02296684

    Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

    Not yet reported Washington University School of Medicine 67 participants Est. completion 2025-07-21 3 sites
    Other conditions: Cancer of Head and Neck, Head and Neck Cancer, Neoplasms, Head and Neck, Carcinoma, Squamous Cell of Head and Neck, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck
    View official trial listing →
  • Completed NCT NCT02296775

    Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis

    Not yet reported, Not yet reported Dr. Reddy's Laboratories Limited 276 participants Est. completion 2017-10-05 28 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02296918

    Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL

    Not yet reported Acerta Pharma BV 69 participants Est. completion 2025-10-22 1 site
    Other conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT02297698

    Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

    Not yet reported Cancer Insight, LLC 100 participants Est. completion 2021-12 24 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02298166

    Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

    Not yet reported University of Ulm 9 participants Est. completion 2020-03-09 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT02298777

    Metabolomic Analysis of Systemic Sclerosis

    University Hospital, Strasbourg, France 121 participants Est. completion 2025-04-24 4 sites
    Alcohol use disorder Other conditions: Scleroderma (Limited and Diffuse), Undifferentiated Connective Tissue Disease, Vascular Disease, Healthy Control Subjects
    View official trial listing →
  • Terminated NCT NCT02299934

    3T MR Angiography of the Hepatic Vasculature

    Not yet reported University of Colorado, Denver 13 participants Est. completion 2017-12
    Other conditions: Liver Blood Supply
    View official trial listing →
  • Withdrawn NCT NCT02300415

    Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.

    Centre Hospitalier Universitaire de Nice Est. completion 2016-12
    Other conditions: Severe Sepsis and Septic Shock
    View official trial listing →
  • Completed NCT NCT02300519

    Thrombin Generation Numerical Models Validation in Haemophilic Case

    Centre Hospitalier Universitaire de Saint Etienne 40 participants Est. completion 2015-07 1 site
    Other conditions: Haemophilia B, Haemophilia A
    View official trial listing →
  • Status unknown NCT NCT02300571

    Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

    Fondazione del Piemonte per l'Oncologia 60 participants Est. completion 2018-01 2 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Terminated NCT NCT02300870

    Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection

    Brigham and Women's Hospital 10 participants Est. completion 2019-12 1 site
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT02300948

    Optimizing Periconceptional and Prenatal Folic Acid Supplementation

    Not yet reported The Hospital for Sick Children 83 participants Est. completion 2013-04 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT02303704

    Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia

    Not yet reported Chaudhry Pervaiz Elahi Institute of Cardiology 448 participants Est. completion 2014-08
    Other conditions: Coronary Artery Bypass Surgery
    View official trial listing →
  • Completed NCT NCT02303730

    Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

    Not yet reported Fudan University 76 participants Est. completion 2017-11 5 sites
    Type 2 diabetes Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Status unknown NCT NCT02304562

    Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair

    Not yet reported Chinese PLA General Hospital 50 participants Est. completion 2017-12 1 site
    Other conditions: Sweat Gland Diseases
    View official trial listing →
  • Completed NCT NCT02305004

    Blood Serum Concentrations of Routine Drugs in Patients Treated in the Intensive Care Unit.

    Uppsala University 359 participants Est. completion 2016-12 1 site
    Other conditions: Serum Concentrations, Intoxication, Post Mortem Concentrations
    View official trial listing →
  • Completed NCT NCT02306928

    PK Analysis of Piperacillin in Septic Shock Patients

    University of Aarhus 15 participants Est. completion 2015-01 1 site
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT02308605

    SMARTCap Stroke Study: A Field Deployable Blood Test for Stroke

    University Hospitals Coventry and Warwickshire NHS Trust 217 participants Est. completion 2015-12 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02308904

    Reproductive Capacity and Iron Burden in Thalassemia

    Not yet reported UCSF Benioff Children's Hospital Oakland 59 participants Est. completion 2020-09-01 1 site
    Other conditions: THALASSEMIA MAJOR
    View official trial listing →
  • Completed NCT NCT02308982

    Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis

    Not yet reported University of Oxford 18 participants Est. completion 2022-09 25 sites
    Other conditions: Encephalitis
    View official trial listing →
  • Completed NCT NCT02309567

    Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?

    Cumhuriyet University 146 participants Est. completion 2016-04 1 site
    Other conditions: Lung Neoplasms, Gene, p53
    View official trial listing →
  • Terminated NCT NCT02309645

    The Paediatric EVICEL® Neuro Study

    Not yet reported Ethicon, Inc. 40 participants Est. completion 2021-09-17 7 sites
    Other conditions: CSF Leak
    View official trial listing →
  • Completed NCT NCT02310295

    Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema

    Not yet reported University of Sao Paulo 45 participants Est. completion 2012-12
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02310412

    A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma

    Not yet reported Cerus Corporation 14 participants Est. completion 2015-09 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02310997

    Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)

    Not yet reported University College, London 11 participants Est. completion 2015-05 12 sites
    Other conditions: Leukaemia, Lymphoma, Other Haematological Diseases
    View official trial listing →
  • Completed NCT NCT02311855

    Duration of Immune Response to Influenza Vaccination in Patients With RA

    Not yet reported Bassett Healthcare 87 participants Est. completion 2016-02 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02311920

    Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

    Not yet reported National Cancer Institute (NCI) 32 participants Est. completion 2022-12-22 11 sites
    Obstructive sleep apnea Other conditions: Supratentorial Glioblastoma
    View official trial listing →
  • Completed NCT NCT02312440

    Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty

    Not yet reported Shanghai Jiao Tong University School of Medicine 173 participants Est. completion 2015-09 1 site
    Other conditions: Blood Loss
    View official trial listing →
  • Completed NCT NCT02313129

    Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis

    Duke University 150 participants Est. completion 2017-01-24 1 site
    Other conditions: Infertility, Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02313272

    Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 32 participants Est. completion 2021-08-09 1 site
    Other conditions: Malignant Glioma
    View official trial listing →
  • Completed NCT NCT02314117

    A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer

    Not yet reported Eli Lilly and Company 645 participants Est. completion 2020-08-14 135 sites
    Other conditions: Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02314130

    No-commercial Enteral Diet for Patients in Home Nutritional Therapy: Effects on Anthropometric and Biochemical Indices

    Not yet reported Federal University of São Paulo 66 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Malnutrition
    View official trial listing →
  • Active, not recruiting NCT NCT02314169

    Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

    Not yet reported National Cancer Institute (NCI) 143 participants Est. completion 2027-03-20 56 sites
    Other conditions: Anal Canal Squamous Cell Carcinoma, Metastatic Anal Canal Carcinoma, Stage IV Anal Cancer AJCC v8
    View official trial listing →
  • Terminated NCT NCT02314455

    Esophageal Absorption in EoE

    Not yet reported Mayo Clinic 14 participants Est. completion 2016-07 1 site
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Completed NCT NCT02314858

    Tailored Treatment to Enhance Risk Perception in Sleep Apnea

    Not yet reported National Jewish Health 284 participants Est. completion 2021-03 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02315898

    Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

    Not yet reported University of Michigan 40 participants Est. completion 2023-06-30 6 sites
    Other conditions: Plastic Bronchitis, Protein-Losing Enteropathies, Healthy
    View official trial listing →
  • Completed NCT NCT02316353

    A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

    Not yet reported CSL Behring 126 participants Est. completion 2017-09-21 32 sites
    Other conditions: Hereditary Angioedema Types I and II
    View official trial listing →
  • Completed NCT NCT02316613

    Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)

    Hoffmann-La Roche 260 participants Est. completion 2013-04 1 site
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Terminated NCT NCT02316691

    B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease

    University of Pittsburgh 2 participants Est. completion 2019-11 1 site
    Other conditions: Thyroid Eye Disease
    View official trial listing →
  • Completed NCT NCT02317094

    Blood-flow Restricted Exercise in Inclusion Body Myositis

    Not yet reported University of Southern Denmark 22 participants Est. completion 2015-09 1 site
    Other conditions: Sporadic Inclusion Body Myositis
    View official trial listing →
  • Completed NCT NCT02317653

    Understanding the Influence of Pregnancy on Breast Milk

    Louisiana State University Health Sciences Center in New Orleans 18 participants Est. completion 2015-12 1 site
    Other conditions: Pregnancy, Breastfeeding
    View official trial listing →
  • Terminated NCT NCT02320292

    Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma

    Not yet reported Mayo Clinic 20 participants Est. completion 2023-11-09 1 site
    Other conditions: Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage IV Grade 1 Follicular Lymphoma, Ann Arbor Stage IV Grade 2 Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT02320357

    Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous

    Not yet reported, Not yet reported University Hospital, Bordeaux 18 participants Est. completion 2017-09-11 3 sites
    Other conditions: Systemic Lupus Erythematous
    View official trial listing →
  • Completed NCT NCT02323165

    A New Method for Detection of Bacteria in the Bloodstream

    University of Florida 14 participants Est. completion 2022-03-04 1 site
    Other conditions: Burns, Wounds
    View official trial listing →
  • Completed NCT NCT02323698

    Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury

    Not yet reported, Not yet reported Spaulding Rehabilitation Hospital 36 participants Est. completion 2022-02-19 1 site
    Other conditions: Spinal Cord Injuries
    View official trial listing →
  • Status unknown NCT NCT02324283

    Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia

    Not yet reported Juntendo University 80 participants Est. completion 2024-12 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT02325440

    Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya

    Not yet reported University Hospital Muenster 15 participants Est. completion 2016-04 1 site
    Other conditions: Relapsing Remitting Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT02325869

    Clinical Study Protocol - Debris Interventional Removal in ACS (DESIRE-ACS)

    Not yet reported Angioslide Ltd. 30 participants Est. completion 2016-03 1 site
    Other conditions: Coronary Disease, Acute Coronary Syndrome, Coronary Occlusion
    View official trial listing →
  • Completed NCT NCT02326766

    Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects

    Not yet reported Yonsei University 62 participants Est. completion 2012-03
    Other conditions: Prehypertension
    View official trial listing →
  • Completed NCT NCT02328339

    Tea and Forearm Blood Flow

    Not yet reported Unilever R&D 20 participants Est. completion 2015-08
    Other conditions: Vascular Function
    View official trial listing →
  • Completed NCT NCT02329223

    Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients

    Not yet reported Novartis Pharmaceuticals 218 participants Est. completion 2015-12 39 sites
    Other conditions: Chronic Spontaneous Uriticaria
    View official trial listing →
  • Completed NCT NCT02330055

    Determination of the Predictors of Nocturnal Desaturation in Postpartum Women

    Not yet reported Massachusetts General Hospital 99 participants Est. completion 2017-12 1 site
    Other conditions: Sleep Disordered Breathing, Nocturnal Oxygen Desaturation, Upper Airway Edema
    View official trial listing →
  • Status unknown NCT NCT02330783

    Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

    Not yet reported Peking University Cancer Hospital & Institute 106 participants Est. completion 2018-12 4 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02332135

    The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

    Not yet reported Wenhu Liu 30 participants Est. completion 2018-03 1 site
    Other conditions: Secondary Hyperparathyroidism, Maintenance Hemodialysis
    View official trial listing →
  • Status unknown NCT NCT02334839

    The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction

    Rabin Medical Center 150 participants Est. completion 2015-09 1 site
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT02335073

    Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis

    General Hospital of Shenyang Military Region 108 participants Est. completion 2016-06 1 site
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT02335918

    A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

    Not yet reported, Not yet reported Celldex Therapeutics 175 participants Est. completion 2018-12-12 19 sites
    Other conditions: Squamous Cell Carcinoma of the Head and Neck (SCCHN), Ovarian Carcinoma-Enrollment Completed, Colorectal Cancer (CRC)-Enrollment Completed, Renal Cell Carcinoma (RCC) (Phase ll Only), Glioblastoma (GBM) (Phase ll Only)-Enrollment Completed
    View official trial listing →
  • Withdrawn NCT NCT02336984

    A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2016-04-04 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02338440

    Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT

    Not yet reported, Not yet reported Seoul National University Hospital 30 participants Est. completion 2021-12 1 site
    Other conditions: Veno-occlusive Disease, Child
    View official trial listing →
  • Withdrawn NCT NCT02338466

    Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion

    Not yet reported University Hospital Center of Martinique Est. completion 2018-09
    Other conditions: Nervous System Disorders, Cerebral Artery
    View official trial listing →
  • Active, not recruiting NCT NCT02338947

    Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

    Not yet reported University of Sao Paulo General Hospital 440 participants Est. completion 2025-12-31 7 sites
    Cardiovascular disease Other conditions: Frail Elderly
    View official trial listing →
  • Completed NCT NCT02340507

    The Impact of the Glycaemic Index (GI) on Daily Blood Glucose Profiles and Food Intake in Young Chinese Adult Males

    Not yet reported Singapore Institute of Food and Biotechnology Innovation 15 participants Est. completion 2015-01
    Type 2 diabetesPrediabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02341664

    Patient and Provider Assessment of Lipid Management Registry

    Duke University 7658 participants Est. completion 2016-02 14 sites
    Cardiovascular diseaseChronic kidney diseaseAlcohol use disorder Other conditions: Hyperlipidemia, Hypercholesterolemia, Diabetes, Hypertension, Smoking, Unstable Angina, Angina, Transient Ischemic Attack (TIA), Carotid Stenosis, Peripheral Arterial Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02344368

    The Effect of Sucrose on Pain Relief During Venous Blood Sampling in Preterm Infants

    Not yet reported Norwegian University of Science and Technology 50 participants Est. completion 2016-06 2 sites
    Other conditions: Pain
    View official trial listing →
  • Terminated NCT NCT02345772

    Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy

    Not yet reported, Not yet reported Western Regional Medical Center 4 participants Est. completion 2015-11 1 site
    Other conditions: HER2-positive Breast Cancer, ER-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02346968

    Evaluation of CAF22 After Renal Transplantation

    Insel Gruppe AG, University Hospital Bern 99 participants Est. completion 2018-09-27 2 sites
    Other conditions: Kidney Transplantation, Delayed Graft Function
    View official trial listing →
  • Status unknown NCT NCT02347358

    Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke

    Not yet reported The Second Artillery General Hospital 100 participants Est. completion 2017-04
    Other conditions: Ischemic Cerebrovascular Accident
    View official trial listing →
  • Completed NCT NCT02350322

    Diet and Learning Abilities in Norwegian Youths

    Not yet reported National Institute of Nutrition and Seafood Research, Norway 478 participants Est. completion 2015-06 1 site
    Other conditions: Cognitive Performance, Health Behavior, Nutrient Status
    View official trial listing →
  • Completed NCT NCT02350530

    FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type

    Not yet reported Sun Yat-sen University 138 participants Est. completion 2020-01-01 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02352389

    A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

    St. Jude Children's Research Hospital 16 participants Est. completion 2022-12-08 1 site
    Other conditions: Influenza, Human
    View official trial listing →
  • Terminated NCT NCT02352753

    Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

    Not yet reported Amgen 153 participants Est. completion 2022-03-26 49 sites
    Other conditions: Osteogenesis Imperfecta
    View official trial listing →
  • Completed NCT NCT02355756

    Biomarker Development for Future PAC1 Antagonists With Maxadilan

    Not yet reported Universitaire Ziekenhuizen KU Leuven 20 participants Est. completion 2015-04 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02355821

    Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women

    Not yet reported National Research Center for Preventive Medicine 114 participants Est. completion 2018-07-10 1 site
    Other conditions: Osteopenia, Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02356068

    Predictions of Bleeding During Liver Transplantation With Thromboelastometry

    Centre hospitalier de l'Université de Montréal (CHUM) 70 participants Est. completion 2018-02 1 site
    Other conditions: Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT02356445

    Use of Immunosuppressive Therapy for Sarcoidosis

    University of Cincinnati 2000 participants Est. completion 2018-12 1 site
    Other conditions: Sarcoidosis
    View official trial listing →
  • Completed NCT NCT02358460

    Pressure-limited Ventilation Versus Volume-targeted Ventilation in Term Newborns

    Not yet reported King's College London 40 participants Est. completion 2014-09 2 sites
    Other conditions: Respiratory Insufficiency
    View official trial listing →
  • Status unknown NCT NCT02360956

    Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)

    Not yet reported Chinese PLA General Hospital 100 participants Est. completion 2016-06 1 site
    Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02363738

    12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

    Not yet reported University Health Network, Toronto 60 participants Est. completion 2017-04 2 sites
    Other conditions: Bipolar Depression
    View official trial listing →
  • Completed NCT NCT02365311

    Echocardiographic Evaluation of the Change on Pulmonary Blood Flow and Cardiac Function During One-lung Ventilation

    Not yet reported Yonsei University 25 participants Est. completion 2015-03 1 site
    Other conditions: Video-assisted Thoracic Surgery
    View official trial listing →
  • Withdrawn NCT NCT02365415

    Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement

    Not yet reported Boston Children's Hospital Est. completion 2018-04 1 site
    Other conditions: Peripheral Pulmonary Stenosis, In-stent Stenosis
    View official trial listing →
  • Completed NCT NCT02366572

    PERFECT Project - Part 1 - Study 2

    Not yet reported University of Manitoba 26 participants Est. completion 2017-12
    Other conditions: Diabetes Prevention, Obesity Prevention
    View official trial listing →
  • Status unknown NCT NCT02366741

    Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study

    Not yet reported Sheba Medical Center 5 participants Est. completion 2017-01 1 site
    Other conditions: Carcinoma, Small Cell
    View official trial listing →
  • Completed NCT NCT02367196

    A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

    Not yet reported Celgene 60 participants Est. completion 2020-12-24 13 sites
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT02367794

    A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]

    Not yet reported Hoffmann-La Roche 1021 participants Est. completion 2021-02-17 242 sites
    Other conditions: Squamous Non-Small Cell Lung Cancer
    View official trial listing →
  • Withdrawn NCT NCT02369913

    A Metabolomic Approach to Probing Myocardial Fuel Shifts in Human Heart Failure

    University of Florida Est. completion 2018-02 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02371096

    Comparative Pharmacokinetic Trial of RGB-03 and MabThera

    Not yet reported Gedeon Richter Plc.
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02371551

    Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT

    Insel Gruppe AG, University Hospital Bern 52 participants Est. completion 2018-06-30 1 site
    Other conditions: Cystic Renal Diseases, Kidney Neoplasms
    View official trial listing →
  • Completed NCT NCT02371876

    Evaluation of an Ascensia Diabetes Care ONYX PLUS Investigational Blood Glucose Monitoring System

    Not yet reported Ascensia Diabetes Care 134 participants Est. completion 2015-03 2 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02372136

    Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants

    Not yet reported University of Texas Southwestern Medical Center 120 participants Est. completion 2023-12-31 1 site
    Other conditions: Infant, Premature, Diseases, Infant, Small for Gestational Age
    View official trial listing →
  • Status unknown NCT NCT02372916

    Geographic Atrophy and Intravitreal Ranibizumab Injections

    University Health Network, Toronto 90 participants 1 site
    Other conditions: Age-related Macular Degeneration, Geographic Atrophy
    View official trial listing →
  • Terminated NCT NCT02373241

    Preventing Sickle Cell Kidney Disease

    Not yet reported University of Alabama at Birmingham 1 participants Est. completion 2021-07 1 site
    Other conditions: Anemia, Sickle Cell, Sickle Cell Disease, Kidney Disease, Hypertension, Proteinuria
    View official trial listing →
  • Completed NCT NCT02373735

    Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

    Not yet reported Asan Medical Center 64 participants Est. completion 2015-12 1 site
    Other conditions: Bladder Cancer
    View official trial listing →
  • Terminated NCT NCT02375711

    Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient

    Not yet reported Centre Hospitalier Universitaire de Besancon 20 participants Est. completion 2017-09 1 site Stand-alone
    Other conditions: Chronic Renal Disease
    View official trial listing →
  • Completed NCT NCT02376114

    Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma

    Not yet reported Maisonneuve-Rosemont Hospital 19 participants Est. completion 2014-02 1 site
    Other conditions: Glaucoma, Open-Angle
    View official trial listing →
  • Status unknown NCT NCT02376712

    Diagnostic Value of Urinary Indices in Differentiating Pre-renal and Renal Acute Kidney Injury

    Peking Union Medical College Hospital 40 participants 1 site
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT02377193

    Simulect Versus ATG in Sensitized Renal Transplant Patient

    Not yet reported University Hospital, Toulouse 60 participants Est. completion 2017-01 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT02378584

    Natural Cycle Versus Endometrial Preparation for Healthy Blastocyst Transfer

    Not yet reported European Hospital 236 participants Est. completion 2015-09 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02378675

    Adipocytokines, Gestational Diabetes Mellitus and Lipid Metabolism

    Medical University of Vienna 300 participants Est. completion 2013-12 1 site
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02379156

    Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia

    Not yet reported James J. Peters Veterans Affairs Medical Center 30 participants Est. completion 2022-12 1 site
    Other conditions: Tetraplegia, Hypothermia, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT02380443

    AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer

    Not yet reported Mirror Biologics, Inc. 13 participants Est. completion 2018-09 1 site
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT02381366

    Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study

    Not yet reported, Not yet reported Medipost, Inc. 12 participants Est. completion 2018-05 1 site
    Other conditions: Bronchopulmonary Dysplasia
    View official trial listing →
  • Completed NCT NCT02381899

    Observational Study in CLL Patients Receiving BR

    Czech CLL Study Group 83 participants Est. completion 2018-12 5 sites
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT02385409

    Incidence and Reasons for Preoperative Anemia in Elective Lower Joint Arthroplasty

    Oeivind Jans 900 participants Est. completion 2015-05 1 site
    Other conditions: Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee
    View official trial listing →
  • Terminated NCT NCT02386241

    Identification of Genomic Changes in Families Having Multiple Members With Tumors

    St. Joseph's Hospital and Medical Center, Phoenix 4 participants Est. completion 2019-07-31 1 site
    Other conditions: Glioma
    View official trial listing →
  • Status unknown NCT NCT02386332

    A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies

    Instituto de Investigacion Sanitaria La Fe 206 participants Est. completion 2020-03
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT02386995

    BIS and Entropy in Deep Brain Simulation

    University Health Network, Toronto 30 participants Est. completion 2014-03 1 site
    Other conditions: Movement Disorders, Depth of Anesthesia Monitors
    View official trial listing →
  • Terminated NCT NCT02387957

    A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)

    Not yet reported Ophthotech Corporation 63 participants Est. completion 2017-01 24 sites
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02387996

    A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

    Not yet reported Bristol-Myers Squibb 270 participants Est. completion 2021-11-12 67 sites
    Other conditions: Various Advanced Cancer
    View official trial listing →
  • Completed NCT NCT02388503

    The Effect of a Natural Extract on the Post-prandial Blood Glucose Response After Bread Consumption: a Dose-response of Efficacy

    Not yet reported Unilever R&D 64 participants Est. completion 2015-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02389127

    Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis

    University of Arkansas 50 participants Est. completion 2017-06-01 1 site
    Type 2 diabetes Other conditions: Cirrhosis
    View official trial listing →
  • Completed NCT NCT02390167

    Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System

    Not yet reported Ascensia Diabetes Care 376 participants Est. completion 2015-04 2 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02390232

    Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH

    University Hospital, Toulouse 176 participants Est. completion 2017-11 1 site
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02390297

    Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

    Calimmune, Inc. 11 participants Est. completion 2031-10 2 sites
    Other conditions: HIV-1 Infection, Receipt of Cal-1 Modified Hematopoietic Cellular Products
    View official trial listing →
  • Active, not recruiting NCT NCT02392429

    FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 87 participants Est. completion 2027-02-13 11 sites
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT02392689

    Improve Management of Heart Failure With Procalcitonin

    Not yet reported Brahms AG 759 participants Est. completion 2018-04-14 15 sites Stand-alone
    Heart failure Other conditions: Infection
    View official trial listing →
  • Completed NCT NCT02392754

    Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older

    Not yet reported Population Health Research Institute 856 participants Est. completion 2020-01-21 28 sites
    Other conditions: Atrial Fibrillation, Hypertension
    View official trial listing →
  • Status unknown NCT NCT02393508

    The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population

    Not yet reported University of Calgary 60 participants Est. completion 2017-12
    Other conditions: Bone Marrow Failure Syndrome
    View official trial listing →
  • Completed NCT NCT02393898

    BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older

    Hoffmann-La Roche 76 participants Est. completion 2019-06-14 26 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02394834

    An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

    Takeda 757 participants Est. completion 2027-09-30 151 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT02394860

    Influence of Periodontal Diseases on Vascular Parameters in Patients Suffering of Hypertension

    University Hospital, Strasbourg, France 76 participants Est. completion 2024-02 1 site
    Other conditions: Chronic Periodontitis, Hypertension
    View official trial listing →
  • Completed NCT NCT02396199

    Zenith® p-Branch® Endovascular Graft Pivotal Study

    Not yet reported Cook Research Incorporated 80 participants Est. completion 2025-01-28 27 sites
    Other conditions: Aortic Aneurysm Abdominal
    View official trial listing →
  • Completed NCT NCT02396511

    TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

    Not yet reported Tracon Pharmaceuticals Inc. 2 participants Est. completion 2017-12 1 site
    Other conditions: Choriocarcinoma
    View official trial listing →
  • Completed NCT NCT02397122

    Platelet-rich Fibrin and Connective Tissue Graft in Recession Treatment

    Not yet reported Kırıkkale University 40 participants Est. completion 2014-05
    Other conditions: Gingival Recession
    View official trial listing →
  • Completed NCT NCT02398656

    A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

    Not yet reported University of Calgary 1274 participants Est. completion 2024-04-10 61 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02400203

    FREE Living Hulled HEMP Seed and Oil Trial

    Not yet reported University of Manitoba 30 participants Est. completion 2017-09 1 site
    Other conditions: Overweight
    View official trial listing →
  • Completed NCT NCT02400437

    Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia

    Not yet reported Dana-Farber Cancer Institute 26 participants Est. completion 2019-11 1 site
    Other conditions: Waldenstrom's Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT02400684

    ENDmetriosis and Reserve Ovarienne

    University Hospital, Strasbourg, France 118 participants Est. completion 2019-03 2 sites
    Other conditions: Deep Endometriosis Stage III, Deep Endometriosis Stage IV
    View official trial listing →
  • Completed NCT NCT02401776

    Effect of Caffeine on Heart Function

    Not yet reported University of Texas at Austin 30 participants Est. completion 2015-12 1 site
    Other conditions: Fatigue, Tachycardia
    View official trial listing →
  • Status unknown NCT NCT02403115

    Prediction of Outcome of Lupus Nephritis

    Istituto Giannina Gaslini 800 participants Est. completion 2022-11 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Withdrawn NCT NCT02404597

    Cardiac Output Monitoring in Burn Patients

    Not yet reported Emory University Est. completion 2018-03 1 site
    Other conditions: Burns
    View official trial listing →
  • Completed NCT NCT02405663

    Methods of Placental Delivery and the Amount of Blood Loss During Cesarean Section

    Not yet reported Benha University 288 participants Est. completion 2016-07 1 site
    Other conditions: Complications; Cesarean Section
    View official trial listing →
  • Completed NCT NCT02406846

    The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.

    Fuda Cancer Hospital, Guangzhou 80 participants Est. completion 2015-12 1 site
    Other conditions: Neoplastic Cells, Circulating
    View official trial listing →
  • Completed NCT NCT02407743

    TEMporal PostOperative Pain Signatures

    University of Florida 428 participants Est. completion 2020-08 1 site
    Other conditions: Pain, Postoperative
    View official trial listing →
  • Completed NCT NCT02408120

    Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes

    Not yet reported Emory University 226 participants Est. completion 2019-12-11 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02409446

    Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins

    Not yet reported Helse Stavanger HF 54 participants Est. completion 2018-11 1 site Stand-alone
    Other conditions: Coronary Disease, Inflammation, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT02409602

    Influence of BIIAL Following PPH on Dorsal Clitoral Artery Blood Flow and FSFI

    Near East University, Turkey 20 participants Est. completion 2015-09 1 site
    Other conditions: Bilateral Iliac Artery Ligation, Postpartum Hemorrhage
    View official trial listing →
  • Completed NCT NCT02409810

    Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes

    Not yet reported, Not yet reported Ohio State University 20 participants Est. completion 2020-03-20 1 site
    Other conditions: Anxiety, Burns
    View official trial listing →
  • Completed NCT NCT02410512

    A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

    Not yet reported Genentech, Inc. 610 participants Est. completion 2019-11-22 27 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02411266

    Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage

    Not yet reported University of Miami 57 participants Est. completion 2020-12-08 1 site
    Other conditions: Ischemic Preconditioning
    View official trial listing →
  • Completed NCT NCT02411318

    Influence of Lifestyle Factors on Neutrophil Migration Pilot Study

    Not yet reported University of Wisconsin, Madison 47 participants Est. completion 2019-12-31 1 site
    Other conditions: Neutrophil Chemotactic Response
    View official trial listing →
  • Terminated NCT NCT02413827

    A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma

    Not yet reported, Not yet reported Celldex Therapeutics 9 participants Est. completion 2016-11-09 8 sites
    Other conditions: Unresectable Stage III or Stage IV Melanoma
    View official trial listing →
  • Terminated NCT NCT02414165

    The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

    Not yet reported, Not yet reported Tocagen Inc. 403 participants Est. completion 2019-12-20 67 sites
    Other conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma
    View official trial listing →
  • Completed NCT NCT02415114

    An Open Label Study Evaluating the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10

    Not yet reported KGK Science Inc. 50 participants Est. completion 2015-06 1 site
    Other conditions: CoQ10 Blood Levels, CoQ10 Blood Levels With Statin Use
    View official trial listing →
  • Completed NCT NCT02415582

    Post-Exercise Hypotension in Elderly Hypertensive Men

    Not yet reported Hospital de Clinicas de Porto Alegre 20 participants Est. completion 2015-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02416843

    Metabolic and Immune System Responses to a Mixed Meal

    Not yet reported University of Bath 30 participants Est. completion 2014-11 1 site
    Other conditions: Inflammation
    View official trial listing →
  • Completed NCT NCT02417519

    Coffee Roasting and Glucose Tolerance

    Not yet reported University of Copenhagen 11 participants Est. completion 2015-11 1 site
    Other conditions: Oral Glucose Tolerance
    View official trial listing →
  • Completed NCT NCT02419742

    Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

    Not yet reported Hoffmann-La Roche 110 participants Est. completion 2021-06-24 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02420132

    Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)

    Hoffmann-La Roche 47 participants Est. completion 2016-08-25 1 site
    Other conditions: Macular Edema, Macular Degeneration
    View official trial listing →
  • Terminated NCT NCT02421354

    Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis

    Not yet reported M.D. Anderson Cancer Center 8 participants Est. completion 2018-04-13 1 site
    Other conditions: Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Splenomegaly
    View official trial listing →
  • Completed NCT NCT02423356

    Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin

    Daniel Rushing 12 participants Est. completion 2018-02-01 2 sites
    Other conditions: Breast Neoplasms, Lymphoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT02423798

    New Generation Enlite Accuracy Study

    Not yet reported Medtronic MiniMed, Inc. 24 participants Est. completion 2015-09
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT02423941

    A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation

    Not yet reported Republican Scientific and Practical Center for Organ and Tissue Transplantation 90 participants Est. completion 2017-05 1 site
    Other conditions: Liver Transplantation, Reperfusion, Delayed Graft Function
    View official trial listing →
  • Terminated NCT NCT02423954

    Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

    Not yet reported, Not yet reported Western Regional Medical Center 33 participants Est. completion 2017-11-01 1 site
    Other conditions: Advanced Cancer, Pancreatic Cancer, Renal Cell Cancer, Non Small Cell Lung Cancer, Colorectal Carcinoma, Endometrial, Uterine
    View official trial listing →
  • Status unknown NCT NCT02424669

    Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients

    Not yet reported Assistance Publique Hopitaux De Marseille 100 participants Est. completion 2018-11 1 site
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
  • Completed NCT NCT02426892

    Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2021-11-30 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT02427867

    Ischaemic PReconditioning In Non Cardiac surgEry

    Not yet reported Università Vita-Salute San Raffaele 1217 participants Est. completion 2026-12 26 sites
    Other conditions: Myocardial Ischemia, Surgery
    View official trial listing →
  • Completed NCT NCT02428842

    Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)

    Not yet reported Institut Curie 419 participants Est. completion 2020-10-20 24 sites
    Other conditions: Cervical Cancer
    View official trial listing →
  • Withdrawn NCT NCT02428959

    Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)

    Not yet reported Johns Hopkins University Est. completion 2018-12 1 site
    Other conditions: Dysphagia, Achalasia
    View official trial listing →
  • Completed NCT NCT02429713

    The Effects of Tourniquet Use in Total Knee Arthroplasty

    Not yet reported Peking University People's Hospital 50 participants Est. completion 2015-03
    Other conditions: Blood Loss
    View official trial listing →
  • Completed NCT NCT02430142

    Microcirculatory Oxygen Uptake in Sepsis

    Universitätsmedizin Mannheim 102 participants Est. completion 2017-08-01 1 site
    Other conditions: Sepsis, Severe Sepsis, Septic Shock
    View official trial listing →
  • Status unknown NCT NCT02430584

    Whole Blood Specimen Collection From Pregnant Subjects

    Progenity, Inc. 5000 participants Est. completion 2021-05 1 site
    Other conditions: Down Syndrome, Edwards Syndrome, Patau Syndrome, Klinefelter Syndrome, Turner Syndrome, DiGeorge Syndrome, Perinatal Infections
    View official trial listing →
  • Completed NCT NCT02432391

    Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose Elevations

    Not yet reported University of Virginia 47 participants Est. completion 2015-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02433262

    WHO Versus IADPSG Diagnostic Criteria of Gestational Diabetes Mellitus and Their Associated Maternal and Neonatal Outcomes

    Not yet reported Universiti Kebangsaan Malaysia Medical Centre 506 participants Est. completion 2018-03 1 site
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02435472

    Active Surveillance Exercise Clinical Trial

    Not yet reported University of California, San Francisco 104 participants Est. completion 2024-12-31 1 site
    Other conditions: Localized Prostate Cancer, Active Surveillance for Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT02435615

    Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis

    Not yet reported University of Miami 15 participants Est. completion 2016-12 1 site
    Other conditions: Dengue
    View official trial listing →
  • Completed NCT NCT02436343

    Cardiac Performance in Pregnant Obese Women:Are They in Jeopardy?

    Benha University 200 participants Est. completion 2017-08 1 site
    Other conditions: Cardiac Performance
    View official trial listing →
  • Terminated NCT NCT02438514

    Biological Biomarkers in MOMS Partnership

    Yale University 20 participants Est. completion 2019-11 1 site
    Other conditions: Psychological Stress
    View official trial listing →
  • Status unknown NCT NCT02438566

    Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery

    Not yet reported The New England Baptist Hospital 118 participants Est. completion 2017-04 1 site
    Osteoarthritis Other conditions: Blood Loss, Surgical, Blood Loss, Postoperative
    View official trial listing →
  • Completed NCT NCT02439385

    Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis

    Not yet reported Gachon University Gil Medical Center 44 participants Est. completion 2019-08-01
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02439996

    Different Doses of IVIG for Kawasaki Disease

    Not yet reported Children's Hospital of Fudan University 404 participants Est. completion 2016-09 1 site
    Other conditions: Kawasaki Disease
    View official trial listing →
  • Completed NCT NCT02440022

    Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae

    Not yet reported C. R. Bard 285 participants Est. completion 2018-06 23 sites
    Other conditions: Arteriovenous Fistula
    View official trial listing →
  • Completed NCT NCT02440555

    Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose

    Centre Hospitalier Universitaire de Saint Etienne 1305 participants Est. completion 2015-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02442505

    Device-detected Paroxysmal Atrial Fibrillation

    University of Birmingham 48 participants Est. completion 2018-12 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT02442648

    B-Cell Targeted Carfilzomib Desensitization

    Not yet reported E. Steve Woodle 32 participants Est. completion 2021-09 2 sites
    Other conditions: Transplants and Implants
    View official trial listing →
  • Withdrawn NCT NCT02444585

    Longjohn Amgen Study - Effect of Denosumab...

    Not yet reported University of Southern California Est. completion 2019-12 1 site
    Other conditions: Arthroplasty, Replacement, Hip
    View official trial listing →
  • Terminated NCT NCT02445144

    Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease

    Albert Einstein College of Medicine 26 participants Est. completion 2020-05-04 2 sites
    Other conditions: Sickle Cell Anemia
    View official trial listing →
  • Completed NCT NCT02445586

    Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer

    Not yet reported Hoffmann-La Roche 52 participants Est. completion 2018-09-26 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02446457

    Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 53 participants Est. completion 2026-04-30 1 site
    Other conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3a Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT02446587

    Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

    The University of Texas Health Science Center, Houston 500 participants Est. completion 2018-05 9 sites
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT02446600

    Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet reported National Cancer Institute (NCI) 579 participants Est. completion 2027-03-04 356 sites
    Other conditions: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Tumor, Ovarian Seromucinous Carcinoma, Ovarian Serous Tumor, Ovarian Transitional Cell Carcinoma, Ovarian Undifferentiated Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal Carcinoma
    View official trial listing →
  • Completed NCT NCT02448667

    Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies

    Not yet reported Copenhagen University Hospital, Rigshospitalet 6 participants Est. completion 2021-05-25 1 site
    Other conditions: Glycogen Storage Disease Type III
    View official trial listing →
  • Completed NCT NCT02449408

    Novel Screening Tools For the Evaluation and Management of Malnourished Children in the Developing World

    Duke University 11 participants Est. completion 2016-05 1 site
    Other conditions: Overweight, Obesity, Small for Gestational Age, Prematurity
    View official trial listing →
  • Completed NCT NCT02449642

    LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation

    Rambam Health Care Campus 10 participants Est. completion 2015-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02450240

    Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders

    Laureate Institute for Brain Research, Inc. 1271 participants Est. completion 2020-06 1 site
    Other conditions: Depression, Anxiety, Eating Disorders, Drug Use Disorders
    View official trial listing →
  • Completed NCT NCT02450357

    The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

    Fuda Cancer Hospital, Guangzhou 60 participants Est. completion 2015-12 1 site
    Other conditions: Neoplastic Cells, Circulating
    View official trial listing →
  • Terminated NCT NCT02452463

    Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

    Not yet reported Roswell Park Cancer Institute 8 participants Est. completion 2019-06-10 1 site
    Other conditions: Lung Non-Squamous Non-Small Cell Carcinoma, Radiation-Induced Pneumonitis, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell Cancer AJCC v7, Stage IV Lung Non-Small Cell Cancer AJCC v7
    View official trial listing →
  • Status unknown NCT NCT02453451

    The Effect of the Hole in the Cardiac Septum Developed by the MitraClip Procedure on the Blood Flow Mechanics

    Not yet reported RWTH Aachen University 40 participants Est. completion 2017-04 1 site
    Other conditions: Atrial Septal Defect
    View official trial listing →
  • Active, not recruiting NCT NCT02453620

    Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

    Not yet reported National Cancer Institute (NCI) 57 participants Est. completion 2027-09-11 5 sites
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Adenocarcinoma, Invasive Breast Carcinoma, Malignant Solid Neoplasm
    View official trial listing →
  • Status unknown NCT NCT02453802

    Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty

    Not yet reported Chang Gung Memorial Hospital 90 participants Est. completion 2016-05 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02454023

    SLEep APnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke

    Not yet reported Sunnybrook Health Sciences Centre 250 participants Est. completion 2018-07 1 site
    Cardiovascular diseaseObstructive sleep apnea Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Completed NCT NCT02455115

    Renal Perfusion, Filtration and Oxygenation After Liver Transplantation -Effects of av Postoperative Blood Pressure

    Not yet reported Sahlgrenska University Hospital 12 participants Est. completion 2016-02 1 site
    Other conditions: Acute Kidney Injury, Liver Failure
    View official trial listing →
  • Completed NCT NCT02456857

    Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

    Not yet reported M.D. Anderson Cancer Center 17 participants Est. completion 2023-05-24 1 site
    Other conditions: Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Terminated NCT NCT02458157

    Forced Fluid Removal in High Risk Acute Kidney Injury

    Not yet reported Nordsjaellands Hospital 21 participants Est. completion 2017-06-08 3 sites
    Other conditions: Acute Kidney Injury, Fluid Overload, Critical Illness
    View official trial listing →
  • Completed NCT NCT02459548

    Continuous Positive Airway Pressure (CPAP) for Primary Care

    Not yet reported Hospital Universitario Araba 220 participants Est. completion 2016-05 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02460211

    Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D

    Not yet reported Intermountain Health Care, Inc. 150 participants Est. completion 2020-10-01 1 site
    Cardiovascular disease Other conditions: Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT02461121

    HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

    Not yet reported The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156 participants Est. completion 2013-05 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT02461264

    Transfusion Strategy in Hematological Intensive Care Unit

    Not yet reported University Hospital, Caen 230 participants Est. completion 2019-09 1 site
    Other conditions: Transfusion Related Complication
    View official trial listing →
  • Terminated NCT NCT02461524

    Endurant Evo International Clinical Trial

    Not yet reported Medtronic Cardiovascular 69 participants Est. completion 2021-06-25 9 sites
    Other conditions: Abdominal Aortic Aneurysm, AAA
    View official trial listing →
  • Completed NCT NCT02462486

    Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

    Not yet reported Allergan 949 participants Est. completion 2019-06-06 187 sites
    Other conditions: Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT02464683

    Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis

    Not yet reported Instituto Nacional de Enfermedades Respiratorias 60 participants Est. completion 2016-12 1 site
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT02464878

    Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2022-12 1 site
    Other conditions: Kidney Transplant, Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT02464904

    Intrapleural Cryotherapy for Malignant Pleural Mesothelioma

    Not yet reported Mayo Clinic 17 participants Est. completion 2021-02-26 1 site
    Other conditions: Mesothelioma
    View official trial listing →
  • Active, not recruiting NCT NCT02465060

    Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

    Not yet reported National Cancer Institute (NCI) 6452 participants Est. completion 2027-12-31 1410 sites Stand-alone
    Other conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Bladder Carcinoma, Breast Carcinoma, Cervical Carcinoma, Colon Carcinoma, Colorectal Carcinoma, Endometrial Carcinoma, Esophageal Carcinoma, Exocrine Pancreas Carcinoma, Gastric Carcinoma, Glioma, Head and Neck Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Kidney Carcinoma, Liver Carcinoma, Lung Carcinoma, Lymphoma, Malignant Uterine Corpus Neoplasm, Malignant Uterine Neoplasm, Melanoma, Multiple Myeloma, Ovarian Carcinoma, Prostate Carcinoma, Rectal Carcinoma, Recurrent Bladder Carcinoma, Recurrent Breast Carcinoma, Recurrent Cervical Carcinoma, Recurrent Colon Carcinoma, Recurrent Colorectal Carcinoma, Recurrent Esophageal Carcinoma, Recurrent Gastric Carcinoma, Recurrent Glioma, Recurrent Head and Neck Carcinoma, Recurrent Liver Carcinoma, Recurrent Lung Carcinoma, Recurrent Lymphoma, Recurrent Malignant Solid Neoplasm, Recurrent Malignant Uterine Corpus Neoplasm, Recurrent Melanoma, Recurrent Multiple Myeloma, Recurrent Ovarian Carcinoma, Recurrent Pancreatic Carcinoma, Recurrent Prostate Carcinoma, Recurrent Rectal Carcinoma, Recurrent Skin Carcinoma, Recurrent Thyroid Gland Carcinoma, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma, Skin Carcinoma, Thyroid Gland Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT02465294

    The Influence of Probiotics on Body Weight and Composition

    Not yet reported University of Florida Est. completion 2016-02
    Other conditions: Healthy, Overweight
    View official trial listing →
  • Withdrawn NCT NCT02466568

    Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2020-07
    Other conditions: Lung Cancer, Adenocarcinoma of the Lung
    View official trial listing →
  • Completed NCT NCT02467946

    Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient

    Not yet reported, Not yet reported Centre Antoine Lacassagne 60 participants Est. completion 2022-04-06 1 site
    Other conditions: Clinical Efficacy, Safety
    View official trial listing →
  • Completed NCT NCT02470221

    Goal-directed Intraoperative Fluid Therapy in High-risk Surgery

    Huang YuGuang 600 participants Est. completion 2018-07-01
    Other conditions: Postoperative Complications, Fluid Overload
    View official trial listing →
  • Completed NCT NCT02470247

    Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients

    Not yet reported Rennes University Hospital 26 participants Est. completion 2020-10-31 1 site
    Other conditions: Nephropathy
    View official trial listing →
  • Completed NCT NCT02471014

    Effect of Obesity on Immune Response to Pneumovax 23

    University of Florida 50 participants Est. completion 2019-05-16 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02471144

    Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

    Not yet reported Novartis Pharmaceuticals 162 participants Est. completion 2023-03-30 46 sites
    Other conditions: Chronic Severe Plaque-type Psoriasis
    View official trial listing →
  • Completed NCT NCT02471534

    Study on Prediction of Fluid Responsiveness Using an Abdominal Compression-induced Change of Blood Pressure in Children

    Not yet reported Seoul National University Hospital 30 participants Est. completion 2015-12 1 site
    Other conditions: Hypovolemia
    View official trial listing →
  • Completed NCT NCT02474446

    Getting Vitamin D Dosing Right

    Not yet reported Sheffield Children's NHS Foundation Trust 60 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Vitamin D Status
    View official trial listing →
  • Terminated NCT NCT02474719

    Transfer and Ultrafiltration In Peritoneal Dialysis

    Not yet reported Centre Hospitalier Universitaire de Besancon 17 participants Est. completion 2018-07-18 1 site
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT02474888

    Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

    Centre Hospitalier Universitaire de Saint Etienne 28 participants Est. completion 2020-06-12 4 sites
    Other conditions: Granulomatosis, Wegener's, Microscopic Polyangiitis
    View official trial listing →
  • Completed NCT NCT02474966

    Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study

    Not yet reported University of Roma La Sapienza 15 participants Est. completion 2015-05
    Other conditions: Glioblastoma Multiforme of Brain
    View official trial listing →
  • Completed NCT NCT02475122

    Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR)

    Not yet reported University Hospital, Angers 71 participants Est. completion 2020-12 1 site
    Other conditions: Bleeding Esophageal Varices, Cirrhosis
    View official trial listing →
  • Completed NCT NCT02476487

    The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia

    Not yet reported Rambam Health Care Campus 143 participants Est. completion 2021-12-31 1 site
    Other conditions: Staphylococcus Aureus Bacteremia
    View official trial listing →
  • Status unknown NCT NCT02477241

    Brain Areas Involved in Bladder Filling and Contraction

    Not yet reported Maastricht University Medical Center 48 participants Est. completion 2017-12 1 site
    Other conditions: Urinary Bladder, Overactive
    View official trial listing →
  • Completed NCT NCT02477462

    Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients

    University of California, Davis 124 participants Est. completion 2019-06-06 1 site
    Other conditions: Primary Biliary Cirrhosis
    View official trial listing →
  • Completed NCT NCT02478086

    Effects of High vs. Standard Protein Intake in Newborn Extreme Premature

    Not yet reported Coordinación de Investigación en Salud, Mexico 52 participants Est. completion 2013-02 1 site
    Other conditions: Abnormal Renal Function, Malnutrition
    View official trial listing →
  • Status unknown NCT NCT02479113

    Maternal Hypertriglyceridaemia Study

    University of Malaya 400 participants Est. completion 2024-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02479230

    Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients

    Not yet reported Joseph Baar, MD, PhD 18 participants Est. completion 2022-07-01 2 sites
    Other conditions: Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02479321

    Goal Directed Hemodynamic Therapy Based on Noninvasive Monitoring in Patients With Hip Fracture

    Not yet reported Juan-Víctor Lorente, MD, PhD 568 participants Est. completion 2019-02 1 site
    Other conditions: Hip Fractures
    View official trial listing →
  • Completed NCT NCT02479529

    Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.

    Not yet reported Centre Hospitalier Universitaire, Amiens 130 participants Est. completion 2016-06 1 site
    Other conditions: Vasoplegic Syndrome
    View official trial listing →
  • Completed NCT NCT02479724

    A-line/CareTaker Comparison Study in ICU Patients

    Empirical Technologies Corporation 60 participants Est. completion 2013-06
    Other conditions: Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT02481310

    Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

    Not yet reported, Not yet reported Northwestern University 38 participants Est. completion 2024-07 5 sites
    Other conditions: Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, MYC Gene Mutation, Plasmablastic Lymphoma
    View official trial listing →
  • Completed NCT NCT02482038

    Geko Venous Leg Ulcer Study

    Not yet reported Firstkind Ltd 22 participants Est. completion 2019-10-10 1 site
    Other conditions: Venous Leg Ulcer
    View official trial listing →
  • Completed NCT NCT02482363

    Vascular Responses to UV Exposure in Pregnancy

    Not yet reported University of Edinburgh 19 participants Est. completion 2016-03-31 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT02482532

    Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma

    Not yet reported Gary Doolittle 7 participants Est. completion 2021-09-13 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT02483663

    Brain Regulation of Appetite in Twins

    University of Washington 122 participants Est. completion 2015-08 1 site
    Other conditions: Obesity, Appetite
    View official trial listing →
  • Completed NCT NCT02483702

    Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair

    Not yet reported Valley Anesthesiology Consultants 20 participants Est. completion 2017-05-11 1 site
    Other conditions: Graft Versus Host Disease, Hyperkalemia, Craniectomy, Synostectomy, FOA, Congenital Malformations
    View official trial listing →
  • Terminated NCT NCT02484638

    Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

    Not yet reported, Not yet reported CSL Behring 25 participants Est. completion 2018-03-28 10 sites
    Other conditions: Hemophilia A With Inhibitors, Hemophilia B With Inhibitors
    View official trial listing →
  • Completed NCT NCT02484690

    A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

    Not yet reported Hoffmann-La Roche 273 participants Est. completion 2017-09-26 52 sites
    Other conditions: Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT02484859

    Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery

    Not yet reported Recep Tayyip Erdogan University 88 participants Est. completion 2016-02 1 site
    Other conditions: Nasal Polyps
    View official trial listing →
  • Completed NCT NCT02485054

    A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)

    Fondation Ophtalmologique Adolphe de Rothschild 403 participants Est. completion 2018-10 2 sites
    Other conditions: Vision Disorders
    View official trial listing →
  • Completed NCT NCT02485782

    Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis

    Medical University of Warsaw 48 participants Est. completion 2015-09 1 site
    Other conditions: End Stage Renal Failure on Dialysis, Body Fluid Retention, Impedance, Cardiac Output, Low
    View official trial listing →
  • Completed NCT NCT02488330

    An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study

    Not yet reported Hoffmann-La Roche 12 participants Est. completion 2018-06-29 10 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT02488564

    A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer

    Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 49 participants Est. completion 2020-03-17 9 sites
    Other conditions: HER-2 Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02489253

    Atherosclerosis in Familial Hypercholesterolemia

    University College, London 100 participants Est. completion 2016-12 1 site
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT02489500

    Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib

    Not yet reported Boston Medical Center 3 participants Est. completion 2017-04-28 1 site
    Other conditions: AL Amyloidosis
    View official trial listing →
  • Status unknown NCT NCT02489929

    Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

    Not yet reported Assistance Publique Hopitaux De Marseille 35 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Withdrawn NCT NCT02492360

    Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy

    Costantine Albany Est. completion 2019-12 1 site
    Other conditions: Peripheral Nervous System Diseases, Testicular Neoplasms
    View official trial listing →
  • Completed NCT NCT02494219

    Pharyngitis,Group A Streptococcal Infection,Rapid Streptococcal Test,Throat Swab Culture

    Not yet reported Hamad Medical Corporation 906 participants Est. completion 2010-12 1 site
    Other conditions: Pharyngitis
    View official trial listing →
  • Active, not recruiting NCT NCT02494869

    Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 75 participants Est. completion 2027-07 1 site
    Other conditions: High Risk for Developing Breast Cancer
    View official trial listing →
  • Completed NCT NCT02495584

    D-Light Intervention

    Not yet reported University of Ulster 52 participants Est. completion 2015-10 1 site
    Other conditions: 25-hydroxyvitamin D Concentration (Vitamin D Status)
    View official trial listing →
  • Completed NCT NCT02495597

    LCI and Bronchial Inflammation in Patients With BO

    Johann Wolfgang Goethe University Hospital 37 participants Est. completion 2014-12 1 site
    Other conditions: Bronchiolitis Obliterans
    View official trial listing →
  • Completed NCT NCT02497469

    An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

    Not yet reported Takeda 771 participants Est. completion 2019-01-18 330 sites
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Completed NCT NCT02497742

    Once Versus Twice Daily Electrolyte Monitoring in CHF

    Not yet reported Vanderbilt University 96 participants Est. completion 2017-08 1 site
    Heart failure
    View official trial listing →
  • Not yet recruiting NCT NCT02497898

    Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

    Not yet reported The First People's Hospital of Changzhou 1000 participants Est. completion 2040-07
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT02498600

    Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not yet reported National Cancer Institute (NCI) 100 participants Est. completion 2025-07-26 201 sites
    Other conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma
    View official trial listing →
  • Completed NCT NCT02499822

    REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial

    Not yet reported Istituto Auxologico Italiano 168 participants Est. completion 2020-11-01 3 sites
    Other conditions: Hypertension, High Blood Pressure Variability
    View official trial listing →
  • Completed NCT NCT02500004

    Brown Adipose Tissue Activity and Energy Metabolism in Cachexia

    Not yet reported Maastricht University Medical Center 16 participants Est. completion 2018-07 1 site
    Other conditions: Cachexia, Neoplasms, Pulmonary Disease, Chronic Obstructive, Pancreatic Neoplasms
    View official trial listing →
  • Completed NCT NCT02500251

    Belimumab Impacting Transplant Eligibility

    Not yet reported, Not yet reported E. Steve Woodle 11 participants Est. completion 2018-08 2 sites
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT02501850

    The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 40 participants Est. completion 2015-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02502448

    Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery

    Not yet reported Konkuk University Medical Center 70 participants Est. completion 2016-06 1 site
    Other conditions: Mitral Regurgitation, Mitral Stenosis, Tricuspid Regurgitation
    View official trial listing →
  • Completed NCT NCT02502552

    Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort

    Centre Hospitalier Universitaire de Saint Etienne 80 participants Est. completion 2015-10 1 site
    Other conditions: Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT02502864

    Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 9 participants Est. completion 2019-01-31 1 site
    Other conditions: Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT02503813

    Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?

    Not yet reported MemorialCare Health System 7 participants Est. completion 2017-09 1 site
    Other conditions: Brain Death
    View official trial listing →
  • Completed NCT NCT02504125

    The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty

    Not yet reported Xijing Hospital 120 participants Est. completion 2015-06 1 site
    Other conditions: Blood Loss
    View official trial listing →
  • Completed NCT NCT02506062

    A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 21 participants Est. completion 2018-08 1 site
    Alcohol use disorder
    View official trial listing →
  • Terminated NCT NCT02506114

    Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer

    Not yet reported Lawrence Fong 15 participants Est. completion 2020-04-22 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02506153

    Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 1301 participants Est. completion 2027-01-23 576 sites
    Obstructive sleep apnea Other conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, Metastatic Non-Cutaneous Melanoma, Non-Cutaneous Melanoma, Recurrent Cutaneous Melanoma, Recurrent Non-Cutaneous Melanoma
    View official trial listing →
  • Completed NCT NCT02506296

    Glucose Response, Excursions And Treatment (GREAT) Study

    Not yet reported Royal Devon and Exeter NHS Foundation Trust 53 participants Est. completion 2015-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02506686

    Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment

    Not yet reported Huashan Hospital 82 participants Est. completion 2009-12
    Other conditions: Central Nervous System Infections
    View official trial listing →
  • Completed NCT NCT02507999

    Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40 participants Est. completion 2019-02 1 site
    Other conditions: Cerebral Aneurysm
    View official trial listing →
  • Completed NCT NCT02509351

    Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?

    Not yet reported, Not yet reported Ain Shams University 280 participants Est. completion 2016-11 1 site
    Other conditions: Postpartum Haemorrhage
    View official trial listing →
  • Terminated NCT NCT02511483

    Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 10 participants Est. completion 2016-11-12 2 sites Stand-alone
    Other conditions: Postoperative Pain
    View official trial listing →
  • Withdrawn NCT NCT02511613

    Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

    Not yet reported Ohr Pharmaceutical Inc. Est. completion 2016-04 4 sites
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02512393

    Transcranial Direct Current Stimulation in Older Persons With Knee Pain (Knee Pain and tDCS): Randomized Pilot Study

    Not yet reported The University of Texas Health Science Center, Houston 40 participants Est. completion 2016-08 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02512666

    Non Invasive Optical Imaging of WBC Count

    Not yet reported Massachusetts General Hospital 45 participants Est. completion 2017-09 1 site
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT02512757

    A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology

    Innovis LLC 150 participants Est. completion 2017-07-17 3 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT02513927

    The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese

    Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 40 participants Est. completion 2018-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02514902

    Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)

    Not yet reported Justin Fraser 48 participants Est. completion 2016-12-16 1 site Stand-alone
    Cardiovascular disease Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT02516514

    The Only Blood Culture for Diagnosis of Bacteremia - Comparative Study of Practice

    Not yet reported University Hospital, Caen 302 participants Est. completion 2012-12
    Other conditions: Bloodstream Infection
    View official trial listing →
  • Completed NCT NCT02516527

    A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors

    Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2018-09-20 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT02516943

    The Effects of Using Pathological- Based Guidelines for Arterial Blood Gas Analysis in Patients Aftercardiac Surgery

    Not yet reported Mahidol University 140 participants Est. completion 2015-05
    Other conditions: Blood Gas Analysis
    View official trial listing →
  • Status unknown NCT NCT02517242

    Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control

    Not yet reported Hospital de Clinicas de Porto Alegre 112 participants 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02517437

    Suprascapular and Axillary Blocks Versus Interscalene Block for Shoulder Surgery

    Not yet reported University Health Network, Toronto 130 participants Est. completion 2018-01 2 sites
    Other conditions: Shoulder Pain
    View official trial listing →
  • Completed NCT NCT02517710

    Study to Compare Suture Material in Closure of Uterine Incision in Cesarian Section

    Not yet reported Evangelical Community Hospital, Lewisburg, PA 100 participants Est. completion 2016-12-31 1 site
    Other conditions: Hysterotomy Closure
    View official trial listing →
  • Completed NCT NCT02517866

    Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

    Not yet reported Takeda 380 participants Est. completion 2016-11-25 11 sites
    Type 2 diabetes Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT02518282

    High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular Surgery

    University of Valladolid 800 participants Est. completion 2016-05 1 site
    Cardiovascular disease Other conditions: Disorder; Heart, Functional, Postoperative, Cardiac Surgery, Heart Valve Diseases
    View official trial listing →
  • Completed NCT NCT02519322

    Neoadjuvant and Adjuvant Checkpoint Blockade

    Not yet reported M.D. Anderson Cancer Center 53 participants Est. completion 2023-01-26 2 sites
    Obstructive sleep apnea Other conditions: Cutaneous Melanoma, Ocular Melanoma, Stage III Acral Lentiginous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIB Uveal Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IIIC Uveal Melanoma AJCC v7, Stage IV Acral Lentiginous Melanoma AJCC v6 and v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Stage IV Uveal Melanoma AJCC v7
    View official trial listing →
  • Terminated NCT NCT02519712

    Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors

    Not yet reported Memorial Sloan Kettering Cancer Center 4 participants Est. completion 2017-09 1 site
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Status unknown NCT NCT02520908

    Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis

    Assistance Publique - Hôpitaux de Paris 98 participants Est. completion 2024-11-19 1 site
    Other conditions: Epidermotropic T-cell Lymphomas
    View official trial listing →
  • Completed NCT NCT02525328

    Genome Study in Constitutional Thinness

    Centre Hospitalier Universitaire de Saint Etienne 210 participants Est. completion 2019-11-11 1 site
    Other conditions: Thinness, Leanness
    View official trial listing →
  • Completed NCT NCT02525445

    Effects of Genuine vs Sham Acupuncture and Communication Type on Relaxation

    Not yet reported Karolinska Institutet 243 participants Est. completion 2014-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02526121

    Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia

    Not yet reported Instituto Aragones de Ciencias de la Salud 60 participants Est. completion 2015-12 1 site
    Other conditions: Hyperferritinemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT02526563

    Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia

    University of Pittsburgh 4 participants Est. completion 2018-08 1 site
    Other conditions: Alveolar Bone Grafting, Alveolar Cleft Grafting
    View official trial listing →
  • Completed NCT NCT02528695

    Adipose Tissue Imaging in Type 2 Diabetes

    Not yet reported Radboud University Medical Center 15 participants Est. completion 2017-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT02528877

    Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

    Not yet reported City of Hope Medical Center 1 site
    Other conditions: Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage, Secondary Acute Myeloid Leukemia, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT02528968

    National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A

    Not yet reported Hampshire Hospitals NHS Foundation Trust 59 participants Est. completion 2017-11-30 1 site
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT02530450

    Continuous Glucose Monitor in Children With Poorly Controlled Diabetes

    The University of Texas Health Science Center at San Antonio 30 participants Est. completion 2013-03
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT02531139

    The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery

    Not yet reported Rigshospitalet, Denmark Est. completion 2017-11 1 site
    Other conditions: Anesthesia, Peripheral Arterial Diseases
    View official trial listing →
  • Completed NCT NCT02531347

    Comparison of Telemedical and Conventional Treatment of Hypertension

    Not yet reported Erling Bjerregaard Pedersen 375 participants Est. completion 2014-12
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02531386

    System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013

    Not yet reported Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm 120 participants Est. completion 2015-11 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02531399

    Measurement of Total Retinal Blood Flow During Flicker Stimulation in Healthy Subjects

    Not yet reported Medical University of Vienna 20 participants Est. completion 2017-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02531542

    Evaluation of Rapid Emergency Echography for Acute Dyspnoea

    Not yet reported Centre Hospitalier Universitaire de Besancon 461 participants Est. completion 2022-12-27 5 sites
    Other conditions: Acute Dyspnea
    View official trial listing →
  • Active, not recruiting NCT NCT02531607

    Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

    AdventHealth 500 participants Est. completion 2026-12-01 1 site
    Other conditions: Pancreatic Neoplasms
    View official trial listing →
  • Completed NCT NCT02532257

    Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

    Not yet reported M.D. Anderson Cancer Center 48 participants Est. completion 2023-08-15 1 site
    Other conditions: Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage III Marginal Zone Lymphoma, Ann Arbor Stage IV Follicular Lymphoma, Ann Arbor Stage IV Marginal Zone Lymphoma, CD20 Positive, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT02533375

    Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

    Not yet reported AbbVie 10 participants Est. completion 2017-07-20
    Other conditions: Generalized Pustular Psoriasis (GPP), Adalimumab, Japanese
    View official trial listing →
  • Terminated NCT NCT02533570

    Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

    Not yet reported Seagen Inc. 20 participants Est. completion 2017-06-05 17 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02534142

    Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence

    Meuhedet. Healthcare Organization 774 participants Est. completion 2017-12-20 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02534506

    Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors

    Not yet reported Bristol-Myers Squibb 18 participants Est. completion 2016-11-11 1 site
    Other conditions: Malignant Tumors
    View official trial listing →
  • Status unknown NCT NCT02534519

    Whole Genome Sequencing for Blood Group Genotyping and Definition as Exemplified on U- and St(a)+.

    Blood Donation Service Zurich, SRC 8 participants Est. completion 2018-06 1 site
    Other conditions: Genetic Blood Group (bg) Polymorphism in U Negativity and St(a) of MNSs
    View official trial listing →
  • Completed NCT NCT02534740

    A Study Comparing Amounts of Tafamidis In The Blood With Or Without Food

    Not yet reported Pfizer 18 participants Est. completion 2015-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02536560

    Intestinal Microbiota Composition After Antibiotic Treatment in Early Life

    Agentschap NL 450 participants Est. completion 2016-10 4 sites
    Other conditions: Microbiota, Eczema, Atopy
    View official trial listing →
  • Completed NCT NCT02538666

    An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy

    Not yet reported Bristol-Myers Squibb 907 participants Est. completion 2021-11-11 197 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT02539368

    Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease

    Pfizer 2565 participants Est. completion 2018-10-31 140 sites
    Other conditions: Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02539771

    Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events

    Not yet reported Assistance Publique - Hôpitaux de Paris 114 participants Est. completion 2019-04-10 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02540187

    Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

    Centre Hospitalier Universitaire de Saint Etienne 164 participants Est. completion 2016-02 7 sites
    Other conditions: Hemophilia
    View official trial listing →
  • Completed NCT NCT02540486

    Long Acting Insulin Glargine Titration Web Tool (LTHome) vs Enhanced Usual Therapy of Glargine Titration

    Not yet reported LMC Diabetes & Endocrinology Ltd. 139 participants Est. completion 2015-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02540590

    Post-operative Blood Flow Measurements of the Oral Mucosa

    Semmelweis University 8 participants Est. completion 2015-07 1 site
    Other conditions: Gingival Recession
    View official trial listing →
  • Completed NCT NCT02542488

    STOPBANG As A Screening Tool for Obstructive Sleep Apnoea in Pregnancy

    City Hospitals Sunderland NHS Foundation Trust 117 participants Est. completion 2018-03-27 1 site
    Other conditions: Obstructive Sleep Apnoea, Pregnancy
    View official trial listing →
  • Status unknown NCT NCT02543697

    Adrenal Venous Sampling in Patients With Overt or Subclinical Cushings Syndrome, and Bilateral Adrenal Tumors

    Not yet reported Haukeland University Hospital 30 participants Est. completion 2020-02 1 site Stand-alone
    Other conditions: Cushing Syndrome
    View official trial listing →
  • Completed NCT NCT02544776

    Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

    Not yet reported Ahmed Fathy Ali Mohamed Ghanem 60 participants Est. completion 2015-09
    Other conditions: Female Infertility Associated With Anovulation
    View official trial listing →
  • Status unknown NCT NCT02547558

    Pulmonary Gas Exchange Response to Indacaterol in COPD

    Not yet reported Hospital Clinic of Barcelona 20 participants Est. completion 2015-11 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02548520

    Maternal and Infant Vitamin Status During the First Nine Months of Infant Life

    University of Aarhus 107 participants Est. completion 2012-03 1 site
    Other conditions: Rickets, Osteomalacia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT02549248

    Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology

    Centre Hospitalier Universitaire de Saint Etienne 100 participants Est. completion 2015-04 1 site
    Other conditions: Interstitial Lung Diseases
    View official trial listing →
  • Terminated NCT NCT02550054

    Erythropoietin in Premature Infants to Prevent Encephalopathy

    Not yet reported Children's Hospital of Fudan University 58 participants Est. completion 2016-12-30 1 site
    Other conditions: Premature Infant
    View official trial listing →
  • Completed NCT NCT02550249

    Neoadjuvant Nivolumab in Glioblastoma

    Not yet reported Clinica Universidad de Navarra, Universidad de Navarra 29 participants Est. completion 2017-03 1 site
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Withdrawn NCT NCT02551003

    Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy

    Not yet reported, Not yet reported Children's Hospital of Fudan University Est. completion 2016-12-30 1 site Stand-alone
    Other conditions: Hypoxic Ischemic Encephalopathy, Cerebral Infarction
    View official trial listing →
  • Completed NCT NCT02551159

    Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

    Not yet reported AstraZeneca 823 participants Est. completion 2021-05-21 197 sites
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Terminated NCT NCT02551211

    Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer

    Not yet reported University Hospital, Rouen 22 participants Est. completion 2020-02-10 1 site
    Other conditions: Resectable Non-small Lung Cancer
    View official trial listing →
  • Completed NCT NCT02551393

    Enhancing the Risk Assessment and Management Program by Promotion of Self-blood Pressure Monitoring

    Not yet reported The University of Hong Kong 291 participants Est. completion 2018-12-30
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02552212

    Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

    Not yet reported UCB BIOSCIENCES GmbH 317 participants Est. completion 2020-05 105 sites
    Other conditions: Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis, Nr-axSpA
    View official trial listing →
  • Withdrawn NCT NCT02553122

    The Combined Efficacy of Evicel and Tranexamic Acid on Total Knee Arthroplasty

    Not yet reported Montefiore Medical Center Est. completion 2016-12
    Other conditions: Arthroplasty, Replacement, Knee
    View official trial listing →
  • Status unknown NCT NCT02554578

    Impact of mHealth in Heart Transplant Management

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 158 participants
    Other conditions: Heart Transplant
    View official trial listing →
  • Completed NCT NCT02554669

    Acute Effects of Postabsorptive and Postprandial Physical Activity

    Not yet reported Inland Norway University of Applied Sciences 12 participants Est. completion 2014-06
    Other conditions: Hyperglycemia, Inflammation
    View official trial listing →
  • Withdrawn NCT NCT02558361

    Treatment With Apremilast in Patients With Psoriatic Arthritis

    Not yet reported University of South Florida Est. completion 2016-10 1 site
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT02559648

    Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis

    Not yet reported Ersi Voskaridou 63 participants Est. completion 2017-12 1 site
    Other conditions: Thalassemia Major, Osteoporosis
    View official trial listing →
  • Completed NCT NCT02559843

    Effects of Pomegranate Juice on Oxidative Stress in Patients With type2 Diabetes

    Not yet reported National Nutrition and Food Technology Institute 60 participants Est. completion 2015-02 1 site
    Other conditions: Diabetes Type 2
    View official trial listing →
  • Terminated NCT NCT02561247

    Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children

    Not yet reported Vantive Health LLC 23 participants Est. completion 2018-04-06 6 sites
    Other conditions: Acute Kidney Injury in Pediatric Patients
    View official trial listing →
  • Completed NCT NCT02561663

    NWT03 and Arterial Stiffness

    Not yet reported Newtricious R&D BV 79 participants Est. completion 2017-09 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02566304

    Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 35 participants Est. completion 2024-02-13 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Aplastic Anemia, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Malignant Neoplasm, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ring Sideroblasts, Refractory Cytopenia With Multilineage Dysplasia, Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts
    View official trial listing →
  • Completed NCT NCT02566460

    The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock

    Not yet reported Peking Union Medical College Hospital 360 participants
    Other conditions: Septic Shock
    View official trial listing →
  • Active, not recruiting NCT NCT02568839

    Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer

    Not yet reported, Not yet reported Thomas Hatschek 202 participants Est. completion 2029-02 7 sites
    Other conditions: Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02568969

    Lactate in High-risk Cardiac Surgery

    Not yet reported Northern State Medical University 21 participants Est. completion 2015-11 1 site
    Other conditions: Continuous Lactate Measurements, Cardiosurgery
    View official trial listing →
  • Completed NCT NCT02569060

    Feeding America Intervention Trial for Health--Diabetes Mellitus

    Not yet reported University of California, San Francisco 568 participants Est. completion 2017-10-31 4 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Not yet recruiting NCT NCT02569151

    20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up

    Kyuzi Kamoi 600 participants Est. completion 2027-04
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02569658

    Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty

    Not yet reported Rush University Medical Center 110 participants Est. completion 2017-04 1 site
    Other conditions: Blood Loss, Anatomic Total Shoulder Arthroplasty, Reverse Total Shoulder Arthroplasty, Transfusion, Tranexamic Acid
    View official trial listing →
  • Active, not recruiting NCT NCT02570542

    Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

    Not yet reported Memorial Sloan Kettering Cancer Center 59 participants Est. completion 2026-10 14 sites
    Other conditions: Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL)
    View official trial listing →
  • Active, not recruiting NCT NCT02570984

    Preventing Asthma in High Risk Kids

    Not yet reported Boston Children's Hospital 200 participants Est. completion 2028-03-31 13 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02572154

    Sperm DNA Fragmentation in Recurrent Pregnancy Loss

    Not yet reported University Hospital, Toulouse 64 participants Est. completion 2015-07 3 sites
    Other conditions: RECURRENT PREGNANCY LOSS
    View official trial listing →
  • Completed NCT NCT02572687

    A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

    Not yet reported Eli Lilly and Company 85 participants Est. completion 2021-01-13 28 sites
    Other conditions: Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02572713

    Systemic Synuclein Sampling Study (S4)

    Michael J. Fox Foundation for Parkinson's Research 80 participants Est. completion 2017-08-01 6 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02573571

    Personalized Needs in Clostridium Difficile Infections

    University of Athens 150 participants Est. completion 2017-10 12 sites
    Other conditions: Biologic Markers, Clinical Markers
    View official trial listing →
  • Completed NCT NCT02574806

    Normal Values of Brain Natriuretic Peptide in Healthy Newborn

    Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud 167 participants Est. completion 2015-04
    Other conditions: Reference Values of BNP in Healthy Newborn
    View official trial listing →
  • Completed NCT NCT02576795

    Gene Therapy Study in Severe Haemophilia A Patients (270-201)

    Not yet reported, Not yet reported BioMarin Pharmaceutical 15 participants Est. completion 2024-02-14 5 sites
    Other conditions: Severe Haemophilia A
    View official trial listing →
  • Status unknown NCT NCT02577484

    Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

    Acist Medical Systems 240 participants Est. completion 2017-01 12 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02578329

    An Intervention Study to Assess the Effect of the Mediterranean Diet on the Plasma Fatty Acid Profile

    Not yet reported Centro Cardiologico Monzino 150 participants Est. completion 2018-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02580084

    Clinical Study of the Aorta-femoral Bypass and Hybrid Intervention and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery Effectiveness in Patients With the Iliac Segment and Femoral Artery Occlusive Disease (TASC C, D)

    Not yet reported Meshalkin Research Institute of Pathology of Circulation 202 participants Est. completion 2021-03 1 site
    Other conditions: Atherosclerosis of the Peripheral Arteries
    View official trial listing →
  • Completed NCT NCT02580864

    Bologna IBD Markers

    Société des Produits Nestlé (SPN) 84 participants Est. completion 2019-01 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02581462

    FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer

    Not yet reported, Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 81 participants Est. completion 2020-07-17 1 site
    Other conditions: Stomach Cancer, Gastroesophageal Junction Cancer
    View official trial listing →
  • Completed NCT NCT02581618

    Remote Ischemic Preconditioning in Elective Percutaneous Interventions

    Not yet reported Trakya University 102 participants Est. completion 2016-02 1 site
    Other conditions: Myocardial Ischemia, Ischemic Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT02581969

    Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

    Bayer 43 participants Est. completion 2018-06-21 1 site
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT02582112

    Warming IV Fluids and Incidence of Hypotension

    Not yet reported Hakki Unlugenc 60 participants Est. completion 2015-10 1 site
    Other conditions: Assault by Hot Fluids
    View official trial listing →
  • Completed NCT NCT02582411

    Laser Speckle Flowgraphy in Caucasians: Age Dependence and Comparison With Doppler Optical Coherence Tomography

    Medical University of Vienna 80 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02582775

    MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

    Not yet reported Masonic Cancer Center, University of Minnesota 17 participants Est. completion 2023-07-26 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02584231

    Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population

    Not yet reported University Ghent 25 participants Est. completion 2019-02-01 1 site
    Other conditions: Monosymptomatic Nocturnal Enuresis
    View official trial listing →
  • Completed NCT NCT02584296

    Physical Activity as Self-Management Approach to Improve Health Outcomes in AML

    Not yet reported Virginia Commonwealth University 23 participants Est. completion 2016-11 1 site
    Other conditions: Leukemia, Myeloid, Monocytic
    View official trial listing →
  • Terminated NCT NCT02585752

    A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b

    Not yet reported ResMed 20 participants Est. completion 2017-11-24 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02585895

    Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

    Not yet reported Amgen 39 participants Est. completion 2017-01-20 17 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02586363

    Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety

    Not yet reported Seoul St. Mary's Hospital 30 participants Est. completion 2016-03
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02586441

    Evaluation of EEG With Respect to the Change of Depth of Anesthesia During General Anesthesia

    Not yet reported Korea University Anam Hospital 40 participants Est. completion 2017-11
    Other conditions: Anesthesia
    View official trial listing →
  • Status unknown NCT NCT02587273

    The Pharmacokinetics of Fentanyl in Intensive Care Patients

    Not yet reported Oslo University Hospital 150 participants Est. completion 2017-11 1 site
    Other conditions: Multiple Organ Failure, Critical Care, Intensive Care
    View official trial listing →
  • Status unknown NCT NCT02587845

    Use of Transexamic Acid in Hip Replacement

    Not yet reported Samsung Medical Center 150 participants Est. completion 2016-12 1 site
    Other conditions: Bleeding, Transfusion Related Complication
    View official trial listing →
  • Active, not recruiting NCT NCT02588690

    Beauty from Within Community Screening Project

    Cedars-Sinai Medical Center 400 participants Est. completion 2030-11 1 site
    Other conditions: Heart Health Screening and Prevention
    View official trial listing →
  • Completed NCT NCT02588898

    B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes

    Universität des Saarlandes 212 participants Est. completion 2011-01 1 site
    Other conditions: Diabetes Complications
    View official trial listing →
  • Status unknown NCT NCT02588924

    Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's Disease

    University of Campania Luigi Vanvitelli 100 participants Est. completion 2017-09 2 sites
    Other conditions: Parkinson Disease, Secondary
    View official trial listing →
  • Status unknown NCT NCT02591264

    Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

    Hillel Yaffe Medical Center 120 participants Est. completion 2016-11 1 site
    Other conditions: Coronary Thrombosis
    View official trial listing →
  • Completed NCT NCT02591914

    An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration

    Not yet reported Retinal Consultants of Arizona 30 participants Est. completion 2016-05-24 1 site
    Other conditions: Neovascular Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02592655

    A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet

    Not yet reported Marcus Migura 19 participants Est. completion 2015-12 1 site
    Other conditions: Hemorrhage, Vascular Injury
    View official trial listing →
  • Completed NCT NCT02593786

    A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors

    Not yet reported, Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2021-09-27 2 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT02593877

    Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy

    Not yet reported Queen Mary University of London 412 participants Est. completion 2018-07-30 7 sites
    Other conditions: Hemorrhage, Coagulopathy, Trauma
    View official trial listing →
  • Status unknown NCT NCT02594423

    Strategies for Management of Corneal Neovascularisation

    Not yet reported University of Nottingham 40 participants Est. completion 2018-08
    Other conditions: Corneal Neovascularisation
    View official trial listing →
  • Completed NCT NCT02594462

    Contraception in Women With Sickle Cell Disease

    Not yet reported University of Sao Paulo 29 participants Est. completion 2019-06 2 sites
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02594761

    Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

    Not yet reported Mylan Pharmaceuticals Inc 132 participants Est. completion 2014-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02596932

    Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus

    Not yet reported Women and Infants Hospital of Rhode Island 76 participants Est. completion 2018-12 1 site
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02598284

    Healthy Hearts in the Heartland

    Not yet reported Northwestern University 226 participants Est. completion 2018-12 5 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02598427

    Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer

    Not yet reported Kimberly Blackwell 1 participants Est. completion 2018-02-22 1 site
    Other conditions: HER2 Positive Untreated Metastatic Breast Cancer, Asymptomatic or Low Symptomatic Brain Metastasis in Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02598674

    Severe Sepsis in Children - IMPRESS-C

    University of Florida Est. completion 2021-09 1 site
    Chronic kidney disease Other conditions: Acute Kidney Injury, Hypertension
    View official trial listing →
  • Completed NCT NCT02598856

    Bioavailability of Nasal Naloxone and Injected Naloxone Compared

    Not yet reported Norwegian University of Science and Technology 22 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Drug Overdose
    View official trial listing →
  • Terminated NCT NCT02599649

    Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)

    Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2019-01-30 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT02600065

    Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy

    University of Erlangen-Nürnberg Medical School 350 participants Est. completion 2022-12-31 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT02600897

    A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

    Not yet reported, Not yet reported Hoffmann-La Roche 114 participants Est. completion 2021-12-15 28 sites
    Other conditions: Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02601430

    BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI

    Not yet reported Zimmer Biomet 5 participants Est. completion 2016-10 1 site
    Other conditions: Peripheral Arterial Disease, Critical Limb Ischemia
    View official trial listing →
  • Completed NCT NCT02602652

    Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

    Not yet reported Chulalongkorn University 50 participants Est. completion 2015-07 Stand-alone
    Other conditions: Japanese Encephalitis
    View official trial listing →
  • Completed NCT NCT02602691

    Cost-utility Analysis of the AlloMap® Test

    Not yet reported Hospices Civils de Lyon 197 participants Est. completion 2022-10-28 13 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT02603237

    Metabolic Response to Fat and Glucose

    Not yet reported Universität des Saarlandes 60 participants Est. completion 2020-06 1 site
    Other conditions: Obesity, Insulin Resistance, Healthy
    View official trial listing →
  • Completed NCT NCT02604433

    An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia

    Not yet reported Celgene 336 participants Est. completion 2021-01-05 76 sites
    Other conditions: Erythrocyte Transfusion, Beta-Thalassemia
    View official trial listing →
  • Completed NCT NCT02604602

    Coagulation Factors and Postpartum Hemorrhage

    University of Zurich 1500 participants Est. completion 2020-04-20 1 site
    Other conditions: Postpartum Hemorrhage
    View official trial listing →
  • Completed NCT NCT02604654

    Effectiveness and Safety of Yiqitongluo Granule for Stroke

    Not yet reported Yi Yang 2197 participants Est. completion 2017-12-06
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02604719

    Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH

    Not yet reported, Not yet reported Ahmed Alanwar 64 participants Est. completion 2016-07
    Other conditions: Postpartum Hemorrhage
    View official trial listing →
  • Completed NCT NCT02606305

    Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer

    Not yet reported, Not yet reported ImmunoGen, Inc. 264 participants Est. completion 2021-03-12 12 sites
    Other conditions: Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
    View official trial listing →
  • Completed NCT NCT02608255

    A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage

    Not yet reported Assistance Publique Hopitaux De Marseille 100 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT02608346

    Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

    Not yet reported Institut Curie 200 participants Est. completion 2021-12-29 4 sites
    Other conditions: Women With BRCA1 Germline Deleterious Mutation
    View official trial listing →
  • Completed NCT NCT02608424

    Effects of Feet Mechanical Stimulation on Cardiovascular Autonomic Profile and Inflammation in Parkinson's Disease

    Not yet reported Istituto Clinico Humanitas 50 participants Est. completion 2017-08 1 site
    Other conditions: Parkinson's Disease, Autonomic Neuropathy, Inflammation, Hypertension
    View official trial listing →
  • Completed NCT NCT02612155

    A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy

    Not yet reported Michael Cotten 35 participants Est. completion 2019-08-05 1 site
    Other conditions: Moderate or Severe Hypoxic-ischemic Encephalopathy in Newborns
    View official trial listing →
  • Completed NCT NCT02612350

    Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease

    Pathway Genomics 1106 participants Est. completion 2017-08 1 site
    Other conditions: Mutation, Neoplasms
    View official trial listing →
  • Completed NCT NCT02612779

    A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

    Not yet reported Bristol-Myers Squibb 74 participants Est. completion 2020-06-12 22 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02613507

    Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer

    Not yet reported Bristol-Myers Squibb 504 participants Est. completion 2023-11-24 33 sites
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02614456

    Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

    Not yet reported Fox Chase Cancer Center 26 participants Est. completion 2019-06-12 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT02614794

    A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

    Not yet reported Seagen Inc. 612 participants Est. completion 2022-08-11 176 sites
    Other conditions: HER2 Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02614820

    The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD

    Not yet reported General Hospital of Chinese Armed Police Forces 100 participants Est. completion 2016-12 1 site
    Other conditions: Duchenne Muscular Dystrophy (DMD)
    View official trial listing →
  • Completed NCT NCT02614872

    Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation

    Not yet reported Kamada, Ltd. 30 participants Est. completion 2019-05-07 1 site
    Other conditions: Transplantation, Lung Rejection
    View official trial listing →
  • Completed NCT NCT02614976

    Incidences of Cuff-related Trauma After Noninvasive Blood Pressure Measurement Between With and Without Padding

    Not yet reported Siriraj Hospital 273 participants Est. completion 2018-02 1 site
    Other conditions: Complication
    View official trial listing →
  • Status unknown NCT NCT02617238

    Strategy for Preventing Cardiovascular and Renal Events Based on ARTErial Stiffness

    Not yet reported Assistance Publique - Hôpitaux de Paris 3000 participants Est. completion 2020-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02617407

    Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

    Not yet reported University of California, San Francisco 44 participants Est. completion 2020-01-27 1 site
    Other conditions: Dental Plaque
    View official trial listing →
  • Status unknown NCT NCT02619071

    ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia

    Not yet reported Institut Paoli-Calmettes 87 participants Est. completion 2017-08 1 site
    Other conditions: Leukemia, Myeloid, Acute
    View official trial listing →
  • Status unknown NCT NCT02619188

    Nutritional Markers in Normal and Hyperemesis Pregnancies

    Haukeland University Hospital 60 participants Est. completion 2018-07 1 site
    Other conditions: Hyperemesis Gravidarum, Pregnancy
    View official trial listing →
  • Completed NCT NCT02622854

    Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis

    Not yet reported University Medical Centre Ljubljana 22 participants Est. completion 2020-08 1 site
    Other conditions: Acute Pancreatitis
    View official trial listing →
  • Completed NCT NCT02624271

    Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk

    Not yet reported Nantes University Hospital 2000 participants Est. completion 2019-05-09 1 site Stand-alone
    Other conditions: Gastric Cancer, Gastric Precancerous Lesions
    View official trial listing →
  • Completed NCT NCT02624609

    Effects of Polyphenols Found in Pomegranate Juice on Postprandial Blood Glucose in Vivo

    Not yet reported University of Leeds 16 participants Est. completion 2016-03 1 site
    Other conditions: Hyperglycaemia
    View official trial listing →
  • Completed NCT NCT02625701

    Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy

    Not yet reported University Hospital, Geneva 400 participants Est. completion 2019-09 1 site
    Other conditions: Complication, Postoperative
    View official trial listing →
  • Completed NCT NCT02627261

    Multiple Myeloma Minimal Residual Disease

    Hospices Civils de Lyon 48 participants Est. completion 2018-09-02 3 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02628197

    Effect of Periodontitis on Bone Mineral Density in Postmenopausal Women

    Not yet reported Postgraduate Institute of Dental Sciences Rohtak 68 participants Est. completion 2015-06
    Other conditions: PERIODONTITIS, Osteopenia
    View official trial listing →
  • Completed NCT NCT02628431

    The Application of the ELFI-TECH Monitor for Perioperative Hemodynamic Measurements

    Leiden University Medical Center 60 participants Est. completion 2017-01-01 1 site
    Other conditions: Colon Carcinima
    View official trial listing →
  • Completed NCT NCT02631538

    Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome

    Not yet reported GlaxoSmithKline 86 participants Est. completion 2020-06-23 36 sites
    Other conditions: Sjogren's Syndrome
    View official trial listing →
  • Completed NCT NCT02632032

    Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon

    Not yet reported Yaounde Central Hospital 46 participants Est. completion 2014-08
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02632838

    Improve Hypertension Monitoring and Self-management by Using mHealth

    Not yet reported Rutgers, The State University of New Jersey 30 participants Est. completion 2017-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02634164

    The Effects of Leucine and Isoleucine on Glucose Metabolism

    Not yet reported Texas Woman's University 12 participants Est. completion 2016-09
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02638246

    Incentives for Internet-based Adherence to SMBG for Teens With T1D

    Not yet reported Rowan University 52 participants Est. completion 2012-12
    Other conditions: Contingent Versus Noncontingent Incentives
    View official trial listing →
  • Completed NCT NCT02640365

    A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 10 participants Est. completion 2016-12-07 1 site
    Other conditions: Unresectable Advanced Cancer
    View official trial listing →
  • Completed NCT NCT02640664

    Rainbow Extension Study

    Not yet reported Novartis Pharmaceuticals 180 participants Est. completion 2022-04-21 73 sites
    Other conditions: Retinopathy of Prematurity (ROP)
    View official trial listing →
  • Status unknown NCT NCT02640820

    Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

    Not yet reported RXi Pharmaceuticals, Corp. 83 participants Est. completion 2018-05 4 sites
    Other conditions: Common Warts, HPV (Human Papillomavirus), Periungual Warts, Plantar Warts
    View official trial listing →
  • Terminated NCT NCT02641002

    A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

    Not yet reported Celgene 28 participants Est. completion 2018-07-18 6 sites
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT02641457

    Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis

    Not yet reported Instituto de Olhos de Goiania 2 participants Est. completion 2015-10 1 site
    Other conditions: Glaucoma, Rubeosis Iridis
    View official trial listing →
  • Terminated NCT NCT02643524

    Weight Change With Controlled Ankle Movement (CAM) Walker Boot Use

    Not yet reported Nell Blake, DPM 20 participants Est. completion 2019-05-23 1 site
    Other conditions: Foot Injury, Ankle Injury
    View official trial listing →
  • Completed NCT NCT02644967

    A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma

    Not yet reported Idera Pharmaceuticals, Inc. 53 participants Est. completion 2021-05 10 sites
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT02646059

    The Effective Ways of Recruiting Lapsed Blood Donors: a Stratified Randomized Pilot Study

    Not yet reported Guangzhou Blood Center 1188 participants Est. completion 2016-06 1 site
    Other conditions: Blood Donor
    View official trial listing →
  • Completed NCT NCT02646254

    Myocardial Protection and Clinical Outcome in Patients Undergoing Tetralogy of Fallot Repair : A Randomized Study of Two Different Cardioplegia Technique

    Not yet reported SUNDER LAL NEGI 56 participants Est. completion 2015-10
    Other conditions: Myocardial Protection in TOF Repair
    View official trial listing →
  • Terminated NCT NCT02647255

    Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

    Not yet reported, Not yet reported Peking University First Hospital 10 participants Est. completion 2020-10 2 sites
    Other conditions: Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency, Rapidly Progressive Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT02650154

    The Effects of the Anesthetic Ketamine in Young Children Undergoing Procedural Sedation

    The Hospital for Sick Children 70 participants Est. completion 2016-02 1 site
    Other conditions: Trauma
    View official trial listing →
  • Completed NCT NCT02651597

    A Study of the Effect of Oats on Post Prandial Glucose Response

    Not yet reported University of Manitoba 24 participants Est. completion 2016-12-10 1 site
    Other conditions: Normoglycemic, Normal Body Weight
    View official trial listing →
  • Completed NCT NCT02654028

    Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection

    Not yet reported Guangxi Medical University 618 participants Est. completion 2021-12-30 1 site
    Other conditions: Liver Cancer
    View official trial listing →
  • Terminated NCT NCT02654639

    Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

    Not yet reported Georgetown University 4 participants Est. completion 2017-11 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02655458

    Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma

    Not yet reported Hearn Jay Cho 15 participants Est. completion 2017-07-13 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02658981

    Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63 participants Est. completion 2023-10-03 11 sites
    Obstructive sleep apnea Other conditions: Glioblastoma, Recurrent Brain Neoplasm
    View official trial listing →
  • Completed NCT NCT02660437

    pCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD

    Not yet reported Schön Klinik Berchtesgadener Land 91 participants Est. completion 2018-07 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02660710

    Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

    Not yet reported UNC Lineberger Comprehensive Cancer Center 39 participants Est. completion 2022-07-22 1 site
    Other conditions: Diffuse Large B-cell Lymphoma, HIV
    View official trial listing →
  • Completed NCT NCT02661399

    Peripheral Blood Biomarkers Associated With CIPN

    St. Louis University 100 participants Est. completion 2020-12-10
    Other conditions: Peripheral Neuropathy, Secondary to Drugs or Chemicals
    View official trial listing →
  • Completed NCT NCT02662400

    Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies

    Not yet reported, Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 7 participants Est. completion 2016-12
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT02664181

    Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial

    Not yet reported Case Comprehensive Cancer Center 13 participants Est. completion 2024-05-19 2 sites
    Other conditions: Lung Cancer, Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02664610

    Community Study to Reduce High Blood Pressure Through Text Messaging (REACH OUT)

    Not yet reported University of Michigan 94 participants Est. completion 2015-05
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02665104

    Middle Cerebral Artery Velocity and Oxygen Saturation of the Brain During Carotid Endarterectomy

    University of Debrecen 100 participants Est. completion 2017-04 2 sites
    Other conditions: Cerebral Oxygen Saturation,MCA Velocity,Intraoperative Neurological Symptoms During Carotid Endarterectomy
    View official trial listing →
  • Completed NCT NCT02665416

    Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors

    Not yet reported Hoffmann-La Roche 94 participants Est. completion 2019-10-30 16 sites
    Other conditions: Advanced/Metastatic Solid Tumors
    View official trial listing →
  • Completed NCT NCT02665637

    Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

    Not yet reported Celltrion 70 participants Est. completion 2016-04 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02665819

    Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility.

    Centre Hospitalier Universitaire de Saint Etienne 101 participants Est. completion 2016-11-29 4 sites
    Other conditions: Pediatric Cancer
    View official trial listing →
  • Completed NCT NCT02666235

    Remote Ischaemic Conditioning and Coronary Endothelial Function (RIC-COR)

    Not yet reported NHS National Waiting Times Centre Board 60 participants Est. completion 2016-05 1 site
    Other conditions: Ischemic Preconditioning, Coronary Disease
    View official trial listing →
  • Completed NCT NCT02666326

    Accelerated Rule Out of Myocardial Infarction

    Not yet reported Aarhus University Hospital Skejby 4516 participants Est. completion 2020-09-03 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02666430

    Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

    Not yet reported Mylan Inc. 127 participants Est. completion 2017-07 81 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02667587

    An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

    Not yet reported Bristol-Myers Squibb 716 participants Est. completion 2024-04-09 123 sites
    Other conditions: Brain Neoplasms
    View official trial listing →
  • Completed NCT NCT02667678

    5 Years Follow-up Evaluation of Deterioration Kidney Biomarkers of HIV Patients

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 173 participants Est. completion 2018-09-30 1 site
    Other conditions: HIV
    View official trial listing →
  • Withdrawn NCT NCT02668510

    RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort

    Not yet reported Edna Rath Est. completion 2023-12-11 1 site
    Other conditions: Fasciitis, Plantar
    View official trial listing →
  • Terminated NCT NCT02668770

    Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

    Not yet reported M.D. Anderson Cancer Center 28 participants Est. completion 2025-11-05 1 site
    Other conditions: Advanced Cancers, Melanoma
    View official trial listing →
  • Completed NCT NCT02670616

    Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma

    Not yet reported Samsung Medical Center 24 participants Est. completion 2020-10 1 site
    Other conditions: Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02670798

    Thromboelastography Transfusion Protocol for Pediatric Neuromuscular Scoliosis Surgery

    Not yet reported Washington University School of Medicine 5 participants Est. completion 2017-07 1 site
    Other conditions: Neuromuscular Scoliosis
    View official trial listing →
  • Completed NCT NCT02671214

    The Effect of Selected Fibres and Flours in Flat Bread on Post-prandial Blood Glucose Responses

    Not yet reported Unilever R&D 42 participants Est. completion 2011-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT02671435

    A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

    Not yet reported, Not yet reported MedImmune LLC 383 participants Est. completion 2027-07-30 49 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT02671682

    Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis

    Not yet reported Albert Christian Ludolph, Prof. 61 participants Est. completion 2019-01-25 1 site
    Other conditions: Multiple Sclerosis, Clinically Isolated Syndrome
    View official trial listing →
  • Completed NCT NCT02672319

    EUS-guided Glue Injection for Varices Study

    Not yet reported Chinese University of Hong Kong 30 participants Est. completion 2020-06-30 1 site
    Other conditions: Gastroesophageal Varices
    View official trial listing →
  • Completed NCT NCT02672384

    Chronic Periodontitis in Critically Ill Patients: Diagnosis and Epidemiology

    Not yet reported University Hospital, Brest 100 participants Est. completion 2018-10-14 1 site
    Other conditions: Chronic Periodontitis, Intensive Care Unit
    View official trial listing →
  • Terminated NCT NCT02673957

    Analysis of Local and Circulating Compounds Released Following Blood Pressure Cuff Inflation

    University of New England, Australia 6 participants Est. completion 2017-05 1 site
    Other conditions: Ischemia
    View official trial listing →
  • Completed NCT NCT02675283

    Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting

    Not yet reported Sheffield Teaching Hospitals NHS Foundation Trust 502 participants Est. completion 2017-10 1 site
    Other conditions: Coeliac Disease
    View official trial listing →
  • Completed NCT NCT02675348

    Beef Protein Supplementation in Endurance Athletes

    Not yet reported University of Greenwich 24 participants Est. completion 2017-02 1 site
    Other conditions: Dietary Modification
    View official trial listing →
  • Status unknown NCT NCT02675569

    ACCESS HD: Comparing Catheters to Fistulas in Elderly Patients Starting Hemodialysis

    Not yet reported University of Calgary 100 participants Est. completion 2025-03 13 sites
    Other conditions: End-stage Kidney Failure
    View official trial listing →
  • Completed NCT NCT02676245

    Parent Education and Choice About Newborn Screening and Bloodspot Retention

    Not yet reported University of Utah 664 participants Est. completion 2014-10
    Other conditions: Neonatal Screening
    View official trial listing →
  • Withdrawn NCT NCT02676622

    Autologous Stem Cell Transplant for Refractory Crohn's Disease

    Not yet reported Nationwide Children's Hospital Est. completion 2013-04
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02677077

    Clinical Disease Activity With Long Term Natalizumab Treatment

    Biogen 277 participants Est. completion 2016-08-18 4 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT02678143

    Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease

    Not yet reported Washington University School of Medicine 1 participants Est. completion 2021-11-16 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02678390

    Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes

    Not yet reported Université de Sherbrooke 20 participants Est. completion 2017-09 1 site
    Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT02678910

    Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment

    Not yet reported Vlad Radulescu 2 participants Est. completion 2017-06-21 2 sites
    Other conditions: Cancer, Hematologic Disorder, Rheumatologic Disorder, Infertility
    View official trial listing →
  • Completed NCT NCT02679898

    Whole Body Vibration and External Load Exercise Training on Cardiovascular and Autonomic Function in Obese Individuals

    Not yet reported Florida State University 60 participants Est. completion 2015-08 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02681549

    Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)

    Not yet reported Yale University 41 participants Est. completion 2025-03-31 2 sites
    Other conditions: Melanoma, Non-small Cell Lung Cancer, Brain Metastasis
    View official trial listing →
  • Completed NCT NCT02682693

    Denosumab as an add-on Neoadjuvant Treatment (GeparX)

    Not yet reported GBG Forschungs GmbH 780 participants Est. completion 2020-12-31 1 site
    Other conditions: Breast Cancer Female NOS, Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II, Invasive Ductal Breast Cancer, HER2 Positive Breast Cancer, Inflammatory Breast Cancer, Tubular Breast Cancer Stage III
    View official trial listing →
  • Completed NCT NCT02684630

    Trima Accel® System Post Count Algorithm Study

    Not yet reported Terumo BCT 131 participants Est. completion 2016-05-28 2 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02684656

    Reduction of Oxalate and Inflammation by Hemodiafiltration vs. Hemodialysis

    Not yet reported University of Erlangen-Nürnberg Medical School 14 participants Est. completion 2016-09 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02684942

    Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy

    Not yet reported Chulabhorn Cancer Center 40 participants Est. completion 2014-03
    Other conditions: Pain, Quality of Life
    View official trial listing →
  • Completed NCT NCT02685618

    Endothelial Dysfunction in Resuscitated Cardiac Arrest

    Not yet reported Pär Johansson 50 participants Est. completion 2017-02-27 1 site
    Other conditions: Cardiac Arrest
    View official trial listing →
  • Completed NCT NCT02686619

    Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients

    Not yet reported Hoffmann-La Roche 237 participants Est. completion 2011-01 17 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02686905

    Vitamin Supplementation After Bariatric Surgery

    Not yet reported California State Polytechnic University, Pomona 30 participants Est. completion 2017-06 1 site
    Other conditions: Complications of Bariatric Procedures, Avitaminosis
    View official trial listing →
  • Status unknown NCT NCT02689921

    NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer

    Not yet reported Midwestern Regional Medical Center 7 participants Est. completion 2018-12 2 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02691546

    Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)

    Istituto Nazionale di Ricovero e Cura per Anziani 2434 participants Est. completion 2020-03-10 9 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02691650

    Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma

    University Hospital Heidelberg 85 participants Est. completion 2018-10 1 site
    Other conditions: Trauma, Burns
    View official trial listing →
  • Completed NCT NCT02693106

    Evaluation of the Ketogenic Potential of Different Diet Supplements

    Not yet reported Université de Sherbrooke 13 participants Est. completion 2015-06 1 site
    Other conditions: Healthy Adults
    View official trial listing →
  • Completed NCT NCT02693366

    Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis

    Not yet reported Universidade Federal do Rio de Janeiro 5 participants Est. completion 2018-05-16 1 site
    Chronic kidney disease Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT02694588

    Clinical and Molecular Phenotyping in IBD

    Not yet reported University Hospital Schleswig-Holstein 90 participants Est. completion 2021-12 1 site
    Other conditions: IBD
    View official trial listing →
  • Status unknown NCT NCT02695186

    Oxidative Stress in Intestinal Metaplasia and Metabolic Syndrome

    General Hospital of Filiates 180 participants Est. completion 2016-06 1 site
    Metabolic syndrome Other conditions: Intestinal Metaplasia, Oxidative Stress, Inflammatory Response
    View official trial listing →
  • Status unknown NCT NCT02696304

    The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis

    Not yet reported Assistance Publique Hopitaux De Marseille 30 participants Est. completion 2016-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT02696759

    Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer

    Not yet reported University of Arkansas 15 participants Est. completion 2021-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02696785

    A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis

    Not yet reported Eli Lilly and Company 341 participants Est. completion 2018-10-17 28 sites
    Other conditions: Spondyloarthritis
    View official trial listing →
  • Terminated NCT NCT02697292

    IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy

    Not yet reported Mayo Clinic 17 participants Est. completion 2018-12-03 1 site
    Other conditions: Autoimmune Epilepsy
    View official trial listing →
  • Completed NCT NCT02698982

    Optimized Anesthesia to Reduce Postoperative Cognitive Impairment in the Elderly

    Not yet reported Erasme University Hospital 41 participants Est. completion 2017-03 1 site
    Other conditions: Elderly ; Moderate Risk Surgery
    View official trial listing →
  • Completed NCT NCT02699437

    Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia

    Mohamed Sayed Abdelhafez 200 participants Est. completion 2019-12-31 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Completed NCT NCT02700854

    Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2

    Not yet reported Semmelweis University 10 participants Est. completion 2019-11 1 site
    Other conditions: Hypoxic-Ischaemic Encephalopathy, Perinatal Asphyxia, Hypocapnia
    View official trial listing →
  • Status unknown NCT NCT02701205

    Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

    Not yet reported Shanghai Celgen Bio-Pharmaceutical Co.,Ltd 216 participants Est. completion 2017-12 4 sites
    Other conditions: Plaque Psoriasis, Psoriasis
    View official trial listing →
  • Completed NCT NCT02701309

    Non-invasive Optical Detection of Iron Deficiency in Children

    Ludwig-Maximilians - University of Munich 100 participants Est. completion 2016-09 2 sites
    Other conditions: Iron Deficiency, Iron-deficiency Anemia, Child
    View official trial listing →
  • Completed NCT NCT02701582

    Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients

    Not yet reported NYU Langone Health 66 participants Est. completion 2016-09 1 site
    Other conditions: Intracranial Aneurysm, Brain Edema, Scoliosis, Surgery
    View official trial listing →
  • Completed NCT NCT02701751

    Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)

    Not yet reported University of Michigan 60 participants Est. completion 2016-10-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02701959

    Effect of Lettuce With Different Nitrate Contents on Blood Pressure

    Not yet reported, Not yet reported Newcastle University 20 participants Est. completion 2015-08 1 site
    Other conditions: Dietary Modification, Blood Pressure
    View official trial listing →
  • Completed NCT NCT02702297

    Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes

    Martin-Luther-Universität Halle-Wittenberg 57 participants Est. completion 2018-11-10 4 sites
    Other conditions: Preterm Premature Rupture of Membranes, Fetal Inflammatory Response Syndrome, Early Onset Neonatal Sepsis, Infection of Amniotic Cavity
    View official trial listing →
  • Withdrawn NCT NCT02702960

    Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2018-01-03 1 site
    Other conditions: Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant), Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02704338

    Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis

    Not yet reported, Not yet reported Nanjing Medical University 30 participants Est. completion 2018-10
    Other conditions: Autoimmune Diseases
    View official trial listing →
  • Status unknown NCT NCT02704676

    CA-125 and Severity of Pre-Eclampsia

    Ain Shams Maternity Hospital 120 participants Est. completion 2016-09
    Other conditions: Pre-Eclampsia
    View official trial listing →
  • Status unknown NCT NCT02704806

    Immunologic Analysis of Peripheral Blood and Aspirated Thromb In AMI Patients

    Jilin University 60 participants Est. completion 2018-04
    Other conditions: Immunol Feature in Circulation and Thromb in AMI Patients
    View official trial listing →
  • Withdrawn NCT NCT02705339

    Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)

    Not yet reported Washington University School of Medicine Est. completion 2020-04
    Other conditions: Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT02705417

    Maximizing Native Arteriovenous Fistulae Rates.

    Medifil AE 136 participants Est. completion 2015-01
    Other conditions: Kidney Failure, Arteriovenous Shunt, Hemodialysis
    View official trial listing →
  • Completed NCT NCT02705638

    Treatment of IgG4-Related Disease With Revlimid and Rituximab

    Not yet reported Mayo Clinic 6 participants Est. completion 2019-04 1 site
    Other conditions: Immunoglobulin G Subclass 4 Related Disease, IgG4-related Disease, Autoimmune Pancreatitis, IgG4-related Sclerosing Cholangitis, Retroperitoneal Fibrosis
    View official trial listing →
  • Completed NCT NCT02706288

    Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health

    Not yet reported Washington University School of Medicine 8 participants Est. completion 2022-12 1 site
    Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02708368

    SOP's for CKD-MBD-Biomarkers

    RWTH Aachen University 32 participants Est. completion 2017-12-01 2 sites
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT02709070

    Resection+Highly Purified CTL Versus Resection Alone for HCC

    Not yet reported Sun Yat-sen University 210 participants Est. completion 2022-03
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT02710370

    Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

    University of Pittsburgh 46 participants Est. completion 2028-08-31 1 site
    Type 2 diabetes Other conditions: Obesity, Endocrine System Diseases, Glucose Metabolism Disorders, Metabolic Diseases
    View official trial listing →
  • Completed NCT NCT02711267

    Bioequivalence of Topical Acyclovir in Healthy Volunteers

    Not yet reported Medical University of Graz 36 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Dermatologic Disorders
    View official trial listing →
  • Status unknown NCT NCT02711618

    Non-Invasive Abdominal Fat Reduction With BMI Above 28

    Not yet reported Syneron Medical 47 participants Est. completion 2017-11 3 sites
    Other conditions: Unwanted Fat
    View official trial listing →
  • Completed NCT NCT02711657

    Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease.

    Not yet reported Odense University Hospital 50 participants Est. completion 2017-04 1 site
    Other conditions: Interstitial Lung Diseases, Rheumatoid Arthritis, Asthma
    View official trial listing →
  • Status unknown NCT NCT02711722

    NAVA Unloading - Effects on Distribution of Ventilation

    Not yet reported Karolinska University Hospital 12 participants Est. completion 2016-09 1 site
    Other conditions: Acute Respiratory Failure
    View official trial listing →
  • Completed NCT NCT02711826

    Treg Therapy in Subclinical Inflammation in Kidney Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2023-08-04 6 sites
    Other conditions: Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney Donor
    View official trial listing →
  • Completed NCT NCT02713048

    Sensitive Troponin I in Out-of-hospital Cardiac Arrest

    University Medical Centre Ljubljana 159 participants Est. completion 2018-10 1 site
    Other conditions: Cardiac Arrest, Acute Coronary Lesion, Stable Obstructive Coronary Disease, Non-obstructive Coronary Disease
    View official trial listing →
  • Completed NCT NCT02713581

    IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism

    Centre Hospitalier Universitaire de Nīmes 34 participants Est. completion 2020-06-23 2 sites
    Other conditions: Venous Thromboembolism, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT02713867

    A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks

    Not yet reported Bristol-Myers Squibb 363 participants Est. completion 2022-01-18 129 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT02713997

    Anti-inflammatory Therapy to Improve Outcomes After TPIAT

    Not yet reported University of Minnesota 43 participants Est. completion 2025-05-01 1 site
    Other conditions: Pancreatitis, Chronic; Diabetes; Transplant
    View official trial listing →
  • Completed NCT NCT02716571

    Recruiting Blood Donor With Allogeneic Natural Killer Cell

    Not yet reported Seoul National University Hospital 90 participants Est. completion 2017-07-27 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02717533

    Blood Volume Analysis and Renal Outcomes in Hemodialysis

    VA New York Harbor Healthcare System 12 participants Est. completion 2015-01 1 site
    Other conditions: End Stage Renal Failure on Dialysis, Actual Impaired Fluid Volume, Kidney Failure
    View official trial listing →
  • Completed NCT NCT02718573

    Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood

    Icahn School of Medicine at Mount Sinai 74 participants Est. completion 2017-12-11 1 site
    Other conditions: Hepatitis C, HCV, Liver Transplant
    View official trial listing →
  • Completed NCT NCT02718703

    Project EV Minus Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation

    Not yet reported LifeScan 34 participants Est. completion 2015-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02719951

    Glutaminergic Transmission in Autism : Molecular Imaging Exploration

    Not yet reported University Hospital, Tours 27 participants Est. completion 2019-05 1 site
    Other conditions: Autism, Fragile-X Syndrome (FXS), Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02721433

    4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases

    Not yet reported Ottawa Hospital Research Institute 263 participants Est. completion 2020-04 1 site
    Other conditions: Breast Cancer, Prostate Cancer, Metastasis
    View official trial listing →
  • Terminated NCT NCT02722304

    Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency

    Not yet reported Baxalta now part of Shire 7 participants Est. completion 2018-09-14 17 sites
    Other conditions: Chronic Obstructive Pulmonary Disease, Alpha1-antitrypsin Deficiency
    View official trial listing →
  • Completed NCT NCT02722668

    UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    Not yet reported Masonic Cancer Center, University of Minnesota 15 participants Est. completion 2024-02-22 1 site
    Other conditions: Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Burkitt's Lymphoma, Natural Killer Cell Malignancies, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, Large-cell Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Relapsed Chronic Lymphocytic Leukemia, Relapsed Small Lymphocytic Lymphoma, Marginal Zone B-cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-cell Lymphoma, Prolymphocytic Leukemia, Bone Marrow Failure Syndromes, Myeloproliferative Neoplasms/Myelofibrosis, Biphenotypic/Undifferentiated/Prolymphocytic Leukemias, MRD Positive Leukemia, Leukemia or MDS in Aplasia, Relapsed T-Cell Lymphoma, Relapsed Multiple Myeloma, Plasma Cell Leukemia
    View official trial listing →
  • Status unknown NCT NCT02722694

    A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

    Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 360 participants Est. completion 2017-12 1 site
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Completed NCT NCT02724488

    Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

    University Health Network, Toronto 14 participants Est. completion 2026-01
    Other conditions: Head and Neck Cancer, Melanoma
    View official trial listing →
  • Status unknown NCT NCT02725502

    Incretin Axis in Type 1 Diabetes Mellitus

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 20 participants Est. completion 2016-05 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02726620

    Decision Support for Intraoperative Low Blood Pressure

    Not yet reported Vanderbilt University Medical Center 22435 participants Est. completion 2018-12-29 1 site
    Other conditions: Hypotension
    View official trial listing →
  • Active, not recruiting NCT NCT02726997

    Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2027-12-31 1 site
    Other conditions: Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7, Stage IIIA Fallopian Tube Cancer AJCC v7, Stage IIIA Ovarian Cancer AJCC v6 and v7, Stage IIIA Primary Peritoneal Cancer AJCC v7, Stage IIIB Fallopian Tube Cancer AJCC v7, Stage IIIB Ovarian Cancer AJCC v6 and v7, Stage IIIB Primary Peritoneal Cancer AJCC v7, Stage IIIC Fallopian Tube Cancer AJCC v7, Stage IIIC Ovarian Cancer AJCC v6 and v7, Stage IIIC Primary Peritoneal Cancer AJCC v7, Stage IV Fallopian Tube Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Primary Peritoneal Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT02727725

    An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images

    Not yet reported Wake Forest University Health Sciences 100 participants Est. completion 2018-01-15 1 site
    Cardiovascular disease Other conditions: Myocardial Fibrosis
    View official trial listing →
  • Completed NCT NCT02727868

    Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans

    Not yet reported Assistance Publique Hopitaux De Marseille 30 participants Est. completion 2017-06-02 1 site
    Other conditions: Patient With Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02727946

    Tissue Perfusion Indices as Predictor of Outcome in Poly Trauma Patients

    Not yet reported Assiut University 40 participants Est. completion 2018-01 1 site
    Other conditions: Multiple Trauma
    View official trial listing →
  • Withdrawn NCT NCT02728154

    The Role of Gut Microbiota in Heart Failure and Pre-Heart Failure With Preserved Ejection Fraction

    University of Florida Est. completion 2025-06-08 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT02729077

    Risk Factors for Post-Operative Respiratory Complications in Patients at Risk for OSA

    Ohio State University 324 participants Est. completion 2021-02-04 1 site
    Other conditions: Respiratory Complications
    View official trial listing →
  • Completed NCT NCT02729896

    A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

    Not yet reported, Not yet reported Hoffmann-La Roche 36 participants Est. completion 2019-10-07 19 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT02730585

    Diagnostic Performance of C Reactive Protein and Delta CRP in Acute Appendicitis

    University of Monastir 500 participants Est. completion 2013-12 1 site
    Other conditions: Appendicitis
    View official trial listing →
  • Completed NCT NCT02731755

    Phenolic-rich Oats and Artery Improvement

    Not yet reported University of Reading 18 participants Est. completion 2016-11 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02732795

    Sleep Apnea and Obesity Affects on Morphine Pharmacokinetics

    Not yet reported Johns Hopkins University 43 participants Est. completion 2018-09-07 1 site
    Other conditions: Pediatric Sleep Apnea, Obesity, Morphine Metabolism
    View official trial listing →
  • Completed NCT NCT02733042

    A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia

    Not yet reported, Not yet reported Celgene 106 participants Est. completion 2022-08-21 66 sites
    Other conditions: Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell
    View official trial listing →
  • Active, not recruiting NCT NCT02734602

    Imaging SV2A in Mood Disorders

    Not yet reported Yale University 130 participants Est. completion 2027-03 1 site
    Other conditions: Major Depressive Disorder, Post-Traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT02734641

    Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone

    HaEmek Medical Center, Israel 111 participants Est. completion 2018-04-17 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT02735486

    Acute Effects of Ginger Extract Consumption on Risk Markers of Cardiovascular Disease

    Not yet reported University of Reading 22 participants Est. completion 2014-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02736006

    Decreases in Diffusing Lung Capacity for Carbon Monoxide (DLCO) in Occupational Divers and Their Impact on Decompression Sickness Risks

    Not yet reported University Hospital, Brest 16 participants Est. completion 2017-05-30 1 site Stand-alone
    Other conditions: Decompression Sickness
    View official trial listing →
  • Completed NCT NCT02736032

    Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

    Not yet reported Cairo University 310 participants Est. completion 2018-05 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02738073

    Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture

    Not yet reported Rothman Institute Orthopaedics 1 site
    Other conditions: Hip Fracture
    View official trial listing →
  • Completed NCT NCT02738970

    A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

    Not yet reported Hoffmann-La Roche 88 participants Est. completion 2018-05-31 2 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT02740595

    E-cigarettes and Blood Vessel Function

    Not yet reported University of California, Los Angeles 148 participants Est. completion 2022-12-01 1 site
    Other conditions: Nicotine Dependence
    View official trial listing →
  • Terminated NCT NCT02741050

    Primary Care-Based Physical Activity for Diabetic Latinas

    Not yet reported University of California, San Diego 25 participants Est. completion 2019-10 1 site
    Other conditions: Diabetes, Sedentary Lifestyle
    View official trial listing →
  • Completed NCT NCT02741336

    Electrophysiologic Changes in Blacks Treated With CBT for Insomnia

    Not yet reported State University of New York - Downstate Medical Center 10 participants Est. completion 2017-06 1 site
    Other conditions: Insomnia
    View official trial listing →
  • Completed NCT NCT02741388

    A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP

    Not yet reported The Lymphoma Academic Research Organisation 39 participants Est. completion 2021-09-29 8 sites
    Other conditions: B-cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02741609

    A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease

    Not yet reported Advanced Laboratory Services, Inc. 218 participants Est. completion 2018-01 16 sites Stand-alone
    Other conditions: Lyme Disease
    View official trial listing →
  • Completed NCT NCT02741648

    RBC Irradiation, Anemia and Gut Injury

    Emory University 324 participants Est. completion 2026-02-19 3 sites
    Other conditions: Anemia, Necrotizing Enterocolitis
    View official trial listing →
  • Completed NCT NCT02741739

    Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects

    Not yet reported Regeneron Pharmaceuticals 28 participants Est. completion 2016-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02742285

    Lumefantrine in Venous Plasma Versus Dried Capillary Blood Spot

    Not yet reported Thierry Buclin 16 participants Est. completion 2016-09 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT02742402

    DIAgnostic iMaging or Observation in Early Equivocal appeNDicitis

    Not yet reported Helsinki University Central Hospital 185 participants Est. completion 2021-04-30 1 site
    Other conditions: Appendicitis
    View official trial listing →
  • Terminated NCT NCT02743078

    Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

    Not yet reported RTOG Foundation, Inc. 3 participants Est. completion 2019-10-15 11 sites
    Obstructive sleep apnea Other conditions: Glioblastoma, Glioma
    View official trial listing →
  • Completed NCT NCT02743130

    Effects of Berry Nectars Sweetened With Inverted Sugar on Post-meal Blood Sugar

    Not yet reported University of Eastern Finland 18 participants Est. completion 2014-11 1 site
    Other conditions: Hyperglycemia, Postprandial
    View official trial listing →
  • Completed NCT NCT02743351

    Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

    Not yet reported, Not yet reported Fate Therapeutics 96 participants Est. completion 2021-11-05 15 sites
    Other conditions: Hematologic Malignancies, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Acute Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT02743390

    Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

    Not yet reported University of Campinas, Brazil 10 participants Est. completion 2017-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02747108

    ForgIng New Paths to Prevent DIabeTes (FINDIT)

    Not yet reported VA Office of Research and Development 315 participants Est. completion 2020-03-30 1 site
    Prediabetes
    View official trial listing →
  • Status unknown NCT NCT02747563

    Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

    Not yet reported Kaplan Medical Center 60 participants Est. completion 2017-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02747680

    Cerebral Responses to Insulin Induced Hypoglycemia

    Not yet reported University of Minnesota 266 participants Est. completion 2020-12 1 site
    Other conditions: Type 1 Diabetes, Healthy, Hypoglycemia Unawareness
    View official trial listing →
  • Completed NCT NCT02748928

    UltraShape Power for Abdominal Fat and Circumference Reduction

    Not yet reported Syneron Medical 62 participants Est. completion 2018-04-23 8 sites
    Other conditions: Excess Abdominal Fat
    View official trial listing →
  • Completed NCT NCT02750293

    The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors

    Not yet reported University of Tromso 411 participants Est. completion 2017-09 1 site
    Other conditions: Vitamin D Deficiency
    View official trial listing →
  • Status unknown NCT NCT02750969

    Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment

    Not yet reported HaEmek Medical Center, Israel 58 participants Est. completion 2019-02 1 site
    Other conditions: Tinnitus
    View official trial listing →
  • Completed NCT NCT02752308

    Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair

    Not yet reported, Not yet reported Isfahan University of Medical Sciences 60 participants Est. completion 2015-03
    Other conditions: Hypospadias
    View official trial listing →
  • Terminated NCT NCT02752607

    Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots

    Dr. Vicky Tagalakis 52 participants Est. completion 2018-11-09 7 sites
    Other conditions: Deep Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT02752672

    Study on the Therapeutic Mechanisms of Dithranol Treatment in Patients With Chronic Plaque Psoriasis

    Medical University of Graz 27 participants Est. completion 2016-11 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT02753647

    Chidamide Plus R-CHOP in Elderly DLBCL

    Not yet reported Ruijin Hospital 49 participants Est. completion 2019-04 1 site
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02753816

    TXA Study in Major Burn Surgery

    Not yet reported Corewell Health West 25 participants Est. completion 2019-12-03 1 site
    Other conditions: Tranexamic Acid, Burn, Major Surgery
    View official trial listing →
  • Active, not recruiting NCT NCT02754037

    Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study

    University of California, Davis 120 participants Est. completion 2026-06-30 1 site
    MASLDMASH
    View official trial listing →
  • Withdrawn NCT NCT02754362

    A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

    Not yet reported NYU Langone Health Est. completion 2019-06 1 site
    Other conditions: Glioblastoma, Glioma
    View official trial listing →
  • Completed NCT NCT02755376

    Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell

    Not yet reported Samsung Medical Center 30 participants Est. completion 2018-12-01 1 site
    Other conditions: Deficiency of Anterior Cruciate Ligament
    View official trial listing →
  • Completed NCT NCT02755909

    The Effect of Pre-anesthetic Education on Cardiac Surgery Patients' Anxiety Level

    Not yet reported Universitas Indonesia 36 participants Est. completion 2016-03
    Other conditions: Cardiac Surgery Patients
    View official trial listing →
  • Completed NCT NCT02756754

    Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

    Not yet reported University Hospital, Toulouse 31 participants Est. completion 2019-05-10 2 sites
    Other conditions: Primary Aldosteronism, Adrenal Adenoma
    View official trial listing →
  • Status unknown NCT NCT02757118

    Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Cardiac Surgery

    Not yet reported Konkuk University Medical Center 30 participants Est. completion 2017-01
    Other conditions: Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT02757456

    Exercise and Vascular Parameters in Hemodialysis

    Not yet reported Sameena Iqbal 21 participants Est. completion 2016-02 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02758678

    Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients

    Science and Technology Park, Center of Innovation Technologies for Human Health 40 participants Est. completion 2016-10 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT02759887

    Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)

    Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 19 participants Est. completion 2018-12 1 site
    Other conditions: Down Syndrome, Alzheimer's Dementia
    View official trial listing →
  • Completed NCT NCT02761122

    Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)

    Not yet reported Institut Pasteur 21 participants Est. completion 2018-04-16 3 sites
    Other conditions: Lichen Planus
    View official trial listing →
  • Completed NCT NCT02761577

    A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia

    Not yet reported Clinical Hospital Centre Zagreb 90 participants Est. completion 2016-04
    Other conditions: Kidney Diseases, Contrast Media Reaction
    View official trial listing →
  • Completed NCT NCT02762370

    Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes

    Not yet reported Pacira Pharmaceuticals, Inc 33 participants Est. completion 2016-11 8 sites
    OsteoarthritisType 2 diabetes
    View official trial listing →
  • Completed NCT NCT02765607

    Circulatory Oscillations in Post Cardiac Surgery Patients

    St. Olavs Hospital 20 participants Est. completion 2017-12 1 site
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT02765945

    Exercise as an Modulator of Immunological Risk Factors for Osteoporosis

    Not yet reported East Tennessee State University 43 participants Est. completion 1998-04 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT02766322

    Alcohol and Bariatric Surgery

    University of Illinois at Urbana-Champaign 54 participants Est. completion 2022-05-25 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02766439

    Rhupus Syndrome and Efficacy of Etanercept Treatment

    Yang Beibei 6 participants Est. completion 2015-03
    Other conditions: Rhupus Syndrome, Etanercept
    View official trial listing →
  • Withdrawn NCT NCT02767024

    Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure

    Not yet reported Montefiore Medical Center Est. completion 2018-06-01 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02767674

    Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 258 participants Est. completion 2020-12 6 sites
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02768688

    MRI of Glymphatic Clearance During Anesthetic Sedation

    Not yet reported University of Pennsylvania 17 participants Est. completion 2017-12 1 site
    Other conditions: Glymphatic Flow
    View official trial listing →
  • Completed NCT NCT02770092

    CHF COPD Sip Feed Anabolic Response

    Not yet reported Texas A&M University 90 participants Est. completion 2018-05-15 1 site
    Heart failure Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02770222

    A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects

    Not yet reported Actelion 40 participants Est. completion 2016-07
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02770534

    Evaluating Thromboelastography (TEG) and ETP in Sickle Adults

    Guy's and St Thomas' NHS Foundation Trust 100 participants Est. completion 2016-06 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02771366

    The Efficient Brain Study

    Not yet reported University of Florida 30 participants Est. completion 2018-07-27 1 site
    Other conditions: Metabolism - Cerebral Energy
    View official trial listing →
  • Completed NCT NCT02771808

    Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients

    University of Virginia 83 participants Est. completion 2015-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT02772575

    A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

    Memorial Sloan Kettering Cancer Center 1 site
    Other conditions: Liver Cancer, Liver Metastases
    View official trial listing →
  • Status unknown NCT NCT02772822

    A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients

    Not yet reported Sinocelltech Ltd. 330 participants Est. completion 2019-12 1 site
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02772835

    nHFOV vs nCPAP: Effects on Gas Exchange for the Treatment of Neonates Recovering From RDS

    Not yet reported Fondazione Poliambulanza Istituto Ospedaliero 30 participants Est. completion 2017-05 8 sites
    Other conditions: Respiratory Distress Syndrome, Preterm Birth
    View official trial listing →
  • Completed NCT NCT02774226

    Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease

    Not yet reported Augusta University 15 participants Est. completion 2018-07-30 1 site Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Active, not recruiting NCT NCT02775851

    Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 57 participants Est. completion 2027-05-15 280 sites
    Other conditions: Desmoplastic Melanoma
    View official trial listing →
  • Status unknown NCT NCT02776020

    Non-invasive, Real-time Anesthetic Drug-monitoring System

    Rambam Health Care Campus 30 participants Est. completion 2017-02
    Other conditions: Anesthesia
    View official trial listing →
  • Completed NCT NCT02776683

    Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

    Not yet reported Boehringer Ingelheim 123 participants Est. completion 2018-10-03 46 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02777099

    Impact of Remote Ischemic Postconditioning on Autonomic Function in Stroke Patients

    Not yet reported Guangzhou University of Traditional Chinese Medicine 150 participants Est. completion 2018-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02777424

    CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients

    Not yet reported Fondation Ophtalmologique Adolphe de Rothschild 18 participants Est. completion 2019-03-27 4 sites
    Other conditions: Intracranial Hemorrhages
    View official trial listing →
  • Status unknown NCT NCT02777840

    High Flow Oxygen With THRIVE Gives Better Oxygenation in Rapid Sequence Induction Patients

    Not yet reported St George's, University of London 80 participants Est. completion 2018-03 1 site
    Other conditions: High Flow Oxygen in Rapid Sequence Induction, Airway Morbidity
    View official trial listing →
  • Completed NCT NCT02778542

    Bidirectional Text Messaging for Measurement and Motivation of Medication Adherence in Hypertension, a Pilot Study

    Not yet reported University of Pennsylvania 150 participants Est. completion 2017-11-07
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02780245

    Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section

    Not yet reported Talkha Central Hospital 100 participants Est. completion 2016-09 1 site
    Other conditions: Hemorrhage of Cesarean Section and/or Perineal Wound, Postpartum Hemorrhage, Uterine Atony
    View official trial listing →
  • Completed NCT NCT02783482

    Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency

    Not yet reported Green Cross Corporation 49 participants Est. completion 2019-07 20 sites
    Other conditions: Immunologic Deficiency Syndromes
    View official trial listing →
  • Terminated NCT NCT02783716

    Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure

    Not yet reported Mayo Clinic 45 participants Est. completion 2021-07-20 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT02783833

    MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

    Not yet reported, Not yet reported Medicines for Malaria Venture 15 participants Est. completion 2017-01-16 1 site
    Other conditions: Malaria
    View official trial listing →
  • Status unknown NCT NCT02784301

    Evaluation of a Biofeedback Tool to Minimize Procedural Pain and Anxiety in Children

    Not yet reported British Columbia Children's Hospital 300 participants Est. completion 2016-12 1 site
    Other conditions: Pain, Anxiety
    View official trial listing →
  • Status unknown NCT NCT02784886

    Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta

    University Hospital, Angers 63 participants Est. completion 2016-11 1 site
    Other conditions: Morbidly Adherent Placenta, Placenta Accreta, Placenta Increta, Placenta Percreta
    View official trial listing →
  • Completed NCT NCT02784990

    Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions

    Centre Hospitalier Universitaire Dijon 770 participants Est. completion 2020-11-03 10 sites
    Other conditions: Pancreatic Fistula
    View official trial listing →
  • Status unknown NCT NCT02786875

    Diet, Exercise and Vitamin D in Breast Cancer Recurrence

    Not yet reported National Cancer Institute, Naples 506 participants Est. completion 2023-12-15 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02789007

    Effects of Parabolic Flight on Spatial Cognition and Hippocampal Plasticity

    Not yet reported University Hospital, Caen 24 participants Est. completion 2019-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02789904

    Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emergency Department

    National Heart Centre Singapore 1200 participants Est. completion 2017-11-01 1 site
    Other conditions: Chest Pain
    View official trial listing →
  • Completed NCT NCT02790281

    A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

    Ferring Pharmaceuticals 33 participants Est. completion 2015-08 2 sites
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT02791204

    SPECT/CT Imaging of Skeletal Muscle Perfusion

    Yale University 34 participants Est. completion 2026-01-30 1 site
    Other conditions: Peripheral Arterial Disease, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02791568

    Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation

    University of Wisconsin, Madison 121 participants Est. completion 2020-07-31 2 sites
    Other conditions: Pregnancy, Obesity, Preeclampsia
    View official trial listing →
  • Active, not recruiting NCT NCT02792114

    T-Cell Therapy for Advanced Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 186 participants Est. completion 2027-06 7 sites
    Other conditions: Breast Cancer, Metastatic HER2-negative Breast
    View official trial listing →
  • Completed NCT NCT02792387

    The Role of CVP and EF in Patients With Cardio-renal Syndromes

    Tbilisi State University 11 participants Est. completion 2017-01
    Heart failure
    View official trial listing →
  • Completed NCT NCT02792751

    Does the Use of Bispectral Index Reduce the Oxidative Stress in Endoscopic Retrograde Cholangiopancreatography?

    Not yet reported Antalya Training and Research Hospital 50 participants Est. completion 2015-10
    Other conditions: Oxidative Stress
    View official trial listing →
  • Status unknown NCT NCT02793427

    Patient With Any Pathology (According to the Appreciation of the Investigator) Which Could Disturb the Participation in the Study

    Not yet reported CHU de Reims 160 participants 1 site
    Other conditions: Type 1 Diabetes in Children
    View official trial listing →
  • Withdrawn NCT NCT02793531

    Anabolic Response Cancer

    Not yet reported Texas A&M University Est. completion 2019-05 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02794688

    Ductal Lavage in Non-lactating Female Women With Mastitis

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32 participants Est. completion 2019-06-05 1 site
    Other conditions: Mastitis
    View official trial listing →
  • Completed NCT NCT02795403

    HCV Virions Bound Proteins

    Not yet reported Hospices Civils de Lyon 10 participants Est. completion 2015-07 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02797119

    Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery

    Not yet reported University Hospital, Lille 225 participants Est. completion 2021-04-15 5 sites
    Other conditions: Pregnancy Complications, Hemorrhage
    View official trial listing →
  • Terminated NCT NCT02798003

    Food Reward in Cachexia Induced by Acute or Chronic Disease

    Maastricht University Medical Center 44 participants Est. completion 2022-02-18 1 site
    Other conditions: Cachexia, Chronic Obstructive Pulmonary Disease, Non-small Cell Lung Cancer, Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT02798497

    Panton Valentine Leucocidin

    Not yet reported Hospices Civils de Lyon 234 participants Est. completion 2016-12-21 1 site
    Other conditions: Staphylococcus Aureus Pneumonias
    View official trial listing →
  • Completed NCT NCT02798523

    Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 33 participants Est. completion 2022-11-14 1 site
    Other conditions: Normal Physiology
    View official trial listing →
  • Completed NCT NCT02798549

    HBV Virions Bound Proteins

    Not yet reported Hospices Civils de Lyon 14 participants Est. completion 2018-08 1 site
    Other conditions: Hepatitis B Virus Infection
    View official trial listing →
  • Terminated NCT NCT02801162

    Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard

    Not yet reported Universitair Ziekenhuis Brussel 20 participants Est. completion 2017-04 1 site
    Other conditions: Hypoxia, Hypercapnia, Anaemia
    View official trial listing →
  • Completed NCT NCT02801552

    Regenerative Endodontic Procedure of Immature Permanent Teeth With Apical Periodontitis Using PRF

    Not yet reported Fujian Medical University 60 participants Est. completion 2020-02 1 site
    Other conditions: Periapical Periodontitis, Tooth Diseases, Stomatognathic Diseases
    View official trial listing →
  • Completed NCT NCT02802943

    iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL

    Not yet reported University Hospital Tuebingen 56 participants Est. completion 2022-11-18 5 sites
    Other conditions: Leukemia, Chronic Lymphatic
    View official trial listing →
  • Completed NCT NCT02803203

    Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 49 participants Est. completion 2022-03-01 7 sites
    Other conditions: Non-small Cell Lung Cancer, EGFR-mutant Lung Cancers
    View official trial listing →
  • Completed NCT NCT02803554

    Young Donor Plasma Transfusion and Age-Related Biomarkers

    Not yet reported Ambrosia LLC 200 participants Est. completion 2018-01-15
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT02808663

    Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis

    Not yet reported CHU de Reims 6 participants Est. completion 2017-02-01 1 site
    Other conditions: Severe Alcoholic Hepatitis
    View official trial listing →
  • Completed NCT NCT02809807

    Gas Mask and Chronic Obstructive Pulmonary Disease (COPD): New Understanding on the Respiratory Index Impact?

    Not yet reported Laval University 9 participants Est. completion 2016-07 1 site
    Other conditions: Work of Breathing
    View official trial listing →
  • Completed NCT NCT02810418

    Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

    Not yet reported, Not yet reported National Cancer Institute (NCI) 40 participants Est. completion 2021-06-22 1 site
    Other conditions: Neoplasms, Pancreatic Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT02810522

    OneTouch Select® [Brand Name]Plus Blood Glucose Monitoring System(BGMS) Registration Study

    Not yet reported Johnson & Johnson Medical, China Est. completion 2017-03-31
    Other conditions: Blood Glucose Measurement
    View official trial listing →
  • Status unknown NCT NCT02812121

    UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure

    Not yet reported Sun Yat-sen University 261 participants Est. completion 2018-06
    Other conditions: Liver Failure
    View official trial listing →
  • Completed NCT NCT02812446

    Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development

    Nantes University Hospital 88 participants Est. completion 2013-12 1 site
    Other conditions: Staphylococcal Infection
    View official trial listing →
  • Completed NCT NCT02812680

    The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma

    University Health Network, Toronto 84 participants Est. completion 2020-11 1 site
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT02813343

    Evaluate the Value of Telehomecare for Diabetes

    Not yet reported Women's College Hospital 221 participants Est. completion 2017-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02813473

    SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease

    ECRI bv 223 participants Est. completion 2018-03-26 6 sites
    Cardiovascular disease Other conditions: Heart Diseases
    View official trial listing →
  • Completed NCT NCT02814929

    Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey

    Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital 6115 participants Est. completion 2017-10-17 1 site
    Other conditions: Retinopathy of Prematurity
    View official trial listing →
  • Active, not recruiting NCT NCT02817633

    A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

    Not yet reported Tesaro, Inc. 463 participants Est. completion 2027-03-01 89 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02818829

    Biological and Clinical Database for Pancreatic Adenocarcinoma

    University Hospital, Toulouse 1700 participants Est. completion 2029-01 16 sites
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02819128

    Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.

    Not yet reported Assistance Publique Hopitaux De Marseille 722 participants Est. completion 2022-10-26 1 site
    Other conditions: Endemic and Emerging Diseases in Populations of Homeless
    View official trial listing →
  • Completed NCT NCT02819206

    Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs

    Not yet reported Assistance Publique Hopitaux De Marseille 225 participants Est. completion 2022-10-26 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT02819960

    Prevention of Irinotecan Induced Diarrhea by Probiotics

    Not yet reported S&D Pharma SK s.r.o. 233 participants Est. completion 2022-11 1 site
    Other conditions: Diarrhea, Cancer
    View official trial listing →
  • Completed NCT NCT02821702

    Fertility Post Placenta Accrete

    Not yet reported Sheba Medical Center 135 participants Est. completion 2019-12 1 site
    Other conditions: Fertility
    View official trial listing →
  • Completed NCT NCT02822911

    Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly

    Not yet reported Groupe Hospitalier de la Region de Mulhouse et Sud Alsace 194 participants Est. completion 2016-10 2 sites
    Other conditions: Alcohol Abuse
    View official trial listing →
  • Completed NCT NCT02822924

    Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

    Not yet reported Chinese University of Hong Kong 82 participants Est. completion 2021-03-10 1 site
    Other conditions: Benign Prostate Hyperplasia
    View official trial listing →
  • Completed NCT NCT02823886

    Inflammatory Response in Myocardial Infarction Evaluated by MRI and Biomarkers

    Not yet reported Hospices Civils de Lyon 21 participants Est. completion 2017-07-10 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02824406

    Cerebrovascular Reserve Measurements in Sickle Cell Disease

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60 participants Est. completion 2017-12 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02826499

    Comparison of the Malposition Rates of the Vertebral Pedicle Screws Using the PediGuard Technique: PediGuard Technique Associated With Fluoroscopy and Fluoroscopy Alone

    Not yet reported Brugmann University Hospital 20 participants Est. completion 2017-07 1 site
    Other conditions: Pedicular Screwing
    View official trial listing →
  • Status unknown NCT NCT02827032

    Controlling and Lowering Blood Pressure With the MobiusHD™

    Not yet reported Vascular Dynamics, Inc. 200 participants Est. completion 2026-06 22 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02827227

    Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)

    Hospices Civils de Lyon 99 participants Est. completion 2016-02 1 site
    Other conditions: HIV-infected Patients
    View official trial listing →
  • Terminated NCT NCT02827838

    Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

    Not yet reported Wake Forest University Health Sciences 17 participants Est. completion 2022-04-22 1 site
    Other conditions: Human Papillomavirus Infection, Stage I Oral Cavity Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma, Stage II Oropharyngeal Squamous Cell Carcinoma, Stage III Oral Cavity Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma, Stage IVA Oral Cavity Squamous Cell Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Oral Cavity Squamous Cell Carcinoma, Stage IVB Oropharyngeal Squamous Cell Carcinoma, Stage IVC Oropharyngeal Squamous Cell Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT02827877

    Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer

    Not yet reported City of Hope Medical Center 18 participants Est. completion 2026-09-25 1 site
    Other conditions: HER2 Positive Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Completed NCT NCT02828436

    Spinal Cord Stimulation to Treat Hypertension

    Not yet reported University of Minnesota 9 participants Est. completion 2019-09-01 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02828852

    Study of the Platelet Function During the Last Month of Pregnancy

    Not yet reported University Hospital, Toulouse 60 participants Est. completion 2016-07 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Status unknown NCT NCT02828878

    Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

    Not yet reported, Not yet reported Cellect Biotechnology 12 participants Est. completion 2020-07 2 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Status unknown NCT NCT02829008

    Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 120 participants Est. completion 2020-04 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02829931

    Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 33 participants Est. completion 2022-11-22 2 sites
    Other conditions: Malignant Glioma
    View official trial listing →
  • Terminated NCT NCT02830087

    Tourniquet Pressure in Primary Total Knee Arthroplasty

    Not yet reported Wake Forest University Health Sciences 21 participants Est. completion 2016-09-20 2 sites
    Other conditions: Tourniquets, Knee Arthroplasty, Total, Knee Replacement, Total
    View official trial listing →
  • Completed NCT NCT02830191

    Therapeutic Drug Monitoring (TDM) of Cyclosporine in Kidney Transplant Patients by Dried Blood Spot Assay. Interest and Feasibility.

    University Hospital, Caen 22 participants Est. completion 2015-07
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02831374

    Effectiveness of Platelet Rich Plasma in Wound Healing

    Not yet reported Linyi People's Hospital 40 participants Est. completion 2016-03
    Other conditions: Impacted Third Molar Tooth
    View official trial listing →
  • Withdrawn NCT NCT02831491

    A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer

    Not yet reported Eli Lilly and Company Est. completion 2018-01
    Other conditions: Stage IV Non-small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT02831933

    Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma

    Not yet reported Eric Bernicker, MD 11 participants Est. completion 2020-11-05 1 site
    Other conditions: Lung Squamous Cell Carcinoma Stage IV, Nonsquamous Nonsmall Cell Neoplasm of Lung, Metastatic Uveal Melanoma
    View official trial listing →
  • Withdrawn NCT NCT02832050

    PLAY Therapy Intervention: Re-Modelling Patient Experience (The PLAYTIME Study)

    Not yet reported Alder Hey Children's NHS Foundation Trust Est. completion 2019-09-30 1 site
    Other conditions: Pain, Anxiety, Rheumatology
    View official trial listing →
  • Active, not recruiting NCT NCT02833064

    Biomarkers in Liver Failure

    University of Edinburgh 200 participants Est. completion 2026-11-30
    Other conditions: Acute Liver Failure, Acute Liver Injury, Acute on Chronic Hepatic Failure
    View official trial listing →
  • Completed NCT NCT02833090

    The Plasma Serotonin and Aortic Stenosis: a Pilot Study.

    Not yet reported University Hospital, Toulouse 52 participants Est. completion 2012-09 1 site
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT02834000

    Haemodynamic Response to General Anaesthesia in Healthy Orthopaedic Patients

    Not yet reported Chelsea and Westminster NHS Foundation Trust 40 participants Est. completion 2014-11
    Other conditions: Hypotension
    View official trial listing →
  • Status unknown NCT NCT02834468

    DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients

    Not yet reported Shandong University 100 participants Est. completion 2018-12 1 site
    Other conditions: Immune Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT02835534

    The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI

    Not yet reported CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. 818 participants Est. completion 2020-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02835716

    Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO

    Millennium Magnetic Technologies, LLC 150 participants Est. completion 2020-09 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT02836782

    HIV-DNA Dynamics in HIV Monoinfected or HIV/HCV Coinfected Patients

    Catholic University of the Sacred Heart 600 participants Est. completion 2025-04 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02837705

    Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers

    University of Zurich 213 participants Est. completion 2019-03-01 7 sites
    Other conditions: Prion Diseases
    View official trial listing →
  • Completed NCT NCT02840058

    Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1

    Not yet reported Centre Hospitalier Universitaire de Besancon 295 participants Est. completion 2025-07-15 4 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02840448

    Impact of Elastin Mediated Vascular Stiffness on End Organs

    National Heart, Lung, and Blood Institute (NHLBI) 159 participants Est. completion 2024-04-06 2 sites
    Cardiovascular disease Other conditions: Williams Syndrome, Supravalvular Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT02841111

    Old Red Blood Cell In Renal Transplantation

    Centre Hospitalier Universitaire de Besancon 12000 participants Est. completion 2008-12
    Other conditions: Disorder Related to Renal Transplantation, Transfusion Reaction
    View official trial listing →
  • Terminated NCT NCT02841358

    Screening of Niemann-Pick Disease, Type C in a Psychiatric Population

    Not yet reported University Hospital, Grenoble 22 participants Est. completion 2016-12 1 site
    Other conditions: Psychiatric Adults Patients
    View official trial listing →
  • Completed NCT NCT02842320

    Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)

    Not yet reported Centre Hospitalier Universitaire de Besancon 53 participants Est. completion 2020-07-15 4 sites
    Other conditions: Chronic Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT02842580

    De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer

    Not yet reported Federation Francophone de Cancerologie Digestive 21 participants Est. completion 2020-10 11 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02843334

    Study of the Prevalence of Fabry Disease in French Dialysis Patients

    Hospices Civils de Lyon 6000 participants Est. completion 2017-05 5 sites
    Other conditions: Fabry Disease, End Stage Renal Disease, Renal Dialysis
    View official trial listing →
  • Status unknown NCT NCT02843347

    STRIDE Biorepository

    Emory University 200 participants Est. completion 2023-07 40 sites
    Other conditions: Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT02843815

    Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported Fuda Cancer Hospital, Guangzhou 30 participants Est. completion 2019-07-01 1 site
    Other conditions: Non-small Cell Lung Cancer Metastatic
    View official trial listing →
  • Terminated NCT NCT02844907

    Regulation of Insulin Secretion by the GLP-1 Receptor

    Not yet reported VA Office of Research and Development 6 participants Est. completion 2021-12-31 1 site
    Other conditions: Insulin Secretion
    View official trial listing →
  • Completed NCT NCT02845310

    The Effect of Intraoperative Goal Directed Restricted Fluid Therapy on Extravascular Lung Water

    Not yet reported Cairo University 56 participants Est. completion 2017-06 1 site
    Other conditions: Surgery
    View official trial listing →
  • Completed NCT NCT02845557

    Glucose Homeostasis and Incretin Effect T2DM in the Youth- a Study of the Malaysian Population

    RCSI & UCD Malaysia Campus 48 participants Est. completion 2014-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02845921

    Comparison of Leg Elevation and Leg Wrapping in the Prevention of Propofol Induced Hypotension

    Not yet reported Nitte University 150 participants Est. completion 2017-12 1 site
    Other conditions: Propofol Induced Hypotension
    View official trial listing →
  • Status unknown NCT NCT02846207

    Yiqi Huoxue Demolition and Recipes on Recovery Stage of Cerebral Infarction

    Not yet reported Dongfang Hospital Beijing University of Chinese Medicine 360 participants Est. completion 2019-12 3 sites
    Other conditions: Cerebral Infarction
    View official trial listing →
  • Status unknown NCT NCT02848417

    Glutathione vs. Curcumin Clinical Trial

    Not yet reported, Not yet reported South Florida Veterans Affairs Foundation for Research and Education 75 participants Est. completion 2020-08 1 site
    Other conditions: Gulf War Syndrome
    View official trial listing →
  • Completed NCT NCT02849314

    Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

    Not yet reported, Not yet reported Fuda Cancer Hospital, Guangzhou 30 participants Est. completion 2019-07-01 1 site
    Other conditions: Recurrent Laryngeal Cancer
    View official trial listing →
  • Completed NCT NCT02849392

    Effects of Pistachio Consumption on Body Composition and Blood and Bone Indicators

    Not yet reported California State Polytechnic University, Pomona 60 participants Est. completion 2014-09
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02849704

    Fat Malabsorption in Chronic Pancreatitis

    Not yet reported Children's Hospital of Philadelphia 48 participants Est. completion 2017-11-01 1 site
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Completed NCT NCT02851134

    Search for New Genetic Mutations Major Effect in Crohn's Disease

    University Hospital, Lille 20 participants Est. completion 2018-04 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT02851602

    Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome

    Not yet reported Centre Hospitalier Universitaire Dijon 89 participants Est. completion 2016-11-14 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02852694

    Reduce Risk for Crohn's Disease Patients

    Not yet reported PIBD-Net 192 participants Est. completion 2021-06-14 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02854787

    Intravenous Bolus of Phenylephrine vs. Norepinephrine in Preventing Hypotension After Spinal Anesthesia

    Not yet reported University Tunis El Manar 120 participants Est. completion 2016-12 1 site
    Other conditions: Anesthesia, Spinal and Epidural, Adverse Effect, Hypotension, Complications, Cesarean Section
    View official trial listing →
  • Completed NCT NCT02856789

    Determination of Fibrin Activity in Plasma on STA-R® Prototype

    Diagnostica Stago R&D 913 participants Est. completion 2020-03 1 site
    Other conditions: Blood Coagulation Disorders, Thrombotic Disorders, Hemorrhagic Disorders, Trauma
    View official trial listing →
  • Completed NCT NCT02857569

    A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma

    Not yet reported, Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 90 participants Est. completion 2022-05-20 1 site
    Other conditions: Stage III/IV Melanoma
    View official trial listing →
  • Completed NCT NCT02858648

    Diabetes Go Mobile! Pilot Study

    Not yet reported The University of Texas Health Science Center, Houston 26 participants Est. completion 2013-08 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02858804

    EDOCH Alternating With DHAP for New Diagnosed Younger MCL

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 55 participants Est. completion 2020-06 1 site
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02859090

    Study of the Expression of Heat Shock Proteins in Populations of B Lymphocytes in Human Tonsils

    Not yet reported Centre Hospitalier Universitaire Dijon 5 participants Est. completion 2014-11-20 1 site
    Other conditions: Tonsillectomy
    View official trial listing →
  • Completed NCT NCT02859324

    A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)

    Not yet reported, Not yet reported Celgene 21 participants Est. completion 2020-03-27 14 sites
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Status unknown NCT NCT02859376

    Analgesic Efficacy of Different Doses of Sucrose During Blood Sampling in Preterm Infants

    Not yet reported University Hospital Padova 144 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Status unknown NCT NCT02859532

    Study of Elastographic Properties of the Clot by Technical SWIRE (Shear Wave Induced Resonance Elastography)

    Not yet reported University Hospital, Grenoble 30 participants Est. completion 2019-02 1 site
    Other conditions: Deep Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT02860533

    iPhone App Compared to Standard Riva-Rocci (RR)-Measurement During Stress Testing

    Not yet reported University Hospital, Basel, Switzerland 220 participants Est. completion 2017-02-01 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT02860546

    A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

    Not yet reported Taiho Oncology, Inc. 18 participants Est. completion 2017-09-07 3 sites
    Other conditions: Refractory Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02860598

    Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy

    Hospices Civils de Lyon 104 participants Est. completion 2019-06 1 site
    Other conditions: Anemia, Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT02860975

    Prolonged Hypoxic Breathing in Healthy Volunteers: a Safety Study

    Not yet reported Massachusetts General Hospital 5 participants Est. completion 2019-04-05 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02861300

    CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer

    Not yet reported, Not yet reported David Bajor, MD 50 participants Est. completion 2023-01-10 2 sites Stand-alone
    Other conditions: Colorectal Cancer, Colon Cancer, Rectal Cancer, Solid Tumor
    View official trial listing →
  • Completed NCT NCT02862314

    PROcalcitonin Pneumonia / Pneumonitis Associated With ASPIration

    Not yet reported Centre Hospitalier Universitaire de Besancon 167 participants Est. completion 2019-11-28 1 site
    Other conditions: Inhalation Pneumonia
    View official trial listing →
  • Completed NCT NCT02862522

    Uric Acid Levels and Endothelial Functions

    Mayo Clinic 229 participants Est. completion 2016-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02862561

    Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

    Not yet reported, Not yet reported Shanghai International Medical Center 40 participants Est. completion 2018-07 1 site
    Other conditions: Precision Cell Immunotherapy, Chemotherapy, Advanced Malignancies
    View official trial listing →
  • Status unknown NCT NCT02863211

    The Assessment of Large and Small Artery Elasticity for the Early Detection of Cardiovascular Disease

    St. Boniface Hospital 1000 participants Est. completion 2022-02 1 site
    Cardiovascular disease Other conditions: Vascular Stiffness
    View official trial listing →
  • Terminated NCT NCT02863588

    Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis

    Not yet reported University Hospital, Strasbourg, France 16 participants Est. completion 2019-11-11 1 site
    Other conditions: Toxoplasmosis Infection, Genotype II, Ocular Toxoplasmosis With Recurrences
    View official trial listing →
  • Terminated NCT NCT02864316

    Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6 participants Est. completion 2018-09 1 site
    Other conditions: Solid Tumors Induced by Prior Radiation Exposure
    View official trial listing →
  • Completed NCT NCT02864563

    Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification

    Not yet reported Institut Curie 560 participants Est. completion 2023-07 27 sites Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT02864706

    SCHEDULE Follow Up Visit 5-7 yr

    Not yet reported Novartis Pharmaceuticals 95 participants Est. completion 2017-09-25 6 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT02866110

    Training of Neural Responding in BPD

    Not yet reported Central Institute of Mental Health, Mannheim 25 participants Est. completion 2018-07 1 site
    Other conditions: Borderline Personality Disorder
    View official trial listing →
  • Completed NCT NCT02866487

    Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor in Children With Asthma

    University of Virginia 72 participants Est. completion 2018-05-14 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02866669

    Southeastern Collaboration to Improve Blood Pressure Control

    Not yet reported University of Alabama at Birmingham 1592 participants Est. completion 2021-02-28 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02868645

    Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia

    Not yet reported Hospices Civils de Lyon 65 participants Est. completion 2018-04-10 1 site
    Other conditions: Bone Fibrous Dysplasia
    View official trial listing →
  • Status unknown NCT NCT02869048

    Amyotrophic Lateral Sclerosis and the Innate Immune System

    Rigshospitalet, Denmark 375 participants Est. completion 2026-06 8 sites
    Other conditions: Amyotrophic Lateral Sclerosis, Neurodegenerative Disease, Motor Neuron Disease
    View official trial listing →
  • Completed NCT NCT02869854

    Increased Physical Activity Through Mindfulness

    Not yet reported Region Skane 88 participants Est. completion 2018-12-18 1 site Stand-alone
    Other conditions: Physical Activity, Life Style, Mindfulness
    View official trial listing →
  • Completed NCT NCT02870010

    Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres

    Not yet reported Centre Hospitalier Universitaire Dijon 21 participants 1 site Stand-alone
    Other conditions: Localized Non-Resectable Adult Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02871362

    Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol

    Not yet reported InQpharm Group 54 participants Est. completion 2018-01-30 1 site
    Other conditions: Blood Pressure, Low Density Lipoprotein Cholesterol Level
    View official trial listing →
  • Status unknown NCT NCT02871869

    Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma

    Not yet reported, Not yet reported Xinjiang Medical University 316 participants Est. completion 2021-12 1 site
    Other conditions: Diffuse, Large B-Cell, Lymphoma
    View official trial listing →
  • Completed NCT NCT02871882

    Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

    Not yet reported Mayo Clinic 24 participants Est. completion 2017-10-30 1 site
    Type 2 diabetes Other conditions: Obese, Overweight
    View official trial listing →
  • Completed NCT NCT02872116

    Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

    Not yet reported Bristol-Myers Squibb 2031 participants Est. completion 2024-06-06 179 sites
    Other conditions: Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02872753

    Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy

    Not yet reported Istituto Ortopedico Rizzoli 90 participants Est. completion 2023-01-31 1 site
    Other conditions: Meniscectomy
    View official trial listing →
  • Completed NCT NCT02873195

    Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

    Not yet reported Academic and Community Cancer Research United 133 participants Est. completion 2023-12-01 10 sites
    Other conditions: Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT02875652

    Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)

    Not yet reported Institut Curie 800 participants Est. completion 2019-04-02 1 site
    Other conditions: Choroidal Melanoma
    View official trial listing →
  • Completed NCT NCT02876367

    The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents

    University of Oxford 1200 participants Est. completion 2018-12-31
    Other conditions: Scrub Typhus
    View official trial listing →
  • Completed NCT NCT02877654

    Is There Any Correlation Between Plasmatic Zonulin and Expression of Intestinal Tight Junction Proteins in IBS Patients?

    Not yet reported University Hospital, Rouen 67 participants Est. completion 2021-05-20 1 site
    Other conditions: Irritable Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT02878460

    ORI2 : ORI for hyperOxia Reduction in ICU

    Not yet reported University Hospital, Angers 150 participants Est. completion 2018-05-22 1 site
    Other conditions: Intensive Care Units
    View official trial listing →
  • Status unknown NCT NCT02879838

    Occupational Respiratory Allergies and Gene-environment Interactions

    Central Hospital, Nancy, France 400 participants Est. completion 2020-09 12 sites
    Other conditions: Work Related Asthma
    View official trial listing →
  • Completed NCT NCT02880020

    Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery

    Not yet reported Jonsson Comprehensive Cancer Center 36 participants Est. completion 2022-08-09 1 site
    Other conditions: Gastrointestinal Stromal Tumor
    View official trial listing →
  • Status unknown NCT NCT02881333

    Various Type of Genetic Events in Patients With Intellectual Disability

    University Hospital, Strasbourg, France 30 participants Est. completion 2017-12
    Other conditions: Intellectual Disability
    View official trial listing →
  • Completed NCT NCT02882386

    Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements

    Not yet reported Norwegian School of Sport Sciences 13 participants Est. completion 2013-02
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT02883192

    The Effect of Preventive Use of Ondansetron in the Cesarean Section Under Spinal Anesthesia

    Not yet reported Bnai Zion Medical Center 100 participants Est. completion 2016-12 1 site
    Other conditions: Adverse Anesthesia Outcome
    View official trial listing →
  • Status unknown NCT NCT02883231

    Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance

    Chun Pan 60 participants Est. completion 2017-03 1 site
    Other conditions: Evaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.
    View official trial listing →
  • Completed NCT NCT02883894

    Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid

    CHU de Reims 120 participants Est. completion 2014-04 1 site
    Other conditions: Bullous Pemphigoid
    View official trial listing →
  • Terminated NCT NCT02887118

    Dense Red Blood Cells in Sickle Cell Children

    Centre Hospitalier Intercommunal Creteil 82 participants Est. completion 2019-07-07 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02887599

    Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities

    Not yet reported Yonsei University 203 participants Est. completion 2017-12-20 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT02887755

    Assessing the Feasibility of a Novel Non-Invasive Sensor for Guiding Wounded Warrior Rehabilitation

    Not yet reported Henry M. Jackson Foundation for the Advancement of Military Medicine 20 participants Est. completion 2017-10 1 site
    Other conditions: Rehabilitation Post-amputation
    View official trial listing →
  • Status unknown NCT NCT02888223

    Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

    Not yet reported Sinocelltech Ltd. 16 participants Est. completion 2017-07 1 site
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT02888431

    Correlation of Arterial and Venous Lactate and Base Deficit Values

    Joseph D. Tobias 50 participants Est. completion 2016-12 1 site
    Other conditions: Arterial Access, Peripheral Access, Central Venous Catheter
    View official trial listing →
  • Completed NCT NCT02888886

    Role of Systemic Inflammation in Increase of Cardio-vascular Risk in Chronic Obstructive Pulmonary Disease

    Not yet reported Central Hospital, Nancy, France 89 participants Est. completion 2015-11
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02889458

    Hong Kong Breast Cancer Study

    The University of Hong Kong 7000 participants Est. completion 2028-12 21 sites
    Other conditions: Breast Cancer, Ductal Carcinoma In Situ
    View official trial listing →
  • Completed NCT NCT02891174

    The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy

    Not yet reported University of Michigan 74 participants Est. completion 2018-06-20 1 site
    Other conditions: Hypertension, Pregnancy-Induced, Pre-eclampsia
    View official trial listing →
  • Terminated NCT NCT02892682

    The Role of the Coagulation Pathways in Recurrent Angioedema

    Not yet reported University Hospital, Montpellier 96 participants Est. completion 2023-05-10 1 site
    Other conditions: Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency
    View official trial listing →
  • Terminated NCT NCT02892734

    Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer

    Not yet reported Northwestern University 3 participants Est. completion 2019-02-04 1 site
    Other conditions: HER2/Neu Negative, Recurrent Inflammatory Breast Carcinoma, Stage IV Breast Cancer, Stage IV Inflammatory Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02894138

    Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study

    Not yet reported Vastra Gotaland Region 80 participants Est. completion 2022-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02894827

    The Effect of When Medication is Taken on Nutritional Status in Hospitalized Patients Older Than 65 Years

    Centre Hospitalier Universitaire Dijon 30 participants 1 site
    Other conditions: Nutritional Status
    View official trial listing →
  • Status unknown NCT NCT02895412

    Infection and Tumour Antigen Cellular Therapy

    Not yet reported University of Sydney 20 participants Est. completion 2020-12 1 site
    Other conditions: Leukemia, Myelocytic, Acute
    View official trial listing →
  • Status unknown NCT NCT02895724

    Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial

    Not yet reported Danish Cancer Society 20 participants Est. completion 2018-12
    Other conditions: Secondary Lymphedema
    View official trial listing →
  • Terminated NCT NCT02897115

    A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment

    Not yet reported AbbVie 22 participants Est. completion 2017-12-21
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Status unknown NCT NCT02897921

    Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy (CICS)

    Copenhagen University Hospital, Rigshospitalet 240 participants Est. completion 2021-08 1 site
    Other conditions: Recessive Gene Myopathies
    View official trial listing →
  • Completed NCT NCT02898402

    Study on Seroprevalence and Risk Factors of Coxiella Burnetii (Q Fever) in the South of Reunion Island

    Centre Hospitalier Universitaire de la Réunion 3500 participants Est. completion 2015-01
    Other conditions: q Fever
    View official trial listing →
  • Completed NCT NCT02899039

    Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease

    Not yet reported Assistance Publique Hopitaux De Marseille 75 participants Est. completion 2016-05-07 1 site
    Other conditions: IgG4-related Disease
    View official trial listing →
  • Status unknown NCT NCT02899624

    Whole Exome Sequencing in Bicuspid Aortic Valve Patients

    Not yet reported Assistance Publique Hopitaux De Marseille 427 participants Est. completion 2018-01 1 site
    Other conditions: Bicuspid Aortic Valve
    View official trial listing →
  • Completed NCT NCT02900469

    Presurgical Trial of Denosumab in Breast Cancer

    Not yet reported NYU Langone Health 44 participants Est. completion 2020-01-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02900976

    Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

    Not yet reported Children's Oncology Group 18 participants Est. completion 2025-12-31 38 sites
    Other conditions: EBV-Related Post-Transplant Lymphoproliferative Disorder, Monomorphic Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder, Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder, Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder, Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder, Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT02901977

    Doxazosin and Ramipril in Hypertension

    Not yet reported Karolinska Institutet 71 participants Est. completion 2015-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02902393

    Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke

    University Hospital, Caen 64 participants Est. completion 2018-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02902588

    Blood-brain Barrier Permeability Study in Adults With Meningitis

    Not yet reported Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences 20 participants Est. completion 2018-01-31 1 site
    Other conditions: Blood-Brain Barrier Permeability
    View official trial listing →
  • Status unknown NCT NCT02902848

    Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow

    University Hospital, Brest 30 participants 1 site
    Other conditions: Haemodialysis
    View official trial listing →
  • Completed NCT NCT02903381

    A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma

    Not yet reported Dana-Farber Cancer Institute 8 participants Est. completion 2021-09-16 1 site
    Other conditions: Smoldering Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02905175

    Rheumatoid Arthritis Patients and Porphyromonas Gingivalis

    Centre Hospitalier Universitaire de Saint Etienne 11 participants Est. completion 2016-06-27 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02905266

    A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma

    Not yet reported Bristol-Myers Squibb 106 participants Est. completion 2019-10-25 16 sites
    Other conditions: Melanoma
    View official trial listing →
  • Terminated NCT NCT02905981

    Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol

    Not yet reported Rockwell Medical Technologies, Inc. 1 participants Est. completion 2018-03-15
    Other conditions: Iron-Refractory Iron-Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT02909023

    Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured

    Hospices Civils de Lyon 34 participants Est. completion 2016-11 1 site
    Other conditions: Hepatitis B
    View official trial listing →
  • Terminated NCT NCT02909504

    Gao NARASD Lithium Study

    Not yet reported Keming Gao 24 participants Est. completion 2018-11 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02909712

    Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania

    Not yet reported London School of Hygiene and Tropical Medicine 201 participants Est. completion 2020-02 1 site
    Other conditions: Malaria, Pregnancy Malaria, Cardiotoxicity, Cardiac Safety, Parasitemia
    View official trial listing →
  • Completed NCT NCT02911415

    Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi

    Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60 participants Est. completion 2017-12-25 1 site
    Other conditions: Ebola Hemorrhagic Fever
    View official trial listing →
  • Completed NCT NCT02911831

    IV Tranexamic Acid Prior to Hysterectomy

    Not yet reported Northwestern University 71 participants Est. completion 2022-04 1 site
    Other conditions: Hysterectomy, Blood Loss, Surgical
    View official trial listing →
  • Completed NCT NCT02915159

    A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

    Not yet reported Bristol-Myers Squibb 250 participants Est. completion 2019-07-23 71 sites
    Other conditions: Sjogrens Disease
    View official trial listing →
  • Completed NCT NCT02915718

    A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 7 participants Est. completion 2023-02 1 site
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT02915861

    Eschar Investigations in Scrub Typhus

    University of Oxford 44 participants Est. completion 2021-05-31 1 site
    Other conditions: Scrub Typhus
    View official trial listing →
  • Completed NCT NCT02916563

    Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study

    Not yet reported LabStyle Innovations Ltd. 50 participants Est. completion 2016-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02916732

    Zika Virus Infection's Pregnancy Consequences in French Department of America

    Institut National de la Santé Et de la Recherche Médicale, France 26980 participants Est. completion 2019-02 4 sites
    Other conditions: Incidence of ZIKV Infection on Fetus During the Pregnancy
    View official trial listing →
  • Status unknown NCT NCT02916992

    Prevalence of Spontaneous Pneumothorax in BHD

    Not yet reported Hans Smit 200 participants Est. completion 2017-07 1 site
    Other conditions: Spontaneous Pneumothorax
    View official trial listing →
  • Completed NCT NCT02917213

    Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction

    Hospital General Universitario Gregorio Marañon 92 participants Est. completion 2022-01-01 1 site
    Cardiovascular disease Other conditions: Acute Disease, Thrombosis, Heart Diseases
    View official trial listing →
  • Status unknown NCT NCT02918123

    Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

    Not yet reported Kang Stem Biotech Co., Ltd. 9 participants Est. completion 2021-12 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02918448

    Resistance Training and Metabolic Syndrome

    Not yet reported Universidade Estadual de Londrina 53 participants Est. completion 2016-03
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02919800

    A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

    Not yet reported OPKO Health, Inc. 32 participants Est. completion 2018-02-21 1 site
    Other conditions: Hemophilia A or B With Inhibitors
    View official trial listing →
  • Terminated NCT NCT02920437

    A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong

    Not yet reported The University of Hong Kong 19 participants Est. completion 2017-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02921178

    Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients

    Ajou University School of Medicine 124 participants Est. completion 2017-09
    Other conditions: Asthma
    View official trial listing →
  • Withdrawn NCT NCT02921373

    Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

    Not yet reported Gregory A. Dekaban Est. completion 2022-12 1 site Stand-alone
    Other conditions: Adverse Reaction to Diagnostic Agents and Kits Nos
    View official trial listing →
  • Completed NCT NCT02922231

    Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea

    Baxalta now part of Shire 57 participants Est. completion 2019-04-04 5 sites
    Other conditions: Hemophilia B
    View official trial listing →
  • Completed NCT NCT02922478

    Role of Comorbidities in Chronic Heart Failure Study

    Medical University of Graz 205 participants Est. completion 2018-12-20 1 site
    Heart failure Other conditions: Comorbidity, Osteoporosis, Pulse Wave Analysis, Blood Pressure Monitoring, Ambulatory, Osteoporotic Fractures
    View official trial listing →
  • Completed NCT NCT02924792

    Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis

    Haukeland University Hospital 30 participants Est. completion 2017-12-05 1 site
    Other conditions: Hypovolemic Shock, Hemorrhagic Shock
    View official trial listing →
  • Completed NCT NCT02924896

    Effect of Palm Olein Intake on Lipid Profile and Appetite Regulation

    Not yet reported Imperial College London 12 participants Est. completion 2017-04 1 site
    Other conditions: Lipidaemia
    View official trial listing →
  • Completed NCT NCT02925013

    Maternal Dietary Lipids and Omega 3 Essential Fatty Acids Profile in Pregnant Women at Term and Their Fetuses

    Not yet reported Sheba Medical Center 20 participants Est. completion 2021-10-30 1 site
    Other conditions: Lipid Profile in Pregnancy
    View official trial listing →
  • Completed NCT NCT02926131

    A Study to Evaluate a New Jaundice Stick Test

    University of Oxford 180 participants Est. completion 2017-12-11 1 site
    Other conditions: Jaundice, Serum Bilirubin
    View official trial listing →
  • Completed NCT NCT02928705

    Quality of Telemedically Guided Prehospital Analgesia

    RWTH Aachen Universi